<SEC-DOCUMENT>0000886163-22-000135.txt : 20221108
<SEC-HEADER>0000886163-22-000135.hdr.sgml : 20221108
<ACCEPTANCE-DATETIME>20221108160323
ACCESSION NUMBER:		0000886163-22-000135
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		66
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221108
DATE AS OF CHANGE:		20221108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		221368793

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lgnd-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:7b2ea99b-5e75-4f19-8ddb-22eedf3c9f68,g:96c50209-ed52-4eb8-96bc-4f2a516dad9f,d:2959cf3610a04d8385d1c4c227b59df4--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:lgnd="http://www.ligand.com/20220930" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80L2ZyYWc6OGI0N2E2MTNlZGM0NDk3MTk0NzQwZTUwMzNjNWMzNGMvdGFibGU6NGQ5MjM0ZmY2MmYzNDFmNThjMDZlNDU4ZDZkY2YzNDgvdGFibGVyYW5nZTo0ZDkyMzRmZjYyZjM0MWY1OGMwNmU0NThkNmRjZjM0OF8yLTEtMS0xLTk1MTE3_6fdeb374-414d-4749-a365-de675ba2b56e">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80L2ZyYWc6OGI0N2E2MTNlZGM0NDk3MTk0NzQwZTUwMzNjNWMzNGMvdGFibGU6NGQ5MjM0ZmY2MmYzNDFmNThjMDZlNDU4ZDZkY2YzNDgvdGFibGVyYW5nZTo0ZDkyMzRmZjYyZjM0MWY1OGMwNmU0NThkNmRjZjM0OF8zLTEtMS0xLTk1MTE3_2d0ded2f-951e-4a96-9b8d-a789ce1e0c92">2022</ix:nonNumeric><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80L2ZyYWc6OGI0N2E2MTNlZGM0NDk3MTk0NzQwZTUwMzNjNWMzNGMvdGFibGU6NGQ5MjM0ZmY2MmYzNDFmNThjMDZlNDU4ZDZkY2YzNDgvdGFibGVyYW5nZTo0ZDkyMzRmZjYyZjM0MWY1OGMwNmU0NThkNmRjZjM0OF80LTEtMS0xLTk1MTE3_a2dcd007-ac3b-4192-b4f8-210fda46da3f">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80L2ZyYWc6OGI0N2E2MTNlZGM0NDk3MTk0NzQwZTUwMzNjNWMzNGMvdGFibGU6NGQ5MjM0ZmY2MmYzNDFmNThjMDZlNDU4ZDZkY2YzNDgvdGFibGVyYW5nZTo0ZDkyMzRmZjYyZjM0MWY1OGMwNmU0NThkNmRjZjM0OF81LTEtMS0xLTk1MTE3_bbe4afae-a7ae-43e1-a78d-f684c3f480ec">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80L2ZyYWc6OGI0N2E2MTNlZGM0NDk3MTk0NzQwZTUwMzNjNWMzNGMvdGFibGU6NGQ5MjM0ZmY2MmYzNDFmNThjMDZlNDU4ZDZkY2YzNDgvdGFibGVyYW5nZTo0ZDkyMzRmZjYyZjM0MWY1OGMwNmU0NThkNmRjZjM0OF82LTEtMS0xLTk1MTE3_41001cf4-518b-4bda-8992-0af5d6cd5eb1">December 31</ix:nonNumeric><ix:nonNumeric contextRef="ice5667b832bb46b58768234cec087173_D20210101-20211231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMy0wLTEtMS05NTExNw_87af1313-893c-4dbd-91d6-8d725b48f5eb">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i4e2b8f073bbb4eeea44fc317eeee6bed_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80Ni9mcmFnOmJjOGUyNDhmNTc3MDQwZDFiZGY1MzBhNjVmMGJlMTRjL3RhYmxlOjFmZTczZWY1NWUzNjRjZWQ4MGY1ZTk1MmFjNDdhODkwL3RhYmxlcmFuZ2U6MWZlNzNlZjU1ZTM2NGNlZDgwZjVlOTUyYWM0N2E4OTBfMi0xLTEtMS05NTExNw_a4b1b29c-2187-404e-b868-788262e5723a">0.0040244</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i2bca3710f8284248a5ce78b298651b77_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80Ni9mcmFnOmJjOGUyNDhmNTc3MDQwZDFiZGY1MzBhNjVmMGJlMTRjL3RhYmxlOjFmZTczZWY1NWUzNjRjZWQ4MGY1ZTk1MmFjNDdhODkwL3RhYmxlcmFuZ2U6MWZlNzNlZjU1ZTM2NGNlZDgwZjVlOTUyYWM0N2E4OTBfNC0xLTEtMS05NTExNw_09790baf-4d72-4f40-937e-74592081e1fe">0.0052317</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5d1d407380348e2a118f44535f6a4f9_I20221104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i7ed21a608d174035a9614928545bff44_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="id713d77cfce844c9acd459debe60471f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i1e4c019116374680b437a7a7e84a8c80_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe9d446b7d574e0a8a446713e4e31f27_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6dd34ce0bee40ea82cba5bfc9584a46_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61be445c11db419296ccc53f473da154_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27111ff24358446e8f6742f1a9a22280_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i805b7ce49b9b477ab1a86dfcd8f4b896_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbc5e665d17d410bbc8f43e5ef950091_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68593efff0be4bcea82e054922dea281_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c883799387843e28ad63ef5c7a3a928_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idca791879e154b79899726f73ac30955_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb48e049cd074424a4b9c75318b0968f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d5bd9d373e34f7ab0ab2dc3b00f0266_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icad679edea5848ca92af3def315765fa_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i198ab94a85514554b7b186297e1b40e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie753396ec7e54b7284e025b438c69c9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90959b048f9d4c9c901d541f37dd4d04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i009cac1d5b03430ea00be4a216999d58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice5667b832bb46b58768234cec087173_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16919bc133394068b70b5dfa72c1fd0e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d2ed7a3614b47c58739fe3a78c8cf50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i239ddea2c7ce41f184f6267304338e4d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7464adf27f3344eaa673a32517540e7c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27cf2b1876194c95b8039376914f66a9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d3fdee71cb945188b3a6480ad8b04b3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90c76c0d56474350ace13a08c8b6be7d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i622a51922d024361bd6340d3356b0611_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc60f1d7e4e64d4da82bc5998ca4409e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3d7b66aebc7403188ff43b263cbde5a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55d2a92d4b1a4569aa0e26eff50b27e1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bd3552261654e0aa2a6e538a4ffd6e0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe1aea5f82664c3d8279c4521c119e7f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i185279a9c1154a6e970cdd3102fb2523_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81a5d969d3cd49018e396c6da4322e1d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19361f68c02f4b6fa38af8257cd7aa3b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib18e9df5868e4c7d9ffa15a018c90a12_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c3698d638594c138f050c501a4bb5bb_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i589ed826afd94e66ac256c87c067d171_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09ea69ed13a2487cb2c216e37f4468a5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc472676953e452a9218d48cdabcd4c9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcc63139d2274ceab9cf48bff4553b66_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5baea90deb8e4265a72ea7026d08379c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b75eb328f4e4243b3e4fdb1e688d35c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i757ee12a916e4b45a2fd76ec35d70c95_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if291edfa693f417bbbb3aaa623e73077_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a6c4eeaf5ad4e0e94b7a1e461895686_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf5089a880dd4f0c91f39d957943a6d0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i302273f452f341388964a61d9618c5ea_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa9e8c41a8d6418a8b594ee335f4c15e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a1087670b3d4e64b4a3354392f53abe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49019251c3644c1b9be5cc7120c8645b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a0567a5633346ecad7f4de1f16113d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5f7904b282b4637855d57757935605b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0608bba36d7e4f2cb5bd38b7d5fa45af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5823b83aff4246d783748aff6ba9b978_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4787c5b04654433aa93a05790c5bb00_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4de83da8ed6348dca0fb66d4c2b5ba46_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i621f76587b9b4167af8ab0cce3f06136_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45854ed7c1894c938845c943e8170bfa_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide4e95b565954f94bdabad5e12ec376c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2163920057fd4ca4898a01c500e82a08_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72687d1596d4483c86609fb362747b63_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaa6a14b6ffd4636950c8681f0e560a1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e93447e0b6144f2a48981aa605997ad_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1dce0e52afa44c69b20605abe6e40de_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ed614688b574fd0983b2980c43392fe_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15b4a7ad28414e03b02122a320252e75_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15167ff194f5408e9eff810879dae577_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88faad5b2d5040e48a57bdd7eae38a44_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe07e2903f194de88402b53dfd03c119_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb0fba93854d45b3a71f274d86a0b25c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib19b40a6687a4043b9c5f217b53cee1f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06b5f93e548a4212a89cf839a5f62b6d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d0cddc5d84e4d48b281640914f3c31a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f39828b4f0d4d30b1bbb778bcb4cb81_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6902f9b70949440389390267fac2a002_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id04346533cc6453daf6686d7ecd0494a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9bd6db87aa44bcdb4346428bc52f796_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b8e47316474452ea41d7654cf4c47aa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac1e1e884548420e9f7f74cb53177b5c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c99db1599d84940b69a2da1fe5207cc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fd7205f82a3406b9f0c0dae4653b877_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3f7ea577fbe4425b5634e5fec8b8b74_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc3e336e701549d0a038218263d74105_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32fea61e3e6a4354bd7504b5be38cea3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5fe64e3bfa140528971aaeae19072a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35e1f2ef2453421db235d4f5debc1ea8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibefdd74dcbb544c7bcd50c4bdc0ea3b1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic183fe3cfc0444ec988c0505dc4aac87_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0662d167252447899eb4741ca4b7d49_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7cd2d0377724f898a6c11769e623b6b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id67bfd452ca34efbabd006d69f7f34b4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47ac025acf224b88b1f6e6ddd566bd90_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb81ed13c9ff4a1e8c098b5fdd85fce8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e3e7744f301495cb31d4020806e39e6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib36bf83f8a274b0a9bf13b0e4652e822_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i827c7e6cdeac4886b9ec06b6f65e8455_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2247afa58cf4d3995002065e43ff1c7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1971a4278a1432a897cda6cc91f0897_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7253785dc35146fc8241d38b8d7cc8bd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia48707413feb4dbab9c2496e3c59a6a0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a7b8932fa4845759b4d1dd6a1d7a232_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id95bfc92bd274c84aa1a9a7994070620_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i055d53a99e864487af223e1ee40ef3de_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i289f60c3b5684e97b642fc712cb0729d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aca03e88f7c4ef7afd5a15c43b2a58b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia87b96b5149b41818034e32448024dfb_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2eac10c65b1641ffa06188a690f2aca9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba465a7198d54ee7b6ad82d779858fd9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a5fa29dc2e848a7b2ac184d57a87bc3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i904cf14c4b3e4fbeb3f577b716e29d42_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib22143b247d14e49b1f87a41cebc0533_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0411fb172a764e2e92a29821f037280d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78881cd8932b4b9093df9eaafe0b57dc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6c61f74a4ae46dfa6cd20104936b527_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i588e8adf3218428d9d65e76ec58ffcb2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia44ee73068f14175b5fd0992341adbfb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57d398f1cb1742cc900354e71b1ecc8b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieedc3bed7980424b96288a7a097ef23f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b25204e1c1e45449277f115819b751e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9683e5a36df8493692166626aea2d25e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b3ad9c76fcb49c091bef77b6c7f4ab3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9ac29ea1484471db0a5f3a8814367c8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0a1285ff321448588acc1bf40c5d032_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7911ef49fdd142e7b67a65d73023df8c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a70bf5a0b90462f88245ce9197a2e96_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i123c75669efe43bd9dc15885da57a867_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c920df29ac544cd8c6902919042761f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7c767ef41d54b72a2eec06f317f26a3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e6619944924d099ebf2550f8a566da_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc2a7c797d8541648d78aca099e523a0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id269671958804d059d42ec1bf2798d24_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i350e5ed791be46a4b5d11307ffa4cb26_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i662334cf40d54566bec6fe57077ce69e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06f8d4ffb4a142d89bec0b51469e199e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie20dcecc9b97461eb7567478745a495f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabc8605b5b5b4402bfa40c6f86cc4521_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic07a20125b6b4a8ebfc0faae2187f7dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i317970eca87540b8b1481240b27a7411_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida31cd3b48ce4d1e9d75b4ab666e503d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifba74fb91aff4709a648d885a295772a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeb3f202176743cfbfef35c2aa9a206a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd672b4aeff947f2be4d57e9a811d2b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20e1b9d42dae41b3b8d258ee144a3142_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice501f8f87084c9b8479455e8bbbc32d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>lgnd:position</xbrli:measure></xbrli:unit><xbrli:context id="i1f2f5a4645194ff8ac4a43834225e441_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51243c6c92784f7f9b969f7ff8364956_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie89e441071a94390acf735662b9d84ca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i879eebb5a7c3459ebc5f9e1980194ee7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i949f68cec8414dfb8cf22d6f87aad59c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d4422300f314cb5b2c8b76da9076612_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65e7975e74c64f75b300ebf474efc3d0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdfc802ffcea4059bb816a071f7ed3b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5860738973c46b7b442c1e31a1fa1b4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8078205bd5974127a86e504b140fa260_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>lgnd:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="i365d6d6bcee9448fa1c6ab3aa3d86e82_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1caa4c3cd5f4732bfdc25dc6f6a9796_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b95b921442e4621abaf805c9c6698fa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c69d20029b545489f7ca2234d28aaa8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73f41ef6652948d1841b05a5469daf7f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cf12e3a53a14d8eb42d4b89b7cf304d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie85097cc30914531bce5696bfe9a1638_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ebb3d8dffba494eaf509dc473ba5887_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i321200c90e1841ba98e56d96bd03dca8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19b98503fe3c47908678fecb01ff99d3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1920d37ac7d74b39bb53487c74e6eddb_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b02440b88c044d992035080107197f1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62640c7e221d4ddf9f77e8cd49490c14_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad2aaa41970748678e953d111259e623_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3e5382a24354732b90a0c8d7480439c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic86919d9459445b0acb504ef008126cb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f173828d5bf43d3b40f98cfda636157_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09fce991826e4593a4adb710b13eee0f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id162adfcca81460486101e12b3597e00_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bd82be627144b3482c05a70e537330b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c042b2ebf24feb89d24e634e666d27_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1f728b109204a9a83575e9f16df629b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31dbf3fbde084ff3a4e51995b5baa515_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7842cd71eeab430eb6922c6dc245b80a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55c5ee22089f41b58b21043995b5b0e3_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ba11ede5ca045f4b14d3ba0dd1568fe_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i538684284d804c57bd3f118d72db7cbe_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i766939c97c5b40dcb5b38a79e41a958f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8da6cb831ae14f8089f18a5b3789e9dc_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f27bc960546423584fb5e22d31ba050_D20220101-20220322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>lgnd:segment</xbrli:measure></xbrli:unit><xbrli:context id="i3c65682d715d4cebb23f79ad72073530_D20220323-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-23</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icba71108b7bb484f90495bc743d1cd62_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04151a540d6044408f287f42f0f848e3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65de87043a1e4dcab7411f098886c292_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ad307c061f3441f89ff5551bae95b94_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ac758bbffaf4b33b4bb7b96b8713d1a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfef621791484893826f75aa4da8f7d4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if060aacdc039409386f29263ea0888fe_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia34a4d36cd974f88abc36f50a6cc10c1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i515e60d0096f49b39df04bcd1c448073_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7806df4e0ca341bd947ac07ff78832bc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5584e6c9205484792148da209de79e0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibac68a1cdeb3437cb24a409ec62e7ae0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib56bece7e0da4f168b25d26c3a937bb8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30ae2842116c43ec9c4d10f553fb44c8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cd956644674461e94c0667f968d8a8d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a249f2388aa45ae9e1b4da3725d791b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabe4ebeb2dcf415199c31a3fe43b9779_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib76e0a2f4e02403e90689f0872ff43ca_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71032e6cf99a4220b3ab9bdf9e1ce780_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb79cf209f1748b7aa2267af51ea59d2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfd0f8876888448aad7af0288accc346_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3796b96c0d94c1da6299853875dac7c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if22d059e053745febd4c8b88a8df2cd8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if30ec34df7ed4597981dae2bffa04dc6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2883789af81b412eaa37f1ebac40224b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0f10944b87f4bb2b93e8fac9eac402f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf8fec3725d042efad094010d20f1c66_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93b00d99d3c34bc685177724979b4ff9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bd2cbdef5c44f8fac9ee6db6ad8fc64_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib57783a54b7b44d0bfe7bfb7bd595b4f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4699144a009d4236a7a7d3ba4f5a71b6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i921e73649a7a4b69a8ed14e11dab4870_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9545ef6cc9054eaba5733eede4f83b2e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id45baf2e1b7e452fa0ab3dee1b630a5e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb9c3ea5d1f94844bc6846f65c475bf2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia44e8d68d457441f87d096b99b424cf9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf43f3e6122f485d9604b85bdf24ca9a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i409fb78206fa48e885e9a25ffed9be5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02baf2e63f634118acc0b5cecd635f91_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea813cc62405437f966419cf2bf8c12d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f66174ae3354eb19f957fd4f8e8990f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e5a64e988a14bc3acc1c82b5a5bc74d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c4985c47c384c0b9b0ab0008644e5a3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if45e52f2a26442e8b69b942641647814_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i006d5206c32b4ffa8c5bf11c4c32263d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eb2b3352eca4a009a173f9f0a39cc12_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29ad1d75d22a4e3f98195a322aa7aadc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82abec3a44c5436095d8c4e9189adff4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68afa5ce123e446ea968ab4615153660_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c76ceca320043319a729e346c30af96_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32d528942e7f4eec9ed16811189f131e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia70b1f37b5444463a665afeeb29fee23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d63d2ebe7124c6c92192fbb621ceb55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa6c7430ceed408ea0129815282f022b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c4aa673a44a49ba91b41ff1867085ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aa4c6644f944c0691c442c1da40ed28_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0e423a6748f4ef5bf5198b8c0ddff62_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c75467deb3e4ddab92d1873ad3c9a15_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a46d7016abc41c5a9d9d807b0e437fc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia76e9fffc6114de8a391f206f62e3b3b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4d765504d314a2aa80653e6e6cf32d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4fa076f03644041966c14890e83f8e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i374aa010c5c546cd97bd8012be328ef2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i417f205a3d994398aa39d14f0aeb46d2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id95d5b3a71314067be9a4acc1f0dec9d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i558cfad5a49e4d288fcb31a70e3d0423_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b8eba0c2f244c68897f2c465f695cb4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cb0b263e3124cc9a0aca9d63fe8c3a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i177d784a77a54241a81da1f857fb9dce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1658e372295b494fa6a5129e877086f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5196ee4cc484b1a8f52931d60ad16ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3ac0c4007a846e08014e8ab0f432750_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b43473351914f1a86d1acd39584c6c2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67aecd998ffc4380be51824531348e09_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebb7edd5169d406595ad57436f4ba57d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a6c5227f1ae46e7a867099dc194d21d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e226666ee01416ea4437da7b90c7394_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8807f0f1743448e897e2affdf0d534b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82de593bdc9e4da984cd72ffbd180620_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e4dff2f452e42e5b71d10fe5e7de15c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i735aa43de0d8473b978acefb4731c01e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88db7dab6b7a424a8ab88ea1d64e42ee_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ee4885695b241d9affa4f86640bf9aa_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e74edc9a24a4d4aba01db56acc201d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a71ba97a53b4cc0889174ac02780ee4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic942e4443ee741a5b559256a2d777257_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32d71f9ce3064ebfae407232f08153f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea631c13053d4cb9a6c3ec25bbe89909_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right"><xbrli:measure>lgnd:contingent_value_right</xbrli:measure></xbrli:unit><xbrli:context id="ia610e91d108b4828b2e383faf35f060c_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58dbd9eaa0a046348cb63f5bc71bc4e8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ae80f0d98ee484383b7285db27e3bf8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dfa24a16ddb4468b3057a86ea1992f8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286c91cbf234442b92d18be9042ac0d1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a563f07df03433d9f3b406175fa5e0d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52253af912264b92a50089624acefcd3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b2e23fc4a3943ad849d871cbc73bb3d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae8e9c1682aa4055a75677062d0d3067_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28ca9f03e482413a80f84d8327155d06_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia13f08ef2fec488aa3e23297a819a673_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf669638100c407a84acc68049e05107_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib34d5ea9024943dab91936ef12ad4821_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i853e09d80a6a46aabdbe6bf00b059c13_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic581556cc99e423a81de86ed53ca8b39_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e2b8f073bbb4eeea44fc317eeee6bed_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i238c5b93b270426ea69664bad2955dba_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18ad0006f29c4e3782c1405fa1ec6c0f_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="ifd2de700e7ee4f82b95550662f3e922e_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91d13b37a564e829094c6726d7a24e2_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief8861b3c3714c46851e7e25c053e239_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i187ac97ada164f7f8fe99815499cf29b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">lgnd:NotesRepurchasedDuringCurrentPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d9a25c6c2143cfb4d8e1a7ebe0d185_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="option"><xbrli:measure>lgnd:option</xbrli:measure></xbrli:unit><xbrli:context id="ib75f8705715d4191a83e17e50b6d144f_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">lgnd:NotesRepurchasedDuringCurrentPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22017c391fb94339803ce6d3d455c551_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe725b5fc54141e2b22eb8fcd4b19e03_D20220801-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bca3710f8284248a5ce78b298651b77_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c3c0791990421eab75d178e60313f8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87ba2111bb0e419c9909cb001f40f3f1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2834ca94385d4db2aacdb319acd70cba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27be544b5f9b4843871454a4846e31e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6abb45e394d9463b85d36c87fa45855a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd55699f74a443efb3dad3f864d69f0d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa972f2a8689410b8773aec2b27958d0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d8fd471caf841f7ac94f8e517939089_I20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b41dd4334ec4f4f8a4cfe7c0d306776_D20190911-20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-11</xbrli:startDate><xbrli:endDate>2019-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9961ee71da6d43899ffda6ea8268a9b4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lgnd:AtTheMarketEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f4e7138c0694ae2ae0c918afaf6d867_D20191031-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-31</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="civil_complaint"><xbrli:measure>lgnd:civil_complaint</xbrli:measure></xbrli:unit><xbrli:context id="ifa102a08d9284fa6b57fb76fdcab4852_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae84b3f2dac8479f98e3fbba153cb912_I20221026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">lgnd:OmniAbMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-26</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2959cf3610a04d8385d1c4c227b59df4_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18xNzI_f9509345-fc32-4161-be1c-94b94413c066">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6YjJiNDZhZmQ4OWQzNDVmNmI0MjkwZDNkMzFiNWRhZWIvdGFibGVyYW5nZTpiMmI0NmFmZDg5ZDM0NWY2YjQyOTBkM2QzMWI1ZGFlYl8wLTAtMS0xLTk1MTE3_4cd77abb-361f-496d-9a35-b2cd29e42caf">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yOTY_a24c97c2-fd57-4c32-a8b6-43c899a663ff">September&#160;30, 2022</ix:nonNumeric>  </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6NTdjMmMyYmEzYTRlNDgzOWExZWFhNjFhNjUwMTM2ODMvdGFibGVyYW5nZTo1N2MyYzJiYTNhNGU0ODM5YTFlYWE2MWE2NTAxMzY4M18wLTAtMS0xLTk1MTE3_f6787764-686f-48b1-bf59-8265233c3351">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the Transition Period From ______ to ______ .     </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTg4_c502d927-285a-41ec-b5c2-8898b93dd718">001-33093</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><img src="lgnd-20220930_g1.jpg" alt="lgnd-20220930_g1.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18zOTg_a2a54974-3791-400c-a61f-700bb94a321e">LIGAND PHARMACEUTICALS INCORPORATED</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:39.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml8wLTAtMS0xLTk1MTE3_bee7864e-c944-4bd3-9b1d-a6a619925e8f">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml8wLTEtMS0xLTk1MTE3_e98be418-6d21-483e-9c57-6758da1719f2">77-0160744</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml8zLTAtMS0xLTk1MTE3_3927e33e-9bb9-4ca9-aecb-12cad8b73223">3911 Sorrento Valley Boulevard, Suite 110</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml80LTAtMS0xLTk1MTE3_755752c8-9283-4cb7-a7f3-ef211cdc5b7b">San Diego</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml81LTAtMS0xLTk1MTE3_532c83fb-1f43-46b7-b35f-088871a1ada4">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml81LTEtMS0xLTk1MTE3_4dbea0fa-a8b4-48c1-83f1-29e1ad860afc">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTg5_809f1f7f-dffe-4383-b753-3e65a2a5b611">858</ix:nonNumeric>) <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTkw_c478a4f1-a9cd-4aaf-b6f0-7b696677d9c4">550-7500</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's Telephone Number, Including Area Code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">5980 Horton Street, Suite 405</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Emeryville, CA 94608</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading symbol:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6MmQ1ODRhYTk5OTA2NDVhYTg2NzA4NzdiMzEwMDZiZWYvdGFibGVyYW5nZToyZDU4NGFhOTk5MDY0NWFhODY3MDg3N2IzMTAwNmJlZl8xLTAtMS0xLTk1MTE3_07213005-352c-447d-b56c-ba7085e39f34">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6MmQ1ODRhYTk5OTA2NDVhYTg2NzA4NzdiMzEwMDZiZWYvdGFibGVyYW5nZToyZDU4NGFhOTk5MDY0NWFhODY3MDg3N2IzMTAwNmJlZl8xLTEtMS0xLTk1MTE3_c507ab27-c363-45ca-88a0-6e6d2114fcbd">LGND</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6MmQ1ODRhYTk5OTA2NDVhYTg2NzA4NzdiMzEwMDZiZWYvdGFibGVyYW5nZToyZDU4NGFhOTk5MDY0NWFhODY3MDg3N2IzMTAwNmJlZl8xLTItMS0xLTk1MTE3_b65b8c1a-1b12-4fcc-b03a-eede73d180cf">The Nasdaq Global Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTkx_3a4a6644-8abd-4f16-bdd6-cb02c793ca10">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTg2_afa9d9fd-8e48-483b-8964-305458efe16a">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of  &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;  &#8220;smaller reporting company,&#8221; </span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and "emerging growth company" in Rule 12b-2 of the Exchange Act.  (Check one)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:29.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6ZDliM2FmMTAwOTI2NDZkODlhMTJlNWM5ZDEwYmNjZDcvdGFibGVyYW5nZTpkOWIzYWYxMDA5MjY0NmQ4OWExMmU1YzlkMTBiY2NkN18wLTAtMS0xLTk1MTE3_d2e29f64-ded0-48c6-818d-6ba9c7a87bb3">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated Filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6ZDliM2FmMTAwOTI2NDZkODlhMTJlNWM5ZDEwYmNjZDcvdGFibGVyYW5nZTpkOWIzYWYxMDA5MjY0NmQ4OWExMmU1YzlkMTBiY2NkN18xLTQtMS0xLTk1MTE3_06d447fe-779e-4038-9960-6367a035d5aa">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6ZDliM2FmMTAwOTI2NDZkODlhMTJlNWM5ZDEwYmNjZDcvdGFibGVyYW5nZTpkOWIzYWYxMDA5MjY0NmQ4OWExMmU1YzlkMTBiY2NkN18yLTEtMS0xLTk1MTE3_0a5a1b45-5795-4a4c-a0c9-0805f7e56e40">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTg3_a1725cce-655c-4d38-ab3d-b612db844db2">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  &#9746;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of November&#160;4, 2022, the registrant had <ix:nonFraction unitRef="shares" contextRef="ia5d1d407380348e2a118f44535f6a4f9_I20221104" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTQ5_13b9416c-1a6d-4fb8-8623-344d44ab6581">16,893,579</ix:nonFraction> shares of common stock outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i2959cf3610a04d8385d1c4c227b59df4_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.  FINANCIAL INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_13">ITEM 1.  Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_22">Condensed Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_25">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_28">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_31">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_61">ITEM 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_61">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_73">ITEM 3.  Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_73">33</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_76">ITEM 4.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_76">33</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.  OTHER INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_82">ITEM 1.  Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_82">34</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_85">ITEM 1A.  Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_85">34</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_88">ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_88">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_91">ITEM 3.  Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_91">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_94">ITEM 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_94">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_97">ITEM 5.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_97">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_100">ITEM 6.  Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_103">38</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_103">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2959cf3610a04d8385d1c4c227b59df4_103">38</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GLOSSARY OF TERMS AND ABBREVIATIONS</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abbreviation</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definition</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021 Annual Report</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the year ended December&#160;31, 2021, filed with the SEC on February 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$750.0 million aggregate principal amount of convertible senior unsecured notes due 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Avista Public Acquisition Corp. II (after its domestication in Delaware, known as OmniAb, Inc.)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent value right</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal Bioscience, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EMA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">European Medicines Agency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan, as amended and restated</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Generally accepted accounting principles in the United States</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen, LLC</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of March 23, 2022, among APAC, Ligand, OmniAb and Merger Sub</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Sub</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orwell Merger Sub, Inc., a wholly owned subsidiary of APAC</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb Operations, Inc. (formerly known as OmniAb, Inc.)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb Business</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Ligand's antibody discovery business</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q3 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q3 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Separation Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Separation and Distribution Agreement, dated as of March 23, 2022, among APAC, Ligand and OmniAb</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">xCella Biosciences, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">YTD</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Year-to-date</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i2959cf3610a04d8385d1c4c227b59df4_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_13"></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">     Item 1. Condensed Consolidated Financial Statements</span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_16"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except par value)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMy0xLTEtMS05NTExNw_9b16aed1-f2c4-49c2-aeef-3ff7d55353df">4,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMy0zLTEtMS05NTExNw_94e0a779-3228-4d46-8591-77547bea65db">19,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNC0xLTEtMS05NTExNw_5208fada-b7b6-4ab9-83b8-043b27704db0">117,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNC0zLTEtMS05NTExNw_61108777-106b-4533-8166-c2bb26166254">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNS0xLTEtMS05NTExNw_d6b1e937-dad6-4384-a1cd-0c59f528575e">65,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNS0zLTEtMS05NTExNw_cca1bf5f-b58c-486e-b2fa-c50d4aac8cfa">85,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNi0xLTEtMS05NTExNw_e1849040-4bac-43eb-a1d0-548bb6dce851">22,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNi0zLTEtMS05NTExNw_e3f2118c-bed1-462a-9aeb-e5749e99aacc">27,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNy0xLTEtMS05NTExNw_c92e764b-9b06-4312-a4f5-afecce104f8e">785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNy0zLTEtMS05NTExNw_7e7e7309-7fcf-4636-a341-284d48cf4b35">6,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfOC0xLTEtMS05NTExNw_12c08de2-f9e2-47b1-ae1b-094717280d6f">10,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfOC0zLTEtMS05NTExNw_4021f059-d7e4-41b4-a8b9-3cec04f95172">4,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfOS0xLTEtMS05NTExNw_4019a578-3f92-48c6-8e09-7765285f5d1f">220,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfOS0zLTEtMS05NTExNw_d2cbda96-a34c-4ba0-9636-fea0e9fc90fa">464,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTAtMS0xLTEtOTUxMTc_f541cafd-3f3c-47c5-b2d5-7d061935c474">35,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTAtMy0xLTEtOTUxMTc_6da31112-3035-45bc-9b6f-1396894a2895">34,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTEtMS0xLTEtOTUxMTc_c7ad697f-6a52-4adb-9048-f6d73102edb1">517,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTEtMy0xLTEtOTUxMTc_b6b86974-66ec-4340-b175-410f9e4f1ee2">551,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTItMS0xLTEtOTUxMTc_fb3fb198-21f3-4196-b9ce-7c1ca13c868e">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTItMy0xLTEtOTUxMTc_01369077-86f1-4a9b-b248-576c08d9c02f">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Commercial license rights, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:CommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTMtMS0xLTEtOTUxMTc_757d24e5-4522-475b-a410-85c9f03dadeb">10,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:CommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTMtMy0xLTEtOTUxMTc_8cca6faf-53ae-4ff0-a8b3-209f6e5580c1">10,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTQtMS0xLTEtOTUxMTc_289d63dd-b40a-4ebb-a297-41482f99fbeb">33,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTQtMy0xLTEtOTUxMTc_aff47bcd-ffb7-4283-833d-472d96c79793">20,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTUtMS0xLTEtOTUxMTc_349cb7ff-5f3b-41c6-b3eb-1710e174223b">32,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTUtMy0xLTEtOTUxMTc_c92b0c17-547c-4532-8412-682fe0a0a9a2">16,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTYtMS0xLTEtOTUxMTc_3f1ed65c-2e4b-46b6-9e07-20e33ca92386">14,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTYtMy0xLTEtOTUxMTc_20b14500-3a58-473d-b021-90292a4c1284">16,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTctMS0xLTEtOTUxMTc_94639f5e-6f52-48b4-96b1-3a0d73fb8cc9">6,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTctMy0xLTEtOTUxMTc_aeeee19f-08c4-438e-8f04-db04d47c713b">2,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTgtMS0xLTEtOTUxMTc_554e4d7a-49cb-4dfb-93c1-36a93ded7da6">1,050,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTgtMy0xLTEtOTUxMTc_22737b45-3265-43be-9c14-cea44e4baf86">1,297,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjEtMS0xLTEtOTUxMTc_5a873015-fd0b-48aa-976e-1743843b7d87">15,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjEtMy0xLTEtOTUxMTc_39cf2e1e-e504-4e99-a519-ad9f031345fe">8,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjItMS0xLTEtOTUxMTc_c36db29e-60b6-486e-b364-c62d041bbf5a">19,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjItMy0xLTEtOTUxMTc_e346009e-a37f-485f-804e-a6fc0843e3a1">17,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjMtMS0xLTEtOTUxMTc_a41337e7-db64-4df5-a8c4-8193f619b54f">9,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjMtMy0xLTEtOTUxMTc_78776f5b-51fa-4955-b97c-f4d2c64e86a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjQtMS0xLTEtOTUxMTc_a771c9a7-4034-4aa2-abaf-3f1622260435">1,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjQtMy0xLTEtOTUxMTc_39bdd199-3930-4a52-b0ce-df35aba42735">2,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjUtMS0xLTEtOTUxMTc_6e5c0a71-ee3f-4bfc-a61f-8b8855e95583">9,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjUtMy0xLTEtOTUxMTc_08e9ae2b-ee6a-4900-accb-92fc15363096">10,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjYtMS0xLTEtOTUxMTc_738fbcd6-ddd6-4adc-82bf-ce66739bea96">2,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjYtMy0xLTEtOTUxMTc_f8574660-e062-4c2e-ab79-dc2e8e91d9a5">2,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current financing lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjctMS0xLTEtOTUxMTc_72957835-9e7d-44fc-bf31-1563e574f045">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjctMy0xLTEtOTUxMTc_8f3c0cbf-ec1a-4d4f-93ef-220ebc1cc33e">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjgtMS0xLTEtOTUxMTc_a8b7af63-85c0-4063-ad2b-f036b9a7738d">76,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjgtMy0xLTEtOTUxMTc_6e4bc349-a672-4056-a5a6-096a91913311">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjktMS0xLTEtOTUxMTc_cfb30f90-4098-45bf-a1eb-2a6a5c73c8cc">135,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjktMy0xLTEtOTUxMTc_35d0aa44-ebf6-4e1c-8d4d-ff9643b62ee0">41,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzAtMS0xLTEtOTUxMTc_63c6604d-d4af-425e-a307-249e1de9b15a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzAtMy0xLTEtOTUxMTc_63b319e7-009a-4345-b8c3-9799605b8888">320,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:LiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzEtMS0xLTEtOTUxMTc_ed77601b-5d6c-494e-af48-904d8ac1ff57">6,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:LiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzEtMy0xLTEtOTUxMTc_a0776847-9108-4ef4-841a-5e10bb86ace6">8,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzItMS0xLTEtOTUxMTc_895a0013-b8a3-409b-8e1f-341451a812de">29,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzItMy0xLTEtOTUxMTc_a88c2ef4-f2a0-46b6-ad90-4e202ececb6c">59,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzMtMS0xLTEtOTUxMTc_1b3fe217-d86b-4453-ae39-65ee7e6ac41d">34,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzMtMy0xLTEtOTUxMTc_cfca7000-9d33-408c-8810-67df56f1d122">15,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Long-term deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzQtMS0xLTEtOTUxMTc_49e7e539-c4ba-4af0-89a1-4f0228ea15a8">5,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzQtMy0xLTEtOTUxMTc_8a99bc9c-afae-4e86-ad86-9e387d07eed0">9,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzUtMS0xLTEtOTUxMTc_d3f5bbfa-d56a-4fec-8293-301ba50baa79">21,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzUtMy0xLTEtOTUxMTc_e200c1cb-aa98-4915-ac86-22ffd98fe01a">21,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzYtMS0xLTEtOTUxMTc_9f6712ad-705c-4c63-8354-1777b2331436">234,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzYtMy0xLTEtOTUxMTc_c4603ebf-d7f0-4cff-9a1c-b521fe157d49">476,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzctMS0xLTEtOTUxMTc_268bd8e0-2a20-407d-87f6-f82874696be8"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzctMy0xLTEtOTUxMTc_39a5d67f-013d-4ab4-910c-880f51830dfd"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF8yNA_b8a61b6f-a41d-4ebe-9039-cb1525b6bf28"><ix:nonFraction unitRef="usdPerShare" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF8yNA_e66c0e8a-c41f-481a-8689-09683e5a6833">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF8zOA_96522c8d-c320-4674-8149-31623606ecc5"><ix:nonFraction unitRef="shares" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF8zOA_e3dc2c77-8b42-44d7-ab9f-fda103715371">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF82MA_3037dab9-5cbb-4e60-a581-711a15f86378"><ix:nonFraction unitRef="shares" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF82MA_3dfd3d05-57c5-4956-9ae3-59f61dd7ac28"><ix:nonFraction unitRef="shares" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF82MA_54eafc1a-881e-4dec-9038-e7a87034efd0"><ix:nonFraction unitRef="shares" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF82MA_87ac3136-8fbc-4694-9d38-50c104cea535">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMS0xLTEtOTUxMTc_bcaaa901-7ca5-4e21-8bef-3023bb587560">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMy0xLTEtOTUxMTc_a2585635-7092-4b3d-a463-8e459053ce28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl8yMQ_105a95aa-78d1-4824-821f-aa3d97a996d3"><ix:nonFraction unitRef="usdPerShare" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl8yMQ_5267e081-45ad-453b-91f8-20ce41653906">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl8zNQ_21572250-0192-4910-9565-befb26958809"><ix:nonFraction unitRef="shares" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl8zNQ_3f64e7ec-7111-46b8-a3e9-dbde02b9ab7f">60,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl81Nw_4d2f3315-d0dd-43dc-86da-a5e611b3fc13"><ix:nonFraction unitRef="shares" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl81Nw_6689141a-8638-4b67-956b-38df4a92a38c">16,894</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl82NA_9818436b-6eed-4a75-8026-4e5c49891c64"><ix:nonFraction unitRef="shares" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl82NA_ecf78d31-4432-4ebe-b5f6-81e081d89511">16,767</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMS0xLTEtOTUxMTc_d75ffd0c-393b-41d8-984b-f424632e6ecc">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMy0xLTEtOTUxMTc_fd756018-2433-4db0-80e2-989032dc206e">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDEtMS0xLTEtOTUxMTc_47da1ba2-6724-4a55-969e-d11c73e248e6">348,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDEtMy0xLTEtOTUxMTc_c4d20c2c-f633-4353-b66d-559c7f2d6740">372,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDItMS0xLTEtOTUxMTc_8925eea2-16c8-4cde-ba63-7d59b4b01c47">1,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDItMy0xLTEtOTUxMTc_da8c8a70-8ab9-4fa4-87b9-cf31d52dfef0">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Retained earnings </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDMtMS0xLTEtOTUxMTc_8a9fadd1-a365-4a51-842a-79179af75684">468,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDMtMy0xLTEtOTUxMTc_bf1c4aa3-52aa-464e-bced-8ee10af10f59">449,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDQtMS0xLTEtOTUxMTc_cc101a83-5f99-4892-9252-c74aab030834">816,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDQtMy0xLTEtOTUxMTc_6809c18b-01d1-4523-8090-52685a7ece03">821,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDUtMS0xLTEtOTUxMTc_7b291747-1126-4d2b-aebb-1a9c10436168">1,050,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDUtMy0xLTEtOTUxMTc_9c032323-84fe-49d4-90df-7fe12caaa7a0">1,297,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:35.277%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e4c019116374680b437a7a7e84a8c80_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNC0xLTEtMS05NTExNw_3c8acf59-ec12-4980-8d37-d6df5ae58df6">19,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe9d446b7d574e0a8a446713e4e31f27_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNC0zLTEtMS05NTExNw_7f823afe-80b5-4151-8eb6-b95487b4066d">15,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6dd34ce0bee40ea82cba5bfc9584a46_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNC01LTEtMS05NTExNw_13be5c9b-1679-4905-ae26-a1114a106b84">51,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61be445c11db419296ccc53f473da154_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNC03LTEtMS05NTExNw_9596a620-fe99-4940-bda1-e9e84d19ca03">31,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27111ff24358446e8f6742f1a9a22280_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNS0xLTEtMS05NTExNw_0f8d3473-2815-48bd-b91b-9cb544470191">35,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805b7ce49b9b477ab1a86dfcd8f4b896_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNS0zLTEtMS05NTExNw_d61a7bdf-b9fa-4671-8343-c21a2034095d">35,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc5e665d17d410bbc8f43e5ef950091_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNS01LTEtMS05NTExNw_e171fce8-35b6-4ee6-a1c4-34cb63d8ba51">77,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68593efff0be4bcea82e054922dea281_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNS03LTEtMS05NTExNw_bf3daed2-8c9b-4e50-9ea8-f9df2bc57892">128,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c883799387843e28ad63ef5c7a3a928_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNi0xLTEtMS05NTExNw_ace469a4-ce8e-4d80-9067-5e5b06e9b1c4">10,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca791879e154b79899726f73ac30955_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNi0zLTEtMS05NTExNw_a59703e8-e095-4b93-b4ba-81f3c1a7b563">14,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb48e049cd074424a4b9c75318b0968f_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNi01LTEtMS05NTExNw_d6406155-be63-4eba-bdfa-46b9a16bd5b2">40,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d5bd9d373e34f7ab0ab2dc3b00f0266_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNi03LTEtMS05NTExNw_0ee85042-342c-4d99-8b04-e4436dd40174">44,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNy0xLTEtMS05NTExNw_0701be9b-cd1d-479e-a1f1-dcd302639a2f">66,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNy0zLTEtMS05NTExNw_859a5e9c-8ff3-41e6-8525-f35ddc943daf">64,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNy01LTEtMS05NTExNw_ce219e80-c139-40b5-8d2c-a86aade50705">169,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNy03LTEtMS05NTExNw_8b548231-6229-4831-b699-f2b619bd8573">204,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfOS0xLTEtMS05NTExNw_be57a5c2-9598-443e-926f-43f8eaa183d3">14,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfOS0zLTEtMS05NTExNw_93abfdd8-5e79-4ccf-bef8-e3d63711136e">11,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfOS01LTEtMS05NTExNw_8d202bf3-1d90-4a3d-bbfb-45bad40a5d23">31,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfOS03LTEtMS05NTExNw_f2beb418-ee31-439c-b003-1ef1dcf9cdf0">50,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTAtMS0xLTEtOTUxMTc_77798849-a5a3-4979-8751-1fafd60d16f1">11,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTAtMy0xLTEtOTUxMTc_988b77d0-acde-4712-b466-ba72dc86114a">11,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTAtNS0xLTEtOTUxMTc_8c84b33c-2f51-4496-a29a-b3163796b8bc">35,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTAtNy0xLTEtOTUxMTc_d9032b46-9294-4c49-8b1e-a022739d83ed">35,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTEtMS0xLTEtOTUxMTc_453312bd-ebcb-472f-891a-856f27799544">22,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTEtMy0xLTEtOTUxMTc_0177c231-6f31-4693-81f3-8b3c9ded17a3">16,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTEtNS0xLTEtOTUxMTc_33430e9b-3352-4034-971c-8a67c03ffcc6">61,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTEtNy0xLTEtOTUxMTc_c32cb811-e611-4710-985b-615d92f52006">50,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTItMS0xLTEtOTUxMTc_1a99327c-6447-40ce-8ada-f48358cbd4c8">17,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTItMy0xLTEtOTUxMTc_f4caab3c-8fc4-46e8-861e-df40f679d204">12,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTItNS0xLTEtOTUxMTc_14ce7d09-2e70-4c5b-b357-6dff56364ec9">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTItNy0xLTEtOTUxMTc_f87f4058-3041-4cd5-a1d4-8d690e5c9e37">39,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTMtMS0xLTEtOTUxMTc_8561307f-1cd0-40e2-ace0-1b837c032e47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTMtMy0xLTEtOTUxMTc_cde4217a-e27e-45bf-9853-0a141c3057b4">3,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTMtNS0xLTEtOTUxMTc_51add167-2db2-498a-af0f-4deb393aed81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:OtherOperatingIncomeExpenseNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTMtNy0xLTEtOTUxMTc_ce6c12a6-0979-4ae9-867e-7d5a2e79d4e8">37,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTQtMS0xLTEtOTUxMTc_df4e7505-4fc5-4441-bf03-8d4170443549">65,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTQtMy0xLTEtOTUxMTc_5a600a5d-2119-4237-802a-8d1e91b98a59">49,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTQtNS0xLTEtOTUxMTc_26f2e11e-8e2b-437c-81e0-ad1331bfb3a6">178,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTQtNy0xLTEtOTUxMTc_1464e509-fe8c-4223-a579-e6cc9b313804">138,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTUtMS0xLTEtOTUxMTc_7c765aab-fa2f-4497-aa45-c2ec37d7b3d5">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTUtMy0xLTEtOTUxMTc_a752ad55-b555-4c52-b399-3edb28895763">15,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTUtNS0xLTEtOTUxMTc_4b1b71c6-f4d7-4124-9d8a-33addcef4dff">9,139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTUtNy0xLTEtOTUxMTc_7580fcd7-6d76-44fc-b922-5d524ece3bf0">66,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain (loss) from short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTctMS0xLTEtOTUxMTc_70c2d157-a080-47e5-bb3e-6435708ff26e">923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTctMy0xLTEtOTUxMTc_8c4bd9b3-45d7-4eb8-8bca-32397517555a">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTctNS0xLTEtOTUxMTc_01bc900b-be62-40c7-a913-911bfbf2914e">15,709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTctNy0xLTEtOTUxMTc_3f652411-caaa-48de-9d0c-9f6c6ff8dc79">8,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTgtMS0xLTEtOTUxMTc_bb093c79-4cd8-44a3-8177-d360949f9b60">591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTgtMy0xLTEtOTUxMTc_07e8e286-d893-43bc-995a-9175e8350468">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTgtNS0xLTEtOTUxMTc_cf673b1a-19f1-4a4f-b1cd-db67cc27c4e3">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTgtNy0xLTEtOTUxMTc_7d447525-43a5-47b2-9fdb-e8aefd5120b0">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTktMS0xLTEtOTUxMTc_06e10b76-1194-49cc-88dc-f4a7a3b3b3fc">332</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTktMy0xLTEtOTUxMTc_67b2f207-dbf7-45b1-90b3-abfde75d5f5a">4,439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTktNS0xLTEtOTUxMTc_0d1be658-df4c-487c-b603-f7b5a0094f0f">1,559</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTktNy0xLTEtOTUxMTc_eeef6370-2129-4140-b1c6-df24bae00f24">15,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjAtMS0xLTEtOTUxMTc_8b1f7a3b-def0-47f0-8c9d-4c8fb2f091a9">885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjAtMy0xLTEtOTUxMTc_92a97c0d-4b85-46ca-8ee4-02ec3ee9bf8d">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjAtNS0xLTEtOTUxMTc_abe8219c-c8d4-4df3-a082-dc1dc543c139">5,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjAtNy0xLTEtOTUxMTc_160b4717-6b46-4a94-86e9-789beff6cb1b">5,516</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjEtMS0xLTEtOTUxMTc_6e921248-df09-4aab-a02a-24c1d9735d56">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjEtMy0xLTEtOTUxMTc_e05359c4-9003-4c87-ab74-ba265e9789a8">447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjEtNS0xLTEtOTUxMTc_7d8ff2d9-8ad1-4932-8d73-ed92ac6e1346">10,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjEtNy0xLTEtOTUxMTc_8715fc2f-9431-49c6-8540-4b319615942e">11,837</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss)  before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjItMS0xLTEtOTUxMTc_9fa21f92-f1ed-40fd-bee4-01b657b88100">857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjItMy0xLTEtOTUxMTc_505e3fa0-99fc-4fcf-be46-e827a2b909c2">15,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjItNS0xLTEtOTUxMTc_a1627406-325a-4ee0-96e8-5f4e702f11b0">19,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjItNy0xLTEtOTUxMTc_f7aa0a01-7f8e-482b-99f3-9647b4261ead">54,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjMtMS0xLTEtOTUxMTc_1447dd27-d7c3-439e-83e4-37faa73a916c">453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjMtMy0xLTEtOTUxMTc_660ed5bd-af2b-45ef-86de-57e3649d103f">1,536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjMtNS0xLTEtOTUxMTc_ce8da757-aa20-4acc-87b4-c09a5a82b251">4,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjMtNy0xLTEtOTUxMTc_0874b4d5-6dae-4935-892a-d8a751bac7a3">8,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjQtMS0xLTEtOTUxMTc_76a5863e-029a-4b43-8a3f-fa07f60cdd51">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjQtMy0xLTEtOTUxMTc_509900ae-bf98-4ce2-80a0-91a5798e91a5">13,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjQtNS0xLTEtOTUxMTc_ea5934ed-7a64-410d-afd4-acb9a1c00982">15,876</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjQtNy0xLTEtOTUxMTc_7a16483c-f896-43b1-a562-ddb1acac33d1">62,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjYtMS0xLTEtOTUxMTc_dc0a1be3-3114-48e0-9c68-18094de405be">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjYtMy0xLTEtOTUxMTc_c2cae370-3f07-4c2e-8a9c-b67f7c60c019">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjYtNS0xLTEtOTUxMTc_af2d46b0-2244-4353-84f6-7fcca6c24183">0.94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjYtNy0xLTEtOTUxMTc_ac642d56-4ae2-48b3-b77c-b56ac1e00acd">3.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in basic per share calculations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjctMS0xLTEtOTUxMTc_f47e43f3-6dc7-4bfe-80cd-a45616d1a51e">16,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjctMy0xLTEtOTUxMTc_de389e71-be17-4b4c-8adb-fd5893955d38">16,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjctNS0xLTEtOTUxMTc_c1ab1b83-41fa-46d9-936b-0c6057b76518">16,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjctNy0xLTEtOTUxMTc_f617aa76-fadf-43b7-8128-fc7a01f5b1b8">16,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income (loss) per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjktMS0xLTEtOTUxMTc_7c86f4b5-9ab6-4cdb-8e48-37fd465b45f9">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjktMy0xLTEtOTUxMTc_e102eb9a-0929-4341-885f-e5abadfb7a8b">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjktNS0xLTEtOTUxMTc_f67af115-b94c-4914-86c8-c9cc8c4c9b97">0.94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjktNy0xLTEtOTUxMTc_bf5137f0-dea4-4f62-a49f-c3ae1cfaa884">3.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in diluted per share calculations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMzAtMS0xLTEtOTUxMTc_4c2710fb-dcef-44c0-b60c-c7fd6bdebac1">17,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMzAtMy0xLTEtOTUxMTc_9fd16885-be19-47da-8cec-1ff20d08faed">17,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMzAtNS0xLTEtOTUxMTc_929ffb8f-2dbe-44f5-bfbf-008b15c1fae8">16,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMzAtNy0xLTEtOTUxMTc_86720d99-3b70-48a9-97cc-54a1b20231a6">17,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i2959cf3610a04d8385d1c4c227b59df4_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfMy0xLTEtMS05NTExNw_7a0ff391-025a-4444-9491-b8aa3d08a315">404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfMy0zLTEtMS05NTExNw_44197315-9ead-4bfc-979f-2880ce9d4ca9">13,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfMy01LTEtMS05NTExNw_ecbb408b-60dd-4361-a9c7-6450a9d4f5b8">15,876</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfMy03LTEtMS05NTExNw_693c9e2b-faab-4f48-a2a2-61cb593dbf0d">62,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized net gain (loss) on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNC0xLTEtMS05NTExNw_2398dea8-5a14-4cbb-8318-46bc292afe2a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNC0zLTEtMS05NTExNw_c84174e5-aff6-4f63-b91e-4109b1e203aa">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNC01LTEtMS05NTExNw_0d1c1f6a-5eb3-4554-a282-077739e24c65">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNC03LTEtMS05NTExNw_1bb3ef8d-bf70-4dfd-aa8c-293de44df7b2">74</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNS0xLTEtMS05NTExNw_dc6242a6-63a3-44c1-ab02-b93ffcbade2d">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNS0zLTEtMS05NTExNw_a2a88a62-824f-4b57-89c7-27fe9a30d0c6">13,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNS01LTEtMS05NTExNw_bb6a4f90-d21c-4e72-92a1-87199cf4e0d7">16,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNS03LTEtMS05NTExNw_dfe54f1a-0675-4d4d-835c-f14ff5f1a71e">62,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i2959cf3610a04d8385d1c4c227b59df4_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i198ab94a85514554b7b186297e1b40e0_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi0xLTEtMS05NTExNw_6ce6cddb-43a3-47d4-8d71-60a2aa82edf3">16,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198ab94a85514554b7b186297e1b40e0_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi0yLTEtMS05NTExNw_22a02c62-2617-41c4-8344-2e6465b85c85">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie753396ec7e54b7284e025b438c69c9a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi0zLTEtMS05NTExNw_c71ac05e-fa78-4844-afa2-fee6e8057299">372,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90959b048f9d4c9c901d541f37dd4d04_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi00LTEtMS05NTExNw_9a3d229d-65c6-4358-84a2-8d10d4b21b45">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009cac1d5b03430ea00be4a216999d58_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi01LTEtMS05NTExNw_f123724e-d107-4741-a709-240193d9b113">449,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi02LTEtMS05NTExNw_50fe5ebb-56aa-4d6e-bdd2-413ac16e4873">821,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMy0wLTEtMS05NTExNw_87af1313-893c-4dbd-91d6-8d725b48f5eb">ASU 2020-06 adoption, net of tax (Note 1)</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16919bc133394068b70b5dfa72c1fd0e_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMy0zLTEtMS05NTExNw_0ee37107-014c-4620-bba3-2f34515aa281">51,130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d2ed7a3614b47c58739fe3a78c8cf50_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMy01LTEtMS05NTExNw_e6152ce6-d668-46e9-b0a8-b3eae0a0953c">35,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i239ddea2c7ce41f184f6267304338e4d_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMy02LTEtMS05NTExNw_a5fb763c-5d17-495e-a1e4-dcab225d0f16">15,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7464adf27f3344eaa673a32517540e7c_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNC0xLTEtMS05NTExNw_abaf2a8f-fbab-47bf-b2af-26a703e3fb24">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27cf2b1876194c95b8039376914f66a9_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNC0zLTEtMS05NTExNw_4552de30-75c3-4666-8511-a0e3a68fc97e">5,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d3fdee71cb945188b3a6480ad8b04b3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNC02LTEtMS05NTExNw_c8badddb-7815-4629-81fb-072908733b2d">5,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27cf2b1876194c95b8039376914f66a9_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNS0zLTEtMS05NTExNw_e2353782-f108-404e-b184-98307c8153b0">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d3fdee71cb945188b3a6480ad8b04b3_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNS02LTEtMS05NTExNw_ba691c1e-405c-4745-9daf-52b533cb47e0">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90c76c0d56474350ace13a08c8b6be7d_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNi00LTEtMS05NTExNw_4630a34f-6bab-4a9a-87f8-a946dd12c4ac">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d3fdee71cb945188b3a6480ad8b04b3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNi02LTEtMS05NTExNw_cfc220f6-8f82-4657-860a-9ded04013998">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i622a51922d024361bd6340d3356b0611_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOC01LTEtMS05NTExNw_ab599318-b856-4b5d-84e6-7905665ad987">15,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d3fdee71cb945188b3a6480ad8b04b3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOC02LTEtMS05NTExNw_6e587c94-c06b-4660-a351-06b31ed4a59b">15,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc60f1d7e4e64d4da82bc5998ca4409e_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS0xLTEtMS05NTExNw_35defca6-4f9b-4e44-bbe1-7ff81393cda5">16,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc60f1d7e4e64d4da82bc5998ca4409e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS0yLTEtMS05NTExNw_6ef5449b-7a81-495f-b25e-48c09883a9e4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3d7b66aebc7403188ff43b263cbde5a_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS0zLTEtMS05NTExNw_95edabfe-7f5f-4f4d-afc1-395cebf8d0d5">325,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55d2a92d4b1a4569aa0e26eff50b27e1_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS00LTEtMS05NTExNw_840e2eb0-ebf5-4eca-83c1-df0f23bd8fcc">1,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bd3552261654e0aa2a6e538a4ffd6e0_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS01LTEtMS05NTExNw_f926905a-6db3-4984-b264-fb62e9bdb0b1">468,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe1aea5f82664c3d8279c4521c119e7f_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS02LTEtMS05NTExNw_f895b835-d38c-4b0a-a3fa-4a1007bffe11">793,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i185279a9c1154a6e970cdd3102fb2523_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTAtMS0xLTEtOTUxMTc_dfbec667-daf6-4a19-94a7-61e17172db17">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a5d969d3cd49018e396c6da4322e1d_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTAtMy0xLTEtOTUxMTc_de31b6b7-9f1d-4c51-ae61-5eba60ac5041">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19361f68c02f4b6fa38af8257cd7aa3b_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTAtNi0xLTEtOTUxMTc_4cc04987-6982-4bb3-b9a9-113ff44eb6f2">604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a5d969d3cd49018e396c6da4322e1d_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTEtMy0xLTEtOTUxMTc_cc7e7138-2abe-410d-bb80-83fbdbaa9de2">9,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19361f68c02f4b6fa38af8257cd7aa3b_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTEtNi0xLTEtOTUxMTc_a1fff2bb-0f3a-4c71-9e77-ffca90860687">9,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib18e9df5868e4c7d9ffa15a018c90a12_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTItNC0xLTEtOTUxMTc_1c6d6f00-94df-436e-99b6-f771d2b22ea7">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19361f68c02f4b6fa38af8257cd7aa3b_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTItNi0xLTEtOTUxMTc_2383ddab-ee71-4d94-ad4b-1abe6905935f">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c3698d638594c138f050c501a4bb5bb_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTQtNS0xLTEtOTUxMTc_ca988738-7ec7-46c7-875a-2dfa0de4d3ad">895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19361f68c02f4b6fa38af8257cd7aa3b_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTQtNi0xLTEtOTUxMTc_aee8c8d3-72fa-4fb5-bbb8-22b795ca1f78">895</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i589ed826afd94e66ac256c87c067d171_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtMS0xLTEtOTUxMTc_4ad5c3d6-5106-4950-961d-deb229a8db89">16,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589ed826afd94e66ac256c87c067d171_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtMi0xLTEtOTUxMTc_8461d97b-40fe-4110-a800-fb5d64ce8fe3">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09ea69ed13a2487cb2c216e37f4468a5_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtMy0xLTEtOTUxMTc_889f4acd-2b57-41ec-b20c-bb8b9610600f">335,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc472676953e452a9218d48cdabcd4c9_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtNC0xLTEtOTUxMTc_33d69ffe-0fba-4ffb-a684-37e640192800">1,066</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcc63139d2274ceab9cf48bff4553b66_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtNS0xLTEtOTUxMTc_1fbdb5f2-8c7a-4093-8143-3edc23d0c2a2">467,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5baea90deb8e4265a72ea7026d08379c_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtNi0xLTEtOTUxMTc_96587441-5b16-40a1-b91a-adf6de883073">802,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b75eb328f4e4243b3e4fdb1e688d35c_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTYtMS0xLTEtOTUxMTc_dcbbb5e0-0f3a-40f4-90fd-e18a3294702a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757ee12a916e4b45a2fd76ec35d70c95_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTYtMy0xLTEtOTUxMTc_5ad74697-7007-4f0d-9567-45f3d6093bda">724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTYtNi0xLTEtOTUxMTc_fcdd0eaa-2463-4609-ac53-c1f0abc34cc5">724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757ee12a916e4b45a2fd76ec35d70c95_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTctMy0xLTEtOTUxMTc_8f3e57d4-7fe2-450a-9bbd-5cbac01eaf23">12,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTctNi0xLTEtOTUxMTc_89b4612e-97db-4057-802a-6a544810b554">12,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net gain on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if291edfa693f417bbbb3aaa623e73077_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTgtNC0xLTEtOTUxMTc_4f2c84c9-378c-4269-bf5e-b9dee9b9f4b5">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTgtNi0xLTEtOTUxMTc_5542331e-8c6e-4819-8461-d34d80cfb3bb">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant and bond hedge unwind transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757ee12a916e4b45a2fd76ec35d70c95_D20220701-20220930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjAtMy0xLTEtOTUxMTc_eaab7739-0938-4067-804d-d6bc975f2b72">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjAtNi0xLTEtOTUxMTc_ba48c49d-43d8-42e5-a893-458a2e65f498">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6c4eeaf5ad4e0e94b7a1e461895686_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjItNS0xLTEtOTUxMTc_4cc3591c-b2f2-4512-898b-40e91dd708a9">404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjItNi0xLTEtOTUxMTc_8600fa67-9c7e-43b5-ac76-5c993f41e77a">404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf5089a880dd4f0c91f39d957943a6d0_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtMS0xLTEtOTUxMTc_35df7eaf-fe6d-4ddf-8cd9-ea17bd37bf8a">16,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf5089a880dd4f0c91f39d957943a6d0_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtMi0xLTEtOTUxMTc_7e9415c7-b74d-4916-8e92-619917875b30">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302273f452f341388964a61d9618c5ea_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtMy0xLTEtOTUxMTc_087bc19c-ba40-4eaa-b1a3-f9428a66c604">348,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa9e8c41a8d6418a8b594ee335f4c15e_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtNC0xLTEtOTUxMTc_7b2bce05-d633-4707-9a54-6dd4de2d8ff5">1,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a1087670b3d4e64b4a3354392f53abe_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtNS0xLTEtOTUxMTc_c996b0e1-1c6d-4ca0-bcf9-016da9fbcd30">468,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtNi0xLTEtOTUxMTc_e2bf66c0-8531-4884-9891-01e4110bc1f9">816,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49019251c3644c1b9be5cc7120c8645b_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi0xLTEtMS05NTExNw_72c0fc2a-8caa-4b8a-814d-1be5d81a7456">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49019251c3644c1b9be5cc7120c8645b_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi0yLTEtMS05NTExNw_0f6b0006-efe3-468d-a5a7-54d78398f865">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a0567a5633346ecad7f4de1f16113d6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi0zLTEtMS05NTExNw_3c283ae7-b3b2-455f-b8ff-13450a06c0f9">318,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5f7904b282b4637855d57757935605b_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi00LTEtMS05NTExNw_e18ee83f-581d-4952-a525-a8ce04bdf5d9">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0608bba36d7e4f2cb5bd38b7d5fa45af_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi01LTEtMS05NTExNw_20bf4fcb-6544-45b5-92e5-adbe0d26d38c">391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5823b83aff4246d783748aff6ba9b978_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi02LTEtMS05NTExNw_2759bf00-a4e7-4eb5-815b-a83d7569e89a">709,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4787c5b04654433aa93a05790c5bb00_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMy0xLTEtMS05NTExNw_b36cdb8a-72dd-48d1-9213-1a25b001c6fc">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4787c5b04654433aa93a05790c5bb00_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMy0yLTEtMS05NTExNw_f36cce80-402e-48f2-bef7-2dcb5b13564f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de83da8ed6348dca0fb66d4c2b5ba46_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMy0zLTEtMS05NTExNw_cc15aedb-da77-4f61-945a-d77a1ab83ecb">20,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMy02LTEtMS05NTExNw_703a16bf-a03e-4bf9-9353-1eba04da5b83">20,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de83da8ed6348dca0fb66d4c2b5ba46_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNC0zLTEtMS05NTExNw_13f04558-efc2-4bee-88bb-44fdf3c485f8">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNC02LTEtMS05NTExNw_29cfb5fc-d0c8-4e4a-aa87-b1ef1385459d">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i621f76587b9b4167af8ab0cce3f06136_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNS00LTEtMS05NTExNw_defb2056-2dd9-4d2b-bc2a-5b050dcfdf7b">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNS02LTEtMS05NTExNw_15b8f467-b647-403d-aec1-4aa7e655c67e">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant and bond hedge unwind transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de83da8ed6348dca0fb66d4c2b5ba46_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNi0zLTEtMS05NTExNw_3c1d1d99-b2f3-40b1-ae2d-a646a614337a">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNi02LTEtMS05NTExNw_3e6ee194-a886-42bc-9e10-a83203c6ec43">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4de83da8ed6348dca0fb66d4c2b5ba46_D20210101-20210331" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNy0zLTEtMS05NTExNw_1baba140-aa6f-4dfa-8a64-70a9f0ce29c8">11,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNy02LTEtMS05NTExNw_09abf193-6259-4617-8b25-290b62b7ed28">11,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45854ed7c1894c938845c943e8170bfa_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfOS01LTEtMS05NTExNw_539ca091-0f68-4d3c-8545-9a787aa19a66">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfOS02LTEtMS05NTExNw_f7781759-08dd-4bb4-b9a0-38c697d3e4db">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide4e95b565954f94bdabad5e12ec376c_I20210331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtMS0xLTEtOTUxMTc_6e423f02-dde9-4159-afcf-dbce38a88e47">16,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide4e95b565954f94bdabad5e12ec376c_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtMi0xLTEtOTUxMTc_1beb6e43-b6ec-47db-b396-315152f6dc7b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2163920057fd4ca4898a01c500e82a08_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtMy0xLTEtOTUxMTc_297ec210-6578-49bc-b93d-51bcf253bfe9">336,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72687d1596d4483c86609fb362747b63_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtNC0xLTEtOTUxMTc_93a2a713-744f-47f9-8eb4-50b48f0e241f">856</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa6a14b6ffd4636950c8681f0e560a1_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtNS0xLTEtOTUxMTc_1e0c4f22-84f7-4218-b9f3-8a81cb637c42">410,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e93447e0b6144f2a48981aa605997ad_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtNi0xLTEtOTUxMTc_72a57320-9af7-4ccf-9728-b37e0c97dada">745,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie1dce0e52afa44c69b20605abe6e40de_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTEtMS0xLTEtOTUxMTc_a575c002-89c3-4f62-a158-f16de5ec2477">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed614688b574fd0983b2980c43392fe_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTEtMy0xLTEtOTUxMTc_63ca3657-993b-4171-ae63-bb621fee2ff8">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTEtNi0xLTEtOTUxMTc_b695bd21-3ee7-4dd9-9733-68a99d2e5932">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed614688b574fd0983b2980c43392fe_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTItMy0xLTEtOTUxMTc_4a153a0d-0570-4463-8a96-4b85c979c994">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTItNi0xLTEtOTUxMTc_ad67bd18-8e86-47bc-96a9-d64fb0d2e8d3">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15b4a7ad28414e03b02122a320252e75_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTMtNC0xLTEtOTUxMTc_5e8bb456-d388-4ab1-b317-b3f2d965db7b">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTMtNi0xLTEtOTUxMTc_8b61dfb9-327b-4a26-8c3a-e2d5c87978e4">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ed614688b574fd0983b2980c43392fe_D20210401-20210630" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTUtMy0xLTEtOTUxMTc_5674be9e-2dfd-480d-ba24-f725f28e4fc6">1,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630" decimals="-3" sign="-" name="lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTUtNi0xLTEtOTUxMTc_bb25f4a0-b5b9-4e64-a8b9-fbe456baf181">1,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15167ff194f5408e9eff810879dae577_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTYtNS0xLTEtOTUxMTc_1000701d-0f98-4ced-98f5-12d47c31644c">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTYtNi0xLTEtOTUxMTc_68dbe594-3d6d-4858-9f18-7b17b599de54">30,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88faad5b2d5040e48a57bdd7eae38a44_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctMS0xLTEtOTUxMTc_86ed6a02-556c-49b7-befe-24412bcb95d3">16,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88faad5b2d5040e48a57bdd7eae38a44_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctMi0xLTEtOTUxMTc_8bf33544-f944-4e06-a0f1-52f5b5e6bd1d">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe07e2903f194de88402b53dfd03c119_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctMy0xLTEtOTUxMTc_9d9b3e8e-5b12-41e8-b7c4-47b9c5713ec4">346,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb0fba93854d45b3a71f274d86a0b25c_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctNC0xLTEtOTUxMTc_08cff5e6-47bb-4f9d-a40e-1eb60721127b">861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19b40a6687a4043b9c5f217b53cee1f_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctNS0xLTEtOTUxMTc_10e6a4da-6fb3-4fa9-a88c-586b72d904f4">440,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b5f93e548a4212a89cf839a5f62b6d_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctNi0xLTEtOTUxMTc_46c6746a-42b4-4cb3-b916-731bd54d4e54">786,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d0cddc5d84e4d48b281640914f3c31a_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTgtMS0xLTEtOTUxMTc_28740e24-de43-408f-8980-e4712c064b0b">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f39828b4f0d4d30b1bbb778bcb4cb81_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTgtMy0xLTEtOTUxMTc_73d8e2ca-2d77-4207-bd91-81ff8c63655b">1,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTgtNi0xLTEtOTUxMTc_b48216ea-831b-46d9-a55f-eeaba598873a">1,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f39828b4f0d4d30b1bbb778bcb4cb81_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTktMy0xLTEtOTUxMTc_7b701933-8191-4a01-bab3-e78cda166325">9,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTktNi0xLTEtOTUxMTc_e9b55802-4b53-45a3-9c65-79cc82080c66">9,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6902f9b70949440389390267fac2a002_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjAtNC0xLTEtOTUxMTc_e23b121f-6c31-41b2-b012-3169f7c103ed">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjAtNi0xLTEtOTUxMTc_8a21c280-66c6-4827-834a-806e639a0f6d">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f39828b4f0d4d30b1bbb778bcb4cb81_D20210701-20210930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjEtMy0xLTEtOTUxMTc_5265a182-d0a0-4d40-8e0f-fa66773e2d40">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjEtNi0xLTEtOTUxMTc_f139a03f-6737-4095-b94f-652f1eba8091">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant and bond hedge unwind transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f39828b4f0d4d30b1bbb778bcb4cb81_D20210701-20210930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjItMy0xLTEtOTUxMTc_9798b50c-37bc-4d48-be9a-093a74b3465f">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjItNi0xLTEtOTUxMTc_c702538d-0114-49f9-80b4-d5b78770776f">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id04346533cc6453daf6686d7ecd0494a_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjMtNS0xLTEtOTUxMTc_eff2f06e-1e24-40c4-9884-16e5ec3cad8d">13,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjMtNi0xLTEtOTUxMTc_fb52faf7-5539-4e63-b4d9-93ddd4853bb5">13,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib9bd6db87aa44bcdb4346428bc52f796_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtMS0xLTEtOTUxMTc_98564ee6-ac61-412d-ac43-9bf0c7ee658e">16,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9bd6db87aa44bcdb4346428bc52f796_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtMi0xLTEtOTUxMTc_6b1ca4a4-f299-4e84-a952-5a52b57f936b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b8e47316474452ea41d7654cf4c47aa_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtMy0xLTEtOTUxMTc_4e19bac3-2001-4a5e-8ab7-e19055a6164b">358,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac1e1e884548420e9f7f74cb53177b5c_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtNC0xLTEtOTUxMTc_0c5b2875-7656-4f01-9b83-6b383b815995">875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c99db1599d84940b69a2da1fe5207cc_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtNS0xLTEtOTUxMTc_701ab161-3260-4538-99d2-99ff19647978">454,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd7205f82a3406b9f0c0dae4653b877_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtNi0xLTEtOTUxMTc_933c7e7e-2644-471d-8e78-3c02bb1c3554">812,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i2959cf3610a04d8385d1c4c227b59df4_28"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNC0xLTEtMS05NTExNw_ba889529-f8a1-4bbd-baa1-91af4425a832">15,876</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNC0zLTEtMS05NTExNw_0433e4c7-7ae9-421a-826f-935d9b966568">62,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimated fair value of contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNi0xLTEtMS05NTExNw_efac4e39-3679-430f-a854-c077e4d1362a">1,378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNi0zLTEtMS05NTExNw_8205f72b-3e02-496c-a8ec-cfc8dc6c7f81">39,377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNy0xLTEtMS05NTExNw_38b9df82-76ef-4507-bf01-6f3632dfb9f7">40,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNy0zLTEtMS05NTExNw_2171f2d9-3ee9-42c2-a2be-07f5f8df43c7">37,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of premium on investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfOC0xLTEtMS05NTExNw_ca9e226f-5323-45d6-a5f1-c144f7de0165">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfOC0zLTEtMS05NTExNw_9cb018db-e5ba-4ff7-ac39-7470ad9c2ac5">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfOS0xLTEtMS05NTExNw_fe5433f9-20ee-4f74-9977-fbe7016b8af6">639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfOS0zLTEtMS05NTExNw_eb6b1765-9708-4224-8b0b-5ab27a6a5f43">12,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of commercial license rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTAtMS0xLTEtOTUxMTc_27a52be3-9b48-4138-b568-9f71b17685f6">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTAtMy0xLTEtOTUxMTc_de28a715-c299-4858-87ca-7d214d016810">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss (gain) on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTEtMS0xLTEtOTUxMTc_b7a98913-4e66-4dbe-896b-4b3405b8741a">4,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTEtMy0xLTEtOTUxMTc_377528cc-6731-4b2d-92c9-4373867ef501">7,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTItMS0xLTEtOTUxMTc_1303a635-1441-4863-ba94-2b608c42787b">31,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTItMy0xLTEtOTUxMTc_3175e579-03b2-4dce-9f34-ecc8d0ead626">28,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTMtMS0xLTEtOTUxMTc_44a05653-5981-4ee6-a4c8-9f25df582a47">25,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTMtMy0xLTEtOTUxMTc_84510c7b-4d5c-49dd-82ba-b298aa4e9a29">8,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss (gain) from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTQtMS0xLTEtOTUxMTc_1f96f105-2bad-4eb7-92b3-6befbfc06b78">15,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTQtMy0xLTEtOTUxMTc_2de161a1-5e2a-4c72-a03e-2699e2ea50ae">8,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lease amortization expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTUtMS0xLTEtOTUxMTc_1045a034-f4f9-4adc-b06f-7976a428a8bc">4,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTUtMy0xLTEtOTUxMTc_58967d12-8955-4f91-815e-758c6eb3fe08">3,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTYtMS0xLTEtOTUxMTc_f9b5b794-7ee0-43b0-aabe-86057e029cf3">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTYtMy0xLTEtOTUxMTc_46452c25-4e5b-4b63-9040-17fb5f5c1c6a">658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTgtMS0xLTEtOTUxMTc_32225bbc-13f6-4719-afde-a61435c2bfcd">20,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTgtMy0xLTEtOTUxMTc_f74c9189-7cd0-4366-b6d3-a050f2938428">8,838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTktMS0xLTEtOTUxMTc_9336aa35-611a-4932-b4dc-9a9e68e898da">10,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTktMy0xLTEtOTUxMTc_4677dee2-ce0e-4212-a63d-2bc0fadd1967">3,103</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjAtMS0xLTEtOTUxMTc_3005c6bc-ab59-48bd-8791-4ec23ee8f420">405</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjAtMy0xLTEtOTUxMTc_9ad18921-495e-4ead-a0bc-00f79ad7bd81">3,635</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income tax receivable and payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjEtMS0xLTEtOTUxMTc_5e0f3d47-dd16-4b08-9c32-d278d01781e2">15,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjEtMy0xLTEtOTUxMTc_d66a3087-e2ca-4556-9d30-1b3308bf9f5b">4,167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjItMS0xLTEtOTUxMTc_22a35a71-ad8c-47d4-9705-4613e3f72336">5,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjItMy0xLTEtOTUxMTc_8f8a41cd-9939-4b17-bedf-3303ef6b6992">20,696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other assets and liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjMtMS0xLTEtOTUxMTc_040a8136-61ff-451f-8013-abac0871cad7">1,671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjMtMy0xLTEtOTUxMTc_34de83f5-e93c-47c0-a3f4-66d12857d2ca">5,909</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjQtMS0xLTEtOTUxMTc_5e07a67b-c059-477f-b7dd-d91411d524ee">84,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjQtMy0xLTEtOTUxMTc_f9221194-f649-4d70-a8ae-9f542ebdb6ed">51,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjctMS0xLTEtOTUxMTc_e9ba8db7-35ba-41af-811f-f155112a37fa">39,052</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjctMy0xLTEtOTUxMTc_07952533-bf05-4f5e-bac7-317e08c1ca43">116,898</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjgtMS0xLTEtOTUxMTc_f6a3796a-210a-4ba7-af9c-7c6adb9d07ea">202,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjgtMy0xLTEtOTUxMTc_ff6b5494-6c96-4c55-b828-9eac31a9926e">152,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjktMS0xLTEtOTUxMTc_336b75a3-6022-49ba-a74d-2ee556102305">24,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjktMy0xLTEtOTUxMTc_244c5bca-1724-460d-8df8-0f184ea89e52">37,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash paid for equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzAtMS0xLTEtOTUxMTc_be613473-444d-42fb-99d8-0e427b24373b">750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzAtMy0xLTEtOTUxMTc_86c164cd-e73f-4254-867b-1c70e8813beb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzEtMS0xLTEtOTUxMTc_d6341e30-8e5d-4670-ab7f-8338f2b231f1">15,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzEtMy0xLTEtOTUxMTc_3b3d7555-2bef-4b41-bc42-7b7bf39420ff">6,566</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersInvestingActivity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzMtMS0xLTEtMTEyMTA5_e3a9fe90-827a-40f3-8f16-8f1029210e76">960</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersInvestingActivity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzMtMy0xLTEtMTEyMTE3_eb32b0d1-ac82-4320-8592-cc7a29e2d5c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzItMS0xLTEtOTUxMTc_484d30ee-86db-4b61-8c07-750535cc784f">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzItMy0xLTEtOTUxMTc_60382c7b-1b07-4798-9e6a-de23ecba3a7d">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzMtMS0xLTEtOTUxMTc_46f1ce83-5740-4f22-b3f5-0b2959478540">170,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzMtMy0xLTEtOTUxMTc_cbe50edc-c210-4804-bd0e-31441038eeb7">66,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of 2023 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzYtMS0xLTEtOTUxMTc_b4109773-503a-45a9-83c1-70bfc8866004">260,949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzYtMy0xLTEtOTUxMTc_6188172d-d362-4f2a-b625-d2cda5c2d062">155,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments under financing lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzctMS0xLTEtOTUxMTc_7dcb06fc-29fe-42c3-a690-66670d2cefa1">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzctMy0xLTEtOTUxMTc_ac65b35c-cdda-4698-87fa-665d0d9317b9">9,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from convertible bond hedge settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromHedgeFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzgtMS0xLTEtOTUxMTc_054d5e04-0c9b-47e3-b1b9-4aa70adf53da">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromHedgeFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzgtMy0xLTEtOTUxMTc_c7e75192-ef4d-4974-9d39-f9d5906f9ee0">18,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to convertible bond holders for warrant purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzktMS0xLTEtOTUxMTc_40eaca57-9df6-43a3-bf7d-e70e38b47604">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzktMy0xLTEtOTUxMTc_bde80e90-2e80-40a5-9a5d-3139f91765b3">18,446</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net proceeds from stock option exercises and ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDAtMS0xLTEtOTUxMTc_188ccc35-d0b0-400e-8828-271fa5567002">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDAtMy0xLTEtOTUxMTc_e5f8a2ae-1948-4307-b2ef-7069da6f13ca">29,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDEtMS0xLTEtOTUxMTc_c270c5fb-34e1-4c21-98cd-b99a3d3fbb10">6,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDEtMy0xLTEtOTUxMTc_6043512c-7537-445e-9ac9-528beb0d4e4c">5,903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDItMS0xLTEtOTUxMTc_d916a087-169f-4140-94d6-76c99cf4eade">1,545</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDItMy0xLTEtOTUxMTc_63e809c6-3ef7-4627-a60d-3c0f827b1fee">1,050</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments for OmniAb transaction costs </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDMtMS0xLTEtOTUxMTc_3c010f4e-a479-464e-870c-64fd1150cbbf">4,171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDMtMy0xLTEtOTUxMTc_7d45ec0e-e893-4b80-9d77-52265a8bf7b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDQtMS0xLTEtOTUxMTc_9535f182-43d0-469c-a3aa-543b7a16f1c2">270,692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDQtMy0xLTEtOTUxMTc_38903d8d-b60e-4c27-be95-d6d5af934b9b">141,925</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDUtMS0xLTEtOTUxMTc_38904aad-af10-4695-a631-e3dd34f58b3e">15,406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDUtMy0xLTEtOTUxMTc_26f087e8-4f38-4813-8673-d18cb9055b35">24,533</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDYtMS0xLTEtOTUxMTc_1eacfd39-4ce1-47f5-9c82-5ea51213d8ea">19,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5823b83aff4246d783748aff6ba9b978_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDYtMy0xLTEtOTUxMTc_cf365b73-4a8a-4e05-990c-77758f35ef38">47,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDctMS0xLTEtOTUxMTc_b3ab5e2c-574f-486c-8e10-a9d6a7656266">4,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd7205f82a3406b9f0c0dae4653b877_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDctMy0xLTEtOTUxMTc_f176d511-eac8-482a-b98e-0e054344a52a">23,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMS0xLTEtMS05NTExNw_a108dd8b-7e35-483f-85d9-9405eb6c207b">1,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMS0zLTEtMS05NTExNw_1f128879-6db9-41ee-8497-06f8b221001e">1,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMi0xLTEtMS05NTExNw_d71c2fc5-1b24-40c2-b5f3-4975cad67de4">6,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMi0zLTEtMS05NTExNw_2629fc90-87f8-4532-aff2-045c0f975265">3,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued fixed asset purchases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfOS0xLTEtMS05NTExNw_fc81a893-e544-4779-91e1-4e2db4a8ae23">3,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfOS0zLTEtMS05NTExNw_c259ea94-bcef-4044-b81e-90d06d485aaf">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="lgnd:AccruedInventoryPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMTAtMS0xLTEtOTUxMTc_bf1dc8c1-175f-47cc-af7c-b410a96e1b0c">7,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="lgnd:AccruedInventoryPurchases" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMTAtMy0xLTEtOTUxMTc_f3213a95-ede2-405e-8d3d-ffb895b0625b">4,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrealized loss on AFS investments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMTItMS0xLTEtOTUxMTc_dad7f8dd-948f-4e2f-a10f-049dd469eda7">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMTItMy0xLTEtOTUxMTc_f4c268f5-612d-4bd1-9154-e2ad8f0d17ce">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:90%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i2959cf3610a04d8385d1c4c227b59df4_31"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_34"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this report to &#8220;Ligand,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; and &#8220;our&#8221; refer to Ligand Pharmaceuticals Incorporated and its consolidated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.  <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMTA_1c547059-5749-4696-b057-9c9c24e3e3a7" continuedAt="i1657ebb44dd147e78741c6f7b3238f47" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1657ebb44dd147e78741c6f7b3238f47" continuedAt="i2ee4211befac491abce438cde9b80c28"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMjE_aba5baaa-0eac-4a93-8db6-642eb9aae1e5" continuedAt="ibd3e74c8e4984c4fb6d8e1a0bb47ca3d" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibd3e74c8e4984c4fb6d8e1a0bb47ca3d">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</ix:continuation>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNTg_f6d877a2-b572-426d-8af1-01b12956e645" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNDI_55ad6668-9cad-427f-969f-0593b1e44102" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;long-term deferred revenue&#8221; has been added to the condensed consolidated balance sheet, separated from &#8220;other long-term liabilities&#8221; in our prior period presentation.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMzE_43da52c2-ba32-45ae-a338-2da638b0895a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Updates, Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended September&#160;30, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $<ix:nonFraction unitRef="usd" contextRef="if3f7ea577fbe4425b5634e5fec8b8b74_I20211231" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDQwMA_72b0d118-c2f5-4719-81f2-0832fec31895">20.4</ix:nonFraction>&#160;million, reduced deferred tax liabilities by $<ix:nonFraction unitRef="usd" contextRef="if3f7ea577fbe4425b5634e5fec8b8b74_I20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDQ0MA_97bc4519-9a67-481b-a2fe-b21f3ece728b">4.4</ix:nonFraction>&#160;million, reduced additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="ibc3e336e701549d0a038218263d74105_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDQ4Mg_6d186329-9234-4ea7-8bf1-b81afb9f33f2">51.1</ix:nonFraction>&#160;million and increased retained earnings by $<ix:nonFraction unitRef="usd" contextRef="i32fea61e3e6a4354bd7504b5be38cea3_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDUyMA_a9374528-1274-4e4a-9a02-f31546cf39b1">35.1</ix:nonFraction>&#160;million. The net balance of the 2023 Notes at January 1, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ic5fe64e3bfa140528971aaeae19072a7_I20211231" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDU4MQ_e173f019-07dd-4584-bc99-9e15490d6a62">341.1</ix:nonFraction>&#160;million which included an unamortized discount of $<ix:nonFraction unitRef="usd" contextRef="ic5fe64e3bfa140528971aaeae19072a7_I20211231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDYyNg_abb0f285-da9e-4945-a16d-94e3f8b7453d">2.2</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><ix:continuation id="i2ee4211befac491abce438cde9b80c28" continuedAt="i9fd9bd476cb74de2842b1163e3d8d5dc"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNDQ_0de827d9-8a79-48e9-957d-ecc74398c79b" continuedAt="i5576f7c46701425595dfe36b9ae04659" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i9fd9bd476cb74de2842b1163e3d8d5dc" continuedAt="i5246099f093c43c3900acd5b61639306"><ix:continuation id="i5576f7c46701425595dfe36b9ae04659" continuedAt="i7319ed8cdd7d4cb1800748b107e7055f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7319ed8cdd7d4cb1800748b107e7055f">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</ix:continuation> During the three months ended September&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTEzNzc_9a460c91-2440-40f6-8a5c-a79f6419552f">4.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTEzODU_6c604096-fc4a-465f-b4b0-ddf311c93a1c">7.7</ix:nonFraction> million, respectively. During the nine months ended September&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTE0OTY_7d396ae9-1edb-4c8c-9664-e79b2557847a">8.8</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTE1MDQ_4f6eaf23-aad0-46e8-ae6f-b8a4b527de3f">22.8</ix:nonFraction> million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNTk_188746a0-6afa-4291-81e9-2f8f719de4aa" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e1f2ef2453421db235d4f5debc1ea8_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNC0xLTEtMS05NTExNw_57038b05-3c64-4a5d-9bb7-caeb6935f0c7">9,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibefdd74dcbb544c7bcd50c4bdc0ea3b1_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNC0zLTEtMS05NTExNw_35a7be80-6c16-4c32-a1fe-9ce11035fe9b">8,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic183fe3cfc0444ec988c0505dc4aac87_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNC01LTEtMS05NTExNw_cb610a8e-fab3-435c-bc98-8323ed0d7cad">20,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0662d167252447899eb4741ca4b7d49_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNC03LTEtMS05NTExNw_bf26ad93-b2cf-401b-89f8-abea884b2fa9">18,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7cd2d0377724f898a6c11769e623b6b_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNS0xLTEtMS05NTExNw_37dc01cc-d119-47c1-9003-ab9c8f8d4f4c">3,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67bfd452ca34efbabd006d69f7f34b4_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNS0zLTEtMS05NTExNw_710c16ed-8e93-4b13-b718-467f06133c98">2,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47ac025acf224b88b1f6e6ddd566bd90_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNS01LTEtMS05NTExNw_49486e65-d5ea-4858-9112-283a39b45cd6">8,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb81ed13c9ff4a1e8c098b5fdd85fce8_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNS03LTEtMS05NTExNw_b5fdc396-1740-46ad-a8d2-f39b128238e4">7,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e3e7744f301495cb31d4020806e39e6_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNi0xLTEtMS05NTExNw_ad26434c-9adf-46ef-9d2c-231a13e9cb4a">4,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36bf83f8a274b0a9bf13b0e4652e822_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNi0zLTEtMS05NTExNw_d4bdb4a5-83be-4dbf-a7fc-b6058b8b2578">2,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i827c7e6cdeac4886b9ec06b6f65e8455_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNi01LTEtMS05NTExNw_8c2e5ad7-ce22-4765-b2e4-43331ec8088a">12,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2247afa58cf4d3995002065e43ff1c7_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNi03LTEtMS05NTExNw_ae46e0b0-dc01-489b-beec-86a14ea7eb6e">2,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1971a4278a1432a897cda6cc91f0897_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNy0xLTEtMS05NTExNw_1b747ca9-490f-405e-92a2-0b349291694f">2,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7253785dc35146fc8241d38b8d7cc8bd_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNy0zLTEtMS05NTExNw_be940287-ecfc-45a0-9989-112c7bb37d6c">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48707413feb4dbab9c2496e3c59a6a0_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNy01LTEtMS05NTExNw_b4115de1-8625-4507-a037-d9ba7d97d92b">6,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a7b8932fa4845759b4d1dd6a1d7a232_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNy03LTEtMS05NTExNw_338c7e96-7b39-49d7-bd54-8a8b6fab72dd">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id95bfc92bd274c84aa1a9a7994070620_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOC0xLTEtMS05NTExNw_c28972ea-9641-4bef-9083-bd664f4ec7bd">1,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055d53a99e864487af223e1ee40ef3de_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOC0zLTEtMS05NTExNw_87a13272-90bb-4a6e-b32d-1cb2175b3455">995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i289f60c3b5684e97b642fc712cb0729d_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOC01LTEtMS05NTExNw_48e96180-9bd9-476f-a748-7f42b65cab45">3,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aca03e88f7c4ef7afd5a15c43b2a58b_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOC03LTEtMS05NTExNw_fa9e90c5-7a15-41ba-8029-307d387795b6">2,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e4c019116374680b437a7a7e84a8c80_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOS0xLTEtMS05NTExNw_867fd795-2dd9-4897-b95f-dcc052893748">19,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe9d446b7d574e0a8a446713e4e31f27_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOS0zLTEtMS05NTExNw_8d3e68bb-c6f0-41a9-bd47-e289d2e7668d">15,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6dd34ce0bee40ea82cba5bfc9584a46_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOS01LTEtMS05NTExNw_a4fc2505-6dfd-48fc-924f-84f927206aac">51,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61be445c11db419296ccc53f473da154_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOS03LTEtMS05NTExNw_135f99df-5a1d-4fae-94c5-239459308b68">31,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87b96b5149b41818034e32448024dfb_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTItMS0xLTEtOTUxMTc_df44eac8-6fc1-4373-954f-d6825b0310da">3,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eac10c65b1641ffa06188a690f2aca9_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTItMy0xLTEtOTUxMTc_4451be74-558f-40c9-bf4f-0a89bc0bf57f">5,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba465a7198d54ee7b6ad82d779858fd9_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTItNS0xLTEtOTUxMTc_f0602c01-454f-479f-8720-9be33d887744">13,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5fa29dc2e848a7b2ac184d57a87bc3_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTItNy0xLTEtOTUxMTc_14b4ed35-b1d4-4c5a-b77f-825da5ad4196">16,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904cf14c4b3e4fbeb3f577b716e29d42_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTMtMS0xLTEtOTUxMTc_1da8ccfa-1890-4b90-959d-0f887d85ba9e">32,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22143b247d14e49b1f87a41cebc0533_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTMtMy0xLTEtOTUxMTc_3612a063-a261-4671-bb21-ea4121572dc4">29,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0411fb172a764e2e92a29821f037280d_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTMtNS0xLTEtOTUxMTc_f52735f6-d080-41eb-b6d7-ea519110f050">64,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78881cd8932b4b9093df9eaafe0b57dc_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTMtNy0xLTEtOTUxMTc_c33e1752-5fe8-429a-93a6-4436186df1db">112,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27111ff24358446e8f6742f1a9a22280_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTQtMS0xLTEtOTUxMTc_a64c5692-b06a-4db8-af51-d0db910159b6">35,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i805b7ce49b9b477ab1a86dfcd8f4b896_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTQtMy0xLTEtOTUxMTc_dae16cdf-a8bc-4135-94d2-8c5e010e5f77">35,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc5e665d17d410bbc8f43e5ef950091_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTQtNS0xLTEtOTUxMTc_42f278c7-5a88-4e69-920d-9499c0d1fd25">77,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68593efff0be4bcea82e054922dea281_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTQtNy0xLTEtOTUxMTc_7365b6af-6468-4427-9f86-5ef34fa4b576">128,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c61f74a4ae46dfa6cd20104936b527_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTctMS0xLTEtOTUxMTc_8c98c8da-cdc2-40ee-971f-af419560b1b7">4,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588e8adf3218428d9d65e76ec58ffcb2_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTctMy0xLTEtOTUxMTc_df85113b-938e-4c53-9613-2f1ac7cec8c1">4,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia44ee73068f14175b5fd0992341adbfb_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTctNS0xLTEtOTUxMTc_b2777036-129e-4f6a-99a7-dae42b8f7769">15,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d398f1cb1742cc900354e71b1ecc8b_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTctNy0xLTEtOTUxMTc_e57d506a-c39a-44b8-a023-6b896a2e3721">17,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieedc3bed7980424b96288a7a097ef23f_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTgtMS0xLTEtOTUxMTc_3a156ecc-0be1-45fb-9c04-f0b1659e9995">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b25204e1c1e45449277f115819b751e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTgtMy0xLTEtOTUxMTc_d67d09f5-3990-47d3-9a04-0b6f9b95ed90">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9683e5a36df8493692166626aea2d25e_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTgtNS0xLTEtOTUxMTc_5971e621-a4c5-471d-adf0-5b1b114994a7">5,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b3ad9c76fcb49c091bef77b6c7f4ab3_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTgtNy0xLTEtOTUxMTc_dfedbeab-aa09-427a-b63d-351a148ab225">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ac29ea1484471db0a5f3a8814367c8_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTktMS0xLTEtOTUxMTc_4b6c67b3-8d62-4185-89df-cbc4c14e5fda">3,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0a1285ff321448588acc1bf40c5d032_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTktMy0xLTEtOTUxMTc_885f71e0-516a-44ec-99f4-834bbad341e3">7,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7911ef49fdd142e7b67a65d73023df8c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTktNS0xLTEtOTUxMTc_aea35ea4-cc02-4aee-84d7-039bc05ad45f">14,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a70bf5a0b90462f88245ce9197a2e96_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTktNy0xLTEtOTUxMTc_2772a214-1a99-40ec-ba2e-f68d20bfc082">19,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i123c75669efe43bd9dc15885da57a867_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjAtMS0xLTEtOTUxMTc_1073c771-f9f3-416b-9f98-5f69a4e93b50">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c920df29ac544cd8c6902919042761f_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjAtMy0xLTEtOTUxMTc_893e6be3-017d-48ac-ab5c-89492094a722">1,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7c767ef41d54b72a2eec06f317f26a3_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjAtNS0xLTEtOTUxMTc_84f267c3-e9c2-4cfb-ad18-0678e80e5f98">5,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e6619944924d099ebf2550f8a566da_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjAtNy0xLTEtOTUxMTc_a0feb3a7-dc0c-471d-a1d2-14a9235df642">5,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c883799387843e28ad63ef5c7a3a928_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjEtMS0xLTEtOTUxMTc_8a9326d3-0c6e-483e-b143-da2356f650d5">10,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca791879e154b79899726f73ac30955_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjEtMy0xLTEtOTUxMTc_38574fce-a3b4-4bbf-8b99-d4f4a587e2e6">14,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb48e049cd074424a4b9c75318b0968f_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjEtNS0xLTEtOTUxMTc_66a28e58-401c-46ba-8364-d22cfdd70038">40,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d5bd9d373e34f7ab0ab2dc3b00f0266_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjEtNy0xLTEtOTUxMTc_39c25d4c-0c33-494a-96a3-e6f959f44d92">44,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjItMS0xLTEtOTUxMTc_e3ee8a0b-45c4-4dab-b11d-ed4f5b135ddb">66,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjItMy0xLTEtOTUxMTc_66912aec-1989-45ad-84d3-175ff1debcd4">64,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjItNS0xLTEtOTUxMTc_8b453162-5194-424f-9b25-61b23b45f190">169,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjItNy0xLTEtOTUxMTc_fc70c55f-326a-49c1-b12f-e1af4c4aee0c">204,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i5246099f093c43c3900acd5b61639306" continuedAt="i46115a54b57b48249f793a8748ea832e"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="lgnd:ScheduleOfShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMjQ_331cb454-434e-41ed-ba4d-2a3b0a63cb49" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at September&#160;30, 2022 and December 31, 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:38.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2a7c797d8541648d78aca099e523a0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMi0xLTEtMS05NTExNw_9f16ad40-8abb-4ef0-bf76-f7d43c3b2a8b">2,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2a7c797d8541648d78aca099e523a0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMi00LTEtMS05NTExNw_9db1fd82-b110-489c-9d0b-71f02aa1b262">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc2a7c797d8541648d78aca099e523a0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMi03LTEtMS05NTExNw_a2191132-5ce9-4e81-a6a2-ce772936b65a">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2a7c797d8541648d78aca099e523a0_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMi0xMC0xLTEtOTUxMTc_c04220c7-5769-4b2f-a31e-fa8d720ec8b2">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id269671958804d059d42ec1bf2798d24_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMy0xLTEtMS05NTExNw_1eb95133-e76a-4901-abf3-fd3687f9a108">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id269671958804d059d42ec1bf2798d24_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMy00LTEtMS05NTExNw_58dbd9f8-4c99-4df4-a63f-d1f1ccda7964">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id269671958804d059d42ec1bf2798d24_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMy03LTEtMS05NTExNw_8486e85d-d237-46ca-a32e-cc397b29b416">107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id269671958804d059d42ec1bf2798d24_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMy0xMC0xLTEtOTUxMTc_ca67ae68-af3d-4611-b155-f866b05959b7">4,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350e5ed791be46a4b5d11307ffa4cb26_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNi0xLTEtMS05NTExNw_6cd1aa18-c9d2-45cc-8b30-8e987cb0f855">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350e5ed791be46a4b5d11307ffa4cb26_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNi00LTEtMS05NTExNw_1b7df2ef-e8a6-4d08-ad9f-23a0532f6167">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i350e5ed791be46a4b5d11307ffa4cb26_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNi03LTEtMS05NTExNw_08f975e3-6f6e-4f46-8c71-90f7f01c8d6d">3,615</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350e5ed791be46a4b5d11307ffa4cb26_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNi0xMC0xLTEtOTUxMTc_05db9da9-c983-4da4-b927-8730ab25f23b">2,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662334cf40d54566bec6fe57077ce69e_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNy0xLTEtMS05NTExNw_a90c446a-67af-4cbd-a65d-d33a9952c4eb">88,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662334cf40d54566bec6fe57077ce69e_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNy00LTEtMS05NTExNw_5a0055f0-37b6-4498-8f34-56a22ffb762c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i662334cf40d54566bec6fe57077ce69e_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNy03LTEtMS05NTExNw_6d6b5b56-4348-4549-b91c-91c2bb1aaead">1,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662334cf40d54566bec6fe57077ce69e_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNy0xMC0xLTEtOTUxMTc_244496de-7bf2-4cb7-8c5a-d643e3730b35">86,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f8d4ffb4a142d89bec0b51469e199e_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOC0xLTEtMS05NTExNw_2159d594-5f7e-4447-a462-9c4b3159fef5">2,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f8d4ffb4a142d89bec0b51469e199e_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOC00LTEtMS05NTExNw_b3697db4-7c21-4fb9-b06e-591205969f17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06f8d4ffb4a142d89bec0b51469e199e_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOC03LTEtMS05NTExNw_5f6c5677-fc9b-43dd-899a-4bd7d4c626fc">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06f8d4ffb4a142d89bec0b51469e199e_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOC0xMC0xLTEtOTUxMTc_0b501138-3bf0-4f35-8866-181b3a06598a">2,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie20dcecc9b97461eb7567478745a495f_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOS0xLTEtMS05NTExNw_079c2c62-60af-49ac-95e5-6eec016f1648">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie20dcecc9b97461eb7567478745a495f_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOS00LTEtMS05NTExNw_2665fc1a-ffd6-4552-bb01-fcec665cc4a7">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie20dcecc9b97461eb7567478745a495f_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOS03LTEtMS05NTExNw_20808dd2-fd05-4e95-a7df-b78b36828506">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie20dcecc9b97461eb7567478745a495f_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOS0xMC0xLTEtOTUxMTc_b3759c01-5c01-49fc-8a4d-8696df225d5e">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTAtMS0xLTEtOTUxMTc_bb54d691-a265-45cf-9f96-3f829cc6a0f8">103,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTAtNC0xLTEtOTUxMTc_301f2df2-10e1-4de8-826f-1cf4975ae514">544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTAtNy0xLTEtOTUxMTc_0a3be26b-2d97-4c86-9648-681ab7f894a0">5,062</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTAtMTAtMS0xLTk1MTE3_dcb90c70-d0e5-4317-819c-51b2465f4090">99,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabc8605b5b5b4402bfa40c6f86cc4521_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTEtMTAtMS0xLTk1MTE3_b6111116-e8c2-4fd1-8992-0bb553692c93">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTItMTAtMS0xLTk1MTE3_8242ff67-f535-4dbc-937c-44fa1a7d6485">117,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic07a20125b6b4a8ebfc0faae2187f7dd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTUtMS0xLTEtOTUxMTc_0bf04d66-f51f-4f4b-8f88-3ddd88c4ae8d">63,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic07a20125b6b4a8ebfc0faae2187f7dd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTUtNC0xLTEtOTUxMTc_795e4c52-7e1c-4640-bdd6-5bdfc83d93f2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic07a20125b6b4a8ebfc0faae2187f7dd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTUtNy0xLTEtOTUxMTc_06bf4995-ca43-4a78-8b0f-e65a506f13f5">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic07a20125b6b4a8ebfc0faae2187f7dd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTUtMTAtMS0xLTk1MTE3_561a10b9-2a3b-462c-8df6-097676a9fa01">63,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317970eca87540b8b1481240b27a7411_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTYtMS0xLTEtOTUxMTc_5f499a25-deec-455d-a371-62547f320bb6">29,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317970eca87540b8b1481240b27a7411_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTYtNC0xLTEtOTUxMTc_d7165828-84b9-4529-a18f-a483047ec40e">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i317970eca87540b8b1481240b27a7411_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTYtNy0xLTEtOTUxMTc_0e681206-3cfa-4080-9e49-fe8eb454fc5a">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317970eca87540b8b1481240b27a7411_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTYtMTAtMS0xLTk1MTE3_65cc0c60-b588-4a30-a087-f2c0800a117c">29,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida31cd3b48ce4d1e9d75b4ab666e503d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTgtMS0xLTEtOTUxMTc_09bf0da3-6ec7-46cf-ab52-a9d699a79665">36,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida31cd3b48ce4d1e9d75b4ab666e503d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTgtNC0xLTEtOTUxMTc_991821a8-736d-48bb-afe6-edf2a0964e04">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida31cd3b48ce4d1e9d75b4ab666e503d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTgtNy0xLTEtOTUxMTc_c44cde08-ad23-4a53-9d97-69b44ee38c75">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida31cd3b48ce4d1e9d75b4ab666e503d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTgtMTAtMS0xLTk1MTE3_74f5614e-2e25-4e64-bffa-d11a1bff5449">35,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifba74fb91aff4709a648d885a295772a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTktMS0xLTEtOTUxMTc_d61e17fb-1e13-475a-bd48-e683481453d3">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifba74fb91aff4709a648d885a295772a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTktNC0xLTEtOTUxMTc_6f80efb6-883a-44af-b16f-50368e88c5e5">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifba74fb91aff4709a648d885a295772a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTktNy0xLTEtOTUxMTc_3cad0a9b-f079-4813-bff3-13b89db76ff3">2,027</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifba74fb91aff4709a648d885a295772a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTktMTAtMS0xLTk1MTE3_0ea881c0-00a6-4fed-a491-5395fb25f37b">4,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb3f202176743cfbfef35c2aa9a206a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjAtMS0xLTEtOTUxMTc_e8773faa-8f03-4e14-9c0c-d4ecec7327ec">152,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb3f202176743cfbfef35c2aa9a206a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjAtNC0xLTEtOTUxMTc_e63aa59c-c344-44f2-a790-5d455db946ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibeb3f202176743cfbfef35c2aa9a206a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjAtNy0xLTEtOTUxMTc_ba2f2489-86b9-4718-bf07-8185b6546077">249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb3f202176743cfbfef35c2aa9a206a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjAtMTAtMS0xLTk1MTE3_ccc8c5e3-2e97-4999-b055-f40dbd32b248">151,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd672b4aeff947f2be4d57e9a811d2b2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjEtMS0xLTEtOTUxMTc_fb4090be-19f0-4330-a2e3-d53e8512fee3">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd672b4aeff947f2be4d57e9a811d2b2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjEtNC0xLTEtOTUxMTc_2a3739c1-a30a-48b0-94a6-bbf5b0203434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd672b4aeff947f2be4d57e9a811d2b2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjEtNy0xLTEtOTUxMTc_223a40c7-da23-4680-b251-6f867007d753">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd672b4aeff947f2be4d57e9a811d2b2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjEtMTAtMS0xLTk1MTE3_2998420e-17e8-4aa7-bc74-5a31508222b4">5,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20e1b9d42dae41b3b8d258ee144a3142_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjItMS0xLTEtOTUxMTc_e8247742-069d-4f56-836d-b815e3dac175">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20e1b9d42dae41b3b8d258ee144a3142_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjItNC0xLTEtOTUxMTc_4ad83d87-5618-43a9-a18e-2bfb6e41161e">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20e1b9d42dae41b3b8d258ee144a3142_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjItNy0xLTEtOTUxMTc_669e77b3-0d77-464c-b416-94613d728213">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20e1b9d42dae41b3b8d258ee144a3142_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjItMTAtMS0xLTk1MTE3_bcdce107-4d42-43c3-963f-e916b9acdee0">408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjMtMS0xLTEtOTUxMTc_c49782d2-5290-4dd7-bd2e-1db18f2e284e">292,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjMtNC0xLTEtOTUxMTc_1a4a919d-7284-40b2-a0d9-2bc25d52018e">842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjMtNy0xLTEtOTUxMTc_8644531b-8600-4205-a6a9-fe04ad0e7e13">2,370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjMtMTAtMS0xLTk1MTE3_584be315-af05-460f-9616-323f97849a41">290,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice501f8f87084c9b8479455e8bbbc32d_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjQtMTAtMS0xLTk1MTE3_73c29727-7cca-4312-8141-52a3ddb3fa56">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjUtMTAtMS0xLTk1MTE3_d4d6260c-0630-4a6b-af1f-24da938298a7">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and nine months ended September&#160;30, 2022.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNjA_b731cebe-46d7-49ed-9c26-7102e70b6ca9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfMi0xLTEtMS05NTExNw_56d04892-ab70-4737-8b91-e6803a02abe4">8,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfMi0zLTEtMS05NTExNw_e5432ffa-b764-4ecb-8fa2-b2bd1a5c3d36">8,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfMy0xLTEtMS05NTExNw_536d57ee-844c-4491-b0d1-ceb39ea115c7">982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfMy0zLTEtMS05NTExNw_ecb836d9-8f78-43d2-8b38-8668340981bd">939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfNC0xLTEtMS05NTExNw_e4dfafd4-e873-4cc6-9ec9-4f39065e1ce8">9,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfNC0zLTEtMS05NTExNw_b9775c27-78db-4d69-8252-5901540bcdf3">9,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of <ix:nonFraction unitRef="position" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTI4MzU_4d2bf840-65db-4c01-8edd-39a04175174c">8</ix:nonFraction> positions which were in an unrealized loss position as of September&#160;30, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, <ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTM0NTU_59272c1a-5218-4756-a85a-6cd1de1bfd7a">no</ix:nonFraction> credit losses were recognized for the three and nine months ended September&#160;30, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i46115a54b57b48249f793a8748ea832e" continuedAt="i7819afd5835f49e9a2efcf8b6800f163"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNjY_9dd1e5d5-7fae-43df-9b4e-9480e3c7b64f" continuedAt="i5e26005dfe53409da708d38fad349803" escape="true">Accounts Receivable and Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5e26005dfe53409da708d38fad349803">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</ix:continuation> During the three and nine months ended September&#160;30, 2022, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $(<ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-5" sign="-" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfODc5NjA5MzA0Mzc4Nw_3a14767e-1042-4eb7-9a2f-09e746516a12">0.1</ix:nonFraction>)&#160;million and $(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-5" sign="-" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfODc5NjA5MzA0MzgwMw_d0d052e1-a4d1-42e3-8506-c5bbac6d6045">0.3</ix:nonFraction>)&#160;million of allowance for credit losses, respectively, as of September&#160;30, 2022.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMjg_38294fc0-220e-441e-94b6-176d8fd3f100" continuedAt="id7384019f33e4bb8b2daff86193436ad" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id7384019f33e4bb8b2daff86193436ad">We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three and nine months ended September&#160;30, 2022 and 2021. As of September&#160;30, 2022 inventory consists of Captisol prepayments of $<ix:nonFraction unitRef="usd" contextRef="i1f2f5a4645194ff8ac4a43834225e441_I20220930" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTUxMzc_33bb5634-0c2d-43a8-95f1-593b26df5243">7.4</ix:nonFraction>&#160;million, and as of December 31, 2021 inventory consists of Captisol prepayments of $<ix:nonFraction unitRef="usd" contextRef="i51243c6c92784f7f9b969f7ff8364956_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTUyMTU_691a5d87-00e3-4d7b-ba82-9b600d71751c">24.6</ix:nonFraction>&#160;million.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMzI_30a65b4e-22b0-4810-adc4-7a9dedf5241b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMy0xLTEtMS05NTExNw_fb3fb198-21f3-4196-b9ce-7c1ca13c868e">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMy0zLTEtMS05NTExNw_ff3280bb-f939-4976-a35d-fc3778e0f009">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89e441071a94390acf735662b9d84ca_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNS0xLTEtMS05NTExNw_46cffbcd-b072-4256-abf1-ffa3d34c06c3">282,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i879eebb5a7c3459ebc5f9e1980194ee7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNS0zLTEtMS05NTExNw_a15797c8-a905-4e90-81b9-c407bef9f2fa">280,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie89e441071a94390acf735662b9d84ca_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNi0xLTEtMS05NTExNw_f0e92425-6287-4956-afae-410845207a10">90,611</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i879eebb5a7c3459ebc5f9e1980194ee7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNi0zLTEtMS05NTExNw_4506155d-bfcf-4a5f-b20a-b00256f7d966">78,991</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949f68cec8414dfb8cf22d6f87aad59c_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNy0xLTEtMS05NTExNw_47f7ed42-7f65-4c30-a83d-24213763a710">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4422300f314cb5b2c8b76da9076612_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNy0zLTEtMS05NTExNw_b9ef4945-f41a-43d7-97af-386205887517">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i949f68cec8414dfb8cf22d6f87aad59c_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfOC0xLTEtMS05NTExNw_45a545c7-0f69-440a-bc70-0a6554cb625d">1,544</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d4422300f314cb5b2c8b76da9076612_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfOC0zLTEtMS05NTExNw_d20d2d05-a630-4111-aaf0-bc90017aa6b1">1,444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e7975e74c64f75b300ebf474efc3d0_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfOS0xLTEtMS05NTExNw_5afaedb6-1b85-4b26-89ed-2502998370a2">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdfc802ffcea4059bb816a071f7ed3b8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfOS0zLTEtMS05NTExNw_9daf8c7d-1a28-44ae-abc2-98a60da2765b">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65e7975e74c64f75b300ebf474efc3d0_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTAtMS0xLTEtOTUxMTc_c714a3f9-d459-481b-91d3-354d2492a600">20,272</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdfc802ffcea4059bb816a071f7ed3b8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTAtMy0xLTEtOTUxMTc_e9ec322e-cf91-4618-98a6-6e06e632410f">18,267</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5860738973c46b7b442c1e31a1fa1b4_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTEtMS0xLTEtOTUxMTc_22ab745b-2898-45e3-aded-cbd835523bf2">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8078205bd5974127a86e504b140fa260_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTEtMy0xLTEtOTUxMTc_7bde9173-1d4d-4649-9315-63de6b1ac0ef">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5860738973c46b7b442c1e31a1fa1b4_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTItMS0xLTEtOTUxMTc_93b65414-db30-4ecd-81c4-43b108479394">57,947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8078205bd5974127a86e504b140fa260_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTItMy0xLTEtOTUxMTc_fa980bbe-a958-431b-89c5-bed87ad84537">36,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTMtMS0xLTEtOTUxMTc_e5ba7fc7-d786-434e-a373-485ab4c9c24e">698,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTMtMy0xLTEtOTUxMTc_d3965b63-0501-44ff-9f20-9e5b12318fc9">732,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2022, we only had <ix:nonFraction unitRef="reporting_unit" contextRef="ice5667b832bb46b58768234cec087173_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTUzOTQ_2e3b0cc6-85df-4892-a946-c56e3de858d0">one</ix:nonFraction> reporting unit and reportable segment. In connection with the announcement in March 2022 of our intention to separate the OmniAb business pursuant to a distribution to Ligand&#8217;s stockholders of Ligand&#8217;s shares in OmniAb followed by a merger with APAC, management concluded that we had two reporting units and reportable segments - the OmniAb business and the Ligand core business. See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. We performed a fair value analysis utilizing a combination of income approach and market approach to determine the fair value of each segment in order to appropriately allocate the goodwill between the segments as of the announcement date. <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMzY_9e9637d2-7397-4594-9f9f-ec5b99a7c074" continuedAt="i2157f15e88734ee19b207435607fc585" escape="true">The following table presents our allocation of goodwill balance by segment (in thousands): </ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="i2157f15e88734ee19b207435607fc585"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:84.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ligand core business</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i365d6d6bcee9448fa1c6ab3aa3d86e82_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjFiN2Q3NGM0MDc0NzQ4MDJiNDljYzA4ODZhNWVjZThjL3RhYmxlcmFuZ2U6MWI3ZDc0YzQwNzQ3NDgwMmI0OWNjMDg4NmE1ZWNlOGNfMi0xLTEtMS05NTExNw_b29a031a-5118-4537-8d74-897e85648d5a">105,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">OmniAb business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if1caa4c3cd5f4732bfdc25dc6f6a9796_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjFiN2Q3NGM0MDc0NzQ4MDJiNDljYzA4ODZhNWVjZThjL3RhYmxlcmFuZ2U6MWI3ZDc0YzQwNzQ3NDgwMmI0OWNjMDg4NmE1ZWNlOGNfMy0xLTEtMS05NTExNw_da131ab1-2597-4930-80f4-3fedb81ffa8b">75,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjFiN2Q3NGM0MDc0NzQ4MDJiNDljYzA4ODZhNWVjZThjL3RhYmxlcmFuZ2U6MWI3ZDc0YzQwNzQ3NDgwMmI0OWNjMDg4NmE1ZWNlOGNfNC0xLTEtMS05NTExNw_99a90d57-7af9-4263-a248-581d22b2649f">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i7819afd5835f49e9a2efcf8b6800f163" continuedAt="i9f85d21cb90e4d09b3ffb77a2f7688ce"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="lgnd:CommercialLicenseRightsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMjk_bbbc4a0f-3dc8-4f2e-bacf-e5637aaf5f8f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Commercial License Rights</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNTA_0bb8aa29-0bae-4882-83c6-b051598d85cb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b95b921442e4621abaf805c9c6698fa_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi0yLTEtMS05NTExNw_0455efa8-0077-4966-b781-2dc89c929f6f">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b95b921442e4621abaf805c9c6698fa_I20220930" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi00LTEtMS05NTExNw_eb90dd3f-a5f4-4d8f-9ff2-7a34c7cfa48f">9,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b95b921442e4621abaf805c9c6698fa_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi02LTEtMS05NTExNw_d2f7ea47-84fc-4c5c-bce1-0fa34b826306">8,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c69d20029b545489f7ca2234d28aaa8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi04LTEtMS05NTExNw_fba83ee6-a778-4915-8199-83c6c10d86b0">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c69d20029b545489f7ca2234d28aaa8_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi0xMC0xLTEtOTUxMTc_1170cb68-9604-4f14-92f0-6e04ab1d52a3">9,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c69d20029b545489f7ca2234d28aaa8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi0xMi0xLTEtOTUxMTc_e214f348-26ae-4905-857e-e1d27f2f22e8">8,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f41ef6652948d1841b05a5469daf7f_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy0yLTEtMS05NTExNw_fc0f3d50-336a-4064-8edc-df1641574673">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73f41ef6652948d1841b05a5469daf7f_I20220930" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy00LTEtMS05NTExNw_0a9e80be-5fb0-4218-a96e-5d635bb6eb20">8,650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f41ef6652948d1841b05a5469daf7f_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy02LTEtMS05NTExNw_1efa762c-aade-48f8-bb16-e5090a4451cc">1,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf12e3a53a14d8eb42d4b89b7cf304d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy04LTEtMS05NTExNw_5e07d225-7a8b-4d98-a078-c66d094da565">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cf12e3a53a14d8eb42d4b89b7cf304d_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy0xMC0xLTEtOTUxMTc_8d256374-33ea-4497-a9d3-c128c3707742">8,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf12e3a53a14d8eb42d4b89b7cf304d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy0xMi0xLTEtOTUxMTc_cfcb9a8d-1eb0-498b-9059-2f6aa2d95e14">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85097cc30914531bce5696bfe9a1638_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC0yLTEtMS05NTExNw_8491a837-586f-40a4-94d3-fca373cb7fc3">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie85097cc30914531bce5696bfe9a1638_I20220930" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC00LTEtMS05NTExNw_d9c24d9b-c078-491f-8c9e-5da1ec33aff3">18,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85097cc30914531bce5696bfe9a1638_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC02LTEtMS05NTExNw_e8d9882a-17b2-4fad-89e9-2372356a4074">10,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebb3d8dffba494eaf509dc473ba5887_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC04LTEtMS05NTExNw_5c208899-6603-4e54-9806-33ba9d8ffae9">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ebb3d8dffba494eaf509dc473ba5887_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC0xMC0xLTEtOTUxMTc_c14f3f8c-3394-44df-ba01-b9208d2adb3f">18,188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebb3d8dffba494eaf509dc473ba5887_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC0xMi0xLTEtOTUxMTc_2ea86c25-86f1-48a1-9017-6c25d80cb8d0">10,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="ie85097cc30914531bce5696bfe9a1638_I20220930" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTA5OTUxMTY0OTI0NA_bf466789-2968-4a62-af0a-8855c9d88c00">11.6</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="ie85097cc30914531bce5696bfe9a1638_I20220930" decimals="-5" sign="-" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTYzNzA_1f252207-8cd4-4e3a-8b0b-5742b73ad6cc">6.5</ix:nonFraction> million as of September&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="i3ebb3d8dffba494eaf509dc473ba5887_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTY0NDY_52a4fcee-07a0-411f-9b1f-e885ab2dcf34">11.7</ix:nonFraction> million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="i3ebb3d8dffba494eaf509dc473ba5887_I20211231" decimals="-5" sign="-" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTY0ODA_fe18cb70-eb0a-411b-9c44-b43ca1578554">6.5</ix:nonFraction>&#160;million as of December&#160;31, 2021.</span></div></ix:nonNumeric><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three and nine months ended September&#160;30, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of September&#160;30, 2022.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMTk_7516a228-bbd9-4606-9ed7-7d915457472c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMi0xLTEtMS05NTExNw_ccc3ca67-8b5a-48df-b77c-7a11df7985c9">6,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMi0zLTEtMS05NTExNw_a9fe48a0-7d5a-4838-92a0-47dc28615dac">6,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMy0xLTEtMS05NTExNw_f9e71b1d-ef44-4a24-a2d9-f180a31efdfd">2,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMy0zLTEtMS05NTExNw_d900de1b-a7bf-466a-affb-d8b7562907f2">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:LicenseeAccrualCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNC0xLTEtMS05NTExNw_c19a568a-9819-4e8e-b6d1-85473d5a62eb">4,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNC0zLTEtMS05NTExNw_34ae7bca-9ff3-4911-a70a-bd3041213f51">630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:ReturnsAccrual" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNi0xLTEtMS05NTExNw_abd18448-ea9c-4465-b3e0-ebdd74227092">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:ReturnsAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNi0zLTEtMS05NTExNw_576d25f2-f180-4fb9-9643-62d883ba4507">2,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:AccruedAssetAcquisitionsCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNy0xLTEtMS05NTExNw_90a1fdc8-68ce-4033-a037-86cd0793a7c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:AccruedAssetAcquisitionsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNy0zLTEtMS05NTExNw_3b65b655-b19a-444e-86c5-c58166384e37">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfOC0xLTEtMS05NTExNw_1aa326b5-e89f-4ab3-8b60-2516b7e95c6e">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfOC0zLTEtMS05NTExNw_1cb2810c-d91a-4c02-b3cd-9de3751ca856">1,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMTEtMS0xLTEtOTUxMTc_6ab36aa8-8906-4dee-8edd-a75cb9671f10">4,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMTEtMy0xLTEtOTUxMTc_05232490-31da-428c-ba6b-ba6dc890d83a">3,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMTItMS0xLTEtOTUxMTc_329df2c8-ccfb-4ebf-9f22-7868b3ce3c31">19,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMTItMy0xLTEtOTUxMTc_0f3ef5e4-d954-42c6-8044-d5e5f77a8c1d">17,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMTU_1aa483fd-e9aa-4c30-842b-be07b727e0d3" continuedAt="i57a51c11f161403183faacfa036d3bbd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMzg_28dadd29-6323-4144-8f33-6bccf6e1ddac" continuedAt="i2afefd4d7b394f87ad14cab2b603c547" escape="true">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="i2afefd4d7b394f87ad14cab2b603c547"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.870%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i321200c90e1841ba98e56d96bd03dca8_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy0xLTEtMS05NTExNw_2a1cf51b-2cb4-42f8-aab1-fc6e16f1a025">6,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b98503fe3c47908678fecb01ff99d3_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy0zLTEtMS05NTExNw_51954843-bb6f-4632-b3f1-cf6589f4e3fd">4,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1920d37ac7d74b39bb53487c74e6eddb_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy01LTEtMS05NTExNw_82fa6b7d-10fa-4139-ae1b-55dcdc88f643"><ix:nonFraction unitRef="usd" contextRef="i1920d37ac7d74b39bb53487c74e6eddb_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy01LTEtMS05NTExNw_b043c680-f53d-41b9-a9fe-095fdc59ec45">14,519</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b02440b88c044d992035080107197f1_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy03LTEtMS05NTExNw_d2e6a29e-9ec8-4da1-9cb2-6567c012b25d"><ix:nonFraction unitRef="usd" contextRef="i3b02440b88c044d992035080107197f1_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy03LTEtMS05NTExNw_fefe5650-f2a8-450c-9978-f3b6b13ab268">12,975</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62640c7e221d4ddf9f77e8cd49490c14_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC0xLTEtMS05NTExNw_7fc44f67-d004-45bf-b8f2-a029987a792c">6,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad2aaa41970748678e953d111259e623_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC0zLTEtMS05NTExNw_284aaf16-e7bd-43c7-9144-615986f22cf4">5,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e5382a24354732b90a0c8d7480439c_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC01LTEtMS05NTExNw_0acf3b6c-50db-4318-bbe9-67c46ffa6343"><ix:nonFraction unitRef="usd" contextRef="if3e5382a24354732b90a0c8d7480439c_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC01LTEtMS05NTExNw_2b0ddccb-c39b-40d1-8e11-076df1adddba">16,621</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic86919d9459445b0acb504ef008126cb_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC03LTEtMS05NTExNw_a1c8e842-49bd-4999-ba5c-fecc8210b053"><ix:nonFraction unitRef="usd" contextRef="ic86919d9459445b0acb504ef008126cb_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC03LTEtMS05NTExNw_e33a9416-a7ae-4e9d-b3b1-f2905745d5e8">15,400</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNS0xLTEtMS05NTExNw_c5d75063-1771-467d-973a-20d626ea8375">12,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNS0zLTEtMS05NTExNw_97e81475-532f-4ef5-be46-029f8cab169b">9,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNS01LTEtMS05NTExNw_4e72da9c-4cc9-476f-b946-445e783f3cfc">31,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNS03LTEtMS05NTExNw_e49058c2-fcf1-49d5-adf8-04c7d08d2497">28,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNTM_36023a55-0c3c-4579-987f-424fdf82b21c" continuedAt="id7d3329132e84cd4820e57de652649cb" escape="true">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</ix:nonNumeric></span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i9f85d21cb90e4d09b3ffb77a2f7688ce" continuedAt="i57fe3833c4dd48a39f42c9a430d874a7"><ix:continuation id="i57a51c11f161403183faacfa036d3bbd"><div><ix:continuation id="id7d3329132e84cd4820e57de652649cb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy0xLTEtMS05NTExNw_33f0922d-42d9-4554-ae94-23a7734b6e45">2.8</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy0zLTEtMS05NTExNw_5a2a8c94-ce15-4eb2-8385-66c34b88a00f">0.8</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy01LTEtMS05NTExNw_6f1ae708-641b-4cf6-ab19-aa3e4a628c2d"><ix:nonFraction unitRef="number" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy01LTEtMS05NTExNw_960266da-d30f-48ca-b5a4-dc9586797b01">2.9</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy03LTEtMS05NTExNw_263422a4-fc65-42b9-b7ae-35fb8af2959e"><ix:nonFraction unitRef="number" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy03LTEtMS05NTExNw_6a479f1d-ecc1-484f-adec-4e24e8051c17">0.5</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC0xLTEtMS05NTExNw_79585a30-4685-470e-ad75-3b1d9fcc058b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC0zLTEtMS05NTExNw_ddefe8f5-1206-438f-96db-14ff9586a21d">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC01LTEtMS05NTExNw_659a5478-eeac-4ee7-813a-e6cce4f07481"><ix:nonFraction unitRef="number" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC01LTEtMS05NTExNw_c29c7b44-5dc4-41f1-9a6d-cfd103b33ff3">&#8212;</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC03LTEtMS05NTExNw_34db0b39-7ec9-4e02-b49a-62fcdcaae7cf"><ix:nonFraction unitRef="number" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC03LTEtMS05NTExNw_90ac3f3a-ce8c-483d-958f-4157f5083dee">&#8212;</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS0xLTEtMS05NTExNw_379f2653-cd68-4ded-a677-eb92162e040a">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS0zLTEtMS05NTExNw_ca0ad918-9380-4c08-befc-dd5b5f550626">48</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS01LTEtMS05NTExNw_6a4cd086-79f6-4bec-bbab-61f1ce067400"><ix:nonFraction unitRef="number" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS01LTEtMS05NTExNw_da24d1fb-e177-46a5-9185-71acacc5cc04">50</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS03LTEtMS05NTExNw_1864e436-83f7-4233-befb-2e156a181f67"><ix:nonFraction unitRef="number" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS03LTEtMS05NTExNw_436ab003-02cc-4c1d-88b6-6714c7753bd5">61</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNi0xLTEtMS05NTExNw_0c09ef6f-20cb-48ec-ac28-43404c3f84aa">4.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNi0zLTEtMS05NTExNw_17ffd122-9dfd-4cb0-8336-21780891e26a">4.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNi01LTEtMS05NTExNw_532fc20a-0220-4745-b307-e9d0301312ad">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNi03LTEtMS05NTExNw_4b118792-8d51-4546-93b2-c37ce4e3aa7a">5.0</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a <ix:nonNumeric contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNzM_874a4263-2822-4238-84e8-cf0935b515b3">three-year</ix:nonNumeric> performance period, with a range of <ix:nonFraction unitRef="number" contextRef="i3f173828d5bf43d3b40f98cfda636157_D20220101-20220930" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTg4MzM_e1b003fa-3510-45e2-88f5-796b9ff5cef5">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i09fce991826e4593a4adb710b13eee0f_D20220101-20220930" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTg4Mzk_50052ea1-0c3e-4eb2-b6c1-7209450b77a4">200</ix:nonFraction>% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNDc_e9e35d6b-4c0a-4a4c-b8cd-e1716639825f" continuedAt="i64a9b8fc65e44c09a62ecba76fec408a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i64a9b8fc65e44c09a62ecba76fec408a">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards.</ix:continuation> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMjY_7011037e-b5c0-4f2f-946e-f16fa1c9bed1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.293%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy0xLTEtMS05NTExNw_69130f1f-9ba1-4fa4-b992-3ad29970fb64"><ix:nonFraction unitRef="shares" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy0xLTEtMS05NTExNw_8aa0626f-27ac-4f04-9dff-ab2a12957755">16,888</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy0zLTEtMS05NTExNw_3f451168-a822-4418-99c5-a1af7acb819b">16,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy01LTEtMS05NTExNw_2dee7072-3996-4919-ac42-2635f361975b"><ix:nonFraction unitRef="shares" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy01LTEtMS05NTExNw_a609f245-0783-44ca-9d27-6131c26b4191">16,860</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy03LTEtMS05NTExNw_cca02332-651d-4090-a575-a68130287142"><ix:nonFraction unitRef="shares" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy03LTEtMS05NTExNw_fcc027d7-e581-4b70-a9cd-ae92217c82a1">16,595</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id162adfcca81460486101e12b3597e00_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNS0xLTEtMS05NTExNw_7bffe9f9-b85e-41fa-b2f3-4ac17e08b4aa">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1bd82be627144b3482c05a70e537330b_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNS0zLTEtMS05NTExNw_ffc87e0d-5689-4619-817e-1d408106a2cd">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15c042b2ebf24feb89d24e634e666d27_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNS01LTEtMS05NTExNw_8f3e1c7a-9b86-4840-8db9-5f3a26cdd01e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1f728b109204a9a83575e9f16df629b_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNS03LTEtMS05NTExNw_29bde807-fb8b-410a-87cb-325cc8786765">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31dbf3fbde084ff3a4e51995b5baa515_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi0xLTEtMS05NTExNw_ed9e040f-82d4-4285-a6cf-bcc97ff91457">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7842cd71eeab430eb6922c6dc245b80a_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi0zLTEtMS05NTExNw_366ad9a6-e047-49fe-8ea0-8cacbefafd0a">379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi01LTEtMS05NTExNw_61ec666b-7a7c-4f46-b82b-f48140e56ee1"><ix:nonFraction unitRef="shares" contextRef="i55c5ee22089f41b58b21043995b5b0e3_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi01LTEtMS05NTExNw_9a95d591-2e51-4b10-a402-31c71d67e730">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ba11ede5ca045f4b14d3ba0dd1568fe_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi03LTEtMS05NTExNw_79b9d2e4-75f5-4fc4-9e5c-ee8460cd4032"><ix:nonFraction unitRef="shares" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi03LTEtMS05NTExNw_c55d8988-0c1c-4059-8c50-a6011b54f07c">507</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOC0xLTEtMS05NTExNw_5a881a41-dfef-42b8-9f63-7b645ddb2b38">17,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOC0zLTEtMS05NTExNw_d74053cd-d449-404c-91b8-e8b5992591cb">17,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOC01LTEtMS05NTExNw_2cf4d4a3-abb3-4824-ad5c-c70107e7b540">16,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOC03LTEtMS05NTExNw_7652985a-ee8a-48e4-a8cf-1e6a6f4ec219">17,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS0xLTEtMS05NTExNw_6ded9d38-8d0a-4945-a7d9-8bf9763539a9">6,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS0zLTEtMS05NTExNw_b1eba642-0ba2-4df0-bcfd-4403b57daa98">5,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS01LTEtMS05NTExNw_40c45a7f-3ff7-4a66-8222-1972a4ba7667"><ix:nonFraction unitRef="shares" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS01LTEtMS05NTExNw_ed765a42-f32c-45d2-ac82-9fb19ed31466">6,503</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS03LTEtMS05NTExNw_00e1b81f-13d8-405c-ae1a-f5a0a2b990df"><ix:nonFraction unitRef="shares" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS03LTEtMS05NTExNw_83d1c867-40ef-4546-91e6-1c836a3656f9">4,984</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i538684284d804c57bd3f118d72db7cbe_D20220701-20220930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjA3NzY_04be84f7-5240-4c4a-abe6-769b42b4ed19">0.6</ix:nonFraction>&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. Under the new standard, we are required to reflect the dilutive effect of the 2023 Notes by application of the if-converted method.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i57fe3833c4dd48a39f42c9a430d874a7">For the nine months ended September&#160;30, 2022, due to the net loss for the period, all of the <ix:nonFraction unitRef="shares" contextRef="i766939c97c5b40dcb5b38a79e41a958f_D20220101-20220930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjA5Mzk_0f6b4c5e-0f0c-40be-807e-f158cd5f3157">0.3</ix:nonFraction>&#160;million weighted average equity awards and <ix:nonFraction unitRef="shares" contextRef="i8da6cb831ae14f8089f18a5b3789e9dc_D20220101-20220930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjA5Nzc_ceea5671-f036-44fa-bd8f-4c4f97823139">1.1</ix:nonFraction>&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i2959cf3610a04d8385d1c4c227b59df4_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RleHRyZWdpb246MDllNWNhODMzNGNhNDQ2NmE0OWFmNTQwY2MzNjY3ZjdfMzU0Nw_040a4734-12bf-4836-bf2c-73fcd6f58aca" continuedAt="id8410b53d0624bf1a25afccf9a5bae08" escape="true">Segment Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id8410b53d0624bf1a25afccf9a5bae08" continuedAt="i292f69a8e28648f59e3d6b7d9e034be2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, establishes annual and interim reporting standards for an enterprise&#8217;s operating segments and related disclosures about its products, services, geographic areas and major customers. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses, and for which discrete financial information is regularly evaluated by the chief operating decision maker in deciding how to allocate resources and assess performance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our operating segments are identified in the same manner as they are reported internally and used by our chief operating decision maker for the purpose of evaluating performance and allocating resources. Historically, we have disclosed <ix:nonFraction unitRef="segment" contextRef="i8f27bc960546423584fb5e22d31ba050_D20220101-20220322" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RleHRyZWdpb246MDllNWNhODMzNGNhNDQ2NmE0OWFmNTQwY2MzNjY3ZjdfOTQ3_95f1a39a-402a-48e4-9725-d8ea8298b17c">one</ix:nonFraction> reportable segment. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC would combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction (collectively, the &#8220;Transactions&#8221;). Immediately prior to the Merger and pursuant to the Separation Agreement, we, among other things, would transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#8220;Reorganization&#8221;) and, in connection therewith, would distribute (the &#8220;Distribution&#8221;) to Ligand stockholders 100% of the common stock of OmniAb. Immediately following the Distribution, Merger Sub would merge with and into OmniAb (the &#8220;Merger&#8221;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC. The entire transaction was completed on November 1, 2022. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Event</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the execution of the Merger Agreement, we made organizational changes to better align our organizational structure with our strategy and operations, and management has reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operated the following <ix:nonFraction unitRef="segment" contextRef="i3c65682d715d4cebb23f79ad72073530_D20220323-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RleHRyZWdpb246MDllNWNhODMzNGNhNDQ2NmE0OWFmNTQwY2MzNjY3ZjdfMjIwMg_4b57d0eb-79c8-4e62-be01-ec9ad823e1a9">two</ix:nonFraction> reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. After the closing date of the Transactions, the historical financial results of OmniAb will be reflected in our consolidated financial statements as discontinued operations under GAAP for all periods presented through the date of the Distribution.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income (loss) represents income (loss) before income taxes, interest income, interest expense, other income (expense), net, unallocated share-based compensation, and unallocated corporate overhead. Our management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RleHRyZWdpb246MDllNWNhODMzNGNhNDQ2NmE0OWFmNTQwY2MzNjY3ZjdfMzU0OA_769289ac-7105-4546-81ae-8b5aee644a66" continuedAt="i2e90cc13f2f84d748faee90fc7a3d799" escape="true">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes (in thousands):</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><ix:continuation id="i292f69a8e28648f59e3d6b7d9e034be2"><ix:continuation id="i2e90cc13f2f84d748faee90fc7a3d799"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business revenue</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icba71108b7bb484f90495bc743d1cd62_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMy0xLTEtMS05NTExNw_1c747444-bc57-45ef-8b5e-71fccecf24f4">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04151a540d6044408f287f42f0f848e3_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMy0zLTEtMS05NTExNw_81a5e220-7390-4fd9-939d-e9e995dbc640">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65de87043a1e4dcab7411f098886c292_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMy01LTEtMS05NTExNw_c4ee5cbe-12da-4482-b867-24ba5c78dc0a">984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad307c061f3441f89ff5551bae95b94_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMy03LTEtMS05NTExNw_de47d659-3a9e-4782-a916-62be8fad9823">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ac758bbffaf4b33b4bb7b96b8713d1a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNC0xLTEtMS05NTExNw_7be73c12-f4c8-4195-b2d1-9d84ae7063e8">6,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfef621791484893826f75aa4da8f7d4_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNC0zLTEtMS05NTExNw_dcfab4d9-29f3-4165-9d8f-b2f6c31773db">5,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060aacdc039409386f29263ea0888fe_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNC01LTEtMS05NTExNw_0476a386-6bb6-447a-a51e-2605eea474d8">22,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia34a4d36cd974f88abc36f50a6cc10c1_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNC03LTEtMS05NTExNw_df81bed1-69a2-47c7-9313-4f87b55dba11">19,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total OmniAb business revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i515e60d0096f49b39df04bcd1c448073_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNS0xLTEtMS05NTExNw_eefb44ee-bb93-4653-97b0-7cdb26d69a62">6,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7806df4e0ca341bd947ac07ff78832bc_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNS0zLTEtMS05NTExNw_962b85d6-3df9-420f-8d1d-fb8ca8d2e8b7">5,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5584e6c9205484792148da209de79e0_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNS01LTEtMS05NTExNw_65dad223-e093-4057-ba01-d3af54be0554">23,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibac68a1cdeb3437cb24a409ec62e7ae0_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNS03LTEtMS05NTExNw_a468fea1-1837-4e03-a221-a4122b2fa866">19,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib56bece7e0da4f168b25d26c3a937bb8_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNy0xLTEtMS05NTExNw_4f65b896-dbc5-49e9-afc6-f3ba89757232">19,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ae2842116c43ec9c4d10f553fb44c8_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNy0zLTEtMS05NTExNw_28597dc6-ddc5-4d18-bd7d-8a31f561e1dd">15,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd956644674461e94c0667f968d8a8d_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNy01LTEtMS05NTExNw_9fea9701-bfaf-43fd-ac8f-5bc5d9d6bfcb">50,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a249f2388aa45ae9e1b4da3725d791b_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNy03LTEtMS05NTExNw_d2628055-108d-4d91-bd40-622a8ba06d2b">31,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - Core </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87b96b5149b41818034e32448024dfb_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOC0xLTEtMS05NTExNw_df44eac8-6fc1-4373-954f-d6825b0310da">3,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eac10c65b1641ffa06188a690f2aca9_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOC0zLTEtMS05NTExNw_4451be74-558f-40c9-bf4f-0a89bc0bf57f">5,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba465a7198d54ee7b6ad82d779858fd9_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOC01LTEtMS05NTExNw_f0602c01-454f-479f-8720-9be33d887744">13,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a5fa29dc2e848a7b2ac184d57a87bc3_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOC03LTEtMS05NTExNw_14b4ed35-b1d4-4c5a-b77f-825da5ad4196">16,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - COVID</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i904cf14c4b3e4fbeb3f577b716e29d42_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOS0xLTEtMS05NTExNw_1da8ccfa-1890-4b90-959d-0f887d85ba9e">32,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib22143b247d14e49b1f87a41cebc0533_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOS0zLTEtMS05NTExNw_3612a063-a261-4671-bb21-ea4121572dc4">29,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0411fb172a764e2e92a29821f037280d_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOS01LTEtMS05NTExNw_f52735f6-d080-41eb-b6d7-ea519110f050">64,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78881cd8932b4b9093df9eaafe0b57dc_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOS03LTEtMS05NTExNw_c33e1752-5fe8-429a-93a6-4436186df1db">112,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe4ebeb2dcf415199c31a3fe43b9779_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTAtMS0xLTEtOTUxMTc_a1e2c79c-8351-4f21-8989-28f065e8fcff">4,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib76e0a2f4e02403e90689f0872ff43ca_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTAtMy0xLTEtOTUxMTc_5f03d432-e1a6-49ed-8b3e-397b26f2df0f">8,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71032e6cf99a4220b3ab9bdf9e1ce780_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTAtNS0xLTEtOTUxMTc_347b1c61-acb5-4613-b87b-d2eadbd590b1">17,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb79cf209f1748b7aa2267af51ea59d2_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTAtNy0xLTEtOTUxMTc_daea646f-fa79-4383-8ae7-1f7d6e128bfe">24,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total Ligand core business revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd0f8876888448aad7af0288accc346_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTEtMS0xLTEtOTUxMTc_24dd6098-2f29-4209-9ed8-9286b6e91e04">59,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3796b96c0d94c1da6299853875dac7c_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTEtMy0xLTEtOTUxMTc_d6ece317-cd20-44d1-8ea3-d41baebf806a">59,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if22d059e053745febd4c8b88a8df2cd8_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTEtNS0xLTEtOTUxMTc_0d0b8b78-b681-4af8-b186-c63f3359703c">145,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if30ec34df7ed4597981dae2bffa04dc6_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTEtNy0xLTEtOTUxMTc_0559dead-f118-4553-8b6a-4808ce60b5de">185,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2883789af81b412eaa37f1ebac40224b_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTItMS0xLTEtOTUxMTc_193a3378-416d-4513-baf6-e407286ae82e">66,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f10944b87f4bb2b93e8fac9eac402f_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTItMy0xLTEtOTUxMTc_3ab15972-1623-4813-a9cd-37bb93319a10">64,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf8fec3725d042efad094010d20f1c66_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTItNS0xLTEtOTUxMTc_d8f4a261-9525-48cd-81bc-5cb8bb56bc39">169,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b00d99d3c34bc685177724979b4ff9_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTItNy0xLTEtOTUxMTc_391fb849-8db6-4639-b8ae-1b5ca40f0a1a">204,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i515e60d0096f49b39df04bcd1c448073_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTUtMS0xLTEtOTUxMTc_92d8a03f-c101-4cf2-8e61-99386e5f431c">11,721</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7806df4e0ca341bd947ac07ff78832bc_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTUtMy0xLTEtOTUxMTc_3aec3439-c951-4d2b-9ac2-d85890f6b43d">9,177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5584e6c9205484792148da209de79e0_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTUtNS0xLTEtOTUxMTc_1384bc70-61bb-49aa-af0a-181efa16c7e8">26,905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibac68a1cdeb3437cb24a409ec62e7ae0_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTUtNy0xLTEtOTUxMTc_f10422f2-4811-486a-b3a3-777aec13cd5d">21,587</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd0f8876888448aad7af0288accc346_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTYtMS0xLTEtOTUxMTc_6f739743-5c37-43fc-a944-3a9c5b335147">22,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3796b96c0d94c1da6299853875dac7c_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTYtMy0xLTEtOTUxMTc_6a2f1692-f911-4662-8f3a-d0f0820dab94">32,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if22d059e053745febd4c8b88a8df2cd8_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTYtNS0xLTEtOTUxMTc_a9bdcfdd-16c8-48bf-9bfc-23ee68d6d1c3">49,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if30ec34df7ed4597981dae2bffa04dc6_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTYtNy0xLTEtOTUxMTc_5ab15b14-c63d-4a88-8ad8-f61c6fbd6188">112,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2883789af81b412eaa37f1ebac40224b_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTctMS0xLTEtOTUxMTc_7e0d44ae-f241-4ad3-8637-27a8d5fc4132">10,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f10944b87f4bb2b93e8fac9eac402f_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTctMy0xLTEtOTUxMTc_01ae8c43-75c8-4ae1-89b2-6bf33d82dd7a">23,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf8fec3725d042efad094010d20f1c66_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTctNS0xLTEtOTUxMTc_58ef95a3-6505-4260-bdc2-0573e8b23eab">22,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b00d99d3c34bc685177724979b4ff9_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTctNy0xLTEtOTUxMTc_e47154c6-5dcc-4dca-9ed1-b717f938430e">91,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unallocated corporate items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd2cbdef5c44f8fac9ee6db6ad8fc64_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjAtMS0xLTEtOTUxMTc_e5f5a2c8-9ca1-4ecf-8a81-f0314a440a79">6,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57783a54b7b44d0bfe7bfb7bd595b4f_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjAtMy0xLTEtOTUxMTc_dbea4c2f-193c-4b32-b7a3-8aa3217a174a">5,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4699144a009d4236a7a7d3ba4f5a71b6_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjAtNS0xLTEtOTUxMTc_4f07066c-c83c-4041-a497-cccb92a0d54d">17,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i921e73649a7a4b69a8ed14e11dab4870_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjAtNy0xLTEtOTUxMTc_66ebdc18-1acb-4790-aa53-8d864c0a3336">16,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd2cbdef5c44f8fac9ee6db6ad8fc64_D20220701-20220930" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjEtMS0xLTEtOTUxMTc_dce7881c-4286-4bd9-a8d1-9a47e012772b">3,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57783a54b7b44d0bfe7bfb7bd595b4f_D20210701-20210930" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjEtMy0xLTEtOTUxMTc_3e4b4ff6-2ed7-4ce9-a2f3-f210b220c84a">1,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4699144a009d4236a7a7d3ba4f5a71b6_D20220101-20220930" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjEtNS0xLTEtOTUxMTc_c2656f9d-4bf0-462e-8d18-7d7201176be7">14,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i921e73649a7a4b69a8ed14e11dab4870_D20210101-20210930" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjEtNy0xLTEtOTUxMTc_1f0f845a-7685-41f5-90e6-6054381fddc0">8,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total unallocated corporate items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd2cbdef5c44f8fac9ee6db6ad8fc64_D20220701-20220930" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjItMS0xLTEtOTUxMTc_d44e7e7d-2886-45f1-833b-0d24563f051e">9,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57783a54b7b44d0bfe7bfb7bd595b4f_D20210701-20210930" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjItMy0xLTEtOTUxMTc_8942eece-0f56-435d-a418-cacb5555e672">7,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4699144a009d4236a7a7d3ba4f5a71b6_D20220101-20220930" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjItNS0xLTEtOTUxMTc_d0fd4cb2-13b5-4464-b637-f48e17450418">31,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i921e73649a7a4b69a8ed14e11dab4870_D20210101-20210930" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjItNy0xLTEtOTUxMTc_4aa6c500-8178-4311-8fac-67342ac1c6dc">24,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjMtMS0xLTEtOTUxMTc_5eab8c32-e5a3-4848-952a-eb0436e295b9">636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjMtMy0xLTEtOTUxMTc_cdfad77b-e255-4ac8-9b58-e9063d3bdcee">15,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjMtNS0xLTEtOTUxMTc_f1c0596b-e1dc-4656-a219-0dab72c59f56">9,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjMtNy0xLTEtOTUxMTc_79127484-4795-4ee2-abfa-628377b7c431">66,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfNTM2NQ_d7ca12ca-10c7-4329-92be-43b3b7cb69a5" continuedAt="id6bcba8474ff40da8c44fa7d473041b3" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id6bcba8474ff40da8c44fa7d473041b3" continuedAt="ifdc0eea05dfc413fa2dc886ab9b6229e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfNTM2NA_5d867837-1676-4279-9a4d-923dcaf6f2aa" continuedAt="i5966de2139ae4b7e84010581786dbd19" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9545ef6cc9054eaba5733eede4f83b2e_I20220930" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy0yLTEtMS05NTExNw_9eebf53d-6ba4-4d86-8c60-c2d1c84c75b2">4,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id45baf2e1b7e452fa0ab3dee1b630a5e_I20220930" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy00LTEtMS05NTExNw_4357e579-fa2f-441b-a316-79c368a7a891">94,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb9c3ea5d1f94844bc6846f65c475bf2_I20220930" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy02LTEtMS05NTExNw_97f36247-fd3a-46af-b1de-9dbca1ffaf2e">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia44e8d68d457441f87d096b99b424cf9_I20220930" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy04LTEtMS05NTExNw_de926130-1d99-475c-b4d7-0feb8dc8a2b6">99,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf43f3e6122f485d9604b85bdf24ca9a_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy0xMC0xLTEtOTUxMTc_5992ae1e-d1a6-4a82-aeb1-1fb945cbaace">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409fb78206fa48e885e9a25ffed9be5f_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy0xMi0xLTEtOTUxMTc_5757fc68-362f-4dcc-a287-67ec1572d312">280,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02baf2e63f634118acc0b5cecd635f91_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy0xNC0xLTEtOTUxMTc_9c25dbe2-fdea-4a83-8ce1-ed686485770a">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea813cc62405437f966419cf2bf8c12d_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy0xNi0xLTEtOTUxMTc_ab7bdb47-d1da-40c5-8d50-fc97d270a452">290,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabc8605b5b5b4402bfa40c6f86cc4521_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC0yLTEtMS05NTExNw_b6111116-e8c2-4fd1-8992-0bb553692c93">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f66174ae3354eb19f957fd4f8e8990f_I20220930" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC00LTEtMS05NTExNw_af540691-da98-469a-b750-90b4ae4c926d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e5a64e988a14bc3acc1c82b5a5bc74d_I20220930" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC02LTEtMS05NTExNw_09215555-3c9f-4be6-ad3a-b1f5144de110">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c4985c47c384c0b9b0ab0008644e5a3_I20220930" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC04LTEtMS05NTExNw_0fe24584-4a86-4d1a-ae2b-afeba924ee2b">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45e52f2a26442e8b69b942641647814_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC0xMC0xLTEtOTUxMTc_a5dbf3e3-8f1e-4195-9188-e54da942c9ba">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i006d5206c32b4ffa8c5bf11c4c32263d_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC0xMi0xLTEtOTUxMTc_540ac133-03c3-4aef-87c4-c75fd47b9a98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eb2b3352eca4a009a173f9f0a39cc12_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC0xNC0xLTEtOTUxMTc_df5c64df-45a4-4bfe-994e-a71cd46fc4f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29ad1d75d22a4e3f98195a322aa7aadc_I20211231" decimals="-3" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC0xNi0xLTEtOTUxMTc_275a20dd-c1e4-46de-88ab-0062d8cf1398">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82abec3a44c5436095d8c4e9189adff4_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi0yLTEtMS05NTExNw_f5616ca9-e4e0-47dd-a282-8280312d2d87">22,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68afa5ce123e446ea968ab4615153660_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi00LTEtMS05NTExNw_7401dba7-ffd4-4463-893e-f73d96fceb53">94,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c76ceca320043319a729e346c30af96_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi02LTEtMS05NTExNw_243ec129-885e-4fd9-b578-b9aaea54413c">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d528942e7f4eec9ed16811189f131e_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi04LTEtMS05NTExNw_dcf0ff64-9f2d-493f-881e-da56fe94b1a9">117,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70b1f37b5444463a665afeeb29fee23_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi0xMC0xLTEtOTUxMTc_230889fb-5550-4610-9185-4c9ca57da23e">40,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d63d2ebe7124c6c92192fbb621ceb55_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi0xMi0xLTEtOTUxMTc_aa78e02d-4750-4b6d-ac6b-c4af83606615">280,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6c7430ceed408ea0129815282f022b_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi0xNC0xLTEtOTUxMTc_94486e06-57b4-478e-bfc0-ddb518082212">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c4aa673a44a49ba91b41ff1867085ff_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi0xNi0xLTEtOTUxMTc_b5b5ee83-5e11-45d5-850b-5020e40f05be">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa4c6644f944c0691c442c1da40ed28_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS0yLTEtMS05NTExNw_3ba030a7-bbb0-40c3-99a2-5f7af327b4ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e423a6748f4ef5bf5198b8c0ddff62_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS00LTEtMS05NTExNw_1e52ebfa-0f83-44f5-8cd8-c2d0d39e39aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c75467deb3e4ddab92d1873ad3c9a15_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS02LTEtMS05NTExNw_358e2114-85fc-46d7-a0b4-18a88809e99a">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a46d7016abc41c5a9d9d807b0e437fc_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS04LTEtMS05NTExNw_22058ac8-28e0-469e-916d-c4c9aa06fae5">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76e9fffc6114de8a391f206f62e3b3b_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS0xMC0xLTEtOTUxMTc_9bee1fbf-c44a-420c-85e1-e1eb54fc0773">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4d765504d314a2aa80653e6e6cf32d5_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS0xMi0xLTEtOTUxMTc_7aa40b6d-8dce-48a3-8c6d-c47e22ed65bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4fa076f03644041966c14890e83f8e8_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS0xNC0xLTEtOTUxMTc_cd547883-1251-4786-a089-8925a5ab1f5e">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i374aa010c5c546cd97bd8012be328ef2_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS0xNi0xLTEtOTUxMTc_3ea8c159-6bb4-4ae8-a751-faa3b86a98fc">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i417f205a3d994398aa39d14f0aeb46d2_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtMi0xLTEtOTUxMTc_a868e70c-a3a0-43c3-9034-d5f23bcb5375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id95d5b3a71314067be9a4acc1f0dec9d_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtNC0xLTEtOTUxMTc_7f030216-5881-40ef-9e27-875207e6effd">2,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i558cfad5a49e4d288fcb31a70e3d0423_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtNi0xLTEtOTUxMTc_4caa87af-bd30-4e61-9fed-20c02d887324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b8eba0c2f244c68897f2c465f695cb4_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtOC0xLTEtOTUxMTc_e5336867-bc30-47be-bddb-8e14636bb27d">2,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0b263e3124cc9a0aca9d63fe8c3a1_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtMTAtMS0xLTk1MTE3_d54dfbb7-12c0-4278-8990-4b1d7fdea88a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i177d784a77a54241a81da1f857fb9dce_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtMTItMS0xLTk1MTE3_5e4805ba-c1c3-4752-a68e-11fe30a57cf3">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1658e372295b494fa6a5129e877086f8_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtMTQtMS0xLTk1MTE3_1931b4c0-09c9-412d-bb31-b5e1408480e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5196ee4cc484b1a8f52931d60ad16ca_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtMTYtMS0xLTk1MTE3_9ef55dd9-bfd4-4dd7-95c1-383a23e8638a">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3ac0c4007a846e08014e8ab0f432750_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtMi0xLTEtOTUxMTc_c033be29-0e4f-4310-af82-82d215335163">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b43473351914f1a86d1acd39584c6c2_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtNC0xLTEtOTUxMTc_eb90db9e-7050-4391-82a0-ce0f22504e8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67aecd998ffc4380be51824531348e09_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtNi0xLTEtOTUxMTc_c7daf9f8-1ea0-4a57-9d14-6d3e0a5ecdec">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebb7edd5169d406595ad57436f4ba57d_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtOC0xLTEtOTUxMTc_11a4ea84-5bcb-4a38-9e14-a185440711c8">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a6c5227f1ae46e7a867099dc194d21d_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtMTAtMS0xLTk1MTE3_b2b1532c-7621-4c0a-9214-87824a070796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e226666ee01416ea4437da7b90c7394_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtMTItMS0xLTk1MTE3_57d073e2-81d6-44f4-a2b5-208444562e5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8807f0f1743448e897e2affdf0d534b9_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtMTQtMS0xLTk1MTE3_1b27ecee-a014-4d8e-a95c-689c09af2ab2">7,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82de593bdc9e4da984cd72ffbd180620_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtMTYtMS0xLTk1MTE3_27c12948-8cfd-4153-8ea1-2ad7bae23372">7,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4dff2f452e42e5b71d10fe5e7de15c_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItMi0xLTEtOTUxMTc_7b1afd73-7dc0-4576-a2e8-c0a433d45af3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735aa43de0d8473b978acefb4731c01e_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItNC0xLTEtOTUxMTc_c4ef9b35-0101-4d3a-88c7-1681b8110fe3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88db7dab6b7a424a8ab88ea1d64e42ee_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItNi0xLTEtOTUxMTc_32e5501f-6940-4afc-9990-a8cff03ec9a9">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ee4885695b241d9affa4f86640bf9aa_I20220930" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItOC0xLTEtOTUxMTc_59cbe33a-022b-46e2-81ab-7e0b6ab29a4b">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e74edc9a24a4d4aba01db56acc201d4_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItMTAtMS0xLTk1MTE3_110b5fab-f9dc-4d12-b8f6-7b97b72c3ff2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a71ba97a53b4cc0889174ac02780ee4_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItMTItMS0xLTk1MTE3_634e4f8d-85f7-4178-b982-c930b1919f0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic942e4443ee741a5b559256a2d777257_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItMTQtMS0xLTk1MTE3_1e16ce53-8f05-4c41-96f2-6b385f332c5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d71f9ce3064ebfae407232f08153f1_I20211231" decimals="-3" name="lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItMTYtMS0xLTk1MTE3_ecaeadbe-2284-4436-ba6a-894cfdaf184c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82abec3a44c5436095d8c4e9189adff4_I20220930" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtMi0xLTEtOTUxMTc_8243e588-12db-45ed-8eaa-ca5f7b0f8e86">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68afa5ce123e446ea968ab4615153660_I20220930" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtNC0xLTEtOTUxMTc_836d4cdf-0535-4822-b10d-ba8996991c0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c76ceca320043319a729e346c30af96_I20220930" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtNi0xLTEtOTUxMTc_a00ce694-3ad3-4213-bb93-93a5ee6b9c5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d528942e7f4eec9ed16811189f131e_I20220930" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtOC0xLTEtOTUxMTc_d04d6020-468f-456a-a2fb-923512d5a6bb">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70b1f37b5444463a665afeeb29fee23_I20211231" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtMTAtMS0xLTk1MTE3_f79ee217-d1f1-43d3-8f2c-4840c7865379">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d63d2ebe7124c6c92192fbb621ceb55_I20211231" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtMTItMS0xLTk1MTE3_bbf3eb30-3f8e-46ff-8c16-84426dc900a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6c7430ceed408ea0129815282f022b_I20211231" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtMTQtMS0xLTk1MTE3_6aeae50d-a504-42bc-93f8-9cda73200394">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c4aa673a44a49ba91b41ff1867085ff_I20211231" decimals="-3" name="lgnd:AmountsOwedToFormerLicensorFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtMTYtMS0xLTk1MTE3_9c387531-7ed0-4ead-afb0-59177dea8d79">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82abec3a44c5436095d8c4e9189adff4_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtMi0xLTEtOTUxMTc_c491da85-98be-4935-a197-420575f8fcdb">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68afa5ce123e446ea968ab4615153660_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtNC0xLTEtOTUxMTc_c860e9f3-6174-42c3-b9e0-fe86a4e425a4">2,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c76ceca320043319a729e346c30af96_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtNi0xLTEtOTUxMTc_12038643-7294-4ad5-a625-a3b7c1e14212">6,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d528942e7f4eec9ed16811189f131e_I20220930" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtOC0xLTEtOTUxMTc_cee42954-cec8-432a-a739-f92e38fe7a30">8,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70b1f37b5444463a665afeeb29fee23_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtMTAtMS0xLTk1MTE3_3c0ef7c2-4568-437b-be91-286a47d6c7f7">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d63d2ebe7124c6c92192fbb621ceb55_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtMTItMS0xLTk1MTE3_dd380fb2-204e-42ea-b764-c0865e29503f">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6c7430ceed408ea0129815282f022b_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtMTQtMS0xLTk1MTE3_6c01245c-d855-42bb-b0b6-44b1365cc2b7">7,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c4aa673a44a49ba91b41ff1867085ff_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtMTYtMS0xLTk1MTE3_06d8fbbd-ff2a-4652-b9a3-0e960134dbf7">11,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black-Scholes value estimated by management on the last day of the period.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ifdc0eea05dfc413fa2dc886ab9b6229e" continuedAt="ia97d5b4662bf43e2aae6bbd1163bb38b"><ix:continuation id="i5966de2139ae4b7e84010581786dbd19" continuedAt="i00961ab6b7b1400f9453a891778bb14d"><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders <ix:nonFraction unitRef="contingent_value_right" contextRef="iea631c13053d4cb9a6c3ec25bbe89909_D20100101-20100131" decimals="INF" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMTQ0Mg_2f793654-da58-4049-8a14-74110c5c9f53">four</ix:nonFraction> tradable CVRs, <ix:nonFraction unitRef="contingent_value_right" contextRef="iea631c13053d4cb9a6c3ec25bbe89909_D20100101-20100131" decimals="INF" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMTQ2MA_79323b5f-2e98-4348-af4b-554044fdf642">one</ix:nonFraction> CVR from each of <ix:nonFraction unitRef="contingent_value_right" contextRef="ia610e91d108b4828b2e383faf35f060c_D20100101-20100131" decimals="INF" name="lgnd:NumberOfContingentValueRightsSeries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMTQ4MA_c1fb8e38-6860-474a-91d4-57867cd77b79">four</ix:nonFraction> respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every <ix:nonNumeric contextRef="iea631c13053d4cb9a6c3ec25bbe89909_D20100101-20100131" name="lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMTYxNQ_5c03a8c0-530c-465d-8293-43321609ea78">six months</ix:nonNumeric> as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $<ix:nonFraction unitRef="usd" contextRef="i58dbd9eaa0a046348cb63f5bc71bc4e8_I20220930" decimals="INF" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMjQxNw_a9e3f832-da34-496f-88f0-4bea4014bd65">375</ix:nonFraction> million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $<ix:nonFraction unitRef="usd" contextRef="i8ae80f0d98ee484383b7285db27e3bf8_I20220930" decimals="-6" name="us-gaap:ContractWithCustomerAssetGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMjUzMg_988b06ff-cbcc-4e8b-82df-22dea864fe5f">10</ix:nonFraction> million payment upon initiation of a Phase 3 clinical trial.  During the three and nine months ended September&#160;30, 2022, we adjusted the balance of the Metabasis CVR liability $<ix:nonFraction unitRef="usd" contextRef="i7dfa24a16ddb4468b3057a86ea1992f8_D20220701-20220930" decimals="-5" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMjY2Mg_f608d893-02b4-480c-bf95-e3d9fcee6bdc">0.1</ix:nonFraction>&#160;million and $(<ix:nonFraction unitRef="usd" contextRef="i286c91cbf234442b92d18be9042ac0d1_D20220101-20220930" decimals="-5" sign="-" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMjY2OQ_515de574-45ae-42fa-b771-b9975e3a9411">0.9</ix:nonFraction>)&#160;million to mark to market, respectively.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the nine months ended September&#160;30, 2022, we paid $<ix:nonFraction unitRef="usd" contextRef="i2a563f07df03433d9f3b406175fa5e0d_D20220101-20220930" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzI2MQ_c3b3edbb-ab37-4e6b-8686-9da36cb6ca73">1.5</ix:nonFraction>&#160;million contingent liability based on revenue milestones to former Icagen shareholders, respectively. During the three and nine months ended September&#160;30, 2022, we adjusted the balance of the Icagen CVR liability $(<ix:nonFraction unitRef="usd" contextRef="i52253af912264b92a50089624acefcd3_D20220701-20220930" decimals="-5" sign="-" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzQyOA_a71edece-7cbc-4a28-bd42-80efc7b3b382">0.2</ix:nonFraction>)&#160;million and $(<ix:nonFraction unitRef="usd" contextRef="i2a563f07df03433d9f3b406175fa5e0d_D20220101-20220930" decimals="-5" sign="-" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzQzNQ_1b9269c1-ddcd-4eb5-81e1-655f87fdb559">0.5</ix:nonFraction>)&#160;million to mark to market, respectively.  </span></div></ix:continuation><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i00961ab6b7b1400f9453a891778bb14d" continuedAt="i4e2094a171144671ac835c0c2a0815e4">4.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"><ix:continuation id="i4e2094a171144671ac835c0c2a0815e4">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. We concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three and nine months ended September&#160;30, 2022, we paid $<ix:nonFraction unitRef="usd" contextRef="i1b2e23fc4a3943ad849d871cbc73bb3d_D20220701-20220930" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzI5ODUzNDg4ODk4MQ_2c0cb1c4-12e1-4e66-879b-162b5e7e16d0"><ix:nonFraction unitRef="usd" contextRef="iae8e9c1682aa4055a75677062d0d3067_D20220101-20220930" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzI5ODUzNDg4ODk4MQ_2ebae6af-5439-452e-9766-003f86fd64cb">1.0</ix:nonFraction></ix:nonFraction>&#160;million contingent liabilities to former xCella shareholders. During the three and nine months ended September&#160;30, 2022, we recorded $<ix:nonFraction unitRef="usd" contextRef="i28ca9f03e482413a80f84d8327155d06_D20220701-20220930" decimals="-5" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzc4Ng_04193cb2-d547-42f6-899f-9caad1567f7c">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia13f08ef2fec488aa3e23297a819a673_D20220101-20220930" decimals="-5" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzc5Mw_b68b5cfb-6ed8-4ca4-8795-cb9bbff3a6db">1.4</ix:nonFraction> million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement, respectively.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfNTM2MA_fc0a7967-7dc9-4573-bb74-ff9c80d74cc8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of September&#160;30, 2022 is as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf669638100c407a84acc68049e05107_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmUyZDA0MWNlMjlmZjRkYzliZjQ5MTg0ZjY2MGJjNjkxL3RhYmxlcmFuZ2U6ZTJkMDQxY2UyOWZmNGRjOWJmNDkxODRmNjYwYmM2OTFfMC0xLTEtMS05NTExNw_fb544fb9-9cf8-4df6-ad55-ac0c2bdb8e0c">7,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib34d5ea9024943dab91936ef12ad4821_D20220101-20220930" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmUyZDA0MWNlMjlmZjRkYzliZjQ5MTg0ZjY2MGJjNjkxL3RhYmxlcmFuZ2U6ZTJkMDQxY2UyOWZmNGRjOWJmNDkxODRmNjYwYmM2OTFfMS0xLTEtMS05NTExNw_ac003073-5bca-4ae1-b07f-1d3ae747e6f6">2,505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib34d5ea9024943dab91936ef12ad4821_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmUyZDA0MWNlMjlmZjRkYzliZjQ5MTg0ZjY2MGJjNjkxL3RhYmxlcmFuZ2U6ZTJkMDQxY2UyOWZmNGRjOWJmNDkxODRmNjYwYmM2OTFfMi0xLTEtMS05NTExNw_9280db99-b81a-45df-912d-a143511b6d32">527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib34d5ea9024943dab91936ef12ad4821_D20220101-20220930" decimals="-3" name="lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmUyZDA0MWNlMjlmZjRkYzliZjQ5MTg0ZjY2MGJjNjkxL3RhYmxlcmFuZ2U6ZTJkMDQxY2UyOWZmNGRjOWJmNDkxODRmNjYwYmM2OTFfMy0xLTEtMS05NTExNw_f1fe5faa-3d85-4086-841b-7cd02c0c2460">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of September&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i853e09d80a6a46aabdbe6bf00b059c13_I20220930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmUyZDA0MWNlMjlmZjRkYzliZjQ5MTg0ZjY2MGJjNjkxL3RhYmxlcmFuZ2U6ZTJkMDQxY2UyOWZmNGRjOWJmNDkxODRmNjYwYmM2OTFfNC0xLTEtMS05NTExNw_b6a09d4b-03d0-4cc1-87c5-58f2c678019f">6,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the organizational changes to the Company&#8217;s reportable segments, we re-allocated goodwill between the <ix:nonFraction unitRef="reporting_unit" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfNDk0Mg_c161b0a9-5245-46b9-a339-6d1d0b2f58e8">two</ix:nonFraction> identified reporting units (OmniAb business and Ligand core business). We performed a goodwill impairment analysis immediately before and after the allocation of goodwill and concluded no impairment. At September 30, 2022, there were no indicators of impairment at either of the reporting units.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="ia97d5b4662bf43e2aae6bbd1163bb38b">At September 30, 2022, there were no indicators of impairment of our indefinite-lived intangible assets, or long-lived assets.</ix:continuation> </span></div><div><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 4.  <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzY3NA_5af0ff13-01af-4cd5-b695-44f93af177df" continuedAt="ic4dadc5f9f2f4d30a8ecb6259cb7fd00" escape="true">Convertible Senior Notes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic4dadc5f9f2f4d30a8ecb6259cb7fd00" continuedAt="i45f2789e6311497cbd5f588fc4e3ed70"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMzU_a3951594-6dcc-47bb-a309-a5784d3d8a91">0.75</ix:nonFraction>%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$<ix:nonFraction unitRef="usd" contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfOTY_11752935-000a-4d87-829e-b4d16eccc695">750.0</ix:nonFraction>&#160;million&#160;aggregate principal amount of&#160;<ix:nonFraction unitRef="number" contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTI5_1998e37b-cdab-4db4-a4bd-0a4a017c1022">0.75</ix:nonFraction>%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $<ix:nonFraction unitRef="usd" contextRef="i4e2b8f073bbb4eeea44fc317eeee6bed_D20180501-20180531" decimals="-5" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjg1_9e60b18e-5e65-4b2f-9c4a-8dc2077efd7e">733.1</ix:nonFraction> million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjA2_9bb5bed6-8bdc-495c-a07b-83f37004fa09">248.48</ix:nonFraction> per share. The maximum conversion rate of the 2023 Notes is 5.2317 per $1,000 principal amount of the 2023 Notes which represents a maximum conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i238c5b93b270426ea69664bad2955dba_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzc2_2d757748-ed49-431d-811c-ad8ad8683377">191.14</ix:nonFraction>. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i45f2789e6311497cbd5f588fc4e3ed70" continuedAt="i48058ea477c846ce9d29f257c5e3f89f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least <ix:nonFraction unitRef="d" contextRef="i18ad0006f29c4e3782c1405fa1ec6c0f_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTEwMA_25b2830b-ed6d-4836-a5a6-0f2935bc5458">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="d" contextRef="i18ad0006f29c4e3782c1405fa1ec6c0f_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTE1Ng_f34a7469-378c-45a5-a428-756e1c545dfd">30</ix:nonFraction> consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than <ix:nonFraction unitRef="number" contextRef="i18ad0006f29c4e3782c1405fa1ec6c0f_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTM1MQ_e29c532b-dbee-4c29-8b09-c3c78c12a721">130</ix:nonFraction>% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the <ix:nonFraction unitRef="d" contextRef="ifd2de700e7ee4f82b95550662f3e922e_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTQxNg_866f1afd-fe3e-474d-8eb7-e91830fa70b2">five</ix:nonFraction> business day period immediately following any <ix:nonFraction unitRef="d" contextRef="ifd2de700e7ee4f82b95550662f3e922e_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTQ2NQ_1a40b225-44fc-46e3-87cf-c9897eb3c838">10</ix:nonFraction> consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than <ix:nonFraction unitRef="number" contextRef="ifd2de700e7ee4f82b95550662f3e922e_D20180501-20180531" decimals="INF" name="lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTU3NA_8b28902a-585b-42a8-b104-2b99bd02e99e">98</ix:nonFraction>% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes (the&#8220;Indenture&#8221;). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#8217;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No holders exercised their right to convert their 2023 Notes during the applicable period for conversion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion rate for the 2023 Notes will be adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first <ix:nonFraction unitRef="d" contextRef="ie91d13b37a564e829094c6726d7a24e2_D20221101-20221101" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzNDUxMg_7c66f336-722c-4367-88e2-0a75afc43a2c">10</ix:nonFraction> consecutive trading days after, and including, the ex-dvidend date of the spin-off (as determined in the Indenture).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTk5OA_26e166b8-44a7-46bc-bcbc-b18854d676f9">248.48</ix:nonFraction> (not accounting for the anticipated adjustment in the conversion rate). In connection with the issuance of the 2023 Notes, we incurred $<ix:nonFraction unitRef="usd" contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjA2NQ_28936958-8a91-46aa-82bf-8c9bab628f56">16.9</ix:nonFraction> million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, is amortized to interest expense using the effective interest method over the <ix:nonNumeric contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzY3Ng_dff4f03d-8ae7-45b6-88cc-c6c7b2c92f55">five year</ix:nonNumeric> expected life of the 2023 Notes, and the effective interest rate as of September&#160;30, 2022 is <ix:nonFraction unitRef="number" contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjMyOA_a5572945-23c6-4fe0-ba0b-6d00f192f5d1">0.5</ix:nonFraction>%.  During the three months ended September&#160;30, 2022 we recognized a total of $<ix:nonFraction unitRef="usd" contextRef="ief8861b3c3714c46851e7e25c053e239_D20220701-20220930" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjM3NQ_1058c8f8-6f66-49be-8e99-f13d1ff616ef">0.3</ix:nonFraction>&#160;million in interest expense which includes $<ix:nonFraction unitRef="usd" contextRef="ief8861b3c3714c46851e7e25c053e239_D20220701-20220930" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjQxMw_8f18efa3-cf33-4eb4-90cc-60ee921af4dd">0.2</ix:nonFraction>&#160;million in contractual interest expense and $<ix:nonFraction unitRef="usd" contextRef="ief8861b3c3714c46851e7e25c053e239_D20220701-20220930" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjQ1Mg_f74e649d-5ade-4370-9957-9506754d5d87">0.1</ix:nonFraction>&#160;million in amortized issuance costs. During the nine months ended September&#160;30, 2022 we recognized a total of $<ix:nonFraction unitRef="usd" contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjUyNg_e1bcd97d-019f-4369-a704-fe8cb748fa4a">1.5</ix:nonFraction>&#160;million in interest expense which includes $<ix:nonFraction unitRef="usd" contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjU2NA_c4f2cae0-cb52-4629-87e3-9197869c72aa">0.9</ix:nonFraction>&#160;million in contractual interest expense and $<ix:nonFraction unitRef="usd" contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjYwMw_55dddf5e-c99e-483e-8a56-ac780c1fbe95">0.6</ix:nonFraction>&#160;million in amortized issuance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we repurchased $<ix:nonFraction unitRef="usd" contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjkyNw_43efa4e4-0587-4307-8c38-2ed187c583db">152.0</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjk2NQ_22cb6dc0-9fae-4712-944b-c405af08e84b">156.0</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMzAwNw_87f66afe-f669-4249-9f05-4474c4e17002">0.3</ix:nonFraction>&#160;million. After the repurchases, approximately $<ix:nonFraction unitRef="usd" contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMzA0OA_af44eb3c-fbc7-48e0-92d4-831a51272170">343.3</ix:nonFraction>&#160;million in principal amount of the 2023 Notes were outstanding as of December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022, we repurchased $<ix:nonFraction unitRef="usd" contextRef="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzIxNA_3a61cf44-e1a9-4339-ab83-8d8533552886">38.6</ix:nonFraction>&#160;million in principal amount of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzM0Ng_79a6e46e-767a-46f3-8174-589b466afe3d">37.7</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzIyOQ_5706d271-0f18-4b42-a19f-18abfc3f671e">0.1</ix:nonFraction>&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $<ix:nonFraction unitRef="usd" contextRef="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzI0NA_0bb9a910-5f22-49e6-98de-11fe35e0aa88">0.9</ix:nonFraction>&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended September 30, 2022, and a $<ix:nonFraction unitRef="usd" contextRef="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930" decimals="-5" sign="-" name="lgnd:IncreaseDecreaseInDebtDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzI1OA_6db261e5-63d9-43fd-9409-fcf635bb831f">0.1</ix:nonFraction>&#160;million reduction in debt discount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, we repurchased $<ix:nonFraction unitRef="usd" contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzI3Mg_1e3711d6-d0ae-45cf-833d-ece8934c1b1d">266.4</ix:nonFraction>&#160;million in principal amount of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzMzMA_254bd483-ebe8-4438-a552-8143de869088">261.4</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzI4OA_1359cc05-7eac-410d-a53c-fa1b656c6f03">0.5</ix:nonFraction>&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $<ix:nonFraction unitRef="usd" contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzMxNg_96868d4d-0379-4433-ac91-56ca97e5e7cd">4.2</ix:nonFraction>&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the nine months ended September 30, 2022, and a $<ix:nonFraction unitRef="usd" contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930" decimals="-5" sign="-" name="lgnd:IncreaseDecreaseInDebtDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzMwMg_8299bef0-7f8e-466b-a831-3b7886fa9f31">1.3</ix:nonFraction>&#160;million reduction in debt discount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering <ix:nonFraction unitRef="shares" contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNDA1Nw_634fa449-e967-45d7-8584-c801d049310b">3,018,327</ix:nonFraction> shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNDMzMQ_9335aac1-9f67-4885-9062-3e1c27ec3a35">248.48</ix:nonFraction> per share and are exercisable when and if the 2023 Notes are converted. We paid $<ix:nonFraction unitRef="usd" contextRef="i4e2b8f073bbb4eeea44fc317eeee6bed_D20180501-20180531" decimals="-5" name="lgnd:PaymentsForConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNDQxNA_bcf37870-505b-44c5-bfbb-8fdc80892dd0">140.3</ix:nonFraction> million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i48058ea477c846ce9d29f257c5e3f89f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately <ix:nonFraction unitRef="shares" contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTMxNA_b8024107-cebf-47b9-8753-f27f68fa791b">3,018,327</ix:nonFraction> shares of common stock with an exercise price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTM4MA_729460a5-45e2-4558-8af4-548e7823958b">315.38</ix:nonFraction> per share, subject to certain adjustments. We received $<ix:nonFraction unitRef="usd" contextRef="i4e2b8f073bbb4eeea44fc317eeee6bed_D20180501-20180531" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQzOA_9bf6adfa-cc36-49ff-8d89-fa3aabab69ea">90.0</ix:nonFraction> million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the repurchases of approximately $<ix:nonFraction unitRef="usd" contextRef="ie7d9a25c6c2143cfb4d8e1a7ebe0d185_D20210101-20210131" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjA4MQ_5f71141e-cb4c-4987-ac7e-ffe86f02fad2">20.3</ix:nonFraction>&#160;million in principal of the 2023 Notes for approximately $<ix:nonFraction unitRef="usd" contextRef="ie7d9a25c6c2143cfb4d8e1a7ebe0d185_D20210101-20210131" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjEzMw_95a764e1-f178-4343-8661-960c5cfbe1c1">19.1</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ie7d9a25c6c2143cfb4d8e1a7ebe0d185_D20210101-20210131" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjE3NQ_9c8c97d3-7d8b-4b13-b8f1-b85b85ac8ada">0.1</ix:nonFraction>&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjcxMg_3a9fc04b-cb1c-4cf3-8428-5ad8c8402efb">152.0</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjc1MA_0fd5b126-045e-4fae-bfaf-93bc0c5984da">156.0</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231" decimals="-5" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjc5Mg_f2851f1d-c7e3-428e-a14a-83343516649f">0.3</ix:nonFraction>&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $<ix:nonFraction unitRef="usd" contextRef="ice5667b832bb46b58768234cec087173_D20210101-20211231" decimals="-5" name="lgnd:PaymentsToUnwindWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzA5Ng_e731c165-f6a6-423d-8f60-dfdda1ab0b78">18.4</ix:nonFraction>&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from <ix:nonFraction unitRef="shares" contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzIwNQ_634fa449-e967-45d7-8584-c801d049310b">3,018,327</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzIxMQ_b41a9d5e-5d5a-4286-81b3-3a5e58dc323a">2,559,254</ix:nonFraction>. We received $<ix:nonFraction unitRef="usd" contextRef="ice5667b832bb46b58768234cec087173_D20210101-20211231" decimals="-5" name="lgnd:ProceedsFromUnwindingConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzIyNw_83591f7f-2c70-42b9-9c34-53bedd226da0">18.9</ix:nonFraction>&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to <ix:nonFraction unitRef="option" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="INF" name="lgnd:NumberOfOptionsUnderConvertibleBondHedges" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzM0OA_451b90a8-782d-4c1f-9d16-466add327a3c">598,021</ix:nonFraction> as of December 31, 2021. These unwind transactions resulted in a $<ix:nonFraction unitRef="usd" contextRef="ice5667b832bb46b58768234cec087173_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzM5Mg_ad98c196-5efd-4955-8041-e18bd88ec7ec">0.5</ix:nonFraction>&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="ib75f8705715d4191a83e17e50b6d144f_D20220801-20220831" decimals="-5" name="lgnd:DebtInstrumentRepurchasedAmountDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQ5NzU1ODIzNDIx_7ab0dc17-a54f-4899-ada8-e5cf95ff6500">227.8</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ib75f8705715d4191a83e17e50b6d144f_D20220801-20220831" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQ5NzU1ODIzNDYy_19d1da11-aad2-4cae-9235-de48ccf2edd1">223.7</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i22017c391fb94339803ce6d3d455c551_D20220101-20220630" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQ5NzU1ODIzNDkz_17b46246-0369-4748-b313-7756a9dc242d">0.4</ix:nonFraction>&#160;million made during the six months ended June 30, 2022, we entered into Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We received $<ix:nonFraction unitRef="usd" contextRef="ibe725b5fc54141e2b22eb8fcd4b19e03_D20220801-20220930" decimals="-5" name="lgnd:ProceedsFromUnwindingConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQ5NzU1ODI0MTk0_a3b5a7c5-d035-413c-8670-b0d595eb2590">0.2</ix:nonFraction>&#160;million as part of these Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to <ix:nonFraction unitRef="option" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="INF" name="lgnd:NumberOfOptionsUnderConvertibleBondHedges" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzM2MQ_13738fb5-a81b-49a5-80cf-48eb6d66b592">370,219</ix:nonFraction> as of September 30, 2022. This transaction resulted in a $<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQ5NzU1ODI0ODE2_7daed2f9-c20b-4f8e-af26-fdd04b011266">0.2</ix:nonFraction>&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of September 30, 2022.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzY3Mw_744ea397-2fee-4c3a-86f1-c86a7c4e6f96" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMS0xLTEtMS05NTExNw_5795715a-4c01-477c-ab81-c3a8e9489971">76,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMS0zLTEtMS05NTExNw_40f4075a-6002-4d4e-b810-88382711bd64">343,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMi0xLTEtMS05NTExNw_4449e5a1-60c3-47ba-9e13-f15167ff3faf">254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMi0zLTEtMS05NTExNw_e73edf63-86b0-4f5e-acbc-9b9cef02db0e">22,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMy0xLTEtMS05NTExNw_7a6f4d59-6785-444c-b507-6e81608f8cfe">76,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMy0zLTEtMS05NTExNw_ee6bdf09-8a90-4e6c-aaa5-40e06a9a6a13">320,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfNi0xLTEtMS05NTExNw_afcc4ac2-8c5e-4a20-9c6e-4afe479a66d0">74,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfNi0zLTEtMS05NTExNw_96d6b658-20bf-4a42-9d3b-271d1cf96a14">341,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfMTM1OA_a24a0029-fd66-4f35-b5c5-cf125ceb6ed9" continuedAt="i84164dc483e24781878d622dd44a56ff" escape="true">Income Tax</ix:nonNumeric></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i84164dc483e24781878d622dd44a56ff"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and nine months ended September&#160;30, 2022 and 2021 was <ix:nonFraction unitRef="number" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDM4_85dcd560-7d83-40b1-86f7-7861c6914f3e">52.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDQ1_345fbc39-54de-4fb7-946c-e2a1720e695b">10.1</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDUz_92e4959c-33ca-4d19-a427-c60d12ffa77e">20.3</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDYw_ce3d3861-8078-48d5-927c-2d3e6a2d81ae">15.1</ix:nonFraction>)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation, non-deductible ISO related stock compensation expense and recognition of non-refundable foreign taxes paid during the period. The variance from the U.S. federal tax rate of 21% for the three and nine months ended September 30, 2021 was significantly impacted by tax benefits related to (1) a $<ix:nonFraction unitRef="usd" contextRef="ic9c3c0791990421eab75d178e60313f8_D20210701-20210930" decimals="-5" name="lgnd:EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDk0NzgwMjMyODAxOA_e9b925ab-5d29-4409-85b2-68966d676112">3.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i87ba2111bb0e419c9909cb001f40f3f1_D20210101-20210930" decimals="-5" name="lgnd:EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDk0NzgwMjMyODAyNw_7631b4ee-fce0-49f1-b146-41aefbe88598">37.6</ix:nonFraction> million Pfenex CVR adjustment recorded during the respective period, due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax windfalls from share-based compensation resulting from increased stock option exercise</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activity.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTU2MA_f29ea9a7-7d21-4df4-b3c0-6213071d6633" continuedAt="i0a949da7dffe4af092a13e1574fcb642" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0a949da7dffe4af092a13e1574fcb642" continuedAt="i032c3864a1dd46849dd241aecd5b033f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2021 Annual Report.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTU1OQ_25d1d33f-3930-4a12-9977-43c66ad24a10" escape="true"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTU2MQ_1ff793b4-2dd5-43ee-9871-72598061485e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2834ca94385d4db2aacdb319acd70cba_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMi0xLTEtMS05NTExNw_aa0ff004-0aaf-4215-8938-5dbf1ae169cf">2,199,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2834ca94385d4db2aacdb319acd70cba_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMi0zLTEtMS05NTExNw_8d570b3c-4401-40ed-ba48-94d1aafc3cbc">106.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27be544b5f9b4843871454a4846e31e7_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMi01LTEtMS05NTExNw_aa1e9d3f-bfda-4ed0-a8d8-520d3086f9e5">264,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i27be544b5f9b4843871454a4846e31e7_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMi03LTEtMS05NTExNw_022005ce-3a3a-4561-b2dd-3021da66d582">138.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMy0xLTEtMS05NTExNw_dfe48691-5021-41ae-8111-55da18ced33d">852,475</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMy0zLTEtMS05NTExNw_a63ea86d-e9bb-4b8a-8c8c-cfac268f8735">91.39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMy01LTEtMS05NTExNw_947fec5e-4ebf-4820-8ed7-cb9e222cfa99">260,577</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMy03LTEtMS05NTExNw_19ab04e1-c6d6-479f-bc04-0ebda6ef8bc2">89.99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNC0xLTEtMS05NTExNw_6ee146b8-d463-4b8e-b537-0be14f310072">34,941</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNC0zLTEtMS05NTExNw_9eeb4103-3615-464a-ab15-69897fb653bc">38.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNC01LTEtMS05NTExNw_9afece25-c98e-4b1d-8130-17bea88d475a">136,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNC03LTEtMS05NTExNw_9b35aa93-27fb-43d7-8eac-b3bef9b6ca5b">120.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNS0xLTEtMS05NTExNw_4f51c1c4-03fa-4c55-be9d-6e6cec800a26">36,529</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNS0zLTEtMS05NTExNw_960e55da-bc60-4119-a6e1-4d61ca7dd14b">76.26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNS01LTEtMS05NTExNw_d4e66d5d-1435-45fa-a6d6-6e13ca906e16">2,059</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNS03LTEtMS05NTExNw_bed72e22-96b0-4a2d-b2fc-1266dfeabe99">121.79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6abb45e394d9463b85d36c87fa45855a_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNi0xLTEtMS05NTExNw_a7f36f55-41b5-4c6c-9413-690cd9068463">2,980,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6abb45e394d9463b85d36c87fa45855a_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNi0zLTEtMS05NTExNw_a2c166ba-06d8-47f1-89b7-fa6ab53521e2">102.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icd55699f74a443efb3dad3f864d69f0d_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNi01LTEtMS05NTExNw_7fa73ffe-10bc-47ee-bc68-3709464be47c">386,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icd55699f74a443efb3dad3f864d69f0d_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNi03LTEtMS05NTExNw_f3a8e2ab-7444-4a6c-9728-914cd49e01a3">111.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, outstanding options to purchase <ix:nonFraction unitRef="shares" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfNDUw_b6865217-5a77-4c26-8f8c-f504737225fa">1.7</ix:nonFraction> million shares were exercisable with a weighted average exercise price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfNTI5_e3b64433-e32f-4ff0-b533-bb01a3b65d7d">102.23</ix:nonFraction>.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to <ix:nonFraction unitRef="number" contextRef="ifa972f2a8689410b8773aec2b27958d0_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfNjc4_eb476b35-20cc-4d22-9c1c-311a68fcd0a9">85</ix:nonFraction>% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of September&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="ifa972f2a8689410b8773aec2b27958d0_D20220101-20220930" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfODA1_cb1038df-67e9-4ba8-bc36-48afaeb0a3f1">38,007</ix:nonFraction> shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i6d8fd471caf841f7ac94f8e517939089_I20190911" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTAyNg_ca880901-1f3e-40d1-a395-a0b7cc2ddcd1">500.0</ix:nonFraction> million of our common stock from time to time over the next <ix:nonNumeric contextRef="i3b41dd4334ec4f4f8a4cfe7c0d306776_D20190911-20190911" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTA4MQ_952add28-6b2c-4e2e-b49e-b35155a64aa4">three years</ix:nonNumeric>. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. We did <ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTQyNw_44381f58-6061-441f-bc99-4824c00e4e82"><ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTQyNw_c0d125b0-7b34-4195-bd59-7ba4ab1708cc">no</ix:nonFraction></ix:nonFraction>t have any share repurchases during the three and nine months ended September&#160;30, 2022. Authorization to repurchase $<ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTUwNA_cda77398-fd66-4402-aae4-051c41b40bdd">248.8</ix:nonFraction> million of our common stock remained available as of September&#160;30, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the Market Equity Offering Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we filed a registration statement on Form S-3 (the &#8220;Shelf Registration Statement&#8221;), which became automatically effective upon filing, covering the offering of common stock, preferred stock, debt securities, warrants and units. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we also entered into an At-The-Market Equity Offering Sales Agreement (the &#8220;Sales Agreement&#8221;) with Stifel, Nicolaus &amp; Company, Incorporated (the &#8220;Agent&#8221;), under which we may, from time to time, sell shares of our </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i032c3864a1dd46849dd241aecd5b033f">common stock having an aggregate offering price of up to $<ix:nonFraction unitRef="usd" contextRef="i9961ee71da6d43899ffda6ea8268a9b4_I20220930" decimals="-3" name="lgnd:SaleOfStockAuthorizedOfferingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMzI5ODUzNDg4ODQ1OA_7377aa6b-437b-4976-8149-dd6a3ad30953">100.0</ix:nonFraction>&#160;million in &#8220;at the market&#8221; offerings through the Agent (the &#8220;ATM Offering&#8221;). The Shelf Registration Statement included a prospectus covering the offering, issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="i9961ee71da6d43899ffda6ea8268a9b4_I20220930" decimals="-3" name="lgnd:SaleOfStockAuthorizedOfferingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMzI5ODUzNDg4OTY5Mw_7377aa6b-437b-4976-8149-dd6a3ad30953">100.0</ix:nonFraction>&#160;million of our common stock from time to time through the ATM Offering. The shares to be sold under the Sales Agreement may be issued and sold pursuant to the Shelf Registration Statement. To date, we have not issued any shares of common stock in the ATM Offering.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81NS9mcmFnOjRlM2Q2NDFhMTUxNTQ5OGJhODAzMDIyNTA2ZWNjM2JjL3RleHRyZWdpb246NGUzZDY0MWExNTE1NDk4YmE4MDMwMjI1MDZlY2MzYmNfMzM2Mg_15255f0f-bae1-4bc4-9b1c-14fce7450e74" continuedAt="i7e699331170a4a188083c658d1631b69" escape="true">Commitment and Contingencies: Legal Proceedings</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7e699331170a4a188083c658d1631b69"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received <ix:nonFraction unitRef="civil_complaint" contextRef="i0f4e7138c0694ae2ae0c918afaf6d867_D20191031-20191031" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81NS9mcmFnOjRlM2Q2NDFhMTUxNTQ5OGJhODAzMDIyNTA2ZWNjM2JjL3RleHRyZWdpb246NGUzZDY0MWExNTE1NDk4YmE4MDMwMjI1MDZlY2MzYmNfNjcw_2a342ce8-9379-4b33-8117-6f308c17771f">three</ix:nonFraction> civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the <ix:nonFraction unitRef="civil_complaint" contextRef="i0f4e7138c0694ae2ae0c918afaf6d867_D20191031-20191031" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81NS9mcmFnOjRlM2Q2NDFhMTUxNTQ5OGJhODAzMDIyNTA2ZWNjM2JjL3RleHRyZWdpb246NGUzZDY0MWExNTE1NDk4YmE4MDMwMjI1MDZlY2MzYmNfMTI1Nw_db2cc8a2-8839-433b-80e4-0497f666ef87">three</ix:nonFraction> complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CyDex, a wholly owned subsidiary of Ligand, and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol&#174; technology and, more specifically, relating to Captisol&#174;-enabled Nexterone&#174; (amiodarone HCl premixed injection).  CyDex contended that Baxter has not paid all of the royalties due to CyDex under the terms of the license agreement and Baxter contends that it has overpaid royalties for several years.  On April 6, 2021, Baxter initiated an arbitration with AAA pursuant to the arbitration provision of the license agreement.  On April 21, 2021, CyDex filed an answering statement and counterdemand. On December 2, 2021, Baxter filed an Amended Notice of Arbitration Demand seeking a declaration limiting the &#8220;royalty term&#8221; of the license agreement to &#8220;the later of i) the expiration of the licensed [p]atent; or ii) when there are no longer any CyDex patents listed in the Orange Book for [Nexterone&#174;].&#8221; Baxter later clarified its position, and asserted that royalties should have ceased being due upon the May 4, 2022 expiry of CyDex&#8217;s U.S. Patent No. 6,869,939.  The parties conducted a three-day arbitration hearing May 24-26, 2022.  In a September 9, 2022 Final Award, the Tribunal ruled in CyDex&#8217;s favor by (1) denying Baxter&#8217;s request for a partial refund of previously paid royalties, (2) granting CyDex&#8217;s request for underpaid royalties, and (3) concluding that &#8220;[g]oing forward Baxter shall pay CyDex&#8221; a royalty consistent with CyDex&#8217;s construction of the license agreement until, at least, the March 13, 2029 expiry of CyDex&#8217;s U.S. Patent No. 7,635,773.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2022, Pfenex Inc. (&#8220;Pfenex&#8221;), a wholly owned subsidiary of Ligand, received a notice of alleged breach from Beijing Kangchen Biological Technology Co., Ltd. (&#8220;Kangchen&#8221;) with respect to a Development and License Agreement between Pfenex and Kangchen (&#8220;License Agreement&#8221;) pertaining to the development and commercialization of teriparatide in certain Southeast Asian countries. The allegations in the notice focused on the activities of Pfenex and other parties. On June 16, 2022, we rejected all claims raised by Kangchen in the notice. On June 24, 2022, Kangchen served Pfenex a notice of termination of the License Agreement and demanded initiation of the dispute resolution process in accordance with the License Agreement. On June 29, 2022, we again rejected all claims raised by Kangchen in the notice of termination and agreed to engage in the applicable dispute resolution process, including good faith negotiations between the parties. On October 20, 2022, we agreed to make a single lump sum payment to Kangchen in connection with a termination agreement that, among other things, terminates the License Agreement and releases all claims between the parties arising from the License Agreement.  We anticipate that the termination agreement between Pfenex and Kangchen will go into effect the fourth quarter of 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div></ix:continuation><div><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.  <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMjI1MA_363a1326-a452-4ec7-8ed9-f46d39572b3e" continuedAt="i48ea68f69ee4458db32cfbf1ed6111ea" escape="true"><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMjI1MA_9bdf1b41-2ea6-4fb2-99f7-014119ca641e" continuedAt="i74e57a99900a401db73008206a23dbfc" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i48ea68f69ee4458db32cfbf1ed6111ea" continuedAt="i74ceff76452c4245a38a28911834fdb8"><ix:continuation id="i74e57a99900a401db73008206a23dbfc" continuedAt="ice9a937997a046d085e231fa729da0c1">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to <ix:nonNumeric contextRef="ifa102a08d9284fa6b57fb76fdcab4852_I20220930" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMTU4_be9a752d-940c-4443-80ee-c349728f2682">ten years</ix:nonNumeric>, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="ifa102a08d9284fa6b57fb76fdcab4852_I20220930" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMjIz_fdd3e280-ba8c-4ea8-995c-31729ff0d5d5">five years</ix:nonNumeric>. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating </ix:continuation></ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i74ceff76452c4245a38a28911834fdb8"><ix:continuation id="ice9a937997a046d085e231fa729da0c1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are primarily related to our right to use the equipment under the agreement with Hovione, our third-party manufacturer, to exclusively manufacture Captisol.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="lgnd:AssetsAndLiabilitiesLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMjI1MQ_2225a3e9-3c09-4260-9dae-df30b324de6e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMS0xLTEtMS05NTExNw_349cb7ff-5f3b-41c6-b3eb-1710e174223b">32,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMS0zLTEtMS05NTExNw_796b479d-b9d1-42f4-8224-bb917e0c5575">16,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMi0xLTEtMS05NTExNw_3f1ed65c-2e4b-46b6-9e07-20e33ca92386">14,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMi0zLTEtMS05NTExNw_178d051b-75fd-4c7f-89f0-d469d8c12728">16,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMy0xLTEtMS05NTExNw_9c02c24c-a5a7-4c03-ad0e-7fab0a18e952">46,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMy0zLTEtMS05NTExNw_78193ae3-34bb-47d2-85bf-9bcec21208e8">32,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfNi0xLTEtMS05NTExNw_738fbcd6-ddd6-4adc-82bf-ce66739bea96">2,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfNi0zLTEtMS05NTExNw_2b83ec5f-4140-4be7-b922-05bcd94f9aac">2,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfNy0xLTEtMS05NTExNw_72957835-9e7d-44fc-bf31-1563e574f045">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfNy0zLTEtMS05NTExNw_23e8bb1c-4ddf-442b-9939-9f516a2c27ed">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:LeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfOC0xLTEtMS05NTExNw_8ec45c52-d685-49c6-8a46-b8c3a7a1f5ee">2,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:LeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfOC0zLTEtMS05NTExNw_75cce8d1-2e08-407c-b3a0-f975c1287485">2,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfOS0xLTEtMS05NTExNw_1b3fe217-d86b-4453-ae39-65ee7e6ac41d">34,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfOS0zLTEtMS05NTExNw_ead5c1b2-3474-4426-9839-79ca5f61a584">15,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMTAtMS0xLTEtOTUxMTc_8d516033-ce0f-4bf8-86c4-3624a6a296d9">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMTAtMy0xLTEtOTUxMTc_6e31da82-6aee-4213-a348-6acc78a9a725">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:LeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMTEtMS0xLTEtOTUxMTc_cd07f8c8-850b-41b3-a18e-c421b535d7d0">37,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id713d77cfce844c9acd459debe60471f_I20211231" decimals="-3" name="lgnd:LeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMTEtMy0xLTEtOTUxMTc_819a1c96-7767-459e-8f5e-4e55e2c5a8e9">17,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022, we entered into several lease agreements and amendments, which resulted in an increase in lease assets of $<ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-5" name="lgnd:OperatingLeasesRightOfUseAssetsIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfODc5NjA5MzAyNTQxMA_1f91d496-0437-4444-911b-973466bf71bd">8.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-5" name="lgnd:OperatingLeasesRightOfUseAssetsIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfODc5NjA5MzAyNTQyNA_471ad5e6-0f0e-4814-ab42-fabf53c1b225">18.4</ix:nonFraction>&#160;million, and liabilities of $<ix:nonFraction unitRef="usd" contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930" decimals="-5" name="lgnd:OperatingLeaseLiabilityIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfODc5NjA5MzAyNTQzOQ_c350ad2f-6a2a-4015-a297-a8273c68d15f">8.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" decimals="-5" name="lgnd:OperatingLeaseLiabilityIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfODc5NjA5MzAyNTQ1Mw_d551fbf7-d875-4f9d-bf5f-126f729774bf">21.7</ix:nonFraction>&#160;million, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMjI0OQ_a52bdf5e-a0c0-46b0-85ac-6f1c539d0a84" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of September&#160;30, 2022 (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:81.668%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.132%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining three months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfMS0xLTEtMS05NTExNw_152290cb-e36f-44a3-b720-75f7a4928cd0">1,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfMi0xLTEtMS05NTExNw_4944caa5-51e2-48fb-bfa6-fc0fcbad6db4">4,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfMy0xLTEtMS05NTExNw_ee05a48e-37ee-4f2f-a561-baec14ff765f">4,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfNC0xLTEtMS05NTExNw_6fa45c5a-07a5-48a7-a4b5-217a3a82c187">4,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfNS0xLTEtMS05NTExNw_757492bd-6274-429c-9cee-e7b9e52b3442">5,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfNi0xLTEtMS05NTExNw_e1336766-76af-4a8c-a322-3254be660c78">5,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfNy0xLTEtMS05NTExNw_1235af05-7e66-4414-8ba8-023cce7830f9">22,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfOC0xLTEtMS05NTExNw_584be296-4b37-4b3f-83a5-e849e032abee">48,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less estimated tenant improvement allowance:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="lgnd:LesseeOperatingLeaseLiabilityTenantImprovementAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfOS0xLTEtMS05NTExNw_5bece715-a090-4c0a-bef1-9641546c5641">1,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfMTAtMS0xLTEtOTUxMTc_36fd737f-0700-458f-a03b-2de147d85aef">10,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed21a608d174035a9614928545bff44_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfMTEtMS0xLTEtOTUxMTc_0abc0a09-4110-446e-a68f-59f23725b362">37,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_476"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80NzYvZnJhZzpiMzlkNDA5YzA0YWY0NGI3OTRjZjFkOWQ0ZDEzOWNkOS90ZXh0cmVnaW9uOmIzOWQ0MDljMDRhZjQ0Yjc5NGNmMWQ5ZDRkMTM5Y2Q5Xzg3OTYwOTMwMjI3OTM_14bbb390-b07b-437e-8275-9389e44ae541" continuedAt="iedcdb96e8f894f6fa3bd8efc527d527d" escape="true">Subsequent Event</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iedcdb96e8f894f6fa3bd8efc527d527d">On November, 1, 2022, Ligand completed the Transactions. Pursuant to the Distribution, Ligand distributed on a pro rata basis to its shareholders as of the close of business on October 26, 2022 shares of the common stock of OmniAb representing <ix:nonFraction unitRef="number" contextRef="iae84b3f2dac8479f98e3fbba153cb912_I20221026" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80NzYvZnJhZzpiMzlkNDA5YzA0YWY0NGI3OTRjZjFkOWQ0ZDEzOWNkOS90ZXh0cmVnaW9uOmIzOWQ0MDljMDRhZjQ0Yjc5NGNmMWQ5ZDRkMTM5Y2Q5Xzg3OTYwOTMwMjQxMTU_bfec13f5-f053-4216-acf2-f912b2df8bd2">100</ix:nonFraction>% of Ligand&#8217;s interest in OmniAb. The Distribution was immediately followed by the Merger, pursuant to which OmniAb merged with Merger Sub, with OmniAb continuing as the surviving entity and becoming a wholly owned subsidiary of APAC. Prior to the Distribution and Merger, OmniAb changed its name to OmniAb Operations, Inc. and APAC changed its name to OmniAb, Inc. Following the Merger, OmniAb, Inc. is an independent, publicly traded company whose common stock trades on NASDAQ under the symbol &#8220;OABI.&#8221;</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i2959cf3610a04d8385d1c4c227b59df4_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Caution:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">  This discussion and analysis may contain predictions, estimates and other forward-looking statements that involve a number of risks and uncertainties, including those discussed in Part II, Item 1A. Risk Factors. This outlook represents our current judgment on the future direction of our business. These statements include those related to our Captisol-related revenues and manufacturing capacity, our Kyprolis and other product royalty revenues, the impact of COVID-19, product returns, product development, and the potential separation of the OmniAb Business. Actual events or results may differ materially from our expectations. For example, there can be no assurance that our revenues or expenses will meet any expectations or follow any trend(s), that we will be able to retain our key employees or that we will be able to enter into any strategic partnerships or other transactions. We cannot assure you that we will receive expected Kyprolis, Captisol and other product revenues to support our ongoing business or that our internal or partnered pipeline products will progress in their development, gain marketing approval or achieve success in the market. In addition, ongoing or future arbitration, litigation or disputes with third parties may have a material adverse effect on us. Such risks and uncertainties, and others, could cause actual results to differ materially from any future performance suggested. We undertake no obligation to make any revisions to these forward-looking statements to reflect events or circumstances arising after the date of this quarterly report. This caution is made under the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">We use our trademarks, trade names and services marks in this report as well as trademarks, trade names and service marks that are the property of other organizations. Solely for convenience, trademarks and trade names referred to in this report appear without the &#174; and &#8482; symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert its rights, to these trade marks and trade names.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to &#8220;Ligand Pharmaceuticals Incorporated,&#8221; &#8220;Ligand,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221; include Ligand Pharmaceuticals Incorporated and our wholly-owned subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i2959cf3610a04d8385d1c4c227b59df4_64"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the completion on November 1, 2022 of the expected tax-free spin-off of our subsidiary OmniAb (further discussed below), our business included OmniAb&#8217;s antibody discovery business. OmniAb&#8217;s discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics. At the heart of the OmniAb platform is the Biological Intelligence&#8482; (BI) of its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur features unique structural attributes of cow antibodies for complex targets. The OmniAb suite of technologies span from BI-powered repertoire generation to cutting edge antibody discovery and optimization offering a highly efficient and customizable end-to-end solution for the growing discovery needs of the global pharmaceutical industry.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the spin-off of our OmniAb antibody discovery business, Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) ultimately to generate our revenue. Our Captisol platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Our Pelican Expression Technology is a robust, validated, cost-effective and scalable platform for recombinant protein production that is especially well-suited for complex, large-scale protein production where traditional systems are not. We have established multiple alliances, licenses and other business relationships with the world&#8217;s leading pharmaceutical companies including Amgen, Merck, Pfizer, Sanofi, Takeda, Gilead Sciences and Baxter International.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue consists of three primary elements: royalties from commercialized products, sale of Captisol material, and contract revenue from license, milestone and other service payments. In addition to discovering and developing our own proprietary drugs, we selectively pursue acquisitions to bring in new assets, pipelines, and technologies to aid in generating additional potential new revenue streams.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Update on the OmniAb Separation Process</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, Ligand completed (the &#8220;Closing&#8221;) the separation (the &#8220;Separation&#8221;) of its antibody discovery business and certain related assets and liabilities (the &#8220;OmniAb Business&#8221;) through a spin-off of OmniAb to Ligand&#8217;s shareholders of record as of October 26, 2022 (the &#8220;Record Date&#8221;) on a pro rata basis (the &#8220;Distribution&#8221;) and merger (the &#8220;Merger&#8221;) of OmniAb with a wholly owned subsidiary of APAC in a Reverse Morris Trust transaction (collectively, the &#8220;Transactions&#8221;) pursuant to the Merger Agreement and the Separation Agreement (collectively with the other related transaction documents, the &#8220;Transaction Agreements&#8221;).  The day prior to the Closing, OmniAb was renamed OmniAb Operations, Inc. and APAC was renamed OmniAb, Inc. (&#8220;New OmniAb&#8221;).  Pursuant to the Transaction Agreements, Ligand contributed to OmniAb cash and certain assets and liabilities constituting the OmniAb Business, including certain related subsidiaries of Ligand, to OmniAb (the &#8220;Contribution&#8221;). In consideration for the Contribution, OmniAb issued to Ligand additional shares of OmniAb common stock such that the number of shares of OmniAb common stock then outstanding equaled the number of shares of OmniAb common stock necessary to effect the Distribution.  Pursuant to the Distribution, Ligand shareholders as of the Record Date received one share of OmniAb common stock for each share of Ligand common stock held as of such date. Pursuant to the Merger Agreement, each share of OmniAb common stock was thereafter exchanged for the right to receive 4.90007 shares of New OmniAb common stock and 0.75842 shares of New OmniAb common stock subject to price-based earnout triggers (the &#8220;Earnout Shares&#8221;). The Earnout Shares will vest based upon the achievement of certain volume-weighted average trading prices (VWAP) for shares of OmniAb for any 20 trading days over a consecutive 30 trading-day period during the five-year period following the Closing, with (i) fifty percent of such Earnout Shares vesting upon achievement of a VWAP of $12.50 per share of OmniAb common stock or upon the occurrence of a change of control transaction that will result in the holders of OmniAb common stock receiving a price per share in excess of $12.50, and (ii) the remaining fifty percent of the Earnout Shares vesting upon achievement of a VWAP of $15.00 per share of OmniAb common stock or upon the occurrence of a change of control transaction that will result in the holders of OmniAb common stock receiving a price per share in excess of $15.00.  The Earnout Shares are not transferable until the vesting condition for the applicable tranche of Earnout Shares has been achieved. Upon the closing of the Transactions, the ownership of the outstanding stock of New OmniAb (including the Earnout Shares) was as follows:  Ligand&#8217;s existing shareholders held approximately </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85.0%, APAC&#8217;s existing public shareholders held approximately 1.1% and the sponsor and related parties of APAC held approximately 13.9%.  Fractional shares of New OmniAb common stock were not issued pursuant to the Merger.  Instead, shareholders received cash in lieu of any fractional share (other than with respect to Earnout Shares).</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the Closing, OmniAb expected to have approximately $95 million of net cash. The transaction is expected to be tax-free to Ligand and its shareholders for U.S. federal income tax purposes. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2022, OmniAb began regular-way trading on NASDAQ under the ticker symbol &#8220;OABI.&#8221; Ligand continues to trade under the ticker symbol &#8220;LGND.&#8221;</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Updates </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travere Therapeutics announced that the previously assigned PDUFA target action date of November 17, 2022 for its NDA under Subpart H for accelerated approval of sparsentan for the treatment of IgA nephropathy (IgAN) is expected to be extended by three months and is now February 17, 2023. Travere subsequently announced the European Medicines Agency has accepted for review the Conditional Marketing Authorization for sparsentan for IgAN in Europe with a review decision expected in the second half of 2023.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verona Pharma announced positive top-line results from its Phase 3 ENHANCE-2 trial evaluating ensifentrine for the treatment of chronic obstructive pulmonary disease (COPD). The trial successfully met its primary and secondary endpoints evaluating lung function, and significantly reduced the rate and risk of COPD exacerbations. Ensifentrine was well tolerated with safety results similar to placebo. Verona subsequently announced additional analyses demonstrating ensifentrine reduced exacerbation rates across all subgroups in the Phase 3 ENHANCE-2 trial.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Merck announced the European Medicines Agency has recommended approval of VAXNEUVANCE for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in individuals from 6 weeks to less than 18 years of age. VAXNEUVANCE is a 15-valent pneumococcal vaccine utilizing Ligand&#8217;s CRM197 vaccine carrier protein and is currently authorized for use in the European Union for individuals 18 years of age and older and is approved in the United States for individuals 6 weeks of age and older. In July 2022 Merck started a broad Phase 3 program for V116, their investigational 21-valent pneumococcal conjugate vaccine utilizing Ligand&#8217;s CRM197 vaccine carrier protein.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sermonix Pharmaceuticals announced results of its ELAINE 1 Phase 2 study of lasofoxifene vs. fulvestrant in postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer and an ESR1 mutation. Median progression-free survival was 6.04 months for lasofoxifene vs. 4.04 months for fulvestrant (p=0.138). Objective response rate was 13.2% for lasofoxifene vs. 2.9% for fulvestrant, (p=0.12), with 1 complete response and 4 partial responses in the lasofoxifene arm vs. no complete responses and 1 partial response in the fulvestrant arm. While the study was not powered for statistical significance, all endpoints numerically favored lasofoxifene.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2022, over 60 partners have access to OmniAb-derived antibodies and more than 270 programs are being actively pursued or commercialized by OmniAb's partners. As of September 30, 2022, the platform has generated 25 clinical- or commercial- stage OmniAb-derived antibodies. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.347%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q3 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q3 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol - Core</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol - COVID</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,082)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,088&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,660&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,460)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Q3 2022 vs. Q3 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total revenue increased by $1.3 million, or 2%, to $66.1 million in Q3 2022 compared to $64.8 million in Q3 2021 primarily due to the $4.2 million increase in royalties revenue which was driven by Kyprolis and sales of products using the Pelican platform. Contract revenue decreased by  $3.8 million, or 27%, to $10.3 million in Q3 2022 primarily due to the achievement of significant milestones tied to the Pelican platform in Q3 2021. Core Captisol sales decreased by $1.8 million, or 33%, to $3.6 million in Q3 2022 primarily due to the timing of customer orders. Captisol sales related to COVID-19 were $32.4&#160;million in Q3 2022, compared with $29.7&#160;million for the same period in 2021 with the increase related to the demand for the pandemic-related treatment.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues attributable to the Ligand core business segment and OmniAb business segment were $59.2 million and $6.9 million, and $59.7 million and $5.1 million, respectively, for Q3 2022 and Q3 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2022 vs. YTD 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total revenue decreased by $35.5 million, or 17%, to $169.2 million in YTD 2022 compared to $204.7 million in YTD 2021 primarily due to the $48.1 million decrease in sales of COVID-related Captisol that is used in formulation with remdesivir. Captisol sales related to COVID-19 were $64.5&#160;million for the nine months ended September 30, 2022, compared with $112.6&#160;million for the same period in 2021. The lower sales were due to reduced demand for the pandemic-related treatment. Royalties increased in YTD 2022 by $20.1 million compared to YTD 2021, with the increase primarily due to Kyprolis and sales of products using the Pelican platform. Core Captisol sales decreased by $3.2 million, or 19%, to $13.1 million in YTD 2022 compared to YTD 2021 primarily due to timing of customer orders. Contract revenue decreased by $4.3 million, or 10%, to $40.1 million in YTD 2022 compared to YTD 2021 primarily due to the achievement of significant milestones tied to the Pelican platform in YTD 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues attributable to the Ligand core business segment and OmniAb business segment were $145.9 million and $23.3 million, and $185.1 million and $19.5 million, respectively, for YTD 2022 and YTD 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Royalty revenue is a function of our partners&#8217; product sales and the applicable royalty rate. Kyprolis royalty rates are under a tiered royalty rate structure with the highest tier being 3.0%. Evomela has a fixed royalty rate of 20%. Teriparatide injection has a tiered royalty between 25% and 40% on sales that have been adjusted for certain deductible items as defined in the respective license agreement. The Rylaze royalty rate is tiered between 3% and 5%. Contract revenue includes service revenue, license fees and development, regulatory and sales based milestone payments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents royalty revenue by program (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">336.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teriparatide injection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">70.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">49.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">483.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">396.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022 Estimated Partner Product Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022 Royalty Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021 Estimated Partner Product Sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">980.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">877.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">41.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teriparatide injection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">36.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">34.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rylaze</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">197.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">174.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">114.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,429.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">51.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,056.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%">(1) - Teriparatide injection sales have been adjusted for certain deductible items as defined in the respective license agreement.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs and Expenses</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.660%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of Captisol</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">31,213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,818</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">35,455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">22,036</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">61,461</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">17,445</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50,210</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">65,452</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,129&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">178,339</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138,499&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Q3 2022 vs. Q3 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total operating costs and expenses increased by $16.3 million, or 33%, to $65.5 million in Q3 2022 compared to $49.1 million in Q3 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cost of Captisol increased by $2.7 million, or 24%, to $14.2 million in Q3 2022 compared to $11.4 million in Q3 2021, with the increase primarily due to higher total sales of Captisol and a shift in the mix of Captisol sales this quarter away from clinical use customers. All of the cost of Captisol is attributable to the Ligand core business segment. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles remained steady in Q3 2022 compared to the same period in 2021 as there have been no significant changes to the gross balance of intangible assets over these periods.  Amortization of intangibles were $8.6&#160;million and $3.2&#160;million for the Ligand core business segment and OmniAb business segment during both Q3 2022 and Q3 2021, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple R&amp;D programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Research and development expense was $22.0 million for Q3 2022, compared with $16.9 million for the same period of 2021, with the increase primarily due to continued investment in the OmniAb business including facilities and headcount related expenditures associated with the spin-off. Excluding $0.9&#160;million in unallocated corporate items, R&amp;D expenses were $8.1&#160;million and $13.0&#160;million for the Ligand core business segment and OmniAb business segment during Q3 2022, respectively. Excluding $0.9&#160;million in unallocated corporate items, R&amp;D expenses were $6.4&#160;million and $9.6&#160;million, for the Ligand core business segment and OmniAb business segment during Q3 2021, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense was $17.4&#160;million for Q3 2022, compared to $12.7&#160;million for the same period in 2021, with the increase primarily due to legal expenses and headcount related expenditures. Excluding $8.7&#160;million in unallocated corporate items, general and administrative expenses were $6.3&#160;million and $2.4&#160;million for the Ligand core business segment and OmniAb business segment during Q3 2022, respectively. Excluding $6.8&#160;million in unallocated corporate items, general and administrative expenses were $4.4&#160;million and $1.5&#160;million for the Ligand core business segment and OmniAb business segment during Q3 2021, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no other operating income for Q3 2022, compared with $3.8 million for Q3 2021, which represented a non-cash valuation adjustment related to eliminating the remaining Pfenex CVR liability.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2022 vs. YTD 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total operating costs and expenses increased by $39.8 million, or 29%, to $178.3 million in YTD 2022 compared to $138.5 million in YTD 2021 primarily attributable to the a non-cash valuation adjustment of $37.6 million recorded in YTD 2021, which represented a non-cash valuation adjustment related to eliminating the Pfenex CVR liability.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cost of Captisol decreased by $19.0 million, or 38%, to $31.2 million in YTD 2022 compared to $50.2 million in YTD 2021, with the decrease primarily due to lower total sales of Captisol. All of the cost of Captisol is attributable to the Ligand core business segment. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles remained steady in YTD 2022 compared to YTD 2021 as there have been no significant changes to the gross balance of intangible assets over these periods.  Amortization of intangibles were $25.7&#160;million and $9.8&#160;million for the Ligand core business segment and OmniAb business segment in YTD 2022, respectively, and $25.9&#160;million and $9.5&#160;million in YTD 2021, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple R&amp;D programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Research and development expenses were $61.5&#160;million in YTD 2022, compared with $50.8&#160;million in YTD 2021, with the increase primarily due to continued investment in the OmniAb business which includes facilities and headcount related expenditures associated with the spin-off of OmniAb. Excluding $2.6&#160;million in unallocated corporate items, R&amp;D expenses were $23.9&#160;million and $35.0&#160;million for the Ligand core business segment and OmniAb business segment in YTD 2022, respectively. Excluding $2.7&#160;million in unallocated corporate items, R&amp;D expenses were $20.8&#160;million and $27.3&#160;million, for the Ligand core business segment and OmniAb business segment in YTD 2021, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $10.5&#160;million, or 26%, to $50.2&#160;million in YTD 2022 compared to $39.7&#160;million in YTD 2021, with the increase primarily due to $5.0&#160;million in transaction costs in connection with the spin-off of OmniAb and other headcount related expenditures and additional legal expenses incurred during the nine months ended September 30, 2022. Excluding $28.7&#160;million in unallocated corporate items, general and administrative expenses were $16.0&#160;million and $5.5&#160;million for the Ligand core business segment and OmniAb business segment in YTD 2022, respectively. Excluding $22.2&#160;million in unallocated corporate items, general and administrative expenses were $13.1&#160;million and $4.4&#160;million for the Ligand core business segment and OmniAb business segment in YTD 2021, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no other operating income in YTD 2022, compared with $37.6 million in YTD 2021, which represented a non-cash valuation adjustment to reduce the Pfenex CVR liability due to an expected lower probability of achieving the required milestone under the Pfenex CVR Agreement. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Income (Expense)</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.170%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) from short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(923)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,860)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(15,709)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23,844)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">591</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1,559)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">885</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,001)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,465</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,516)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,981&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">221</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(10,780)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,837)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Q3 2022 vs. Q3 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and other equity security investments, contributing an unrealized loss of $0.9 million in Q3 2022 as compared to an unrealized gain of $1.6 million in Q3 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The increase over the prior year was due to the increase in interest rate, partially offset by the decrease in our short-term investment balance.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes in both Q3 2022 and Q3 2021. The decrease was primarily due to the adoption of ASU 2020-06 which significantly reduced the debt discount balance subject to amortization. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for detail on ASU 2020-06 adoption. In addition, we carried a lower average debt outstanding balance in Q3 2022 as compared to Q3 2021. During Q3 2022, we repurchased $38.6&#160;million in principal amount of the 2023 Notes. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in Q3 2022 decreased by $1.0 million as compared to Q3 2021, primarily due to the $0.9&#160;million gain on extinguishment of debt during Q3 2022 compared to a $2.0 million reduction in fair value adjustment of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metabasis and Icagen CVRs during Q3 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Fair Value Measurements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">YTD 2022 vs. YTD 2021</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock and other equity security investments, contributing an unrealized loss of $15.4 million in YTD 2022, as compared to an unrealized gain of $2.4 million and a realized gain of $5.7 million in YTD 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The increase over the prior year was due to the increase in interest rate, partially offset by the decrease in our short-term investment balance.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes in both YTD 2022 and YTD 2021. The decrease was primarily due to the adoption of ASU 2020-06 which significantly reduced the debt discount balance subject to amortization. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for detail on ASU 2020-06 adoption. In addition, we carried a lower average debt outstanding balance during YTD 2022 as compared YTD 2021. During YTD 2022, we repurchased $266.4&#160;million in principal amount of the 2023 Notes. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in YTD 2022 increased by $11.0 million as compared to YTD 2021, primarily due to a $4.2&#160;million gain on extinguishment of debt and $1.4&#160;million gain for the fair value adjustment of Metabasis, Icagen and CyDex CVRs during YTD 2022 compared to a $7.3&#160;million loss on extinguishment of debt, which was partially offset by $1.8&#160;million gain for the fair value adjustment of Metabasis, Icagen and CyDex CVRs during YTD 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Fair Value Measurements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit (Expense)</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:31.834%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.139%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">857</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,402)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(19,919)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(74,243)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(453)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,536)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,043</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,187)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">404</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,319)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(15,876)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(78,430)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute our income tax provision by applying the estimated annual effective tax rate to income from operations and adding the effects of any discrete income tax items specific to the period. The effective tax rate for the three and nine months ended September&#160;30, 2022 and 2021 was 52.9% and 10.1%, and 20.3% and (15.1)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation and non-deductible ISO related stock compensation expense during the period. The variance from the U.S. federal statutory tax rate of 21% for the three and nine months ended September 30, 2021 was significantly impacted by tax benefits related to (1) a $3.8 million and $37.6 million Pfenex CVR adjustment recorded during the respective period due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax windfalls from share-based compensation resulting from increased stock option exercise activity.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Liquidity and Capital Resources </span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, our cash, cash equivalents, and short-term investments totaled $121.4 million, which decreased by $219.7&#160;million from the end of last year due to factors described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. Our primary source of liquidity, other than our holdings of cash, cash equivalents, and short-term investments, has been cash flows from operations. Our ability to generate cash from operations provides us with the financial flexibility we need to meet operating, investing, and financing needs.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have liquidated our short-term investments and/or issued debt and equity securities to finance our business needs as a supplement to cash provided by operating activities. Our short-term investments include U.S. government debt securities, investment-grade corporate debt securities, mutual funds and certificates of deposit. We have established guidelines relative to diversification and maturities of our investments in order to provide both safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. Additionally, we own certain securities which are classified as short-term investments that we received as a result of a milestone and an upfront license payment as well as 6.7 million shares of common stock in Viking.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued an aggregate principal amount of $750.0 million of the 2023 Notes. During the nine months ended September&#160;30, 2022, we repurchased $266.4&#160;million in principal amount of the 2023 Notes for $261.4&#160;million in cash, including accrued interest of $0.5&#160;million. After the repurchases, $76.9 million in principal amount of the 2023 Notes remain outstanding. We may continue to use cash on hand to repurchase additional 2023 Notes through open-market transactions, including through Rule 10b5-1 trading plans to facilitate open-market repurchases, or otherwise, from time to time. The timing and amount of repurchase transactions will be determined by management based on the evaluation of market conditions, trading price of the 2023 Notes, legal requirements and other factors. The 2023 Notes were not convertible as of September&#160;30, 2022. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#8217;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No holders exercised their right to convert their 2023 Notes during the applicable period for conversion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion rate for the 2023 Notes will be adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first 10 consecutive trading days after, and including, the ex-dvidend date of the spin-off (as determined in the Indenture).</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we entered into the Sales Agreement with the Agent, under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $100.0&#160;million in &#8220;at the market&#8221; offerings through the Agent. Sales of the shares of common stock, if any, will be made at prevailing market prices at the time of sale, or as otherwise agreed with the Agent. The Agent will receive a commission from the Company of up to 3.0% of the gross proceeds of any shares of common stock sold under the Sales Agreement. The shares will be issued pursuant to our shelf registration statement on Form S-3 (File No. 333-267678), including the sales agreement prospectus contained therein, which automatically became effective upon filing with the SEC on September 30, 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing funds, cash generated from operations and existing sources of and access to financing are adequate to fund our need for working capital, capital expenditures, debt service requirements, continued advancement of research and development efforts, potential stock repurchases and other business initiatives we plan to strategically pursue, including acquisitions and strategic investments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had $8.6 million in fair value of contingent consideration liabilities associated with prior acquisitions to be settled in future periods.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:65.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.854%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">YTD 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270,692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(141,925)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, we repurchased $266.4&#160;million in principal of the 2023 Notes for $261.4&#160;million in cash, including accrued interest of $0.5&#160;million. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, we repurchased $152.0 million in principal amount of the 2023 Notes for $156.0 million in cash, including accrued interest of $0.3 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our policies require the application of management judgment in making estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Those estimates and assumptions are based on historical experience and various other factors deemed applicable and reasonable under the circumstances. The use of judgment in determining such estimates and assumptions is by nature, subject to a degree of uncertainty. Accordingly, actual results could differ materially from the estimates made. There have been no material changes in our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our 2021 Annual Report, other than the adoption of the Accounting Standards Updates described in Item 1. Condensed consolidated Financial Statements - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to convertible debt.</span></div><div style="text-indent:14pt"><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_73"></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no substantial changes to our market risks in the nine months ended September&#160;30, 2022, when compared to the disclosures in Item 7A of our 2021 Annual Report.</span></div><div><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_76"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of September&#160;30, 2022 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_79"></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information that updates the disclosures set forth under Part I. Item 3. Legal Proceedings in our 2021 Annual Report, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7, Commitment and Contingencies: Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Condensed Consolidated Financial Statements contained in Part I. Item 1. of this report.</span></div><div><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as set forth below, we do not believe that there have been any material changes to the risk factors disclosed in Part I, Item 1A of our 2021 Annual Report. The risk factors described in our 2021 Annual Report and below are not the only risks we face. Factors we currently do not know, factors that we currently consider immaterial or factors that are not specific to us, such as general economic conditions, may also materially adversely affect our business or our consolidated operating results, financial condition or cash flows.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If the Distribution, together with certain related transactions, fails to qualify as a reorganization under Sections 355 and 368(a)(1)(D) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), or the Merger fails to qualify as a reorganization under Section 368(a) of the Code, Ligand and its stockholders could incur significant tax liabilities, and APAC and OmniAb could be required to indemnify Ligand for taxes that could be material pursuant to indemnification obligations under the tax matters agreement to be entered into in connection with the closing of the Merger (the &#8220;Tax Matters Agreement&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ligand received a tax opinion from Latham &amp; Watkins LLP, tax counsel to Ligand, which shall provide that the Distribution will qualify as a reorganization under Sections 355 and 368(a)(1)(D) of the Code and that the Merger will not cause Section 355(e) of the Code to apply to the Distribution. In addition, the obligations of Ligand and OmniAb to complete the Merger were conditioned upon, among other things, Ligand&#8217;s receipt of such tax opinion. The obligation of APAC to complete the Merger was conditioned upon, among other things, receipt of an opinion of Weil, Gotshal &amp; Manges LLP, tax counsel to APAC, that the Merger will be treated as a reorganization under Section 368(a) of the Code. The opinions were delivered in connection with the closing of the Merger and were based on, among other things, certain facts, assumptions, representations and undertakings from Ligand, OmniAb and APAC, including those regarding the past and future conduct of the companies&#8217; respective businesses and other matters. If any of these facts, assumptions, representations, or undertakings are incorrect or not satisfied, Ligand may not be able to rely on the opinions, and Ligand and its stockholders could be subject to significant U.S. federal income tax liabilities. In addition, the opinions will not be binding on the IRS or the courts. Notwithstanding the opinions, the IRS could determine on audit that the Distribution or Merger does not qualify as a reorganization if it determines that any of the facts, assumptions, representations or undertakings on which the opinions are based are not correct or have been violated or that the Distribution or Merger should be taxable for other reasons, including as a result of a significant change in stock or asset ownership after the Distribution.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Distribution, together with certain related transactions, is ultimately determined not to qualify as a reorganization, the Distribution could be treated as a taxable disposition of shares of OmniAb stock by Ligand and as a taxable dividend or capital gain to Ligand&#8217;s stockholders for U.S. federal income tax purposes. If the Merger is ultimately determined not to qualify as a reorganization, the Merger could be treated as a taxable disposition of OmniAb stock by Ligand stockholders. In either </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such case, Ligand and its stockholders that are subject to U.S. federal income tax could incur significant U.S. federal income tax liabilities. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Tax Matters Agreement that APAC and OmniAb entered into with Ligand, APAC and OmniAb will generally be required to indemnify Ligand against taxes incurred by Ligand that arise as a result of certain actions or omissions by APAC or OmniAb that prevent the Distribution, together with certain related transactions, from qualifying as a reorganization under Sections 355 and 368(a)(1)(D) of the Code. Further, even if APAC and OmniAb are not responsible for tax liabilities of Ligand under the Tax Matters Agreement, OmniAb nonetheless could be liable under applicable U.S. federal tax law for such liabilities if Ligand were to fail to pay them. If APAC or OmniAb are required to pay any liabilities under the circumstances set forth in the Tax Matters Agreement or pursuant to applicable tax law, the amounts may be significant. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The anticipated benefits of the Separation and Merger may not be achieved.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to achieve the full strategic and financial benefits expected to result from the Separation and Merger, including the potential that the Separation and Merger Combination will:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">allow each business to pursue its own operational and strategic priorities and more quickly respond to trends, developments and opportunities in its respective markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">create two separate and distinct management teams focused on each business&#8217;s unique strategic priorities, target markets and corporate development opportunities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">give each business opportunity and flexibility by pursuing its own investment, capital allocation and growth strategies consistent with its long-term objectives;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">allow investors to separately value each business based on the unique merits, performance and future prospects of each business, providing investors with two distinct investment opportunities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">enhance the ability of each business to attract and retain qualified management and to better align incentive-based compensation with the performance of each separate business; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">give each of OmniAb and Ligand its own equity currency for use in connection with acquisitions.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not achieve the anticipated benefits of the Separation and Merger for a variety of reasons. Further, such benefits, if ultimately achieved, may be delayed. In addition, the Separation and Merger could materially and adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Separation and Distribution may expose Ligand and OmniAb to potential liabilities arising out of state and federal fraudulent conveyance laws and legal dividend requirements.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Separation and Distribution are subject to review under various state and federal fraudulent conveyance laws. Fraudulent conveyance laws generally provide that an entity engages in a constructive fraudulent conveyance when (i) the entity transfers assets and does not receive fair consideration or reasonably equivalent value in return; and (ii) the entity: (a) is insolvent at the time of the transfer or is rendered insolvent by the transfer; (b) has unreasonably small capital with which to carry on its business; or (c) intends to incur or believes it will incur debts beyond its ability to repay its debts as they mature. An unpaid creditor or an entity acting on behalf of a creditor (including without limitation a trustee or debtor-in-possession in a bankruptcy by OmniAb or Ligand or any of our respective subsidiaries) may bring an action alleging that the Separation or Distribution or any of the related transactions constituted a constructive fraudulent conveyance. If a court accepts these allegations, it could impose a number of remedies, including without limitation, voiding OmniAb&#8217;s claims against Ligand, requiring the future OmniAb stockholders to return to Ligand some or all of the shares of OmniAb common stock issued in the Distribution, or providing Ligand with a claim for money damages against OmniAb in an amount equal to the difference between the consideration received by Ligand and OmniAb fair market value at the time of the Distribution.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measure of insolvency for purposes of the fraudulent conveyance laws will vary depending on which jurisdiction&#8217;s law is applied. Generally, an entity would be considered insolvent if (i) the present fair saleable value of its assets is less than the amount of its liabilities (including contingent liabilities); (ii) the present fair saleable value of its assets is less than its probable liabilities on its debts as such debts become absolute and matured; (iii) it cannot pay its debts and other liabilities (including contingent liabilities and other commitments) as they mature; or (iv) it has unreasonably small capital for the business in which it is engaged. We cannot assure you what standard a court would apply to determine insolvency or that a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">court would determine that OmniAb or Ligand or any of our subsidiaries were solvent at the time of or after giving effect to the Distribution.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Distribution of OmniAb common stock is also subject to review under state corporate distribution statutes. Under the DGCL, a corporation may only pay dividends to its stockholders either (i) out of its surplus (net assets minus capital) or (ii) if there is no such surplus, out of its net profits for the fiscal year in which the dividend is declared or the preceding fiscal year. Although Ligand intends to make the Distribution of OmniAb common stock entirely from surplus, we cannot assure you that a court will not later determine that some or all of the Distribution to Ligand stockholders was unlawful.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Completion of the separation of OmniAb resulted in substantial changes in our board of directors and management.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Completion of the Separation of OmniAb on November 1, 2022 resulted in substantial changes in our board of directors and management. In particular, Matthew Foehr, our former President and Chief Operating Officer, and Charles Berkman, our former Senior Vice President, General Counsel and Secretary, resigned from their positions with us upon the completion of the Separation to join management positions with OmniAb, Inc. In connection with the Separation and the departure of the foregoing officers, Ligand appointed new officers. Matthew Korenberg, our former Executive Vice President, Finance and Chief Financial Officer, was appointed our President and Chief Operating Officer. Octavio Espinoza, our former Senior Vice President, Finance, was appointed our Chief Financial Officer. Andrew Reardon, our former Vice President, Special Counsel, was appointed Chief Legal Officer and Secretary. Furthermore, Sarah Boyce, Jennifer Cochran and Sunil Patel resigned as members of our board of directors in connection with the Separation to join the board of directors of OmniAb Inc. These senior officer and board level changes could be disruptive to our operations, present significant management challenges and could harm our business.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Separation of OmniAb, the following risk factors described in our 2021 Annual Report are no longer applicable to our business:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.8pt">Our OmniAb antibody platform faces specific risks, including the quality of our antibody discovery platform and technological capabilities and their acceptance by new and existing partners in our market.  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.8pt">The OmniAb antibody platform could become subject to more extensive government regulation than we currently anticipate, and regulatory compliance obligations and the investigational exemption and approval processes to which our animals may become subject are expensive, time-consuming and uncertain both in timing and in outcome.  </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.8pt">Our OmniAb antibody platform utilizes various species of animals that could contract disease or die and could otherwise subject us to controversy and adverse publicity, which may interrupt our business operations or harm our reputation.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_88"></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_91"></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_94"></div><div><span><br/></span></div><div style="text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   Item 4.  Mine Safety Disclosures</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_97"></div><div><span><br/></span></div><div style="text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i2959cf3610a04d8385d1c4c227b59df4_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Incorporated by Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Description of Exhibit</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Form</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">File Number</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Date of Filing</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Filed</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000886163/000119312522083443/d337089dex21.htm">2.1*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Agreement and Plan of Merger, dated as of March, 23, 2022, by and among Avista Public Acquisition Corp. II, Ligand Pharmaceuticals Incorporated, OmniAb, Inc. and Orwell Merger Sub Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex22.htm">2.2*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Separation and Distribution Agreement, dated as of March 23, 2022, by and among Avista Public Acquisition Corp. II, Ligand Pharmaceuticals Incorporated and OmniAb, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex23.htm">2.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sponsor Insider Agreement, dated March 23, 2022, by and among OmniAb, Inc., Avista Public Acquisition Corp. II and the other parties signatory thereto</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.3</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex24.htm">2.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among Avista Public Acquisition Corp. II, Avista Acquisition LP II and OmniAb, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.4</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/0000936392-98-001000.txt">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Amended and Restated Certificate of Incorporation of the Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">S-4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">333-58823</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">July 9, 1998</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616301000008/0000886163-01-000008-0002.txt">3.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated June 14, 2000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">0-20720</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 29, 2001</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.5</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616304000015/ex3-6.txt">3.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated June 30, 2004</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">0-20720</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">August 5, 2004</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312510264942/dex31.htm">3.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated November 17, 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">November 19, 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616319000157/exhibit36.htm">3.5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certification of Incorporation of the Company, dated June 19, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">S-8</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">333-233130</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">August 8, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000116/exhibit31-ligandxfourt.htm">3.6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Fourth Amended and Restated Bylaws of the Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">October 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616318000030/lgndexhibi41.htm">4.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Specimen stock certificate for shares of the common stock of the Company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 1, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616318000076/exhibit41.htm">4.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indenture, dated as of May 22, 2018, between the Company and Wilmington Trust, National Association, as trustee, including the form of 0.75% Convertible Senior Notes due 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit101-aremployeematte.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Amended and Restated Employee Matters Agreement, dated as of August 18, 2022, by and among Ligand Pharmaceuticals Incorporated, OmniAb Operations, Inc. (f/k/a OmniAb, Inc.), OmniAb, Inc. (f/k/a Avista Public Acquisition Corp. II) and Orwell Merger Sub Inc.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616322000129/exhibit101-taxmattersagree.htm">10.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Tax Matters Agreement, dated as of November 1, 2022, by and among OmniAb, Inc.(f/k/a Avista Public Acquisition Corp. II) Ligand Pharmaceuticals Incorporated and OmniAb Operations, Inc. (f/k/a OmniAb, Inc.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">November 4, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_93022exhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certification by Principal Executive Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_93022exhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certification by Principal Financial Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_93022exhibit321.htm">32.1**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certifications by Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">101</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The following financial information from our Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2022, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Consolidated Condensed Balance Sheets, (ii) Consolidated Condensed Statements of Operations, (iii) Consolidated Condensed Statement of Comprehensive Income, (iv) Consolidated Condensed Statements of Stockholders' Equity, (v) Consolidated Condensed Statements of Cash Flows, and (vi) the Notes to Consolidated Condensed Financial Statements.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">104</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2022, formatted in Inline XBRL and contained in Exhibit 101.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr></table></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">*   Schedules and exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K. Ligand Pharmaceuticals Incorporated agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">** These certifications are deemed not filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div id="i2959cf3610a04d8385d1c4c227b59df4_103"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Octavio Espinoza</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Octavio Espinoza</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Duly Authorized Officer and Principal Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">38</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-aremployeematte.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibb0f923cae014b4895534475ba6f7df2_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%;text-decoration:underline">AMENDED AND RESTATED EMPLOYEE MATTERS AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">This AMENDED AND RESTATED EMPLOYEE MATTERS AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8221;), dated as of August 18, 2022, is entered into by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8221;), OmniAb, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">SpinCo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8221;), Avista Public Acquisition Corp. II, a Cayman Islands exempted company (which will migrate to and domesticate as a Delaware corporation) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8221;), and Orwell Merger Sub Inc., a Delaware corporation and wholly owned Subsidiary of Parent (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8221;). &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8221; means the Company, SpinCo, Parent or Merger Sub, individually or collectively, as the case may be. Capitalized terms used in this Agreement, but not otherwise defined in this Agreement, the Separation Agreement or the Merger Agreement, shall have the meaning set forth in Section 1.1.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">W I T N E S S E T H&#58;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">WHEREAS, the Company, acting through its direct and indirect Subsidiaries, currently conducts the Company Retained Business and the SpinCo Business&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">WHEREAS, the Company Board previously determined that it is appropriate, desirable and in the best interests of the Company and its stockholders to separate the Company into two separate companies, one for each of (i) the Company Retained Business, which shall be owned and conducted, directly or indirectly, by the Company and its Subsidiaries (other than SpinCo and its Subsidiaries) and (ii) the SpinCo Business, which shall be owned and conducted, directly or indirectly, by SpinCo and its Subsidiaries, in the manner contemplated by the Separation and Distribution Agreement by and among the Parties, dated as of March 23, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Separation Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8221;) and the other Transaction Documents&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">WHEREAS, following the Domestication and the Separation and pursuant to the Merger Agreement, Merger Sub shall merge with and into SpinCo and SpinCo will be the surviving corporation and a wholly owned Subsidiary of Parent&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">WHEREAS, in connection with the transactions contemplated by the Separation Agreement and the Merger Agreement, the Parties previously entered into that certain Employee Matters Agreement, by and among the Parties, dated March 23, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">Prior Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#8221;) for the purpose of allocating assets, Liabilities and responsibilities with respect to certain employee matters and employee compensation and benefit plans and programs among them and to address certain other employment-related matters&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">WHEREAS, the Parties desire to amend and restate the terms of the Prior Agreement in their entirety as set forth herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">NOW, THEREFORE, in consideration of the foregoing and the mutual agreements, provisions and covenants contained in this Agreement, the Parties hereby agree as follows&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article I</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%;text-decoration:underline">DEFINITIONS AND INTERPRETATION</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As used in this Agreement, the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">401(k) Plan Transition Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (i) December 31 of the calendar year in which the Distribution Time occurs, or (ii) such earlier date as mutually agreed by the Parties.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Parent Equity Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an Adjusted Parent Option, Adjusted Parent RSU Award or Adjusted Parent PSU Award.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Parent Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in&#160;Section 4.2(d).</font></div><div style="padding-left:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Parent PSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in&#160;Section 4.4(g).</font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Parent RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in&#160;Section 4.3(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an &#8220;employee benefit plan&#8221; (within the meaning of Section 3(3) of ERISA but regardless of whether such plan is subject to ERISA) and each compensation plan, program, agreement or arrangement, including each pension, retirement, profit sharing, 401(k), severance, health and welfare, disability, deferred compensation, employment, termination, change-in-control, retention, fringe benefit, stock purchase, cash bonus or equity-based incentive or other benefit plan, program, agreement, policy or other arrangement, in each case, that is or was maintained for the benefit of current and&#47;or former directors, officers, consultants or employees.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended, or any successor federal income tax law. Reference to a specific Code provision also includes any proposed, temporary or final regulation in force under that provision.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company 2021 TSR PSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a Company PSU Award granted in 2021 (or portion thereof) the vesting of which is tied to the Company&#8217;s total shareholder return for the three-year performance period ending December 31, 2023.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company 401(k) Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Company&#8217;s Section 401(k) Savings&#47;Retirement Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Allocation Factor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the quotient obtained by dividing (i) the Company Post-Adjustment Stock Value, by (ii) the sum of (A) the Company Post-Adjustment Stock Value, plus (B) the product of (x) the SpinCo Stock Value times (y) the Distribution Ratio.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Benefit Plan sponsored, maintained or contributed to (or required to be contributed to) by any member of the Company Group that (i) is or has been maintained, sponsored, contributed to or entered into by any member of the Company Group for the benefit of any SpinCo Employee or SpinCo Independent Contractor or for which any member of the SpinCo Group could have any Liability and (ii) that is not a SpinCo Benefit Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each employee of the Company or any of its Subsidiaries or Affiliates who does not qualify as a SpinCo Employee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Employee List</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in Section 2.2(d).</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Equity Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a Company Option, Company RSU Award or a Company PSU Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Equity Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Company&#8217;s 2002 Stock Incentive Plan, as amended from time to time, that certain Non-Qualified Employment Inducement Stock Option Agreement dated April 8, 2022, between the Company and Kurt Gustafson, and such other equity plans as the Company may adopt prior to the Distribution Time in accordance with the terms of the Merger Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company ESPP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Company&#8217;s 2002 Employee Stock Purchase Plan, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.45pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (i) the Company, the Company Retained Business and each Person that is a direct or indirect Subsidiary of the Company as of immediately following the Distribution Time and (ii) each Business Entity that becomes a Subsidiary of the Company after the Distribution Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Independent Contractor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each individual who is engaged as an independent contractor or consultant by the Company or any of its Subsidiaries or Affiliates who does not qualify as a SpinCo Independent Contractor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Individual Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each Benefit Plan sponsored, maintained entered into or contributed to by the Company under which no more than one service provider is eligible to receive compensation and&#47;or benefits.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an option to purchase shares of Company Common Stock granted pursuant to the Company Equity Plans.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.12pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Post-Adjustment Stock Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the average closing price per share of Company Common Stock trading on an ex-dividend basis on the Nasdaq Stock Market during regular trading hours for the five (5) trading days ending on the date on which the Distribution Time occurs (or, if the Distribution Time occurs prior to regular trading hours, for the five (5) trading days ending on the date prior to the date on which the Distribution Time occurs). </font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Pre-Adjustment Stock Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the average closing price per share of Company Common Stock trading &#8220;regular way with due bills&#8221; (if applicable) on the Nasdaq Stock Market during regular trading hours for the five (5) trading days ending on the date on which the Distribution Time occurs (or, if the Distribution Time occurs prior to regular trading hours, for the five (5) trading days ending on the date prior to the date on which the Distribution Time occurs).</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company PSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a performance stock unit award granted pursuant to the Company Equity Plans.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the quotient obtained by dividing the Company Pre-Adjustment Stock Value by the Company Post-Adjustment Stock Value.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(aa)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.48pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a restricted stock unit award granted pursuant to the Company Equity Plans that vests solely based on the continued employment or service of the recipient.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(bb)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a Company Employee, a Company Independent Contractor or a member of the Company Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(cc)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">      &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Severance Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Company&#8217;s Amended and Restated Severance Plan, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dd)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">        &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cutoff Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means March 2, 2022.</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ee)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">       &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Distribution Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the number of shares (and&#47;or fraction of a share, expressed as a decimal) of SpinCo Common Stock to be distributed in respect of one share of Company Common Stock in the Distribution, as determined by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ff)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Distribution Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the effective time of the Distribution pursuant to the Separation Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(gg)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">    &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the &#8220;Effective Time&#8221; as defined in the Merger Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(hh)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Former Company Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) any individual (other than a SpinCo Employee or SpinCo Independent Contractor) who, as of the Distribution Time is a former employee or independent contractor of the Company or any of its Subsidiaries, or (ii) any individual who is a Company Employee or Company Independent Contractor as of the Distribution Time or thereafter who ceases to be an employee or independent contractor of the Company or any of its Subsidiaries following the Distribution Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(jj)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Former SpinCo Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any individual who is a SpinCo Employee or SpinCo Independent Contractor as of the Distribution Time and thereafter ceases to be an employee or independent contractor of the SpinCo Group following the Distribution Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(kk)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Merger Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Agreement and Plan of Merger, dated as of March 23, 2022, by and among the Company, SpinCo, Parent, and Merger Sub.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ll)          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(mm)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Equity Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in Section 4.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(nn)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Equity Plan Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in Section 4.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(oo)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent ESPP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in Section 4.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(pp)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent ESPP Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in Section 4.6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(qq)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meanings set forth in the Preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(rr)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Transition Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the date that is the earlier to occur of (i) January 1, 2023 or (ii) such earlier date as agreed among the Parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ss)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prior Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(tt)         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(uu)       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo 401(k) Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in&#160;Section 3.3(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(vv)     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Allocation Factor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the quotient obtained by dividing (i) the product of (A) the SpinCo Stock Value times (B) the Distribution Ratio, by (ii) the sum of (A) the Company Post-Adjustment Stock Value, plus (B) the product of (x) the SpinCo Stock Value times (y) the Distribution Ratio.</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ww)   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Benefit Plan sponsored, maintained or contributed to exclusively by any member of the SpinCo Group.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(xx)     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the common stock, par value $0.001 per share, of SpinCo.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(yy)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each individual listed on the SpinCo Employee List.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(zz)        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Employee List</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in Section 2.2(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(aaa)    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Equity Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a SpinCo Option, SpinCo RSU Award or SpinCo PSU Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(bbb)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Equity Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in&#160;Section 4.5.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ccc)     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean SpinCo and each SpinCo Entity as of the Distribution Time (but after giving effect to the Separation), and, following the Effective Time, Parent and each Person that becomes a Subsidiary of Parent or SpinCo thereafter, provided, however, that for the avoidance of doubt, no member of the Company Group shall be treated as a member of the SpinCo Group.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ddd)    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Independent Contractor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each individual engaged as an independent contractor or consultant by the SpinCo Group as of the Distribution Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(eee)   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Individual Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each Benefit Plan sponsored, maintained entered into or contributed to by SpinCo under which no more than one service provider is eligible to receive compensation and&#47;or benefits.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(fff)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an option to purchase shares of SpinCo Common Stock issued pursuant to the SpinCo Equity Plans as part of an equitable adjustment to a Company Option made in connection with the Distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ggg)    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo PSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an award of restricted stock units covering SpinCo Common Stock issued pursuant to the SpinCo Equity Plans as part of an equitable adjustment to a Company PSU Award made in connection with the Distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(hhh)     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the quotient obtained by dividing the Company Pre-Adjustment Stock Value by the SpinCo Stock Value.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an award of restricted stock units covering SpinCo Common Stock that vests solely based on the continued employment or service of the recipient issued pursuant to the SpinCo Equity Plans as part of an equitable adjustment to a Company RSU Award made in connection with the Distribution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(jjj)      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Service Provider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a SpinCo Employee, a SpinCo Independent Contractor or a member of the board of directors of SpinCo, or any individual independent contractor, consultant or director who is reasonably expected to become a SpinCo Service Provider prior to the Distribution Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(kkk)    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Severance Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in&#160;Section 5.2(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(lll)     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Stock Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (i) the Base Exchange Ratio, multiplied by (ii) $10 per share.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(mmm) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Separation Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning set forth in the Recitals.</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> References&#59; Interpretation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> References in this Agreement to any gender include references to all genders, and references to the singular include references to the plural and vice versa. Unless the context otherwise requires, the words &#8220;include&#8221;, &#8220;includes&#8221; and &#8220;including&#8221; when used in this Agreement shall be deemed to be followed by the phrase &#8220;without limitation&#8221;. Unless the context otherwise requires, references in this Agreement to Articles, Sections, Annexes, Exhibits and Schedules shall be deemed references to Articles and Sections of, and Annexes, Exhibits and Schedules to, this Agreement. Unless the context otherwise requires, the words &#8220;hereof&#8221;, &#8220;hereby&#8221; and &#8220;herein&#8221; and words of similar meaning when used in this Agreement refer to this Agreement in its entirety and not to any particular Article, Section or provision of this Agreement. The words &#8220;written request&#8221; when used in this Agreement shall include email. Reference in this Agreement to any time shall be to New York City, New York time unless otherwise expressly provided herein. Unless the context requires otherwise, references in this Agreement to the &#8220;Company&#8221; shall also be deemed to refer to the applicable member of the Company Group, references to &#8220;SpinCo&#8221; shall also be deemed to refer to the applicable member of the SpinCo Group (including, with respect to periods of time following the Effective Time, Parent), and, in connection therewith, any references to actions or omissions to be taken, or refrained from being taken, as the case may be, by the Company or SpinCo shall be deemed to require the Company, SpinCo or Parent, as the case may be, to cause the applicable members of the Company Group or the SpinCo Group, respectively, to take, or refrain from taking, any such action. In the event of any inconsistency or conflict which may arise in the application or interpretation of any of the definitions set forth in&#160;Section 1.1, for the purpose of determining what is and is not included in such definitions, any item explicitly included on a Schedule referred to in any such definition shall take priority over any provision of the text thereof.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article II</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%;text-decoration:underline">GENERAL PRINCIPLES</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Nature of Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. All Liabilities assumed or retained by a member of the Company Group under this Agreement shall be &#8220;Ligand Retained Liabilities&#8221; for purposes of the Separation Agreement. All Liabilities assumed or retained by a member of the SpinCo Group under this Agreement shall be &#8220;OmniAb Liabilities&#8221; for purposes of the Separation Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Transfers of Employees and Independent Contractors Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt;text-decoration:underline">Schedule A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto sets forth a complete list of each Company Employee as of March 23, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Employee List</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto sets forth a complete list of each employee of the Company Group whose employment will be transferred to SpinCo prior to the Distribution Time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Employee List</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The Company and SpinCo shall mutually update the Company Employee List and the SpinCo Employee List from time to time between the date hereof and the Distribution Time to remove terminated employees and to add any new Company Employees or SpinCo Employees hired following March 23, 2022.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">All SpinCo Employees who are employed by the SpinCo Group as of the Distribution Time shall continue to be employees of the SpinCo Group immediately after the Distribution Time. The Company and SpinCo will cooperate to cause each of the SpinCo Employees to be employed by a member of the SpinCo Group prior to the Distribution Time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">The Company and SpinCo will cooperate to cause the contract of any individual who is engaged as an independent contractor or consultant and who provides services on behalf of the SpinCo Business to the extent of such service, to be transferred to a member of the SpinCo Group prior to the Distribution Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">The Company Group and SpinCo Group agree to execute, and to seek to have the applicable SpinCo Employees execute, such documentation, if any, as may be necessary to reflect the transfers described in this&#160;Section 2.2.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Assumption and Retention of Liabilities Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">Except as pursuant to this Agreement, from and after the Distribution Time, the Company shall, or shall cause one or more members of the Company Group to, accept, assume (or, as applicable, retain) and perform, discharge and fulfill (i) all Liabilities under all Company Benefit Plans with respect to Company Employees, Former Company Service Providers and their respective dependents and beneficiaries (and any alternate payees in respect thereof), whenever incurred, unless this Agreement expressly provides for such Liabilities to be assumed by the SpinCo Group or subject to reimbursement by the SpinCo Group&#59; (ii) all Liabilities with respect to the employment, service, termination of employment or termination of service of all Company Employees, Former Company Service Providers and their respective dependents and beneficiaries (and any alternate payees in respect thereof), in each case to the extent arising in connection with or as a result of employment with or the performance of services to any member of the Company Group&#59; and (iii) all other Liabilities or obligations expressly assigned to or assumed by a member of the Company Group under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">Except as pursuant to this Agreement, from and after the Distribution Time, SpinCo shall, or shall cause one or more members of the SpinCo Group to, accept, assume (or, as applicable, retain) and perform, discharge and fulfill (i) all Liabilities under all SpinCo Benefit Plans, whenever incurred&#59; (ii) all Liabilities with respect to the employment, service, termination of employment or termination of service of all SpinCo Employees, Former SpinCo Service Providers and SpinCo Independent Contractors and their respective dependents and beneficiaries (and any alternate payees in respect thereof), in each case to the extent arising in connection with or as a result of employment with or the performance of services to any member of the SpinCo Group or the Company Group&#59; and (iii) all other Liabilities or obligations expressly assigned to or assumed by a member of the SpinCo Group under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">The Parties shall promptly reimburse one another, upon reasonable request of the Party requesting reimbursement and the presentation by such Party of such substantiating documentation as the other Party shall reasonably request, for the cost of any obligations or Liabilities satisfied or assumed by the Party requesting reimbursement or its Affiliates that are, or that have been made pursuant to this Agreement, the responsibility of the other Parties or any of its Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">Notwithstanding any provision of this Agreement or the Separation Agreement to the contrary, SpinCo shall, or shall cause one or more members of the SpinCo Group to, accept, assume (or, as applicable, retain) and perform, discharge and fulfill all Liabilities that have been accepted, assumed or retained under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Treatment of Compensation and Benefit Plans&#59; Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except as otherwise (i) required by applicable Law, or (ii) expressly provided for in this Agreement, for a period of twelve (12) months following the Distribution Time (or if shorter, during the period of employment), SpinCo shall, or shall cause a member of the SpinCo Group to provide or cause to be provided to each SpinCo Employee (A) a base salary or hourly wage rate, as applicable, that is at least equal to the base salary or hourly wage rate provided to such SpinCo Employee immediately prior to the Distribution Time, (B) subject to&#160;Section 5.1, a cash incentive or sales commission opportunity no less favorable than the cash incentive or sales commission opportunity in effect for such SpinCo Employee, if any, immediately prior to the Distribution Time, (C) health, welfare and retirement benefits that are substantially similar in the aggregate to those provided to such SpinCo Employee immediately prior to the Distribution Time, and (D) severance benefits (including severance payments, transition payments and continued health coverage) that are substantially similar to those provided to such SpinCo Employee immediately prior to the Distribution Time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Participation in Company Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except as otherwise provided pursuant to this Agreement or as required by Applicable Law, effective no later than the Plan Transition Date, (i) SpinCo and each member of the SpinCo Group, to the extent applicable, shall cease to be a participating company in any Company Benefit Plan and (ii) each then active SpinCo Employee shall cease to participate in, be covered by, accrue benefits under, be eligible to contribute to or have any rights under any Company Benefit Plan (except to the extent of previously accrued obligations that remain a Liability of any member of the Company Group pursuant to this Agreement).</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Service Recognition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">From and after the Distribution Time, and in addition to any applicable obligations under applicable Law, SpinCo shall, and shall cause each member of the SpinCo Group to, give each SpinCo Employee full credit for purposes of eligibility, vesting, and determination of level of benefits under any SpinCo Benefit Plan for such SpinCo Employee&#8217;s prior service with any member of the Company Group or SpinCo Group or any predecessor thereto, to the same extent such service was recognized by the applicable Company Benefit Plan&#59;&#160;provided, that, such service shall not be recognized to the extent it would result in the duplication of benefits or accruals under any defined benefit pension plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">Except to the extent prohibited by applicable Law, as soon as administratively practicable on or after the Plan Transition Date with respect to any applicable SpinCo Benefit Plan that is a health or welfare benefit plan&#58; (i) SpinCo shall waive or cause to be waived all limitations as to preexisting conditions or waiting periods with respect to participation and coverage requirements applicable to each SpinCo Employee under any SpinCo Benefit Plan in which SpinCo Employees participate (or are eligible to participate) to the same extent that such conditions and waiting periods were satisfied or waived under an analogous Company Benefit Plan, and (ii) SpinCo shall use commercially reasonable efforts to provide or cause each SpinCo Employee to be provided with credit for any co-payments, deductibles or other out-of-pocket amounts paid during the plan year in which the SpinCo Employees become eligible to participate in the SpinCo Benefit Plans in satisfying any applicable co-payments, deductibles or other out-of-pocket requirements under any such plans for such plan year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">WARN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything set forth in this Agreement to the contrary, none of the transactions contemplated by or undertaken by this Agreement is intended to and shall not constitute or give rise to an &#8220;employment loss&#8221; or employment separation within the meaning of the federal Worker Adjustment and Retraining Notification (WARN) Act, or any other federal, state, or local law or legal requirement addressing mass employment separations.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">No Termination&#59; No Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. No Company Employee or SpinCo Employee shall be deemed to (a) terminate employment or service solely by virtue of the consummation of the Distribution, any transfer of employment or other service relationship contemplated hereby, or any related transactions or events contemplated by the Separation Agreement, this Agreement, the Merger Agreement, or any other Transaction Document, or (b) become entitled to any severance, termination, separation or similar rights, payments or benefits, whether under any Benefit Plan, the Company Equity Plans, the SpinCo Equity Plans, the Company Severance Plan, any Company Individual Agreement or any other compensatory agreement or arrangement maintained by the Company or SpinCo or otherwise, in connection with any of the foregoing.  The Parties hereto agree that none of the transactions contemplated by the Separation Agreement, the Merger Agreement, or this Agreement, constitutes a &#8220;change in control,&#8221; &#8220;change of control&#8221; or similar term, as applicable, within the meaning of any Benefit Plan, the Company Equity Plans, the SpinCo Equity Plans, the Company Severance Plan, any Company Individual Agreement or any other compensatory agreement or arrangement maintained by the Company or SpinCo.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article III</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">CERTAIN BENEFIT PLAN PROVISIONS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Health and Welfare Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">(i) Effective as of the Plan Transition Date, the participation of each then-active SpinCo Employee who is a participant in a Company Benefit Plan shall automatically cease and (ii) SpinCo shall or shall cause a member of the SpinCo Group to (A) have in effect, no later than the Business Day immediately prior to the Plan Transition Date, SpinCo Benefit Plans providing health and welfare benefits for the benefit of each such SpinCo Employee with terms that are substantially similar to those provided to the applicable SpinCo Employee immediately prior to the date on which such SpinCo Benefit Plans become effective&#59; and (B) effective on and after the Plan Transition Date, fully perform, pay and discharge all claims of SpinCo Employees or Former SpinCo Service Providers, including but not </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">limited to any claims incurred under any Company Benefit Plan (to the extent not fully covered by insurance) on or prior to the date on which such SpinCo Benefit Plans become effective, that remain unpaid as of the date on which such SpinCo Benefit Plans become effective, regardless of whether any such claim was presented for payment prior to, on or after such date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">Without duplication of amounts otherwise already covered in this Agreement or the Transition Services Agreement, the applicable member of the SpinCo Group shall reimburse the Company or the applicable Company Benefit Plan in the ordinary course of business consistent with past practice for any premiums and its proportionate share of any administrative or services costs related to SpinCo Employees or Former SpinCo Service Providers paid by a Company Benefit Plan (whether prior to or after the Distribution Time) and not charged back to the appropriate and applicable member of the SpinCo Group prior to the Plan Transition Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">Notwithstanding anything to the contrary in this Section 3.1, SpinCo Employees will continue to be considered to be &#8220;participants&#8221; in any Company Benefit Plan that is either a health care flexible spending account program or a dependent-care flexible spending account program for the duration of any grace period and&#47;or claims run-out period following the calendar year in which the Plan Transition Date occurs (in either case, solely as provided under the terms of such Company Benefit Plans), provided that such SpinCo Employees will be considered to be participants solely for purposes of utilizing such grace period and&#47;or claims run-out period&#59; will not be allowed to make any deferral or contribution elections under such Company Benefit Plans beyond the Plan Transition Date&#59; and will cease to be participants in such Company Benefit Plans upon the expiration of any grace period and&#47;or claims run-out period.  Effective as of the Plan Transition Date, SpinCo shall establish a health care flexible spending account program or a dependent-care flexible spending account program for SpinCo Employees.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">To the extent any SpinCo Employee is, as of the Plan Transition Date, receiving payments as part of any short-term disability program that is part of a Company Benefit Plan, such SpinCo Employee&#8217;s rights to continued short-term disability benefits (a) will end under any Company Benefit Plan as of the Plan Transition Date&#59; and (b) all remaining rights will be recognized under a SpinCo Benefit Plan as of the Plan Transition Date, and the remainder (if any) of such SpinCo Employee&#8217;s short-term disability benefits will be paid by a SpinCo Benefit Plan. In the event that any SpinCo Employee described above shall have any dispute with the short-term disability benefits they are receiving under a SpinCo Benefit Plan, any and all appeal rights of such employees shall be realized through the SpinCo Benefit Plan (and any appeal rights such SpinCo Employee may have under any Company Benefit Plan will be limited to benefits received and time periods occurring prior to the Plan Transition Date).</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any SpinCo Employee or Former SpinCo Service Provider who is receiving short-term disability benefits under a Company Benefit Plan as of the Plan Transition Date and thereafter becomes entitled to long-term disability benefits upon the expiration of such short-term disability period (whether under a Company Benefit Plan or SpinCo Benefit Plan), shall be provided long-term disability benefits under the long-term disability plan which is a Company Benefit Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">For any Former SpinCo Service Provider who is, as of the Distribution Time, receiving payments as part of any long-term disability program that is part of a Company Benefit Plan, and has been receiving payments from such plan for twelve (12) months or fewer before the Distribution Time, to the extent such Former SpinCo Service Provider may have any &#8220;return to work&#8221; rights under the terms of such Company Benefit Plan, such Former SpinCo Service Provider&#8217;s eligibility for re-employment shall be with SpinCo or a member of the SpinCo Group, subject to availability of a suitable position (with such availability to be determined in the sole discretion by SpinCo or the applicable member of the SpinCo Group),&#160;provided&#160;however&#160;that, notwithstanding the foregoing, no Former SpinCo Service Provider described in this subsection will be eligible for re-employment as described in this subsection after the first anniversary of the Distribution Time.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">401(k) Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">From the Distribution Time and continuing until the 401(k) Plan Transition Date, SpinCo shall become an &#8220;adopting employer&#8221; (as defined in the Company 401(k) Plan) and the Company </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">401(k) Plan shall provide for the SpinCo Group to participate in the Company 401(k) Plan for the benefit of SpinCo Employees and Former SpinCo Service Providers, and the Company consents to such adoption and maintenance, in accordance with the terms of the Company 401(k) Plan.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">(i) &#160;&#160;&#160;&#160;Effective no later than the 401(k) Plan Transition Date, SpinCo shall establish a defined contribution savings plan and related trust that satisfies the requirements of Sections 401(a) and 401(k) of the Code in which each SpinCo Employee who participated in the Company 401(k) Plan immediately prior thereto shall be eligible to participate (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo 401(k) Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), with terms that are substantially similar to those provided by the Company 401(k) Plan immediately prior to the date on which such SpinCo 401(k) Plan become effective, (ii) the active participation of each SpinCo Employee who is a participant in the Company 401(k) Plan shall automatically cease effective upon the date on which the SpinCo 401(k) Plan becomes effective, and (iii) as soon as practicable after the SpinCo 401(k) Plan becomes effective, subject to the consent of the SpinCo 401(k) Plan administrator and reasonable proof of qualification of the Company 401(k) Plan, the Company shall cause the accounts (including any outstanding participant loan balances) in the Company 401(k) Plan attributable to SpinCo Employees and all of the assets in the Company 401(k) Plan related thereto to be transferred in-kind to the SpinCo 401(k) Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">The Company shall retain all accounts and all assets and Liabilities relating to the Company 401(k) Plan in respect of each Former SpinCo Service Provider whose employment terminated prior to the 401(k) Plan Transition Date.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Chargeback of Certain Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Without duplication of amounts otherwise already covered in this Agreement or the Transition Services Agreement, nothing contained in this Agreement shall limit the Company&#8217;s ability to charge back any Liabilities that it incurs in respect of any SpinCo Service Provider under a Company Benefit Plan which is a retirement plan or health or welfare benefit plan to any of its operating companies in the ordinary course of business consistent with its past practices. Subject, and in addition, to the foregoing, the Company shall allocate and charge back to SpinCo or a member of the SpinCo Group (without duplication) its proportionate share of Liabilities (other than those arising from the Company&#8217;s or its agent&#8217;s gross misconduct or negligence) that the Company incurs by reason of the continued participation of SpinCo Employees, SpinCo Independent Contractors and Former SpinCo Service Providers in such Company Benefit Plans following the Distribution Time (which Liabilities shall, for the avoidance of doubt, be subject to reimbursement under Section 2.3(c) of this Agreement).</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article IV</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EQUITY INCENTIVE AWARDS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Parties shall use commercially reasonable efforts to take all actions necessary or appropriate so that each outstanding Company Equity Award and SpinCo Equity Award held by any individual shall be adjusted as set forth in this Article IV and in accordance with applicable Law, the applicable equity plan and the applicable award agreement. The adjustments set forth below shall be the sole adjustments made with respect to Company Equity Awards in connection with the Distribution.  The adjustments set forth below shall be the sole adjustments made with respect to SpinCo Equity Awards in connection with the Merger and are subject to the terms and conditions of the Merger Agreement.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of Company Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt;text-decoration:underline">Company Options Other than (i) Company Options Held by Former Company Service Providers or (ii) Company Options Granted on or following the Cutoff Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As determined by the Compensation Committee of the Company Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) pursuant to its authority under the Company Equity Plans, each Company Option outstanding as of immediately prior to the Distribution Time, other than (x) any Company Option held by a Former Company Service Provider and (y) any Company Option granted on or following the Cutoff Date, shall, </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">immediately prior to the Distribution Time, be converted into both a SpinCo Option and a Company Option and shall otherwise be, subject to Section 4.2(d) below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company Option immediately prior to the Distribution Time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time&#58;</font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Subject to Post-Distribution Company Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The number of shares of Company Common Stock subject to such Company Option shall be equal to the product obtained by multiplying (I) the number of shares of Company Common Stock subject to such Company Option immediately prior to the Distribution Time by (II) the Company Ratio by (III) the Company Allocation Factor, and rounding such result down to the nearest whole share.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Subject to Post-Distribution SpinCo Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The number of shares of SpinCo Common Stock subject to such SpinCo Option shall be equal to the product obtained by multiplying (I) the number of shares of Company Common Stock subject to the Company Option immediately prior to the Distribution Time by (II) the SpinCo Ratio by (III) the SpinCo Allocation Factor, and rounding such result down to the nearest whole share.  Each SpinCo Option that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section 4.2(d) below.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price of Post-Distribution Company Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The per share exercise price of such Company Option shall be equal to the quotient obtained by dividing (I) the per share exercise price of such Company Option immediately prior to the Distribution Time by (II) the Company Ratio, and rounding such quotient up to the nearest whole cent.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price of Post-Distribution SpinCo Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The per share exercise price of such SpinCo Option shall be equal to the quotient obtained by dividing (I) the per share exercise price of the Company Option immediately prior to the Distribution Time by (II) the SpinCo Ratio, and rounding such quotient up to the nearest whole cent.  Each SpinCo Option that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section 4.2(d) below.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">Company Options (i) Held by Former Company Service Providers or (ii) Granted on or following the Cutoff Date and Held by Company Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plans, each Company Option outstanding as of immediately prior to the Distribution Time (x) that is held by a Former Company Service Provider or (y) that was granted on or following the Cutoff Date and is held by a Company Service Provider, shall be subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company Option immediately prior to the Distribution Time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time&#58;</font></div><div style="padding-left:144pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Subject to Post-Distribution Company Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The number of shares of Company Common Stock subject to such Company Option shall be equal to the product obtained by multiplying (A) the number of shares of Company Common Stock subject to such Company Option immediately prior to the Distribution Time by (B) the Company Ratio, and rounding such product down to the nearest whole share.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price of Post-Distribution Company Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The per share exercise price of such Company Option shall be equal to the quotient obtained by dividing (A) the per share exercise price of such Company Option immediately prior to the Distribution Time by (B) the Company Ratio, and rounding such quotient up to the nearest whole cent.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt;text-decoration:underline">Company Options Granted on or following the Cutoff Date and Held by SpinCo Service Providers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plans, each Company Option outstanding as of immediately prior to the Distribution Time that was granted on or following the Cutoff Date and is held by a SpinCo Service Provider, shall, immediately prior to the Distribution Time, be converted solely into an SpinCo Option and shall otherwise be, subject to Section 4.2(d) below, subject to the same terms and conditions after the </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Distribution Time as the terms and conditions applicable to such Company Option immediately prior to the Distribution Time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time&#58;</font></div><div style="padding-left:144pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Subject to Post-Distribution SpinCo Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The number of shares of Company Common Stock subject to such SpinCo Option shall be equal to the product obtained by multiplying (A) the number of shares of Company Common Stock subject to such Company Option immediately prior to the Distribution Time by (B) the SpinCo Ratio, and rounding such product down to the nearest whole share.    Each SpinCo Option that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section 4.2(d) below.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price of Post-Distribution SpinCo Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The per share exercise price of such Company Option shall be equal to the quotient obtained by dividing (A) the per share exercise price of such Company Option immediately prior to the Distribution Time by (B) the SpinCo Ratio, and rounding such quotient up to the nearest whole cent.    Each SpinCo Option that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section 4.2(d) below.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt;text-decoration:underline">SpinCo Options Outstanding as of Immediately Prior to the Effective Time.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  As of the Effective Time, each SpinCo Option that is then outstanding and unexercised shall be converted into the right to receive an option relating to shares of Domesticated Parent Common Stock upon substantially the same terms and conditions as are in effect with respect to such option immediately prior to the Effective Time (other than terms that have been rendered inoperative by the Transactions), including with respect to vesting and termination-related provisions (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Parent Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), except that (A) such Adjusted Parent Option shall relate to that whole number of shares of Domesticated Parent Common Stock (rounded down to the nearest whole share) equal to the number of shares of SpinCo Common Stock subject to such SpinCo Option, multiplied by the Base Exchange Ratio, and (B) the exercise price per share for each such Adjusted Parent Option shall be equal to the exercise price per share of such SpinCo Option in effect immediately prior to the Effective Time, divided by the Base Exchange Ratio (the exercise price per share, as so determined, being rounded up to the nearest full cent).  In addition, at the Effective Time, Parent will issue to each holder of a SpinCo Option a number of Earnout Shares equal to the product of (A) the number of shares of SpinCo Common Stock subject to the SpinCo Option, multiplied by (B) the Earnout Exchange Ratio, which Earnout Shares will be subject to the restrictions set forth in the Merger Agreement.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.3       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of Company RSU Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;(a)&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company RSU Awards Other than (i) Company RSU Awards Held by Former Company Service Providers or (ii) Company RSU Awards Granted on or following the Cutoff Date</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plans, each Company RSU Award outstanding as of immediately prior to the Distribution Time, other than (x) any Company RSU Award granted on or following the Cutoff Date and (y) any Company RSU Award held by a Former Company Service Provider, shall, immediately prior to the Distribution Time, be converted into both a SpinCo RSU Award and a Company RSU Award and shall otherwise be, subject to Section 4.3(d) below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company RSU Award immediately prior to the Distribution Time&#59;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time&#58;</font></div><div style="margin-top:6pt;padding-left:38.1pt;text-align:justify;text-indent:69.9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Subject to Post-Distribution Company RSU</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The number of shares of Company Common Stock subject to such Company RSU Award shall be equal to the number of shares of Company Common Stock subject to such Company RSU Award immediately prior to the Distribution Time, and</font></div><div style="margin-top:6pt;padding-left:38.1pt;text-align:justify;text-indent:69.9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Subject to Post-Distribution SpinCo RSU.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The number of shares of SpinCo Common Stock subject to such SpinCo RSU Award shall be equal to the product obtained by multiplying (A)&#160;the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Distribution Time by (B)&#160;the Distribution Ratio, and rounding such product down to the nearest whole share.  Each SpinCo RSU Award that is </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-top:6pt;padding-left:38.1pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section 4.3(d) below.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company RSU Awards (i) Held by Former Company Service Providers or (ii) Granted on or following the Cutoff Date and Held by Company Service Providers</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plans, each Company RSU Award that is outstanding as of immediately prior to the Distribution Time (x) that is held by a Former Company Service Provider or (y) that was granted on or following the Cutoff Date and is held by a Company Service Provider, shall be subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company RSU Award immediately prior to the Distribution Time&#59; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time, the number of shares of Company Common Stock covered by such Company RSU Award held by the participant, as applicable, rounded to the nearest whole share, shall be equal to the product obtained by multiplying (i) the number of shares of Company Common Stock covered by such Company RSU Award immediately prior to the Distribution Time by (ii) the Company Ratio.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company RSU Awards Granted on or following the Cutoff Date and Held by SpinCo Service Providers</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plans, each Company RSU Award that is outstanding as of immediately prior to the Distribution Time that was granted on or following the Cutoff Date and is held by a SpinCo Service Provider shall, immediately prior to the Distribution Time, be converted solely into a SpinCo RSU Award and shall otherwise be, subject to Section 4.3(d) below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company RSU Award immediately prior to the Distribution Time&#59;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time the number of shares of SpinCo Common Stock subject to such SpinCo RSU Award shall be equal to the product obtained by multiplying (x) the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Distribution Time by (y) the SpinCo Ratio, and rounding down to the nearest whole share.    Each SpinCo RSU Award that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section 4.3(d) below.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo RSU Awards Outstanding as of the Effective Time</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As of the Effective Time, each SpinCo RSU Award that is outstanding immediately prior to the Effective Time shall be converted into the right to receive restricted stock units relating to shares of Domesticated Parent Common Stock (each, an &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Parent RSU Award</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with substantially the same terms and conditions as were applicable to such SpinCo RSU Award immediately prior to the Effective Time (other than terms that have been rendered inoperative by the Transactions), including with respect to vesting and termination-related provisions, except that such Adjusted Parent RSU Award shall relate to that whole number of shares of Domesticated Parent Common Stock as is equal to the product of (B) the number of shares of SpinCo Common Stock subject to such SpinCo RSU Awards immediately prior to the Effective Time, multiplied by (B) the Base Exchange Ratio, with any fractional shares rounded down to the nearest whole share. In addition, at the Effective Time, Parent will issue to each holder of a SpinCo RSU Award a number of Earnout Shares equal to the product of (A) the number of shares of SpinCo Common Stock subject to the SpinCo RSU Award, multiplied by (B) the Earnout Exchange Ratio, which Earnout Shares will be subject to the restrictions set forth in the Merger Agreement. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.4       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of Company PSU Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company PSU Awards Other than (i) Company 2021 TSR PSU Awards, (ii) Company PSU Awards Held by Former Company Service Providers, or (iii) Company PSU Awards Granted on or following the Cutoff Date</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plans, each Company PSU Award outstanding as of immediately prior to the Distribution Time, other than (x) any Company PSU Award held by a Former Company Service Provider, (y) any Company PSU Award that is a Company 2021 TSR PSU Award, and (z) any Company PSU Award granted on or following the Cutoff Date, shall, immediately prior to the Distribution Time, be converted into both a SpinCo PSU Award and a Company PSU Award and shall, subject to Sections 4.4(f) and (g) below, otherwise be subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company PSU Award immediately prior to the Distribution Time&#59;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time&#58;</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-top:6pt;padding-left:38.1pt;text-align:justify;text-indent:69.9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Subject to Post-Distribution Company PSU.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The number of shares of Company Common Stock subject to such Company PSU Award shall be equal to the number of shares of Company Common Stock subject to such Company PSU Award immediately prior to the Distribution Time, and</font></div><div style="margin-top:6pt;padding-left:38.1pt;text-align:justify;text-indent:69.9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Subject to Post-Distribution SpinCo PSU.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The number of shares of SpinCo Common Stock subject to such SpinCo PSU Award shall be equal to the product obtained by multiplying (A)&#160;the number of shares of Company Common Stock subject to the Company PSU Award immediately prior to the Distribution Time by (B)&#160;the Distribution Ratio, and rounding such product down to the nearest whole share.   Each SpinCo PSU Award that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section 4.4(g) below.</font></div><div style="padding-left:38.1pt;text-align:justify;text-indent:69.9pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company 2021 TSR PSU Awards Not Held by Former Company Service Providers</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plans, each Company 2021 TSR PSU Award outstanding as of immediately prior to the Distribution Time, other than any 2021 TSR PSU Award that is held by a Former Company Service Provider, shall, immediately prior to the Distribution Time, be converted into both an SpinCo PSU Award and a Company PSU Award and shall, subject to Sections 4.4(f) and (g) below, otherwise be subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company PSU Award immediately prior to the Distribution Time&#59;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time&#58;</font></div><div style="margin-top:6pt;padding-left:38.1pt;text-align:justify;text-indent:69.9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Subject to Post-Distribution Company PSU.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The number of shares of Company Common Stock subject to such Company PSU Award shall be equal to (x) the number of shares of Company Common Stock subject to such Company 2021 TSR PSU Award immediately prior to the Distribution Time, multiplied by (y) such percentage (not to exceed 200%) as is mutually determined by the Company and SpinCo prior to the Distribution Time, and rounding such product down to the nearest whole share, and</font></div><div style="margin-top:6pt;padding-left:38.1pt;text-align:justify;text-indent:69.9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) &#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Subject to Post-Distribution SpinCo PSU.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The number of shares of SpinCo Common Stock subject to such SpinCo PSU Award shall be equal to the product obtained by multiplying (A) (x)&#160;the number of shares of Company Common Stock subject to the Company PSU Award immediately prior to the Distribution Time, multiplied by (y) such percentage (not to exceed 200%) as is mutually determined by the Company and SpinCo prior to the Distribution Time by (B)&#160;the Distribution Ratio, and rounding such product down to the nearest whole share&#59;</font></div><div style="margin-top:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">provided, further, that from and after the Distribution Time, such Company 2021 TSR PSU Award shall no longer vest based on the performance objectives applicable to such Company 2021 TSR PSU Award immediately prior to the Distribution Time and shall instead be amended to vest solely based on continuous employment or service on December 31, 2023.  Each SpinCo PSU Award that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section 4.4(g) below.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company PSU Awards (Other than Company 2021 TSR PSU Awards) (i) Held by Former Company Service Providers or (ii) Granted on or following the Cutoff Date and Held by Company Service Providers</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plans, each Company PSU Award that is not a Company 2021 TSR PSU Award and is outstanding as of immediately prior to the Distribution Time (x) that is held by a Former Company Service Provider or (y) that was granted on or following the Cutoff Date and is held by a Company Service Provider shall be, subject to Sections 4.4(f) and (g) below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company PSU Award immediately prior to the Distribution Time&#59;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time, the number of shares of Company Common Stock covered by such Company PSU Award held by the participant, as applicable, rounded to the nearest whole share, shall be equal to the product obtained by multiplying (i) the number of shares of Company Common Stock covered by such Company PSU Award immediately prior to the Distribution Time by (ii) the Company Ratio.  The Company Compensation Committee will set forth the vesting terms (including any vesting terms that will apply upon the consummation of the transactions contemplated by the Separation Agreement and the </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Merger Agreement) of any such Company PSU Awards in the applicable award agreement at the time of grant.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company 2021 TSR PSU Awards Held by Former Company Service Providers</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plans, each Company 2021 TSR PSU Award held by a Former Company Service Provider that is outstanding as of immediately prior to the Distribution Time shall be, subject to Sections 4.4(f) and (g) below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company 2021 TSR PSU Award immediately prior to the Distribution Time&#59;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time, the number of shares of Company Common Stock covered by such Company 2021 TSR PSU Award held by the participant, as applicable, rounded to the nearest whole share, shall be equal to the product obtained by multiplying (i) the number of shares of Company Common Stock covered by such Company 2021 TSR PSU Award immediately prior to the Distribution Time by (ii) such percentage (not to exceed 200%) as is mutually determined by the Company and SpinCo prior to the Distribution Time by (iii) the Company Ratio&#59; provided, further, that from and after the Distribution Time, such Company 2021 TSR PSU Award shall no longer vest based on the performance objectives applicable to such Company 2021 TSR PSU Award immediately prior to the Distribution Time and shall instead be amended to vest solely based on continuous employment or service on December 31, 2023.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company PSU Awards (Other than Company 2021 TSR PSU Awards) Granted on or following the Cutoff Date and Held by SpinCo Service Providers</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plans, each Company PSU Award that is outstanding as of immediately prior to the Distribution Time that was granted on or following the Cutoff Date and is held by a SpinCo Service Provider shall, immediately prior to the Distribution Time, be converted solely into a SpinCo PSU Award and shall otherwise be, subject to Sections 4.4(f) and (g) below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company PSU Award immediately prior to the Distribution Time&#59;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that from and after the Distribution Time the number of shares of SpinCo Common Stock subject to such SpinCo PSU Award shall be equal to the product obtained by multiplying (x) the number of shares of Company Common Stock subject to the Company PSU Award immediately prior to the Distribution Time by (y) the SpinCo Ratio, and rounding down to the nearest whole share. The Company Compensation Committee will set forth the vesting terms (including any vesting terms that will apply upon the consummation of the transactions contemplated by the Separation Agreement and the Merger Agreement) of any such Company PSU Awards in the applicable award agreement at the time of grant.  Each SpinCo PSU Award that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section 4.4(g) below.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment to Vesting Terms</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Prior to the Distribution Time, the Company and SpinCo may mutually agree to amend the vesting terms of any or all outstanding Company PSU Awards. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo PSU Awards Outstanding as of the Effective Time</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As of the Effective Time, each SpinCo PSU Award that is outstanding immediately prior to the Effective Time shall be converted into the right to receive (i) performance-vesting restricted stock units relating to shares of Domesticated Parent Common Stock (each, an &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Parent PSU Award</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with substantially the same terms and conditions as were applicable to such SpinCo PSU Award immediately prior to the Effective Time (other than terms that have been rendered inoperative by the Transactions), including with respect to vesting and termination-related provisions, except that such Adjusted Parent PSU Award shall relate to that whole number of shares of Domesticated Parent Common Stock as is equal to the product of (A) the number of shares of SpinCo Common Stock subject to such SpinCo PSU Awards immediately prior to the Effective Time, multiplied by (B) the Base Exchange Ratio, with any fractional shares rounded down to the nearest whole share. Any performance targets to which an Adjusted Parent PSU Awards are subject will be adjusted to reflect the Transactions contemplated hereby. In addition, at the Effective Time, Parent will issue to each holder of a SpinCo PSU Award a number of Earnout Shares equal to the product of (A) the number of shares of SpinCo Common Stock subject to the SpinCo PSU Award, multiplied by (B) the Earnout Exchange Ratio, which Earnout Shares will be subject to the restrictions set forth in the Merger Agreement.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.5     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Equity Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Effective as of the date immediately prior to the date on which the Distribution occurs, SpinCo shall have adopted the OmniAb, Inc. 2022 OmniAb Service Provider Assumed Award Plan and the OmniAb, Inc. 2022 Ligand Service Provider Assumed Award Plan (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Equity Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which shall permit the grant and issuance of equity incentive awards denominated in SpinCo Common Stock as described in this Article IV.  In addition, prior to the Distribution Time, the Company shall approve the SpinCo Equity Plans as the sole stockholder of SpinCo.  As of the Effective Time, Parent will assume the SpinCo Equity Plans and all outstanding equity awards thereunder in accordance with the terms of this Article IV.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.6       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Equity Plan and Parent ESPP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Prior to the Effective Time, Parent shall approve and adopt, subject to receipt of Parent Shareholder Approval&#58; (i) an incentive equity plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Equity Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and (ii) an employee stock purchase plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parent ESPP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), in each case, in form and substance reasonably acceptable to the Company and SpinCo in consultation with Parent, and effective as of the Effective Time.  The Parent Equity Plan will provide for the grant of awards of Domesticated Parent Common Stock with a total pool of shares equal to (i) 14% of the aggregate number of Fully Diluted SpinCo Shares as of the Effective Time, plus (ii) any shares which, as of the effective date of the Parent Equity Plan, are subject to Adjusted Parent Equity Awards under the SpinCo Equity Plans which, on or following such effective date, become available for issuance under the Parent Equity Plan pursuant to its terms, plus (iii) an annual &#8220;evergreen&#8221; increase of 5% of the shares of Parent Common Stock outstanding as of the day prior to such increase (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Equity Plan Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The ESPP will provide for the grant of purchase rights with respect to Domesticated Parent Common Stock with a total pool of shares equal to 1.5% of the aggregate number of Fully Diluted SpinCo Shares as of the Effective Time, plus an annual &#8220;evergreen&#8221; increase of 1% of the shares of Parent Common Stock outstanding as of the day prior to such increase (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parent ESPP Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  As soon as reasonably practicable following the expiration of the sixty (60) day period following the date Parent has filed current Form 10 information with the SEC reflecting its status as an entity that is not a shell company, Parent shall file an effective registration statement on Form S-8 (or other applicable form, including Form S-1 or Form S-3) with respect to the Domesticated Parent Common Stock issuable under the Parent Equity Plan and the Parent ESPP, and Parent shall use commercially reasonable efforts to maintain the effectiveness of such registration statement(s) (and maintain the current status of the prospectus or prospectuses contained therein) for so long as awards granted pursuant to the Parent Equity Plan and the Parent ESPP remain outstanding. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.7       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting&#59; Accelerated Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) &#160;&#160;&#160;&#160;The Distribution Time shall not constitute a termination of employment or service for any SpinCo Service Providers for purposes of any Company Equity Award and, except as otherwise provided in this Agreement, with respect to grants adjusted pursuant to this Article IV, continued employment with the SpinCo Group shall be treated as continued employment with the Company Group with respect to Company Equity Awards held by SpinCo Service Providers and continued employment with the Company Group shall be treated as continued employment with the SpinCo Group with respect to SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) held by Company Service Providers.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, with respect to any unvested SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) granted to a Company Service Provider in accordance with this Agreement, if the original Company Equity Award (that was partially adjusted into the SpinCo Equity Award (or, following the Effective Time, Adjusted Parent Equity Award)) was subject, as of immediately prior to the Distribution, to accelerated vesting provisions (i) by reference to a termination of employment or service with the Company and&#47;or (ii) in connection with a &#8220;Change in Control&#8221; (as defined in the applicable award agreement and&#47;or Company Equity Plan) of the Company, then the SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-top:12pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Awards) also shall be subject to such same acceleration provisions upon the Company Service Provider&#8217;s termination of employment or service with the Company Group and&#47;or in connection with a &#8220;Change in Control&#8221; (as defined in the applicable award agreement and&#47;or Company Equity Plan) of the Company.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;Further notwithstanding the foregoing, with respect to any unvested Company Equity Awards or unvested SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) granted to an SpinCo Service Provider in accordance with this Agreement, if the original Company Equity Award (including any Company Equity Award that was solely or partially adjusted into the SpinCo Equity Award (or, following the Effective Time, Adjusted Parent Equity Award)), was subject, as of immediately prior to the Distribution, to accelerated vesting provisions (i) by reference to a termination of employment or service with the Company and&#47;or (ii) in connection with a &#8220;Change in Control&#8221; (as defined in the applicable award agreement and&#47;or Company Equity Plan) of the Company, then the Company Equity Award or SpinCo Equity Award (or, following the Effective Time, Adjusted Parent Equity Award), as applicable, also shall be subject to such same acceleration provisions upon the SpinCo Service Provider&#8217;s termination of employment or service with the relevant member of the SpinCo Group and&#47;or in connection with a &#8220;Change in Control&#8221; (as defined in the applicable award agreement and&#47;or SpinCo Equity Plan) of SpinCo.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d) &#160;&#160;&#160;&#160;In addition, with respect to any unvested SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) held by a Company Service Provider following the Distribution Time, notwithstanding anything herein or in the applicable award agreement to the contrary, such SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) will vest in full upon a &#8220;Change in Control&#8221; (as defined in the applicable award agreement and&#47;or SpinCo Equity Plans) of SpinCo (or, following the Effective Time, Parent). Further, with respect to any unvested Company Equity Awards which are adjusted as of immediately prior to the Distribution Time and continue to be held by a SpinCo Service Provider following the Distribution, in each case, in accordance with this Agreement, notwithstanding anything herein or in the applicable award agreement to the contrary, such Company Equity Awards will vest in full upon a &#8220;Change in Control&#8221; (as defined in the applicable award agreement and&#47;or Company Equity Plan) of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;Additionally, notwithstanding anything herein or in the applicable award agreement to the contrary, if, following the Distribution Time, the Company Board determines, in its discretion, to accelerate in full the vesting of all Company Equity Awards then held by Company Service Providers and Former Company Service Providers (other than in connection with a &#8220;Change in Control&#8221; (as defined in the applicable award agreement and&#47;or Company Equity Plan)), the Company Board shall also accelerate in full the vesting of all outstanding Company Equity Awards which are then held by SpinCo Service Providers and Former SpinCo Service Providers. Further notwithstanding anything herein or in the applicable award agreement to the contrary, if, following the Distribution Time, the SpinCo Board or Parent Board determines, in its discretion, to accelerate in full the vesting of all SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) then held by SpinCo Service Providers and Former SpinCo Service Providers (other than in connection with a &#8220;Change in Control&#8221; (as defined in the applicable award agreement and&#47;or SpinCo Equity Plans)), the SpinCo Board or Parent Board shall also accelerate in full the vesting of all outstanding SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) which are then held by Company Service Providers and Former Company Service Providers.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;The Parties hereto acknowledge and agree that in no event shall the vesting of any Company Equity Awards or SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards), in any case, accelerate solely by reason of the transactions or events contemplated by the Separation Agreement, this Agreement, the Merger Agreement or any other Transaction Document. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.8       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">General Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">The adjustments contemplated by this Article IV are all intended to comply in all respects with the requirements of Sections 409A and 424 of the Code, in each case, to the extent applicable, and all such provisions shall be interpreted and implemented in accordance with the foregoing.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">The Parties shall use their commercially reasonable efforts to maintain effective registration statements with the Securities Exchange Commission with respect to the awards described in this Article IV, to the extent any such registration statement is required by applicable Law.  For the avoidance of doubt, Parent shall use commercially reasonable efforts to file an effective registration statement on Form S-8 (or other applicable form, including Form S-1 or Form S-3) with respect to the Domesticated Parent Common Stock issuable under the Adjusted Parent Equity Awards issuable under the SpinCo Equity Plans, and Parent shall use commercially reasonable efforts to maintain the effectiveness of such registration statement(s) (and maintain the current status of the prospectus or prospectuses contained therein) for so long as such awards remain outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">The Parties hereby acknowledge that the provisions of this Article IV are intended to achieve certain tax, legal and accounting objectives and, in the event such objectives are not achieved, the Parties agree to negotiate in good faith regarding such other actions that may be necessary or appropriate to achieve such objectives.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d) &#160;&#160;&#160;&#160;After the Distribution Time, Company Equity Awards adjusted pursuant to this Article IV, regardless of by whom held, shall be settled by the Company pursuant to the terms of the Company Equity Plans, and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards), regardless of by whom held, shall be settled by SpinCo or Parent (as applicable) pursuant to the terms of the SpinCo Equity Plans. Accordingly, it is intended that, to the extent of the issuance of such SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) and in connection with the adjustment provisions of this Article IV, the SpinCo Equity Plans shall be considered successors to the Company Equity Plans and to have assumed the obligations of the Company Equity Plans to make the adjustments of the Company Equity Awards as set forth in this Article IV. </font></div><div style="text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;The Parties acknowledge and agree that each of the applicable tax deductions for which they may be eligible for federal income tax purposes with regard to the Company Equity Awards and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards), in any case, shall be determined in accordance with Revenue Ruling 2002-1.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;By approving the form, terms and conditions of, and the entrance by the Parties into, this Agreement, the Company Board, the SpinCo Board and the Parent Board intend to exempt from the short-swing profit recovery provisions of Section 16(b) of the Exchange Act, by reason of the application of Rule 16b&#8722;3 thereunder, all acquisitions and dispositions of Company Equity Awards,  SpinCo Equity Awards and&#47;or Adjusted Parent Equity Awards by directors and executive officers of each of the Parties contemplated herein, and the Company Board, the SpinCo Board and the Parent Board also intend to expressly approve, in respect of any Company Equity Awards, SpinCo Equity Awards and&#47;or Adjusted Parent Equity Awards, the use of any method for the payment of an exercise price and the satisfaction of any applicable tax withholding (specifically including the actual or constructive tendering of shares in payment of an exercise price and the withholding of shares from delivery in satisfaction of applicable tax withholding requirements) to the extent such method is permitted under the Company Equity Plans or SpinCo Equity Plans (as applicable) and the applicable award agreement.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;Each of the Parties shall establish an appropriate administration system in order to handle, in an orderly manner that complies with applicable Laws, (i) exercises of Ligand Options and SpinCo Options (or, following the Effective Time, Adjusted Parent Options), (ii) the settlement of other Ligand Equity Awards and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards), (iii) the vesting of Ligand Equity Awards and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) and (iv) the satisfaction of applicable withholding taxes with respect to Ligand Equity Awards and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards). The Parties shall work together to unify and consolidate all indicative data and payroll and employment information on regular timetables and make certain that each applicable entity&#8217;s data and records in respect of such awards are correct and updated on a timely basis. The foregoing shall include employment status and information required for tax withholding&#47;remittance and reporting, compliance with trading windows and compliance with the requirements of the Exchange Act and other applicable Laws.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article V</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%;text-decoration:underline">ADDITIONAL MATTERS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Cash Incentive Programs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  SpinCo shall assume all Liabilities with respect to all cash incentive compensation, commissions or similar cash payments earned by or payable to SpinCo Employees for the year in which the Distribution Time occurs and thereafter. The Company shall retain all Liabilities with respect to any cash incentive compensation, commissions or similar cash payments earned by or payable to Company Employees for the year in which the Distribution Time occurs and thereafter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.91pt">Effective as of the Distribution Time, SpinCo shall have adopted a severance plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SpinCo Severance Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) for the benefit of eligible SpinCo Employees containing terms substantially similar to those set forth in the Company Severance Plan.  Following the Distribution Time, the Company shall be responsible for any and all Liabilities and other obligations with respect to the Company Severance Plan, and SpinCo shall be responsible for any and all Liabilities and other obligations with respect to the SpinCo Severance Plan.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.34pt">A SpinCo Employee shall not be deemed to have terminated employment for purposes of determining eligibility for severance benefits in connection with or in anticipation of the consummation of the transactions contemplated by the Separation Agreement or Merger Agreement. SpinCo shall be solely responsible for all Liabilities in respect of all costs arising out of payments and benefits relating to the termination or alleged termination of any SpinCo Employee&#8217;s employment that occurs on or after the Distribution Time, including as a result of, in connection with or following the consummation of the transactions contemplated by the Separation Agreement or Merger Agreement, including any amounts required to be paid (including any payroll or other taxes), and the costs of providing benefits, under any applicable severance, separation, redundancy, termination or similar plan, program, practice, contract, agreement, law or regulation (such benefits to include any medical or other welfare benefits, outplacement benefits, accrued vacation, and taxes).</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Time-Off Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Unless otherwise required under applicable Law (or as would result in duplication of benefits), SpinCo shall (i) credit each SpinCo Employee with the amount of accrued but unused vacation time, paid time-off and other time-off benefits as such SpinCo Employee had with the Company Group as of immediately before the date on which the employment of the SpinCo Employee transfers to SpinCo and (ii) permit each such SpinCo Employee to use such accrued but unused vacation time, paid time off and other time-off benefits in the same manner and upon the same terms and conditions as the SpinCo Employee would have been so permitted under the terms and conditions of the applicable Company policies in effect for the year in which such transfer of employment occurs, up to and including full exhaustion of such transferred unused vacation time, paid-time off and other time-off benefits (if such full exhaustion would be permitted under the applicable Company policies in effect for that year in which the transfer of employment occurs).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Workers&#8217; Compensation Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Effective no later than the Distribution Time, SpinCo shall assume all Liabilities for SpinCo Employees, SpinCo Independent Contractors and Former SpinCo Service Providers related to any and all workers&#8217; compensation injuries, incidents, conditions, claims or coverage, whenever incurred (including claims incurred prior to the Distribution Time but not reported until after the Distribution Time), and SpinCo shall be fully responsible for the administration, management and payment of all such claims and satisfaction of all such Liabilities. Notwithstanding the foregoing, if SpinCo is unable to assume any such Liability or the administration, management or payment of any such claim solely because of the operation of applicable Law, the Company shall retain such Liabilities and SpinCo shall reimburse and otherwise fully indemnify the Company for all such Liabilities, including the costs of administering the plans, programs or arrangements under which any such Liabilities have accrued or otherwise arisen.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">COBRA Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Company shall retain responsibility for compliance with the health care continuation requirements of COBRA with respect to SpinCo Employees or Former SpinCo </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Service Providers who, as of the Plan Transition Date, were covered under a Company Benefit Plan or who had incurred a COBRA qualifying event and were eligible to elect COBRA under a Company Benefit Plan. SpinCo shall be responsible for administering compliance with the health care continuation requirements of COBRA, and the corresponding provisions of the SpinCo Benefit Plans with respect to SpinCo Employees and their covered dependents who incur a COBRA qualifying event or loss of coverage at any time after the Plan Transition Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything in this Agreement to the contrary, the Parties shall negotiate in good faith regarding the need for any treatment different from that otherwise provided herein with respect to the payment of compensation to ensure that the treatment of such compensation does not cause the imposition of a Tax under Section 409A of the Code. In no event, however, shall any Party be liable to another in respect of any Taxes imposed under, or any other costs or Liabilities relating to, Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Payroll Taxes and Reporting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Parties shall, to the extent practicable, (i) treat SpinCo or a member of the SpinCo Group as a &#8220;successor employer&#8221; and the Company (or the appropriate member of the Company Group) as a &#8220;predecessor,&#8221; within the meaning of Sections 3121(a)(1) and 3306(b)(1) of the Code, with respect to SpinCo Employees for purposes of Taxes imposed under the United States Federal Unemployment Tax Act or the United States Federal Insurance Contributions Act, and (ii) cooperate with each other to avoid, to the extent reasonably practicable, the filing of more than one IRS Form W-2 with respect to each SpinCo Employee for the calendar year in which the Distribution Time occurs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Regulatory Filings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to applicable Law and the Tax Matters Agreement, the Company shall retain responsibility for all employee-related regulatory filings for reporting periods ending at or prior to the Distribution Time, except for Equal Employment Opportunity Commission EEO-1 reports and affirmative action program (AAP) reports and responses to Office of Federal Contract Compliance Programs (OFCCP) submissions, for which the Company shall provide data and information (to the extent permitted by applicable Laws) to SpinCo, which shall be responsible for making such filings in respect of SpinCo Employees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Certain Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything in this Agreement to the contrary, if applicable Law requires that any assets or Liabilities be retained by the Company Group or transferred to or assumed by the SpinCo Group in a manner that is different from that set forth in this Agreement, such retention, transfer or assumption shall be made in accordance with the terms of such applicable Law and shall not be made as otherwise set forth in this Agreement and the Parties shall reasonably cooperate to adjust for any related economic consequences.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article VI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">OBLIGATIONS OF PARENT AND MERGER SUB</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Obligations of Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Following the Merger Effective Time, Parent agrees to cause, and to take all actions to enable, SpinCo and the members of the SpinCo Group to adhere to each provision of this Agreement which requires an act on the part of SpinCo or any member of the SpinCo Group or any of its or their Affiliates, and to cause or enable SpinCo and the SpinCo Group to comply with their obligations to provide or establish compensation or benefits to SpinCo Service Providers in accordance with this Agreement pursuant to a Benefit Plan sponsored or maintained by Parent or any of its Subsidiaries.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article VII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%;text-decoration:underline">GENERAL AND ADMINISTRATIVE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.1      </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Employer Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing in this Agreement shall be deemed to be an amendment to any Company Benefit Plan or SpinCo Benefit Plan or to prohibit any member of the Company Group or SpinCo Group, as the case may be, from amending, modifying or terminating any Company Benefit Plan or SpinCo Benefit Plan at any time within its sole discretion.</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.2       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effect on Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing in this Agreement is intended to or shall confer upon any employee or former employee of the Company, SpinCo or any of their respective Affiliates any right to continued employment, or any recall or similar rights to any such individual on layoff or any type of approved leave.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.3       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consent of Third Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. If any provision of this Agreement is dependent on the consent of any third party and such consent is withheld, the Parties shall use their reasonable efforts to implement the applicable provisions of this Agreement to the fullest extent practicable. If any provision of this Agreement cannot be implemented due to the failure of such third party to consent, the Parties hereto shall negotiate in good faith to implement the provision (as applicable) in a mutually satisfactory manner.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.4       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Access to Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. On and after the Distribution Time, the Parties shall, or shall cause each of their respective Affiliates to, make available to each other those of their employees who may reasonably be needed in order to defend or prosecute any legal or administrative action (other than a legal action among the Parties) to which any employee or director of the Company Group or the SpinCo Group or any Company Benefit Plan or SpinCo Benefit Plan is a party and which relates to a Company Benefit Plan or SpinCo Benefit Plan. The Party to whom an employee is made available in accordance with this&#160;Section 7.4&#160;shall pay or reimburse the other Parties for all reasonable expenses which may be incurred by such employee in connection therewith, including all reasonable travel, lodging, and meal expenses, but excluding any amount for such employee&#8217;s time spent in connection herewith.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.5       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficiary Designation&#47;Release of Information&#47;Right to Reimbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. To the extent permitted by applicable Law and except as otherwise provided for in this Agreement, all beneficiary designations, authorizations for the release of information and rights to reimbursement made by or relating to SpinCo Employees under Company Benefit Plan shall be transferred to and be in full force and effect under the corresponding SpinCo Benefit Plan until such beneficiary designations, authorizations or rights are replaced or revoked by, or no longer apply, to the relevant SpinCo Employee.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Third Party Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement is solely for the benefit of the Parties and, except to the extent otherwise expressly provided herein, nothing in this Agreement, express or implied, is intended to confer any rights, benefits, remedies, obligations or Liabilities under this Agreement upon any Person, including any SpinCo Employee or other current or former employee, officer, director or contractor of the Company Group or SpinCo Group, other than the Parties and their respective successors and assigns.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.7       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Employee Benefits Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. At all times following the date hereof, the Parties will cooperate in good faith as necessary to facilitate the administration of employee benefits and the resolution of related employee benefit claims with respect to SpinCo Employees, Former SpinCo Service Providers and employees and other service providers of the Company, as applicable, including with respect to the provision of employee level information necessary for the other Parties to manage, administer, finance and file required reports with respect to such administration.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.8       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Audit Rights With Respect to Information Provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a) &#160;&#160;&#160;&#160;Each Party, and their duly authorized representatives, shall have the right to conduct reasonable audits with respect to all information required to be provided to it by the other Parties under this Agreement. The Party conducting the audit (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Auditing Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may adopt reasonable procedures and guidelines for conducting audits and the selection of audit representatives under this Section&#160;7.8. The Auditing Party shall have the right to make copies of any records at its expense, subject to any restrictions imposed by applicable laws and to any confidentiality provisions set forth in the Separation Agreement, which are incorporated by reference herein. The Party being audited shall provide the Auditing Party&#8217;s representatives with reasonable access during normal business hours to its operations, computer systems and paper and electronic files, and provide workspace to its representatives. After any audit is completed, the Party being audited shall have the right to review a draft of the audit findings and to comment on those findings in writing within thirty business days after receiving such draft.</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;The Auditing Party&#8217;s audit rights under this Section&#160;7.8 shall include the right to audit, or participate in an audit facilitated by the Party being audited, of any Subsidiaries and Affiliates of the Party being audited and to require the other Parties to request any benefit providers and third parties with whom the Party being audited has a relationship, or agents of such Party, to agree to such an audit to the extent any such Persons are affected by or addressed in this Agreement (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Party being audited shall, upon written request from the Auditing Party, provide an individual (at the Auditing Party&#8217;s expense) to supervise any audit of a Non-party. The Auditing Party shall be responsible for supplying, at the Auditing Party&#8217;s expense, additional personnel sufficient to complete the audit in a reasonably timely manner. The responsibility of the Party being audited shall be limited to providing, at the Auditing Party&#8217;s expense, a single individual at each audited site for purposes of facilitating the audit.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.9       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each of the Parties hereto will use its commercially reasonable efforts to share information and promptly take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Laws to consummate the transactions contemplated by this Agreement.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Article VIII</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%;text-decoration:underline">MISCELLANEOUS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement, the Separation Agreement, the Merger Agreement, and the other Transaction Documents, including the Exhibits and Schedules thereto, shall constitute the entire agreement among the Parties with respect to the subject matter hereof and shall supersede all previous negotiations, commitments, course of dealings and writings with respect to such subject matter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement may be executed in two or more counterparts (including by electronic or .pdf transmission), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  Delivery of any signature page by facsimile, electronic or .pdf transmission shall be binding to the same extent as an original signature page.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Survival of Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except as otherwise contemplated by this Agreement, all covenants and agreements of the Parties contained in this Agreement shall survive the Distribution Time and Merger Effective Time and remain in full force and effect in accordance with their applicable terms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All notices and other communications among the Parties shall be in writing and shall be deemed to have been duly given (a) when delivered in person, (b) when delivered after posting in the national mail having been sent registered or certified mail return receipt requested, postage prepaid, (c) when delivered by FedEx or other internationally recognized overnight delivery service or (d) when delivered by facsimile (solely if receipt is confirmed) or email (so long as the sender of such email does not receive an automatic reply from the recipient&#8217;s email server indicating that the recipient did not receive such email), addressed as follows&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">To the Company&#58;</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Ligand Pharmaceuticals Incorporated</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">3911 Sorrento Valley Boulevard, Suite 110</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">San Diego, California 92121</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Attn&#58; Chief Financial Officer</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Email&#58; tespinoza&#64;ligand.com</font></div><div><font><br></font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with a copy (which shall not constitute notice) to&#58;</font></div><div style="padding-left:90pt"><font><br></font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Latham &#38; Watkins, LLP</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12670 High Bluff Dr.</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">San Diego, California 92130</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attention&#58;&#160;&#160;&#160;&#160;Matthew Bush</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Scott Shean</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Email&#58;&#160;&#160;&#160;&#160;matt.bush&#64;lw.com</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;scott.shean&#64;lw.com</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">To SpinCo&#58;</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">OmniAb, Inc.</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">5980 Horton Street, Suite 405</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Emeryville, California 94608</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Attn&#58; Chief Legal Officer</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Email&#58; cberkman&#64;omniab.com</font></div><div style="text-indent:90pt"><font><br></font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with a copy (which shall not constitute notice) to&#58;</font></div><div style="padding-left:90pt"><font><br></font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Latham &#38; Watkins, LLP</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12670 High Bluff Dr.</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">San Diego, California 92130</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Attention&#58;&#160;&#160;&#160;&#160;Matthew Bush</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Scott Shean</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Email&#58;&#160;&#160;&#160;&#160;matt.bush&#64;lw.com</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;scott.shean&#64;lw.com</font></div><div style="text-indent:90pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To Parent or Merger Sub&#58;</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Avista Public Acquisition Corp. II</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">65 East 55</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> Street, 18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%"> Floor</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">New York, New York 10022</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Attn&#58; General Counsel</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Email&#58;  Silbert&#64;avistacap.com </font></div><div style="text-indent:90pt"><font><br></font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">with a copy (which shall not constitute notice) to&#58;</font></div><div style="text-indent:90pt"><font><br></font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Weil, Gotshal &#38; Manges LLP</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">767 5th Avenue</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">New York, New York 10153</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Attention&#58;&#160;&#160;&#160;&#160;Jaclyn L. Cohen, Esq.</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Raymond O. Gietz, Esq.</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Email&#58;&#160;&#160;&#160;&#160;jackie.cohen&#64;weil.com</font></div><div style="text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Raymond.gietz&#64;weil.com</font></div><div style="text-indent:90pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or to such other address or addresses as the Parties may from time to time designate in writing by like notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any consent required or permitted to be given by any Party to the other Parties under this Agreement shall be in writing and signed by the Party giving such consent and shall be effective only against such Party (and its Group).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement shall not be assignable, in whole or in part, directly or indirectly, by any Party hereto without the prior written consent of the other Parties, and any attempt to assign any rights or obligations arising under this Agreement without such consent shall be void. </font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, and subject to any restrictions on assignment by SpinCo pursuant to Article IV of the Tax Matters Agreement, this Agreement shall be assignable to (i) with respect to the Company, an Affiliate of the Company, and with respect to SpinCo, and Affiliate of SpinCo, or (ii) a bona fide third party in connection with a merger, reorganization, consolidation or the sale of all or substantially all the assets of a party hereto so long as the resulting, surviving or transferee entity assumes all the obligations of the relevant party hereto by operation of Law or pursuant to an agreement in form and substance reasonably satisfactory to the other Parties to this Agreement&#59;&#160;provided&#160;however&#160;that in the case of each of the preceding clauses (i) and (ii), no assignment permitted by this&#160;Section 8.6&#160;shall release the assigning Party from liability for the full performance of its obligations under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The provisions of this Agreement and the obligations and rights hereunder shall be binding upon, inure to the benefit of and be enforceable by (and against) the Parties and their respective successors and permitted assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Termination and Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement may be amended or modified, in whole or in part, only by a duly authorized agreement in writing executed by the Parties in the same manner (but not necessarily by the same Persons) as this Agreement, and which makes reference to this Agreement.  This Agreement shall terminate automatically without any further action of the Parties upon a termination of the Merger Agreement, and no Party will have any further obligations to the other Parties hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Each of the Parties shall cause to be performed, and hereby guarantees the performance of, all actions, agreements and obligations set forth herein to be performed by any Subsidiary of such Party or by any entity that becomes a Subsidiary of such Party at and after the Distribution Time, to the extent such Subsidiary remains a Subsidiary of the applicable Party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Title and Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Titles and headings to sections herein are inserted for the convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement, and all claims, disputes, controversies or causes of action (whether in contract, tort, equity or otherwise) that may be based upon, arise out of or relate to this Agreement (including any schedule or exhibit hereto) or the negotiation, execution or performance of this Agreement (including any claim, dispute, controversy or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter into this Agreement), shall be governed by and construed in accordance with the Laws of the State of Delaware, without regard to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware.  Each of the Parties agrees that any Action related to this agreement shall be brought exclusively in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Chosen Courts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  By executing and delivering this Agreement, each of the Parties irrevocably&#58; (a) accepts generally and unconditionally submits to the exclusive jurisdiction of the Chosen Courts for any Action relating to this Agreement&#59; (b) waives any objections which such party may now or hereafter have to the laying of venue of any such Action contemplated by this Section 8.11 and hereby further irrevocably waives and agrees not to plead or claim that any such Action has been brought in an inconvenient forum&#59; (c) agrees that it will not attempt to deny or defeat the personal jurisdiction of the Chosen Courts by motion or other request for leave from any such court&#59; (d) agrees that it will not bring any Action contemplated by this Section 8.11 in any court other than the Chosen Courts&#59; (e) agrees that service of all process, including the summons and complaint, in any Action may be made by registered or certified mail, return receipt requested, to such party at their respective addresses provided in accordance with Section 8.4 or in any other manner permitted by Law&#59; and (f)&#160;agrees that service as provided in the preceding clause (e) is sufficient to confer personal jurisdiction over such party in the Action, and otherwise constitutes effective and binding service in every respect.  Each of the parties hereto agrees that a final judgment in any Action in a Chosen Court as provided above may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law, and each party further agrees to the non-exclusive jurisdiction of the Chosen Courts for the enforcement or execution of any such judgment.</font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt">WAIVER OF JURY TRIAL.  THE PARTIES HEREBY UNCONDITIONALLY AND IRREVOCABLY WAIVE THEIR RIGHT TO TRIAL BY JURY IN ANY JUDICIAL PROCEEDING IN ANY COURT RELATING TO ANY DISPUTE, CONTROVERSY OR CLAIM ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT (INCLUDING ANY SCHEDULE OR EXHIBIT HERETO) OR THE BREACH, TERMINATION OR VALIDITY OF THIS AGREEMENT OR THE NEGOTIATION, EXECUTION OR PERFORMANCE OF THIS AGREEMENT.  NO PARTY TO THIS AGREEMENT SHALL SEEK A JURY TRIAL IN ANY LAWSUIT, PROCEEDING, COUNTERCLAIM OR ANY OTHER LITIGATION PROCEDURE BASED UPON, OR ARISING OUT OF, THIS AGREEMENT OR ANY RELATED INSTRUMENTS.  NO PARTY WILL SEEK TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED.  EACH PARTY TO THIS AGREEMENT CERTIFIES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT OR INSTRUMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS SET FORTH ABOVE IN THIS SECTION 8.12.  NO PARTY HAS IN ANY WAY AGREED WITH OR REPRESENTED TO ANY OTHER PARTY THAT THE PROVISIONS OF THIS SECTION 8.12 WILL NOT BE FULLY ENFORCED IN ALL INSTANCES.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:18.5pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any provision of this Agreement, or the application of any such provision to any Person or circumstance, shall be held invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision hereof.  The Parties further agree that if any provision contained herein is, to any extent, held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by Law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable provision giving effect to the intent of the Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Parties have participated jointly in the negotiation and drafting of this Agreement. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the Party drafting or causing any instrument to be drafted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">No Duplication&#59; No Double Recovery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing in this Agreement is intended to confer to or impose upon any Party a duplicative right, entitlement, obligation or recovery with respect to any matter arising out of the same facts and circumstances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. No failure to exercise and no delay in exercising, on the part of any Party, any right, remedy, power or privilege hereunder shall operate as a waiver hereof&#59; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt;text-decoration:underline">No Admission of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The allocation of Assets and Liabilities herein is solely for the purpose of allocating such Assets and Liabilities among the Parties and is not intended as an admission of liability or responsibility for any alleged Liabilities vis-&#224;-vis any third party, including with respect to the Liabilities of any non-wholly owned subsidiary of any Party.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:139%">&#91;Signature Page Follows&#93;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the day and year first above written.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:9.48pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"><tr><td style="width:1.0%"></td><td style="width:35.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.824%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"><div style="text-indent:36pt"><font><br></font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Matthew Korenberg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">OMNIAB, INC. </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew W. Foehr</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Matthew W. Foehr</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:16pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AVISTA PUBLIC ACQUISITION CORP. II</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:16pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Benjamin Silbert</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benjamin Silbert</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">General Counsel</font></td></tr><tr style="height:16pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:16pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ORWELL MERGER SUB INC.</font></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:16pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Benjamin Silbert</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="6" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">David Burgstahler</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">President</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:139%">&#91;Signature Page to Amended and Restated Employee Matters Agreement&#93;</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:77.76pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>lgnd_93022exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id9729c211a6b4833a60217f7276c2354_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, John L. Higgins, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.064%"><tr><td style="width:1.0%"></td><td style="width:11.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;November&#160;8, 2022 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.166%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John L. Higgins</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>lgnd_93022exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie44bcb2c10d847e192b924119bf0cc69_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Octavio Espinoza, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;&#160;November&#160;8, 2022 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.416%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Octavio Espinoza</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Octavio Espinoza</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>lgnd_93022exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icf63d966343248eaa5dc610578a9a1d7_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John L. Higgins, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John L. Higgins<br>Chief Executive Officer <br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Octavio Espinoza, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Octavio Espinoza</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Octavio Espinoza<br>Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>lgnd-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7b2ea99b-5e75-4f19-8ddb-22eedf3c9f68,g:96c50209-ed52-4eb8-96bc-4f2a516dad9f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.ligand.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.ligand.com/role/SegmentInformation">
        <link:definition>0000009 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.ligand.com/role/FairValueMeasurements">
        <link:definition>0000010 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotes" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes">
        <link:definition>0000011 - Disclosure - Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://www.ligand.com/role/IncomeTax">
        <link:definition>0000012 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.ligand.com/role/StockholdersEquity">
        <link:definition>0000013 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedings" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings">
        <link:definition>0000014 - Disclosure - Commitment and Contingencies: Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.ligand.com/role/Leases">
        <link:definition>0000015 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvent" roleURI="http://www.ligand.com/role/SubsequentEvent">
        <link:definition>0000016 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000017 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000018 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.ligand.com/role/SegmentInformationTables">
        <link:definition>0000019 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.ligand.com/role/FairValueMeasurementsTables">
        <link:definition>0000020 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesTables" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables">
        <link:definition>0000021 - Disclosure - Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.ligand.com/role/StockholdersEquityTables">
        <link:definition>0000022 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.ligand.com/role/LeasesTables">
        <link:definition>0000023 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
        <link:definition>0000025 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
        <link:definition>0000026 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>0000027 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
        <link:definition>0000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails">
        <link:definition>0000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails">
        <link:definition>0000030 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails">
        <link:definition>0000031 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
        <link:definition>0000032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails">
        <link:definition>0000033 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
        <link:definition>0000034 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://www.ligand.com/role/SegmentInformationDetails">
        <link:definition>0000035 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>0000036 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
        <link:definition>0000037 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>0000038 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNarrativeDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails">
        <link:definition>0000039 - Disclosure - Convertible Senior Notes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNotesPayableDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails">
        <link:definition>0000040 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxDetails" roleURI="http://www.ligand.com/role/IncomeTaxDetails">
        <link:definition>0000041 - Disclosure - Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
        <link:definition>0000042 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>0000043 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedingsDetails" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails">
        <link:definition>0000044 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.ligand.com/role/LeasesNarrativeDetails">
        <link:definition>0000045 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails">
        <link:definition>0000046 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityofOperatingLeaseLiabilitiesDetails" roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails">
        <link:definition>0000047 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>0000047 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventDetails" roleURI="http://www.ligand.com/role/SubsequentEventDetails">
        <link:definition>0000048 - Disclosure - Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_KyprolisMember" abstract="true" name="KyprolisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersFinancingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PfenexMember" abstract="true" name="PfenexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LeaseLiabilityCurrent" abstract="false" name="LeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CommercialLicenseRights" abstract="false" name="CommercialLicenseRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolCoreMember" abstract="true" name="MaterialSalesCaptisolCoreMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LeaseRightOfUseAsset" abstract="false" name="LeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_GainLossOnShortTermInvestments" abstract="false" name="GainLossOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" abstract="false" name="AmountsOwedToFormerLicensorFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" abstract="true" name="USDistrictCourtForTheNorthernDistrictOfOhioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_IncreaseDecreaseInDebtDiscount" abstract="false" name="IncreaseDecreaseInDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" abstract="false" name="DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_PaymentsToUnwindWarrants" abstract="false" name="PaymentsToUnwindWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanAbstract" abstract="true" name="EmployeeStockPurchasePlanAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_SaleOfStockAuthorizedOfferingAmount" abstract="false" name="SaleOfStockAuthorizedOfferingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NotesRepurchasedDuringCurrentPeriodOneMember" abstract="true" name="NotesRepurchasedDuringCurrentPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ReturnsAccrual" abstract="false" name="ReturnsAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedInventoryPurchases" abstract="false" name="AccruedInventoryPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_XCellaBiosciencesIncMember" abstract="true" name="XCellaBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" abstract="false" name="DebtInstrumentRepurchasedAmountDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MilestoneMember" abstract="true" name="MilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" abstract="true" name="DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" abstract="true" name="EarnoutRightsForPartnerResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ProceedsFromUnwindingConvertibleBondHedges" abstract="false" name="ProceedsFromUnwindingConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" abstract="false" name="FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" abstract="false" name="ScheduleOfShortTermInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_EvomelaMember" abstract="true" name="EvomelaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" abstract="false" name="AmortizationOfCommercialLicenseAndOtherEconomicRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" abstract="false" name="ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_RoyaltyOtherMember" abstract="true" name="RoyaltyOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" abstract="true" name="CommercialLicenseAndOtherEconomicRightsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" abstract="false" name="NonCashChangeInEstimatedFairValueOfContingentValueRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContractRevenueServiceMember" abstract="true" name="ContractRevenueServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BasisOfPresentationLineItems" abstract="true" name="BasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" abstract="false" name="COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" abstract="false" name="ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AziyoAndCorMatrixMember" abstract="true" name="AziyoAndCorMatrixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_IcagenMember" abstract="true" name="IcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NumberOfContingentValueRightsSeries" abstract="false" name="NumberOfContingentValueRightsSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_TeriparatideInjectionMember" abstract="true" name="TeriparatideInjectionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AccruedAssetAcquisitionsCurrent" abstract="false" name="AccruedAssetAcquisitionsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease" abstract="false" name="OperatingLeasesRightOfUseAssetsIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_SelexisAndDianomiMember" abstract="true" name="SelexisAndDianomiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LicenseeAccrualCurrent" abstract="false" name="LicenseeAccrualCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContractRevenueMember" abstract="true" name="ContractRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_OmniAbMember" abstract="true" name="OmniAbMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MetabasisMember" abstract="true" name="MetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" abstract="false" name="LesseeOperatingLeaseLiabilityTenantImprovementAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRights" abstract="false" name="LiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" abstract="false" name="BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" abstract="true" name="NotesRepurchasedDuringCurrentPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_OperatingLeaseLiabilityIncreaseDecrease" abstract="false" name="OperatingLeaseLiabilityIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CurrentPortionOfLiabilityForContingentValueRights" abstract="false" name="CurrentPortionOfLiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersInvestingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BasisOfPresentationTable" abstract="true" name="BasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_RepaymentsOfNotesPayableInterestPortion" abstract="false" name="RepaymentsOfNotesPayableInterestPortion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LicenseFeesMember" abstract="true" name="LicenseFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_OmniAbTechnologiesSegmentMember" abstract="true" name="OmniAbTechnologiesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" abstract="false" name="ScheduleOfCommercialLicenseRightsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHolders" abstract="false" name="PaymentsToContingentValueRightHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AtTheMarketEquityOfferingMember" abstract="true" name="AtTheMarketEquityOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PaymentsForConvertibleBondHedges" abstract="false" name="PaymentsForConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolMember" abstract="true" name="MaterialSalesCaptisolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" abstract="true" name="LicenseFeesMilestonesAndProductOtherProductOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_Phase3ClinicalTrialMember" abstract="true" name="Phase3ClinicalTrialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LigandCoreBusinessSegmentMember" abstract="true" name="LigandCoreBusinessSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NumberOfOptionsUnderConvertibleBondHedges" abstract="false" name="NumberOfOptionsUnderConvertibleBondHedges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_CyDexMember" abstract="true" name="CyDexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_CommercialLicenseRightsPolicyTextBlock" abstract="false" name="CommercialLicenseRightsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" abstract="false" name="BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_RylazeMember" abstract="true" name="RylazeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AccruedSubcontractorExpensesCurrent" abstract="false" name="AccruedSubcontractorExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolCOVIDMember" abstract="true" name="MaterialSalesCaptisolCOVIDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContingentLiabilitiesMember" abstract="true" name="ContingentLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>lgnd-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7b2ea99b-5e75-4f19-8ddb-22eedf3c9f68,g:96c50209-ed52-4eb8-96bc-4f2a516dad9f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_85d70e03-420c-4bfc-b462-dd8951e1580d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c6767244-9823-48e3-bbca-e25d670098f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_85d70e03-420c-4bfc-b462-dd8951e1580d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c6767244-9823-48e3-bbca-e25d670098f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_85a7b286-36f1-4427-83dc-6d0427f6788e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_85d70e03-420c-4bfc-b462-dd8951e1580d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_85a7b286-36f1-4427-83dc-6d0427f6788e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e97d4029-48b6-4bf9-86b9-24e1ce3d6790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_85d70e03-420c-4bfc-b462-dd8951e1580d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_e97d4029-48b6-4bf9-86b9-24e1ce3d6790" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_92a3b8a7-e9d7-4894-8eb1-e940e34c39c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_85d70e03-420c-4bfc-b462-dd8951e1580d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_92a3b8a7-e9d7-4894-8eb1-e940e34c39c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_f83b8771-dfee-4772-b345-1555f3fb2097" xlink:href="lgnd-20220930.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_85d70e03-420c-4bfc-b462-dd8951e1580d" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_f83b8771-dfee-4772-b345-1555f3fb2097" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7968eeeb-5ff6-4810-ac74-00d9a1290171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_85d70e03-420c-4bfc-b462-dd8951e1580d" xlink:to="loc_us-gaap_AccountsPayableCurrent_7968eeeb-5ff6-4810-ac74-00d9a1290171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_630d780d-66f6-4184-9eae-7c90149a7355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_85d70e03-420c-4bfc-b462-dd8951e1580d" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_630d780d-66f6-4184-9eae-7c90149a7355" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_115ecbdf-9305-45c0-910d-f89c7e087095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_85d70e03-420c-4bfc-b462-dd8951e1580d" xlink:to="loc_us-gaap_TaxesPayableCurrent_115ecbdf-9305-45c0-910d-f89c7e087095" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_863387ec-dd18-4e2e-b976-8d6242649df0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e8249d81-6d72-44e4-9076-65c71a9ce872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_863387ec-dd18-4e2e-b976-8d6242649df0" xlink:to="loc_us-gaap_Goodwill_e8249d81-6d72-44e4-9076-65c71a9ce872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3e5567e5-85e1-4d78-a372-7be6c45b7252" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_863387ec-dd18-4e2e-b976-8d6242649df0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3e5567e5-85e1-4d78-a372-7be6c45b7252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_38a6dcda-75dc-49e0-8cef-6cd3f383a01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_863387ec-dd18-4e2e-b976-8d6242649df0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_38a6dcda-75dc-49e0-8cef-6cd3f383a01b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_15701bae-a327-4cca-a6a2-fbed1907ee55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_863387ec-dd18-4e2e-b976-8d6242649df0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_15701bae-a327-4cca-a6a2-fbed1907ee55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_4c083765-31fc-4886-8695-4ee40c0c1f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_863387ec-dd18-4e2e-b976-8d6242649df0" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_4c083765-31fc-4886-8695-4ee40c0c1f88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_d9c579a1-0061-44d7-a940-2052d00a1146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_863387ec-dd18-4e2e-b976-8d6242649df0" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_d9c579a1-0061-44d7-a940-2052d00a1146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f29fcc19-95eb-41e7-9055-84e0ad49bbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_863387ec-dd18-4e2e-b976-8d6242649df0" xlink:to="loc_us-gaap_AssetsCurrent_f29fcc19-95eb-41e7-9055-84e0ad49bbcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_95b90977-1a44-46f0-a7ee-83c450592908" xlink:href="lgnd-20220930.xsd#lgnd_CommercialLicenseRights"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_863387ec-dd18-4e2e-b976-8d6242649df0" xlink:to="loc_lgnd_CommercialLicenseRights_95b90977-1a44-46f0-a7ee-83c450592908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a43f338b-6498-4e45-a876-52f7c488cfed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_863387ec-dd18-4e2e-b976-8d6242649df0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a43f338b-6498-4e45-a876-52f7c488cfed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4080af9c-304f-4612-bb1c-da9c06391250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d5fe3329-f0cb-41b1-8fe9-24a0c0149d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4080af9c-304f-4612-bb1c-da9c06391250" xlink:to="loc_us-gaap_Liabilities_d5fe3329-f0cb-41b1-8fe9-24a0c0149d10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d679c306-4232-40b0-a571-dc5942e5de8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4080af9c-304f-4612-bb1c-da9c06391250" xlink:to="loc_us-gaap_StockholdersEquity_d679c306-4232-40b0-a571-dc5942e5de8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a064de4a-ad34-4ab9-951c-47100f0ffa7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_4080af9c-304f-4612-bb1c-da9c06391250" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a064de4a-ad34-4ab9-951c-47100f0ffa7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_20567a0c-e4e7-4c89-a699-9d3e5eac7edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9581f88c-fcce-4ab1-ab2d-5deb90d1b474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_20567a0c-e4e7-4c89-a699-9d3e5eac7edc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9581f88c-fcce-4ab1-ab2d-5deb90d1b474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_76f20e7c-b715-4425-89c6-ee1e1c33db6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_20567a0c-e4e7-4c89-a699-9d3e5eac7edc" xlink:to="loc_us-gaap_CommonStockValue_76f20e7c-b715-4425-89c6-ee1e1c33db6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1ac97b35-0fdd-4f24-a1a0-b529a36adf05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_20567a0c-e4e7-4c89-a699-9d3e5eac7edc" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1ac97b35-0fdd-4f24-a1a0-b529a36adf05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_27e6e547-596c-4ad2-81e3-60c6e6e75ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_20567a0c-e4e7-4c89-a699-9d3e5eac7edc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_27e6e547-596c-4ad2-81e3-60c6e6e75ca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_50f35991-5b9d-4bfc-8231-437d75e4f484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_20567a0c-e4e7-4c89-a699-9d3e5eac7edc" xlink:to="loc_us-gaap_PreferredStockValue_50f35991-5b9d-4bfc-8231-437d75e4f484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e20cd5f5-685a-4df3-9f03-89f66d7130ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_90427de3-947b-4f44-8429-f320869de927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e20cd5f5-685a-4df3-9f03-89f66d7130ea" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_90427de3-947b-4f44-8429-f320869de927" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_d855afd7-bed0-44ec-9704-8b54977ba4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e20cd5f5-685a-4df3-9f03-89f66d7130ea" xlink:to="loc_us-gaap_ShortTermInvestments_d855afd7-bed0-44ec-9704-8b54977ba4bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_46a97922-1aab-4170-bfd2-19deedc83549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e20cd5f5-685a-4df3-9f03-89f66d7130ea" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_46a97922-1aab-4170-bfd2-19deedc83549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ca053e3b-5032-4c57-8759-0024fd2c3826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e20cd5f5-685a-4df3-9f03-89f66d7130ea" xlink:to="loc_us-gaap_InventoryNet_ca053e3b-5032-4c57-8759-0024fd2c3826" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_abe6a847-f3e8-4e78-ab57-3378fff460f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e20cd5f5-685a-4df3-9f03-89f66d7130ea" xlink:to="loc_us-gaap_IncomeTaxesReceivable_abe6a847-f3e8-4e78-ab57-3378fff460f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_cf8bcded-46aa-47ca-902a-3d23619c93fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e20cd5f5-685a-4df3-9f03-89f66d7130ea" xlink:to="loc_us-gaap_OtherAssetsCurrent_cf8bcded-46aa-47ca-902a-3d23619c93fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_34229ab9-f2c6-40f7-b754-9bff70d6ffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b93439ce-1615-4cf9-8bf5-b61e55544461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_34229ab9-f2c6-40f7-b754-9bff70d6ffa5" xlink:to="loc_us-gaap_LiabilitiesCurrent_b93439ce-1615-4cf9-8bf5-b61e55544461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_48a7749e-a41b-4eb9-9594-8a54116fbf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_34229ab9-f2c6-40f7-b754-9bff70d6ffa5" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_48a7749e-a41b-4eb9-9594-8a54116fbf6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_36ecfd92-e4f6-472a-a1b9-8d558bc07eba" xlink:href="lgnd-20220930.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_34229ab9-f2c6-40f7-b754-9bff70d6ffa5" xlink:to="loc_lgnd_LiabilityForContingentValueRights_36ecfd92-e4f6-472a-a1b9-8d558bc07eba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d0592c9f-1c26-4123-bbb2-86bbd1bfb331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_34229ab9-f2c6-40f7-b754-9bff70d6ffa5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d0592c9f-1c26-4123-bbb2-86bbd1bfb331" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_780e432e-7e95-430a-8e31-b371b007fbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_34229ab9-f2c6-40f7-b754-9bff70d6ffa5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_780e432e-7e95-430a-8e31-b371b007fbe7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_599b17be-dcb9-41ee-9722-8123b367083e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_34229ab9-f2c6-40f7-b754-9bff70d6ffa5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_599b17be-dcb9-41ee-9722-8123b367083e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_365c028a-1bd7-40d4-80ae-002761856423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_34229ab9-f2c6-40f7-b754-9bff70d6ffa5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_365c028a-1bd7-40d4-80ae-002761856423" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_4c35d177-42c7-4c49-9b67-3d6bf2d70bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_7ef65ad4-01d1-4354-8acd-b969d4a0e7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_4c35d177-42c7-4c49-9b67-3d6bf2d70bc0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_7ef65ad4-01d1-4354-8acd-b969d4a0e7ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1a07d707-2b5f-437e-9d39-2670b695463e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_4c35d177-42c7-4c49-9b67-3d6bf2d70bc0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1a07d707-2b5f-437e-9d39-2670b695463e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_58929ee3-87b0-4e4a-9fb0-4f07f3183340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_4c35d177-42c7-4c49-9b67-3d6bf2d70bc0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_58929ee3-87b0-4e4a-9fb0-4f07f3183340" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_992b62f7-af80-4042-ae66-9ef3d66ffb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_4c35d177-42c7-4c49-9b67-3d6bf2d70bc0" xlink:to="loc_us-gaap_CostDirectMaterial_992b62f7-af80-4042-ae66-9ef3d66ffb6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_3d7a8e3e-459e-4914-bbc6-c51a71db92f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_4c35d177-42c7-4c49-9b67-3d6bf2d70bc0" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_3d7a8e3e-459e-4914-bbc6-c51a71db92f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c038cc30-6ec3-4f8a-b96d-f7084e0fdfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_555a9c3c-1173-4c40-836a-6cb12f8b4c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c038cc30-6ec3-4f8a-b96d-f7084e0fdfe8" xlink:to="loc_us-gaap_GainLossOnInvestments_555a9c3c-1173-4c40-836a-6cb12f8b4c19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_36e89f83-bdc4-4a86-8119-7c8d60c07b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c038cc30-6ec3-4f8a-b96d-f7084e0fdfe8" xlink:to="loc_us-gaap_InvestmentIncomeInterest_36e89f83-bdc4-4a86-8119-7c8d60c07b31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4aaf265a-4e9a-42e9-93af-4e3306a164ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c038cc30-6ec3-4f8a-b96d-f7084e0fdfe8" xlink:to="loc_us-gaap_InterestExpense_4aaf265a-4e9a-42e9-93af-4e3306a164ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c31fe1e5-cc09-45d8-b127-c03d00a968c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c038cc30-6ec3-4f8a-b96d-f7084e0fdfe8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c31fe1e5-cc09-45d8-b127-c03d00a968c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3a538bec-26f3-4df1-aa16-b1187c5c6aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_acff2a54-abd6-456f-9a24-4f477b7e5343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3a538bec-26f3-4df1-aa16-b1187c5c6aea" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_acff2a54-abd6-456f-9a24-4f477b7e5343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_180babf6-8704-44be-b4ad-e1edc8629df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3a538bec-26f3-4df1-aa16-b1187c5c6aea" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_180babf6-8704-44be-b4ad-e1edc8629df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_36a78be9-2cdd-45d6-9a7a-bc2fe3ea9615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_72bb27aa-1f6d-47dc-99bf-f10e56ac83c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_36a78be9-2cdd-45d6-9a7a-bc2fe3ea9615" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_72bb27aa-1f6d-47dc-99bf-f10e56ac83c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_f893bcb3-6b44-4ce4-879e-b24a66ec258d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_36a78be9-2cdd-45d6-9a7a-bc2fe3ea9615" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_f893bcb3-6b44-4ce4-879e-b24a66ec258d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ef524ae-93f2-4e54-b45b-70b7fb11d030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cec4879b-d4a2-4145-a00f-74848bd1ecf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ef524ae-93f2-4e54-b45b-70b7fb11d030" xlink:to="loc_us-gaap_OperatingIncomeLoss_cec4879b-d4a2-4145-a00f-74848bd1ecf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cf69adfe-f1bf-4d5b-8a4d-01f382b0ea5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ef524ae-93f2-4e54-b45b-70b7fb11d030" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cf69adfe-f1bf-4d5b-8a4d-01f382b0ea5e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6fe9e96b-8b88-45f7-9b37-9407d3f84e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2d1a38f0-45ba-49cc-b74a-f353b933f5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6fe9e96b-8b88-45f7-9b37-9407d3f84e4a" xlink:to="loc_us-gaap_NetIncomeLoss_2d1a38f0-45ba-49cc-b74a-f353b933f5d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a4f95d8c-0f38-4aef-bd3c-4a123b247b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6fe9e96b-8b88-45f7-9b37-9407d3f84e4a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_a4f95d8c-0f38-4aef-bd3c-4a123b247b4e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f50e46b-2097-4b18-afc0-d873271a0c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b191b2ca-19c3-4f6d-830f-655b144a4989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f50e46b-2097-4b18-afc0-d873271a0c8b" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b191b2ca-19c3-4f6d-830f-655b144a4989" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_3b208955-a67e-47ef-8ebe-717349b5943c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f50e46b-2097-4b18-afc0-d873271a0c8b" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_3b208955-a67e-47ef-8ebe-717349b5943c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b99a918d-82b9-4452-b9bb-e7e6d1148e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f50e46b-2097-4b18-afc0-d873271a0c8b" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_b99a918d-82b9-4452-b9bb-e7e6d1148e5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f38f73ca-0db7-4b1c-aca9-9b92d1cbffbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f50e46b-2097-4b18-afc0-d873271a0c8b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f38f73ca-0db7-4b1c-aca9-9b92d1cbffbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_dca247d0-cab2-4c12-b508-3f9a4eac5d81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f50e46b-2097-4b18-afc0-d873271a0c8b" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_dca247d0-cab2-4c12-b508-3f9a4eac5d81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_4fb64d9f-40fe-4b17-954b-c7a4edfdc28e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f50e46b-2097-4b18-afc0-d873271a0c8b" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_4fb64d9f-40fe-4b17-954b-c7a4edfdc28e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_cc8bb621-0095-43ba-8763-375d2a918b10" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToContingentValueRightHoldersInvestingActivity"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9f50e46b-2097-4b18-afc0-d873271a0c8b" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_cc8bb621-0095-43ba-8763-375d2a918b10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_860eda97-5832-4872-ae84-2d5abf3f36a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_56381e92-be33-4e24-837d-6d325c3d0174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_860eda97-5832-4872-ae84-2d5abf3f36a5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_56381e92-be33-4e24-837d-6d325c3d0174" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c89e1583-f2bb-47e4-a5e8-92f4ce136944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_860eda97-5832-4872-ae84-2d5abf3f36a5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c89e1583-f2bb-47e4-a5e8-92f4ce136944" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6e41a40-271f-49ae-a735-18fcc3554dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_860eda97-5832-4872-ae84-2d5abf3f36a5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6e41a40-271f-49ae-a735-18fcc3554dff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_905b7e78-e640-4f63-b710-0f9b3e15131a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_ProfitLoss_905b7e78-e640-4f63-b710-0f9b3e15131a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_687bda96-695d-4179-8e57-2eb9cdf3d23f" xlink:href="lgnd-20220930.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_687bda96-695d-4179-8e57-2eb9cdf3d23f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b30baf25-c8d9-43cf-9e33-93ec7cfbaff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b30baf25-c8d9-43cf-9e33-93ec7cfbaff3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_dc14e1d5-1d88-455a-8c0b-485f65e789e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_dc14e1d5-1d88-455a-8c0b-485f65e789e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_f7f87f9f-bf47-40f8-89af-d070cc34631c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_f7f87f9f-bf47-40f8-89af-d070cc34631c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_f690560a-6b93-4cc9-84cc-59674f61d990" xlink:href="lgnd-20220930.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_f690560a-6b93-4cc9-84cc-59674f61d990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_75f72fef-fac5-46bf-b412-1272d26a36fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_75f72fef-fac5-46bf-b412-1272d26a36fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7063c85a-fe85-4d63-8ce0-338f1c264d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_ShareBasedCompensation_7063c85a-fe85-4d63-8ce0-338f1c264d28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_16c5dfda-319d-4cbc-bd4e-05539e4349ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_16c5dfda-319d-4cbc-bd4e-05539e4349ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_724efb21-bc9a-4c81-8266-f022339a5eb0" xlink:href="lgnd-20220930.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_724efb21-bc9a-4c81-8266-f022339a5eb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_401795ea-3e80-4b30-90ad-942f329d7c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_401795ea-3e80-4b30-90ad-942f329d7c6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f8ca783-69c6-4de4-b69b-d3c032027e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f8ca783-69c6-4de4-b69b-d3c032027e3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_178c989b-3d73-41fd-94eb-2b426b3adb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_178c989b-3d73-41fd-94eb-2b426b3adb1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b0ec3ff8-e4cd-4708-8289-b871181703b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b0ec3ff8-e4cd-4708-8289-b871181703b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_d14af856-52b6-44cc-be1e-f915868ff2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_d14af856-52b6-44cc-be1e-f915868ff2e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d25aee7a-aa9c-4dd9-af60-ec03305c261f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d25aee7a-aa9c-4dd9-af60-ec03305c261f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6788faf9-4de5-432c-9311-405dc3e01cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6788faf9-4de5-432c-9311-405dc3e01cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_4056970e-9f8e-48bd-bfc2-70520cf5e3e9" xlink:href="lgnd-20220930.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88a97a7a-beb8-4604-93d9-b4a74f50417e" xlink:to="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_4056970e-9f8e-48bd-bfc2-70520cf5e3e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_691df317-9133-4252-b8c5-0b70120cb5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_dec26472-efdf-4d76-93d2-8c6c9af1a5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_691df317-9133-4252-b8c5-0b70120cb5ff" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_dec26472-efdf-4d76-93d2-8c6c9af1a5e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_534ce514-cb40-4433-af1d-9fa9cb240b37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_691df317-9133-4252-b8c5-0b70120cb5ff" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_534ce514-cb40-4433-af1d-9fa9cb240b37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e9029df7-6aa9-468a-bd62-c926e1cfa31a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_691df317-9133-4252-b8c5-0b70120cb5ff" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e9029df7-6aa9-468a-bd62-c926e1cfa31a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_205844a3-7a2e-43b8-a602-93c6243226b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_691df317-9133-4252-b8c5-0b70120cb5ff" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_205844a3-7a2e-43b8-a602-93c6243226b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_245fedd4-1c66-47d1-8066-865492b5c4a6" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_691df317-9133-4252-b8c5-0b70120cb5ff" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_245fedd4-1c66-47d1-8066-865492b5c4a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_46527fcf-f5a3-44b3-81b1-daa5b32e2f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_691df317-9133-4252-b8c5-0b70120cb5ff" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_46527fcf-f5a3-44b3-81b1-daa5b32e2f60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_8e09e2d0-65c4-4f8b-90ce-8a9317cf544e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_691df317-9133-4252-b8c5-0b70120cb5ff" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_8e09e2d0-65c4-4f8b-90ce-8a9317cf544e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_94a85ea7-78a2-4cca-991d-71eb50d62c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_691df317-9133-4252-b8c5-0b70120cb5ff" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_94a85ea7-78a2-4cca-991d-71eb50d62c19" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e6d4fa81-f8cd-4d45-9fd8-506a07f92f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dee7fd06-0e3a-49eb-8364-52eed9aa6fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e6d4fa81-f8cd-4d45-9fd8-506a07f92f85" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dee7fd06-0e3a-49eb-8364-52eed9aa6fa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_30d9c620-f935-464e-8369-e02a15e5d54d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e6d4fa81-f8cd-4d45-9fd8-506a07f92f85" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_30d9c620-f935-464e-8369-e02a15e5d54d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ed24f464-33d2-4cb6-a5a8-8605d360fa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e6d4fa81-f8cd-4d45-9fd8-506a07f92f85" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ed24f464-33d2-4cb6-a5a8-8605d360fa4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_a2f5b7b2-4551-411a-a2fe-91cd937d4fe9" xlink:href="lgnd-20220930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fa3d5625-b090-4b93-93a7-f898e1a617fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_a2f5b7b2-4551-411a-a2fe-91cd937d4fe9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fa3d5625-b090-4b93-93a7-f898e1a617fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2bc0348b-3dad-4a97-9d25-cebd4a8341fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_a2f5b7b2-4551-411a-a2fe-91cd937d4fe9" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2bc0348b-3dad-4a97-9d25-cebd4a8341fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_54073ace-7c3b-43a6-b22c-70ad719a1a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_835cc21a-7429-482d-afc8-94ccaca12ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_54073ace-7c3b-43a6-b22c-70ad719a1a07" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_835cc21a-7429-482d-afc8-94ccaca12ae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_e1b8e240-b6b5-4e45-9e54-4932789db1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_54073ace-7c3b-43a6-b22c-70ad719a1a07" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_e1b8e240-b6b5-4e45-9e54-4932789db1cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_b44eb006-cc7a-471e-b974-5aea07ddeb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_f6d47b79-4569-4182-9f15-461e56a2411b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_b44eb006-cc7a-471e-b974-5aea07ddeb2a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_f6d47b79-4569-4182-9f15-461e56a2411b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_430266a4-27d6-4188-ab59-e1cc02ba6481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_b44eb006-cc7a-471e-b974-5aea07ddeb2a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_430266a4-27d6-4188-ab59-e1cc02ba6481" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_932a152a-83ca-4fdf-930a-acf1a588c171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7d630c9c-a679-4b5b-8fa8-d58705d3f8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_932a152a-83ca-4fdf-930a-acf1a588c171" xlink:to="loc_us-gaap_Goodwill_7d630c9c-a679-4b5b-8fa8-d58705d3f8fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7556c836-422c-4abd-840a-387c62e62e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_932a152a-83ca-4fdf-930a-acf1a588c171" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7556c836-422c-4abd-840a-387c62e62e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_25f2aa6b-5ae4-42b8-b787-5bfcec3e0a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_932a152a-83ca-4fdf-930a-acf1a588c171" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_25f2aa6b-5ae4-42b8-b787-5bfcec3e0a0c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8b758407-89b4-4bfb-a00c-c5c81a234109" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_8fb3b955-f75d-4e55-87ed-8bc069dad80d" xlink:href="lgnd-20220930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8b758407-89b4-4bfb-a00c-c5c81a234109" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_8fb3b955-f75d-4e55-87ed-8bc069dad80d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_352a0cd0-1415-4304-a7ab-982f265568cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8b758407-89b4-4bfb-a00c-c5c81a234109" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_352a0cd0-1415-4304-a7ab-982f265568cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0dd057d0-4ca0-43aa-ab49-35f10613b19d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4b2d5b14-0f74-4ba7-93d2-048bb3b9acbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0dd057d0-4ca0-43aa-ab49-35f10613b19d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4b2d5b14-0f74-4ba7-93d2-048bb3b9acbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_18db4a63-4e83-4d4f-805a-3eb71504e5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0dd057d0-4ca0-43aa-ab49-35f10613b19d" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_18db4a63-4e83-4d4f-805a-3eb71504e5ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_6cfd86d0-eb15-4026-9766-14d57e67f365" xlink:href="lgnd-20220930.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0dd057d0-4ca0-43aa-ab49-35f10613b19d" xlink:to="loc_lgnd_LicenseeAccrualCurrent_6cfd86d0-eb15-4026-9766-14d57e67f365" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_1846b86e-3b5f-4795-b540-a9a3385b6d17" xlink:href="lgnd-20220930.xsd#lgnd_ReturnsAccrual"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0dd057d0-4ca0-43aa-ab49-35f10613b19d" xlink:to="loc_lgnd_ReturnsAccrual_1846b86e-3b5f-4795-b540-a9a3385b6d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_bff4a746-e6f4-4983-b844-1891bd39b2c6" xlink:href="lgnd-20220930.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0dd057d0-4ca0-43aa-ab49-35f10613b19d" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_bff4a746-e6f4-4983-b844-1891bd39b2c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_49d19d0b-a319-4722-8a1c-37dbb3766a80" xlink:href="lgnd-20220930.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0dd057d0-4ca0-43aa-ab49-35f10613b19d" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_49d19d0b-a319-4722-8a1c-37dbb3766a80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4530a686-5301-4a54-a3ec-585fa357b551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0dd057d0-4ca0-43aa-ab49-35f10613b19d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4530a686-5301-4a54-a3ec-585fa357b551" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44838789-b87d-4276-b060-0b1f0791f0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_731f733f-e1c2-476f-b56a-d690a76a79eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44838789-b87d-4276-b060-0b1f0791f0f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_731f733f-e1c2-476f-b56a-d690a76a79eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_955da879-3cad-40d0-ad03-a6680e2927f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44838789-b87d-4276-b060-0b1f0791f0f8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_955da879-3cad-40d0-ad03-a6680e2927f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#SegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_575997ae-00f3-452d-8999-faecf99d7703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2e59b299-be66-416b-99ad-0ff07d0a8fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_575997ae-00f3-452d-8999-faecf99d7703" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2e59b299-be66-416b-99ad-0ff07d0a8fcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_1fb9d616-4bb2-49e2-937f-0978bced0183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_575997ae-00f3-452d-8999-faecf99d7703" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_1fb9d616-4bb2-49e2-937f-0978bced0183" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_178db7b0-e8f2-44f0-ad4d-ed962957098d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_5e48cc73-3dd7-490e-9e3c-860798b18af4" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_178db7b0-e8f2-44f0-ad4d-ed962957098d" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_5e48cc73-3dd7-490e-9e3c-860798b18af4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_e1073c08-e310-496c-9170-179308b1c4b4" xlink:href="lgnd-20220930.xsd#lgnd_AmountsOwedToFormerLicensorFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_178db7b0-e8f2-44f0-ad4d-ed962957098d" xlink:to="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_e1073c08-e310-496c-9170-179308b1c4b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c61762dc-ccb2-42b5-8f65-1978f96c3ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_a49e8977-b214-4e95-a7d8-9b9ab382f5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_c61762dc-ccb2-42b5-8f65-1978f96c3ffd" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_a49e8977-b214-4e95-a7d8-9b9ab382f5f8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_1660e74c-0e94-4248-b9b6-0e08991064f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_022680c4-2a01-4b3a-8139-9d944834f475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_1660e74c-0e94-4248-b9b6-0e08991064f3" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_022680c4-2a01-4b3a-8139-9d944834f475" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9bacded0-202f-46e6-af83-7b061e383b33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_1660e74c-0e94-4248-b9b6-0e08991064f3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9bacded0-202f-46e6-af83-7b061e383b33" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_7e039f86-04b8-4336-bec0-daebf0a40652" xlink:href="lgnd-20220930.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_3b9aa0ce-7269-464f-8132-3ee05fa6bbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiabilityCurrent_7e039f86-04b8-4336-bec0-daebf0a40652" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_3b9aa0ce-7269-464f-8132-3ee05fa6bbfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bd936f33-2e38-404b-86cf-3ea9635259fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiabilityCurrent_7e039f86-04b8-4336-bec0-daebf0a40652" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bd936f33-2e38-404b-86cf-3ea9635259fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset_d4877733-c0db-4819-ba29-2b1aac208a2d" xlink:href="lgnd-20220930.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1ac788d6-97be-4a5c-8913-0682f5f9f601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseRightOfUseAsset_d4877733-c0db-4819-ba29-2b1aac208a2d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1ac788d6-97be-4a5c-8913-0682f5f9f601" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_6c6203d0-db02-4f32-adb8-b1a225850357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseRightOfUseAsset_d4877733-c0db-4819-ba29-2b1aac208a2d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_6c6203d0-db02-4f32-adb8-b1a225850357" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability_647671f1-b6d3-4a16-8873-4f6a92febbc2" xlink:href="lgnd-20220930.xsd#lgnd_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7f1bbd43-deec-4e5e-90ff-03981faf8c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_647671f1-b6d3-4a16-8873-4f6a92febbc2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7f1bbd43-deec-4e5e-90ff-03981faf8c68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_dd4bec6a-52ee-4275-9fcb-4e4a31cfbac7" xlink:href="lgnd-20220930.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_647671f1-b6d3-4a16-8873-4f6a92febbc2" xlink:to="loc_lgnd_LeaseLiabilityCurrent_dd4bec6a-52ee-4275-9fcb-4e4a31cfbac7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f40f7bac-3e9e-47ba-b28a-45a53e38efee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_647671f1-b6d3-4a16-8873-4f6a92febbc2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f40f7bac-3e9e-47ba-b28a-45a53e38efee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6de22133-2ded-4d77-ae95-0003a838b323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_07a400c0-615d-40b6-a7e7-aa9d58445a23" xlink:href="lgnd-20220930.xsd#lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6de22133-2ded-4d77-ae95-0003a838b323" xlink:to="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_07a400c0-615d-40b6-a7e7-aa9d58445a23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_12b74050-9fc3-487b-9038-9c00e2443f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6de22133-2ded-4d77-ae95-0003a838b323" xlink:to="loc_us-gaap_OperatingLeaseLiability_12b74050-9fc3-487b-9038-9c00e2443f81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7116e99a-7062-4e5a-a072-778e74239d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6de22133-2ded-4d77-ae95-0003a838b323" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7116e99a-7062-4e5a-a072-778e74239d53" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lgnd-20220930.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4fdf1b89-56d5-404a-b429-be07172fd26c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_76c09eb3-5cc7-4f7a-868e-3a219651241f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4fdf1b89-56d5-404a-b429-be07172fd26c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_76c09eb3-5cc7-4f7a-868e-3a219651241f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e51eaf3a-9619-4e6f-bf48-e515c9c79a17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4fdf1b89-56d5-404a-b429-be07172fd26c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e51eaf3a-9619-4e6f-bf48-e515c9c79a17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_aa6af8f3-a456-4e55-bbd4-4592e4d4d61a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4fdf1b89-56d5-404a-b429-be07172fd26c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_aa6af8f3-a456-4e55-bbd4-4592e4d4d61a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8e983487-3fe1-4700-b937-e33a7b3d9ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4fdf1b89-56d5-404a-b429-be07172fd26c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8e983487-3fe1-4700-b937-e33a7b3d9ad9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0580d18d-1c2a-4e47-be88-c89584548739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4fdf1b89-56d5-404a-b429-be07172fd26c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0580d18d-1c2a-4e47-be88-c89584548739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2d08c64d-fa27-4bd6-b1bf-461bfa7a1d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4fdf1b89-56d5-404a-b429-be07172fd26c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2d08c64d-fa27-4bd6-b1bf-461bfa7a1d61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5130a2f8-a105-43eb-b7b8-432f3153d33c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4fdf1b89-56d5-404a-b429-be07172fd26c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5130a2f8-a105-43eb-b7b8-432f3153d33c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>lgnd-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7b2ea99b-5e75-4f19-8ddb-22eedf3c9f68,g:96c50209-ed52-4eb8-96bc-4f2a516dad9f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="idf20b085dd744a83b9093426787658a2_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_6c89d6cb-07e2-44c0-aa9a-3c41e429cfea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_RevenuesAbstract_6c89d6cb-07e2-44c0-aa9a-3c41e429cfea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_947c5b0f-912f-4d8d-8954-0b1d99419ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_6c89d6cb-07e2-44c0-aa9a-3c41e429cfea" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_947c5b0f-912f-4d8d-8954-0b1d99419ee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_6ce82bf0-bb3f-449f-83b3-396fb48d1f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_CostDirectMaterial_6ce82bf0-bb3f-449f-83b3-396fb48d1f9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_23d32056-c2ca-493c-a5ee-c9aa6c31a0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_23d32056-c2ca-493c-a5ee-c9aa6c31a0c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6b232633-af65-4de6-859f-955fb841164d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6b232633-af65-4de6-859f-955fb841164d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c318e892-b68e-4ca4-a49f-8d7efbd97825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c318e892-b68e-4ca4-a49f-8d7efbd97825" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_66e3506c-4f49-4589-a82a-43b88b881b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_66e3506c-4f49-4589-a82a-43b88b881b34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_88d456a6-9302-408b-a7e9-b9e55f44d778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_88d456a6-9302-408b-a7e9-b9e55f44d778" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_75a07e94-9b81-4ed1-8798-cd93e5d20743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_OperatingIncomeLoss_75a07e94-9b81-4ed1-8798-cd93e5d20743" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_32ce4adf-9150-49a1-a43b-ca6f161d4eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:to="loc_us-gaap_GainLossOnInvestments_32ce4adf-9150-49a1-a43b-ca6f161d4eac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8ae2ec07-5314-4a1d-a15d-f65a33af9262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8ae2ec07-5314-4a1d-a15d-f65a33af9262" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2de18d97-842a-451d-af0e-dd824110da3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:to="loc_us-gaap_InterestExpense_2de18d97-842a-451d-af0e-dd824110da3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e03705fd-3b61-4976-b5ed-4f04888406cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e03705fd-3b61-4976-b5ed-4f04888406cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cc49805d-7d72-46a5-a3e5-5383eb1b8f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cc49805d-7d72-46a5-a3e5-5383eb1b8f1b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b09c0952-2621-4233-96be-91d42149dbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b09c0952-2621-4233-96be-91d42149dbd0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2c7bbc53-b376-4b0e-acf6-a1efc42ecfce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2c7bbc53-b376-4b0e-acf6-a1efc42ecfce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_34b63a41-97e0-495e-b084-566fcfea262a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_NetIncomeLoss_34b63a41-97e0-495e-b084-566fcfea262a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_aa15d590-fe46-4493-9546-436bda999e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:to="loc_us-gaap_EarningsPerShareBasic_aa15d590-fe46-4493-9546-436bda999e17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a84a07ad-c069-4bd3-998c-18a750f52754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a84a07ad-c069-4bd3-998c-18a750f52754" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5e473d14-4861-43a4-b888-6d70f018b565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5e473d14-4861-43a4-b888-6d70f018b565" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80cdc0c5-d776-4332-8846-107a227cdc59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80cdc0c5-d776-4332-8846-107a227cdc59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_53d5b716-d8a2-4992-9ae4-13247890b6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_StatementTable_53d5b716-d8a2-4992-9ae4-13247890b6ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d5cce2fe-acac-493e-a5ec-6ba22ce304d9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_53d5b716-d8a2-4992-9ae4-13247890b6ab" xlink:to="loc_srt_ProductOrServiceAxis_d5cce2fe-acac-493e-a5ec-6ba22ce304d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d5cce2fe-acac-493e-a5ec-6ba22ce304d9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d5cce2fe-acac-493e-a5ec-6ba22ce304d9" xlink:to="loc_srt_ProductsAndServicesDomain_d5cce2fe-acac-493e-a5ec-6ba22ce304d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a751208e-0af1-4e3f-8528-45bd6ff39b7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d5cce2fe-acac-493e-a5ec-6ba22ce304d9" xlink:to="loc_srt_ProductsAndServicesDomain_a751208e-0af1-4e3f-8528-45bd6ff39b7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_571064e4-d9d6-424b-a171-84e7c14cbe4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a751208e-0af1-4e3f-8528-45bd6ff39b7e" xlink:to="loc_us-gaap_RoyaltyMember_571064e4-d9d6-424b-a171-84e7c14cbe4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_630b5785-3422-41a2-b02a-aa87768d2128" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a751208e-0af1-4e3f-8528-45bd6ff39b7e" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_630b5785-3422-41a2-b02a-aa87768d2128" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_af90dc5f-a3d2-457e-ae6b-54e265371ba7" xlink:href="lgnd-20220930.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a751208e-0af1-4e3f-8528-45bd6ff39b7e" xlink:to="loc_lgnd_ContractRevenueMember_af90dc5f-a3d2-457e-ae6b-54e265371ba7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i00b881ad13fd4ed59a9abc15ca8ad0be_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6662dd3c-2e69-4bd9-be1f-be2836ea6bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6662dd3c-2e69-4bd9-be1f-be2836ea6bce" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dd361bbf-86ba-40e8-8ea0-64cb1901c272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dd361bbf-86ba-40e8-8ea0-64cb1901c272" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_dfb21cc7-3b36-43a6-9d17-971cb10b3901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_StockholdersEquity_dfb21cc7-3b36-43a6-9d17-971cb10b3901" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_6500d81d-dafe-424e-b0a3-c2004c225e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_6500d81d-dafe-424e-b0a3-c2004c225e50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a11c32df-8203-44bb-b049-76b7bff2a93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a11c32df-8203-44bb-b049-76b7bff2a93e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6e8fa4f1-4b4a-4bda-b969-617c938f8054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6e8fa4f1-4b4a-4bda-b969-617c938f8054" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_10144c75-f318-4d2f-9e98-25a530cafc66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_10144c75-f318-4d2f-9e98-25a530cafc66" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_67099ca9-6a4d-46df-b057-22c9bfbafb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_67099ca9-6a4d-46df-b057-22c9bfbafb29" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax_e35a8014-397a-4763-a2a8-2c0ea8ec50a0" xlink:href="lgnd-20220930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax_e35a8014-397a-4763-a2a8-2c0ea8ec50a0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_47819b3c-2b68-4e6d-9ada-b077a3a76717" xlink:href="lgnd-20220930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_47819b3c-2b68-4e6d-9ada-b077a3a76717" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_20ceeacc-765f-4c4b-9ea7-7d52a98782ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_NetIncomeLoss_20ceeacc-765f-4c4b-9ea7-7d52a98782ec" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_06093b66-5649-453b-bfc0-37bca5f251f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c06d366e-462e-4da0-978e-1c7e1dd9ab41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_17e3359c-72f5-4d87-8286-b849fb27e929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6662dd3c-2e69-4bd9-be1f-be2836ea6bce" xlink:to="loc_us-gaap_StatementTable_17e3359c-72f5-4d87-8286-b849fb27e929" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0104a6bc-70b1-44ca-b8e7-8290e43966ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_17e3359c-72f5-4d87-8286-b849fb27e929" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0104a6bc-70b1-44ca-b8e7-8290e43966ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0104a6bc-70b1-44ca-b8e7-8290e43966ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0104a6bc-70b1-44ca-b8e7-8290e43966ce" xlink:to="loc_us-gaap_EquityComponentDomain_0104a6bc-70b1-44ca-b8e7-8290e43966ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0104a6bc-70b1-44ca-b8e7-8290e43966ce" xlink:to="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7324b903-e467-46a4-9d03-abbec4418ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:to="loc_us-gaap_CommonStockMember_7324b903-e467-46a4-9d03-abbec4418ddb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_66d172e0-621b-4e0c-a134-3c8065e13118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_66d172e0-621b-4e0c-a134-3c8065e13118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fb2a2b68-f754-462b-aa4a-b46db4e582d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fb2a2b68-f754-462b-aa4a-b46db4e582d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d2e45ce6-68a3-47a1-bebe-ac7c8aa7cb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:to="loc_us-gaap_RetainedEarningsMember_d2e45ce6-68a3-47a1-bebe-ac7c8aa7cb8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f3bad984-b80a-4ac3-b07b-02259d2d9404" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_17e3359c-72f5-4d87-8286-b849fb27e929" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f3bad984-b80a-4ac3-b07b-02259d2d9404" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f3bad984-b80a-4ac3-b07b-02259d2d9404_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f3bad984-b80a-4ac3-b07b-02259d2d9404" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f3bad984-b80a-4ac3-b07b-02259d2d9404_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea78faf2-be3c-4b45-9c38-b0b80cc1b6cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f3bad984-b80a-4ac3-b07b-02259d2d9404" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea78faf2-be3c-4b45-9c38-b0b80cc1b6cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4df2f6b4-bb13-4431-9ed3-f561bf9effe3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea78faf2-be3c-4b45-9c38-b0b80cc1b6cd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4df2f6b4-bb13-4431-9ed3-f561bf9effe3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i04a64dad6b9f46a89c5c33f921f20f46_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_c73f1749-0de2-4a2d-8896-e2f439606c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_ConvertibleNotesPayable_c73f1749-0de2-4a2d-8896-e2f439606c70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bf1ea654-bf4e-4abd-ab8d-466888801d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bf1ea654-bf4e-4abd-ab8d-466888801d4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_895e4b8c-a336-45a7-8172-92b0dbff258e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_StockholdersEquity_895e4b8c-a336-45a7-8172-92b0dbff258e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_7cd897b2-1bf2-458c-8048-57162197f393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_7cd897b2-1bf2-458c-8048-57162197f393" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d2f461d9-7f2f-4f23-988f-4bee8ee912eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d2f461d9-7f2f-4f23-988f-4bee8ee912eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_46182079-93d1-45d7-88c0-c467a9fb5867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_46182079-93d1-45d7-88c0-c467a9fb5867" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_390e7469-4efe-4011-8718-39a45aee87c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_390e7469-4efe-4011-8718-39a45aee87c5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_efc6b7aa-2a1d-4208-87cf-79391df44948" xlink:href="lgnd-20220930.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_efc6b7aa-2a1d-4208-87cf-79391df44948" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ba65b9be-e664-496b-ad10-f7975e45e776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_InventoryNet_ba65b9be-e664-496b-ad10-f7975e45e776" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_cabca75c-a432-4aaa-b1c7-4776ff56bafb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_NumberOfReportingUnits_cabca75c-a432-4aaa-b1c7-4776ff56bafb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_ad45f4b5-73db-47a4-8734-7083a6535d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_ad45f4b5-73db-47a4-8734-7083a6535d9e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_70a97555-d568-49bd-bce0-192f1276e27e" xlink:href="lgnd-20220930.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_70a97555-d568-49bd-bce0-192f1276e27e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_25e6f4a8-427a-4dee-988e-3b71a97c397d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_25e6f4a8-427a-4dee-988e-3b71a97c397d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_03939e20-6dae-4de6-87ab-08009b7d3eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_03939e20-6dae-4de6-87ab-08009b7d3eac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_03939e20-6dae-4de6-87ab-08009b7d3eac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_03939e20-6dae-4de6-87ab-08009b7d3eac" xlink:to="loc_us-gaap_EquityComponentDomain_03939e20-6dae-4de6-87ab-08009b7d3eac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6de14217-a2db-4433-b9fd-27854872dbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_03939e20-6dae-4de6-87ab-08009b7d3eac" xlink:to="loc_us-gaap_EquityComponentDomain_6de14217-a2db-4433-b9fd-27854872dbd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_642431b8-9f51-499f-b849-89ed92bccd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6de14217-a2db-4433-b9fd-27854872dbd4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_642431b8-9f51-499f-b849-89ed92bccd97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a39e7fbe-39bb-4d58-97e6-d5cf18932e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6de14217-a2db-4433-b9fd-27854872dbd4" xlink:to="loc_us-gaap_RetainedEarningsMember_a39e7fbe-39bb-4d58-97e6-d5cf18932e36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7ff55936-934a-4475-b1ec-92b1ba74c36a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7ff55936-934a-4475-b1ec-92b1ba74c36a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_7ff55936-934a-4475-b1ec-92b1ba74c36a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7ff55936-934a-4475-b1ec-92b1ba74c36a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_7ff55936-934a-4475-b1ec-92b1ba74c36a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8a857b9b-1106-4ace-a248-6333cf92685b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7ff55936-934a-4475-b1ec-92b1ba74c36a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8a857b9b-1106-4ace-a248-6333cf92685b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_ccc8f638-17c9-4ec4-a74a-f88bbc119b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8a857b9b-1106-4ace-a248-6333cf92685b" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_ccc8f638-17c9-4ec4-a74a-f88bbc119b38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1edf4ffe-945f-48cc-9c2e-30d92953e611" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1edf4ffe-945f-48cc-9c2e-30d92953e611" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1edf4ffe-945f-48cc-9c2e-30d92953e611_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1edf4ffe-945f-48cc-9c2e-30d92953e611" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1edf4ffe-945f-48cc-9c2e-30d92953e611_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a8a7fd8-2968-41e3-85d5-e0ebe693d162" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1edf4ffe-945f-48cc-9c2e-30d92953e611" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a8a7fd8-2968-41e3-85d5-e0ebe693d162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bbee24b9-f74e-473d-aecb-61dcca971613" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a8a7fd8-2968-41e3-85d5-e0ebe693d162" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bbee24b9-f74e-473d-aecb-61dcca971613" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_fda85eaf-725f-4e62-b5c5-a8eaaa16daac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a8a7fd8-2968-41e3-85d5-e0ebe693d162" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_fda85eaf-725f-4e62-b5c5-a8eaaa16daac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_907a2494-599b-4258-b21d-3e6599ac8bba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_srt_ProductOrServiceAxis_907a2494-599b-4258-b21d-3e6599ac8bba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_907a2494-599b-4258-b21d-3e6599ac8bba_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_907a2494-599b-4258-b21d-3e6599ac8bba" xlink:to="loc_srt_ProductsAndServicesDomain_907a2494-599b-4258-b21d-3e6599ac8bba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7c8b4c6e-e86d-453e-be4d-d48f0a584d64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_907a2494-599b-4258-b21d-3e6599ac8bba" xlink:to="loc_srt_ProductsAndServicesDomain_7c8b4c6e-e86d-453e-be4d-d48f0a584d64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_24c9a2e3-5239-4d41-96a8-292b4d9e16df" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7c8b4c6e-e86d-453e-be4d-d48f0a584d64" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_24c9a2e3-5239-4d41-96a8-292b4d9e16df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f0186b66-d088-4ea6-ac68-0b13b3f4e251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_us-gaap_AwardTypeAxis_f0186b66-d088-4ea6-ac68-0b13b3f4e251" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0186b66-d088-4ea6-ac68-0b13b3f4e251_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f0186b66-d088-4ea6-ac68-0b13b3f4e251" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0186b66-d088-4ea6-ac68-0b13b3f4e251_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cc44f96-41be-484e-a6f0-c2aeebf386c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f0186b66-d088-4ea6-ac68-0b13b3f4e251" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cc44f96-41be-484e-a6f0-c2aeebf386c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_2463851b-a987-4141-8eec-cf77186655e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cc44f96-41be-484e-a6f0-c2aeebf386c5" xlink:to="loc_us-gaap_RestrictedStockMember_2463851b-a987-4141-8eec-cf77186655e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_880d2898-15ef-437b-bb9c-441fd18301a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_srt_RangeAxis_880d2898-15ef-437b-bb9c-441fd18301a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_880d2898-15ef-437b-bb9c-441fd18301a9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_880d2898-15ef-437b-bb9c-441fd18301a9" xlink:to="loc_srt_RangeMember_880d2898-15ef-437b-bb9c-441fd18301a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bc2366fa-ea81-4179-8f1b-6727ac24d5c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_880d2898-15ef-437b-bb9c-441fd18301a9" xlink:to="loc_srt_RangeMember_bc2366fa-ea81-4179-8f1b-6727ac24d5c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ab9e6691-c93f-443f-968a-79c28de66c05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bc2366fa-ea81-4179-8f1b-6727ac24d5c4" xlink:to="loc_srt_MinimumMember_ab9e6691-c93f-443f-968a-79c28de66c05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4dff8300-6d41-4251-88f4-b0b3fbffcb52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bc2366fa-ea81-4179-8f1b-6727ac24d5c4" xlink:to="loc_srt_MaximumMember_4dff8300-6d41-4251-88f4-b0b3fbffcb52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a03f55cc-d92a-4b26-a485-ed2e84f94039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a03f55cc-d92a-4b26-a485-ed2e84f94039" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a03f55cc-d92a-4b26-a485-ed2e84f94039_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a03f55cc-d92a-4b26-a485-ed2e84f94039" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a03f55cc-d92a-4b26-a485-ed2e84f94039_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3b3902df-d1bf-4657-8223-4d705c4f4102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a03f55cc-d92a-4b26-a485-ed2e84f94039" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3b3902df-d1bf-4657-8223-4d705c4f4102" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_bc0f5f8d-9ee7-4775-af05-17422e4e7b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3b3902df-d1bf-4657-8223-4d705c4f4102" xlink:to="loc_us-gaap_StockCompensationPlanMember_bc0f5f8d-9ee7-4775-af05-17422e4e7b19" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended" id="i236674e633f24edba5d682f10e1e5fbf_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_500c46e6-8795-4128-9b0d-df3b7dfabb32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b1db25d-f610-4239-82c9-4319e5ff282d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_500c46e6-8795-4128-9b0d-df3b7dfabb32" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b1db25d-f610-4239-82c9-4319e5ff282d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fe15b4be-f241-493f-9bd0-f3e9681c3abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_500c46e6-8795-4128-9b0d-df3b7dfabb32" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fe15b4be-f241-493f-9bd0-f3e9681c3abb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bba029b4-c12e-480b-8375-4b1a0ab6c6e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fe15b4be-f241-493f-9bd0-f3e9681c3abb" xlink:to="loc_srt_ProductOrServiceAxis_bba029b4-c12e-480b-8375-4b1a0ab6c6e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bba029b4-c12e-480b-8375-4b1a0ab6c6e9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_bba029b4-c12e-480b-8375-4b1a0ab6c6e9" xlink:to="loc_srt_ProductsAndServicesDomain_bba029b4-c12e-480b-8375-4b1a0ab6c6e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5e18d08a-10a4-44d9-b3be-6b37e3b38ef4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_bba029b4-c12e-480b-8375-4b1a0ab6c6e9" xlink:to="loc_srt_ProductsAndServicesDomain_5e18d08a-10a4-44d9-b3be-6b37e3b38ef4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5e18d08a-10a4-44d9-b3be-6b37e3b38ef4" xlink:to="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_cb39a12e-0890-4383-9d82-28c1e05e4c85" xlink:href="lgnd-20220930.xsd#lgnd_KyprolisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:to="loc_lgnd_KyprolisMember_cb39a12e-0890-4383-9d82-28c1e05e4c85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_148811ea-c3b3-4c5f-8a47-384a25a34d3f" xlink:href="lgnd-20220930.xsd#lgnd_EvomelaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:to="loc_lgnd_EvomelaMember_148811ea-c3b3-4c5f-8a47-384a25a34d3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember_a0b35bb0-bb22-4a4b-9fd1-12e62ce7f827" xlink:href="lgnd-20220930.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:to="loc_lgnd_TeriparatideInjectionMember_a0b35bb0-bb22-4a4b-9fd1-12e62ce7f827" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember_ab93a42e-8aff-4773-b36b-92b130973cf4" xlink:href="lgnd-20220930.xsd#lgnd_RylazeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:to="loc_lgnd_RylazeMember_ab93a42e-8aff-4773-b36b-92b130973cf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_4514cbeb-7ced-40ce-af9b-fd3f88c299f2" xlink:href="lgnd-20220930.xsd#lgnd_RoyaltyOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:to="loc_lgnd_RoyaltyOtherMember_4514cbeb-7ced-40ce-af9b-fd3f88c299f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_a9828705-7127-47d2-94fe-ce94630b44a8" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5e18d08a-10a4-44d9-b3be-6b37e3b38ef4" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_a9828705-7127-47d2-94fe-ce94630b44a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_1c5ac65a-ea75-46f6-b66f-aa7fa1712924" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_a9828705-7127-47d2-94fe-ce94630b44a8" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_1c5ac65a-ea75-46f6-b66f-aa7fa1712924" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_15496a3e-6696-4b72-ba31-6bb9549bc5ab" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_a9828705-7127-47d2-94fe-ce94630b44a8" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_15496a3e-6696-4b72-ba31-6bb9549bc5ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:href="lgnd-20220930.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5e18d08a-10a4-44d9-b3be-6b37e3b38ef4" xlink:to="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_d0d7adfd-cc99-438d-b8fd-172e47c59963" xlink:href="lgnd-20220930.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:to="loc_lgnd_ContractRevenueServiceMember_d0d7adfd-cc99-438d-b8fd-172e47c59963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_572d1423-8f29-4a9b-ba3a-8a3423b9dacf" xlink:href="lgnd-20220930.xsd#lgnd_LicenseFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:to="loc_lgnd_LicenseFeesMember_572d1423-8f29-4a9b-ba3a-8a3423b9dacf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_bdd5c941-1ed3-41a6-9b42-b997feb2e44f" xlink:href="lgnd-20220930.xsd#lgnd_MilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:to="loc_lgnd_MilestoneMember_bdd5c941-1ed3-41a6-9b42-b997feb2e44f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_dbdbe702-cc6e-4648-98ee-ffdbdd2c1759" xlink:href="lgnd-20220930.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_dbdbe702-cc6e-4648-98ee-ffdbdd2c1759" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended" id="i71140133dff94015be09a2f0744b3264_BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f7c7a26-0cd9-457a-870e-1805190b7964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f7c7a26-0cd9-457a-870e-1805190b7964" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d55705a6-6e50-4805-9225-189a36c38e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d55705a6-6e50-4805-9225-189a36c38e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_46873469-fb13-4353-a217-cb16b281568c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_46873469-fb13-4353-a217-cb16b281568c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9c44fe28-76ba-4993-8d85-be9e7cff343b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9c44fe28-76ba-4993-8d85-be9e7cff343b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3efc9903-9799-4c7e-9f7b-f0de3da07062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3efc9903-9799-4c7e-9f7b-f0de3da07062" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_dee70124-17df-4a74-98f5-4b2f3d6d5fc8" xlink:href="lgnd-20220930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_dee70124-17df-4a74-98f5-4b2f3d6d5fc8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf5e7874-b969-4b18-b443-68c9c9ac2b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf5e7874-b969-4b18-b443-68c9c9ac2b82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a7f4b4da-772a-480a-bb79-9546fac6fa8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf5e7874-b969-4b18-b443-68c9c9ac2b82" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a7f4b4da-772a-480a-bb79-9546fac6fa8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a7f4b4da-772a-480a-bb79-9546fac6fa8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a7f4b4da-772a-480a-bb79-9546fac6fa8e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a7f4b4da-772a-480a-bb79-9546fac6fa8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a7f4b4da-772a-480a-bb79-9546fac6fa8e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_2805c7ea-c04c-459d-9e87-46141ae63d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_DemandDepositsMember_2805c7ea-c04c-459d-9e87-46141ae63d6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_1957f210-d585-491e-9894-9b5c8b8aaf18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_1957f210-d585-491e-9894-9b5c8b8aaf18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_17143193-ee26-4787-83fa-27814d649425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_CommercialPaperMember_17143193-ee26-4787-83fa-27814d649425" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_4741e8c2-400f-4cd8-8f09-f2e5aecca832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_EquitySecuritiesMember_4741e8c2-400f-4cd8-8f09-f2e5aecca832" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_2218159d-22a8-4e01-b83a-b937d31d4f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_MutualFundMember_2218159d-22a8-4e01-b83a-b937d31d4f14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_e7b43f53-6073-4f24-b193-f9b9b438dfd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_e7b43f53-6073-4f24-b193-f9b9b438dfd3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_74ccfe10-9ac3-4cef-b864-3660bdfd7f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_WarrantMember_74ccfe10-9ac3-4cef-b864-3660bdfd7f86" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_52e8f9a2-f686-4f0d-ad70-7a39fd689c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_CommonStockMember_52e8f9a2-f686-4f0d-ad70-7a39fd689c6e" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="i4215d5fa93264dbaadaae9c8b8fde349_BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_2dfbc107-cf4d-4619-9b57-30b8cd6cdaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_2dfbc107-cf4d-4619-9b57-30b8cd6cdaf2" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8021d310-ec71-4bbb-8fe4-1a7c40d72ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:to="loc_us-gaap_Goodwill_8021d310-ec71-4bbb-8fe4-1a7c40d72ed9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_02ad40f1-bc6c-4c4a-ad6f-f0793b04876f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_02ad40f1-bc6c-4c4a-ad6f-f0793b04876f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ca450d74-a674-47ec-a786-02cd77b54c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ca450d74-a674-47ec-a786-02cd77b54c5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_ea0b3398-3fc8-4a39-88a6-be989ec994dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_ea0b3398-3fc8-4a39-88a6-be989ec994dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7477a5de-6e37-405c-a144-060ec5307f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_2dfbc107-cf4d-4619-9b57-30b8cd6cdaf2" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7477a5de-6e37-405c-a144-060ec5307f32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a7998d21-44c9-4800-ac36-3c485c06055f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7477a5de-6e37-405c-a144-060ec5307f32" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a7998d21-44c9-4800-ac36-3c485c06055f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7998d21-44c9-4800-ac36-3c485c06055f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a7998d21-44c9-4800-ac36-3c485c06055f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a7998d21-44c9-4800-ac36-3c485c06055f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a7998d21-44c9-4800-ac36-3c485c06055f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_192b9e42-f85d-435a-8c36-2881feb255a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:to="loc_us-gaap_PatentedTechnologyMember_192b9e42-f85d-435a-8c36-2881feb255a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1a20fba1-eef6-43ee-a13b-28a5e91032d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:to="loc_us-gaap_TradeNamesMember_1a20fba1-eef6-43ee-a13b-28a5e91032d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a4ac5af8-3b98-4d16-90fe-59e260ab8384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a4ac5af8-3b98-4d16-90fe-59e260ab8384" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_328bc31d-b9bd-4ee1-866d-edb83071ef9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:to="loc_us-gaap_ContractualRightsMember_328bc31d-b9bd-4ee1-866d-edb83071ef9c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails" xlink:type="extended" id="ib78a373ae18a4638b53b21fb444ef870_BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_2800e972-801f-402d-8c1a-1e7bb27dbc3b" xlink:href="lgnd-20220930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ee0ccf6d-960f-4ee7-8b6b-94680f4744ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_2800e972-801f-402d-8c1a-1e7bb27dbc3b" xlink:to="loc_us-gaap_Goodwill_ee0ccf6d-960f-4ee7-8b6b-94680f4744ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_cdcb4569-c215-4cae-802a-13f86dd7e6d8" xlink:href="lgnd-20220930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_2800e972-801f-402d-8c1a-1e7bb27dbc3b" xlink:to="loc_lgnd_BasisOfPresentationTable_cdcb4569-c215-4cae-802a-13f86dd7e6d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_43187b73-fa39-444b-9e61-cebdf39579d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_cdcb4569-c215-4cae-802a-13f86dd7e6d8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_43187b73-fa39-444b-9e61-cebdf39579d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_43187b73-fa39-444b-9e61-cebdf39579d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43187b73-fa39-444b-9e61-cebdf39579d0" xlink:to="loc_us-gaap_SegmentDomain_43187b73-fa39-444b-9e61-cebdf39579d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e6ca8b59-ee6d-4fda-9592-cf07deff129e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43187b73-fa39-444b-9e61-cebdf39579d0" xlink:to="loc_us-gaap_SegmentDomain_e6ca8b59-ee6d-4fda-9592-cf07deff129e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_c605f5bd-bc46-4975-9c30-bb1122e5da9a" xlink:href="lgnd-20220930.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e6ca8b59-ee6d-4fda-9592-cf07deff129e" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_c605f5bd-bc46-4975-9c30-bb1122e5da9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember_a581a38b-00bf-4a86-8a6a-8e75e1019325" xlink:href="lgnd-20220930.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e6ca8b59-ee6d-4fda-9592-cf07deff129e" xlink:to="loc_lgnd_OmniAbTechnologiesSegmentMember_a581a38b-00bf-4a86-8a6a-8e75e1019325" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended" id="i11333ae837c745b0bcc086b58662e745_BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5825f05-18d6-4941-876b-2fcea518feaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:href="lgnd-20220930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5825f05-18d6-4941-876b-2fcea518feaf" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0a7a6f6b-864f-4081-9b08-e2a702c5fd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0a7a6f6b-864f-4081-9b08-e2a702c5fd27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_4b4f2404-d6bf-4cc4-8a29-ab471c682f9f" xlink:href="lgnd-20220930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_4b4f2404-d6bf-4cc4-8a29-ab471c682f9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a29051de-301f-402d-9c76-840d93a93e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a29051de-301f-402d-9c76-840d93a93e25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_45a181c7-3a4b-402e-83dd-92df3a7eaf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_45a181c7-3a4b-402e-83dd-92df3a7eaf2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_2ab1c3b2-5f01-45ff-abb9-b93531825852" xlink:href="lgnd-20220930.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_2ab1c3b2-5f01-45ff-abb9-b93531825852" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cc8e85cf-ebbe-4704-adcb-9e7013e2d743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5825f05-18d6-4941-876b-2fcea518feaf" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cc8e85cf-ebbe-4704-adcb-9e7013e2d743" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59a4cf12-72c2-4e6a-9583-649a59190e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cc8e85cf-ebbe-4704-adcb-9e7013e2d743" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59a4cf12-72c2-4e6a-9583-649a59190e02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59a4cf12-72c2-4e6a-9583-649a59190e02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59a4cf12-72c2-4e6a-9583-649a59190e02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_59a4cf12-72c2-4e6a-9583-649a59190e02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82b57473-6ad6-485a-bbc9-cb4c11ca76f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59a4cf12-72c2-4e6a-9583-649a59190e02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82b57473-6ad6-485a-bbc9-cb4c11ca76f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_e1d14862-baed-4a82-9295-0d617e310c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82b57473-6ad6-485a-bbc9-cb4c11ca76f6" xlink:to="loc_us-gaap_LicensingAgreementsMember_e1d14862-baed-4a82-9295-0d617e310c09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f81c57d7-927f-4ba2-8b22-83eec20e361b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cc8e85cf-ebbe-4704-adcb-9e7013e2d743" xlink:to="loc_srt_CounterpartyNameAxis_f81c57d7-927f-4ba2-8b22-83eec20e361b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f81c57d7-927f-4ba2-8b22-83eec20e361b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_f81c57d7-927f-4ba2-8b22-83eec20e361b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f81c57d7-927f-4ba2-8b22-83eec20e361b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e0bd008b-73d3-459c-a5b7-7fef341c2fe4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_f81c57d7-927f-4ba2-8b22-83eec20e361b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e0bd008b-73d3-459c-a5b7-7fef341c2fe4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_3bc99323-b602-4850-b2f9-1c75b9229bba" xlink:href="lgnd-20220930.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e0bd008b-73d3-459c-a5b7-7fef341c2fe4" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_3bc99323-b602-4850-b2f9-1c75b9229bba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_aeef209d-f3f0-4f1b-8564-a24741063228" xlink:href="lgnd-20220930.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e0bd008b-73d3-459c-a5b7-7fef341c2fe4" xlink:to="loc_lgnd_SelexisAndDianomiMember_aeef209d-f3f0-4f1b-8564-a24741063228" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended" id="i1d90deea8d794f10b58474e9f7653429_BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_98c70da0-f257-46b0-97aa-2323295a7cbd" xlink:href="lgnd-20220930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_d18082c1-bda5-4096-81c6-b5eed72439aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_98c70da0-f257-46b0-97aa-2323295a7cbd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_d18082c1-bda5-4096-81c6-b5eed72439aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_6a5ace04-bc6d-4575-956e-816ef39671e1" xlink:href="lgnd-20220930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_98c70da0-f257-46b0-97aa-2323295a7cbd" xlink:to="loc_lgnd_BasisOfPresentationTable_6a5ace04-bc6d-4575-956e-816ef39671e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0c59a391-24f9-4f40-a13e-83866967cacb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_6a5ace04-bc6d-4575-956e-816ef39671e1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0c59a391-24f9-4f40-a13e-83866967cacb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0c59a391-24f9-4f40-a13e-83866967cacb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0c59a391-24f9-4f40-a13e-83866967cacb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0c59a391-24f9-4f40-a13e-83866967cacb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9e3a0f5f-2e62-4ebb-b914-5bcdf9ca9b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0c59a391-24f9-4f40-a13e-83866967cacb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9e3a0f5f-2e62-4ebb-b914-5bcdf9ca9b52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3c9cea2d-05aa-4794-ae9a-5c1e0a64b948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9e3a0f5f-2e62-4ebb-b914-5bcdf9ca9b52" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3c9cea2d-05aa-4794-ae9a-5c1e0a64b948" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_13db2c71-5ab3-419e-9eb2-a3f6426a2153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9e3a0f5f-2e62-4ebb-b914-5bcdf9ca9b52" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_13db2c71-5ab3-419e-9eb2-a3f6426a2153" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended" id="i2c53562897ee42539cadb7f066205cca_BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0eda3ea9-d360-4ee6-ae94-de1fc3b25f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf2bdea7-89ba-4f4d-a305-4838af804405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0eda3ea9-d360-4ee6-ae94-de1fc3b25f29" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf2bdea7-89ba-4f4d-a305-4838af804405" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_8ed4fd78-06ba-4ae6-a107-fefd64863ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0eda3ea9-d360-4ee6-ae94-de1fc3b25f29" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_8ed4fd78-06ba-4ae6-a107-fefd64863ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_301c9723-a895-4825-83ef-32877bddf956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_8ed4fd78-06ba-4ae6-a107-fefd64863ef5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_301c9723-a895-4825-83ef-32877bddf956" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8dc61558-fb19-49e4-9e96-95c15b0b05f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_8ed4fd78-06ba-4ae6-a107-fefd64863ef5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8dc61558-fb19-49e4-9e96-95c15b0b05f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8364c038-92af-4be2-89cb-e18c0601d1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0eda3ea9-d360-4ee6-ae94-de1fc3b25f29" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8364c038-92af-4be2-89cb-e18c0601d1fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3a484016-35b5-4bb9-8f32-fe9b8f826660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0eda3ea9-d360-4ee6-ae94-de1fc3b25f29" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3a484016-35b5-4bb9-8f32-fe9b8f826660" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3dc07017-a645-4e83-9d4f-567761c7035b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3a484016-35b5-4bb9-8f32-fe9b8f826660" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3dc07017-a645-4e83-9d4f-567761c7035b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3dc07017-a645-4e83-9d4f-567761c7035b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3dc07017-a645-4e83-9d4f-567761c7035b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3dc07017-a645-4e83-9d4f-567761c7035b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_15c598f1-df83-4208-8c87-2bcbc244ce10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3dc07017-a645-4e83-9d4f-567761c7035b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_15c598f1-df83-4208-8c87-2bcbc244ce10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9f4fc7f9-30db-4a5e-9e2f-edaa33d09b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_15c598f1-df83-4208-8c87-2bcbc244ce10" xlink:to="loc_us-gaap_RestrictedStockMember_9f4fc7f9-30db-4a5e-9e2f-edaa33d09b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6a5bbe70-edab-403b-99f9-e5c5b8e738f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_15c598f1-df83-4208-8c87-2bcbc244ce10" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6a5bbe70-edab-403b-99f9-e5c5b8e738f1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#SegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="extended" id="i8d0ddf1132b4417d8d143e5b7b6ab635_SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9786516c-2213-4249-b187-e3d1640d5a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9786516c-2213-4249-b187-e3d1640d5a95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2dc46303-650e-4a31-bdb1-e7e064b83189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2dc46303-650e-4a31-bdb1-e7e064b83189" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f1f749c6-6039-4162-aeb2-bf721317ff19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f1f749c6-6039-4162-aeb2-bf721317ff19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_01c24335-9d29-4d6b-aca2-e3eeb4e277fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_01c24335-9d29-4d6b-aca2-e3eeb4e277fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_7ccffdf6-3ef6-4c2f-9aae-c9640e3aab71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_7ccffdf6-3ef6-4c2f-9aae-c9640e3aab71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_04e64d56-4d5c-4ac7-9ccf-ba4f20c3ce8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_OperatingIncomeLoss_04e64d56-4d5c-4ac7-9ccf-ba4f20c3ce8b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b5ca7be2-78bb-4b0b-ac9a-be384f050d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b5ca7be2-78bb-4b0b-ac9a-be384f050d1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b5ca7be2-78bb-4b0b-ac9a-be384f050d1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b5ca7be2-78bb-4b0b-ac9a-be384f050d1a" xlink:to="loc_us-gaap_SegmentDomain_b5ca7be2-78bb-4b0b-ac9a-be384f050d1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cfacfaa8-fcbf-4131-b50c-38c1ca9068a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b5ca7be2-78bb-4b0b-ac9a-be384f050d1a" xlink:to="loc_us-gaap_SegmentDomain_cfacfaa8-fcbf-4131-b50c-38c1ca9068a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember_ea3b6395-0a9a-47f9-8f4d-1bc2b2227d94" xlink:href="lgnd-20220930.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cfacfaa8-fcbf-4131-b50c-38c1ca9068a2" xlink:to="loc_lgnd_OmniAbTechnologiesSegmentMember_ea3b6395-0a9a-47f9-8f4d-1bc2b2227d94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_25e34a31-4ec8-468d-8a13-ad96aa65299d" xlink:href="lgnd-20220930.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cfacfaa8-fcbf-4131-b50c-38c1ca9068a2" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_25e34a31-4ec8-468d-8a13-ad96aa65299d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_adf70084-5084-489f-8aa1-dd7f1516c250" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:to="loc_srt_ProductOrServiceAxis_adf70084-5084-489f-8aa1-dd7f1516c250" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_adf70084-5084-489f-8aa1-dd7f1516c250_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_adf70084-5084-489f-8aa1-dd7f1516c250" xlink:to="loc_srt_ProductsAndServicesDomain_adf70084-5084-489f-8aa1-dd7f1516c250_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_adf70084-5084-489f-8aa1-dd7f1516c250" xlink:to="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_5b218d29-91dc-4e4c-a7e8-f4339fa55269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:to="loc_us-gaap_RoyaltyMember_5b218d29-91dc-4e4c-a7e8-f4339fa55269" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_4a9841ec-65c2-4614-8807-3a2e23300118" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_4a9841ec-65c2-4614-8807-3a2e23300118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d9cf9ee3-f792-40bd-b4b2-cc2677fab07b" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d9cf9ee3-f792-40bd-b4b2-cc2677fab07b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_ff0b00e5-5201-4c9c-b0f9-e9fd2c153e2a" xlink:href="lgnd-20220930.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:to="loc_lgnd_ContractRevenueMember_ff0b00e5-5201-4c9c-b0f9-e9fd2c153e2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_9b3014ae-4ff9-42a3-aa39-8530b2edb61d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:to="loc_srt_ConsolidationItemsAxis_9b3014ae-4ff9-42a3-aa39-8530b2edb61d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9b3014ae-4ff9-42a3-aa39-8530b2edb61d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_9b3014ae-4ff9-42a3-aa39-8530b2edb61d" xlink:to="loc_srt_ConsolidationItemsDomain_9b3014ae-4ff9-42a3-aa39-8530b2edb61d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6b62cd3a-299d-410e-85ef-7e0b0c81723e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_9b3014ae-4ff9-42a3-aa39-8530b2edb61d" xlink:to="loc_srt_ConsolidationItemsDomain_6b62cd3a-299d-410e-85ef-7e0b0c81723e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_be246f91-2a4a-4701-b7aa-d9b9e0ffd3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6b62cd3a-299d-410e-85ef-7e0b0c81723e" xlink:to="loc_us-gaap_OperatingSegmentsMember_be246f91-2a4a-4701-b7aa-d9b9e0ffd3f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_446611f3-5ff5-4a04-83a5-32a034e20300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6b62cd3a-299d-410e-85ef-7e0b0c81723e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_446611f3-5ff5-4a04-83a5-32a034e20300" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="ia664759593ad4fb0bef1660cbf8bbb48_FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_2380433a-31dd-4763-b8d1-3c7ec5f0664e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_2380433a-31dd-4763-b8d1-3c7ec5f0664e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_3b1be444-009d-4f23-9e2d-4105dbe55a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_3b1be444-009d-4f23-9e2d-4105dbe55a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_d35aa745-b16b-4c01-856d-d0c296665242" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_d35aa745-b16b-4c01-856d-d0c296665242" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_a5cbfc1e-f9c8-463f-9db2-85e87033d00c" xlink:href="lgnd-20220930.xsd#lgnd_AmountsOwedToFormerLicensorFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_a5cbfc1e-f9c8-463f-9db2-85e87033d00c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_79f8c9f0-6005-45cf-bc54-304b7d6cea79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_79f8c9f0-6005-45cf-bc54-304b7d6cea79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_956f5a91-2b92-49c2-a314-17386ef85980" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_956f5a91-2b92-49c2-a314-17386ef85980" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_082d9173-7179-44f4-83e2-3b82c35da0ba" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_082d9173-7179-44f4-83e2-3b82c35da0ba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_b30728d9-fb1f-448e-a660-8f8555f5906c" xlink:href="lgnd-20220930.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_b30728d9-fb1f-448e-a660-8f8555f5906c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_8aba442e-11e9-4ee0-89a4-45e2105a5448" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_8aba442e-11e9-4ee0-89a4-45e2105a5448" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_ee9b199e-a352-4528-978c-700e3c399438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_Investments_ee9b199e-a352-4528-978c-700e3c399438" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_d2539483-fe36-481f-a14f-da66a96e8e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_d2539483-fe36-481f-a14f-da66a96e8e97" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_d77a0908-8599-41e2-b5aa-aaadde37b769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_d77a0908-8599-41e2-b5aa-aaadde37b769" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_759471f7-7d59-4162-8adf-fe167555e07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_759471f7-7d59-4162-8adf-fe167555e07a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_3b64a10a-c4f4-4438-9e7d-98f4dcb284b7" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_3b64a10a-c4f4-4438-9e7d-98f4dcb284b7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d300283-84ab-4077-a991-81865ebd50fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d300283-84ab-4077-a991-81865ebd50fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d300283-84ab-4077-a991-81865ebd50fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d300283-84ab-4077-a991-81865ebd50fd" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d300283-84ab-4077-a991-81865ebd50fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d4defaab-52fa-4188-89f9-4006bde03c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d300283-84ab-4077-a991-81865ebd50fd" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d4defaab-52fa-4188-89f9-4006bde03c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_0c54aaad-6b56-487f-bdbc-82d16130adbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d4defaab-52fa-4188-89f9-4006bde03c48" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_0c54aaad-6b56-487f-bdbc-82d16130adbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41171850-85c4-4602-b5d9-16bc0ad431ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41171850-85c4-4602-b5d9-16bc0ad431ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_41171850-85c4-4602-b5d9-16bc0ad431ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41171850-85c4-4602-b5d9-16bc0ad431ae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_41171850-85c4-4602-b5d9-16bc0ad431ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2945535-2a0d-4d6c-8f6b-9d0c0e99e451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41171850-85c4-4602-b5d9-16bc0ad431ae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2945535-2a0d-4d6c-8f6b-9d0c0e99e451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_588e3ac2-f082-4e97-9f17-533b7705a909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2945535-2a0d-4d6c-8f6b-9d0c0e99e451" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_588e3ac2-f082-4e97-9f17-533b7705a909" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7ee399a9-7ade-433e-bbbf-4c4a06d6ca58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2945535-2a0d-4d6c-8f6b-9d0c0e99e451" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7ee399a9-7ade-433e-bbbf-4c4a06d6ca58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e5512084-e6c3-42ad-9b4f-b47c8b668014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2945535-2a0d-4d6c-8f6b-9d0c0e99e451" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e5512084-e6c3-42ad-9b4f-b47c8b668014" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_98f32ffd-eaac-4593-926b-8832651f7346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_98f32ffd-eaac-4593-926b-8832651f7346" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_98f32ffd-eaac-4593-926b-8832651f7346_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_98f32ffd-eaac-4593-926b-8832651f7346" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_98f32ffd-eaac-4593-926b-8832651f7346_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_880a7d38-4e78-4b93-8f9a-008947bcf127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_98f32ffd-eaac-4593-926b-8832651f7346" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_880a7d38-4e78-4b93-8f9a-008947bcf127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_43c2eacc-c939-4400-888a-604797944a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_880a7d38-4e78-4b93-8f9a-008947bcf127" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_43c2eacc-c939-4400-888a-604797944a07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_edb256f8-9e0e-4b37-843a-5f028a25b5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_880a7d38-4e78-4b93-8f9a-008947bcf127" xlink:to="loc_us-gaap_CommonStockMember_edb256f8-9e0e-4b37-843a-5f028a25b5ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilitiesMember_fb38bc5b-2c35-44b4-8661-0d12865ad37c" xlink:href="lgnd-20220930.xsd#lgnd_ContingentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_880a7d38-4e78-4b93-8f9a-008947bcf127" xlink:to="loc_lgnd_ContingentLiabilitiesMember_fb38bc5b-2c35-44b4-8661-0d12865ad37c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0c3ec29a-6abe-4214-a644-4d357144a9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0c3ec29a-6abe-4214-a644-4d357144a9f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c3ec29a-6abe-4214-a644-4d357144a9f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0c3ec29a-6abe-4214-a644-4d357144a9f1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c3ec29a-6abe-4214-a644-4d357144a9f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0c3ec29a-6abe-4214-a644-4d357144a9f1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CyDexMember_740211aa-0a0a-4a4f-9d87-1e6ec37377cc" xlink:href="lgnd-20220930.xsd#lgnd_CyDexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:to="loc_lgnd_CyDexMember_740211aa-0a0a-4a4f-9d87-1e6ec37377cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_d9cd0759-83ae-4240-81d0-273504399831" xlink:href="lgnd-20220930.xsd#lgnd_MetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:to="loc_lgnd_MetabasisMember_d9cd0759-83ae-4240-81d0-273504399831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember_ef66d8cb-9db5-4923-9b13-2681fc604b09" xlink:href="lgnd-20220930.xsd#lgnd_IcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:to="loc_lgnd_IcagenMember_ef66d8cb-9db5-4923-9b13-2681fc604b09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_23065b2d-5abd-463e-b923-b659401ebb10" xlink:href="lgnd-20220930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_23065b2d-5abd-463e-b923-b659401ebb10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7a1c2b05-4707-4088-a764-e2099e908050" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_srt_RangeAxis_7a1c2b05-4707-4088-a764-e2099e908050" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7a1c2b05-4707-4088-a764-e2099e908050_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7a1c2b05-4707-4088-a764-e2099e908050" xlink:to="loc_srt_RangeMember_7a1c2b05-4707-4088-a764-e2099e908050_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_501297f7-a46f-4521-9aa9-aaf8ad6cba6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7a1c2b05-4707-4088-a764-e2099e908050" xlink:to="loc_srt_RangeMember_501297f7-a46f-4521-9aa9-aaf8ad6cba6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ffe62cfc-cb68-41c4-b535-42b4f10b6d10" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_501297f7-a46f-4521-9aa9-aaf8ad6cba6b" xlink:to="loc_srt_MaximumMember_ffe62cfc-cb68-41c4-b535-42b4f10b6d10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c148b64c-f5b7-4eeb-84c2-fca99ed5ffb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c148b64c-f5b7-4eeb-84c2-fca99ed5ffb8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c148b64c-f5b7-4eeb-84c2-fca99ed5ffb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c148b64c-f5b7-4eeb-84c2-fca99ed5ffb8" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c148b64c-f5b7-4eeb-84c2-fca99ed5ffb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5069384a-d562-4f46-a503-22595a88993f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c148b64c-f5b7-4eeb-84c2-fca99ed5ffb8" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5069384a-d562-4f46-a503-22595a88993f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_34891c51-0635-45df-b04a-bb7a16949134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5069384a-d562-4f46-a503-22595a88993f" xlink:to="loc_us-gaap_TransferredOverTimeMember_34891c51-0635-45df-b04a-bb7a16949134" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_89471b28-69a8-46f2-ad47-33a40516913f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_srt_ProductOrServiceAxis_89471b28-69a8-46f2-ad47-33a40516913f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_89471b28-69a8-46f2-ad47-33a40516913f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_89471b28-69a8-46f2-ad47-33a40516913f" xlink:to="loc_srt_ProductsAndServicesDomain_89471b28-69a8-46f2-ad47-33a40516913f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d7f96f9d-2a02-4bb2-88f5-af0c8b0dba0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_89471b28-69a8-46f2-ad47-33a40516913f" xlink:to="loc_srt_ProductsAndServicesDomain_d7f96f9d-2a02-4bb2-88f5-af0c8b0dba0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_ea3f7b11-d7cc-4856-8799-49dca5c39bb7" xlink:href="lgnd-20220930.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d7f96f9d-2a02-4bb2-88f5-af0c8b0dba0d" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_ea3f7b11-d7cc-4856-8799-49dca5c39bb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_9741f037-6198-4297-ac4d-81d42c807604" xlink:href="lgnd-20220930.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d7f96f9d-2a02-4bb2-88f5-af0c8b0dba0d" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_9741f037-6198-4297-ac4d-81d42c807604" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_1b98a651-5428-42b9-9c37-6950bc404962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_1b98a651-5428-42b9-9c37-6950bc404962" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_1b98a651-5428-42b9-9c37-6950bc404962_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_1b98a651-5428-42b9-9c37-6950bc404962" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_1b98a651-5428-42b9-9c37-6950bc404962_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_edc4a902-466c-41c1-a264-fd93b86c69a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_1b98a651-5428-42b9-9c37-6950bc404962" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_edc4a902-466c-41c1-a264-fd93b86c69a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_57da348d-87c3-4ba3-85b1-3b431db9fc1c" xlink:href="lgnd-20220930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_edc4a902-466c-41c1-a264-fd93b86c69a8" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_57da348d-87c3-4ba3-85b1-3b431db9fc1c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended" id="ic80ff4a1c7c04851b1ea707d507a9452_FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bfae289b-bd93-45aa-a642-a9850ed4e352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bfae289b-bd93-45aa-a642-a9850ed4e352" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_217a9f19-a9ec-4d64-b230-66bbecca7b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_217a9f19-a9ec-4d64-b230-66bbecca7b0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_79af4739-1c4b-4f4e-8bdf-aa3ae4b243f8" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_79af4739-1c4b-4f4e-8bdf-aa3ae4b243f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2eb15cc4-ef71-4650-ac33-da57191eba01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2eb15cc4-ef71-4650-ac33-da57191eba01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_a6d8872d-41b2-4bb9-8123-2aba3c036714" xlink:href="lgnd-20220930.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_a6d8872d-41b2-4bb9-8123-2aba3c036714" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fbbf4142-5795-4de1-a213-2440270c79b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a2c15d51-965d-4529-a770-ecc748f932ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bfae289b-bd93-45aa-a642-a9850ed4e352" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a2c15d51-965d-4529-a770-ecc748f932ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eaa8dff4-ea31-491c-9458-37735b3edbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a2c15d51-965d-4529-a770-ecc748f932ef" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eaa8dff4-ea31-491c-9458-37735b3edbb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eaa8dff4-ea31-491c-9458-37735b3edbb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eaa8dff4-ea31-491c-9458-37735b3edbb1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eaa8dff4-ea31-491c-9458-37735b3edbb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1b210ce5-5c62-4631-95c5-3f93b7408104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eaa8dff4-ea31-491c-9458-37735b3edbb1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1b210ce5-5c62-4631-95c5-3f93b7408104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1962794e-5b33-40f2-b1f0-31d8e4ad3322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1b210ce5-5c62-4631-95c5-3f93b7408104" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1962794e-5b33-40f2-b1f0-31d8e4ad3322" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended" id="i3655e2a9f1c34b4cb81cd05e44856159_ConvertibleSeniorNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bb1e09c8-0f1d-4363-97b6-d32106d1934c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bb1e09c8-0f1d-4363-97b6-d32106d1934c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6d86189d-3c72-4f66-9b73-af5ef3ac8e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6d86189d-3c72-4f66-9b73-af5ef3ac8e37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_2b07b7de-0af1-43d4-8928-95bafdc12c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_2b07b7de-0af1-43d4-8928-95bafdc12c4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_9bfb054c-d405-42b5-9d0c-8edeb8b01b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_9bfb054c-d405-42b5-9d0c-8edeb8b01b80" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_a9d8e01a-7ca5-4b49-bb9b-e02ae6a76fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_a9d8e01a-7ca5-4b49-bb9b-e02ae6a76fc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_0a2f9ede-9ba7-4ca3-8d94-bf82408c43a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_0a2f9ede-9ba7-4ca3-8d94-bf82408c43a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_08d38b64-b79c-4a7e-bbf8-6929bb2808f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_08d38b64-b79c-4a7e-bbf8-6929bb2808f2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_80927bb5-c414-4634-8282-da63f8cefa54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_80927bb5-c414-4634-8282-da63f8cefa54" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_239ac470-293c-4a1b-be5e-7a9096cf46c2" xlink:href="lgnd-20220930.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_239ac470-293c-4a1b-be5e-7a9096cf46c2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_05de4bdd-1b44-4822-8cdb-9691f3190339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_05de4bdd-1b44-4822-8cdb-9691f3190339" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_fb08cbd0-cf01-4101-840d-58a1e523f3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentTerm_fb08cbd0-cf01-4101-840d-58a1e523f3d6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_0ce848bb-3e58-4d06-9637-00e518d52920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_0ce848bb-3e58-4d06-9637-00e518d52920" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_df0664fe-ec8c-4655-9ca8-689d00d1099f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_InterestExpenseDebt_df0664fe-ec8c-4655-9ca8-689d00d1099f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_e6acb47b-f471-4779-a1be-407f14435846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_e6acb47b-f471-4779-a1be-407f14435846" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_779e027e-8345-4123-bcdc-87e89e40f3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_779e027e-8345-4123-bcdc-87e89e40f3a8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_830b1d3a-6ddd-4006-8abe-09ee00fa7e4e" xlink:href="lgnd-20220930.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_830b1d3a-6ddd-4006-8abe-09ee00fa7e4e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_5e034bd9-6b3d-4f76-9ec1-69e4bf8c1f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_5e034bd9-6b3d-4f76-9ec1-69e4bf8c1f19" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_76f592a7-2beb-47e4-8a28-de21d82658ec" xlink:href="lgnd-20220930.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_76f592a7-2beb-47e4-8a28-de21d82658ec" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c6a30b24-3103-40c5-af7d-4ee3225e465d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c6a30b24-3103-40c5-af7d-4ee3225e465d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b2aa5332-5d8e-46ee-8ded-8d0ad90e852c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b2aa5332-5d8e-46ee-8ded-8d0ad90e852c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_fdcd2468-9337-4dcc-93fe-3f5761dd5c03" xlink:href="lgnd-20220930.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_fdcd2468-9337-4dcc-93fe-3f5761dd5c03" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_df9ba749-8e32-457e-b8b6-1f1e6262b8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_df9ba749-8e32-457e-b8b6-1f1e6262b8f9" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_1f6d1f01-63ab-4031-bad8-e0d94ab2131c" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_1f6d1f01-63ab-4031-bad8-e0d94ab2131c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3d85d735-8fd9-418b-b431-e01e6bc66d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3d85d735-8fd9-418b-b431-e01e6bc66d5f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_00d988b3-e8c0-43b7-96ce-67e9a5dd60b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_00d988b3-e8c0-43b7-96ce-67e9a5dd60b7" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_7ef268e5-aa36-41e0-86a4-2c549a3757a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_7ef268e5-aa36-41e0-86a4-2c549a3757a2" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_910c66cc-e2ab-4f23-891e-55e014452bf4" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_910c66cc-e2ab-4f23-891e-55e014452bf4" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_bee69c0b-66ed-4877-ba07-107c646aa3da" xlink:href="lgnd-20220930.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_bee69c0b-66ed-4877-ba07-107c646aa3da" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_a2f4d71c-fa05-4392-8839-e714e1b26c8d" xlink:href="lgnd-20220930.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_a2f4d71c-fa05-4392-8839-e714e1b26c8d" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a30e0e14-33da-4034-a764-7bd228312e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a30e0e14-33da-4034-a764-7bd228312e2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a30e0e14-33da-4034-a764-7bd228312e2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a30e0e14-33da-4034-a764-7bd228312e2c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a30e0e14-33da-4034-a764-7bd228312e2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_39134f58-e81b-46a9-91cc-9b92339f618b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a30e0e14-33da-4034-a764-7bd228312e2c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_39134f58-e81b-46a9-91cc-9b92339f618b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_37f2499e-5bad-4573-8abd-e6e3025a29b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39134f58-e81b-46a9-91cc-9b92339f618b" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_37f2499e-5bad-4573-8abd-e6e3025a29b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e612586d-acef-482a-8376-65d69118dafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_DebtInstrumentAxis_e612586d-acef-482a-8376-65d69118dafc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e612586d-acef-482a-8376-65d69118dafc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e612586d-acef-482a-8376-65d69118dafc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e612586d-acef-482a-8376-65d69118dafc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8712fad2-ab86-4254-b618-4ef39bf4d913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e612586d-acef-482a-8376-65d69118dafc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8712fad2-ab86-4254-b618-4ef39bf4d913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_cdfe1b9a-661e-472d-b776-ca47d22aef23" xlink:href="lgnd-20220930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8712fad2-ab86-4254-b618-4ef39bf4d913" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_cdfe1b9a-661e-472d-b776-ca47d22aef23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6940721f-6af2-4b3c-8b5e-84c223ede323" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_srt_RangeAxis_6940721f-6af2-4b3c-8b5e-84c223ede323" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6940721f-6af2-4b3c-8b5e-84c223ede323_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6940721f-6af2-4b3c-8b5e-84c223ede323" xlink:to="loc_srt_RangeMember_6940721f-6af2-4b3c-8b5e-84c223ede323_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7aad0025-83da-4a33-97d0-4ed20abf3ea9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6940721f-6af2-4b3c-8b5e-84c223ede323" xlink:to="loc_srt_RangeMember_7aad0025-83da-4a33-97d0-4ed20abf3ea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c1463080-634c-4bfe-bd5e-6d9528db8181" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7aad0025-83da-4a33-97d0-4ed20abf3ea9" xlink:to="loc_srt_MaximumMember_c1463080-634c-4bfe-bd5e-6d9528db8181" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e04c026-404a-49d6-9a04-17662143ada1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e04c026-404a-49d6-9a04-17662143ada1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6e04c026-404a-49d6-9a04-17662143ada1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e04c026-404a-49d6-9a04-17662143ada1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_6e04c026-404a-49d6-9a04-17662143ada1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0c6c1085-f1b9-4b44-a0ba-64e8d905d665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e04c026-404a-49d6-9a04-17662143ada1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0c6c1085-f1b9-4b44-a0ba-64e8d905d665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_c8f343a4-8490-41fe-9ad2-6c0a6f49bd19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0c6c1085-f1b9-4b44-a0ba-64e8d905d665" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_c8f343a4-8490-41fe-9ad2-6c0a6f49bd19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ed8f41c3-b3d7-4f6f-ba5a-c3fd99dbc3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0c6c1085-f1b9-4b44-a0ba-64e8d905d665" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ed8f41c3-b3d7-4f6f-ba5a-c3fd99dbc3da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_441d285f-62e7-46ab-9acb-900594256dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_441d285f-62e7-46ab-9acb-900594256dfe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_441d285f-62e7-46ab-9acb-900594256dfe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_441d285f-62e7-46ab-9acb-900594256dfe" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_441d285f-62e7-46ab-9acb-900594256dfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1c274922-cf54-4868-b891-1d832b8a2adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_441d285f-62e7-46ab-9acb-900594256dfe" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1c274922-cf54-4868-b891-1d832b8a2adb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_684bd20f-174b-4e18-869d-93fce78f3e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1c274922-cf54-4868-b891-1d832b8a2adb" xlink:to="loc_us-gaap_SubsequentEventMember_684bd20f-174b-4e18-869d-93fce78f3e68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_d863c30d-e3f8-4733-bde2-23cfe9bfcd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_d863c30d-e3f8-4733-bde2-23cfe9bfcd9b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_d863c30d-e3f8-4733-bde2-23cfe9bfcd9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_d863c30d-e3f8-4733-bde2-23cfe9bfcd9b" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_d863c30d-e3f8-4733-bde2-23cfe9bfcd9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_9318e450-a7ec-4ca3-a6a1-7f51f6de1ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_d863c30d-e3f8-4733-bde2-23cfe9bfcd9b" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_9318e450-a7ec-4ca3-a6a1-7f51f6de1ba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember_131c5ede-e579-4189-8d14-26ceff246a22" xlink:href="lgnd-20220930.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_9318e450-a7ec-4ca3-a6a1-7f51f6de1ba0" xlink:to="loc_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember_131c5ede-e579-4189-8d14-26ceff246a22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_44ad8637-f9bc-4983-80ff-d63dc5941c7e" xlink:href="lgnd-20220930.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_9318e450-a7ec-4ca3-a6a1-7f51f6de1ba0" xlink:to="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_44ad8637-f9bc-4983-80ff-d63dc5941c7e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended" id="ic82c6096708e456b9c475ef8a2b3ffbc_ConvertibleSeniorNotesNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_24d0eed2-49ce-4b01-af09-9d30c356884a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_253280e2-c7f6-4121-86e8-e30615ff5cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_24d0eed2-49ce-4b01-af09-9d30c356884a" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_253280e2-c7f6-4121-86e8-e30615ff5cdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1cc027c8-a3ca-4ea7-bb59-acbac9ff9d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_253280e2-c7f6-4121-86e8-e30615ff5cdf" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1cc027c8-a3ca-4ea7-bb59-acbac9ff9d56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_bcdaf6fd-faba-48cb-84b5-c2509b6691d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_253280e2-c7f6-4121-86e8-e30615ff5cdf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_bcdaf6fd-faba-48cb-84b5-c2509b6691d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_59788670-2b07-4e7b-bdd6-01a6309f4618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_253280e2-c7f6-4121-86e8-e30615ff5cdf" xlink:to="loc_us-gaap_LongTermNotesPayable_59788670-2b07-4e7b-bdd6-01a6309f4618" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_ca165947-b470-4a2e-8816-da33fe9967df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_24d0eed2-49ce-4b01-af09-9d30c356884a" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_ca165947-b470-4a2e-8816-da33fe9967df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_951e543a-5a0a-4cc9-a02b-8ddecad87b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_24d0eed2-49ce-4b01-af09-9d30c356884a" xlink:to="loc_us-gaap_DebtInstrumentTable_951e543a-5a0a-4cc9-a02b-8ddecad87b6d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4c3d1022-84f5-4ffc-8c25-b8910c7cbffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_951e543a-5a0a-4cc9-a02b-8ddecad87b6d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4c3d1022-84f5-4ffc-8c25-b8910c7cbffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4c3d1022-84f5-4ffc-8c25-b8910c7cbffa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4c3d1022-84f5-4ffc-8c25-b8910c7cbffa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4c3d1022-84f5-4ffc-8c25-b8910c7cbffa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_71d1551e-9638-4510-a1b5-1538eb7d2f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4c3d1022-84f5-4ffc-8c25-b8910c7cbffa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_71d1551e-9638-4510-a1b5-1538eb7d2f59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_25404551-695d-4d70-a9be-c83ddf05d312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_71d1551e-9638-4510-a1b5-1538eb7d2f59" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_25404551-695d-4d70-a9be-c83ddf05d312" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1e39aac2-9720-4e3b-837b-be27015ac367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_951e543a-5a0a-4cc9-a02b-8ddecad87b6d" xlink:to="loc_us-gaap_DebtInstrumentAxis_1e39aac2-9720-4e3b-837b-be27015ac367" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1e39aac2-9720-4e3b-837b-be27015ac367_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1e39aac2-9720-4e3b-837b-be27015ac367" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1e39aac2-9720-4e3b-837b-be27015ac367_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9b0143a-cf9f-46ca-ac64-d01530e73dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1e39aac2-9720-4e3b-837b-be27015ac367" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9b0143a-cf9f-46ca-ac64-d01530e73dd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_502f71be-a645-41e2-ac1c-d6055feffd3e" xlink:href="lgnd-20220930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9b0143a-cf9f-46ca-ac64-d01530e73dd8" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_502f71be-a645-41e2-ac1c-d6055feffd3e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#IncomeTaxDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="extended" id="i332833ab2dc84083bccc47a3c7830e70_IncomeTaxDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_0a6e9799-164b-4877-99d3-30eec1d75262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_09abd582-c562-413c-b155-cd1145310989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0a6e9799-164b-4877-99d3-30eec1d75262" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_09abd582-c562-413c-b155-cd1145310989" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_51d65e40-025b-467b-ae9b-3dc6ad9be700" xlink:href="lgnd-20220930.xsd#lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0a6e9799-164b-4877-99d3-30eec1d75262" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_51d65e40-025b-467b-ae9b-3dc6ad9be700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_fa5bd303-7c09-4f9d-84f5-3d351dd265ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0a6e9799-164b-4877-99d3-30eec1d75262" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_fa5bd303-7c09-4f9d-84f5-3d351dd265ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_64c8836b-d97c-46b8-9ab7-7a6bf98c0ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_fa5bd303-7c09-4f9d-84f5-3d351dd265ae" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_64c8836b-d97c-46b8-9ab7-7a6bf98c0ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c8836b-d97c-46b8-9ab7-7a6bf98c0ada_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_64c8836b-d97c-46b8-9ab7-7a6bf98c0ada" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64c8836b-d97c-46b8-9ab7-7a6bf98c0ada_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5d63570f-6d38-49a2-aa80-a1606bfa009d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_64c8836b-d97c-46b8-9ab7-7a6bf98c0ada" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5d63570f-6d38-49a2-aa80-a1606bfa009d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_9680fed4-1363-4acc-be77-1f94070e2acd" xlink:href="lgnd-20220930.xsd#lgnd_PfenexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5d63570f-6d38-49a2-aa80-a1606bfa009d" xlink:to="loc_lgnd_PfenexMember_9680fed4-1363-4acc-be77-1f94070e2acd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended" id="ia040f430d99540c5ac7fbd16d2cca436_StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6a2ad4a-7f67-4c09-bea8-a84c3693c4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6a2ad4a-7f67-4c09-bea8-a84c3693c4c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_14c2d6e4-f8bb-4a2d-9b4e-4b72d151aa3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_14c2d6e4-f8bb-4a2d-9b4e-4b72d151aa3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8dd4fec1-7804-4ee9-a0d4-ec1515d75085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8dd4fec1-7804-4ee9-a0d4-ec1515d75085" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_00e656ff-7a37-4f86-980f-913d3e0c89ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_00e656ff-7a37-4f86-980f-913d3e0c89ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_32d342b4-6b88-46a4-8d22-b00cf3f16e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ea7f24aa-bd92-4cfb-86dd-b77603484dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ea7f24aa-bd92-4cfb-86dd-b77603484dbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_521f1d40-73f7-4ff5-9293-a34822357e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_521f1d40-73f7-4ff5-9293-a34822357e6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5c0bc24a-f6e0-48e1-8fc5-5c636c8b8c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5c0bc24a-f6e0-48e1-8fc5-5c636c8b8c16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9192e98d-f6c1-4b85-bb13-8acd1bb9bb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9192e98d-f6c1-4b85-bb13-8acd1bb9bb23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14715341-9733-4977-9543-3e744f19002e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6ef1ba04-5e70-4fa0-b913-938bce64dbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6ef1ba04-5e70-4fa0-b913-938bce64dbaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d1e9da15-93c4-44f3-802c-184a36c74763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d1e9da15-93c4-44f3-802c-184a36c74763" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3fa2e16d-3670-49c9-94b6-f2278c2423ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3fa2e16d-3670-49c9-94b6-f2278c2423ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_09e58634-23e1-4ab7-a6c4-df9c4d85c150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_09e58634-23e1-4ab7-a6c4-df9c4d85c150" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_41b8c92d-651c-4f16-a0c9-84bdd2b394ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_95774e0c-95b0-4628-b3b7-ee00b9edcb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_95774e0c-95b0-4628-b3b7-ee00b9edcb74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90f4b545-87e4-406b-886d-65e4c09e3091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90f4b545-87e4-406b-886d-65e4c09e3091" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4e76f3b1-f93a-489e-9fc1-9b2fca9b8b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4e76f3b1-f93a-489e-9fc1-9b2fca9b8b96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a89d41a9-9430-4625-9bae-1e2f79eb0286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a89d41a9-9430-4625-9bae-1e2f79eb0286" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b63253b2-911d-4f9c-b8f4-368b3126fa0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_7c66b437-6ec9-4520-a82e-87e420d08278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_7c66b437-6ec9-4520-a82e-87e420d08278" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e568dd00-df7d-4b5e-addf-60d09e318258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7c66b437-6ec9-4520-a82e-87e420d08278" xlink:to="loc_us-gaap_AwardTypeAxis_e568dd00-df7d-4b5e-addf-60d09e318258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e568dd00-df7d-4b5e-addf-60d09e318258_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e568dd00-df7d-4b5e-addf-60d09e318258" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e568dd00-df7d-4b5e-addf-60d09e318258_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8403ce59-d565-491c-bc47-062d020a93f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e568dd00-df7d-4b5e-addf-60d09e318258" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8403ce59-d565-491c-bc47-062d020a93f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_76616063-13bd-4427-9784-d23a42ad1c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8403ce59-d565-491c-bc47-062d020a93f8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_76616063-13bd-4427-9784-d23a42ad1c78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_1b216356-1a4f-4a41-bee1-da4a7d193688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8403ce59-d565-491c-bc47-062d020a93f8" xlink:to="loc_us-gaap_RestrictedStockMember_1b216356-1a4f-4a41-bee1-da4a7d193688" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i3c5a93c806aa40fe995b427203ddb32b_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0bbe80c0-365e-4e6e-a133-404dce1f12e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0bbe80c0-365e-4e6e-a133-404dce1f12e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_110e2440-f395-4ba2-bfe8-e46a69289f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_110e2440-f395-4ba2-bfe8-e46a69289f79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_b640f4cd-a96e-4e26-a6e3-2a046330e253" xlink:href="lgnd-20220930.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_b640f4cd-a96e-4e26-a6e3-2a046330e253" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_3df88830-2f34-419a-a553-7f2c81b33b74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_b640f4cd-a96e-4e26-a6e3-2a046330e253" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_3df88830-2f34-419a-a553-7f2c81b33b74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_3f161824-d3cc-4463-9b02-89b8ee1c4e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_b640f4cd-a96e-4e26-a6e3-2a046330e253" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_3f161824-d3cc-4463-9b02-89b8ee1c4e62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9fcec549-45af-4e3d-b3fc-b056a79aba62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9fcec549-45af-4e3d-b3fc-b056a79aba62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_b0acad71-f93c-4f62-9ecf-9ae095bec24e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_b0acad71-f93c-4f62-9ecf-9ae095bec24e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_05d42954-7ecb-48e1-a8c5-af20abe2dac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_05d42954-7ecb-48e1-a8c5-af20abe2dac1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_42b36e16-dada-4b58-ba9d-602ce3b21c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_42b36e16-dada-4b58-ba9d-602ce3b21c77" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_7b8cc838-5b62-4723-a14d-45717a0eb326" xlink:href="lgnd-20220930.xsd#lgnd_SaleOfStockAuthorizedOfferingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_7b8cc838-5b62-4723-a14d-45717a0eb326" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da15053b-f07a-4cae-a723-a89a643990b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da15053b-f07a-4cae-a723-a89a643990b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_dae64172-86e6-46c2-8089-37c6c229db9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da15053b-f07a-4cae-a723-a89a643990b3" xlink:to="loc_us-gaap_PlanNameAxis_dae64172-86e6-46c2-8089-37c6c229db9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_dae64172-86e6-46c2-8089-37c6c229db9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_dae64172-86e6-46c2-8089-37c6c229db9b" xlink:to="loc_us-gaap_PlanNameDomain_dae64172-86e6-46c2-8089-37c6c229db9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ffc91edd-ab5f-4b24-8dd1-4cd7ec2be01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_dae64172-86e6-46c2-8089-37c6c229db9b" xlink:to="loc_us-gaap_PlanNameDomain_ffc91edd-ab5f-4b24-8dd1-4cd7ec2be01d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_37fd359e-934a-4e98-8cb2-4e74127a140f" xlink:href="lgnd-20220930.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_ffc91edd-ab5f-4b24-8dd1-4cd7ec2be01d" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_37fd359e-934a-4e98-8cb2-4e74127a140f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6a1e4ce8-eb54-4519-afd9-7a76cde0ed2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da15053b-f07a-4cae-a723-a89a643990b3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6a1e4ce8-eb54-4519-afd9-7a76cde0ed2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6a1e4ce8-eb54-4519-afd9-7a76cde0ed2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6a1e4ce8-eb54-4519-afd9-7a76cde0ed2d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6a1e4ce8-eb54-4519-afd9-7a76cde0ed2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9e17e269-bc2f-45a1-ad68-6858d45391e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6a1e4ce8-eb54-4519-afd9-7a76cde0ed2d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9e17e269-bc2f-45a1-ad68-6858d45391e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AtTheMarketEquityOfferingMember_6a01a631-e272-43c8-aa81-6caf4ff50c89" xlink:href="lgnd-20220930.xsd#lgnd_AtTheMarketEquityOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9e17e269-bc2f-45a1-ad68-6858d45391e6" xlink:to="loc_lgnd_AtTheMarketEquityOfferingMember_6a01a631-e272-43c8-aa81-6caf4ff50c89" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CommitmentandContingenciesLegalProceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="extended" id="i50fad8fc080c4602b43f85f2116a5acf_CommitmentandContingenciesLegalProceedingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c477d330-d373-4234-abc3-e08b52564024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_17eb19ab-2ee6-43d1-b532-fee10cbbb293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c477d330-d373-4234-abc3-e08b52564024" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_17eb19ab-2ee6-43d1-b532-fee10cbbb293" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c846004c-83de-478e-848c-55cc03f9b835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c477d330-d373-4234-abc3-e08b52564024" xlink:to="loc_us-gaap_LossContingenciesTable_c846004c-83de-478e-848c-55cc03f9b835" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b79841b9-daf0-4a70-aa24-3dec03d95cc1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c846004c-83de-478e-848c-55cc03f9b835" xlink:to="loc_srt_LitigationCaseAxis_b79841b9-daf0-4a70-aa24-3dec03d95cc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b79841b9-daf0-4a70-aa24-3dec03d95cc1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_b79841b9-daf0-4a70-aa24-3dec03d95cc1" xlink:to="loc_srt_LitigationCaseTypeDomain_b79841b9-daf0-4a70-aa24-3dec03d95cc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a29e6d28-6d3c-4e3d-b60c-3972fb2bb3ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_b79841b9-daf0-4a70-aa24-3dec03d95cc1" xlink:to="loc_srt_LitigationCaseTypeDomain_a29e6d28-6d3c-4e3d-b60c-3972fb2bb3ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_a9a2de4b-bf3d-4afc-88c9-14db3ef8a3a4" xlink:href="lgnd-20220930.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a29e6d28-6d3c-4e3d-b60c-3972fb2bb3ad" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_a9a2de4b-bf3d-4afc-88c9-14db3ef8a3a4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i9dc77734498c4727a1c4a5c2379b207c_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_1b942677-60d6-44a7-acc6-c75d8200f1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_1b942677-60d6-44a7-acc6-c75d8200f1d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_56b36253-4ab5-469a-9678-254d5d40649b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_56b36253-4ab5-469a-9678-254d5d40649b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease_c93f4520-11de-403c-a8c7-cdb80f9b7850" xlink:href="lgnd-20220930.xsd#lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:to="loc_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease_c93f4520-11de-403c-a8c7-cdb80f9b7850" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OperatingLeaseLiabilityIncreaseDecrease_65177312-5fd4-4f73-9e01-5f2f591d8cfd" xlink:href="lgnd-20220930.xsd#lgnd_OperatingLeaseLiabilityIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:to="loc_lgnd_OperatingLeaseLiabilityIncreaseDecrease_65177312-5fd4-4f73-9e01-5f2f591d8cfd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b1cdff47-37b3-4eff-9911-11084576d880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b1cdff47-37b3-4eff-9911-11084576d880" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8d96661c-d896-4cf4-a887-c8f086ef2a1e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b1cdff47-37b3-4eff-9911-11084576d880" xlink:to="loc_srt_RangeAxis_8d96661c-d896-4cf4-a887-c8f086ef2a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8d96661c-d896-4cf4-a887-c8f086ef2a1e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8d96661c-d896-4cf4-a887-c8f086ef2a1e" xlink:to="loc_srt_RangeMember_8d96661c-d896-4cf4-a887-c8f086ef2a1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7ff40b0c-acc3-442e-a871-54489e154d29" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8d96661c-d896-4cf4-a887-c8f086ef2a1e" xlink:to="loc_srt_RangeMember_7ff40b0c-acc3-442e-a871-54489e154d29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bc1448ef-9003-4172-a303-66f2427e0924" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7ff40b0c-acc3-442e-a871-54489e154d29" xlink:to="loc_srt_MaximumMember_bc1448ef-9003-4172-a303-66f2427e0924" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#SubsequentEventDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="extended" id="i59bf4180d5f54387bd8705d9fb6fc804_SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_5c054083-2261-443b-81c0-3de1b17a4973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_497b2e01-3de4-40d1-803b-6c8dd21fd12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5c054083-2261-443b-81c0-3de1b17a4973" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_497b2e01-3de4-40d1-803b-6c8dd21fd12c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_8d95dc86-58e7-4129-99ea-6b43b7378bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_5c054083-2261-443b-81c0-3de1b17a4973" xlink:to="loc_us-gaap_SubsequentEventTable_8d95dc86-58e7-4129-99ea-6b43b7378bbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_37f217e7-0dad-4089-bfef-20c9ce3d8805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_8d95dc86-58e7-4129-99ea-6b43b7378bbb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_37f217e7-0dad-4089-bfef-20c9ce3d8805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_37f217e7-0dad-4089-bfef-20c9ce3d8805_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_37f217e7-0dad-4089-bfef-20c9ce3d8805" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_37f217e7-0dad-4089-bfef-20c9ce3d8805_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c3dd584b-8a9d-456f-8640-9fcbe1d174fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_37f217e7-0dad-4089-bfef-20c9ce3d8805" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c3dd584b-8a9d-456f-8640-9fcbe1d174fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_859e0589-4a42-4a6d-9fb2-b00687d44f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c3dd584b-8a9d-456f-8640-9fcbe1d174fe" xlink:to="loc_us-gaap_SubsequentEventMember_859e0589-4a42-4a6d-9fb2-b00687d44f2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_690ad124-eb1a-49b0-a896-70aea427e91f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_8d95dc86-58e7-4129-99ea-6b43b7378bbb" xlink:to="loc_srt_OwnershipAxis_690ad124-eb1a-49b0-a896-70aea427e91f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_690ad124-eb1a-49b0-a896-70aea427e91f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_690ad124-eb1a-49b0-a896-70aea427e91f" xlink:to="loc_srt_OwnershipDomain_690ad124-eb1a-49b0-a896-70aea427e91f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_cea6fee1-ae72-4149-bc4e-dc63583ee739" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_690ad124-eb1a-49b0-a896-70aea427e91f" xlink:to="loc_srt_OwnershipDomain_cea6fee1-ae72-4149-bc4e-dc63583ee739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbMember_13994664-aa23-4b4f-97ba-945d359187f5" xlink:href="lgnd-20220930.xsd#lgnd_OmniAbMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_cea6fee1-ae72-4149-bc4e-dc63583ee739" xlink:to="loc_lgnd_OmniAbMember_13994664-aa23-4b4f-97ba-945d359187f5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>lgnd-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7b2ea99b-5e75-4f19-8ddb-22eedf3c9f68,g:96c50209-ed52-4eb8-96bc-4f2a516dad9f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_36679a03-9786-407d-9038-8fc9aee47c8a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PfenexMember_1fa0140f-4bb8-4d1e-b91a-b2ed45fda802_terseLabel_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:label id="lab_lgnd_PfenexMember_label_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex [Member]</link:label>
    <link:label id="lab_lgnd_PfenexMember_documentation_en-US" xlink:label="lab_lgnd_PfenexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember" xlink:href="lgnd-20220930.xsd#lgnd_PfenexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PfenexMember" xlink:to="lab_lgnd_PfenexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_14881552-b844-410c-9db5-6de1c438cdc1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_22a599b9-d911-4d5d-851b-6a5bb5b9d6e3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7feb8fdf-c574-43c9-95fc-2936861448f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_16cce78d-07c6-4216-a3ab-e2566a0523e1_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_b84b6ecf-00f3-4c0f-9f6c-8be24a66505b_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_OperatingLeaseLiabilityIncreaseDecrease_290723e3-29c9-4e5f-a7b4-bb7d5c11aee8_terseLabel_en-US" xlink:label="lab_lgnd_OperatingLeaseLiabilityIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in operating lease liabilities</link:label>
    <link:label id="lab_lgnd_OperatingLeaseLiabilityIncreaseDecrease_label_en-US" xlink:label="lab_lgnd_OperatingLeaseLiabilityIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Increase (Decrease)</link:label>
    <link:label id="lab_lgnd_OperatingLeaseLiabilityIncreaseDecrease_documentation_en-US" xlink:label="lab_lgnd_OperatingLeaseLiabilityIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OperatingLeaseLiabilityIncreaseDecrease" xlink:href="lgnd-20220930.xsd#lgnd_OperatingLeaseLiabilityIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_OperatingLeaseLiabilityIncreaseDecrease" xlink:to="lab_lgnd_OperatingLeaseLiabilityIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_bfbd98b0-48e1-4b73-826f-967ce11ef1f6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_966adeaf-1481-40f8-a3d3-520ba1d5f07d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_889536b3-7741-475f-94ec-febe55eeed1c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_81d64466-6ad6-4947-b0a2-e9711f43159e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_c2982d01-3bc2-440b-8e01-4a9b25df4df0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_3619d1e3-5140-4065-81be-2b87028fc3a1_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_104ded4f-a51e-4814-913b-c8e6b05ee42b_negatedLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_c918afed-4d36-4ecd-ae40-bb7a5e19b4da_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights [Policy Text Block]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:href="lgnd-20220930.xsd#lgnd_CommercialLicenseRightsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:to="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_e5fbbc27-78b8-4112-aa3f-cf42adb37092_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_e2658a36-ebe0-4218-9f3d-dd102022bad9_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from short-term investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_daa62d6e-466a-4be2-bb0f-4a45e9ce6c48_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_1c5e8d89-a11d-40a2-abd6-73eb00ea326d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_d813a9df-b0b5-4bb0-b9d0-3ddd6026fd70_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_9ccb9a63-2d89-4784-a540-0a741cf8ba59_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_4638242a-f3bb-48e5-939f-57abb5e160f5_verboseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights [Abstract]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:href="lgnd-20220930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6164a6ca-a40f-44fc-9e44-7e796374deb4_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember_b4688933-c014-4fdc-b232-6f4dd4d21b8a_terseLabel_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes repurchased during current period</link:label>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember_label_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Repurchased During Current Period, One [Member]</link:label>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember_documentation_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Repurchased During Current Period, One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember" xlink:href="lgnd-20220930.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember" xlink:to="lab_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a73a6c44-9501-40bc-98b6-04796d4c17d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_393ee98e-ebff-4c41-9584-af65ae7ced23_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_44441ff7-e7cc-438b-8c78-44bffc80cc84_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8a04d3d4-39c4-43e8-a387-bc9c545a33c4_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_b7bbbfad-03ad-42c5-8fe5-19f162d2e7bb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_3a37ee83-2f89-4019-a958-914d63b422db_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_2782d69e-b7c3-4cb8-8e27-641b374c9b73_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_77960579-e683-497f-abdf-edc4b00d434b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_0028ef73-165e-40c6-be19-44c5521dc824_terseLabel_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease amortization expense</link:label>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_documentation_en-US" xlink:label="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:href="lgnd-20220930.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:to="lab_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_0a751ed5-f6d0-42c8-a8be-ee2f89358ad1_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_686d16ef-3435-4a29-8201-3b1bb28a14c9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_8e2e4253-7f6e-48c3-951b-94f11b484b6c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_d5231f86-b81a-4df8-8b36-2b4ca4e4c228_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b492a2b6-8985-4a10-afa0-0aea77763f39_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_1df96541-2215-42b3-8d0b-76239dfb3c51_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair-Value Options Awarded to Employees and Directors</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_3b537df2-f044-46ae-8b6a-b7d320e63361_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_963c0baf-e17e-43a2-b1fe-5c81f901fe6e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_79b74118-9da5-40d2-831f-a47a2a2371d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_6252c10f-a89e-473a-8452-a196ff23d887_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_92e5e62c-189f-4ecc-94e8-773d8b8d6082_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_683903b9-83c0-48a9-8f4a-b22be87379d7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_8d2d9400-7555-4625-979d-2d968f885d8b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_dac8f152-3eab-490b-9ab9-038187e255a2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_42823281-9a2a-4bb0-8c37-df637b5aff2a_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_a0bc8b1d-0a55-4471-a3cb-502c98517ac4_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_cef07586-ff4f-42b6-a31b-6d45e8415c20_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for convertible bond hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:to="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_a6c173eb-e741-423a-9dff-936a2db5fb92_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_d71edb6d-99d9-4174-bb7c-633711601b6f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e6f11359-01f5-40ff-91b4-03221e5b9363_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_baa3476f-8b2f-430a-9542-7f29cd7af847_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_1ec5ab00-7c14-4d8c-bc1d-d3f4ce624504_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_41b09bd6-d8ad-4d26-825b-f74f8a3fb900_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_59be78b2-5d23-406c-a506-aeda7db5877d_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_cd08aab3-d4e2-4da8-b15a-0355137079a6_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased amount of debt instrument</link:label>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_label_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Amount During Period</link:label>
    <link:label id="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_documentation_en-US" xlink:label="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Amount During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:href="lgnd-20220930.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:to="lab_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_4105ae7c-269f-4507-921d-0f42d7645673_verboseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_f7468e5a-c777-4302-9648-81f5f5bb5068_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_b0de62dd-15df-459a-9e0c-e12a7194f6da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ReturnsAccrual_6aaf216e-0e20-4f54-914c-ae836e776a39_terseLabel_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return reserve</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_label_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_documentation_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual" xlink:href="lgnd-20220930.xsd#lgnd_ReturnsAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ReturnsAccrual" xlink:to="lab_lgnd_ReturnsAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_b9c64b4e-7750-42ed-961e-3e0f7801ab43_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_cfd91b29-bc9d-4875-8cfb-e5cd594d56c7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining three months ending December 31, 2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2f030e03-3f70-462f-bd35-5f4db5fc4360_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_46b8fb2f-3b28-44d1-8054-a410f967aa7e_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_b692db5b-797a-43c8-93c8-eb75f952a154_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_1d0b0d73-5cf2-4748-abf4-5775f59ff9f2_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_88ec0d50-b53d-4200-87ac-82b34460f52c_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_95f0554e-b98e-4910-ab61-bb307c214a86_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_acfce166-76ee-480e-9b25-8b5827a0639e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b7e7e16d-01c8-4464-890e-08339669ce0e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_473a2385-cdf0-424b-9775-fe936526fc74_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems" xlink:href="lgnd-20220930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationLineItems" xlink:to="lab_lgnd_BasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_48ee25f6-891a-42a4-8661-c8e8e35b79d1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1bf57560-fea0-4282-a13f-3cc356726614_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_363ddf91-b5eb-4cc6-aea5-0d9ac86df3a8_terseLabel_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensees</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_label_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_documentation_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent" xlink:href="lgnd-20220930.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseeAccrualCurrent" xlink:to="lab_lgnd_LicenseeAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_4c3340fa-3ed5-4915-b8a3-f40c4003053a_totalLabel_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease assets</link:label>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_label_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset" xlink:href="lgnd-20220930.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseRightOfUseAsset" xlink:to="lab_lgnd_LeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_3f02429a-de90-4cff-bf80-2d9fe1c09f4e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_931f6a46-4b66-4f0d-9d46-811eda63b189_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_OmniAbTechnologiesSegmentMember_4a79a6ba-d6f9-4372-a4a7-b28a1cbf4a46_terseLabel_en-US" xlink:label="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb business</link:label>
    <link:label id="lab_lgnd_OmniAbTechnologiesSegmentMember_label_en-US" xlink:label="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb Technologies Segment [Member]</link:label>
    <link:label id="lab_lgnd_OmniAbTechnologiesSegmentMember_documentation_en-US" xlink:label="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb Technologies Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember" xlink:href="lgnd-20220930.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_OmniAbTechnologiesSegmentMember" xlink:to="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_0afe83af-005c-456f-9449-680e20805708_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_4d2c411f-948d-4cf2-96db-9f0ecf9d3608_terseLabel_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_label_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_documentation_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:href="lgnd-20220930.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:to="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_314f2f14-5c74-4a18-865f-e573cea0dfc7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1c37ba70-63a1-4bbb-8ed3-e0dc5fbbf147_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0a4f3309-8549-4601-a38b-41cc26526fae_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9176e6be-3f89-452c-bc8a-12b0ab3e9896_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_1a8ff373-eb6c-401d-ac4d-042ade3c71ed_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e1080733-dea6-4ab3-a4ac-a838f1178a36_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_217a6f43-8ff2-4f74-b77f-8f613595f777_negatedLabel_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimated fair value of contingent liabilities</link:label>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_label_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NonCashChangeInEstimatedFairValueOfContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:href="lgnd-20220930.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:to="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4c2ebfc4-b873-47c9-a7be-24007cb9f6cd_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1cca05c1-3d56-42e0-ba07-63be872265a3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1ac48c05-102d-451a-b127-39161d693d4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_760f0be6-217c-4d68-b257-1eb09fa9b57f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_af7b4495-11b1-48e2-85de-929d0da7b619_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_c1915e60-74c0-404b-97d4-ddb99af7f19f_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Contingent Value Right Holders, Investing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Contingent Value Right Holders, Investing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToContingentValueRightHoldersInvestingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_74624f19-5405-4938-9fce-fa60d2721a73_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c9a3be3-a159-4837-a779-30b8ab1d6e8f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_cf8ed082-8335-4100-b29f-46953255e7fd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_43fdbc63-d835-41dd-a6d1-07be40d5e062_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_013a5612-bc92-42b8-8b8d-80a0f75a9521_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_85bd4355-5ff0-4951-b3e2-16f477355194_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_2875f103-b74f-4ab1-8fcb-40a9d2b47d57_terseLabel_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from unwinding convertible bond hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:href="lgnd-20220930.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:to="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_62c1933b-05df-40da-9dd8-58d5897968ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5b0792b0-bf8c-4cc8-a9ab-b41fc42cecf4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_1613a054-ecfc-4359-a5c9-ac35fd971f8c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_edeaec35-5a28-4ff8-a356-648592dea8e1_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued per acquiree share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_e24b8b84-8e08-44e4-950b-596f855571cb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_a7b6eaba-8e49-4384-8ea2-84f7d65505b5_terseLabel_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_label_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial [Member]</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_documentation_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember" xlink:href="lgnd-20220930.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_Phase3ClinicalTrialMember" xlink:to="lab_lgnd_Phase3ClinicalTrialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_fe15adfa-5806-4f4c-8a9a-7abc2161274a_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_037dc0ad-c316-42f3-baa9-851aebdd134c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_989765fc-0744-4db3-9fa0-44679ac9ce10_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_9c3c209e-d8d6-468a-907c-7932fa37ed9f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b3dd6d29-6398-4924-8db3-99509dd8852b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_86d3fc9d-98ed-46ab-8c0d-e920f5d55620_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_14b0e077-13d0-4216-a85e-53db61eca316_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_eea68dea-ad04-421e-843c-55032a6713b7_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_95798a0a-7e4d-450f-8b9e-cbfc8c7ba943_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_73b2185f-18eb-4293-8f9b-fed169790e1e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d3f76ce9-0720-4b55-8b6c-536c4602f4d9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_c4d45b7d-7e13-4cca-b518-fc972e4340ef_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease_4ce82c09-b4ef-4f66-a69a-9012f9ffcded_terseLabel_en-US" xlink:label="lab_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in operating lease assets</link:label>
    <link:label id="lab_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease_label_en-US" xlink:label="lab_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Right Of Use Assets, Increase (Decrease)</link:label>
    <link:label id="lab_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease_documentation_en-US" xlink:label="lab_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Right Of Use Assets, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease" xlink:href="lgnd-20220930.xsd#lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease" xlink:to="lab_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f5586114-959a-4361-a6aa-376b7ffecaaf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_741c6866-8bbd-4363-b6df-d5eabb31e663_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_5537cf4f-8472-47b8-898a-bde2dffedb76_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_015b175d-a415-40ac-954f-8f7ef0731f39_terseLabel_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related liabilities</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_label_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:href="lgnd-20220930.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:to="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_e78826be-db4e-4eaf-b043-07532e56eeb8_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_49931402-f4cc-405a-bd73-e92e3b324e3f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7e71273c-f60f-4daf-b91c-c469867f25a7_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_8047bf33-4b87-424f-977e-d90bda47c2ac_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase of carrying amount of Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayable" xlink:to="lab_us-gaap_ConvertibleNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1eb173b2-dd01-424e-9b95-5c099c408e8a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e24a1192-0ec6-4bd3-a1ab-b2bb3c0e6de8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total segment operating income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_775505b5-06fe-4605-a095-7ad81572d068_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_36638ac3-1fc7-49ac-91df-eaf97eb65a5e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax_8a59335a-04cd-424a-91eb-a90d44a1b476_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Reacquisition Of Equity Due To Debt Extinguishment, Net Of Tax</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Reacquisition Of Equity Due To Debt Extinguishment, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" xlink:href="lgnd-20220930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_3b3afe8e-6dd8-415f-914c-543e1bf186b2_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_374a85d2-1884-4ad4-b36a-4d7685371cdc_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_218de0aa-9484-4e73-a384-e8b02017a3fa_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_c6ba54b3-45da-416d-b801-0e762a9f4804_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc1fb2b2-2346-416c-b6aa-bd475344103c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_f8a5f032-ae75-450b-9e8f-1be722314e42_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued in public offering (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_e3fd160f-b214-49cf-9f64-783a73d8ffd8_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_6ccc42c3-ed77-4267-8d7c-be59f8c79fbd_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_fa3555e2-9ed7-4a95-90bd-3afc3acf1133_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_58c4070b-1ba9-4369-a868-3cf7f804a9bc_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent liabilities</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights" xlink:href="lgnd-20220930.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRights" xlink:to="lab_lgnd_LiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationTable_5293fd11-3d95-4881-af9b-3666b4588431_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable" xlink:href="lgnd-20220930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationTable" xlink:to="lab_lgnd_BasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_9087b1d9-9828-4daa-85bf-c0e874c34fd3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_438f64d5-54f9-4e24-9b6c-cf29a3356fa1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_674ff55e-1a56-48ee-b4d8-74aeaa3de700_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1e22a8c4-e952-4a88-a837-e9f8287a415d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_1bbd6982-f990-41c0-87c6-2038e39b44ad_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1b268fcb-56e6-4454-8d94-d1b2427d0195_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_c7287882-afc0-4453-b9f0-83e8d2cedb65_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual fund</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_afd795df-ff1e-4b93-87c1-c55d5681f854_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_ea670b2b-6f11-4407-9eb9-00ed148b3d0b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_34184325-3815-4372-8d77-bd758a231427_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate (shares per $1,000)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_344b4146-3f3a-421d-8058-3695b49db747_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_8f7c067a-0a1c-4f53-a7bb-cab0d6dc5c20_verboseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_c3b9cfc6-0b29-4484-aa09-4ec63e487a7f_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_b5ebb7fb-ed20-470b-92f5-724a5993faed_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_2c9fc8c0-6a0e-4785-9dcf-23781a4d8721_terseLabel_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfenex CVR adjustment amount</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_label_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, CVR Adjustment, Amount</link:label>
    <link:label id="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_documentation_en-US" xlink:label="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, CVR Adjustment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:href="lgnd-20220930.xsd#lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:to="lab_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_ba4eca5b-5b52-4fb7-ab09-7ec9c3ac27d1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_68474c2a-0ed3-4601-9d07-8c9383873746_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_663d43fd-10ee-47e8-b989-1d96e72a96b2_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CyDexMember_e10a6c57-79f4-47a0-a64e-32a2afc92c77_terseLabel_en-US" xlink:label="lab_lgnd_CyDexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CyDex</link:label>
    <link:label id="lab_lgnd_CyDexMember_label_en-US" xlink:label="lab_lgnd_CyDexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CyDex [Member]</link:label>
    <link:label id="lab_lgnd_CyDexMember_documentation_en-US" xlink:label="lab_lgnd_CyDexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CyDex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CyDexMember" xlink:href="lgnd-20220930.xsd#lgnd_CyDexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CyDexMember" xlink:to="lab_lgnd_CyDexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0fcda4d1-91f4-49cf-9926-ee9e8b2eadf5_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_29abb5fc-25f8-4751-ae96-4332825c916c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueMember_73177be7-82cf-4efe-a3e8-8ce0c3939795_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember" xlink:href="lgnd-20220930.xsd#lgnd_ContractRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueMember" xlink:to="lab_lgnd_ContractRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_df2045ed-31e1-43bb-97cf-da48567e37a2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_600584d9-e5ba-4ccb-82ab-9e8fe4ea9a84_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_aabb1926-7c08-4527-aec8-5195b41bdf39_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_8e7a0373-5b9e-44a3-b869-56bb7e9e6fb6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e5d2b2e4-60cf-4ed1-b10d-702d9222590d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_42a9269e-f16d-4515-bb5f-c26d13784797_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_a9f98a3e-da76-476b-8aca-d0bf2478a183_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_871d1f9c-e180-4bef-bc6f-7e5a35a7cad9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_456306fa-b1c9-41c1-b063-7208e14837e8_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9791c6f9-2488-4c80-8368-dff12bfd0ec9_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of September&#160;30, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_1f475dda-ac46-4b75-aaf1-252670f8b78e_totalLabel_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_label_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Current</link:label>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent" xlink:href="lgnd-20220930.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseLiabilityCurrent" xlink:to="lab_lgnd_LeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a8371d8f-fca0-493e-961a-6b8fe28cb3d8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_818e6396-125e-410e-b635-ad95c3830e8b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_23079a02-d470-434e-9799-85f36d22375c_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:href="lgnd-20220930.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:to="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_7761352b-2877-45ab-b2f1-fcbfc2fb4daf_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_1666892c-5b79-4852-b7b2-4177b09bfbcc_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options under convertible bond hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:href="lgnd-20220930.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:to="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_24bbf721-9339-4f1a-9b4b-c7c73e8793c0_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_71640128-fbd5-4ae3-a884-ad84c2dd6f6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_ebb03901-92e7-4bd3-b440-894a5050f637_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_5fcd8450-838a-4ec0-a0ed-2eaa3ebbc09e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_59c3275a-5f2b-4377-9d04-325ffc4831c2_terseLabel_en-US" xlink:label="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensor</link:label>
    <link:label id="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_label_en-US" xlink:label="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Owed To Former Licensor, Fair Value Disclosure</link:label>
    <link:label id="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_documentation_en-US" xlink:label="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Owed To Former Licensor, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:href="lgnd-20220930.xsd#lgnd_AmountsOwedToFormerLicensorFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:to="lab_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2f45d076-e5b4-43e1-97b8-cb85ee082898_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_b4e32c5e-59b4-4e40-b790-6b1f4a46e3c4_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtCurrent" xlink:to="lab_us-gaap_ConvertibleDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7209c29e-bc5a-4433-b659-706dd1e5f696_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_3b45bf8d-1a71-4557-8dd4-2ebb0d401991_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period for awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_774193db-cc1f-42c3-b54f-757891683925_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_7b0d6fda-1981-4c77-bd9d-f532b9df61c4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_9f38f6be-f6e7-4a80-8c98-2b1850d1b58a_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_ca7a3425-e7cb-4d19-8bfa-a2b00f5f832e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_38f2906c-452a-44f4-af77-13e0f2389c54_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e52822e2-be4a-4842-8e54-0de8676880bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_1c4747b4-c69d-4ccd-9763-bde2a629a4d0_negatedLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease (increase) of stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_ce2d4962-3fe9-42bd-a56c-9a56ac7c97a4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_b1e4ac46-9185-46b0-9593-cbc7e7604c5d_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:href="lgnd-20220930.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:to="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_39248986-f6c6-4a8d-88f9-fc7ca0c76b31_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses related to available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_1f1042f0-ae99-45f0-8349-3b8b1282a68e_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a165630e-05fc-4346-9850-9ab021a121d7_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2c2cc3fe-27d4-4c7a-9176-665e26cb30a6_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8e96767d-e14d-4262-bb32-af263c3192df_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization on finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_891fac37-c39e-43fd-bb90-705ef509d185_terseLabel_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide injection</link:label>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_label_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide Injection [Member]</link:label>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_documentation_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide Injection</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember" xlink:href="lgnd-20220930.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_TeriparatideInjectionMember" xlink:to="lab_lgnd_TeriparatideInjectionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_c48ad2ce-ce33-4a3e-8168-8daa715c98b5_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:href="lgnd-20220930.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b33bab69-5403-4062-a347-12df3e8f68ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_84352f63-5968-494f-a206-396da7cd0e3c_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMember_d3683667-7919-476c-b57a-55c63484a131_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember" xlink:href="lgnd-20220930.xsd#lgnd_LicenseFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMember" xlink:to="lab_lgnd_LicenseFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6bb71f29-c17d-42eb-be8e-01dae30d6253_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Level 3 Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_a5dcce4c-9713-4757-9951-1e5c8302adca_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_15b2169f-ef0c-460e-a67b-e9dcc36be506_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1f742872-0a39-40e8-aa57-866111e5353b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_b00c73b5-444e-452c-a4dc-4cca67a73c1e_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued from each CVR series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_15306fc2-670f-47e0-b41c-a6f75e26124a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_8eddcc65-8219-4cc5-b36a-b8f32c782f35_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_a058a52c-0bee-4d2f-858d-193cc515d8b2_negatedLabel_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in debt discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_label_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_documentation_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:href="lgnd-20220930.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:to="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_6af95723-dae5-4287-9528-87f7aa07786a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_e67ecb6a-ba4c-439c-91cb-409a6c3cd708_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4d0b2d24-663e-464b-8427-ea29a3f5575e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fce9a23f-ad3c-47ca-9969-4924cf6c2761_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f3b5126f-3dc0-454f-bda2-691f167c6068_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_4f4d10ee-827f-4367-b1a9-4bf104853e12_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_4725c30b-3e7b-4250-97f4-31ff43bd152b_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_a6db3583-4e50-4787-8733-0d17850821bb_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f0fa2dae-339d-490d-987a-ae7fb2d9aaaa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_8b0168b1-abc3-486f-88d9-cb54feb959f8_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_893fd190-b747-48ec-8578-4e93323e69d9_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to unwind warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_label_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_documentation_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToUnwindWarrants" xlink:to="lab_lgnd_PaymentsToUnwindWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_03b400a2-db5f-4512-a75a-0c0cf9ec1ad1_verboseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentPortionOfLiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:href="lgnd-20220930.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:to="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_fcdd15aa-d9a0-45ae-86a6-ab2546cfaac3_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_0d06084f-31b1-439e-b009-254685934060_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_0fa3f4a7-eea0-4699-affe-ff25e81bb18f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_feb91fc3-2083-470e-889a-2d2115ace1a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_65eec1df-fc90-4c55-b723-a6d40214e9d4_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the 2023 Notes outstanding (Level 2)</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_dd3eb2c9-ccb5-4b34-a1a6-9908cc6fc923_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_5c88c5c0-2593-42bf-afb6-5c7018d86e67_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR holders and other contingent payments</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:to="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_b8c504a9-c445-43d7-901f-0d2c507f1d9d_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_6466436c-fc08-4fbf-814d-30ce144d6600_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6cf5f280-8fc6-45cf-98e5-7c26b625c50d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable, weighted average exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseLiability_e60b9f38-752d-46c3-8c8a-b5c9cb2e62e0_totalLabel_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_lgnd_LeaseLiability_label_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_lgnd_LeaseLiability_documentation_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability" xlink:href="lgnd-20220930.xsd#lgnd_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseLiability" xlink:to="lab_lgnd_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_b3727bda-59c1-48dc-acb2-caa4f563c4d3_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_0f3194aa-4332-4715-a1fc-82403066601a_negatedTerseLabel_en-US" xlink:label="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less estimated tenant improvement allowance:</link:label>
    <link:label id="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_label_en-US" xlink:label="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Tenant Improvement Allowance</link:label>
    <link:label id="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_documentation_en-US" xlink:label="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Tenant Improvement Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:href="lgnd-20220930.xsd#lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:to="lab_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_84bc60ea-9614-43aa-823c-7190c1995a21_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_17fe13f3-a59b-4058-bcda-e513859e6315_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a23bdf82-a162-4a11-9ab1-168153ffbd8a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_c413c1cf-bb39-4339-8bbb-4617eab32525_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4fb802c8-0767-42af-9ffc-60310c646663_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d2b6088e-a08b-4179-a6f0-95eb007f275a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_64956eae-8006-44e8-9771-d0832bf77fc6_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_KyprolisMember_63a94637-6ea9-4791-a4fa-dbc38bc6c420_terseLabel_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:label id="lab_lgnd_KyprolisMember_label_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis [Member]</link:label>
    <link:label id="lab_lgnd_KyprolisMember_documentation_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember" xlink:href="lgnd-20220930.xsd#lgnd_KyprolisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_KyprolisMember" xlink:to="lab_lgnd_KyprolisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_ad6c7816-d68d-445a-a628-fab09b9e1e9e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_72ffea8b-241a-494c-b3b5-9d43bd5b3b86_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_baf016a5-8d3e-4552-936d-21195868a2b7_netLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_140f5e85-93ea-4b9c-98c3-cf8b8c4700cb_terseLabel_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes repurchased in August 2022</link:label>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_label_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Repurchased During Current Period, Two [Member]</link:label>
    <link:label id="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_documentation_en-US" xlink:label="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Repurchased During Current Period, Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:href="lgnd-20220930.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:to="lab_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_e9038988-d626-41d8-ab34-b6d36706b79a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ba9428af-631c-4fc2-98f7-0ad953112f26_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_fe37d5ad-4ccc-47d8-a101-c5fee38b8442_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e25880ad-d3ec-4dd1-ac43-b4581322f061_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_c20d7e0b-cd03-4efe-8bab-ba575b0710ec_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6ee88094-e8b2-4b26-9b2e-ff53f027a4b4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_becb1816-b060-4f32-b33f-3907f87dfa67_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_25306a3b-89ed-4e77-b464-ec26e2b8e7fc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_0ed1baa1-06f9-45bf-bb51-b2988a07ecb4_verboseLabel_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete technology</link:label>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentedTechnologyMember" xlink:to="lab_us-gaap_PatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_c03cc9b1-b776-4a0b-b015-caadf3276530_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Plan Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d265a986-da41-4b72-80ed-c2c3b38212fa_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_fe32ed3b-5b55-496f-b494-bc538392eeb8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_3278c64e-68f8-4e12-9045-7a678aaae5f4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_f3ffa5f2-2092-4401-b431-fe0ca5224250_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other corporate expenses</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_label_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8de5ebbd-17e7-499b-b12a-269bc7bef3b0_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Updates, Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_3fa8a7e4-08e5-42c3-bdc9-3b8bdd70d190_terseLabel_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payout range (as a percent)</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_label_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_documentation_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:href="lgnd-20220930.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:to="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_36b91565-27d8-4279-8c73-37468acf316f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_3a49de54-8701-4ed0-a93f-d68ef5cf0254_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount (including unamortized debt issuance cost)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4f3ca643-395b-4003-91b0-14e95d445274_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a21bae82-fadb-4015-8f33-9e7ae5ed2875_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9bc5a290-f0cd-44c3-b88b-0f8cd20f2a56_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_8df12439-08a8-4e70-8b6e-09086515e26d_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_abbb7668-8c8b-4f6e-97e0-d71fc7120420_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_af02a786-aa61-46d3-b96e-915256100910_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f5e2a86b-eabc-45b6-9b73-347c59d21d69_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9fd55c06-62d4-4dab-9127-4cf163d8b3dd_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_c78383ca-7d11-4edd-8ae3-0ab92309fdb9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_893a3258-f51c-4d5c-90c1-24745a81cf9c_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease of deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_30594ee2-feb9-4fab-b6d4-45e249083ed5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e0f44e1c-f4bd-4c0b-9371-83ae4f7873d0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3a89619b-09ea-45fc-a40e-14dd55e31be8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_92c8487a-0ac5-4caa-8c7e-a8cffa2bf3f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_5c28d4d9-3cb8-4134-9917-e5cf8a6bf176_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_cc1befc8-97bf-44ee-966f-b31c4ca1f62a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_84f19bf9-7b1b-40ab-b144-db30c954d243_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Balance</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_4b6f8553-16fe-4122-9f73-5efd90b7f5c1_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future purchases (in shares)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_38169f19-b731-4a2a-9cbc-60ffa1fc50f6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted per share calculations (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_249cdb26-67b2-4866-8d01-f11b0c48ad22_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e33c459c-94ba-402d-b2c5-9027fa9d6e1e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_392707b0-2d99-4394-adb1-3715fe044db8_verboseLabel_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounting for Share-Based Compensation</link:label>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:href="lgnd-20220930.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:to="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_055e93ea-9f70-4069-bd2c-e3ad8dd04125_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRights_ba3e1257-fb35-43c0-9f98-93c690c4536f_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights, net</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights" xlink:href="lgnd-20220930.xsd#lgnd_CommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRights" xlink:to="lab_lgnd_CommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_4e0d36c4-afc4-46f5-bddd-571ef7b8b9f7_terseLabel_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_label_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc. [Member]</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_documentation_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember" xlink:href="lgnd-20220930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_XCellaBiosciencesIncMember" xlink:to="lab_lgnd_XCellaBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EvomelaMember_e5940404-3bc0-4814-8b24-93f091f7c046_terseLabel_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:label id="lab_lgnd_EvomelaMember_label_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela [Member]</link:label>
    <link:label id="lab_lgnd_EvomelaMember_documentation_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember" xlink:href="lgnd-20220930.xsd#lgnd_EvomelaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EvomelaMember" xlink:to="lab_lgnd_EvomelaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_bc5db1b6-cadd-4b48-b659-d299e0ffa298_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dce17625-4dad-421c-99b3-6d582503b399_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_e661287c-0f70-429e-8641-799aff35e188_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_28d74f22-129f-48d3-926b-f6ef3104972b_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_88c839d7-fb8a-4fe0-a6e3-7d57717468b3_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 60,000 shares authorized; 16,894 and 16,767 shares issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_c50e0e31-43b3-4dbc-aa61-a652faef4b41_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_8c0de995-bedf-46ca-bb72-c47be8300f4f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_69d5aa80-611c-4a91-9bca-b195816be5eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_d30c4083-6cc1-4ed7-a3f0-441e6ca993e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_5fa39da3-62ef-448b-a26d-e07a7b42d39c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_fe589fa2-055d-4936-9be4-aeaacb4385f3_terseLabel_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_label_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases" xlink:href="lgnd-20220930.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedInventoryPurchases" xlink:to="lab_lgnd_AccruedInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_d78f600e-81f1-4302-807e-beebd063c3d7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_efba25f9-ac77-49ea-9327-6e1149e89ec2_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frequency of cash payments to CVR holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_label_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:to="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_5b02bd6e-c0e4-4318-885d-c08bbbf2128f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e0c2366d-2b4f-4a19-b14d-48ba0997aea7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_95388273-02a2-4b13-bc5c-30804bc1dd0f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_88e4ead1-9f85-4a99-9780-15d12e044b86_terseLabel_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating and Finance Lease Assets and Liabilities</link:label>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_label_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Leases [Table Text Block]</link:label>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:href="lgnd-20220930.xsd#lgnd_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:to="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_b36ab5c8-da30-4469-87f2-b87f575e3528_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid-in-capital from warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8b10d367-ac92-452c-856a-3664df296057_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and Contingencies: Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_2724e96c-a460-4b0f-8410-19b198084995_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_5eab6e5d-45b0-4dcc-a198-7b0ea88acc96_netLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_4b0907bf-88c9-469f-9e2b-7ad892fb7b6f_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol - Core</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, Core [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, Core</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolCoreMember" xlink:to="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_f9316ec4-6632-482a-83ac-1cb5cb6d3bbf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock option exercises and ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4583a74e-5ac1-4e41-b815-ce01db90d293_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_5e793121-3ec1-4be4-a326-d0b7327c621b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ece8cba8-008e-430d-8996-4e5c66b1fbd0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued fixed asset purchases</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_70bbd5e9-c3af-4e63-b259-d50b3434fa0b_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_64264a8e-2e6a-4e40-b885-d0aa221c63e7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_7b547514-dce0-4ba1-ab93-383f9eea24f4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3bfe236f-091d-4b31-81a6-ab5be6ae8cd7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_41af5a62-54bf-4256-8647-8d5d34707926_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f81152e5-2b9c-48ab-97ad-36e85bdd274a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_bb3bb51a-c62f-4091-ac45-738a8bd2292a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1a4f87c2-9b4b-4326-ab3a-0c29c66eefd6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_8248453a-9a85-4e86-990e-ebd652b193f3_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_9238a1a5-26a4-4e5d-9f61-ab86b8ebcf67_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of the 2023 Notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_854bf8e3-85e0-4a4e-85cb-088de0c5ab81_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolMember" xlink:to="lab_lgnd_MaterialSalesCaptisolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_60f923cb-7e6f-43e3-a901-bddd56b4c7f9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of civil complaints filed against entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_969640c9-b73f-4f50-9f18-df2b22a44de2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_d4902c4b-4174-42f5-ae8c-b227e0220d6c_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_93694199-a3e4-45af-8d6e-84df902f5da5_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVR Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_label_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_documentation_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:href="lgnd-20220930.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:to="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_979af048-bbc3-4128-9a2e-277ac5e328c6_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_2c14ec43-1bee-462a-8e74-29796a02fc1b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_99747ebd-0bf3-4ab6-bd95-232e9f0fb041_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_7831387f-9c0a-44df-87ee-6d359299a106_terseLabel_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses adjustment related to COVID-19</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="lgnd-20220930.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_abb0b073-81a6-4955-a306-8daeb16df862_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_f3bfcde3-48a7-4998-b414-387b3ae918a9_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_43ebddfe-e26c-4e16-9c5e-ab2973249ebd_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_e01c3762-3fce-4a96-a52b-f510a37d1407_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_4eace189-a883-4f52-851c-58d033381e99_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mark-to-market adjustment of CVR liability</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:to="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_f58a496b-6f1d-4833-b967-28b9d515e878_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_documentation_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:href="lgnd-20220930.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:to="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_ce6f70c7-9ed4-46da-9044-5a181d4fd275_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_801ef62e-4875-427a-b3d7-ba5529f30809_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_070d55e4-8054-495c-b9a6-09491fd9f1b8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a5170a91-0d96-494c-a7e8-eebb2c726bcc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyOtherMember_c387af44-adef-4cc0-ac40-c283c6ba17e2_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_label_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember" xlink:href="lgnd-20220930.xsd#lgnd_RoyaltyOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyOtherMember" xlink:to="lab_lgnd_RoyaltyOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_4860fab6-7e18-45d0-a52a-3c0b728ad995_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_645503a1-3a49-40c8-a84e-2aacebe9e312_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total goodwill and other identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_36c93553-1711-471d-bc78-29ebc2257943_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_3b1056b1-e569-4408-b7a3-db6887b5669b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_54d331f9-a948-4748-b582-2508637a9356_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_bcc245e4-48c8-4e94-9a79-765152fa2301_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_8101bd4d-07f0-4eea-b656-2dc931565ab8_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_b0f455f2-de70-4d66-9782-6b39e70d2997_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments to contingent liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5e6e61ff-ad76-4e1f-9683-130539f995ba_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_ff642bc7-f0e4-4c76-972a-81866ee419b1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_224f29ac-4149-4d16-a1b0-d4d09a9a0822_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_785bb713-bfaa-40fb-9602-0fb7e364babc_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_84b3c69e-e824-4198-82d7-dca3773b3ba4_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_35586b73-eadb-4802-9b36-26d24ec9f348_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7e8f33ef-65e1-4ff9-975e-68aa2dfca99b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_55558765-7c8e-4377-8d33-7ff285f2e6dd_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d26bdaec-225c-406e-8c6c-47112deef63f_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c80f97f5-6cdc-43c3-a010-09040118e3a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_34a04ff3-668a-431d-9efd-cf9eb72af531_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_eba1c0fd-8ccc-41cb-8a2b-6c548bf01f96_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_2782026c-4bab-4772-bb67-8c29b7e8feaa_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_0b7932a6-7f10-4ba6-a477-82d1776e70ba_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_033388ce-b0c1-48e9-8c74-0f10c8b88904_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was previously deferred</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_e68f3def-8660-4ac6-910d-d9011276ecce_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MetabasisMember_aaccae68-7bf2-4f26-9f82-91a76e914ed1_terseLabel_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:label id="lab_lgnd_MetabasisMember_label_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_MetabasisMember_documentation_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember" xlink:href="lgnd-20220930.xsd#lgnd_MetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MetabasisMember" xlink:to="lab_lgnd_MetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_a5d40ab5-2540-4f5f-a0e9-b0864c63d2d5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_111a2bbf-a3ee-48a4-be27-0636a58f2f53_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_bbae9678-e476-4639-bfc8-6629c65ee87f_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_8eb5308c-bae3-4af4-847a-18dfd08807d3_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_db1e3801-c916-4a68-b039-f7a4f9deadf2_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_297ffc13-07a3-49b3-ae5e-85afa9cf862f_verboseLabel_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of commercial license rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_label_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Commercial License And Other Economic Rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_documentation_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Commercial License And Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:href="lgnd-20220930.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:to="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_a688fb0a-a752-4b87-bbba-a1e3f3a75653_terseLabel_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:href="lgnd-20220930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:to="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_f097dab3-b5f9-4842-acd5-e418627516d7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a20b2c2b-c8ec-458b-b08c-3d1a41c77d0a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_7e8ddd4a-d867-4716-8d8d-72b1e165a065_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6ec473e7-c74a-4ad7-871c-0f9967885205_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_OmniAbMember_5d7e302c-72b1-4c58-a950-12b0f366f361_terseLabel_en-US" xlink:label="lab_lgnd_OmniAbMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb</link:label>
    <link:label id="lab_lgnd_OmniAbMember_label_en-US" xlink:label="lab_lgnd_OmniAbMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb [Member]</link:label>
    <link:label id="lab_lgnd_OmniAbMember_documentation_en-US" xlink:label="lab_lgnd_OmniAbMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbMember" xlink:href="lgnd-20220930.xsd#lgnd_OmniAbMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_OmniAbMember" xlink:to="lab_lgnd_OmniAbMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_041c1138-7b58-4d4a-bd0a-a5a8640d8b0d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:to="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_bdf43115-0c8c-45c1-87ac-d18741e833b5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_8eafac05-43dc-418a-ac37-b23a5d504e25_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_dcc47c67-73e7-4ee8-9ca0-218c2912409f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_8c40136e-f9b0-4352-8705-c01f9e33f078_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_2131be63-33f9-443a-9919-18b877cc82f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_d751d466-3925-47ce-8038-dbe9361afd95_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a43c8b79-5931-4f6f-b37b-0fdc22aa0c9c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d21335c3-0189-48e0-89b2-fb463c946f16_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_a6e18538-9681-469b-891a-b2b392f07d64_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f8f2b7e8-5b5b-40ff-8b00-237ef22a29a3_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investments, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_eb78b168-c389-4656-a305-2f7573460d68_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9187bada-d6c6-46bc-9e91-26bdced99461_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_ad66a4c9-65ec-4224-910e-12eb49169e1b_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US government securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_558da0cf-baee-494a-8395-ac37e8d90c7d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ee5187ae-aa0d-4b8c-9006-27132caa6c02_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_e7ff45aa-7b59-4d46-b5d7-7bb37da3fc98_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7d72c310-6752-4504-bc35-9b4eb3defb6c_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_0cdd8963-9bde-4efb-ae1a-c9d8e9ea094d_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant and bond hedge unwind transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:href="lgnd-20220930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_b85b51bb-5577-40a2-ae44-d035d1f44496_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_1687033e-1e35-459c-89f5-830d9cc087b5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_55f16f1a-1f5e-414b-a409-9a849e58af12_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_6ee897b4-5cd4-4b88-8012-21c7774a32b2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_188b0a67-8ae6-4404-a8c5-ec0a906b0b56_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_d65f38b2-17b5-4f47-8cb6-338aafd7bd6c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger to classify convertible debt as current (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_d7c50efe-a748-4bf5-9aa5-4f6aec0f8ed5_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_e89dccf9-ad24-4dd4-86c2-eff7fbc5ad4d_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c7780c72-92fb-4d73-b677-844e75fcf12b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_99e25932-bb56-4386-9b99-2a79e923f733_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in basic per share calculations (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1011940b-238f-4bba-a708-a8fe19bd9d4a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RylazeMember_c926bc78-751f-4c26-b88d-68c070484e89_terseLabel_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze</link:label>
    <link:label id="lab_lgnd_RylazeMember_label_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze [Member]</link:label>
    <link:label id="lab_lgnd_RylazeMember_documentation_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember" xlink:href="lgnd-20220930.xsd#lgnd_RylazeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RylazeMember" xlink:to="lab_lgnd_RylazeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_7cb31e5e-7d67-4dec-b786-aa09e907464b_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout rights recognized</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_89ea79a0-0c1c-4e17-86a4-2f953bbcca85_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Investments</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:href="lgnd-20220930.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_ea16a1cc-7078-4a4b-b05c-0c00e7eacad7_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_b37f1e2f-bcb9-45a6-ac68-df9bd7d58354_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash activity:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_c5eb4908-d14d-4a68-9cbf-4e0803a1801a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c0e0f6e5-9c57-40b0-9c22-0e99c479aacf_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4859da24-b200-4b7e-9555-f0323376b6e8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3dcdffc9-da66-4043-8402-933d96c4b838_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_6cc307cb-e5ca-4840-89f6-5058dff5bd2c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_b8d5b543-cd29-405f-a339-ca71f27ed390_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Revenue from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_add01347-f3ee-4bf0-bc60-bd2b8acbb14b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_1f1f606e-d127-4fca-af34-5ab4763ea56b_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_4754f765-8a20-45e7-a1a0-2bcad4970ed4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_0c13263f-5e25-4cf7-86ca-c063af1c6bbe_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_98326b74-670d-4d05-9189-c3aa8a95f1e2_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b5925772-160c-4165-a350-4fb2393430bd_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d56f0ec1-3358-431a-89b4-6d53d5700c40_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_88bb7e3f-1286-415f-a45b-6409f08e92bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable and payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_416ab93a-39f3-499e-8cee-4ebde3ea3476_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_e71bd090-4a2d-4d8f-a7d0-3bc12dba7bf1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_96b71800-2884-4cd1-b3b1-0f9705606524_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_b3b2fa18-536a-4f74-bbff-52c812e5917a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_565e662f-c7e3-4267-a0dc-cd56db8f016a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AtTheMarketEquityOfferingMember_0c91b7e7-caba-4992-ba35-c0ebf09f3a67_terseLabel_en-US" xlink:label="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-the Market Equity Offering</link:label>
    <link:label id="lab_lgnd_AtTheMarketEquityOfferingMember_label_en-US" xlink:label="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The Market Equity Offering [Member]</link:label>
    <link:label id="lab_lgnd_AtTheMarketEquityOfferingMember_documentation_en-US" xlink:label="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The Market Equity Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AtTheMarketEquityOfferingMember" xlink:href="lgnd-20220930.xsd#lgnd_AtTheMarketEquityOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AtTheMarketEquityOfferingMember" xlink:to="lab_lgnd_AtTheMarketEquityOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_1fc96d36-bb5f-4a8a-a53b-d72b00542c69_terseLabel_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_label_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi [Member]</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_documentation_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember" xlink:href="lgnd-20220930.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisAndDianomiMember" xlink:to="lab_lgnd_SelexisAndDianomiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_695241f7-9c3d-4adf-9c49-1bd261b21341_negatedLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss adjustments of finite-lived intangible assets</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:href="lgnd-20220930.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_1847bf11-c351-4a28-a536-d9ac6d97d5b7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_7cbca922-3230-487e-9f82-3e45e3d4903c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period in force of stock repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_00148e25-7179-4012-8433-a5005eb342a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ad002f86-a502-414b-9f82-ae556c0caeb9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LigandCoreBusinessSegmentMember_7e304a2e-ce37-4a78-a5ab-a2433802a4fd_terseLabel_en-US" xlink:label="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand core business</link:label>
    <link:label id="lab_lgnd_LigandCoreBusinessSegmentMember_label_en-US" xlink:label="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business Segment [Member]</link:label>
    <link:label id="lab_lgnd_LigandCoreBusinessSegmentMember_documentation_en-US" xlink:label="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember" xlink:href="lgnd-20220930.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LigandCoreBusinessSegmentMember" xlink:to="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8aafbdf9-9e19-4634-92ad-696a05c5bca0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostDirectMaterial_f7713c03-5d09-49fe-a76e-10fe040ac867_terseLabel_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Captisol</link:label>
    <link:label id="lab_us-gaap_CostDirectMaterial_label_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Direct Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostDirectMaterial" xlink:to="lab_us-gaap_CostDirectMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_87b20fe4-09c2-48d2-9c4f-416d4d99cc63_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_1440bea0-0e7b-4045-a2da-850387011e93_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_645486ea-52ef-440d-918c-4ea0fd0a6ebd_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_1e28d13d-4632-4d12-8c70-e741f4d5f036_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_370e4758-64f6-42ac-901c-e071f44fd0b8_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_923ec7c3-904e-4e1d-af4c-a04bcf1d0e89_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_221b2e4d-ad70-4cd7-b663-18fa0c5aad9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_31f226b4-e141-4fc2-94e1-607080999e0f_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_b7b66478-1eb7-4ee9-8570-72042ca30d9a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositsMember_69a70b3a-65d5-4d34-968b-d8327adfa950_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositsMember_label_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositsMember" xlink:to="lab_us-gaap_DemandDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_526fe029-65b9-4bd5-a753-c0207ab55f26_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c08405a7-deb3-409d-ad34-b3d838d237ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestoneMember_3f326596-a654-4a05-ba79-6559de0bca30_terseLabel_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:label id="lab_lgnd_MilestoneMember_label_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone [Member]</link:label>
    <link:label id="lab_lgnd_MilestoneMember_documentation_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember" xlink:href="lgnd-20220930.xsd#lgnd_MilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestoneMember" xlink:to="lab_lgnd_MilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_e5f1dd29-4953-42c6-889e-7f58fee2cff8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b47f2051-0a40-406c-9969-084f6979620f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_059c47d4-5e14-45d7-ba1d-b5ce306c7c07_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_a34b79ba-dc0f-4ab3-be7b-5ea6b9fed759_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_d96755ed-1cb6-483b-8958-e9182ea3cd80_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_82044293-2db2-468d-91f6-4bbe3825a4fd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SaleOfStockAuthorizedOfferingAmount_17c212ac-1965-40d9-829e-6e5a2c5f5d4a_terseLabel_en-US" xlink:label="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, authorized offering amount</link:label>
    <link:label id="lab_lgnd_SaleOfStockAuthorizedOfferingAmount_label_en-US" xlink:label="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Authorized Offering Amount</link:label>
    <link:label id="lab_lgnd_SaleOfStockAuthorizedOfferingAmount_documentation_en-US" xlink:label="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Authorized Offering Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:href="lgnd-20220930.xsd#lgnd_SaleOfStockAuthorizedOfferingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:to="lab_lgnd_SaleOfStockAuthorizedOfferingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_76419309-d405-4c75-a84a-09e6292097c9_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold of debt trading price trigger (as a percent)</link:label>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_label_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:href="lgnd-20220930.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:to="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_fc52bfd2-8ee6-405d-b394-1d257c7eef42_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_16913850-f340-4779-b681-e98cd5e9e393_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_282d0fba-02e6-486f-a1bf-15a594c83a08_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible bond hedge settlement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_3587df24-98fa-42eb-83c7-5c5dd8020767_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_562441bb-342a-47fb-9c73-1a9428ccd675_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4ceed025-84f7-439b-ba49-cf908b0e59b3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_e9028326-5311-4ecf-8254-fbcb8d037ef1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_ffda4e5d-2a9b-4ed2-8201-222861dd8e7e_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_2d62de37-9b69-4af7-a2a4-6d9fb1979bcb_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_780fb6c1-7722-460c-b670-7c2efd1848bb_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_45754279-3fe7-4066-9c25-7311a03ecad7_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_07cd19bf-4468-430d-b35a-e6659a700596_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a386c4cd-53aa-439a-89a7-5d26955c8cfa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_8b9cbe34-f9f3-4bff-a479-6b724e5d38f6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_b1144fe5-6413-4be4-871c-4799617c6eca_terseLabel_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Convertible Senior Notes</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_label_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023 [Member]</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:href="lgnd-20220930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:to="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_47dfab64-3411-495f-9210-905928d023c6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for OmniAb transaction costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_a79c30ec-ae17-49f4-8ad6-ea5c77328b28_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EmployeeStockPurchasePlanMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:href="lgnd-20220930.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:to="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_4c8ebb53-45a2-4bb7-8ba1-047c90cd20b6_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on AFS investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_79d06eac-29a1-4b67-8a59-c661c219b27e_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_330c5840-040d-4d92-b0a6-c3d3a97120b6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_b76e055e-823d-4e6b-96e8-b52e811af5cc_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_2af6bf12-de9f-469c-b36f-293a52bd87c1_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_468b5ac5-b619-46ee-af6b-4edd0137ee01_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember" xlink:href="lgnd-20220930.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueServiceMember" xlink:to="lab_lgnd_ContractRevenueServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_5b8aa306-d0dd-4f73-9a21-48dce85e3d34_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_f719ff4d-7c59-49ed-b2e2-2222eb91e677_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_84be4850-a231-45c3-a3c8-b502922a11d2_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_96fdde95-9178-4d01-a567-fcc5ea169ecc_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_66a5e5e1-2c53-43c9-a1ea-c0dbdf4e5a6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share purchase price as percent of market price (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_18c8ff0c-8d12-4755-83a1-871f1358f7b4_negatedLabel_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) from short-term investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_label_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_documentation_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments" xlink:href="lgnd-20220930.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GainLossOnShortTermInvestments" xlink:to="lab_lgnd_GainLossOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_744c4b0d-d174-47c7-8597-171f57445cd1_terseLabel_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_label_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix [Member]</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_documentation_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember" xlink:href="lgnd-20220930.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoAndCorMatrixMember" xlink:to="lab_lgnd_AziyoAndCorMatrixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContingentLiabilitiesMember_dcd94862-b485-45bc-b846-6be0553e1033_terseLabel_en-US" xlink:label="lab_lgnd_ContingentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liabilities</link:label>
    <link:label id="lab_lgnd_ContingentLiabilitiesMember_label_en-US" xlink:label="lab_lgnd_ContingentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liabilities [Member]</link:label>
    <link:label id="lab_lgnd_ContingentLiabilitiesMember_documentation_en-US" xlink:label="lab_lgnd_ContingentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilitiesMember" xlink:href="lgnd-20220930.xsd#lgnd_ContingentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContingentLiabilitiesMember" xlink:to="lab_lgnd_ContingentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3cccddbe-2aa3-447e-985a-d03e212c653a_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8b8e5641-d1b4-49c2-84f9-eba983446ff1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Source</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_b290c9f2-ab34-40c9-bf4a-569c7f44968c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to convertible bond holders for warrant purchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2f2c05ed-0f57-4360-902f-6f6ad4d80846_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ac69bd3-b489-49a3-963d-ee8dabfab805_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IcagenMember_0236adca-131e-4f53-b81b-d6cc8da34d0e_terseLabel_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen</link:label>
    <link:label id="lab_lgnd_IcagenMember_label_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen [Member]</link:label>
    <link:label id="lab_lgnd_IcagenMember_documentation_en-US" xlink:label="lab_lgnd_IcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Icagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember" xlink:href="lgnd-20220930.xsd#lgnd_IcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IcagenMember" xlink:to="lab_lgnd_IcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_1c0d85a3-db56-4314-b9fd-a6d95d4b986b_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_abac0ed9-df19-490c-8e98-cadc3d878950_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_b1c3dd77-6090-410c-b6a9-345f177868a4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_dd99f481-f85b-49c3-ad14-d4b7f0a8cdbe_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_12ccb1bd-980d-4e7b-bb07-44449367ec9b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2f559dbb-ff69-43e3-be50-c47da1f0c58f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_be251ed4-edf9-4630-89de-0c4216f92acc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8fa7e39b-3f07-4766-8290-668201848806_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_bbfadb1b-6508-4445-9496-6deb05f3360e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_1b2caba0-bda4-415c-b329-218d654d7d50_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b7a9c4eb-35fb-4c48-9586-eb94f088dcb4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_5fd69a16-dad7-40e1-a6b6-1f0b621f2dc7_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_5eaec471-d954-4808-bc9f-f2ed924a9fb7_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2a062563-82a4-4bdb-9d5b-20b9d319a7b5_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_d3bd671f-db2b-4189-95ba-4db7b7636363_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_8c7f670a-7676-4e67-a273-4fce4feb723d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_cb881437-b733-4687-bfec-8774f90efa10_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_e866ab9c-bd59-47fc-98d2-ff0b2608e913_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_c203493b-32de-4d26-9645-940f0bd62fee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_95a729a6-b582-44fe-9eed-d18396b59ad7_terseLabel_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities from xCella asset acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_label_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_documentation_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:href="lgnd-20220930.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:to="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fbc4d502-c509-4673-8b41-19c9afcd3f5d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_62d001f6-b309-4f04-9b28-dccb25566355_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (Loss) Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2441255a-7a9b-48d5-9bce-42691daf1b33_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_774e51e4-2661-4692-82dd-87e4b3763bdb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_a6910927-ab43-4a3f-bd85-ad6083426a6f_terseLabel_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest portion of repurchased amount of debt instrument</link:label>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_label_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Notes Payable, Interest Portion</link:label>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_documentation_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Notes Payable, Interest Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:href="lgnd-20220930.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:to="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_5e07b5a4-6415-4079-8fe7-bd9ac1b20ddc_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol - COVID</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, COVID [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, COVID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:to="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_91a34dbf-0b60-4e0f-ae58-c2e8ec1572ee_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_234de521-21e2-48bd-945a-26519221bb93_terseLabel_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_label_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio [Member]</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_documentation_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:href="lgnd-20220930.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:to="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b2fde425-9642-4e38-8820-70d56bae057a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_9ac1c1ff-1800-4412-84af-ad6df9d14a44_negatedTerseLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:href="lgnd-20220930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_e6c3126d-915f-4b58-bf4d-ee785e1ccb58_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_7173949b-6f31-4191-993a-6727c8a0e7d7_totalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total short-term investments</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, FV-NI</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:href="lgnd-20220930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_66eb0a7e-0267-4652-8238-7e40796d438d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_6c0b1fd4-a79e-4c5c-b4c0-d98c52e1bc1f_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_289dd8bb-3b08-462a-b19b-8d06c8bdb0aa_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_7054e012-8123-4d48-8c38-94f960bb08fb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>lgnd-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7b2ea99b-5e75-4f19-8ddb-22eedf3c9f68,g:96c50209-ed52-4eb8-96bc-4f2a516dad9f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/Cover" xlink:type="simple" xlink:href="lgnd-20220930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_46f8b0ea-afb1-48a0-83ca-c5cfb04fcf35" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_DocumentType_46f8b0ea-afb1-48a0-83ca-c5cfb04fcf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_710d4d59-6a2e-42b3-b447-f2b6693b7177" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_DocumentQuarterlyReport_710d4d59-6a2e-42b3-b447-f2b6693b7177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a314d303-bfcc-44fb-9d88-6d29231c42d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_DocumentPeriodEndDate_a314d303-bfcc-44fb-9d88-6d29231c42d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_0f8fe3f3-0b85-4854-ab9e-f2a256822285" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_DocumentTransitionReport_0f8fe3f3-0b85-4854-ab9e-f2a256822285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2c7c4b41-017b-48cf-a213-89de43f6394a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityFileNumber_2c7c4b41-017b-48cf-a213-89de43f6394a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e1130e6d-a28a-426b-928d-6d0020378f7e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityRegistrantName_e1130e6d-a28a-426b-928d-6d0020378f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7aa83c47-9348-47a1-aa37-3baf34aa44f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7aa83c47-9348-47a1-aa37-3baf34aa44f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_adff7e77-ee5b-4e89-8bd7-b9230abd7460" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityTaxIdentificationNumber_adff7e77-ee5b-4e89-8bd7-b9230abd7460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2f0101e1-8204-41de-9e09-19b40687bd9d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityAddressAddressLine1_2f0101e1-8204-41de-9e09-19b40687bd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_94cc4605-2f55-46bf-839a-78dadaa336b5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityAddressCityOrTown_94cc4605-2f55-46bf-839a-78dadaa336b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f61bb613-9936-47c3-91d2-b3dbf2d05d67" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityAddressStateOrProvince_f61bb613-9936-47c3-91d2-b3dbf2d05d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_07b9dc59-c3e9-4f35-beda-f4a475f81b23" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityAddressPostalZipCode_07b9dc59-c3e9-4f35-beda-f4a475f81b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9ed5b651-e625-4501-8dd2-8a778f9a1f26" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_CityAreaCode_9ed5b651-e625-4501-8dd2-8a778f9a1f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_576f3c87-2cb3-442c-abfa-1a53d87c8212" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_LocalPhoneNumber_576f3c87-2cb3-442c-abfa-1a53d87c8212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8383113f-e525-46cb-b599-0cf84d6eda1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_Security12bTitle_8383113f-e525-46cb-b599-0cf84d6eda1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ca771a9d-a171-4407-b587-29cc7a9c4a87" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_TradingSymbol_ca771a9d-a171-4407-b587-29cc7a9c4a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f1436069-494d-4d7c-866b-d22f38835ac2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_SecurityExchangeName_f1436069-494d-4d7c-866b-d22f38835ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_cc0e2875-8ccf-4aba-ba21-c2eb5fe211b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityCurrentReportingStatus_cc0e2875-8ccf-4aba-ba21-c2eb5fe211b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_80b645be-ae42-477e-af62-dd7f1f30b96a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityInteractiveDataCurrent_80b645be-ae42-477e-af62-dd7f1f30b96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_81795261-f077-44cd-9d41-d106244bd69c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityFilerCategory_81795261-f077-44cd-9d41-d106244bd69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_22cecd99-12b0-449a-850c-c97d7d96a70f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntitySmallBusiness_22cecd99-12b0-449a-850c-c97d7d96a70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_aad66487-c07a-4189-a7ed-6b17c569f150" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityEmergingGrowthCompany_aad66487-c07a-4189-a7ed-6b17c569f150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3a7387f9-d70e-4e51-b478-45e64985c739" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityShellCompany_3a7387f9-d70e-4e51-b478-45e64985c739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b481080d-8e6f-4f83-889f-207e64361cb6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b481080d-8e6f-4f83-889f-207e64361cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b7d91b50-a0ea-4b53-af81-47f5e64f7993" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_AmendmentFlag_b7d91b50-a0ea-4b53-af81-47f5e64f7993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_16e6a515-aa12-4231-95a8-30c13c17abaf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_DocumentFiscalYearFocus_16e6a515-aa12-4231-95a8-30c13c17abaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c57408d4-f009-4060-882c-bde91d316676" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c57408d4-f009-4060-882c-bde91d316676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4ef019fd-f32d-4403-853c-ba0245755586" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_EntityCentralIndexKey_4ef019fd-f32d-4403-853c-ba0245755586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_0daf914f-2f27-4b8f-8cb0-9845155be789" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1d300deb-4039-4542-8fd7-c5ef0c904fc1" xlink:to="loc_dei_CurrentFiscalYearEndDate_0daf914f-2f27-4b8f-8cb0-9845155be789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_79dd277d-d141-46cd-825e-67e5cb1634bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79dd277d-d141-46cd-825e-67e5cb1634bc" xlink:to="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1870aca5-95c9-4829-9cfa-a57142b9aad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1870aca5-95c9-4829-9cfa-a57142b9aad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81f1a517-a23a-4a33-acb3-5cd1c6aa4570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1870aca5-95c9-4829-9cfa-a57142b9aad2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81f1a517-a23a-4a33-acb3-5cd1c6aa4570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_c78abc4d-7051-4e81-965b-bb74b4f45f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1870aca5-95c9-4829-9cfa-a57142b9aad2" xlink:to="loc_us-gaap_ShortTermInvestments_c78abc4d-7051-4e81-965b-bb74b4f45f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_136eb994-e2d0-4d98-ae6b-dd0850542236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1870aca5-95c9-4829-9cfa-a57142b9aad2" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_136eb994-e2d0-4d98-ae6b-dd0850542236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_17177585-17fb-41ac-b884-2d3761ce5996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1870aca5-95c9-4829-9cfa-a57142b9aad2" xlink:to="loc_us-gaap_InventoryNet_17177585-17fb-41ac-b884-2d3761ce5996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_4a21b594-cb59-478b-b76a-6c17d06cf85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1870aca5-95c9-4829-9cfa-a57142b9aad2" xlink:to="loc_us-gaap_IncomeTaxesReceivable_4a21b594-cb59-478b-b76a-6c17d06cf85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_3e7d30a1-21de-468e-830e-e94f5f3a5255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1870aca5-95c9-4829-9cfa-a57142b9aad2" xlink:to="loc_us-gaap_OtherAssetsCurrent_3e7d30a1-21de-468e-830e-e94f5f3a5255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cb613550-6ff3-4211-bbc7-59c2aa51908d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1870aca5-95c9-4829-9cfa-a57142b9aad2" xlink:to="loc_us-gaap_AssetsCurrent_cb613550-6ff3-4211-bbc7-59c2aa51908d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_f959708b-8a0f-42c0-bf50-60106b95a8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_f959708b-8a0f-42c0-bf50-60106b95a8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_258c02cf-e7e3-4274-afa8-347848385ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_258c02cf-e7e3-4274-afa8-347848385ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dba8d61c-33ab-4786-a605-ef4131021ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:to="loc_us-gaap_Goodwill_dba8d61c-33ab-4786-a605-ef4131021ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_de87e29d-df95-4b50-bb57-76ad6da8ebb5" xlink:href="lgnd-20220930.xsd#lgnd_CommercialLicenseRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:to="loc_lgnd_CommercialLicenseRights_de87e29d-df95-4b50-bb57-76ad6da8ebb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_24a22d25-1ee4-4901-bc6e-06fd6152ab08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_24a22d25-1ee4-4901-bc6e-06fd6152ab08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_16dff998-54b9-4e0e-b0d6-9ed782fa1995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_16dff998-54b9-4e0e-b0d6-9ed782fa1995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_b8d02dec-123f-4e9b-a593-8e6c28115d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_b8d02dec-123f-4e9b-a593-8e6c28115d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_deffd545-46c8-478b-b844-bddacc551f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_deffd545-46c8-478b-b844-bddacc551f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_54805c0d-c09d-4ebc-b6fc-24d56979ef40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e8dbbaef-4c63-4915-9950-c9f4997c90d3" xlink:to="loc_us-gaap_Assets_54805c0d-c09d-4ebc-b6fc-24d56979ef40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_79dd277d-d141-46cd-825e-67e5cb1634bc" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_5fa5c1a6-0052-4d45-b15b-05077bcd5723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:to="loc_us-gaap_AccountsPayableCurrent_5fa5c1a6-0052-4d45-b15b-05077bcd5723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_17476609-ffeb-4ab8-a6cb-90fe7e4ed3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_17476609-ffeb-4ab8-a6cb-90fe7e4ed3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_f1487bfd-8667-4e83-94e0-baadc244ce95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:to="loc_us-gaap_TaxesPayableCurrent_f1487bfd-8667-4e83-94e0-baadc244ce95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_18aa0f13-55a7-46e8-ad11-57989ae890b9" xlink:href="lgnd-20220930.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_18aa0f13-55a7-46e8-ad11-57989ae890b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_662084b8-bd11-4b9e-8e70-d240919b2ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_662084b8-bd11-4b9e-8e70-d240919b2ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e861a083-c0aa-4c72-9abc-8d948c51e8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e861a083-c0aa-4c72-9abc-8d948c51e8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_4102339e-64c1-445a-8ae1-373eff71ffe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_4102339e-64c1-445a-8ae1-373eff71ffe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtCurrent_7b1ed724-eb37-42fc-a028-3519b65c6206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:to="loc_us-gaap_ConvertibleDebtCurrent_7b1ed724-eb37-42fc-a028-3519b65c6206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_274fd6ac-f82e-45ce-a610-d13c8ef16bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3b53b0b4-6955-4974-a995-49843dccfb5d" xlink:to="loc_us-gaap_LiabilitiesCurrent_274fd6ac-f82e-45ce-a610-d13c8ef16bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_2ae993ee-7bd1-48db-8569-2002bbb1a440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_2ae993ee-7bd1-48db-8569-2002bbb1a440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_108dc978-6ad2-4606-b475-ee9df16fd71a" xlink:href="lgnd-20220930.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_lgnd_LiabilityForContingentValueRights_108dc978-6ad2-4606-b475-ee9df16fd71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_998bd577-ce57-4610-abc8-f6adbfba7114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_998bd577-ce57-4610-abc8-f6adbfba7114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3e58051e-2563-454b-813b-21ab66da9d95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3e58051e-2563-454b-813b-21ab66da9d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_8364ba61-b3dd-445a-9583-77a41193a34d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_8364ba61-b3dd-445a-9583-77a41193a34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8062f399-2196-477a-85a5-5be5db649609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_8062f399-2196-477a-85a5-5be5db649609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8ccda501-5d71-4812-aa90-60799d4e88ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_us-gaap_Liabilities_8ccda501-5d71-4812-aa90-60799d4e88ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7b832377-fa9e-493d-bde5-72b19569e3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7b832377-fa9e-493d-bde5-72b19569e3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_d856d5ce-ca42-4e6a-b654-1003dc162d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_us-gaap_StockholdersEquityAbstract_d856d5ce-ca42-4e6a-b654-1003dc162d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_5131aac9-c50f-4538-a847-2d1db6fa2f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d856d5ce-ca42-4e6a-b654-1003dc162d3c" xlink:to="loc_us-gaap_PreferredStockValue_5131aac9-c50f-4538-a847-2d1db6fa2f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d898117f-72ca-44d8-8076-ef636c04254e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d856d5ce-ca42-4e6a-b654-1003dc162d3c" xlink:to="loc_us-gaap_CommonStockValue_d898117f-72ca-44d8-8076-ef636c04254e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_354c5df3-0d1b-4319-8aee-d8f7dab209b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d856d5ce-ca42-4e6a-b654-1003dc162d3c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_354c5df3-0d1b-4319-8aee-d8f7dab209b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_eb9d8013-154b-4a17-90c5-ab1b74ca80ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d856d5ce-ca42-4e6a-b654-1003dc162d3c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_eb9d8013-154b-4a17-90c5-ab1b74ca80ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5e697e80-79dd-4f95-97f3-7ea142a5c273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d856d5ce-ca42-4e6a-b654-1003dc162d3c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5e697e80-79dd-4f95-97f3-7ea142a5c273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_34ec641b-f705-4290-8a59-8257b9ce046a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_d856d5ce-ca42-4e6a-b654-1003dc162d3c" xlink:to="loc_us-gaap_StockholdersEquity_34ec641b-f705-4290-8a59-8257b9ce046a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ce84713b-bc92-48d5-b122-921eb1ef0496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dd65e5cf-1733-487c-bd0f-1899dd05c3b2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_ce84713b-bc92-48d5-b122-921eb1ef0496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5b6e0a6f-3248-4b96-aeb5-7d7fc2844208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0ec30095-6dc7-43d9-aea3-820874c182eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b6e0a6f-3248-4b96-aeb5-7d7fc2844208" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0ec30095-6dc7-43d9-aea3-820874c182eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_83737a3a-44ca-49dd-bf5b-ca71f2ae73e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b6e0a6f-3248-4b96-aeb5-7d7fc2844208" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_83737a3a-44ca-49dd-bf5b-ca71f2ae73e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_e101ef2e-336f-4aaa-a3f4-ad47e7907fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b6e0a6f-3248-4b96-aeb5-7d7fc2844208" xlink:to="loc_us-gaap_PreferredStockSharesIssued_e101ef2e-336f-4aaa-a3f4-ad47e7907fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_6be87543-e65a-4cdd-a62b-29c02ef79020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b6e0a6f-3248-4b96-aeb5-7d7fc2844208" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_6be87543-e65a-4cdd-a62b-29c02ef79020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f491443f-43f7-4a1e-8dfa-412d76a11c64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b6e0a6f-3248-4b96-aeb5-7d7fc2844208" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f491443f-43f7-4a1e-8dfa-412d76a11c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_53718592-7d4e-4630-9499-1f738668f43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b6e0a6f-3248-4b96-aeb5-7d7fc2844208" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_53718592-7d4e-4630-9499-1f738668f43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_820a9d15-80f6-446f-a4a3-81b3e75caa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b6e0a6f-3248-4b96-aeb5-7d7fc2844208" xlink:to="loc_us-gaap_CommonStockSharesIssued_820a9d15-80f6-446f-a4a3-81b3e75caa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cfb101d8-dd79-4746-9d0b-d549f745ded9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b6e0a6f-3248-4b96-aeb5-7d7fc2844208" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cfb101d8-dd79-4746-9d0b-d549f745ded9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ba941c8f-060a-4bc2-a2b9-f1efe9b79714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_53d5b716-d8a2-4992-9ae4-13247890b6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ba941c8f-060a-4bc2-a2b9-f1efe9b79714" xlink:to="loc_us-gaap_StatementTable_53d5b716-d8a2-4992-9ae4-13247890b6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d5cce2fe-acac-493e-a5ec-6ba22ce304d9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_53d5b716-d8a2-4992-9ae4-13247890b6ab" xlink:to="loc_srt_ProductOrServiceAxis_d5cce2fe-acac-493e-a5ec-6ba22ce304d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a751208e-0af1-4e3f-8528-45bd6ff39b7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d5cce2fe-acac-493e-a5ec-6ba22ce304d9" xlink:to="loc_srt_ProductsAndServicesDomain_a751208e-0af1-4e3f-8528-45bd6ff39b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_571064e4-d9d6-424b-a171-84e7c14cbe4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a751208e-0af1-4e3f-8528-45bd6ff39b7e" xlink:to="loc_us-gaap_RoyaltyMember_571064e4-d9d6-424b-a171-84e7c14cbe4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_630b5785-3422-41a2-b02a-aa87768d2128" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a751208e-0af1-4e3f-8528-45bd6ff39b7e" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_630b5785-3422-41a2-b02a-aa87768d2128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_af90dc5f-a3d2-457e-ae6b-54e265371ba7" xlink:href="lgnd-20220930.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a751208e-0af1-4e3f-8528-45bd6ff39b7e" xlink:to="loc_lgnd_ContractRevenueMember_af90dc5f-a3d2-457e-ae6b-54e265371ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_53d5b716-d8a2-4992-9ae4-13247890b6ab" xlink:to="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_6c89d6cb-07e2-44c0-aa9a-3c41e429cfea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_RevenuesAbstract_6c89d6cb-07e2-44c0-aa9a-3c41e429cfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_947c5b0f-912f-4d8d-8954-0b1d99419ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_6c89d6cb-07e2-44c0-aa9a-3c41e429cfea" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_947c5b0f-912f-4d8d-8954-0b1d99419ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_6ce82bf0-bb3f-449f-83b3-396fb48d1f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostDirectMaterial"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_CostDirectMaterial_6ce82bf0-bb3f-449f-83b3-396fb48d1f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_23d32056-c2ca-493c-a5ee-c9aa6c31a0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_23d32056-c2ca-493c-a5ee-c9aa6c31a0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6b232633-af65-4de6-859f-955fb841164d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6b232633-af65-4de6-859f-955fb841164d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c318e892-b68e-4ca4-a49f-8d7efbd97825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c318e892-b68e-4ca4-a49f-8d7efbd97825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_66e3506c-4f49-4589-a82a-43b88b881b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_66e3506c-4f49-4589-a82a-43b88b881b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_88d456a6-9302-408b-a7e9-b9e55f44d778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_efa0a6ba-83c3-48b2-83d1-1f57dccdd9ec" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_88d456a6-9302-408b-a7e9-b9e55f44d778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_75a07e94-9b81-4ed1-8798-cd93e5d20743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_OperatingIncomeLoss_75a07e94-9b81-4ed1-8798-cd93e5d20743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_32ce4adf-9150-49a1-a43b-ca6f161d4eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:to="loc_us-gaap_GainLossOnInvestments_32ce4adf-9150-49a1-a43b-ca6f161d4eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8ae2ec07-5314-4a1d-a15d-f65a33af9262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8ae2ec07-5314-4a1d-a15d-f65a33af9262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2de18d97-842a-451d-af0e-dd824110da3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:to="loc_us-gaap_InterestExpense_2de18d97-842a-451d-af0e-dd824110da3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_e03705fd-3b61-4976-b5ed-4f04888406cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_e03705fd-3b61-4976-b5ed-4f04888406cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_cc49805d-7d72-46a5-a3e5-5383eb1b8f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e042ca12-fa09-470f-aa9d-c7e66ab9302f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_cc49805d-7d72-46a5-a3e5-5383eb1b8f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b09c0952-2621-4233-96be-91d42149dbd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b09c0952-2621-4233-96be-91d42149dbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2c7bbc53-b376-4b0e-acf6-a1efc42ecfce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2c7bbc53-b376-4b0e-acf6-a1efc42ecfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_34b63a41-97e0-495e-b084-566fcfea262a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_NetIncomeLoss_34b63a41-97e0-495e-b084-566fcfea262a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7d1b2e1e-b9d1-4f26-8402-f0dfacaeff85" xlink:to="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_aa15d590-fe46-4493-9546-436bda999e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:to="loc_us-gaap_EarningsPerShareBasic_aa15d590-fe46-4493-9546-436bda999e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a84a07ad-c069-4bd3-998c-18a750f52754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a84a07ad-c069-4bd3-998c-18a750f52754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5e473d14-4861-43a4-b888-6d70f018b565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5e473d14-4861-43a4-b888-6d70f018b565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80cdc0c5-d776-4332-8846-107a227cdc59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13ab9926-de2a-492a-af23-77f8c786fe99" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80cdc0c5-d776-4332-8846-107a227cdc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3bf0df33-face-4315-913c-d63a0525abe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_919bd54c-6774-4d82-919d-33179b7545a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3bf0df33-face-4315-913c-d63a0525abe6" xlink:to="loc_us-gaap_NetIncomeLoss_919bd54c-6774-4d82-919d-33179b7545a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_214393ca-81f4-45d4-b9b1-91b61db775ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3bf0df33-face-4315-913c-d63a0525abe6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_214393ca-81f4-45d4-b9b1-91b61db775ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0b155ffe-811d-47ae-90a5-eb9e57f19dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3bf0df33-face-4315-913c-d63a0525abe6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0b155ffe-811d-47ae-90a5-eb9e57f19dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ce526e0a-04e2-4bd8-8971-e41dcd95ae68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_17e3359c-72f5-4d87-8286-b849fb27e929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ce526e0a-04e2-4bd8-8971-e41dcd95ae68" xlink:to="loc_us-gaap_StatementTable_17e3359c-72f5-4d87-8286-b849fb27e929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0104a6bc-70b1-44ca-b8e7-8290e43966ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_17e3359c-72f5-4d87-8286-b849fb27e929" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0104a6bc-70b1-44ca-b8e7-8290e43966ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0104a6bc-70b1-44ca-b8e7-8290e43966ce" xlink:to="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7324b903-e467-46a4-9d03-abbec4418ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:to="loc_us-gaap_CommonStockMember_7324b903-e467-46a4-9d03-abbec4418ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_66d172e0-621b-4e0c-a134-3c8065e13118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_66d172e0-621b-4e0c-a134-3c8065e13118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fb2a2b68-f754-462b-aa4a-b46db4e582d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fb2a2b68-f754-462b-aa4a-b46db4e582d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d2e45ce6-68a3-47a1-bebe-ac7c8aa7cb8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fc38d73a-ac5f-4998-8846-45974ddaec58" xlink:to="loc_us-gaap_RetainedEarningsMember_d2e45ce6-68a3-47a1-bebe-ac7c8aa7cb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f3bad984-b80a-4ac3-b07b-02259d2d9404" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_17e3359c-72f5-4d87-8286-b849fb27e929" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f3bad984-b80a-4ac3-b07b-02259d2d9404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea78faf2-be3c-4b45-9c38-b0b80cc1b6cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f3bad984-b80a-4ac3-b07b-02259d2d9404" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea78faf2-be3c-4b45-9c38-b0b80cc1b6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4df2f6b4-bb13-4431-9ed3-f561bf9effe3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ea78faf2-be3c-4b45-9c38-b0b80cc1b6cd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4df2f6b4-bb13-4431-9ed3-f561bf9effe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6662dd3c-2e69-4bd9-be1f-be2836ea6bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_17e3359c-72f5-4d87-8286-b849fb27e929" xlink:to="loc_us-gaap_StatementLineItems_6662dd3c-2e69-4bd9-be1f-be2836ea6bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6662dd3c-2e69-4bd9-be1f-be2836ea6bce" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dd361bbf-86ba-40e8-8ea0-64cb1901c272" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dd361bbf-86ba-40e8-8ea0-64cb1901c272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_dfb21cc7-3b36-43a6-9d17-971cb10b3901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_StockholdersEquity_dfb21cc7-3b36-43a6-9d17-971cb10b3901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_6500d81d-dafe-424e-b0a3-c2004c225e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_6500d81d-dafe-424e-b0a3-c2004c225e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a11c32df-8203-44bb-b049-76b7bff2a93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a11c32df-8203-44bb-b049-76b7bff2a93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6e8fa4f1-4b4a-4bda-b969-617c938f8054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6e8fa4f1-4b4a-4bda-b969-617c938f8054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_10144c75-f318-4d2f-9e98-25a530cafc66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_10144c75-f318-4d2f-9e98-25a530cafc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_67099ca9-6a4d-46df-b057-22c9bfbafb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_67099ca9-6a4d-46df-b057-22c9bfbafb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax_e35a8014-397a-4763-a2a8-2c0ea8ec50a0" xlink:href="lgnd-20220930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax_e35a8014-397a-4763-a2a8-2c0ea8ec50a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_47819b3c-2b68-4e6d-9ada-b077a3a76717" xlink:href="lgnd-20220930.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_47819b3c-2b68-4e6d-9ada-b077a3a76717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_20ceeacc-765f-4c4b-9ea7-7d52a98782ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_NetIncomeLoss_20ceeacc-765f-4c4b-9ea7-7d52a98782ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_06093b66-5649-453b-bfc0-37bca5f251f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_06093b66-5649-453b-bfc0-37bca5f251f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c06d366e-462e-4da0-978e-1c7e1dd9ab41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e5c1f81-6a06-455d-beba-e80746b18b4a" xlink:to="loc_us-gaap_StockholdersEquity_c06d366e-462e-4da0-978e-1c7e1dd9ab41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_92b78387-d90c-48a1-a49f-3cf3c53a55d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8afce05e-4848-4d5e-ad06-21d5a744ad46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_92b78387-d90c-48a1-a49f-3cf3c53a55d3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8afce05e-4848-4d5e-ad06-21d5a744ad46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8859301f-83c3-4146-af05-60efd366eee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8afce05e-4848-4d5e-ad06-21d5a744ad46" xlink:to="loc_us-gaap_ProfitLoss_8859301f-83c3-4146-af05-60efd366eee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8afce05e-4848-4d5e-ad06-21d5a744ad46" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_bd3d9d16-2b98-46a0-86dc-c4c4da6c9f67" xlink:href="lgnd-20220930.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_bd3d9d16-2b98-46a0-86dc-c4c4da6c9f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_db5808a8-c494-4d4d-a5fc-1c1edc7d227f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_db5808a8-c494-4d4d-a5fc-1c1edc7d227f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_4085c03f-5287-489a-b67d-ff6426f6888b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_4085c03f-5287-489a-b67d-ff6426f6888b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1aafcf9a-0310-4cff-93a1-53100e569dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1aafcf9a-0310-4cff-93a1-53100e569dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_e8511473-631b-4b18-badf-017b95319571" xlink:href="lgnd-20220930.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_e8511473-631b-4b18-badf-017b95319571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f24cd7de-3126-4c35-95e3-1b4b1c9e499d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f24cd7de-3126-4c35-95e3-1b4b1c9e499d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9cd84229-bf35-428b-a6aa-9129c751439d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_us-gaap_ShareBasedCompensation_9cd84229-bf35-428b-a6aa-9129c751439d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d1487e85-8ac5-482c-8b7b-4e986e45cfd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d1487e85-8ac5-482c-8b7b-4e986e45cfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_8cf8461c-3865-490d-908c-3e231ec48dff" xlink:href="lgnd-20220930.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_8cf8461c-3865-490d-908c-3e231ec48dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_5e2bf17f-52fe-4910-917e-ab93500b92ed" xlink:href="lgnd-20220930.xsd#lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization_5e2bf17f-52fe-4910-917e-ab93500b92ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_9fec99be-1b21-4b12-88c0-26b771822e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_dffa2855-f32b-4474-9c01-bee6510c25ae" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_9fec99be-1b21-4b12-88c0-26b771822e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4cadae66-0437-4084-b354-a455bb906b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8afce05e-4848-4d5e-ad06-21d5a744ad46" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4cadae66-0437-4084-b354-a455bb906b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fc3636b2-85c8-476c-987c-20b7fb8d7c36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4cadae66-0437-4084-b354-a455bb906b8c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fc3636b2-85c8-476c-987c-20b7fb8d7c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1ef3f9d8-85f0-4a84-9251-821762252166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4cadae66-0437-4084-b354-a455bb906b8c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1ef3f9d8-85f0-4a84-9251-821762252166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_69e47032-22fc-4f24-bfe3-6edb68aa3225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4cadae66-0437-4084-b354-a455bb906b8c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_69e47032-22fc-4f24-bfe3-6edb68aa3225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_152c3989-eb38-4a2d-b60c-0149a9819342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4cadae66-0437-4084-b354-a455bb906b8c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_152c3989-eb38-4a2d-b60c-0149a9819342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_784d9c55-1586-4e60-b556-0e221b13b191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4cadae66-0437-4084-b354-a455bb906b8c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_784d9c55-1586-4e60-b556-0e221b13b191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ce578c28-4ba3-45d2-b2c8-f27cf5c61420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4cadae66-0437-4084-b354-a455bb906b8c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ce578c28-4ba3-45d2-b2c8-f27cf5c61420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aa910658-e383-42e3-9dbc-05fd79c0fa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8afce05e-4848-4d5e-ad06-21d5a744ad46" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_aa910658-e383-42e3-9dbc-05fd79c0fa3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_defc7911-7888-4c83-af73-8edcb4e37e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_92b78387-d90c-48a1-a49f-3cf3c53a55d3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_defc7911-7888-4c83-af73-8edcb4e37e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_3f3572f3-079f-4fac-95b1-9508a7d4ec4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_defc7911-7888-4c83-af73-8edcb4e37e90" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_3f3572f3-079f-4fac-95b1-9508a7d4ec4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_ee0962b8-caf6-40f7-bf54-3bbff0d0aa05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_defc7911-7888-4c83-af73-8edcb4e37e90" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_ee0962b8-caf6-40f7-bf54-3bbff0d0aa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_cfdb9615-f632-47e7-867d-a0c28cc80874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_defc7911-7888-4c83-af73-8edcb4e37e90" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_cfdb9615-f632-47e7-867d-a0c28cc80874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b0427762-837f-48ef-8486-6c3e7b297734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_defc7911-7888-4c83-af73-8edcb4e37e90" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b0427762-837f-48ef-8486-6c3e7b297734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_740d21c8-60cc-4268-bf68-26b9f577ceb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_defc7911-7888-4c83-af73-8edcb4e37e90" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_740d21c8-60cc-4268-bf68-26b9f577ceb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_8379b6f3-949e-499d-b9f3-f3b49e714d03" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToContingentValueRightHoldersInvestingActivity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_defc7911-7888-4c83-af73-8edcb4e37e90" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity_8379b6f3-949e-499d-b9f3-f3b49e714d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_be213a1c-5738-4c67-9570-b0362c4ebce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_defc7911-7888-4c83-af73-8edcb4e37e90" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_be213a1c-5738-4c67-9570-b0362c4ebce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5b5015de-194c-41d2-bc6a-a0df894a7985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_defc7911-7888-4c83-af73-8edcb4e37e90" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5b5015de-194c-41d2-bc6a-a0df894a7985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_92b78387-d90c-48a1-a49f-3cf3c53a55d3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_3c4aee8d-7ce6-4939-a9b8-141cefc037df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_3c4aee8d-7ce6-4939-a9b8-141cefc037df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_c9860e4e-8684-4b0c-877b-88335786d2da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_c9860e4e-8684-4b0c-877b-88335786d2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_5b848df3-ff7b-42a9-a8e6-60bfb73f1bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_5b848df3-ff7b-42a9-a8e6-60bfb73f1bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_d7c27be1-1ad9-4b49-b26d-d69bea863f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_d7c27be1-1ad9-4b49-b26d-d69bea863f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d68b2126-8361-4617-a6a9-9f6dec240c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d68b2126-8361-4617-a6a9-9f6dec240c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9559a116-4d3c-491d-8f91-05b1abe2c89e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9559a116-4d3c-491d-8f91-05b1abe2c89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_edef259b-f4b3-4e17-8c35-abe682b39a45" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_edef259b-f4b3-4e17-8c35-abe682b39a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b004eb83-ef59-43ea-a84b-61ab56208740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b004eb83-ef59-43ea-a84b-61ab56208740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97e2ef7e-e7f4-4fde-9d2e-7e2d53c51f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f36b4e08-d4f6-4014-9e64-22c3d8e676d4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97e2ef7e-e7f4-4fde-9d2e-7e2d53c51f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6fa69da1-4e91-4d63-98b8-519959f37a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_92b78387-d90c-48a1-a49f-3cf3c53a55d3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6fa69da1-4e91-4d63-98b8-519959f37a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3f9fc9a-0898-4658-8e8a-b163bfa00ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_92b78387-d90c-48a1-a49f-3cf3c53a55d3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3f9fc9a-0898-4658-8e8a-b163bfa00ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d8b292d0-be3a-4323-94a2-5a8d6877db5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_92b78387-d90c-48a1-a49f-3cf3c53a55d3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d8b292d0-be3a-4323-94a2-5a8d6877db5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7cc3a2a9-a942-4187-9e52-7885a4fe4e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_92b78387-d90c-48a1-a49f-3cf3c53a55d3" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7cc3a2a9-a942-4187-9e52-7885a4fe4e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_928f817d-ff56-49e5-8301-c6eacacedda7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7cc3a2a9-a942-4187-9e52-7885a4fe4e5d" xlink:to="loc_us-gaap_InterestPaidNet_928f817d-ff56-49e5-8301-c6eacacedda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_8a928d87-3809-41b6-b575-e8bb2a0aa411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7cc3a2a9-a942-4187-9e52-7885a4fe4e5d" xlink:to="loc_us-gaap_IncomeTaxesPaid_8a928d87-3809-41b6-b575-e8bb2a0aa411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1a700a3f-b533-4579-a0c1-f5183c74f43c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_92b78387-d90c-48a1-a49f-3cf3c53a55d3" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1a700a3f-b533-4579-a0c1-f5183c74f43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_cd9a807b-f2ea-42da-bf6d-0832864783fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1a700a3f-b533-4579-a0c1-f5183c74f43c" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_cd9a807b-f2ea-42da-bf6d-0832864783fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases_44a24216-f577-42bb-b1d1-2403330862bc" xlink:href="lgnd-20220930.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1a700a3f-b533-4579-a0c1-f5183c74f43c" xlink:to="loc_lgnd_AccruedInventoryPurchases_44a24216-f577-42bb-b1d1-2403330862bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_bab2d370-2b3f-46dd-be3a-575875f14fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1a700a3f-b533-4579-a0c1-f5183c74f43c" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_bab2d370-2b3f-46dd-be3a-575875f14fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8127ce08-2b20-4daa-a1d2-0d3c045923b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_a2591453-8e36-42cb-8203-3ad83495619b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8127ce08-2b20-4daa-a1d2-0d3c045923b9" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_a2591453-8e36-42cb-8203-3ad83495619b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformation" xlink:type="simple" xlink:href="lgnd-20220930.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ce86c475-848e-4a7a-b94c-a1cc943875ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_463bbff3-cdb8-413f-acab-f083f8e748bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ce86c475-848e-4a7a-b94c-a1cc943875ef" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_463bbff3-cdb8-413f-acab-f083f8e748bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20220930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_29ce48e4-58a8-4a48-a513-5803c8433df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_9a5439a2-35d6-4d4f-a5ff-7e33dd19032e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_29ce48e4-58a8-4a48-a513-5803c8433df4" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_9a5439a2-35d6-4d4f-a5ff-7e33dd19032e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20220930.xsd#ConvertibleSeniorNotes"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7a94296d-b602-47f5-9d0e-b02e25107d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_6bcc20b2-752c-475c-8ada-99e961170975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7a94296d-b602-47f5-9d0e-b02e25107d98" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_6bcc20b2-752c-475c-8ada-99e961170975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20220930.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6026f068-79ed-4568-8418-5a29246877d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_c78fc2c8-0adf-4ece-9190-1905992b64f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6026f068-79ed-4568-8418-5a29246877d1" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_c78fc2c8-0adf-4ece-9190-1905992b64f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20220930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ef614289-834c-4218-b22a-45a09df49f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fb6903a9-d04c-4d01-b9c4-32b6a5f14e15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ef614289-834c-4218-b22a-45a09df49f6f" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fb6903a9-d04c-4d01-b9c4-32b6a5f14e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_634d1191-18fa-4885-a55f-79144928fabe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a01b0f8b-f168-49f5-a262-a1f67509e226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_634d1191-18fa-4885-a55f-79144928fabe" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a01b0f8b-f168-49f5-a262-a1f67509e226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Leases" xlink:type="simple" xlink:href="lgnd-20220930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3271a817-f1d9-4d56-8365-58253501cf20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_98c94ad6-1d5a-4f31-9434-b283812c7159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3271a817-f1d9-4d56-8365-58253501cf20" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_98c94ad6-1d5a-4f31-9434-b283812c7159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_e19008af-81bb-4e1f-b1c0-cc780b7a9bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3271a817-f1d9-4d56-8365-58253501cf20" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_e19008af-81bb-4e1f-b1c0-cc780b7a9bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEvent" xlink:type="simple" xlink:href="lgnd-20220930.xsd#SubsequentEvent"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SubsequentEvent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_13250911-fa08-4d52-b8fb-97d02b27ed4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_ef3abf4a-95c8-4a84-a532-788236a716bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_13250911-fa08-4d52-b8fb-97d02b27ed4c" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_ef3abf4a-95c8-4a84-a532-788236a716bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_e2c42397-d951-4fd9-aee9-c04ae920a8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_e2c42397-d951-4fd9-aee9-c04ae920a8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_54c417e3-947e-479c-9f97-d2d7aba25d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:to="loc_us-gaap_UseOfEstimates_54c417e3-947e-479c-9f97-d2d7aba25d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60703e16-3183-4b8c-8659-ba30acc35426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_60703e16-3183-4b8c-8659-ba30acc35426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_86fe5660-4a1f-44b8-a370-0c38c8852dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_86fe5660-4a1f-44b8-a370-0c38c8852dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1a29dac6-c8e6-4ccd-8706-3ef87ad196e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1a29dac6-c8e6-4ccd-8706-3ef87ad196e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_16ac26be-ecfd-4b73-8648-c9730235b88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_16ac26be-ecfd-4b73-8648-c9730235b88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_d6f7dcc4-a5ef-46ec-9aa3-5e231daefc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_d6f7dcc4-a5ef-46ec-9aa3-5e231daefc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRightsPolicyTextBlock_b2d19ed5-0230-43c2-92df-10e94b793709" xlink:href="lgnd-20220930.xsd#lgnd_CommercialLicenseRightsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:to="loc_lgnd_CommercialLicenseRightsPolicyTextBlock_b2d19ed5-0230-43c2-92df-10e94b793709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7211cd39-43e0-41de-924c-9c7e67d12bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7211cd39-43e0-41de-924c-9c7e67d12bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_87e5be56-d787-4bde-abd8-e1c2592f9336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_931cd43d-5485-4b2d-b89c-32527b5a2e49" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_87e5be56-d787-4bde-abd8-e1c2592f9336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_67abe95e-bfbe-4208-af41-1bc014cc1218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_67abe95e-bfbe-4208-af41-1bc014cc1218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_323d975c-7c1f-4eaa-8f0b-a29862216861" xlink:href="lgnd-20220930.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:to="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_323d975c-7c1f-4eaa-8f0b-a29862216861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_1da94728-1032-4dd4-9cd3-023efd7c1af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_1da94728-1032-4dd4-9cd3-023efd7c1af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_6f53a4eb-cbe4-42cd-ae80-43cd30c6c707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_6f53a4eb-cbe4-42cd-ae80-43cd30c6c707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_97aef65a-90fe-4f19-bf40-1b5b6aed34b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_97aef65a-90fe-4f19-bf40-1b5b6aed34b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_cac5bcc6-f6bf-4d2a-98e4-98a261cfc971" xlink:href="lgnd-20220930.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:to="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_cac5bcc6-f6bf-4d2a-98e4-98a261cfc971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3f62cd2b-f4c2-4dfc-96dd-b0b407897afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3f62cd2b-f4c2-4dfc-96dd-b0b407897afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_c8ecc500-2a6f-433c-887b-ef9fdfa4b89b" xlink:href="lgnd-20220930.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:to="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_c8ecc500-2a6f-433c-887b-ef9fdfa4b89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_d37efde5-941d-4b97-a775-4a73f2c88587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_d37efde5-941d-4b97-a775-4a73f2c88587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7da8fb23-966d-4836-a7bb-8d8bb8b893f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b72c44b-2d9c-46e7-a425-1543a937816c" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7da8fb23-966d-4836-a7bb-8d8bb8b893f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="lgnd-20220930.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_15268644-e824-43eb-8f47-8c981f9621d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_79bc59c8-9eef-4232-b180-8e653cf68598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_15268644-e824-43eb-8f47-8c981f9621d9" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_79bc59c8-9eef-4232-b180-8e653cf68598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20220930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_28bb8fa9-f2b8-439b-8e58-cf03a88ab108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_1fc8352b-90a9-4cb3-89cc-92072c3670b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_28bb8fa9-f2b8-439b-8e58-cf03a88ab108" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_1fc8352b-90a9-4cb3-89cc-92072c3670b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_e39de686-7aed-4ba2-87ed-c072b48c1718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_28bb8fa9-f2b8-439b-8e58-cf03a88ab108" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_e39de686-7aed-4ba2-87ed-c072b48c1718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20220930.xsd#ConvertibleSeniorNotesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bdc80805-fe01-44d5-b27a-7c1d6c57705f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_8cfb0e36-39cc-49b0-9571-ddccf96cc92f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bdc80805-fe01-44d5-b27a-7c1d6c57705f" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_8cfb0e36-39cc-49b0-9571-ddccf96cc92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20220930.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_95b762a5-54e7-4982-a274-d654d4310e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9b1d1fbb-e3ae-4cab-945c-695c40513335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_95b762a5-54e7-4982-a274-d654d4310e21" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9b1d1fbb-e3ae-4cab-945c-695c40513335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_be9dc4c0-1bf5-4852-8dc2-f98a7f09f9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_95b762a5-54e7-4982-a274-d654d4310e21" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_be9dc4c0-1bf5-4852-8dc2-f98a7f09f9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesTables" xlink:type="simple" xlink:href="lgnd-20220930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8de8bcad-3405-4c2e-9160-76878d4ae51a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_107591c2-ba26-488a-8405-3e1cdb59fa0c" xlink:href="lgnd-20220930.xsd#lgnd_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8de8bcad-3405-4c2e-9160-76878d4ae51a" xlink:to="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_107591c2-ba26-488a-8405-3e1cdb59fa0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5d0cbe5a-ef05-4f6a-9c27-4177a4d0c7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8de8bcad-3405-4c2e-9160-76878d4ae51a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5d0cbe5a-ef05-4f6a-9c27-4177a4d0c7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_217d906a-d7ab-4f9b-9597-c0c2f481fd45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_217d906a-d7ab-4f9b-9597-c0c2f481fd45" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_03939e20-6dae-4de6-87ab-08009b7d3eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_03939e20-6dae-4de6-87ab-08009b7d3eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6de14217-a2db-4433-b9fd-27854872dbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_03939e20-6dae-4de6-87ab-08009b7d3eac" xlink:to="loc_us-gaap_EquityComponentDomain_6de14217-a2db-4433-b9fd-27854872dbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_642431b8-9f51-499f-b849-89ed92bccd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6de14217-a2db-4433-b9fd-27854872dbd4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_642431b8-9f51-499f-b849-89ed92bccd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a39e7fbe-39bb-4d58-97e6-d5cf18932e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6de14217-a2db-4433-b9fd-27854872dbd4" xlink:to="loc_us-gaap_RetainedEarningsMember_a39e7fbe-39bb-4d58-97e6-d5cf18932e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7ff55936-934a-4475-b1ec-92b1ba74c36a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7ff55936-934a-4475-b1ec-92b1ba74c36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_8a857b9b-1106-4ace-a248-6333cf92685b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7ff55936-934a-4475-b1ec-92b1ba74c36a" xlink:to="loc_us-gaap_TypeOfAdoptionMember_8a857b9b-1106-4ace-a248-6333cf92685b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_ccc8f638-17c9-4ec4-a74a-f88bbc119b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_8a857b9b-1106-4ace-a248-6333cf92685b" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_ccc8f638-17c9-4ec4-a74a-f88bbc119b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1edf4ffe-945f-48cc-9c2e-30d92953e611" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1edf4ffe-945f-48cc-9c2e-30d92953e611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a8a7fd8-2968-41e3-85d5-e0ebe693d162" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_1edf4ffe-945f-48cc-9c2e-30d92953e611" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a8a7fd8-2968-41e3-85d5-e0ebe693d162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bbee24b9-f74e-473d-aecb-61dcca971613" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a8a7fd8-2968-41e3-85d5-e0ebe693d162" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_bbee24b9-f74e-473d-aecb-61dcca971613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_fda85eaf-725f-4e62-b5c5-a8eaaa16daac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a8a7fd8-2968-41e3-85d5-e0ebe693d162" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_fda85eaf-725f-4e62-b5c5-a8eaaa16daac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_907a2494-599b-4258-b21d-3e6599ac8bba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_srt_ProductOrServiceAxis_907a2494-599b-4258-b21d-3e6599ac8bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7c8b4c6e-e86d-453e-be4d-d48f0a584d64" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_907a2494-599b-4258-b21d-3e6599ac8bba" xlink:to="loc_srt_ProductsAndServicesDomain_7c8b4c6e-e86d-453e-be4d-d48f0a584d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_24c9a2e3-5239-4d41-96a8-292b4d9e16df" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7c8b4c6e-e86d-453e-be4d-d48f0a584d64" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_24c9a2e3-5239-4d41-96a8-292b4d9e16df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f0186b66-d088-4ea6-ac68-0b13b3f4e251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_us-gaap_AwardTypeAxis_f0186b66-d088-4ea6-ac68-0b13b3f4e251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cc44f96-41be-484e-a6f0-c2aeebf386c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f0186b66-d088-4ea6-ac68-0b13b3f4e251" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cc44f96-41be-484e-a6f0-c2aeebf386c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_2463851b-a987-4141-8eec-cf77186655e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8cc44f96-41be-484e-a6f0-c2aeebf386c5" xlink:to="loc_us-gaap_RestrictedStockMember_2463851b-a987-4141-8eec-cf77186655e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_880d2898-15ef-437b-bb9c-441fd18301a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_srt_RangeAxis_880d2898-15ef-437b-bb9c-441fd18301a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bc2366fa-ea81-4179-8f1b-6727ac24d5c4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_880d2898-15ef-437b-bb9c-441fd18301a9" xlink:to="loc_srt_RangeMember_bc2366fa-ea81-4179-8f1b-6727ac24d5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ab9e6691-c93f-443f-968a-79c28de66c05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bc2366fa-ea81-4179-8f1b-6727ac24d5c4" xlink:to="loc_srt_MinimumMember_ab9e6691-c93f-443f-968a-79c28de66c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4dff8300-6d41-4251-88f4-b0b3fbffcb52" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bc2366fa-ea81-4179-8f1b-6727ac24d5c4" xlink:to="loc_srt_MaximumMember_4dff8300-6d41-4251-88f4-b0b3fbffcb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a03f55cc-d92a-4b26-a485-ed2e84f94039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a03f55cc-d92a-4b26-a485-ed2e84f94039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3b3902df-d1bf-4657-8223-4d705c4f4102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a03f55cc-d92a-4b26-a485-ed2e84f94039" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3b3902df-d1bf-4657-8223-4d705c4f4102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_bc0f5f8d-9ee7-4775-af05-17422e4e7b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3b3902df-d1bf-4657-8223-4d705c4f4102" xlink:to="loc_us-gaap_StockCompensationPlanMember_bc0f5f8d-9ee7-4775-af05-17422e4e7b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_43647d45-a8e3-45cb-8827-cb50157b0591" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_c73f1749-0de2-4a2d-8896-e2f439606c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_ConvertibleNotesPayable_c73f1749-0de2-4a2d-8896-e2f439606c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bf1ea654-bf4e-4abd-ab8d-466888801d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bf1ea654-bf4e-4abd-ab8d-466888801d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_895e4b8c-a336-45a7-8172-92b0dbff258e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_StockholdersEquity_895e4b8c-a336-45a7-8172-92b0dbff258e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_7cd897b2-1bf2-458c-8048-57162197f393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_7cd897b2-1bf2-458c-8048-57162197f393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d2f461d9-7f2f-4f23-988f-4bee8ee912eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d2f461d9-7f2f-4f23-988f-4bee8ee912eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_46182079-93d1-45d7-88c0-c467a9fb5867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_46182079-93d1-45d7-88c0-c467a9fb5867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_390e7469-4efe-4011-8718-39a45aee87c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_390e7469-4efe-4011-8718-39a45aee87c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_efc6b7aa-2a1d-4208-87cf-79391df44948" xlink:href="lgnd-20220930.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_efc6b7aa-2a1d-4208-87cf-79391df44948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ba65b9be-e664-496b-ad10-f7975e45e776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_InventoryNet_ba65b9be-e664-496b-ad10-f7975e45e776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_cabca75c-a432-4aaa-b1c7-4776ff56bafb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_NumberOfReportingUnits_cabca75c-a432-4aaa-b1c7-4776ff56bafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_ad45f4b5-73db-47a4-8734-7083a6535d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_ad45f4b5-73db-47a4-8734-7083a6535d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_70a97555-d568-49bd-bce0-192f1276e27e" xlink:href="lgnd-20220930.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_70a97555-d568-49bd-bce0-192f1276e27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_25e6f4a8-427a-4dee-988e-3b71a97c397d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f968495a-6912-411e-9c2c-8949e7c8bf3a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_25e6f4a8-427a-4dee-988e-3b71a97c397d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a171449d-eb94-4f9d-8905-8e27dbc9a2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fe15b4be-f241-493f-9bd0-f3e9681c3abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a171449d-eb94-4f9d-8905-8e27dbc9a2c5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fe15b4be-f241-493f-9bd0-f3e9681c3abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bba029b4-c12e-480b-8375-4b1a0ab6c6e9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fe15b4be-f241-493f-9bd0-f3e9681c3abb" xlink:to="loc_srt_ProductOrServiceAxis_bba029b4-c12e-480b-8375-4b1a0ab6c6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5e18d08a-10a4-44d9-b3be-6b37e3b38ef4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_bba029b4-c12e-480b-8375-4b1a0ab6c6e9" xlink:to="loc_srt_ProductsAndServicesDomain_5e18d08a-10a4-44d9-b3be-6b37e3b38ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5e18d08a-10a4-44d9-b3be-6b37e3b38ef4" xlink:to="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_cb39a12e-0890-4383-9d82-28c1e05e4c85" xlink:href="lgnd-20220930.xsd#lgnd_KyprolisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:to="loc_lgnd_KyprolisMember_cb39a12e-0890-4383-9d82-28c1e05e4c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_148811ea-c3b3-4c5f-8a47-384a25a34d3f" xlink:href="lgnd-20220930.xsd#lgnd_EvomelaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:to="loc_lgnd_EvomelaMember_148811ea-c3b3-4c5f-8a47-384a25a34d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember_a0b35bb0-bb22-4a4b-9fd1-12e62ce7f827" xlink:href="lgnd-20220930.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:to="loc_lgnd_TeriparatideInjectionMember_a0b35bb0-bb22-4a4b-9fd1-12e62ce7f827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember_ab93a42e-8aff-4773-b36b-92b130973cf4" xlink:href="lgnd-20220930.xsd#lgnd_RylazeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:to="loc_lgnd_RylazeMember_ab93a42e-8aff-4773-b36b-92b130973cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_4514cbeb-7ced-40ce-af9b-fd3f88c299f2" xlink:href="lgnd-20220930.xsd#lgnd_RoyaltyOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_201df879-d5e7-4adb-b3be-8ab453cd9e71" xlink:to="loc_lgnd_RoyaltyOtherMember_4514cbeb-7ced-40ce-af9b-fd3f88c299f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_a9828705-7127-47d2-94fe-ce94630b44a8" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5e18d08a-10a4-44d9-b3be-6b37e3b38ef4" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_a9828705-7127-47d2-94fe-ce94630b44a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_1c5ac65a-ea75-46f6-b66f-aa7fa1712924" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_a9828705-7127-47d2-94fe-ce94630b44a8" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_1c5ac65a-ea75-46f6-b66f-aa7fa1712924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_15496a3e-6696-4b72-ba31-6bb9549bc5ab" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_a9828705-7127-47d2-94fe-ce94630b44a8" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_15496a3e-6696-4b72-ba31-6bb9549bc5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:href="lgnd-20220930.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5e18d08a-10a4-44d9-b3be-6b37e3b38ef4" xlink:to="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_d0d7adfd-cc99-438d-b8fd-172e47c59963" xlink:href="lgnd-20220930.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:to="loc_lgnd_ContractRevenueServiceMember_d0d7adfd-cc99-438d-b8fd-172e47c59963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_572d1423-8f29-4a9b-ba3a-8a3423b9dacf" xlink:href="lgnd-20220930.xsd#lgnd_LicenseFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:to="loc_lgnd_LicenseFeesMember_572d1423-8f29-4a9b-ba3a-8a3423b9dacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_bdd5c941-1ed3-41a6-9b42-b997feb2e44f" xlink:href="lgnd-20220930.xsd#lgnd_MilestoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:to="loc_lgnd_MilestoneMember_bdd5c941-1ed3-41a6-9b42-b997feb2e44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_dbdbe702-cc6e-4648-98ee-ffdbdd2c1759" xlink:href="lgnd-20220930.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_f0ab8f3b-1aed-463a-977c-af01db235cc5" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_dbdbe702-cc6e-4648-98ee-ffdbdd2c1759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_500c46e6-8795-4128-9b0d-df3b7dfabb32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fe15b4be-f241-493f-9bd0-f3e9681c3abb" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_500c46e6-8795-4128-9b0d-df3b7dfabb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b1db25d-f610-4239-82c9-4319e5ff282d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_500c46e6-8795-4128-9b0d-df3b7dfabb32" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b1db25d-f610-4239-82c9-4319e5ff282d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_20842acc-d4a7-4165-bf8b-5cca190b7477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf5e7874-b969-4b18-b443-68c9c9ac2b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_20842acc-d4a7-4165-bf8b-5cca190b7477" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf5e7874-b969-4b18-b443-68c9c9ac2b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a7f4b4da-772a-480a-bb79-9546fac6fa8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf5e7874-b969-4b18-b443-68c9c9ac2b82" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a7f4b4da-772a-480a-bb79-9546fac6fa8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a7f4b4da-772a-480a-bb79-9546fac6fa8e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_2805c7ea-c04c-459d-9e87-46141ae63d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_DemandDepositsMember_2805c7ea-c04c-459d-9e87-46141ae63d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_1957f210-d585-491e-9894-9b5c8b8aaf18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_1957f210-d585-491e-9894-9b5c8b8aaf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_17143193-ee26-4787-83fa-27814d649425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_CommercialPaperMember_17143193-ee26-4787-83fa-27814d649425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_4741e8c2-400f-4cd8-8f09-f2e5aecca832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_EquitySecuritiesMember_4741e8c2-400f-4cd8-8f09-f2e5aecca832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_2218159d-22a8-4e01-b83a-b937d31d4f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_MutualFundMember_2218159d-22a8-4e01-b83a-b937d31d4f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_e7b43f53-6073-4f24-b193-f9b9b438dfd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_e7b43f53-6073-4f24-b193-f9b9b438dfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_74ccfe10-9ac3-4cef-b864-3660bdfd7f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_WarrantMember_74ccfe10-9ac3-4cef-b864-3660bdfd7f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_52e8f9a2-f686-4f0d-ad70-7a39fd689c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88309ea8-912d-4b0f-989c-4e2ee6eacbe2" xlink:to="loc_us-gaap_CommonStockMember_52e8f9a2-f686-4f0d-ad70-7a39fd689c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_cf5e7874-b969-4b18-b443-68c9c9ac2b82" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f7c7a26-0cd9-457a-870e-1805190b7964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2f7c7a26-0cd9-457a-870e-1805190b7964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d55705a6-6e50-4805-9225-189a36c38e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d55705a6-6e50-4805-9225-189a36c38e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_46873469-fb13-4353-a217-cb16b281568c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_46873469-fb13-4353-a217-cb16b281568c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9c44fe28-76ba-4993-8d85-be9e7cff343b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9c44fe28-76ba-4993-8d85-be9e7cff343b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3efc9903-9799-4c7e-9f7b-f0de3da07062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3efc9903-9799-4c7e-9f7b-f0de3da07062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_dee70124-17df-4a74-98f5-4b2f3d6d5fc8" xlink:href="lgnd-20220930.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_cc5e1ca7-0c0d-470e-990b-bffac2c9fcab" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_dee70124-17df-4a74-98f5-4b2f3d6d5fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a37e3604-fc02-4011-a87c-421c117be27a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_85a13eb6-1611-4aab-a644-cdcd374cab56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a37e3604-fc02-4011-a87c-421c117be27a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_85a13eb6-1611-4aab-a644-cdcd374cab56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_a7c04462-eb4d-4956-bf87-cb5224272b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_85a13eb6-1611-4aab-a644-cdcd374cab56" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_a7c04462-eb4d-4956-bf87-cb5224272b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_38789026-27fa-46c7-b081-d7d76ba1d259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_85a13eb6-1611-4aab-a644-cdcd374cab56" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_38789026-27fa-46c7-b081-d7d76ba1d259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_cc9c97c7-3fe2-4891-ba61-328b555420ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_85a13eb6-1611-4aab-a644-cdcd374cab56" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_cc9c97c7-3fe2-4891-ba61-328b555420ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fbf4fcb2-b0ef-4d28-8465-50b6410c2caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a37e3604-fc02-4011-a87c-421c117be27a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fbf4fcb2-b0ef-4d28-8465-50b6410c2caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_1725f6e6-fb8d-4492-a43d-367a77a93460" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fbf4fcb2-b0ef-4d28-8465-50b6410c2caf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_1725f6e6-fb8d-4492-a43d-367a77a93460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_2506aea7-db0b-49e9-a383-f184df5cbdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fbf4fcb2-b0ef-4d28-8465-50b6410c2caf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_2506aea7-db0b-49e9-a383-f184df5cbdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_f4d5ff75-7fa1-438b-8293-03ff3c471132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_fbf4fcb2-b0ef-4d28-8465-50b6410c2caf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_f4d5ff75-7fa1-438b-8293-03ff3c471132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87a5d1cc-76e5-4711-b18b-b8bbb269e0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7477a5de-6e37-405c-a144-060ec5307f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87a5d1cc-76e5-4711-b18b-b8bbb269e0c4" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7477a5de-6e37-405c-a144-060ec5307f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a7998d21-44c9-4800-ac36-3c485c06055f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7477a5de-6e37-405c-a144-060ec5307f32" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a7998d21-44c9-4800-ac36-3c485c06055f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a7998d21-44c9-4800-ac36-3c485c06055f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_192b9e42-f85d-435a-8c36-2881feb255a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:to="loc_us-gaap_PatentedTechnologyMember_192b9e42-f85d-435a-8c36-2881feb255a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1a20fba1-eef6-43ee-a13b-28a5e91032d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:to="loc_us-gaap_TradeNamesMember_1a20fba1-eef6-43ee-a13b-28a5e91032d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a4ac5af8-3b98-4d16-90fe-59e260ab8384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a4ac5af8-3b98-4d16-90fe-59e260ab8384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_328bc31d-b9bd-4ee1-866d-edb83071ef9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_28ddf870-5f45-465c-8fd3-b7ac7a98bd15" xlink:to="loc_us-gaap_ContractualRightsMember_328bc31d-b9bd-4ee1-866d-edb83071ef9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_2dfbc107-cf4d-4619-9b57-30b8cd6cdaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7477a5de-6e37-405c-a144-060ec5307f32" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_2dfbc107-cf4d-4619-9b57-30b8cd6cdaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_2dfbc107-cf4d-4619-9b57-30b8cd6cdaf2" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8021d310-ec71-4bbb-8fe4-1a7c40d72ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:to="loc_us-gaap_Goodwill_8021d310-ec71-4bbb-8fe4-1a7c40d72ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_02ad40f1-bc6c-4c4a-ad6f-f0793b04876f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_02ad40f1-bc6c-4c4a-ad6f-f0793b04876f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ca450d74-a674-47ec-a786-02cd77b54c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ca450d74-a674-47ec-a786-02cd77b54c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_ea0b3398-3fc8-4a39-88a6-be989ec994dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_525dd09b-e832-49d0-918a-989f364feb9c" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_ea0b3398-3fc8-4a39-88a6-be989ec994dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_92281617-5a99-493e-b7cd-46290e71bacb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_cdcb4569-c215-4cae-802a-13f86dd7e6d8" xlink:href="lgnd-20220930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_92281617-5a99-493e-b7cd-46290e71bacb" xlink:to="loc_lgnd_BasisOfPresentationTable_cdcb4569-c215-4cae-802a-13f86dd7e6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_43187b73-fa39-444b-9e61-cebdf39579d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_cdcb4569-c215-4cae-802a-13f86dd7e6d8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_43187b73-fa39-444b-9e61-cebdf39579d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e6ca8b59-ee6d-4fda-9592-cf07deff129e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_43187b73-fa39-444b-9e61-cebdf39579d0" xlink:to="loc_us-gaap_SegmentDomain_e6ca8b59-ee6d-4fda-9592-cf07deff129e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_c605f5bd-bc46-4975-9c30-bb1122e5da9a" xlink:href="lgnd-20220930.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e6ca8b59-ee6d-4fda-9592-cf07deff129e" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_c605f5bd-bc46-4975-9c30-bb1122e5da9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember_a581a38b-00bf-4a86-8a6a-8e75e1019325" xlink:href="lgnd-20220930.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e6ca8b59-ee6d-4fda-9592-cf07deff129e" xlink:to="loc_lgnd_OmniAbTechnologiesSegmentMember_a581a38b-00bf-4a86-8a6a-8e75e1019325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_2800e972-801f-402d-8c1a-1e7bb27dbc3b" xlink:href="lgnd-20220930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_cdcb4569-c215-4cae-802a-13f86dd7e6d8" xlink:to="loc_lgnd_BasisOfPresentationLineItems_2800e972-801f-402d-8c1a-1e7bb27dbc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ee0ccf6d-960f-4ee7-8b6b-94680f4744ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_2800e972-801f-402d-8c1a-1e7bb27dbc3b" xlink:to="loc_us-gaap_Goodwill_ee0ccf6d-960f-4ee7-8b6b-94680f4744ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f2395943-eaee-4a03-93ba-7c4d4d6f9e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cc8e85cf-ebbe-4704-adcb-9e7013e2d743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f2395943-eaee-4a03-93ba-7c4d4d6f9e44" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cc8e85cf-ebbe-4704-adcb-9e7013e2d743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59a4cf12-72c2-4e6a-9583-649a59190e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cc8e85cf-ebbe-4704-adcb-9e7013e2d743" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59a4cf12-72c2-4e6a-9583-649a59190e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82b57473-6ad6-485a-bbc9-cb4c11ca76f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_59a4cf12-72c2-4e6a-9583-649a59190e02" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82b57473-6ad6-485a-bbc9-cb4c11ca76f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_e1d14862-baed-4a82-9295-0d617e310c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82b57473-6ad6-485a-bbc9-cb4c11ca76f6" xlink:to="loc_us-gaap_LicensingAgreementsMember_e1d14862-baed-4a82-9295-0d617e310c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f81c57d7-927f-4ba2-8b22-83eec20e361b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cc8e85cf-ebbe-4704-adcb-9e7013e2d743" xlink:to="loc_srt_CounterpartyNameAxis_f81c57d7-927f-4ba2-8b22-83eec20e361b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e0bd008b-73d3-459c-a5b7-7fef341c2fe4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f81c57d7-927f-4ba2-8b22-83eec20e361b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e0bd008b-73d3-459c-a5b7-7fef341c2fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_3bc99323-b602-4850-b2f9-1c75b9229bba" xlink:href="lgnd-20220930.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e0bd008b-73d3-459c-a5b7-7fef341c2fe4" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_3bc99323-b602-4850-b2f9-1c75b9229bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_aeef209d-f3f0-4f1b-8564-a24741063228" xlink:href="lgnd-20220930.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e0bd008b-73d3-459c-a5b7-7fef341c2fe4" xlink:to="loc_lgnd_SelexisAndDianomiMember_aeef209d-f3f0-4f1b-8564-a24741063228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5825f05-18d6-4941-876b-2fcea518feaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_cc8e85cf-ebbe-4704-adcb-9e7013e2d743" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5825f05-18d6-4941-876b-2fcea518feaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:href="lgnd-20220930.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5825f05-18d6-4941-876b-2fcea518feaf" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0a7a6f6b-864f-4081-9b08-e2a702c5fd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0a7a6f6b-864f-4081-9b08-e2a702c5fd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_4b4f2404-d6bf-4cc4-8a29-ab471c682f9f" xlink:href="lgnd-20220930.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_4b4f2404-d6bf-4cc4-8a29-ab471c682f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a29051de-301f-402d-9c76-840d93a93e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a29051de-301f-402d-9c76-840d93a93e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_45a181c7-3a4b-402e-83dd-92df3a7eaf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_45a181c7-3a4b-402e-83dd-92df3a7eaf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_2ab1c3b2-5f01-45ff-abb9-b93531825852" xlink:href="lgnd-20220930.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_6631f20c-66b5-452c-985d-6850678c6f58" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_2ab1c3b2-5f01-45ff-abb9-b93531825852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_29d0c053-5f11-4026-9f21-a490b41dc3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_78698fd0-5319-4882-b0ed-567d02a2f6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_29d0c053-5f11-4026-9f21-a490b41dc3a7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_78698fd0-5319-4882-b0ed-567d02a2f6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1e324776-b4cc-4b1e-a426-5762ede346a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_78698fd0-5319-4882-b0ed-567d02a2f6a2" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1e324776-b4cc-4b1e-a426-5762ede346a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_d87b6bcc-2cf0-4cef-8ffc-e766b3ac3b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_78698fd0-5319-4882-b0ed-567d02a2f6a2" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_d87b6bcc-2cf0-4cef-8ffc-e766b3ac3b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_c7c48793-7c02-472b-9ce7-bc897a1d358f" xlink:href="lgnd-20220930.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_78698fd0-5319-4882-b0ed-567d02a2f6a2" xlink:to="loc_lgnd_LicenseeAccrualCurrent_c7c48793-7c02-472b-9ce7-bc897a1d358f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_81c3d0a0-8a2b-4f55-9fcf-5355c868ad36" xlink:href="lgnd-20220930.xsd#lgnd_ReturnsAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_78698fd0-5319-4882-b0ed-567d02a2f6a2" xlink:to="loc_lgnd_ReturnsAccrual_81c3d0a0-8a2b-4f55-9fcf-5355c868ad36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_1492cfc8-2bcb-42a5-bf91-06feb6b90ccd" xlink:href="lgnd-20220930.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_78698fd0-5319-4882-b0ed-567d02a2f6a2" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_1492cfc8-2bcb-42a5-bf91-06feb6b90ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_e91f8af4-2c42-4c83-a189-b8c935f50a48" xlink:href="lgnd-20220930.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_78698fd0-5319-4882-b0ed-567d02a2f6a2" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_e91f8af4-2c42-4c83-a189-b8c935f50a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_55184973-b75a-4371-a70a-0440a1cc7eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_78698fd0-5319-4882-b0ed-567d02a2f6a2" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_55184973-b75a-4371-a70a-0440a1cc7eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0fde7e77-76c9-4b0e-aee1-8b7a0a0944d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_78698fd0-5319-4882-b0ed-567d02a2f6a2" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_0fde7e77-76c9-4b0e-aee1-8b7a0a0944d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_999b8357-ef79-4d28-b327-e210da8e2453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_6a5ace04-bc6d-4575-956e-816ef39671e1" xlink:href="lgnd-20220930.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_999b8357-ef79-4d28-b327-e210da8e2453" xlink:to="loc_lgnd_BasisOfPresentationTable_6a5ace04-bc6d-4575-956e-816ef39671e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0c59a391-24f9-4f40-a13e-83866967cacb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_6a5ace04-bc6d-4575-956e-816ef39671e1" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0c59a391-24f9-4f40-a13e-83866967cacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9e3a0f5f-2e62-4ebb-b914-5bcdf9ca9b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0c59a391-24f9-4f40-a13e-83866967cacb" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9e3a0f5f-2e62-4ebb-b914-5bcdf9ca9b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3c9cea2d-05aa-4794-ae9a-5c1e0a64b948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9e3a0f5f-2e62-4ebb-b914-5bcdf9ca9b52" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3c9cea2d-05aa-4794-ae9a-5c1e0a64b948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_13db2c71-5ab3-419e-9eb2-a3f6426a2153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9e3a0f5f-2e62-4ebb-b914-5bcdf9ca9b52" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_13db2c71-5ab3-419e-9eb2-a3f6426a2153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_98c70da0-f257-46b0-97aa-2323295a7cbd" xlink:href="lgnd-20220930.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_6a5ace04-bc6d-4575-956e-816ef39671e1" xlink:to="loc_lgnd_BasisOfPresentationLineItems_98c70da0-f257-46b0-97aa-2323295a7cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_d18082c1-bda5-4096-81c6-b5eed72439aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_98c70da0-f257-46b0-97aa-2323295a7cbd" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_d18082c1-bda5-4096-81c6-b5eed72439aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_15815bc2-359a-430c-a5ef-3ccc1b098572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a7bc181e-cd2c-46d6-ab3b-077c81660846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_15815bc2-359a-430c-a5ef-3ccc1b098572" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a7bc181e-cd2c-46d6-ab3b-077c81660846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1de9004d-1cfd-4822-b133-29c81a5bdaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_15815bc2-359a-430c-a5ef-3ccc1b098572" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1de9004d-1cfd-4822-b133-29c81a5bdaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1fdc9458-a596-4f74-a39e-bb83e0bea832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_15815bc2-359a-430c-a5ef-3ccc1b098572" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1fdc9458-a596-4f74-a39e-bb83e0bea832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7dad047d-bc7c-43b7-bf77-a287c81ef585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_15815bc2-359a-430c-a5ef-3ccc1b098572" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7dad047d-bc7c-43b7-bf77-a287c81ef585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fc3b8fb6-0f45-41a4-a5ed-6e45654b0137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3a484016-35b5-4bb9-8f32-fe9b8f826660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fc3b8fb6-0f45-41a4-a5ed-6e45654b0137" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3a484016-35b5-4bb9-8f32-fe9b8f826660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3dc07017-a645-4e83-9d4f-567761c7035b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3a484016-35b5-4bb9-8f32-fe9b8f826660" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3dc07017-a645-4e83-9d4f-567761c7035b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_15c598f1-df83-4208-8c87-2bcbc244ce10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3dc07017-a645-4e83-9d4f-567761c7035b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_15c598f1-df83-4208-8c87-2bcbc244ce10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9f4fc7f9-30db-4a5e-9e2f-edaa33d09b29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_15c598f1-df83-4208-8c87-2bcbc244ce10" xlink:to="loc_us-gaap_RestrictedStockMember_9f4fc7f9-30db-4a5e-9e2f-edaa33d09b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6a5bbe70-edab-403b-99f9-e5c5b8e738f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_15c598f1-df83-4208-8c87-2bcbc244ce10" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6a5bbe70-edab-403b-99f9-e5c5b8e738f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0eda3ea9-d360-4ee6-ae94-de1fc3b25f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3a484016-35b5-4bb9-8f32-fe9b8f826660" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0eda3ea9-d360-4ee6-ae94-de1fc3b25f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf2bdea7-89ba-4f4d-a305-4838af804405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0eda3ea9-d360-4ee6-ae94-de1fc3b25f29" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf2bdea7-89ba-4f4d-a305-4838af804405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_8ed4fd78-06ba-4ae6-a107-fefd64863ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0eda3ea9-d360-4ee6-ae94-de1fc3b25f29" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_8ed4fd78-06ba-4ae6-a107-fefd64863ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_301c9723-a895-4825-83ef-32877bddf956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_8ed4fd78-06ba-4ae6-a107-fefd64863ef5" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_301c9723-a895-4825-83ef-32877bddf956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8dc61558-fb19-49e4-9e96-95c15b0b05f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_8ed4fd78-06ba-4ae6-a107-fefd64863ef5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8dc61558-fb19-49e4-9e96-95c15b0b05f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8364c038-92af-4be2-89cb-e18c0601d1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0eda3ea9-d360-4ee6-ae94-de1fc3b25f29" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8364c038-92af-4be2-89cb-e18c0601d1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#SegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a75c50d8-ca07-4d31-8f41-3bcdaf610d76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b1f788fe-e500-44f4-a644-8a471dedfda0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a75c50d8-ca07-4d31-8f41-3bcdaf610d76" xlink:to="loc_us-gaap_NumberOfReportableSegments_b1f788fe-e500-44f4-a644-8a471dedfda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a75c50d8-ca07-4d31-8f41-3bcdaf610d76" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b5ca7be2-78bb-4b0b-ac9a-be384f050d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b5ca7be2-78bb-4b0b-ac9a-be384f050d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cfacfaa8-fcbf-4131-b50c-38c1ca9068a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b5ca7be2-78bb-4b0b-ac9a-be384f050d1a" xlink:to="loc_us-gaap_SegmentDomain_cfacfaa8-fcbf-4131-b50c-38c1ca9068a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember_ea3b6395-0a9a-47f9-8f4d-1bc2b2227d94" xlink:href="lgnd-20220930.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cfacfaa8-fcbf-4131-b50c-38c1ca9068a2" xlink:to="loc_lgnd_OmniAbTechnologiesSegmentMember_ea3b6395-0a9a-47f9-8f4d-1bc2b2227d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_25e34a31-4ec8-468d-8a13-ad96aa65299d" xlink:href="lgnd-20220930.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cfacfaa8-fcbf-4131-b50c-38c1ca9068a2" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_25e34a31-4ec8-468d-8a13-ad96aa65299d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_adf70084-5084-489f-8aa1-dd7f1516c250" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:to="loc_srt_ProductOrServiceAxis_adf70084-5084-489f-8aa1-dd7f1516c250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_adf70084-5084-489f-8aa1-dd7f1516c250" xlink:to="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_5b218d29-91dc-4e4c-a7e8-f4339fa55269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:to="loc_us-gaap_RoyaltyMember_5b218d29-91dc-4e4c-a7e8-f4339fa55269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_4a9841ec-65c2-4614-8807-3a2e23300118" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_4a9841ec-65c2-4614-8807-3a2e23300118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d9cf9ee3-f792-40bd-b4b2-cc2677fab07b" xlink:href="lgnd-20220930.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d9cf9ee3-f792-40bd-b4b2-cc2677fab07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_ff0b00e5-5201-4c9c-b0f9-e9fd2c153e2a" xlink:href="lgnd-20220930.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bee66e73-d4b2-4866-a83c-a8ca626c8fc6" xlink:to="loc_lgnd_ContractRevenueMember_ff0b00e5-5201-4c9c-b0f9-e9fd2c153e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_9b3014ae-4ff9-42a3-aa39-8530b2edb61d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:to="loc_srt_ConsolidationItemsAxis_9b3014ae-4ff9-42a3-aa39-8530b2edb61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6b62cd3a-299d-410e-85ef-7e0b0c81723e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_9b3014ae-4ff9-42a3-aa39-8530b2edb61d" xlink:to="loc_srt_ConsolidationItemsDomain_6b62cd3a-299d-410e-85ef-7e0b0c81723e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_be246f91-2a4a-4701-b7aa-d9b9e0ffd3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6b62cd3a-299d-410e-85ef-7e0b0c81723e" xlink:to="loc_us-gaap_OperatingSegmentsMember_be246f91-2a4a-4701-b7aa-d9b9e0ffd3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_446611f3-5ff5-4a04-83a5-32a034e20300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6b62cd3a-299d-410e-85ef-7e0b0c81723e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_446611f3-5ff5-4a04-83a5-32a034e20300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_232087ac-5b9c-4cb7-b6d2-34df1fd8d61f" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9786516c-2213-4249-b187-e3d1640d5a95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9786516c-2213-4249-b187-e3d1640d5a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2dc46303-650e-4a31-bdb1-e7e064b83189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2dc46303-650e-4a31-bdb1-e7e064b83189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f1f749c6-6039-4162-aeb2-bf721317ff19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f1f749c6-6039-4162-aeb2-bf721317ff19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_01c24335-9d29-4d6b-aca2-e3eeb4e277fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_01c24335-9d29-4d6b-aca2-e3eeb4e277fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_7ccffdf6-3ef6-4c2f-9aae-c9640e3aab71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_7ccffdf6-3ef6-4c2f-9aae-c9640e3aab71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_04e64d56-4d5c-4ac7-9ccf-ba4f20c3ce8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b421ff2c-a404-4a33-bbc7-fda8c1b76a2d" xlink:to="loc_us-gaap_OperatingIncomeLoss_04e64d56-4d5c-4ac7-9ccf-ba4f20c3ce8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1e1c9012-6ba0-41dc-b75d-318d5d4722b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e1c9012-6ba0-41dc-b75d-318d5d4722b9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d300283-84ab-4077-a991-81865ebd50fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d300283-84ab-4077-a991-81865ebd50fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d4defaab-52fa-4188-89f9-4006bde03c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d300283-84ab-4077-a991-81865ebd50fd" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d4defaab-52fa-4188-89f9-4006bde03c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_0c54aaad-6b56-487f-bdbc-82d16130adbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d4defaab-52fa-4188-89f9-4006bde03c48" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_0c54aaad-6b56-487f-bdbc-82d16130adbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41171850-85c4-4602-b5d9-16bc0ad431ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41171850-85c4-4602-b5d9-16bc0ad431ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2945535-2a0d-4d6c-8f6b-9d0c0e99e451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_41171850-85c4-4602-b5d9-16bc0ad431ae" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2945535-2a0d-4d6c-8f6b-9d0c0e99e451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_588e3ac2-f082-4e97-9f17-533b7705a909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2945535-2a0d-4d6c-8f6b-9d0c0e99e451" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_588e3ac2-f082-4e97-9f17-533b7705a909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7ee399a9-7ade-433e-bbbf-4c4a06d6ca58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2945535-2a0d-4d6c-8f6b-9d0c0e99e451" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7ee399a9-7ade-433e-bbbf-4c4a06d6ca58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e5512084-e6c3-42ad-9b4f-b47c8b668014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2945535-2a0d-4d6c-8f6b-9d0c0e99e451" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e5512084-e6c3-42ad-9b4f-b47c8b668014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_98f32ffd-eaac-4593-926b-8832651f7346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_98f32ffd-eaac-4593-926b-8832651f7346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_880a7d38-4e78-4b93-8f9a-008947bcf127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_98f32ffd-eaac-4593-926b-8832651f7346" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_880a7d38-4e78-4b93-8f9a-008947bcf127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_43c2eacc-c939-4400-888a-604797944a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_880a7d38-4e78-4b93-8f9a-008947bcf127" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_43c2eacc-c939-4400-888a-604797944a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_edb256f8-9e0e-4b37-843a-5f028a25b5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_880a7d38-4e78-4b93-8f9a-008947bcf127" xlink:to="loc_us-gaap_CommonStockMember_edb256f8-9e0e-4b37-843a-5f028a25b5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContingentLiabilitiesMember_fb38bc5b-2c35-44b4-8661-0d12865ad37c" xlink:href="lgnd-20220930.xsd#lgnd_ContingentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_880a7d38-4e78-4b93-8f9a-008947bcf127" xlink:to="loc_lgnd_ContingentLiabilitiesMember_fb38bc5b-2c35-44b4-8661-0d12865ad37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0c3ec29a-6abe-4214-a644-4d357144a9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0c3ec29a-6abe-4214-a644-4d357144a9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0c3ec29a-6abe-4214-a644-4d357144a9f1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CyDexMember_740211aa-0a0a-4a4f-9d87-1e6ec37377cc" xlink:href="lgnd-20220930.xsd#lgnd_CyDexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:to="loc_lgnd_CyDexMember_740211aa-0a0a-4a4f-9d87-1e6ec37377cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_d9cd0759-83ae-4240-81d0-273504399831" xlink:href="lgnd-20220930.xsd#lgnd_MetabasisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:to="loc_lgnd_MetabasisMember_d9cd0759-83ae-4240-81d0-273504399831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IcagenMember_ef66d8cb-9db5-4923-9b13-2681fc604b09" xlink:href="lgnd-20220930.xsd#lgnd_IcagenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:to="loc_lgnd_IcagenMember_ef66d8cb-9db5-4923-9b13-2681fc604b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_23065b2d-5abd-463e-b923-b659401ebb10" xlink:href="lgnd-20220930.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1004b883-e7ca-4bc9-a90c-74523b81688c" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_23065b2d-5abd-463e-b923-b659401ebb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7a1c2b05-4707-4088-a764-e2099e908050" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_srt_RangeAxis_7a1c2b05-4707-4088-a764-e2099e908050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_501297f7-a46f-4521-9aa9-aaf8ad6cba6b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7a1c2b05-4707-4088-a764-e2099e908050" xlink:to="loc_srt_RangeMember_501297f7-a46f-4521-9aa9-aaf8ad6cba6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ffe62cfc-cb68-41c4-b535-42b4f10b6d10" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_501297f7-a46f-4521-9aa9-aaf8ad6cba6b" xlink:to="loc_srt_MaximumMember_ffe62cfc-cb68-41c4-b535-42b4f10b6d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c148b64c-f5b7-4eeb-84c2-fca99ed5ffb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c148b64c-f5b7-4eeb-84c2-fca99ed5ffb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5069384a-d562-4f46-a503-22595a88993f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_c148b64c-f5b7-4eeb-84c2-fca99ed5ffb8" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5069384a-d562-4f46-a503-22595a88993f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_34891c51-0635-45df-b04a-bb7a16949134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_5069384a-d562-4f46-a503-22595a88993f" xlink:to="loc_us-gaap_TransferredOverTimeMember_34891c51-0635-45df-b04a-bb7a16949134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_89471b28-69a8-46f2-ad47-33a40516913f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_srt_ProductOrServiceAxis_89471b28-69a8-46f2-ad47-33a40516913f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d7f96f9d-2a02-4bb2-88f5-af0c8b0dba0d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_89471b28-69a8-46f2-ad47-33a40516913f" xlink:to="loc_srt_ProductsAndServicesDomain_d7f96f9d-2a02-4bb2-88f5-af0c8b0dba0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_ea3f7b11-d7cc-4856-8799-49dca5c39bb7" xlink:href="lgnd-20220930.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d7f96f9d-2a02-4bb2-88f5-af0c8b0dba0d" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_ea3f7b11-d7cc-4856-8799-49dca5c39bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_9741f037-6198-4297-ac4d-81d42c807604" xlink:href="lgnd-20220930.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d7f96f9d-2a02-4bb2-88f5-af0c8b0dba0d" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_9741f037-6198-4297-ac4d-81d42c807604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_1b98a651-5428-42b9-9c37-6950bc404962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_1b98a651-5428-42b9-9c37-6950bc404962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_edc4a902-466c-41c1-a264-fd93b86c69a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_1b98a651-5428-42b9-9c37-6950bc404962" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_edc4a902-466c-41c1-a264-fd93b86c69a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_57da348d-87c3-4ba3-85b1-3b431db9fc1c" xlink:href="lgnd-20220930.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_edc4a902-466c-41c1-a264-fd93b86c69a8" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_57da348d-87c3-4ba3-85b1-3b431db9fc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9676fe17-2f91-454f-87c5-6452dcc1f2a8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_2380433a-31dd-4763-b8d1-3c7ec5f0664e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_2380433a-31dd-4763-b8d1-3c7ec5f0664e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_3b1be444-009d-4f23-9e2d-4105dbe55a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_3b1be444-009d-4f23-9e2d-4105dbe55a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_d35aa745-b16b-4c01-856d-d0c296665242" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure_d35aa745-b16b-4c01-856d-d0c296665242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_a5cbfc1e-f9c8-463f-9db2-85e87033d00c" xlink:href="lgnd-20220930.xsd#lgnd_AmountsOwedToFormerLicensorFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure_a5cbfc1e-f9c8-463f-9db2-85e87033d00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_79f8c9f0-6005-45cf-bc54-304b7d6cea79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_79f8c9f0-6005-45cf-bc54-304b7d6cea79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_956f5a91-2b92-49c2-a314-17386ef85980" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_956f5a91-2b92-49c2-a314-17386ef85980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_082d9173-7179-44f4-83e2-3b82c35da0ba" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_082d9173-7179-44f4-83e2-3b82c35da0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_b30728d9-fb1f-448e-a660-8f8555f5906c" xlink:href="lgnd-20220930.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_b30728d9-fb1f-448e-a660-8f8555f5906c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_8aba442e-11e9-4ee0-89a4-45e2105a5448" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_8aba442e-11e9-4ee0-89a4-45e2105a5448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_ee9b199e-a352-4528-978c-700e3c399438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_Investments_ee9b199e-a352-4528-978c-700e3c399438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_d2539483-fe36-481f-a14f-da66a96e8e97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_d2539483-fe36-481f-a14f-da66a96e8e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_d77a0908-8599-41e2-b5aa-aaadde37b769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_d77a0908-8599-41e2-b5aa-aaadde37b769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_759471f7-7d59-4162-8adf-fe167555e07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_759471f7-7d59-4162-8adf-fe167555e07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_3b64a10a-c4f4-4438-9e7d-98f4dcb284b7" xlink:href="lgnd-20220930.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_feacf10a-911b-4a3c-95e2-d3b859015d98" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_3b64a10a-c4f4-4438-9e7d-98f4dcb284b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8070f521-b704-4720-81e9-2f19dd05618a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a2c15d51-965d-4529-a770-ecc748f932ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8070f521-b704-4720-81e9-2f19dd05618a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a2c15d51-965d-4529-a770-ecc748f932ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eaa8dff4-ea31-491c-9458-37735b3edbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a2c15d51-965d-4529-a770-ecc748f932ef" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eaa8dff4-ea31-491c-9458-37735b3edbb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1b210ce5-5c62-4631-95c5-3f93b7408104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_eaa8dff4-ea31-491c-9458-37735b3edbb1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1b210ce5-5c62-4631-95c5-3f93b7408104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1962794e-5b33-40f2-b1f0-31d8e4ad3322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1b210ce5-5c62-4631-95c5-3f93b7408104" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1962794e-5b33-40f2-b1f0-31d8e4ad3322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bfae289b-bd93-45aa-a642-a9850ed4e352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a2c15d51-965d-4529-a770-ecc748f932ef" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bfae289b-bd93-45aa-a642-a9850ed4e352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bfae289b-bd93-45aa-a642-a9850ed4e352" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_217a9f19-a9ec-4d64-b230-66bbecca7b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_217a9f19-a9ec-4d64-b230-66bbecca7b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_79af4739-1c4b-4f4e-8bdf-aa3ae4b243f8" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_79af4739-1c4b-4f4e-8bdf-aa3ae4b243f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2eb15cc4-ef71-4650-ac33-da57191eba01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2eb15cc4-ef71-4650-ac33-da57191eba01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_a6d8872d-41b2-4bb9-8123-2aba3c036714" xlink:href="lgnd-20220930.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_a6d8872d-41b2-4bb9-8123-2aba3c036714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fbbf4142-5795-4de1-a213-2440270c79b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_4327a00d-f366-4e3d-81ec-b6053f947b2b" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_fbbf4142-5795-4de1-a213-2440270c79b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6c5017b9-52ad-455c-bca6-8a41e0c5b638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_11cb7bf8-865f-40c8-ade3-9024293c3e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6c5017b9-52ad-455c-bca6-8a41e0c5b638" xlink:to="loc_us-gaap_NumberOfReportingUnits_11cb7bf8-865f-40c8-ade3-9024293c3e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7bdb71ae-a32a-42ec-98d8-49745202e0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7bdb71ae-a32a-42ec-98d8-49745202e0a4" xlink:to="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a30e0e14-33da-4034-a764-7bd228312e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a30e0e14-33da-4034-a764-7bd228312e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_39134f58-e81b-46a9-91cc-9b92339f618b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a30e0e14-33da-4034-a764-7bd228312e2c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_39134f58-e81b-46a9-91cc-9b92339f618b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_37f2499e-5bad-4573-8abd-e6e3025a29b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_39134f58-e81b-46a9-91cc-9b92339f618b" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_37f2499e-5bad-4573-8abd-e6e3025a29b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e612586d-acef-482a-8376-65d69118dafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_DebtInstrumentAxis_e612586d-acef-482a-8376-65d69118dafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8712fad2-ab86-4254-b618-4ef39bf4d913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e612586d-acef-482a-8376-65d69118dafc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8712fad2-ab86-4254-b618-4ef39bf4d913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_cdfe1b9a-661e-472d-b776-ca47d22aef23" xlink:href="lgnd-20220930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8712fad2-ab86-4254-b618-4ef39bf4d913" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_cdfe1b9a-661e-472d-b776-ca47d22aef23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6940721f-6af2-4b3c-8b5e-84c223ede323" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_srt_RangeAxis_6940721f-6af2-4b3c-8b5e-84c223ede323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7aad0025-83da-4a33-97d0-4ed20abf3ea9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6940721f-6af2-4b3c-8b5e-84c223ede323" xlink:to="loc_srt_RangeMember_7aad0025-83da-4a33-97d0-4ed20abf3ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c1463080-634c-4bfe-bd5e-6d9528db8181" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7aad0025-83da-4a33-97d0-4ed20abf3ea9" xlink:to="loc_srt_MaximumMember_c1463080-634c-4bfe-bd5e-6d9528db8181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e04c026-404a-49d6-9a04-17662143ada1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e04c026-404a-49d6-9a04-17662143ada1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0c6c1085-f1b9-4b44-a0ba-64e8d905d665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_6e04c026-404a-49d6-9a04-17662143ada1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0c6c1085-f1b9-4b44-a0ba-64e8d905d665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_c8f343a4-8490-41fe-9ad2-6c0a6f49bd19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0c6c1085-f1b9-4b44-a0ba-64e8d905d665" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_c8f343a4-8490-41fe-9ad2-6c0a6f49bd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ed8f41c3-b3d7-4f6f-ba5a-c3fd99dbc3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0c6c1085-f1b9-4b44-a0ba-64e8d905d665" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_ed8f41c3-b3d7-4f6f-ba5a-c3fd99dbc3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_441d285f-62e7-46ab-9acb-900594256dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_441d285f-62e7-46ab-9acb-900594256dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1c274922-cf54-4868-b891-1d832b8a2adb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_441d285f-62e7-46ab-9acb-900594256dfe" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1c274922-cf54-4868-b891-1d832b8a2adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_684bd20f-174b-4e18-869d-93fce78f3e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1c274922-cf54-4868-b891-1d832b8a2adb" xlink:to="loc_us-gaap_SubsequentEventMember_684bd20f-174b-4e18-869d-93fce78f3e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_d863c30d-e3f8-4733-bde2-23cfe9bfcd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_d863c30d-e3f8-4733-bde2-23cfe9bfcd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_9318e450-a7ec-4ca3-a6a1-7f51f6de1ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_d863c30d-e3f8-4733-bde2-23cfe9bfcd9b" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_9318e450-a7ec-4ca3-a6a1-7f51f6de1ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember_131c5ede-e579-4189-8d14-26ceff246a22" xlink:href="lgnd-20220930.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_9318e450-a7ec-4ca3-a6a1-7f51f6de1ba0" xlink:to="loc_lgnd_NotesRepurchasedDuringCurrentPeriodOneMember_131c5ede-e579-4189-8d14-26ceff246a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_44ad8637-f9bc-4983-80ff-d63dc5941c7e" xlink:href="lgnd-20220930.xsd#lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_9318e450-a7ec-4ca3-a6a1-7f51f6de1ba0" xlink:to="loc_lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember_44ad8637-f9bc-4983-80ff-d63dc5941c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8777db51-4439-4340-96a0-f3c7b6766616" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bb1e09c8-0f1d-4363-97b6-d32106d1934c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_bb1e09c8-0f1d-4363-97b6-d32106d1934c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6d86189d-3c72-4f66-9b73-af5ef3ac8e37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6d86189d-3c72-4f66-9b73-af5ef3ac8e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_2b07b7de-0af1-43d4-8928-95bafdc12c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_2b07b7de-0af1-43d4-8928-95bafdc12c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_9bfb054c-d405-42b5-9d0c-8edeb8b01b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_9bfb054c-d405-42b5-9d0c-8edeb8b01b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_a9d8e01a-7ca5-4b49-bb9b-e02ae6a76fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_a9d8e01a-7ca5-4b49-bb9b-e02ae6a76fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_0a2f9ede-9ba7-4ca3-8d94-bf82408c43a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_0a2f9ede-9ba7-4ca3-8d94-bf82408c43a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_08d38b64-b79c-4a7e-bbf8-6929bb2808f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_08d38b64-b79c-4a7e-bbf8-6929bb2808f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_80927bb5-c414-4634-8282-da63f8cefa54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_80927bb5-c414-4634-8282-da63f8cefa54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_239ac470-293c-4a1b-be5e-7a9096cf46c2" xlink:href="lgnd-20220930.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_239ac470-293c-4a1b-be5e-7a9096cf46c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_05de4bdd-1b44-4822-8cdb-9691f3190339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_05de4bdd-1b44-4822-8cdb-9691f3190339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_fb08cbd0-cf01-4101-840d-58a1e523f3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentTerm_fb08cbd0-cf01-4101-840d-58a1e523f3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_0ce848bb-3e58-4d06-9637-00e518d52920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_0ce848bb-3e58-4d06-9637-00e518d52920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_df0664fe-ec8c-4655-9ca8-689d00d1099f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_InterestExpenseDebt_df0664fe-ec8c-4655-9ca8-689d00d1099f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_e6acb47b-f471-4779-a1be-407f14435846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_e6acb47b-f471-4779-a1be-407f14435846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_779e027e-8345-4123-bcdc-87e89e40f3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_779e027e-8345-4123-bcdc-87e89e40f3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_830b1d3a-6ddd-4006-8abe-09ee00fa7e4e" xlink:href="lgnd-20220930.xsd#lgnd_DebtInstrumentRepurchasedAmountDuringPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod_830b1d3a-6ddd-4006-8abe-09ee00fa7e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_5e034bd9-6b3d-4f76-9ec1-69e4bf8c1f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_5e034bd9-6b3d-4f76-9ec1-69e4bf8c1f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_76f592a7-2beb-47e4-8a28-de21d82658ec" xlink:href="lgnd-20220930.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_76f592a7-2beb-47e4-8a28-de21d82658ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c6a30b24-3103-40c5-af7d-4ee3225e465d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c6a30b24-3103-40c5-af7d-4ee3225e465d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b2aa5332-5d8e-46ee-8ded-8d0ad90e852c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b2aa5332-5d8e-46ee-8ded-8d0ad90e852c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_fdcd2468-9337-4dcc-93fe-3f5761dd5c03" xlink:href="lgnd-20220930.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_fdcd2468-9337-4dcc-93fe-3f5761dd5c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_df9ba749-8e32-457e-b8b6-1f1e6262b8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_df9ba749-8e32-457e-b8b6-1f1e6262b8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_1f6d1f01-63ab-4031-bad8-e0d94ab2131c" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_1f6d1f01-63ab-4031-bad8-e0d94ab2131c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3d85d735-8fd9-418b-b431-e01e6bc66d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3d85d735-8fd9-418b-b431-e01e6bc66d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_00d988b3-e8c0-43b7-96ce-67e9a5dd60b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_00d988b3-e8c0-43b7-96ce-67e9a5dd60b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_7ef268e5-aa36-41e0-86a4-2c549a3757a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_7ef268e5-aa36-41e0-86a4-2c549a3757a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_910c66cc-e2ab-4f23-891e-55e014452bf4" xlink:href="lgnd-20220930.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_910c66cc-e2ab-4f23-891e-55e014452bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_bee69c0b-66ed-4877-ba07-107c646aa3da" xlink:href="lgnd-20220930.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_bee69c0b-66ed-4877-ba07-107c646aa3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_a2f4d71c-fa05-4392-8839-e714e1b26c8d" xlink:href="lgnd-20220930.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a74873f4-1af7-4632-b2f8-c3cee0683b9e" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_a2f4d71c-fa05-4392-8839-e714e1b26c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fd2ac0ad-c358-42ff-963d-f6b71257ae61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_951e543a-5a0a-4cc9-a02b-8ddecad87b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fd2ac0ad-c358-42ff-963d-f6b71257ae61" xlink:to="loc_us-gaap_DebtInstrumentTable_951e543a-5a0a-4cc9-a02b-8ddecad87b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4c3d1022-84f5-4ffc-8c25-b8910c7cbffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_951e543a-5a0a-4cc9-a02b-8ddecad87b6d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4c3d1022-84f5-4ffc-8c25-b8910c7cbffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_71d1551e-9638-4510-a1b5-1538eb7d2f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4c3d1022-84f5-4ffc-8c25-b8910c7cbffa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_71d1551e-9638-4510-a1b5-1538eb7d2f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_25404551-695d-4d70-a9be-c83ddf05d312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_71d1551e-9638-4510-a1b5-1538eb7d2f59" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_25404551-695d-4d70-a9be-c83ddf05d312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1e39aac2-9720-4e3b-837b-be27015ac367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_951e543a-5a0a-4cc9-a02b-8ddecad87b6d" xlink:to="loc_us-gaap_DebtInstrumentAxis_1e39aac2-9720-4e3b-837b-be27015ac367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9b0143a-cf9f-46ca-ac64-d01530e73dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1e39aac2-9720-4e3b-837b-be27015ac367" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9b0143a-cf9f-46ca-ac64-d01530e73dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_502f71be-a645-41e2-ac1c-d6055feffd3e" xlink:href="lgnd-20220930.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9b0143a-cf9f-46ca-ac64-d01530e73dd8" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_502f71be-a645-41e2-ac1c-d6055feffd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_24d0eed2-49ce-4b01-af09-9d30c356884a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_951e543a-5a0a-4cc9-a02b-8ddecad87b6d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_24d0eed2-49ce-4b01-af09-9d30c356884a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_253280e2-c7f6-4121-86e8-e30615ff5cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_24d0eed2-49ce-4b01-af09-9d30c356884a" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_253280e2-c7f6-4121-86e8-e30615ff5cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1cc027c8-a3ca-4ea7-bb59-acbac9ff9d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_253280e2-c7f6-4121-86e8-e30615ff5cdf" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1cc027c8-a3ca-4ea7-bb59-acbac9ff9d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_bcdaf6fd-faba-48cb-84b5-c2509b6691d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_253280e2-c7f6-4121-86e8-e30615ff5cdf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_bcdaf6fd-faba-48cb-84b5-c2509b6691d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_59788670-2b07-4e7b-bdd6-01a6309f4618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_253280e2-c7f6-4121-86e8-e30615ff5cdf" xlink:to="loc_us-gaap_LongTermNotesPayable_59788670-2b07-4e7b-bdd6-01a6309f4618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_ca165947-b470-4a2e-8816-da33fe9967df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_24d0eed2-49ce-4b01-af09-9d30c356884a" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_ca165947-b470-4a2e-8816-da33fe9967df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#IncomeTaxDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fb34a125-0c4c-4732-b223-971967aa0245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_fa5bd303-7c09-4f9d-84f5-3d351dd265ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fb34a125-0c4c-4732-b223-971967aa0245" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_fa5bd303-7c09-4f9d-84f5-3d351dd265ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_64c8836b-d97c-46b8-9ab7-7a6bf98c0ada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_fa5bd303-7c09-4f9d-84f5-3d351dd265ae" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_64c8836b-d97c-46b8-9ab7-7a6bf98c0ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5d63570f-6d38-49a2-aa80-a1606bfa009d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_64c8836b-d97c-46b8-9ab7-7a6bf98c0ada" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5d63570f-6d38-49a2-aa80-a1606bfa009d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PfenexMember_9680fed4-1363-4acc-be77-1f94070e2acd" xlink:href="lgnd-20220930.xsd#lgnd_PfenexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5d63570f-6d38-49a2-aa80-a1606bfa009d" xlink:to="loc_lgnd_PfenexMember_9680fed4-1363-4acc-be77-1f94070e2acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_0a6e9799-164b-4877-99d3-30eec1d75262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_fa5bd303-7c09-4f9d-84f5-3d351dd265ae" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_0a6e9799-164b-4877-99d3-30eec1d75262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_09abd582-c562-413c-b155-cd1145310989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0a6e9799-164b-4877-99d3-30eec1d75262" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_09abd582-c562-413c-b155-cd1145310989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_51d65e40-025b-467b-ae9b-3dc6ad9be700" xlink:href="lgnd-20220930.xsd#lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_0a6e9799-164b-4877-99d3-30eec1d75262" xlink:to="loc_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount_51d65e40-025b-467b-ae9b-3dc6ad9be700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_40201385-906d-432c-867f-e1e2c42add3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_7c66b437-6ec9-4520-a82e-87e420d08278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_40201385-906d-432c-867f-e1e2c42add3e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_7c66b437-6ec9-4520-a82e-87e420d08278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e568dd00-df7d-4b5e-addf-60d09e318258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7c66b437-6ec9-4520-a82e-87e420d08278" xlink:to="loc_us-gaap_AwardTypeAxis_e568dd00-df7d-4b5e-addf-60d09e318258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8403ce59-d565-491c-bc47-062d020a93f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e568dd00-df7d-4b5e-addf-60d09e318258" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8403ce59-d565-491c-bc47-062d020a93f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_76616063-13bd-4427-9784-d23a42ad1c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8403ce59-d565-491c-bc47-062d020a93f8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_76616063-13bd-4427-9784-d23a42ad1c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_1b216356-1a4f-4a41-bee1-da4a7d193688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8403ce59-d565-491c-bc47-062d020a93f8" xlink:to="loc_us-gaap_RestrictedStockMember_1b216356-1a4f-4a41-bee1-da4a7d193688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7c66b437-6ec9-4520-a82e-87e420d08278" xlink:to="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6a2ad4a-7f67-4c09-bea8-a84c3693c4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6a2ad4a-7f67-4c09-bea8-a84c3693c4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_14c2d6e4-f8bb-4a2d-9b4e-4b72d151aa3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_14c2d6e4-f8bb-4a2d-9b4e-4b72d151aa3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8dd4fec1-7804-4ee9-a0d4-ec1515d75085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8dd4fec1-7804-4ee9-a0d4-ec1515d75085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_00e656ff-7a37-4f86-980f-913d3e0c89ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_00e656ff-7a37-4f86-980f-913d3e0c89ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_32d342b4-6b88-46a4-8d22-b00cf3f16e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_74fbc4f0-2b1d-472d-9cb4-63e64298b3f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_32d342b4-6b88-46a4-8d22-b00cf3f16e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ea7f24aa-bd92-4cfb-86dd-b77603484dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ea7f24aa-bd92-4cfb-86dd-b77603484dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_521f1d40-73f7-4ff5-9293-a34822357e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_521f1d40-73f7-4ff5-9293-a34822357e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5c0bc24a-f6e0-48e1-8fc5-5c636c8b8c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5c0bc24a-f6e0-48e1-8fc5-5c636c8b8c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9192e98d-f6c1-4b85-bb13-8acd1bb9bb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9192e98d-f6c1-4b85-bb13-8acd1bb9bb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14715341-9733-4977-9543-3e744f19002e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_16bffd42-9b23-42e1-8c9f-a5c24046eeb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14715341-9733-4977-9543-3e744f19002e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6ef1ba04-5e70-4fa0-b913-938bce64dbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6ef1ba04-5e70-4fa0-b913-938bce64dbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d1e9da15-93c4-44f3-802c-184a36c74763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d1e9da15-93c4-44f3-802c-184a36c74763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3fa2e16d-3670-49c9-94b6-f2278c2423ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3fa2e16d-3670-49c9-94b6-f2278c2423ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_09e58634-23e1-4ab7-a6c4-df9c4d85c150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_09e58634-23e1-4ab7-a6c4-df9c4d85c150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_41b8c92d-651c-4f16-a0c9-84bdd2b394ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fc94d67c-630c-4902-8da5-c1b426d1b5d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_41b8c92d-651c-4f16-a0c9-84bdd2b394ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_78bef3b4-65b4-4f58-ba95-98e4498f44e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_95774e0c-95b0-4628-b3b7-ee00b9edcb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_95774e0c-95b0-4628-b3b7-ee00b9edcb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90f4b545-87e4-406b-886d-65e4c09e3091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_90f4b545-87e4-406b-886d-65e4c09e3091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4e76f3b1-f93a-489e-9fc1-9b2fca9b8b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4e76f3b1-f93a-489e-9fc1-9b2fca9b8b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a89d41a9-9430-4625-9bae-1e2f79eb0286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_a89d41a9-9430-4625-9bae-1e2f79eb0286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b63253b2-911d-4f9c-b8f4-368b3126fa0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1bad2a97-0909-4d36-9eca-37a79c9f62bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b63253b2-911d-4f9c-b8f4-368b3126fa0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_13ecf02b-edf7-4539-b523-a9546fcb7e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da15053b-f07a-4cae-a723-a89a643990b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_13ecf02b-edf7-4539-b523-a9546fcb7e33" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da15053b-f07a-4cae-a723-a89a643990b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_dae64172-86e6-46c2-8089-37c6c229db9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da15053b-f07a-4cae-a723-a89a643990b3" xlink:to="loc_us-gaap_PlanNameAxis_dae64172-86e6-46c2-8089-37c6c229db9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ffc91edd-ab5f-4b24-8dd1-4cd7ec2be01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_dae64172-86e6-46c2-8089-37c6c229db9b" xlink:to="loc_us-gaap_PlanNameDomain_ffc91edd-ab5f-4b24-8dd1-4cd7ec2be01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_37fd359e-934a-4e98-8cb2-4e74127a140f" xlink:href="lgnd-20220930.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_ffc91edd-ab5f-4b24-8dd1-4cd7ec2be01d" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_37fd359e-934a-4e98-8cb2-4e74127a140f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_6a1e4ce8-eb54-4519-afd9-7a76cde0ed2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da15053b-f07a-4cae-a723-a89a643990b3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_6a1e4ce8-eb54-4519-afd9-7a76cde0ed2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9e17e269-bc2f-45a1-ad68-6858d45391e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_6a1e4ce8-eb54-4519-afd9-7a76cde0ed2d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9e17e269-bc2f-45a1-ad68-6858d45391e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AtTheMarketEquityOfferingMember_6a01a631-e272-43c8-aa81-6caf4ff50c89" xlink:href="lgnd-20220930.xsd#lgnd_AtTheMarketEquityOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9e17e269-bc2f-45a1-ad68-6858d45391e6" xlink:to="loc_lgnd_AtTheMarketEquityOfferingMember_6a01a631-e272-43c8-aa81-6caf4ff50c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da15053b-f07a-4cae-a723-a89a643990b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0bbe80c0-365e-4e6e-a133-404dce1f12e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0bbe80c0-365e-4e6e-a133-404dce1f12e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_110e2440-f395-4ba2-bfe8-e46a69289f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_110e2440-f395-4ba2-bfe8-e46a69289f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_b640f4cd-a96e-4e26-a6e3-2a046330e253" xlink:href="lgnd-20220930.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_b640f4cd-a96e-4e26-a6e3-2a046330e253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_3df88830-2f34-419a-a553-7f2c81b33b74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_b640f4cd-a96e-4e26-a6e3-2a046330e253" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_3df88830-2f34-419a-a553-7f2c81b33b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_3f161824-d3cc-4463-9b02-89b8ee1c4e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_b640f4cd-a96e-4e26-a6e3-2a046330e253" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_3f161824-d3cc-4463-9b02-89b8ee1c4e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9fcec549-45af-4e3d-b3fc-b056a79aba62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9fcec549-45af-4e3d-b3fc-b056a79aba62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_b0acad71-f93c-4f62-9ecf-9ae095bec24e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_b0acad71-f93c-4f62-9ecf-9ae095bec24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_05d42954-7ecb-48e1-a8c5-af20abe2dac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_05d42954-7ecb-48e1-a8c5-af20abe2dac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_42b36e16-dada-4b58-ba9d-602ce3b21c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_42b36e16-dada-4b58-ba9d-602ce3b21c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_7b8cc838-5b62-4723-a14d-45717a0eb326" xlink:href="lgnd-20220930.xsd#lgnd_SaleOfStockAuthorizedOfferingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5247b88-9b97-4e1c-8850-0e0b29f7e06b" xlink:to="loc_lgnd_SaleOfStockAuthorizedOfferingAmount_7b8cc838-5b62-4723-a14d-45717a0eb326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#CommitmentandContingenciesLegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bd563176-81ed-458d-ab06-480c72853a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c846004c-83de-478e-848c-55cc03f9b835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bd563176-81ed-458d-ab06-480c72853a1c" xlink:to="loc_us-gaap_LossContingenciesTable_c846004c-83de-478e-848c-55cc03f9b835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b79841b9-daf0-4a70-aa24-3dec03d95cc1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c846004c-83de-478e-848c-55cc03f9b835" xlink:to="loc_srt_LitigationCaseAxis_b79841b9-daf0-4a70-aa24-3dec03d95cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a29e6d28-6d3c-4e3d-b60c-3972fb2bb3ad" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_b79841b9-daf0-4a70-aa24-3dec03d95cc1" xlink:to="loc_srt_LitigationCaseTypeDomain_a29e6d28-6d3c-4e3d-b60c-3972fb2bb3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_a9a2de4b-bf3d-4afc-88c9-14db3ef8a3a4" xlink:href="lgnd-20220930.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_a29e6d28-6d3c-4e3d-b60c-3972fb2bb3ad" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_a9a2de4b-bf3d-4afc-88c9-14db3ef8a3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c477d330-d373-4234-abc3-e08b52564024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c846004c-83de-478e-848c-55cc03f9b835" xlink:to="loc_us-gaap_LossContingenciesLineItems_c477d330-d373-4234-abc3-e08b52564024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_17eb19ab-2ee6-43d1-b532-fee10cbbb293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c477d330-d373-4234-abc3-e08b52564024" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_17eb19ab-2ee6-43d1-b532-fee10cbbb293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_46a61907-d737-461e-a404-bb1ac20326e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b1cdff47-37b3-4eff-9911-11084576d880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_46a61907-d737-461e-a404-bb1ac20326e5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b1cdff47-37b3-4eff-9911-11084576d880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8d96661c-d896-4cf4-a887-c8f086ef2a1e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b1cdff47-37b3-4eff-9911-11084576d880" xlink:to="loc_srt_RangeAxis_8d96661c-d896-4cf4-a887-c8f086ef2a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7ff40b0c-acc3-442e-a871-54489e154d29" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8d96661c-d896-4cf4-a887-c8f086ef2a1e" xlink:to="loc_srt_RangeMember_7ff40b0c-acc3-442e-a871-54489e154d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bc1448ef-9003-4172-a303-66f2427e0924" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7ff40b0c-acc3-442e-a871-54489e154d29" xlink:to="loc_srt_MaximumMember_bc1448ef-9003-4172-a303-66f2427e0924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b1cdff47-37b3-4eff-9911-11084576d880" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_1b942677-60d6-44a7-acc6-c75d8200f1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_1b942677-60d6-44a7-acc6-c75d8200f1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_56b36253-4ab5-469a-9678-254d5d40649b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_56b36253-4ab5-469a-9678-254d5d40649b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease_c93f4520-11de-403c-a8c7-cdb80f9b7850" xlink:href="lgnd-20220930.xsd#lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:to="loc_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease_c93f4520-11de-403c-a8c7-cdb80f9b7850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OperatingLeaseLiabilityIncreaseDecrease_65177312-5fd4-4f73-9e01-5f2f591d8cfd" xlink:href="lgnd-20220930.xsd#lgnd_OperatingLeaseLiabilityIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_97a7061a-c63b-4148-b535-024b1224f561" xlink:to="loc_lgnd_OperatingLeaseLiabilityIncreaseDecrease_65177312-5fd4-4f73-9e01-5f2f591d8cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2aa21f25-f56a-4ea8-895f-d064b381e51a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ab1382ef-42a0-4680-a924-688be8042493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2aa21f25-f56a-4ea8-895f-d064b381e51a" xlink:to="loc_us-gaap_AssetsAbstract_ab1382ef-42a0-4680-a924-688be8042493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_75a0765d-f05b-4d72-bb05-d9d37c332dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ab1382ef-42a0-4680-a924-688be8042493" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_75a0765d-f05b-4d72-bb05-d9d37c332dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_16e905c1-3c39-4e52-b90d-48c77882860c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ab1382ef-42a0-4680-a924-688be8042493" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_16e905c1-3c39-4e52-b90d-48c77882860c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset_c8f7131c-695d-4a28-8443-369a21261579" xlink:href="lgnd-20220930.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ab1382ef-42a0-4680-a924-688be8042493" xlink:to="loc_lgnd_LeaseRightOfUseAsset_c8f7131c-695d-4a28-8443-369a21261579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_a4b82f00-7257-4027-ba15-1cdce49d1376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2aa21f25-f56a-4ea8-895f-d064b381e51a" xlink:to="loc_us-gaap_LiabilitiesAbstract_a4b82f00-7257-4027-ba15-1cdce49d1376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b66d1b3f-be7d-4e07-975e-9cf07e52c7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a4b82f00-7257-4027-ba15-1cdce49d1376" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b66d1b3f-be7d-4e07-975e-9cf07e52c7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_fc41a3a0-2015-4b01-b41d-0c6ca66ee91b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b66d1b3f-be7d-4e07-975e-9cf07e52c7ee" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_fc41a3a0-2015-4b01-b41d-0c6ca66ee91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_90d18ffb-659c-4c94-880c-1df92052a4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b66d1b3f-be7d-4e07-975e-9cf07e52c7ee" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_90d18ffb-659c-4c94-880c-1df92052a4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_9313ec2c-de27-4a87-a342-1bf10586698a" xlink:href="lgnd-20220930.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b66d1b3f-be7d-4e07-975e-9cf07e52c7ee" xlink:to="loc_lgnd_LeaseLiabilityCurrent_9313ec2c-de27-4a87-a342-1bf10586698a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_fa2d9304-9c60-47cb-a583-26d26c88564e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a4b82f00-7257-4027-ba15-1cdce49d1376" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_fa2d9304-9c60-47cb-a583-26d26c88564e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_73f8406a-a449-4286-bc18-e7a7e5587702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_fa2d9304-9c60-47cb-a583-26d26c88564e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_73f8406a-a449-4286-bc18-e7a7e5587702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_56fb4987-c0c3-4c05-a45b-4d05c408bdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_fa2d9304-9c60-47cb-a583-26d26c88564e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_56fb4987-c0c3-4c05-a45b-4d05c408bdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability_6e7d2b51-e5a0-4b20-bd85-8db6141dae60" xlink:href="lgnd-20220930.xsd#lgnd_LeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_a4b82f00-7257-4027-ba15-1cdce49d1376" xlink:to="loc_lgnd_LeaseLiability_6e7d2b51-e5a0-4b20-bd85-8db6141dae60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_d4dd037c-508f-4aa4-9679-ba4c4e54eaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_d4dd037c-508f-4aa4-9679-ba4c4e54eaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_aa669b8c-eb95-4e5d-9e4c-1daac895aef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_aa669b8c-eb95-4e5d-9e4c-1daac895aef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e4ad2df2-2f93-4051-ba98-541daf5e7a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e4ad2df2-2f93-4051-ba98-541daf5e7a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_57a920d8-b7e8-4ae5-9fa3-6bcefc9a4bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_57a920d8-b7e8-4ae5-9fa3-6bcefc9a4bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_da4af436-1b25-428f-a552-259ab737cbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_da4af436-1b25-428f-a552-259ab737cbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_a9df5181-b641-445a-aa3d-8b9b8c84465c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_a9df5181-b641-445a-aa3d-8b9b8c84465c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7be82d68-ae4d-4ea3-ad44-0149a628a6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7be82d68-ae4d-4ea3-ad44-0149a628a6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3b33dc67-b233-4ec2-b3c4-577666c6a303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3b33dc67-b233-4ec2-b3c4-577666c6a303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_2d75e1c1-f140-4ee9-93a2-c7386c7ee67f" xlink:href="lgnd-20220930.xsd#lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance_2d75e1c1-f140-4ee9-93a2-c7386c7ee67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c3f6858e-4a49-4450-934c-73370cc962b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c3f6858e-4a49-4450-934c-73370cc962b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7903c202-ea8f-40df-853e-b552676d1019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_079e8fdd-e758-42ca-9882-ff349f47d1df" xlink:to="loc_us-gaap_OperatingLeaseLiability_7903c202-ea8f-40df-853e-b552676d1019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lgnd-20220930.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="lgnd-20220930.xsd#SubsequentEventDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SubsequentEventDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_e3540add-66ec-4b4e-8f1b-f94be3c39742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_8d95dc86-58e7-4129-99ea-6b43b7378bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_e3540add-66ec-4b4e-8f1b-f94be3c39742" xlink:to="loc_us-gaap_SubsequentEventTable_8d95dc86-58e7-4129-99ea-6b43b7378bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_37f217e7-0dad-4089-bfef-20c9ce3d8805" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8d95dc86-58e7-4129-99ea-6b43b7378bbb" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_37f217e7-0dad-4089-bfef-20c9ce3d8805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c3dd584b-8a9d-456f-8640-9fcbe1d174fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_37f217e7-0dad-4089-bfef-20c9ce3d8805" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c3dd584b-8a9d-456f-8640-9fcbe1d174fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_859e0589-4a42-4a6d-9fb2-b00687d44f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c3dd584b-8a9d-456f-8640-9fcbe1d174fe" xlink:to="loc_us-gaap_SubsequentEventMember_859e0589-4a42-4a6d-9fb2-b00687d44f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_690ad124-eb1a-49b0-a896-70aea427e91f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8d95dc86-58e7-4129-99ea-6b43b7378bbb" xlink:to="loc_srt_OwnershipAxis_690ad124-eb1a-49b0-a896-70aea427e91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_cea6fee1-ae72-4149-bc4e-dc63583ee739" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_690ad124-eb1a-49b0-a896-70aea427e91f" xlink:to="loc_srt_OwnershipDomain_cea6fee1-ae72-4149-bc4e-dc63583ee739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbMember_13994664-aa23-4b4f-97ba-945d359187f5" xlink:href="lgnd-20220930.xsd#lgnd_OmniAbMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_cea6fee1-ae72-4149-bc4e-dc63583ee739" xlink:to="loc_lgnd_OmniAbMember_13994664-aa23-4b4f-97ba-945d359187f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_5c054083-2261-443b-81c0-3de1b17a4973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_8d95dc86-58e7-4129-99ea-6b43b7378bbb" xlink:to="loc_us-gaap_SubsequentEventLineItems_5c054083-2261-443b-81c0-3de1b17a4973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_497b2e01-3de4-40d1-803b-6c8dd21fd12c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5c054083-2261-443b-81c0-3de1b17a4973" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_497b2e01-3de4-40d1-803b-6c8dd21fd12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>lgnd-20220930_g1.jpg
<TEXT>
begin 644 lgnd-20220930_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(P
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (+!<8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\IP<88*1\RY%?E!^TU\ /%G_  3Z_:3BM;74;J":PE74O#^M0#RS<Q;CM?N
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MIKEW/?W/A359-+M[B9R\CV_E1RQJS'DE2[*,]%"CM7UM7PQ_P09_Y-T\8_\
M8QG_ -)8:^YZA[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "OYQZ_HXK^<>JB 44450!1110 5^WG_!+S_DPOX=?]><__I7-
M7XAU^WG_  2\_P"3"_AU_P!><_\ Z5S4I >^4445 !1110 5@?%3P!:_%;X9
M^(?#%]@6GB'3KC3I6QDHLL;)N'N-V1[@5OT4 ?@M\(/&FK_L9_M7Z5JE_:NF
MI^!]::#4+9>&=%9H;B-2<?>C,@!Z?,#7[:>-/%NG>/?V>=9UO2+N*^TO5O#]
MQ=VEQ&<K-$]NS*P^H-?'7_!7#_@GA>?$UYOBCX'L&NM;MX0-=TV!,RW\:+A;
MB-1RTBJ &4<LJ@CE<-\X?\$_O^"E]_\ LJ6K>$/%5G/XA^']W(V;< -<:67)
M\PQ*W#QMDEHF(&<D$$L&IZ@4/^"._P#R?IX7_P"O._\ _222OTP_X*%_"0?&
MG]CCQWI"0&>\M].;4K-57+^=;$3J%_VF"%/HY'>C]G7XA? CXFS6VK_#H_#\
M:GM(065E;V>HP;A@@QE5F3()'3!YZU[!JVJ6FBZ?+<WUS;VEI$I:26>18XT'
M<ECP!]:38'XY_P#!'GXH+\.OVVM&M)IO)M?%5E<Z/(2?E+LHEB!]S)"BCW>O
MIC_@N7^TA;:)\/-&^&-A<*^HZW.FJ:HBG)AM8B?*1O=Y?F'_ %Q]QG6_:J_;
MO^ 7[.5M+%X%\*^ _%WC>V8/9OINE6QLM/F!RLKW*+@E2,A8F+9&"4ZCX8^#
MGP;^(7_!1G]HNZ=I[B_U'5+@76MZU.F8-/B) W-C &%&V.-<9V@# !(?F!]7
M_P#!!_X%S";QC\1+R K;R1+H&GLR\3?,LUP1GL"L !'?<.U%?>WP7^$.B_ 7
MX7:+X1\/P&#2M$MQ!%NY>5NKR.>[NQ9F/JQX XHI,#^>^BBBK **** "BBB@
M#]4?^"#/_)NGC'_L8S_Z2PU]SU\,?\$&?^3=/&/_ &,9_P#26&ON>H>X!111
M2 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^<>OZ.
M*_G'JH@%%%%4 4444 %?MY_P2\_Y,+^'7_7G/_Z5S5^(=?MY_P $O/\ DPOX
M=?\ 7G/_ .E<U*0'OE%%%0 4444 %%%% !7R[^UI_P $HOAW^TUJ%SK-AYG@
MOQ3<9:2^T^%6M[IS_%-;Y"LV>2R%&)/)-?45% 'Y$?$+_@B3\8O"EVXT9_#7
MBBVY,;6U_P#9I2/]I9@B@^P9A[US=A_P2/\ V@]<N(XKOPG#:1Q*$22ZUVR=
M(UST 29R /0"OV;HI\P'YL? K_@@]?2WD5U\1_%UM#;J06T_05:1Y!GH9Y5
M7W C;KP1BOO[X/\ P4\+? /P7!X?\(Z+9Z)I<'/EP*2\S="\CG+2.?[S$G@<
M\5U-%%P"BBBD!_./1116@!1110 4444 ?JC_ ,$&?^3=/&/_ &,9_P#26&ON
M>OAC_@@S_P FZ>,?^QC/_I+#7W/4/< HHHI %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6#XW^*/AKX:VPF\0Z_HVAQL-RF^O(X-X_V0Q!/X5\?_P#!0/\ X**Z
MCX*\37G@7P#="UO;%C#JVK( SPR=X(>H#+T9^H;(&"":^#]:UR]\2:I-?:C>
M75_>W#;Y;BYE:664^K,Q))^IK\CXH\5\+EV(E@\#3]K.+LVW:*?9;MVZ[+S9
M^Q<*>$6*S+#QQF/J>RA)722O)KHWLHWZ;OR1^KVN?\%'?@QH3LC^-(;B11D+
M;6%U,&^C+&5_6LK_ (>C?!K_ *&"_P#_  57/_Q%?E917P,_&7.F[QITDO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OYQZ_HXK^<>JB 44450!1110 5^WG_!+S_DPOX=?]><
M_P#Z5S5^(=?MY_P2\_Y,+^'7_7G/_P"E<U*0'OE%%%0 4444 %%%% !1110
M4444 %%%% !1110!_./1116@!1110 4444 ?JC_P09_Y-T\8_P#8QG_TEAK[
MGKX8_P""#/\ R;IXQ_[&,_\ I+#7W/4/< HHHI %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7\X]?T<5_./51 ****H HHHH *_;S_@EY_P F%_#K
M_KSG_P#2N:OQ#K]O/^"7G_)A?PZ_Z\Y__2N:E(#WRBBBH **** "BBB@ HHH
MH **** "BBB@ HHHH _G'HHHK0 HHHH **** /U1_P""#/\ R;IXQ_[&,_\
MI+#7W/7PQ_P09_Y-T\8_]C&?_26&ON>H>X!1112 **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%<AXH_:"\!>!Y3'K7C?PAH[J<%;W6;>W(/T=Q0!U]%
M>/:A_P % _@IIJJ9/B9X2;?T\J]$OY[,X_&C3_\ @H'\%-25C'\3/"2[.OFW
MHB_+?C/X4 >PT5P.A?M6?"_Q.R+IWQ&\"WLCA2(X==M6?GH"H?(/L1FNVTS5
MK76K19[.YM[N!NDD,@D0]^HX[T 6**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BL_P 0>+=*\)VXFU74]/TR
M$\A[NX2%?S8@5PVL_MC_  E\/LRW?Q-\!Q2*0&C&NVSR+D9&55R1Q[4 >DT5
MXU>_\%#/@E83^7)\2_"S,!G,=SYJ_FH(JSIO[>WP7U98S%\3O!J>:VT>=J4<
M.#G'.\C ]S@4 >N45R_A7XW^"_';JNA^+_"^LL^-HL=5@N"V>F-C&NHH ***
M* "BBB@ HHHH *_G'K^CBOYQZJ(!1115 %%%% !7[>?\$O/^3"_AU_UYS_\
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MGFM;JV<2PS0N4DB<'(96'((/((K]9?\ @F)_P4I3]H[3X/ _C6XA@\<V,/\
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M $U^\?X=N-S?GW<W,E[<R332/+-*Q=W=BS.Q.223R23WIE%6D 4444 %%%%
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M $KFK\0Z_;S_ ()>?\F%_#K_ *\Y_P#TKFI2 ]\HHHJ "BBB@ HHHH ****
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M110 4444 ?SCT445H 4444 %%%% 'ZH_\$&?^3=/&/\ V,9_])8:^YZ^&/\
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M=^TG)\3/@3J'@74KCS-3\#2+]C+M\TEC,6*#GD^7('7T"M&*_)ZOH+_@E_\
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M]I/_ ).+\??]C'J/_I5)7%5H@"BBB@ HHHH **** "BBNK^"_P $_$W[07Q
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M544 ?@-^T3^S'XR_9:\;MH7C#2GLIGRUM=1YDM+] <;X9, ,.F1PPR,@'BN
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MS_Z2PU]SU#W ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQS^SSX$UIFWOJOAZPNW.>=SV\;,#R>02<\GFNTK, HHHH **** /Y_/VD_\
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M110 4444 %%%% !1110 4444 ?S^?M)_\G%^/O\ L8]1_P#2J2N*KM?VD_\
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M HHHH **** -CX?^ -8^*?C73?#N@6$^IZQJ\XM[6VB&6D8_H !DDG@ $D@
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MU:8!1113 **** "OV\_X)>?\F%_#K_KSG_\ 2N:OQ#K]O/\ @EY_R87\.O\
MKSG_ /2N:E(#WRBBBH **** "BBB@ HHHH **** "BBB@ HHHH _G'HHHK0
MHHHH **** /U1_X(,_\ )NGC'_L8S_Z2PU]SU\,?\$&?^3=/&/\ V,9_])8:
M^YZA[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_26&ON>H>X!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_TEAK[GJ'N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@L/%>BVNI:7>VFHZ=>QB:WNK:5989T/1E=20P/J#4- 7****0!1110 4444
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M(Y]V/)JO113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F/\
M@CO_ ,F&>&/^OR__ /2J2OJ"OE__ (([_P#)AGAC_K\O_P#TJDKZ@J& 4444
M@"BBB@#^?S]I/_DXOQ]_V,>H_P#I5)7%5VO[2?\ R<7X^_[&/4?_ $JDKBJT
M0!1110 4444 ?M5_P23_ .4?/P__ .XC_P"G*ZKZ.KYQ_P""2?\ RCY^'_\
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M<=.5-? WQA^./BSX_>+7USQAKM_KNHL"J/</\D"YSLC086-,_P *@"N4HII
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MO_@YM/\ XNC_ (<[_'K_ *%?3?\ P<VG_P 71<#Y?HKZ@_X<[_'K_H5]-_\
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M% 'ZH_\ !!G_ )-T\8_]C&?_ $EAK[GKX8_X(,_\FZ>,?^QC/_I+#7W/4/<
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MA7>Y520BY R?09(&?<4R@ HHHH **** "BBB@ HHHH **** "BBB@ HH +$
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MX[U3XG^-M5\1:W=O>ZMK5T]W=3/U>1R2<#L!T '   ' K(JT@"BBBF 4444
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M"VABMX(AM2.- B(/0 <"I:*0!1110 4444 %%%% !1110!^$'[=W_)YOQ/\
M^QDO?_1K5Y-7K/[=W_)YOQ/_ .QDO?\ T:U>35H@"BBB@ HHHH _9C_@CO\
M\F&>&/\ K\O_ /TJDKZ@KY?_ ."._P#R89X8_P"OR_\ _2J2OJ"H8!1112 *
M*** /Y_/VD_^3B_'W_8QZC_Z525Q5=K^TG_R<7X^_P"QCU'_ -*I*XJM$ 44
M44 %%%% '[5?\$D_^4?/P_\ ^XC_ .G*ZKZ.KYQ_X))_\H^?A_\ ]Q'_ -.5
MU7T=4, HHHI %%%% !1110 4444 %%%% !1110 4444 ?./_  5L_P"4?/Q
M_P"X=_Z<K6OQ5K]JO^"MG_*/GX@?]P[_ -.5K7XJU<0"BBBF 4444 =K^S9_
MR<7X!_[&/3O_ $JCK^@.OY_/V;/^3B_ /_8QZ=_Z51U_0'4R ****D HHHH
M_-7_ (+]Z:8O$OPPO-J!9[;4H0P^\2CVQP?8>8,?4U^>-?IK_P %]=!^T?#W
MX<ZGLR+/4;RUW;,X\V*)L9[9\GIWQ[5^956M@"BBBF 4444 =I^S?K1\-_M$
M> M1!(-AXCT^Y! R1LN8VZ'KTK^@2OYS+"]?3;Z&XB($MO(LB9&1D'(_E7]%
M.AZO%X@T6SOX#F"]@2XC.<Y5U##]#4R M4445(!1110 4444 %%%% !1110
M4444 %%%% !1110 5_./7]'%?SCU40"BBBJ **** "OV\_X)>?\ )A?PZ_Z\
MY_\ TKFK\0Z_;S_@EY_R87\.O^O.?_TKFI2 ]\HHHJ "BBB@ HHHH **** "
MBBB@ HHHH **** /YQZ***T **** "BBB@#]4?\ @@S_ ,FZ>,?^QC/_ *2P
MU]SU\,?\$&?^3=/&/_8QG_TEAK[GJ'N 4444@"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#^?S]I/_DXOQ]_V,>H_P#I5)7%5VO[
M2?\ R<7X^_[&/4?_ $JDKBJT0!1110 4444 ?M5_P23_ .4?/P__ .XC_P"G
M*ZKZ.KYQ_P""2?\ RCY^'_\ W$?_ $Y75?1U0P"BBBD 4444 ?&__!9C]J5_
M@W\!(?!>E3F/7/'OF6\S*?F@L% $Q]C(66,>JF3TK\CZ]]_X*:_'"3XZ?MD^
M++M)C+IV@3_V%8#.56*V)1RI[AIC*X]GKP*K0!1113 *FT[3KC5]0@M+6&6Y
MNKJ18888E+O*['"JH')))  'K4-?:O\ P13_ &9H?BG\<K_QSJMN9=,\"HC6
M89?DDOY,[&]#Y:*S8[,T9^HP/L[_ ()\?L!:/^RS\&I8]>L+'4_%_BFVVZ[)
M-&LT:1,/^/)0<@Q*/O=0[9)R H7QS]K;_@B7H_C2YN=;^%=_!X=OY,R/HEZ6
M:PE;K^ZD&6A[_*0RY(QL K[XHJ+@?@%\:_V9/'O[.VJ&U\9>%]5T3+;4N)(_
M,M9C_L3)F-_HK$UPE?T8:KI-KKNG36=];6]Y:7"E)8)XQ)'*I[,IR"/8U\[_
M !>_X)0?!/XN22S?\(P_AB]F))N- G^QXSZ1$-"/PCI\P'XKT5^C/Q%_X(&R
MB627PE\0T9#_ *NVU?3B"OUFB8Y_[]BO'/%G_!%3XV^'6865OX8UX#H;'50F
M?^_ZQT[H#Y)HKW_5?^"6_P >]'+^=\.[]]B[CY%]9SY'MLE.3[#FLO\ X=S?
M'#_HFOB3_OVG_P 53N!XI17OVF_\$N/CWJKQ+%\.]04RC<OG7UI"!QGDO*-I
M]CCTZUUOAO\ X(R_'/7&076D:%HP;&3>:O$^WCOY/F?3C/6E<#Y4HK[\\$?\
M$$/%5ZZ'Q)X_\/Z:N?G73;*:^./8R&'^7'7GI7NOPQ_X(B_"/P<T<NO7/B3Q
M;,,;X[F[%I;-]%A"N/QD-%T!^2VDZ1=Z]J4-G8VMQ>W=PVR*""-I))3Z*H!)
M/TKZB_9Y_P""0/Q8^-4D-UK-E%X$T:3!-QJZG[4RGKLMA\^1Z2&,>]?J_P#"
MSX >"?@C9>1X2\*Z'H"D89[.T1)9/]^3&]_^!$]*Z^DY ?/?[+7_  3.^&/[
M+C6VH6FFGQ%XF@PW]L:JJRRQ/ZPQXV1<YP5&_!P6-?0E%%2 4444 %%%% !1
M110 4444 %?FE_P7:^/[7WB3PO\ #6RF_<6$?]MZFJGAI7W1P(>>JH)&((Z2
MJ:_2VOP9_;8^*Q^-?[5_CSQ$)?.M[K5I8+1\Y#6T)\F$_C'&A_&F@/+:***L
M HHHH *DM+26_NHH((I)IYG$<<<:EGD8G 4 <DD]A4=?8W_!&/\ 9EB^,7[0
MMQXOU2W$VC> 42YB5TRDU])N$'7KY85Y..0RQ^M# ^R_^"9__!/ZS_91\ 1:
M_K]K#/\ $'78 UW(P#'28F (M8STW=/,8=6X!*J"?J>BBLP"BBB@ HHHH **
M** "BBB@ HHHH **** /P@_;N_Y/-^)__8R7O_HUJ\FKUG]N[_D\WXG_ /8R
M7O\ Z-:O)JT0!1110 4444 ?LQ_P1W_Y,,\,?]?E_P#^E4E?4%?+_P#P1W_Y
M,,\,?]?E_P#^E4E?4%0P"BBBD 4444 ?S^?M)_\ )Q?C[_L8]1_]*I*XJNU_
M:3_Y.+\??]C'J/\ Z525Q5:( HHHH **** /VJ_X))_\H^?A_P#]Q'_TY75?
M1U?./_!)/_E'S\/_ /N(_P#IRNJ^CJA@%%%%( HHHH **** "BBB@ HHHH *
M*** "BBB@#YQ_P""MG_*/GX@?]P[_P!.5K7XJU^U7_!6S_E'S\0/^X=_Z<K6
MOQ5JX@%%%%, HHHH [7]FS_DXOP#_P!C'IW_ *51U_0'7\_G[-G_ "<7X!_[
M&/3O_2J.OZ ZF0!1114@%%%% 'QM_P %QO#']M?L?:=?*HWZ/XCMIV;'(1X9
MXB/Q9T_*OR0K]N_^"H/@\^-?V$OB#;JH,EG:1:@A_N^1<13,?^^$8?C7XB5<
M0"BBBF 4444 %?O5^Q;XP'CS]DGX<:H7\R2;P]9QS-G.Z6.)8Y#_ -]HU?@K
M7[$?\$8?B#_PF?[$MAI[2%Y?"^J7>F,"?F"LPN5_#%Q@?3':ID!]84445(!1
M110 4444 %%%% !1110 4444 %%%% !1110 5_./7]'%?SCU40"BBBJ ****
M "OV\_X)>?\ )A?PZ_Z\Y_\ TKFK\0Z_;S_@EY_R87\.O^O.?_TKFI2 ]\HH
MHJ "BBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?\
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M%7P?PUI\N-;OX),KJLZ'(@0CK"C#)/1W QPH+?"-6D 4444P"BBB@ K]O/\
M@EY_R87\.O\ KSG_ /2N:OQ#K]O/^"7G_)A?PZ_Z\Y__ $KFI2 ]\HHHJ "B
MBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?^"#/_)N
MGC'_ +&,_P#I+#7W/7PQ_P $&?\ DW3QC_V,9_\ 26&ON>H>X!1112 ****
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MW!'_ '[_ -[[OY5W-S)>W,DTTCRS2L7=W8LSL3DDD\DD]ZI(!E%%%4 4444
M%%%% !7[>?\ !+S_ ),+^'7_ %YS_P#I7-7XAU^WG_!+S_DPOX=?]><__I7-
M2D![Y1114 %%%% !1110 4444 %%%% !1110 4444 ?SCT445H 4444 %%%%
M 'ZH_P#!!G_DW3QC_P!C&?\ TEAK[GKX8_X(,_\ )NGC'_L8S_Z2PU]SU#W
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M@_;:_IS0VVL6H6#6=,#Y?3[C![=3&^"4;N,C[RL!Z[68!1110 4444 %%%%
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M:K_@DG_RCY^'_P#W$?\ TY75?1U?./\ P23_ .4?/P__ .XC_P"G*ZKZ.J&
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MDDD)9F8Y+$]23W--HHJ@"BBB@ HHHH **** "OV\_P""7G_)A?PZ_P"O.?\
M]*YJ_$.OV\_X)>?\F%_#K_KSG_\ 2N:E(#WRBBBH **** "BBB@ HHHH ***
M* "BBB@ HHHH _G'HHHK0 HHHH **** /:?V9_V^?B%^R9X4O]%\'W.E0V.I
M7?VV875DL[&38J<$G@84<5Z3_P /I/CA_P __AO_ ,%*?XU\FT4K ?67_#Z3
MXX?\_P#X;_\ !2G^-'_#Z3XX?\__ (;_ /!2G^-?)M%%D!]9?\/I/CA_S_\
MAO\ \%*?XT?\/I/CA_S_ /AO_P %*?XU\FT460'UE_P^D^.'_/\ ^&__  4I
M_C1_P^D^.'_/_P"&_P#P4I_C7R;119 ?67_#Z3XX?\__ (;_ /!2G^-'_#Z3
MXX?\_P#X;_\ !2G^-?)M%%D!]9?\/I/CA_S_ /AO_P %*?XT?\/I/CA_S_\
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MA!)%+$X=)5(R&5AP01W%35^+'[#O_!23Q=^R%JT.FW4EQXB\#ROB?2)I<M:
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M?_*/GX?_ /<1_P#3E=5]'5\X_P#!)/\ Y1\_#_\ [B/_ *<KJOHZH8!1112
M**** "BBB@ HHHH **** "BBB@ HHHH ^<?^"MG_ "CY^('_ '#O_3E:U^*M
M?M5_P5L_Y1\_$#_N'?\ IRM:_%6KB 4444P"BBB@#M?V;/\ DXOP#_V,>G?^
ME4=?T!U_/Y^S9_R<7X!_[&/3O_2J.OZ ZF0!1114@%%%% !1110!A?$_X<:5
M\7_AYK/AC7+<7.DZ[:/9W*=#M88W*>S*<$'L0#VK\&?VB/@9K'[-WQBUSP=K
M:'[7I$Y2.8*52\A/,<R9_A=2#[9(/(-?T!U\B_\ !63]B!OVD_A:GBSP[:"3
MQIX2A9ECC7,FJ68RSP<<EU.70>I=<9<$-,#\@:*""I((((ZBBK **** "BBB
M@"2TNY;"ZBG@EDAGA<21R1L5>-@<A@1R"#W%?=7['W_!:C7?AW;6N@_%&UN_
M%.E18CCUFWP=2@7MYJDA9QT^;*OU)+GBOA&BBP'[[?!']JOX>_M%Z>DW@_Q5
MI6K2LNYK,2^5>1<<[H'Q(O?G;CC@FO0J_G*M[B2TG26)WBEB8.CH2K(0<@@C
MH17K?P__ &^/C+\,(HX](^(OB588L>7%>7'VZ) .@"3AU ]L8J>4#]VJ*_&W
M1_\ @LC\=M,AV3:_H^H-@#?<:/;JW'?]VJ#GZ=N,5->_\%F_CG=P%(]7T&V;
M.=\>D1%OI\V1^E+E8'[&5SWQ$^+/ACX1Z,VH>*/$&CZ!9J,^;?W:0!_9=Q!8
M^@&2:_%?QM_P4B^./Q A:._^(^O0(W4:=Y>G'\[=$/ZUXYKOB"_\4:E)>ZG?
M7FHWDO+SW4S32O\ 5F))I\H'Z>?M+?\ !</PMX2@N=.^&FE3>*-2P534[]'M
MM/B;LRQG$LOT/ECIR:_.WXZ?M%^,_P!I+Q:=9\9:[=ZQ=+D01N0D%HI/W(HE
MPJ#IT&3C))/-<3132 ****8!1110 5V?AWX"^)?$OP<\0^/8K%HO"_AR6&WG
MO9<JD\\LB(L,?]YAOW-CA1C)!90?6?\ @G[_ ,$_=:_;*\:?:[O[1I7@72I@
M-2U(+AKAA@_9X,\&0C&6Y" Y.255OO/_ (*C_#W1?A3_ ,$V=6\/>'M.M]*T
M;2IM/@MK:!<+&HNH_P 2Q.26.2Q)))))I-@?D!1113 **** "OV\_P""7G_)
MA?PZ_P"O.?\ ]*YJ_$.OV\_X)>?\F%_#K_KSG_\ 2N:E(#WRBBBH **** "B
MBB@ HHHH **** "BBB@ HHHH _G'HI]Q ]K.\4BLDD;%65A@J1P0:96@!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =;\ ]
M3;1?CKX*O$!+VFO6,R@'&2MQ&1SVZ5_077\^'P-LGU+XU^#[:+!EN-;LHTR<
M#)G0#^=?T'U,@"BBBI **** /Y_/VD_^3B_'W_8QZC_Z525Q5=K^TG_R<7X^
M_P"QCU'_ -*I*XJM$ 4444 %%%% '[5?\$D_^4?/P_\ ^XC_ .G*ZKZ.KYQ_
MX))_\H^?A_\ ]Q'_ -.5U7T=4, HHHI %%%% !117YM?\%1/^"HG]I?VC\-?
MAKJ/^C?-;:YKEL_^N[-;6[#^'J'D'WN57C)9I =;_P %%O\ @K3%\.I]0\"_
M"ZZANM>C+6^I:ZN'BTUAD-%!V>4="_*IR!EN4_,;5-4N=;U*XO+VXGO+R[D:
M:>>>0R23.QRS,QY9B222>34%%4D 4444P"BBM;P+X$UGXF^+;'0?#^FW>KZQ
MJ<HBMK2VC+R2MUZ=@ "23@  DD $T 9-%?I3\'?^"$&EW7@.SG\=^+-7MO$4
MX\R>VTCROL]H#TCWNC%V'=A@9X (&X[E[_P03\$R3YMO'7BF*+'W9+>"1L_4
M!?Y4KH#\NJ*_3&Z_X($:&]PQ@^)6JQQ'[JOI$;L/J1*,_D*S)O\ @W]1IG,?
MQ998R3M5O#&X@=@3]K&3[X%%T!^<-%?H4_\ P0&U@9V_$S33Z9T5QG_R-67-
M_P $$?&*PN8_'OAEI IVJUI.H)[ GG ]\&BZ ^":*^X[K_@@Y\2TMV,'BWP-
M)*/NJ\MTBGZD0G'Y5F7G_!"OXP6MN737/A[<L/\ EG'J%V&/_?5L!^M%T!\7
MT5]>7_\ P1*^-5G"&C/A&Z8G&R+5&!'O\T:C'X]ZRM4_X(U_'6P13%H6C7Q(
M)(AUB $8[?.5Z_T[470'RQ17N/BW_@FO\=/!<;M>?#?79@@R?L#17YZ \"!W
M)Z]O?T->2>+_  %KOP^U$V>O:+JVB78_Y8:A9R6TG_?+@&F!DT444 %%%% !
M1110 5[;^P]^VQK_ .QG\3H]0M&GO_#6HNJ:SI._Y;J,<>8F>%F0$E6XS]T\
M$UXE10!_0]\.?B'H_P 6? VE^)/#]]%J.C:S;K<VMQ'T=3V(/*L#D%3RI!!
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M\_Y,+^'7_7G/_P"E<U?B'7[>?\$O/^3"_AU_UYS_ /I7-2D![Y1114 %%%%
M!1110 4444 %%%% !1110 4444 ?AK_P4.^ =W^SU^UCXKTR6W>+3-5NY-7T
MN0KA);:=V<!3WV,6C/O&:\1K]XOVL_V//"'[8G@1-'\302PWED6DTW4[;"W6
MGR,!DJ2,,C8&Y#PV!T(5A^8WQY_X(_?%[X1:G.^BZ;%XYT9,F.[TIE$^.P>V
M8^8&]DWC_:JTP/E:BO2'_8W^+L;E3\+/B-E3CCPW>$?GY=)_PQU\7?\ HE?Q
M'_\ ":O?_C=,#SBBO1_^&.OB[_T2OXC_ /A-7O\ \;H_X8Z^+O\ T2OXC_\
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M?%FAZ=KVF2\^3=Q!]C8QN1OO(WHRD$>M-,#^>JBOTI_:,_X(56=^]QJ'PO\
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MG>$_"6E^!/#MII&BZ?9Z5I=A&(K>UM85BAA4=E5>!6C114@9OC+_ )%#5?\
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M HHJYH7AW4/%.I)9Z98WFHWDGW(+6%II&^BJ"30!U/[-G_)Q?@'_ +&/3O\
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M#P3_ .".U_\ B*U?#WPG\*^$9$?2?#7A_2WCY5K33H8"O.>-JC'(!^HKH**
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M+_X(<^#FU[]KK4=49#Y.A>'[B4/C@222Q1*/Q5I#_P !-)@?K;1114 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH Y7XI_ WP=\;M*^Q>+?#.B^(8%!5/MMJLDD.?[CXW(?=2#7R
MA\8?^"&WPV\9/-<>$M9UWP;<R'*0L1J-G']$D(E_.4U]LT47 _(SXH?\$2/B
M[X->230)O#OBZV&?+6VO/LEPP]TF"H#["0UX)X]_8W^*WPR=_P"V_A[XLM(X
MSAIUTZ2: ?\ ;6,,G_CU?O=15<P'\Y4]O):S-'*CQR(=K*PPRGT(IE?T0^*/
MA]H'C>/9K6AZ1JZ8QMO;..X&/^!@UYSXC_8&^"_BK?\ :OAEX/C+@@FTT]+,
M\C'_ "RVX/OZ\]:.8#\)**_8GXP?\$O?@5I&@?;;7P'';W#SHA,>K7ZKC:>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622171145648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Nov. 04, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3911 Sorrento Valley Boulevard, Suite 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,893,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622170773824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,116<span></span>
</td>
<td class="nump">$ 19,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">117,291<span></span>
</td>
<td class="nump">321,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">65,168<span></span>
</td>
<td class="nump">85,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">22,326<span></span>
</td>
<td class="nump">27,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">785<span></span>
</td>
<td class="nump">6,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">10,746<span></span>
</td>
<td class="nump">4,671<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">220,432<span></span>
</td>
<td class="nump">464,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes, net</a></td>
<td class="nump">35,500<span></span>
</td>
<td class="nump">34,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">517,025<span></span>
</td>
<td class="nump">551,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">181,206<span></span>
</td>
<td class="nump">181,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseRights', window );">Commercial license rights, net</a></td>
<td class="nump">10,193<span></span>
</td>
<td class="nump">10,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">33,418<span></span>
</td>
<td class="nump">20,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">32,108<span></span>
</td>
<td class="nump">16,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Financing lease right-of-use assets</a></td>
<td class="nump">14,444<span></span>
</td>
<td class="nump">16,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">6,279<span></span>
</td>
<td class="nump">2,741<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,050,605<span></span>
</td>
<td class="nump">1,297,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">15,887<span></span>
</td>
<td class="nump">8,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">19,338<span></span>
</td>
<td class="nump">17,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">9,703<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights', window );">Current contingent liabilities</a></td>
<td class="nump">1,773<span></span>
</td>
<td class="nump">2,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">9,547<span></span>
</td>
<td class="nump">10,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,345<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">76,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">135,241<span></span>
</td>
<td class="nump">41,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">320,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LiabilityForContingentValueRights', window );">Long-term contingent liabilities</a></td>
<td class="nump">6,855<span></span>
</td>
<td class="nump">8,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">29,832<span></span>
</td>
<td class="nump">59,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">34,893<span></span>
</td>
<td class="nump">15,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long-term deferred revenue</a></td>
<td class="nump">5,537<span></span>
</td>
<td class="nump">9,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">21,949<span></span>
</td>
<td class="nump">21,707<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">234,307<span></span>
</td>
<td class="nump">476,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 60,000 shares authorized; 16,894 and 16,767 shares issued and outstanding at September&#160;30, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">348,994<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,060)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">468,347<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">816,298<span></span>
</td>
<td class="nump">821,159<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 1,050,605<span></span>
</td>
<td class="nump">$ 1,297,590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CurrentPortionOfLiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622171004272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="nump">16,894,000<span></span>
</td>
<td class="nump">16,767,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">16,894,000<span></span>
</td>
<td class="nump">16,767,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622167351216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 66,088<span></span>
</td>
<td class="nump">$ 64,835<span></span>
</td>
<td class="nump">$ 169,200<span></span>
</td>
<td class="nump">$ 204,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostDirectMaterial', window );">Cost of Captisol</a></td>
<td class="nump">14,153<span></span>
</td>
<td class="nump">11,446<span></span>
</td>
<td class="nump">31,213<span></span>
</td>
<td class="nump">50,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">11,818<span></span>
</td>
<td class="nump">11,827<span></span>
</td>
<td class="nump">35,455<span></span>
</td>
<td class="nump">35,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">22,036<span></span>
</td>
<td class="nump">16,938<span></span>
</td>
<td class="nump">61,461<span></span>
</td>
<td class="nump">50,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">17,445<span></span>
</td>
<td class="nump">12,718<span></span>
</td>
<td class="nump">50,210<span></span>
</td>
<td class="nump">39,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,800)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(37,600)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">65,452<span></span>
</td>
<td class="nump">49,129<span></span>
</td>
<td class="nump">178,339<span></span>
</td>
<td class="nump">138,499<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">15,706<span></span>
</td>
<td class="num">(9,139)<span></span>
</td>
<td class="nump">66,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Gain (loss) from short-term investments</a></td>
<td class="num">(923)<span></span>
</td>
<td class="nump">1,937<span></span>
</td>
<td class="num">(15,709)<span></span>
</td>
<td class="nump">8,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
<td class="nump">698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(332)<span></span>
</td>
<td class="num">(4,439)<span></span>
</td>
<td class="num">(1,559)<span></span>
</td>
<td class="num">(15,154)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">885<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
<td class="nump">5,465<span></span>
</td>
<td class="num">(5,516)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="nump">221<span></span>
</td>
<td class="num">(447)<span></span>
</td>
<td class="num">(10,780)<span></span>
</td>
<td class="num">(11,837)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">857<span></span>
</td>
<td class="nump">15,259<span></span>
</td>
<td class="num">(19,919)<span></span>
</td>
<td class="nump">54,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(453)<span></span>
</td>
<td class="num">(1,536)<span></span>
</td>
<td class="nump">4,043<span></span>
</td>
<td class="nump">8,230<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 404<span></span>
</td>
<td class="nump">$ 13,723<span></span>
</td>
<td class="num">$ (15,876)<span></span>
</td>
<td class="nump">$ 62,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (in USD per share)</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.82<span></span>
</td>
<td class="num">$ (0.94)<span></span>
</td>
<td class="nump">$ 3.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in basic per share calculations (in shares)</a></td>
<td class="nump">16,888<span></span>
</td>
<td class="nump">16,688<span></span>
</td>
<td class="nump">16,860<span></span>
</td>
<td class="nump">16,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (in USD per share)</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="num">$ (0.94)<span></span>
</td>
<td class="nump">$ 3.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted per share calculations (in shares)</a></td>
<td class="nump">17,132<span></span>
</td>
<td class="nump">17,142<span></span>
</td>
<td class="nump">16,860<span></span>
</td>
<td class="nump">17,187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 19,837<span></span>
</td>
<td class="nump">$ 15,648<span></span>
</td>
<td class="nump">$ 51,491<span></span>
</td>
<td class="nump">$ 31,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">35,949<span></span>
</td>
<td class="nump">35,093<span></span>
</td>
<td class="nump">77,616<span></span>
</td>
<td class="nump">128,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 10,302<span></span>
</td>
<td class="nump">$ 14,094<span></span>
</td>
<td class="nump">$ 40,093<span></span>
</td>
<td class="nump">$ 44,409<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostDirectMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of material used for good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostDirectMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622174901664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 404<span></span>
</td>
<td class="nump">$ 13,723<span></span>
</td>
<td class="num">$ (15,876)<span></span>
</td>
<td class="nump">$ 62,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(143)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 410<span></span>
</td>
<td class="nump">$ 13,709<span></span>
</td>
<td class="num">$ (16,019)<span></span>
</td>
<td class="nump">$ 62,480<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622163778816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th">
<div>Additional paid in capital </div>
<div>Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 709,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 318,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (801)<span></span>
</td>
<td class="nump">$ 391,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="nump">20,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">20,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">8,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(11,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions', window );">Warrant and bond hedge unwind transactions</a></td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">18,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="nump">745,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">336,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(856)<span></span>
</td>
<td class="nump">410,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">709,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">318,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(801)<span></span>
</td>
<td class="nump">391,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(74)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">62,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="nump">812,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">358,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(875)<span></span>
</td>
<td class="nump">454,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 709,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">318,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(801)<span></span>
</td>
<td class="nump">391,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standards Update 2020-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2021</a></td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2021</a></td>
<td class="nump">$ 821,159<span></span>
</td>
<td class="num">$ (15,997)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
<td class="num">$ (51,130)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
<td class="nump">$ 35,133<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2021</a></td>
<td class="nump">745,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">336,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(856)<span></span>
</td>
<td class="nump">410,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="nump">1,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">10,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(1,362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">30,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="nump">786,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">346,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(861)<span></span>
</td>
<td class="nump">440,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="nump">1,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">9,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions', window );">Warrant and bond hedge unwind transactions</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">13,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2021</a></td>
<td class="nump">$ 812,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">358,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(875)<span></span>
</td>
<td class="nump">454,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 821,159<span></span>
</td>
<td class="num">(15,997)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
<td class="num">(51,130)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
<td class="nump">35,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="num">(5,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">9,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(15,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2022</a></td>
<td class="nump">$ 793,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">325,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
<td class="nump">468,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 821,159<span></span>
</td>
<td class="num">$ (15,997)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
<td class="num">$ (51,130)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
<td class="nump">$ 35,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (15,876)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2022</a></td>
<td class="nump">16,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2022</a></td>
<td class="nump">$ 816,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">348,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,060)<span></span>
</td>
<td class="nump">468,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Mar. 31, 2022</a></td>
<td class="nump">793,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">325,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
<td class="nump">468,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="nump">604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">9,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(895)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(895)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Jun. 30, 2022</a></td>
<td class="nump">802,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">335,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,066)<span></span>
</td>
<td class="nump">467,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="nump">724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">12,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net gain (loss) on available-for-sale securities, net of deferred tax</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions', window );">Warrant and bond hedge unwind transactions</a></td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2022</a></td>
<td class="nump">16,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Sep. 30, 2022</a></td>
<td class="nump">$ 816,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 348,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,060)<span></span>
</td>
<td class="nump">$ 468,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Reacquisition Of Equity Due To Debt Extinguishment, Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622170853232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (15,876)<span></span>
</td>
<td class="nump">$ 62,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights', window );">Change in estimated fair value of contingent liabilities</a></td>
<td class="num">(1,378)<span></span>
</td>
<td class="num">(39,377)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">40,399<span></span>
</td>
<td class="nump">37,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium on investments, net</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance fees</a></td>
<td class="nump">639<span></span>
</td>
<td class="nump">12,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights', window );">Amortization of commercial license rights</a></td>
<td class="num">(163)<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on debt extinguishment</a></td>
<td class="num">(4,192)<span></span>
</td>
<td class="nump">7,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">31,140<span></span>
</td>
<td class="nump">28,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(25,570)<span></span>
</td>
<td class="num">(8,229)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_GainLossOnShortTermInvestments', window );">Loss (gain) from short-term investments</a></td>
<td class="nump">15,709<span></span>
</td>
<td class="num">(8,135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization', window );">Lease amortization expense</a></td>
<td class="nump">4,535<span></span>
</td>
<td class="nump">3,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">20,550<span></span>
</td>
<td class="num">(8,838)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">10,702<span></span>
</td>
<td class="num">(3,103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(405)<span></span>
</td>
<td class="num">(3,635)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax receivable and payable</a></td>
<td class="nump">15,111<span></span>
</td>
<td class="num">(4,167)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(5,182)<span></span>
</td>
<td class="num">(20,696)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="num">(1,671)<span></span>
</td>
<td class="num">(5,909)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">84,378<span></span>
</td>
<td class="nump">51,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(39,052)<span></span>
</td>
<td class="num">(116,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">202,552<span></span>
</td>
<td class="nump">152,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">24,830<span></span>
</td>
<td class="nump">37,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Cash paid for equity method investment</a></td>
<td class="num">(750)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(15,792)<span></span>
</td>
<td class="num">(6,566)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">(960)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">170,908<span></span>
</td>
<td class="nump">66,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repurchase of 2023 Notes</a></td>
<td class="num">(260,949)<span></span>
</td>
<td class="num">(155,760)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments under financing lease obligations</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(9,188)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeFinancingActivities', window );">Proceeds from convertible bond hedge settlement</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">18,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeFinancingActivities', window );">Payments to convertible bond holders for warrant purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,446)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from stock option exercises and ESPP</a></td>
<td class="nump">1,831<span></span>
</td>
<td class="nump">29,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(6,018)<span></span>
</td>
<td class="num">(5,903)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">(1,545)<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Payments for OmniAb transaction costs</a></td>
<td class="num">(4,171)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(270,692)<span></span>
</td>
<td class="num">(141,925)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents and restricted cash</a></td>
<td class="num">(15,406)<span></span>
</td>
<td class="num">(24,533)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">19,522<span></span>
</td>
<td class="nump">47,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">4,116<span></span>
</td>
<td class="nump">23,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">1,139<span></span>
</td>
<td class="nump">1,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes paid</a></td>
<td class="nump">6,630<span></span>
</td>
<td class="nump">3,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued fixed asset purchases</a></td>
<td class="nump">3,626<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccruedInventoryPurchases', window );">Accrued inventory purchases</a></td>
<td class="nump">7,676<span></span>
</td>
<td class="nump">4,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on AFS investments</a></td>
<td class="num">$ (143)<span></span>
</td>
<td class="num">$ (74)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Commercial License And Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease And Operating Lease, Right-of-Use Asset, Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_GainLossOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Short-term Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_GainLossOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersInvestingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Contingent Value Right Holders, Investing Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersInvestingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622173896288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;long-term deferred revenue&#8221; has been added to the condensed consolidated balance sheet, separated from &#8220;other long-term liabilities&#8221; in our prior period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Updates, Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended September&#160;30, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 was $341.1&#160;million which included an unamortized discount of $2.2&#160;million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended September&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $4.1 million, and $7.7 million, respectively. During the nine months ended September&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $8.8 million, and $22.8 million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,093&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,088&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,660&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at September&#160;30, 2022 and December 31, 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:38.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,062)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,370)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and nine months ended September&#160;30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,458&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,641&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of 8 positions which were in an unrealized loss position as of September&#160;30, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three and nine months ended September&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and nine months ended September&#160;30, 2022, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $(0.1)&#160;million and $(0.3)&#160;million of allowance for credit losses, respectively, as of September&#160;30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three and nine months ended September&#160;30, 2022 and 2021. As of September&#160;30, 2022 inventory consists of Captisol prepayments of $7.4&#160;million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">282,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,611)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,544)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to 2022, we only had one reporting unit and reportable segment. In connection with the announcement in March 2022 of our intention to separate the OmniAb business pursuant to a distribution to Ligand&#8217;s stockholders of Ligand&#8217;s shares in OmniAb followed by a merger with APAC, management concluded that we had two reporting units and reportable segments - the OmniAb business and the Ligand core business. See Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. We performed a fair value analysis utilizing a combination of income approach and market approach to determine the fair value of each segment in order to appropriately allocate the goodwill between the segments as of the announcement date. The following table presents our allocation of goodwill balance by segment (in thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:84.298%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ligand core business</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">OmniAb business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">75,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">181,206&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Commercial License Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of September&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three and nine months ended September&#160;30, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of September&#160;30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,338&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,579&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,597&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,754&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,595&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,706&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,574&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,503&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2022, 0.6&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. Under the new standard, we are required to reflect the dilutive effect of the 2023 Notes by application of the if-converted method.</span></div>For the nine months ended September&#160;30, 2022, due to the net loss for the period, all of the 0.3&#160;million weighted average equity awards and 1.1&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622176357680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, establishes annual and interim reporting standards for an enterprise&#8217;s operating segments and related disclosures about its products, services, geographic areas and major customers. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses, and for which discrete financial information is regularly evaluated by the chief operating decision maker in deciding how to allocate resources and assess performance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our operating segments are identified in the same manner as they are reported internally and used by our chief operating decision maker for the purpose of evaluating performance and allocating resources. Historically, we have disclosed one reportable segment. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC would combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction (collectively, the &#8220;Transactions&#8221;). Immediately prior to the Merger and pursuant to the Separation Agreement, we, among other things, would transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#8220;Reorganization&#8221;) and, in connection therewith, would distribute (the &#8220;Distribution&#8221;) to Ligand stockholders 100% of the common stock of OmniAb. Immediately following the Distribution, Merger Sub would merge with and into OmniAb (the &#8220;Merger&#8221;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC. The entire transaction was completed on November 1, 2022. See Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Event</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the execution of the Merger Agreement, we made organizational changes to better align our organizational structure with our strategy and operations, and management has reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operated the following two reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. After the closing date of the Transactions, the historical financial results of OmniAb will be reflected in our consolidated financial statements as discontinued operations under GAAP for all periods presented through the date of the Distribution.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income (loss) represents income (loss) before income taxes, interest income, interest expense, other income (expense), net, unallocated share-based compensation, and unallocated corporate overhead. Our management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business revenue</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total OmniAb business revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,520&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - Core </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - COVID</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total Ligand core business revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,695&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,863&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">185,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,721)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26,905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,443&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unallocated corporate items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total unallocated corporate items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,139)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622175174960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,157&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black-Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three and nine months ended September&#160;30, 2022, we adjusted the balance of the Metabasis CVR liability $0.1&#160;million and $(0.9)&#160;million to mark to market, respectively.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the nine months ended September&#160;30, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders, respectively. During the three and nine months ended September&#160;30, 2022, we adjusted the balance of the Icagen CVR liability $(0.2)&#160;million and $(0.5)&#160;million to mark to market, respectively.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. We concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three and nine months ended September&#160;30, 2022, we paid $1.0&#160;million contingent liabilities to former xCella shareholders. During the three and nine months ended September&#160;30, 2022, we recorded $0.5 million and $1.4 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of September&#160;30, 2022 is as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(527)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of September&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the organizational changes to the Company&#8217;s reportable segments, we re-allocated goodwill between the two identified reporting units (OmniAb business and Ligand core business). We performed a goodwill impairment analysis immediately before and after the allocation of goodwill and concluded no impairment. At September 30, 2022, there were no indicators of impairment at either of the reporting units.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>At September 30, 2022, there were no indicators of impairment of our indefinite-lived intangible assets, or long-lived assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622173811888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text">Convertible Senior Notes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share. The maximum conversion rate of the 2023 Notes is 5.2317 per $1,000 principal amount of the 2023 Notes which represents a maximum conversion price of approximately $191.14. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes (the&#8220;Indenture&#8221;). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#8217;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No holders exercised their right to convert their 2023 Notes during the applicable period for conversion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion rate for the 2023 Notes will be adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first 10 consecutive trading days after, and including, the ex-dvidend date of the spin-off (as determined in the Indenture).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48 (not accounting for the anticipated adjustment in the conversion rate). In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes, and the effective interest rate as of September&#160;30, 2022 is 0.5%.  During the three months ended September&#160;30, 2022 we recognized a total of $0.3&#160;million in interest expense which includes $0.2&#160;million in contractual interest expense and $0.1&#160;million in amortized issuance costs. During the nine months ended September&#160;30, 2022 we recognized a total of $1.5&#160;million in interest expense which includes $0.9&#160;million in contractual interest expense and $0.6&#160;million in amortized issuance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million. After the repurchases, approximately $343.3&#160;million in principal amount of the 2023 Notes were outstanding as of December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022, we repurchased $38.6&#160;million in principal amount of the 2023 Notes for $37.7&#160;million in cash, including accrued interest of $0.1&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $0.9&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended September 30, 2022, and a $0.1&#160;million reduction in debt discount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, we repurchased $266.4&#160;million in principal amount of the 2023 Notes for $261.4&#160;million in cash, including accrued interest of $0.5&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $4.2&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the nine months ended September 30, 2022, and a $1.3&#160;million reduction in debt discount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the repurchases of approximately $20.3&#160;million in principal of the 2023 Notes for approximately $19.1&#160;million in cash, including accrued interest of $0.1&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, in connection with the repurchases of $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. We received $18.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 598,021 as of December 31, 2021. These unwind transactions resulted in a $0.5&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, in connection with the repurchases of $227.8&#160;million in principal of the 2023 Notes for $223.7&#160;million in cash, including accrued interest of $0.4&#160;million made during the six months ended June 30, 2022, we entered into Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We received $0.2&#160;million as part of these Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 370,219 as of September 30, 2022. This transaction resulted in a $0.2&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of September 30, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622173915888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income Tax<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and nine months ended September&#160;30, 2022 and 2021 was 52.9% and 10.1%, and 20.3% and (15.1)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation, non-deductible ISO related stock compensation expense and recognition of non-refundable foreign taxes paid during the period. The variance from the U.S. federal tax rate of 21% for the three and nine months ended September 30, 2021 was significantly impacted by tax benefits related to (1) a $3.8 million and $37.6 million Pfenex CVR adjustment recorded during the respective period, due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax windfalls from share-based compensation resulting from increased stock option exercise</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">activity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622173811888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2021 Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">852,475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,577&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(136,448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,529)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,059)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,980,603&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, outstanding options to purchase 1.7 million shares were exercisable with a weighted average exercise price per share of $102.23.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of September&#160;30, 2022, 38,007 shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. We did not have any share repurchases during the three and nine months ended September&#160;30, 2022. Authorization to repurchase $248.8 million of our common stock remained available as of September&#160;30, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the Market Equity Offering Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we filed a registration statement on Form S-3 (the &#8220;Shelf Registration Statement&#8221;), which became automatically effective upon filing, covering the offering of common stock, preferred stock, debt securities, warrants and units. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2022, we also entered into an At-The-Market Equity Offering Sales Agreement (the &#8220;Sales Agreement&#8221;) with Stifel, Nicolaus &amp; Company, Incorporated (the &#8220;Agent&#8221;), under which we may, from time to time, sell shares of our </span></div>common stock having an aggregate offering price of up to $100.0&#160;million in &#8220;at the market&#8221; offerings through the Agent (the &#8220;ATM Offering&#8221;). The Shelf Registration Statement included a prospectus covering the offering, issuance and sale of up to $100.0&#160;million of our common stock from time to time through the ATM Offering. The shares to be sold under the Sales Agreement may be issued and sold pursuant to the Shelf Registration Statement. To date, we have not issued any shares of common stock in the ATM Offering.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622173906304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitment and Contingencies: Legal Proceedings</a></td>
<td class="text">Commitment and Contingencies: Legal Proceedings<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CyDex, a wholly owned subsidiary of Ligand, and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol&#174; technology and, more specifically, relating to Captisol&#174;-enabled Nexterone&#174; (amiodarone HCl premixed injection).  CyDex contended that Baxter has not paid all of the royalties due to CyDex under the terms of the license agreement and Baxter contends that it has overpaid royalties for several years.  On April 6, 2021, Baxter initiated an arbitration with AAA pursuant to the arbitration provision of the license agreement.  On April 21, 2021, CyDex filed an answering statement and counterdemand. On December 2, 2021, Baxter filed an Amended Notice of Arbitration Demand seeking a declaration limiting the &#8220;royalty term&#8221; of the license agreement to &#8220;the later of i) the expiration of the licensed [p]atent; or ii) when there are no longer any CyDex patents listed in the Orange Book for [Nexterone&#174;].&#8221; Baxter later clarified its position, and asserted that royalties should have ceased being due upon the May 4, 2022 expiry of CyDex&#8217;s U.S. Patent No. 6,869,939.  The parties conducted a three-day arbitration hearing May 24-26, 2022.  In a September 9, 2022 Final Award, the Tribunal ruled in CyDex&#8217;s favor by (1) denying Baxter&#8217;s request for a partial refund of previously paid royalties, (2) granting CyDex&#8217;s request for underpaid royalties, and (3) concluding that &#8220;[g]oing forward Baxter shall pay CyDex&#8221; a royalty consistent with CyDex&#8217;s construction of the license agreement until, at least, the March 13, 2029 expiry of CyDex&#8217;s U.S. Patent No. 7,635,773.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2022, Pfenex Inc. (&#8220;Pfenex&#8221;), a wholly owned subsidiary of Ligand, received a notice of alleged breach from Beijing Kangchen Biological Technology Co., Ltd. (&#8220;Kangchen&#8221;) with respect to a Development and License Agreement between Pfenex and Kangchen (&#8220;License Agreement&#8221;) pertaining to the development and commercialization of teriparatide in certain Southeast Asian countries. The allegations in the notice focused on the activities of Pfenex and other parties. On June 16, 2022, we rejected all claims raised by Kangchen in the notice. On June 24, 2022, Kangchen served Pfenex a notice of termination of the License Agreement and demanded initiation of the dispute resolution process in accordance with the License Agreement. On June 29, 2022, we again rejected all claims raised by Kangchen in the notice of termination and agreed to engage in the applicable dispute resolution process, including good faith negotiations between the parties. On October 20, 2022, we agreed to make a single lump sum payment to Kangchen in connection with a termination agreement that, among other things, terminates the License Agreement and releases all claims between the parties arising from the License Agreement.  We anticipate that the termination agreement between Pfenex and Kangchen will go into effect the fourth quarter of 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622174198896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesWe lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are primarily related to our right to use the equipment under the agreement with Hovione, our third-party manufacturer, to exclusively manufacture Captisol.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022, we entered into several lease agreements and amendments, which resulted in an increase in lease assets of $8.3&#160;million and $18.4&#160;million, and liabilities of $8.5&#160;million and $21.7&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of September&#160;30, 2022 (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:81.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.132%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining three months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less estimated tenant improvement allowance:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesWe lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are primarily related to our right to use the equipment under the agreement with Hovione, our third-party manufacturer, to exclusively manufacture Captisol.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2022, we entered into several lease agreements and amendments, which resulted in an increase in lease assets of $8.3&#160;million and $18.4&#160;million, and liabilities of $8.5&#160;million and $21.7&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of September&#160;30, 2022 (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:81.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.132%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining three months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less estimated tenant improvement allowance:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622173912464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">Subsequent EventOn November, 1, 2022, Ligand completed the Transactions. Pursuant to the Distribution, Ligand distributed on a pro rata basis to its shareholders as of the close of business on October 26, 2022 shares of the common stock of OmniAb representing 100% of Ligand&#8217;s interest in OmniAb. The Distribution was immediately followed by the Merger, pursuant to which OmniAb merged with Merger Sub, with OmniAb continuing as the surviving entity and becoming a wholly owned subsidiary of APAC. Prior to the Distribution and Merger, OmniAb changed its name to OmniAb Operations, Inc. and APAC changed its name to OmniAb, Inc. Following the Merger, OmniAb, Inc. is an independent, publicly traded company whose common stock trades on NASDAQ under the symbol &#8220;OABI.&#8221;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622169515712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#8220;long-term deferred revenue&#8221; has been added to the condensed consolidated balance sheet, separated from &#8220;other long-term liabilities&#8221; in our prior period presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Standards Updates, Recently Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Updates, Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended September&#160;30, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 was $341.1&#160;million which included an unamortized discount of $2.2&#160;million.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </span></div>The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. </span></div>We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three and nine months ended September&#160;30, 2022 and 2021. As of September&#160;30, 2022 inventory consists of Captisol prepayments of $7.4&#160;million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseRightsPolicyTextBlock', window );">Commercial License Rights</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Commercial License Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of September&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three and nine months ended September&#160;30, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of September&#160;30, 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,597&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,754&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net (Loss) Income Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net (Loss) Income Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div>Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRightsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRightsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622171062608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,949&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,093&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,088&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169,200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,660&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock', window );">Schedule of Short-Term Investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at September&#160;30, 2022 and December 31, 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:38.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,615)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,062)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,370)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,458&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,641&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Identifiable Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">282,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,611)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,544)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">698,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis</a></td>
<td class="text">The following table presents our allocation of goodwill balance by segment (in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:84.298%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ligand core business</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">105,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">OmniAb business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">75,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">181,206&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock', window );">Schedule of Commercial License Rights</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of September&#160;30, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued liabilities consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,338&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,579&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock', window );">Schedule of Accounting for Share-Based Compensation</a></td>
<td class="text">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,597&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,754&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Fair-Value Options Awarded to Employees and Directors</a></td>
<td class="text">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.597%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,888&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,595&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,706&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,574&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,503&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Short-Term investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622173853648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Schedule of Reconciliation of Revenue from Segments to Consolidated</a></td>
<td class="text">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business revenue</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,353&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total OmniAb business revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,867&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,337&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,520&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - Core </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - COVID</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total Ligand core business revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,695&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,863&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">185,140&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,721)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26,905)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,443&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unallocated corporate items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total unallocated corporate items</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,139)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622174077536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,157&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black-Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three and nine months ended September&#160;30, 2022, we adjusted the balance of the Metabasis CVR liability $0.1&#160;million and $(0.9)&#160;million to mark to market, respectively.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the nine months ended September&#160;30, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders, respectively. During the three and nine months ended September&#160;30, 2022, we adjusted the balance of the Icagen CVR liability $(0.2)&#160;million and $(0.5)&#160;million to mark to market, respectively.  </span></div>4.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. We concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three and nine months ended September&#160;30, 2022, we paid $1.0&#160;million contingent liabilities to former xCella shareholders. During the three and nine months ended September&#160;30, 2022, we recorded $0.5 million and $1.4 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Reconciliation of Level 3 Financial Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of September&#160;30, 2022 is as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(527)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of September&#160;30, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622174230112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622173892896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Plan Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">852,475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,577&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(136,448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,529)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,059)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,980,603&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">852,475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260,577&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(136,448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,529)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,059)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,980,603&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622167271904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock', window );">Schedule of Operating and Finance Lease Assets and Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Lease Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of September&#160;30, 2022 (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:81.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.132%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining three months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less estimated tenant improvement allowance:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,238&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AssetsAndLiabilitiesLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622168119088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>position </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>position </div>
<div>reporting_unit </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Decrease of deferred tax liabilities</a></td>
<td class="num">$ (29,832,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (29,832,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (59,095,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) of stockholders' equity</a></td>
<td class="num">(816,298,000)<span></span>
</td>
<td class="num">$ (812,066,000)<span></span>
</td>
<td class="num">(816,298,000)<span></span>
</td>
<td class="num">$ (812,066,000)<span></span>
</td>
<td class="num">(821,159,000)<span></span>
</td>
<td class="num">$ (802,365,000)<span></span>
</td>
<td class="num">$ (793,192,000)<span></span>
</td>
<td class="num">$ (786,517,000)<span></span>
</td>
<td class="num">$ (745,840,000)<span></span>
</td>
<td class="num">$ (709,525,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was previously deferred</a></td>
<td class="nump">$ 4,100,000<span></span>
</td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="nump">$ 22,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of positions in an unrealized loss position | position</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Credit losses related to available-for-sale debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease', window );">Allowance for credit losses adjustment related to COVID-19</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 22,326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares) | shares</a></td>
<td class="nump">6,706<span></span>
</td>
<td class="nump">5,574<span></span>
</td>
<td class="nump">6,503<span></span>
</td>
<td class="nump">4,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Performance period for awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) of stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,997,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember', window );">Adjusted Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Increase of carrying amount of Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares) | shares</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Increase of carrying amount of Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Decrease of deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) of stockholders' equity</a></td>
<td class="num">$ (348,994,000)<span></span>
</td>
<td class="num">$ (358,418,000)<span></span>
</td>
<td class="num">$ (348,994,000)<span></span>
</td>
<td class="num">$ (358,418,000)<span></span>
</td>
<td class="num">(372,969,000)<span></span>
</td>
<td class="num">(335,471,000)<span></span>
</td>
<td class="num">(325,368,000)<span></span>
</td>
<td class="num">(346,578,000)<span></span>
</td>
<td class="num">(336,621,000)<span></span>
</td>
<td class="num">(318,358,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid in capital | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) of stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid in capital | Accounting Standards Update 2020-06 | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) of stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) of stockholders' equity</a></td>
<td class="num">$ (468,347,000)<span></span>
</td>
<td class="num">$ (454,506,000)<span></span>
</td>
<td class="num">$ (468,347,000)<span></span>
</td>
<td class="num">$ (454,506,000)<span></span>
</td>
<td class="num">(449,090,000)<span></span>
</td>
<td class="num">$ (467,943,000)<span></span>
</td>
<td class="num">$ (468,838,000)<span></span>
</td>
<td class="num">$ (440,783,000)<span></span>
</td>
<td class="num">$ (410,058,000)<span></span>
</td>
<td class="num">$ (391,952,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained earnings | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) of stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,133,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained earnings | Accounting Standards Update 2020-06 | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Decrease (increase) of stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (35,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622156562720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 66,088<span></span>
</td>
<td class="nump">$ 64,835<span></span>
</td>
<td class="nump">$ 169,200<span></span>
</td>
<td class="nump">$ 204,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">19,837<span></span>
</td>
<td class="nump">15,648<span></span>
</td>
<td class="nump">51,491<span></span>
</td>
<td class="nump">31,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9,123<span></span>
</td>
<td class="nump">8,821<span></span>
</td>
<td class="nump">20,872<span></span>
</td>
<td class="nump">18,548<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember', window );">Evomela</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,123<span></span>
</td>
<td class="nump">2,665<span></span>
</td>
<td class="nump">8,218<span></span>
</td>
<td class="nump">7,191<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember', window );">Teriparatide injection</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,071<span></span>
</td>
<td class="nump">2,567<span></span>
</td>
<td class="nump">12,484<span></span>
</td>
<td class="nump">2,831<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RylazeMember', window );">Rylaze</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,099<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">6,065<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,421<span></span>
</td>
<td class="nump">995<span></span>
</td>
<td class="nump">3,852<span></span>
</td>
<td class="nump">2,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">35,949<span></span>
</td>
<td class="nump">35,093<span></span>
</td>
<td class="nump">77,616<span></span>
</td>
<td class="nump">128,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember', window );">Captisol - Core</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,582<span></span>
</td>
<td class="nump">5,374<span></span>
</td>
<td class="nump">13,133<span></span>
</td>
<td class="nump">16,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember', window );">Captisol - COVID</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">32,367<span></span>
</td>
<td class="nump">29,719<span></span>
</td>
<td class="nump">64,483<span></span>
</td>
<td class="nump">112,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">10,302<span></span>
</td>
<td class="nump">14,094<span></span>
</td>
<td class="nump">40,093<span></span>
</td>
<td class="nump">44,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember', window );">Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,975<span></span>
</td>
<td class="nump">4,828<span></span>
</td>
<td class="nump">15,574<span></span>
</td>
<td class="nump">17,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember', window );">License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">5,154<span></span>
</td>
<td class="nump">2,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember', window );">Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,658<span></span>
</td>
<td class="nump">7,419<span></span>
</td>
<td class="nump">14,022<span></span>
</td>
<td class="nump">19,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,209<span></span>
</td>
<td class="nump">$ 1,647<span></span>
</td>
<td class="nump">$ 5,343<span></span>
</td>
<td class="nump">$ 5,030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_KyprolisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_EvomelaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RylazeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RylazeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622169443536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">$ 103,544<span></span>
</td>
<td class="nump">$ 292,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">544<span></span>
</td>
<td class="nump">842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(5,062)<span></span>
</td>
<td class="num">(2,370)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">99,026<span></span>
</td>
<td class="nump">290,697<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI', window );">Total short-term investments</a></td>
<td class="nump">117,291<span></span>
</td>
<td class="nump">321,586<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">2,506<span></span>
</td>
<td class="nump">63,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">2,453<span></span>
</td>
<td class="nump">63,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">4,887<span></span>
</td>
<td class="nump">29,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(107)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">4,780<span></span>
</td>
<td class="nump">29,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Corporate equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">5,807<span></span>
</td>
<td class="nump">5,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">312<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(3,615)<span></span>
</td>
<td class="num">(2,027)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">2,504<span></span>
</td>
<td class="nump">4,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember', window );">Mutual fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">88,115<span></span>
</td>
<td class="nump">152,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(1,203)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">86,912<span></span>
</td>
<td class="nump">151,887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">2,229<span></span>
</td>
<td class="nump">5,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">2,145<span></span>
</td>
<td class="nump">5,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Viking common stock</a></td>
<td class="nump">$ 18,265<span></span>
</td>
<td class="nump">$ 30,889<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities, FV-NI</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622171061824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Within one year</a></td>
<td class="nump">$ 8,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">After one year through five years</a></td>
<td class="nump">982<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total</a></td>
<td class="nump">9,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Within one year</a></td>
<td class="nump">8,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">After one year through five years</a></td>
<td class="nump">939<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 9,397<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622156563424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 181,206<span></span>
</td>
<td class="nump">$ 181,206<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other identifiable intangible assets, net</a></td>
<td class="nump">698,231<span></span>
</td>
<td class="nump">732,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember', window );">Complete technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">282,057<span></span>
</td>
<td class="nump">280,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(90,611)<span></span>
</td>
<td class="num">(78,991)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(1,544)<span></span>
</td>
<td class="num">(1,444)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">40,700<span></span>
</td>
<td class="nump">40,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(20,272)<span></span>
</td>
<td class="num">(18,267)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contractual relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">362,000<span></span>
</td>
<td class="nump">362,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">$ (57,947)<span></span>
</td>
<td class="num">$ (36,217)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622167311088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 181,206<span></span>
</td>
<td class="nump">$ 181,206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand core business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">105,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 75,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622171102752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details) - Commercial license rights - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">$ 28,298<span></span>
</td>
<td class="nump">$ 28,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(18,105)<span></span>
</td>
<td class="num">(18,188)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">10,193<span></span>
</td>
<td class="nump">10,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on finite-lived intangible assets</a></td>
<td class="nump">11,600<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments of finite-lived intangible assets</a></td>
<td class="nump">6,500<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Aziyo and CorMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">17,696<span></span>
</td>
<td class="nump">17,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(9,455)<span></span>
</td>
<td class="num">(9,461)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">8,241<span></span>
</td>
<td class="nump">8,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Selexis and Dianomi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">10,602<span></span>
</td>
<td class="nump">10,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(8,650)<span></span>
</td>
<td class="num">(8,727)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 1,952<span></span>
</td>
<td class="nump">$ 1,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622167308992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation</a></td>
<td class="nump">$ 6,229<span></span>
</td>
<td class="nump">$ 6,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">2,848<span></span>
</td>
<td class="nump">2,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LicenseeAccrualCurrent', window );">Amounts owed to former licensees</a></td>
<td class="nump">4,042<span></span>
</td>
<td class="nump">630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ReturnsAccrual', window );">Return reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccruedAssetAcquisitionsCurrent', window );">Acquisition related liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AccruedSubcontractorExpensesCurrent', window );">Subcontractor</a></td>
<td class="nump">1,756<span></span>
</td>
<td class="nump">1,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">4,463<span></span>
</td>
<td class="nump">3,192<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 19,338<span></span>
</td>
<td class="nump">$ 17,579<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedAssetAcquisitionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Asset Acquisitions, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedAssetAcquisitionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSubcontractorExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Subcontractor Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSubcontractorExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LicenseeAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licensee Accrual, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LicenseeAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ReturnsAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Returns Accrual</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ReturnsAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622170766752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 12,597<span></span>
</td>
<td class="nump">$ 9,754<span></span>
</td>
<td class="nump">$ 31,140<span></span>
</td>
<td class="nump">$ 28,375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">SBC - Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">6,104<span></span>
</td>
<td class="nump">4,480<span></span>
</td>
<td class="nump">14,519<span></span>
</td>
<td class="nump">12,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">SBC - General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 6,493<span></span>
</td>
<td class="nump">$ 5,274<span></span>
</td>
<td class="nump">$ 16,621<span></span>
</td>
<td class="nump">$ 15,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622170767616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622174643888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in shares)</a></td>
<td class="nump">16,888<span></span>
</td>
<td class="nump">16,688<span></span>
</td>
<td class="nump">16,860<span></span>
</td>
<td class="nump">16,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted income per share (in shares)</a></td>
<td class="nump">17,132<span></span>
</td>
<td class="nump">17,142<span></span>
</td>
<td class="nump">16,860<span></span>
</td>
<td class="nump">17,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)</a></td>
<td class="nump">6,706<span></span>
</td>
<td class="nump">5,574<span></span>
</td>
<td class="nump">6,503<span></span>
</td>
<td class="nump">4,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares (in shares)</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares (in shares)</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">379<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622168318480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 22, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,835<span></span>
</td>
<td class="nump">$ 169,200<span></span>
</td>
<td class="nump">$ 204,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,259<span></span>
</td>
<td class="num">(19,919)<span></span>
</td>
<td class="nump">54,324<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,129<span></span>
</td>
<td class="nump">178,339<span></span>
</td>
<td class="nump">138,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,706<span></span>
</td>
<td class="num">(9,139)<span></span>
</td>
<td class="nump">66,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,835<span></span>
</td>
<td class="nump">169,200<span></span>
</td>
<td class="nump">204,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,443<span></span>
</td>
<td class="nump">22,145<span></span>
</td>
<td class="nump">91,014<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Shared-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,811<span></span>
</td>
<td class="nump">17,255<span></span>
</td>
<td class="nump">16,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other corporate expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,926<span></span>
</td>
<td class="nump">14,029<span></span>
</td>
<td class="nump">8,424<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,737<span></span>
</td>
<td class="nump">31,284<span></span>
</td>
<td class="nump">24,853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,648<span></span>
</td>
<td class="nump">51,491<span></span>
</td>
<td class="nump">31,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember', window );">Captisol - Core</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,374<span></span>
</td>
<td class="nump">13,133<span></span>
</td>
<td class="nump">16,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember', window );">Captisol - COVID</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,719<span></span>
</td>
<td class="nump">64,483<span></span>
</td>
<td class="nump">112,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,094<span></span>
</td>
<td class="nump">40,093<span></span>
</td>
<td class="nump">44,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb business | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,140<span></span>
</td>
<td class="nump">23,337<span></span>
</td>
<td class="nump">19,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,721)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,177)<span></span>
</td>
<td class="num">(26,905)<span></span>
</td>
<td class="num">(21,587)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb business | Royalties | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">984<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb business | Contract revenue | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,140<span></span>
</td>
<td class="nump">22,353<span></span>
</td>
<td class="nump">19,520<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand core business | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,695<span></span>
</td>
<td class="nump">145,863<span></span>
</td>
<td class="nump">185,140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,620<span></span>
</td>
<td class="nump">49,050<span></span>
</td>
<td class="nump">112,601<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand core business | Royalties | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,648<span></span>
</td>
<td class="nump">50,507<span></span>
</td>
<td class="nump">31,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand core business | Contract revenue | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,954<span></span>
</td>
<td class="nump">$ 17,740<span></span>
</td>
<td class="nump">$ 24,889<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622166443120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>contingent_value_right</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightsSeries', window );">Number of CVR Series | contingent_value_right</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time | Phase 3 Clinical Trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Gross contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Transferred over Time | Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000,000<span></span>
</td>
<td class="nump">375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember', window );">Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare', window );">Number of CVRs issued per acquiree share | contingent_value_right</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries', window );">Number of CVRs issued from each CVR series | contingent_value_right</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders', window );">Frequency of cash payments to CVR holders</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Mark-to-market adjustment of CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember', window );">Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Mark-to-market adjustment of CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment for contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment for contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Earnout Rights for Partner Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency', window );">Earnout rights recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,291,000<span></span>
</td>
<td class="nump">117,291,000<span></span>
</td>
<td class="nump">$ 321,586,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,701,000<span></span>
</td>
<td class="nump">8,701,000<span></span>
</td>
<td class="nump">11,157,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,026,000<span></span>
</td>
<td class="nump">99,026,000<span></span>
</td>
<td class="nump">290,697,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,265,000<span></span>
</td>
<td class="nump">18,265,000<span></span>
</td>
<td class="nump">30,889,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent Liabilities | CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,000<span></span>
</td>
<td class="nump">308,000<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent Liabilities | Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,507,000<span></span>
</td>
<td class="nump">2,507,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent Liabilities | Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,333,000<span></span>
</td>
<td class="nump">5,333,000<span></span>
</td>
<td class="nump">7,364,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent Liabilities | xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,000<span></span>
</td>
<td class="nump">480,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,914,000<span></span>
</td>
<td class="nump">22,914,000<span></span>
</td>
<td class="nump">40,624,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="nump">73,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,649,000<span></span>
</td>
<td class="nump">4,649,000<span></span>
</td>
<td class="nump">9,735,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,889,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent Liabilities | CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent Liabilities | Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent Liabilities | Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent Liabilities | xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,145,000<span></span>
</td>
<td class="nump">94,145,000<span></span>
</td>
<td class="nump">280,553,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,507,000<span></span>
</td>
<td class="nump">2,507,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,145,000<span></span>
</td>
<td class="nump">94,145,000<span></span>
</td>
<td class="nump">280,553,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent Liabilities | CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent Liabilities | Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,507,000<span></span>
</td>
<td class="nump">2,507,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent Liabilities | Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent Liabilities | xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,000<span></span>
</td>
<td class="nump">232,000<span></span>
</td>
<td class="nump">409,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure', window );">Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,121,000<span></span>
</td>
<td class="nump">6,121,000<span></span>
</td>
<td class="nump">7,713,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,000<span></span>
</td>
<td class="nump">232,000<span></span>
</td>
<td class="nump">409,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent Liabilities | CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,000<span></span>
</td>
<td class="nump">308,000<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent Liabilities | Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent Liabilities | Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,333,000<span></span>
</td>
<td class="nump">5,333,000<span></span>
</td>
<td class="nump">7,364,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent Liabilities | xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure', window );">Contingent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480,000<span></span>
</td>
<td class="nump">$ 480,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmountsOwedToFormerLicensorFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts Owed To Former Licensor, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmountsOwedToFormerLicensorFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightsSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Contingent Value Rights Series</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightsSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_IcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=lgnd_ContingentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=lgnd_ContingentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_CyDexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_CyDexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622167349712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details) - Level 3<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of December&#160;31, 2021</a></td>
<td class="nump">$ 7,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments to CVR holders and other contingent payments</a></td>
<td class="num">(2,505)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments to contingent liabilities</a></td>
<td class="num">(527)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition', window );">Contingent liabilities from xCella asset acquisition</a></td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of September&#160;30, 2022</a></td>
<td class="nump">$ 6,121<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622171007664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - reporting_unit<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622167024880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>d</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>option</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>option</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>option</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>option </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,192,000<span></span>
</td>
<td class="num">$ (7,303,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsToUnwindWarrants', window );">Payments to unwind warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges', window );">Proceeds from unwinding convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges', window );">Number of options under convertible bond hedges | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,219<span></span>
</td>
<td class="nump">370,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">$ 76,854,000<span></span>
</td>
<td class="nump">$ 76,854,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,854,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,301,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 733,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0040244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900,000<span></span>
</td>
<td class="nump">$ 16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortized issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod', window );">Repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_RepaymentsOfNotesPayableInterestPortion', window );">Accrued interest portion of repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInDebtDiscount', window );">Decrease in debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued in public offering (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,018,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,559,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_PaymentsForConvertibleBondHedges', window );">Payments for convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Notes repurchased during current period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod', window );">Repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_RepaymentsOfNotesPayableInterestPortion', window );">Accrued interest portion of repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInDebtDiscount', window );">Decrease in debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Notes repurchased in August 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod', window );">Repurchased amount of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 227,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Stock price trigger to classify convertible debt as current (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger', window );">Maximum threshold of debt trading price trigger (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0052317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentRepurchasedAmountDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Repurchased Amount During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentRepurchasedAmountDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncreaseDecreaseInDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Debt Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncreaseDecreaseInDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Options under Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfOptionsUnderConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsForConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments for Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsForConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToUnwindWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Unwind Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToUnwindWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Unwinding Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ProceedsFromUnwindingConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_RepaymentsOfNotesPayableInterestPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Notes Payable, Interest Portion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_RepaymentsOfNotesPayableInterestPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=lgnd_NotesRepurchasedDuringCurrentPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=lgnd_NotesRepurchasedDuringCurrentPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622174376752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Senior Notes - Notes Payable (Details) - Convertible Notes - 2023 Convertible Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract', window );"><strong>Notes Payable, Current and Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of the 2023 Notes outstanding</a></td>
<td class="nump">$ 76,854,000<span></span>
</td>
<td class="nump">$ 343,301,000<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized discount (including unamortized debt issuance cost)</a></td>
<td class="num">(254,000)<span></span>
</td>
<td class="num">(22,584,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Total long-term portion of notes payable</a></td>
<td class="nump">76,600,000<span></span>
</td>
<td class="nump">320,717,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of the 2023 Notes outstanding (Level 2)</a></td>
<td class="nump">$ 74,395,000<span></span>
</td>
<td class="nump">$ 341,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622174377584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="nump">52.90%<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
<td class="nump">20.30%<span></span>
</td>
<td class="num">(15.10%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember', window );">Pfenex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount', window );">Pfenex CVR adjustment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, CVR Adjustment, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_PfenexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622156572768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (in shares) | shares</a></td>
<td class="nump">2,199,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">852,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares) | shares</a></td>
<td class="num">(34,941)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(36,529)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (in shares) | shares</a></td>
<td class="nump">2,980,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (in USD per share) | $ / shares</a></td>
<td class="nump">$ 106.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in USD per share) | $ / shares</a></td>
<td class="nump">91.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in USD per share) | $ / shares</a></td>
<td class="nump">38.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in USD per share) | $ / shares</a></td>
<td class="nump">76.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (in USD per share) | $ / shares</a></td>
<td class="nump">$ 102.98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares) | shares</a></td>
<td class="nump">264,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">260,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (in shares) | shares</a></td>
<td class="num">(136,448)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(2,059)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares) | shares</a></td>
<td class="nump">386,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in USD per share) | $ / shares</a></td>
<td class="nump">$ 138.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in USD per share) | $ / shares</a></td>
<td class="nump">89.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSUs vested (in USD per share) | $ / shares</a></td>
<td class="nump">120.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in USD per share) | $ / shares</a></td>
<td class="nump">121.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in USD per share) | $ / shares</a></td>
<td class="nump">$ 111.93<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622171104480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 11, 2019</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Outstanding options that are exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding options that are exercisable, weighted average exercise price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102.23<span></span>
</td>
<td class="nump">$ 102.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized stock repurchase amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Period in force of stock repurchase program</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized stock repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248,800,000<span></span>
</td>
<td class="nump">248,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=lgnd_AtTheMarketEquityOfferingMember', window );">At-the Market Equity Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_SaleOfStockAuthorizedOfferingAmount', window );">Sale of stock, authorized offering amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Share purchase price as percent of market price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod', window );">Shares available for future purchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,007<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EmployeeStockPurchasePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EmployeeStockPurchasePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_SaleOfStockAuthorizedOfferingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Authorized Offering Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_SaleOfStockAuthorizedOfferingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=lgnd_AtTheMarketEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=lgnd_AtTheMarketEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622175036080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings (Details)<br></strong></div></th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>civil_complaint</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember', window );">US District Court for the Northern District of Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of civil complaints filed against entity</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622175053392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease', window );">Increase in operating lease assets</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="nump">$ 18.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_OperatingLeaseLiabilityIncreaseDecrease', window );">Increase in operating lease liabilities</a></td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="nump">$ 21.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term of operating leases</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term of operating leases</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_OperatingLeaseLiabilityIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_OperatingLeaseLiabilityIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Leases, Right Of Use Assets, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622163707536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Operating and Finance Lease Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 32,108<span></span>
</td>
<td class="nump">$ 16,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease assets</a></td>
<td class="nump">14,444<span></span>
</td>
<td class="nump">16,207<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LeaseRightOfUseAsset', window );">Total lease assets</a></td>
<td class="nump">46,552<span></span>
</td>
<td class="nump">32,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">2,345<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">2,393<span></span>
</td>
<td class="nump">2,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Noncurrent liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">34,893<span></span>
</td>
<td class="nump">15,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liabilities</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 37,300<span></span>
</td>
<td class="nump">$ 17,651<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622156940208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturity of Operating Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remaining three months ending December 31, 2022</a></td>
<td class="nump">$ 1,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">4,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">4,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">4,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">5,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">5,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">22,317<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">48,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance', window );">Less estimated tenant improvement allowance:</a></td>
<td class="num">(1,030)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(10,494)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 37,238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Tenant Improvement Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140622175036080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Event (Details)<br></strong></div></th>
<th class="th"><div>Oct. 26, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | OmniAb</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=lgnd_OmniAbMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=lgnd_OmniAbMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>lgnd-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lgnd="http://www.ligand.com/20220930"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lgnd-20220930.xsd" xlink:type="simple"/>
    <context id="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia5d1d407380348e2a118f44535f6a4f9_I20221104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-11-04</instant>
        </period>
    </context>
    <context id="i7ed21a608d174035a9614928545bff44_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id713d77cfce844c9acd459debe60471f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e4c019116374680b437a7a7e84a8c80_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibe9d446b7d574e0a8a446713e4e31f27_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie6dd34ce0bee40ea82cba5bfc9584a46_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i61be445c11db419296ccc53f473da154_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i27111ff24358446e8f6742f1a9a22280_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i805b7ce49b9b477ab1a86dfcd8f4b896_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idbc5e665d17d410bbc8f43e5ef950091_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i68593efff0be4bcea82e054922dea281_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3c883799387843e28ad63ef5c7a3a928_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idca791879e154b79899726f73ac30955_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibb48e049cd074424a4b9c75318b0968f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9d5bd9d373e34f7ab0ab2dc3b00f0266_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icad679edea5848ca92af3def315765fa_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i198ab94a85514554b7b186297e1b40e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie753396ec7e54b7284e025b438c69c9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i90959b048f9d4c9c901d541f37dd4d04_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i009cac1d5b03430ea00be4a216999d58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice5667b832bb46b58768234cec087173_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i16919bc133394068b70b5dfa72c1fd0e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d2ed7a3614b47c58739fe3a78c8cf50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i239ddea2c7ce41f184f6267304338e4d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7464adf27f3344eaa673a32517540e7c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i27cf2b1876194c95b8039376914f66a9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8d3fdee71cb945188b3a6480ad8b04b3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i90c76c0d56474350ace13a08c8b6be7d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i622a51922d024361bd6340d3356b0611_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifc60f1d7e4e64d4da82bc5998ca4409e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic3d7b66aebc7403188ff43b263cbde5a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i55d2a92d4b1a4569aa0e26eff50b27e1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9bd3552261654e0aa2a6e538a4ffd6e0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibe1aea5f82664c3d8279c4521c119e7f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i185279a9c1154a6e970cdd3102fb2523_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i81a5d969d3cd49018e396c6da4322e1d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i19361f68c02f4b6fa38af8257cd7aa3b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib18e9df5868e4c7d9ffa15a018c90a12_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3c3698d638594c138f050c501a4bb5bb_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i589ed826afd94e66ac256c87c067d171_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i09ea69ed13a2487cb2c216e37f4468a5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icc472676953e452a9218d48cdabcd4c9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibcc63139d2274ceab9cf48bff4553b66_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5baea90deb8e4265a72ea7026d08379c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1b75eb328f4e4243b3e4fdb1e688d35c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i757ee12a916e4b45a2fd76ec35d70c95_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if291edfa693f417bbbb3aaa623e73077_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7a6c4eeaf5ad4e0e94b7a1e461895686_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaf5089a880dd4f0c91f39d957943a6d0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i302273f452f341388964a61d9618c5ea_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifa9e8c41a8d6418a8b594ee335f4c15e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4a1087670b3d4e64b4a3354392f53abe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i49019251c3644c1b9be5cc7120c8645b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a0567a5633346ecad7f4de1f16113d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5f7904b282b4637855d57757935605b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0608bba36d7e4f2cb5bd38b7d5fa45af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5823b83aff4246d783748aff6ba9b978_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4787c5b04654433aa93a05790c5bb00_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4de83da8ed6348dca0fb66d4c2b5ba46_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i621f76587b9b4167af8ab0cce3f06136_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i45854ed7c1894c938845c943e8170bfa_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ide4e95b565954f94bdabad5e12ec376c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2163920057fd4ca4898a01c500e82a08_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i72687d1596d4483c86609fb362747b63_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idaa6a14b6ffd4636950c8681f0e560a1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7e93447e0b6144f2a48981aa605997ad_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie1dce0e52afa44c69b20605abe6e40de_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0ed614688b574fd0983b2980c43392fe_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i15b4a7ad28414e03b02122a320252e75_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i15167ff194f5408e9eff810879dae577_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i88faad5b2d5040e48a57bdd7eae38a44_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibe07e2903f194de88402b53dfd03c119_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifb0fba93854d45b3a71f274d86a0b25c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib19b40a6687a4043b9c5f217b53cee1f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i06b5f93e548a4212a89cf839a5f62b6d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6d0cddc5d84e4d48b281640914f3c31a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0f39828b4f0d4d30b1bbb778bcb4cb81_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6902f9b70949440389390267fac2a002_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id04346533cc6453daf6686d7ecd0494a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib9bd6db87aa44bcdb4346428bc52f796_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3b8e47316474452ea41d7654cf4c47aa_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iac1e1e884548420e9f7f74cb53177b5c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9c99db1599d84940b69a2da1fe5207cc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5fd7205f82a3406b9f0c0dae4653b877_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if3f7ea577fbe4425b5634e5fec8b8b74_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibc3e336e701549d0a038218263d74105_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32fea61e3e6a4354bd7504b5be38cea3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5fe64e3bfa140528971aaeae19072a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i35e1f2ef2453421db235d4f5debc1ea8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibefdd74dcbb544c7bcd50c4bdc0ea3b1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic183fe3cfc0444ec988c0505dc4aac87_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id0662d167252447899eb4741ca4b7d49_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie7cd2d0377724f898a6c11769e623b6b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id67bfd452ca34efbabd006d69f7f34b4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i47ac025acf224b88b1f6e6ddd566bd90_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idb81ed13c9ff4a1e8c098b5fdd85fce8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5e3e7744f301495cb31d4020806e39e6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib36bf83f8a274b0a9bf13b0e4652e822_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i827c7e6cdeac4886b9ec06b6f65e8455_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie2247afa58cf4d3995002065e43ff1c7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id1971a4278a1432a897cda6cc91f0897_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7253785dc35146fc8241d38b8d7cc8bd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia48707413feb4dbab9c2496e3c59a6a0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9a7b8932fa4845759b4d1dd6a1d7a232_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id95bfc92bd274c84aa1a9a7994070620_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i055d53a99e864487af223e1ee40ef3de_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i289f60c3b5684e97b642fc712cb0729d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1aca03e88f7c4ef7afd5a15c43b2a58b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia87b96b5149b41818034e32448024dfb_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2eac10c65b1641ffa06188a690f2aca9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iba465a7198d54ee7b6ad82d779858fd9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0a5fa29dc2e848a7b2ac184d57a87bc3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i904cf14c4b3e4fbeb3f577b716e29d42_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib22143b247d14e49b1f87a41cebc0533_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0411fb172a764e2e92a29821f037280d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i78881cd8932b4b9093df9eaafe0b57dc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie6c61f74a4ae46dfa6cd20104936b527_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i588e8adf3218428d9d65e76ec58ffcb2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia44ee73068f14175b5fd0992341adbfb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i57d398f1cb1742cc900354e71b1ecc8b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieedc3bed7980424b96288a7a097ef23f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7b25204e1c1e45449277f115819b751e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9683e5a36df8493692166626aea2d25e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3b3ad9c76fcb49c091bef77b6c7f4ab3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic9ac29ea1484471db0a5f3a8814367c8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie0a1285ff321448588acc1bf40c5d032_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7911ef49fdd142e7b67a65d73023df8c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7a70bf5a0b90462f88245ce9197a2e96_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i123c75669efe43bd9dc15885da57a867_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9c920df29ac544cd8c6902919042761f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia7c767ef41d54b72a2eec06f317f26a3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i98e6619944924d099ebf2550f8a566da_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibc2a7c797d8541648d78aca099e523a0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id269671958804d059d42ec1bf2798d24_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i350e5ed791be46a4b5d11307ffa4cb26_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i662334cf40d54566bec6fe57077ce69e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i06f8d4ffb4a142d89bec0b51469e199e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie20dcecc9b97461eb7567478745a495f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iabc8605b5b5b4402bfa40c6f86cc4521_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic07a20125b6b4a8ebfc0faae2187f7dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i317970eca87540b8b1481240b27a7411_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida31cd3b48ce4d1e9d75b4ab666e503d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifba74fb91aff4709a648d885a295772a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibeb3f202176743cfbfef35c2aa9a206a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd672b4aeff947f2be4d57e9a811d2b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20e1b9d42dae41b3b8d258ee144a3142_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice501f8f87084c9b8479455e8bbbc32d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f2f5a4645194ff8ac4a43834225e441_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i51243c6c92784f7f9b969f7ff8364956_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie89e441071a94390acf735662b9d84ca_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i879eebb5a7c3459ebc5f9e1980194ee7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i949f68cec8414dfb8cf22d6f87aad59c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1d4422300f314cb5b2c8b76da9076612_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65e7975e74c64f75b300ebf474efc3d0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibdfc802ffcea4059bb816a071f7ed3b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5860738973c46b7b442c1e31a1fa1b4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8078205bd5974127a86e504b140fa260_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i365d6d6bcee9448fa1c6ab3aa3d86e82_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if1caa4c3cd5f4732bfdc25dc6f6a9796_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7b95b921442e4621abaf805c9c6698fa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8c69d20029b545489f7ca2234d28aaa8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73f41ef6652948d1841b05a5469daf7f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1cf12e3a53a14d8eb42d4b89b7cf304d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie85097cc30914531bce5696bfe9a1638_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3ebb3d8dffba494eaf509dc473ba5887_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i321200c90e1841ba98e56d96bd03dca8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i19b98503fe3c47908678fecb01ff99d3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1920d37ac7d74b39bb53487c74e6eddb_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3b02440b88c044d992035080107197f1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i62640c7e221d4ddf9f77e8cd49490c14_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iad2aaa41970748678e953d111259e623_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if3e5382a24354732b90a0c8d7480439c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic86919d9459445b0acb504ef008126cb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3f173828d5bf43d3b40f98cfda636157_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i09fce991826e4593a4adb710b13eee0f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id162adfcca81460486101e12b3597e00_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1bd82be627144b3482c05a70e537330b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i15c042b2ebf24feb89d24e634e666d27_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id1f728b109204a9a83575e9f16df629b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i31dbf3fbde084ff3a4e51995b5baa515_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7842cd71eeab430eb6922c6dc245b80a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i55c5ee22089f41b58b21043995b5b0e3_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6ba11ede5ca045f4b14d3ba0dd1568fe_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i538684284d804c57bd3f118d72db7cbe_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i766939c97c5b40dcb5b38a79e41a958f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8da6cb831ae14f8089f18a5b3789e9dc_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8f27bc960546423584fb5e22d31ba050_D20220101-20220322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-22</endDate>
        </period>
    </context>
    <context id="i3c65682d715d4cebb23f79ad72073530_D20220323-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-03-23</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icba71108b7bb484f90495bc743d1cd62_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i04151a540d6044408f287f42f0f848e3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i65de87043a1e4dcab7411f098886c292_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7ad307c061f3441f89ff5551bae95b94_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5ac758bbffaf4b33b4bb7b96b8713d1a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idfef621791484893826f75aa4da8f7d4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if060aacdc039409386f29263ea0888fe_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia34a4d36cd974f88abc36f50a6cc10c1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i515e60d0096f49b39df04bcd1c448073_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7806df4e0ca341bd947ac07ff78832bc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic5584e6c9205484792148da209de79e0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibac68a1cdeb3437cb24a409ec62e7ae0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib56bece7e0da4f168b25d26c3a937bb8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i30ae2842116c43ec9c4d10f553fb44c8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7cd956644674461e94c0667f968d8a8d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6a249f2388aa45ae9e1b4da3725d791b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iabe4ebeb2dcf415199c31a3fe43b9779_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib76e0a2f4e02403e90689f0872ff43ca_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i71032e6cf99a4220b3ab9bdf9e1ce780_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibb79cf209f1748b7aa2267af51ea59d2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibfd0f8876888448aad7af0288accc346_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia3796b96c0d94c1da6299853875dac7c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if22d059e053745febd4c8b88a8df2cd8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if30ec34df7ed4597981dae2bffa04dc6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2883789af81b412eaa37f1ebac40224b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if0f10944b87f4bb2b93e8fac9eac402f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaf8fec3725d042efad094010d20f1c66_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i93b00d99d3c34bc685177724979b4ff9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6bd2cbdef5c44f8fac9ee6db6ad8fc64_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib57783a54b7b44d0bfe7bfb7bd595b4f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4699144a009d4236a7a7d3ba4f5a71b6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i921e73649a7a4b69a8ed14e11dab4870_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9545ef6cc9054eaba5733eede4f83b2e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id45baf2e1b7e452fa0ab3dee1b630a5e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibb9c3ea5d1f94844bc6846f65c475bf2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia44e8d68d457441f87d096b99b424cf9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idf43f3e6122f485d9604b85bdf24ca9a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i409fb78206fa48e885e9a25ffed9be5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02baf2e63f634118acc0b5cecd635f91_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea813cc62405437f966419cf2bf8c12d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f66174ae3354eb19f957fd4f8e8990f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2e5a64e988a14bc3acc1c82b5a5bc74d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1c4985c47c384c0b9b0ab0008644e5a3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if45e52f2a26442e8b69b942641647814_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i006d5206c32b4ffa8c5bf11c4c32263d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3eb2b3352eca4a009a173f9f0a39cc12_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29ad1d75d22a4e3f98195a322aa7aadc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82abec3a44c5436095d8c4e9189adff4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i68afa5ce123e446ea968ab4615153660_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2c76ceca320043319a729e346c30af96_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i32d528942e7f4eec9ed16811189f131e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia70b1f37b5444463a665afeeb29fee23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d63d2ebe7124c6c92192fbb621ceb55_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa6c7430ceed408ea0129815282f022b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c4aa673a44a49ba91b41ff1867085ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8aa4c6644f944c0691c442c1da40ed28_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id0e423a6748f4ef5bf5198b8c0ddff62_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0c75467deb3e4ddab92d1873ad3c9a15_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2a46d7016abc41c5a9d9d807b0e437fc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia76e9fffc6114de8a391f206f62e3b3b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4d765504d314a2aa80653e6e6cf32d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4fa076f03644041966c14890e83f8e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i374aa010c5c546cd97bd8012be328ef2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:CyDexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i417f205a3d994398aa39d14f0aeb46d2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id95d5b3a71314067be9a4acc1f0dec9d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i558cfad5a49e4d288fcb31a70e3d0423_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7b8eba0c2f244c68897f2c465f695cb4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6cb0b263e3124cc9a0aca9d63fe8c3a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i177d784a77a54241a81da1f857fb9dce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1658e372295b494fa6a5129e877086f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5196ee4cc484b1a8f52931d60ad16ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3ac0c4007a846e08014e8ab0f432750_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0b43473351914f1a86d1acd39584c6c2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i67aecd998ffc4380be51824531348e09_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iebb7edd5169d406595ad57436f4ba57d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5a6c5227f1ae46e7a867099dc194d21d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e226666ee01416ea4437da7b90c7394_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8807f0f1743448e897e2affdf0d534b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82de593bdc9e4da984cd72ffbd180620_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e4dff2f452e42e5b71d10fe5e7de15c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i735aa43de0d8473b978acefb4731c01e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i88db7dab6b7a424a8ab88ea1d64e42ee_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9ee4885695b241d9affa4f86640bf9aa_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4e74edc9a24a4d4aba01db56acc201d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a71ba97a53b4cc0889174ac02780ee4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic942e4443ee741a5b559256a2d777257_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32d71f9ce3064ebfae407232f08153f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">lgnd:ContingentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea631c13053d4cb9a6c3ec25bbe89909_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="ia610e91d108b4828b2e383faf35f060c_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="i58dbd9eaa0a046348cb63f5bc71bc4e8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8ae80f0d98ee484383b7285db27e3bf8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7dfa24a16ddb4468b3057a86ea1992f8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i286c91cbf234442b92d18be9042ac0d1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2a563f07df03433d9f3b406175fa5e0d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i52253af912264b92a50089624acefcd3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:IcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1b2e23fc4a3943ad849d871cbc73bb3d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iae8e9c1682aa4055a75677062d0d3067_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i28ca9f03e482413a80f84d8327155d06_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia13f08ef2fec488aa3e23297a819a673_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idf669638100c407a84acc68049e05107_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib34d5ea9024943dab91936ef12ad4821_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i853e09d80a6a46aabdbe6bf00b059c13_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic581556cc99e423a81de86ed53ca8b39_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i4e2b8f073bbb4eeea44fc317eeee6bed_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i238c5b93b270426ea69664bad2955dba_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i18ad0006f29c4e3782c1405fa1ec6c0f_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="ifd2de700e7ee4f82b95550662f3e922e_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="ie91d13b37a564e829094c6726d7a24e2_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ief8861b3c3714c46851e7e25c053e239_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i187ac97ada164f7f8fe99815499cf29b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">lgnd:NotesRepurchasedDuringCurrentPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie7d9a25c6c2143cfb4d8e1a7ebe0d185_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ib75f8705715d4191a83e17e50b6d144f_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">lgnd:NotesRepurchasedDuringCurrentPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i22017c391fb94339803ce6d3d455c551_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibe725b5fc54141e2b22eb8fcd4b19e03_D20220801-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2bca3710f8284248a5ce78b298651b77_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="ic9c3c0791990421eab75d178e60313f8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i87ba2111bb0e419c9909cb001f40f3f1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:PfenexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2834ca94385d4db2aacdb319acd70cba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27be544b5f9b4843871454a4846e31e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6abb45e394d9463b85d36c87fa45855a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icd55699f74a443efb3dad3f864d69f0d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifa972f2a8689410b8773aec2b27958d0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6d8fd471caf841f7ac94f8e517939089_I20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-09-11</instant>
        </period>
    </context>
    <context id="i3b41dd4334ec4f4f8a4cfe7c0d306776_D20190911-20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-09-11</startDate>
            <endDate>2019-09-11</endDate>
        </period>
    </context>
    <context id="i9961ee71da6d43899ffda6ea8268a9b4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">lgnd:AtTheMarketEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0f4e7138c0694ae2ae0c918afaf6d867_D20191031-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-31</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ifa102a08d9284fa6b57fb76fdcab4852_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iae84b3f2dac8479f98e3fbba153cb912_I20221026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">lgnd:OmniAbMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-26</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="position">
        <measure>lgnd:position</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>lgnd:reporting_unit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>lgnd:segment</measure>
    </unit>
    <unit id="contingent_value_right">
        <measure>lgnd:contingent_value_right</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="option">
        <measure>lgnd:option</measure>
    </unit>
    <unit id="civil_complaint">
        <measure>lgnd:civil_complaint</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80L2ZyYWc6OGI0N2E2MTNlZGM0NDk3MTk0NzQwZTUwMzNjNWMzNGMvdGFibGU6NGQ5MjM0ZmY2MmYzNDFmNThjMDZlNDU4ZDZkY2YzNDgvdGFibGVyYW5nZTo0ZDkyMzRmZjYyZjM0MWY1OGMwNmU0NThkNmRjZjM0OF8yLTEtMS0xLTk1MTE3_6fdeb374-414d-4749-a365-de675ba2b56e">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80L2ZyYWc6OGI0N2E2MTNlZGM0NDk3MTk0NzQwZTUwMzNjNWMzNGMvdGFibGU6NGQ5MjM0ZmY2MmYzNDFmNThjMDZlNDU4ZDZkY2YzNDgvdGFibGVyYW5nZTo0ZDkyMzRmZjYyZjM0MWY1OGMwNmU0NThkNmRjZjM0OF8zLTEtMS0xLTk1MTE3_2d0ded2f-951e-4a96-9b8d-a789ce1e0c92">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80L2ZyYWc6OGI0N2E2MTNlZGM0NDk3MTk0NzQwZTUwMzNjNWMzNGMvdGFibGU6NGQ5MjM0ZmY2MmYzNDFmNThjMDZlNDU4ZDZkY2YzNDgvdGFibGVyYW5nZTo0ZDkyMzRmZjYyZjM0MWY1OGMwNmU0NThkNmRjZjM0OF80LTEtMS0xLTk1MTE3_a2dcd007-ac3b-4192-b4f8-210fda46da3f">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80L2ZyYWc6OGI0N2E2MTNlZGM0NDk3MTk0NzQwZTUwMzNjNWMzNGMvdGFibGU6NGQ5MjM0ZmY2MmYzNDFmNThjMDZlNDU4ZDZkY2YzNDgvdGFibGVyYW5nZTo0ZDkyMzRmZjYyZjM0MWY1OGMwNmU0NThkNmRjZjM0OF81LTEtMS0xLTk1MTE3_bbe4afae-a7ae-43e1-a78d-f684c3f480ec">0000886163</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80L2ZyYWc6OGI0N2E2MTNlZGM0NDk3MTk0NzQwZTUwMzNjNWMzNGMvdGFibGU6NGQ5MjM0ZmY2MmYzNDFmNThjMDZlNDU4ZDZkY2YzNDgvdGFibGVyYW5nZTo0ZDkyMzRmZjYyZjM0MWY1OGMwNmU0NThkNmRjZjM0OF82LTEtMS0xLTk1MTE3_41001cf4-518b-4bda-8992-0af5d6cd5eb1">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="ice5667b832bb46b58768234cec087173_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMy0wLTEtMS05NTExNw_87af1313-893c-4dbd-91d6-8d725b48f5eb">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i4e2b8f073bbb4eeea44fc317eeee6bed_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80Ni9mcmFnOmJjOGUyNDhmNTc3MDQwZDFiZGY1MzBhNjVmMGJlMTRjL3RhYmxlOjFmZTczZWY1NWUzNjRjZWQ4MGY1ZTk1MmFjNDdhODkwL3RhYmxlcmFuZ2U6MWZlNzNlZjU1ZTM2NGNlZDgwZjVlOTUyYWM0N2E4OTBfMi0xLTEtMS05NTExNw_a4b1b29c-2187-404e-b868-788262e5723a"
      unitRef="number">0.0040244</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i2bca3710f8284248a5ce78b298651b77_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80Ni9mcmFnOmJjOGUyNDhmNTc3MDQwZDFiZGY1MzBhNjVmMGJlMTRjL3RhYmxlOjFmZTczZWY1NWUzNjRjZWQ4MGY1ZTk1MmFjNDdhODkwL3RhYmxlcmFuZ2U6MWZlNzNlZjU1ZTM2NGNlZDgwZjVlOTUyYWM0N2E4OTBfNC0xLTEtMS05NTExNw_09790baf-4d72-4f40-937e-74592081e1fe"
      unitRef="number">0.0052317</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18xNzI_f9509345-fc32-4161-be1c-94b94413c066">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6YjJiNDZhZmQ4OWQzNDVmNmI0MjkwZDNkMzFiNWRhZWIvdGFibGVyYW5nZTpiMmI0NmFmZDg5ZDM0NWY2YjQyOTBkM2QzMWI1ZGFlYl8wLTAtMS0xLTk1MTE3_4cd77abb-361f-496d-9a35-b2cd29e42caf">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yOTY_a24c97c2-fd57-4c32-a8b6-43c899a663ff">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6NTdjMmMyYmEzYTRlNDgzOWExZWFhNjFhNjUwMTM2ODMvdGFibGVyYW5nZTo1N2MyYzJiYTNhNGU0ODM5YTFlYWE2MWE2NTAxMzY4M18wLTAtMS0xLTk1MTE3_f6787764-686f-48b1-bf59-8265233c3351">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTg4_c502d927-285a-41ec-b5c2-8898b93dd718">001-33093</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18zOTg_a2a54974-3791-400c-a61f-700bb94a321e">LIGAND PHARMACEUTICALS INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml8wLTAtMS0xLTk1MTE3_bee7864e-c944-4bd3-9b1d-a6a619925e8f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml8wLTEtMS0xLTk1MTE3_e98be418-6d21-483e-9c57-6758da1719f2">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml8zLTAtMS0xLTk1MTE3_3927e33e-9bb9-4ca9-aecb-12cad8b73223">3911 Sorrento Valley Boulevard, Suite 110</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml80LTAtMS0xLTk1MTE3_755752c8-9283-4cb7-a7f3-ef211cdc5b7b">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml81LTAtMS0xLTk1MTE3_532c83fb-1f43-46b7-b35f-088871a1ada4">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6N2ZjY2RhMTllNGFmNGJlMWIyODY0MmVjMGJkYzRmNjIvdGFibGVyYW5nZTo3ZmNjZGExOWU0YWY0YmUxYjI4NjQyZWMwYmRjNGY2Ml81LTEtMS0xLTk1MTE3_4dbea0fa-a8b4-48c1-83f1-29e1ad860afc">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTg5_809f1f7f-dffe-4383-b753-3e65a2a5b611">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTkw_c478a4f1-a9cd-4aaf-b6f0-7b696677d9c4">550-7500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6MmQ1ODRhYTk5OTA2NDVhYTg2NzA4NzdiMzEwMDZiZWYvdGFibGVyYW5nZToyZDU4NGFhOTk5MDY0NWFhODY3MDg3N2IzMTAwNmJlZl8xLTAtMS0xLTk1MTE3_07213005-352c-447d-b56c-ba7085e39f34">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6MmQ1ODRhYTk5OTA2NDVhYTg2NzA4NzdiMzEwMDZiZWYvdGFibGVyYW5nZToyZDU4NGFhOTk5MDY0NWFhODY3MDg3N2IzMTAwNmJlZl8xLTEtMS0xLTk1MTE3_c507ab27-c363-45ca-88a0-6e6d2114fcbd">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6MmQ1ODRhYTk5OTA2NDVhYTg2NzA4NzdiMzEwMDZiZWYvdGFibGVyYW5nZToyZDU4NGFhOTk5MDY0NWFhODY3MDg3N2IzMTAwNmJlZl8xLTItMS0xLTk1MTE3_b65b8c1a-1b12-4fcc-b03a-eede73d180cf">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTkx_3a4a6644-8abd-4f16-bdd6-cb02c793ca10">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTg2_afa9d9fd-8e48-483b-8964-305458efe16a">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6ZDliM2FmMTAwOTI2NDZkODlhMTJlNWM5ZDEwYmNjZDcvdGFibGVyYW5nZTpkOWIzYWYxMDA5MjY0NmQ4OWExMmU1YzlkMTBiY2NkN18wLTAtMS0xLTk1MTE3_d2e29f64-ded0-48c6-818d-6ba9c7a87bb3">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6ZDliM2FmMTAwOTI2NDZkODlhMTJlNWM5ZDEwYmNjZDcvdGFibGVyYW5nZTpkOWIzYWYxMDA5MjY0NmQ4OWExMmU1YzlkMTBiY2NkN18xLTQtMS0xLTk1MTE3_06d447fe-779e-4038-9960-6367a035d5aa">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGFibGU6ZDliM2FmMTAwOTI2NDZkODlhMTJlNWM5ZDEwYmNjZDcvdGFibGVyYW5nZTpkOWIzYWYxMDA5MjY0NmQ4OWExMmU1YzlkMTBiY2NkN18yLTEtMS0xLTk1MTE3_0a5a1b45-5795-4a4c-a0c9-0805f7e56e40">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTg3_a1725cce-655c-4d38-ab3d-b612db844db2">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia5d1d407380348e2a118f44535f6a4f9_I20221104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xL2ZyYWc6MWYyNTYwZWFiMWFkNGEzZGFlZWZhOWFiZjkyZjJlYjcvdGV4dHJlZ2lvbjoxZjI1NjBlYWIxYWQ0YTNkYWVlZmE5YWJmOTJmMmViN18yMTQ5_13b9416c-1a6d-4fb8-8623-344d44ab6581"
      unitRef="shares">16893579</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMy0xLTEtMS05NTExNw_9b16aed1-f2c4-49c2-aeef-3ff7d55353df"
      unitRef="usd">4116000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMy0zLTEtMS05NTExNw_94e0a779-3228-4d46-8591-77547bea65db"
      unitRef="usd">19522000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNC0xLTEtMS05NTExNw_5208fada-b7b6-4ab9-83b8-043b27704db0"
      unitRef="usd">117291000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNC0zLTEtMS05NTExNw_61108777-106b-4533-8166-c2bb26166254"
      unitRef="usd">321586000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNS0xLTEtMS05NTExNw_d6b1e937-dad6-4384-a1cd-0c59f528575e"
      unitRef="usd">65168000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNS0zLTEtMS05NTExNw_cca1bf5f-b58c-486e-b2fa-c50d4aac8cfa"
      unitRef="usd">85453000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNi0xLTEtMS05NTExNw_e1849040-4bac-43eb-a1d0-548bb6dce851"
      unitRef="usd">22326000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNi0zLTEtMS05NTExNw_e3f2118c-bed1-462a-9aeb-e5749e99aacc"
      unitRef="usd">27326000</us-gaap:InventoryNet>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNy0xLTEtMS05NTExNw_c92e764b-9b06-4312-a4f5-afecce104f8e"
      unitRef="usd">785000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNy0zLTEtMS05NTExNw_7e7e7309-7fcf-4636-a341-284d48cf4b35"
      unitRef="usd">6193000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfOC0xLTEtMS05NTExNw_12c08de2-f9e2-47b1-ae1b-094717280d6f"
      unitRef="usd">10746000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfOC0zLTEtMS05NTExNw_4021f059-d7e4-41b4-a8b9-3cec04f95172"
      unitRef="usd">4671000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfOS0xLTEtMS05NTExNw_4019a578-3f92-48c6-8e09-7765285f5d1f"
      unitRef="usd">220432000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfOS0zLTEtMS05NTExNw_d2cbda96-a34c-4ba0-9636-fea0e9fc90fa"
      unitRef="usd">464751000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTAtMS0xLTEtOTUxMTc_f541cafd-3f3c-47c5-b2d5-7d061935c474"
      unitRef="usd">35500000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTAtMy0xLTEtOTUxMTc_6da31112-3035-45bc-9b6f-1396894a2895"
      unitRef="usd">34482000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTEtMS0xLTEtOTUxMTc_c7ad697f-6a52-4adb-9048-f6d73102edb1"
      unitRef="usd">517025000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTEtMy0xLTEtOTUxMTc_b6b86974-66ec-4340-b175-410f9e4f1ee2"
      unitRef="usd">551040000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTItMS0xLTEtOTUxMTc_fb3fb198-21f3-4196-b9ce-7c1ca13c868e"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTItMy0xLTEtOTUxMTc_01369077-86f1-4a9b-b248-576c08d9c02f"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRights
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTMtMS0xLTEtOTUxMTc_757d24e5-4522-475b-a410-85c9f03dadeb"
      unitRef="usd">10193000</lgnd:CommercialLicenseRights>
    <lgnd:CommercialLicenseRights
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTMtMy0xLTEtOTUxMTc_8cca6faf-53ae-4ff0-a8b3-209f6e5580c1"
      unitRef="usd">10110000</lgnd:CommercialLicenseRights>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTQtMS0xLTEtOTUxMTc_289d63dd-b40a-4ebb-a297-41482f99fbeb"
      unitRef="usd">33418000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTQtMy0xLTEtOTUxMTc_aff47bcd-ffb7-4283-833d-472d96c79793"
      unitRef="usd">20511000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTUtMS0xLTEtOTUxMTc_349cb7ff-5f3b-41c6-b3eb-1710e174223b"
      unitRef="usd">32108000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTUtMy0xLTEtOTUxMTc_c92b0c17-547c-4532-8412-682fe0a0a9a2"
      unitRef="usd">16542000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTYtMS0xLTEtOTUxMTc_3f1ed65c-2e4b-46b6-9e07-20e33ca92386"
      unitRef="usd">14444000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTYtMy0xLTEtOTUxMTc_20b14500-3a58-473d-b021-90292a4c1284"
      unitRef="usd">16207000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTctMS0xLTEtOTUxMTc_94639f5e-6f52-48b4-96b1-3a0d73fb8cc9"
      unitRef="usd">6279000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTctMy0xLTEtOTUxMTc_aeeee19f-08c4-438e-8f04-db04d47c713b"
      unitRef="usd">2741000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTgtMS0xLTEtOTUxMTc_554e4d7a-49cb-4dfb-93c1-36a93ded7da6"
      unitRef="usd">1050605000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMTgtMy0xLTEtOTUxMTc_22737b45-3265-43be-9c14-cea44e4baf86"
      unitRef="usd">1297590000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjEtMS0xLTEtOTUxMTc_5a873015-fd0b-48aa-976e-1743843b7d87"
      unitRef="usd">15887000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjEtMy0xLTEtOTUxMTc_39cf2e1e-e504-4e99-a519-ad9f031345fe"
      unitRef="usd">8403000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjItMS0xLTEtOTUxMTc_c36db29e-60b6-486e-b364-c62d041bbf5a"
      unitRef="usd">19338000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjItMy0xLTEtOTUxMTc_e346009e-a37f-485f-804e-a6fc0843e3a1"
      unitRef="usd">17579000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjMtMS0xLTEtOTUxMTc_a41337e7-db64-4df5-a8c4-8193f619b54f"
      unitRef="usd">9703000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjMtMy0xLTEtOTUxMTc_78776f5b-51fa-4955-b97c-f4d2c64e86a8"
      unitRef="usd">0</us-gaap:TaxesPayableCurrent>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjQtMS0xLTEtOTUxMTc_a771c9a7-4034-4aa2-abaf-3f1622260435"
      unitRef="usd">1773000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjQtMy0xLTEtOTUxMTc_39bdd199-3930-4a52-b0ce-df35aba42735"
      unitRef="usd">2588000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjUtMS0xLTEtOTUxMTc_6e5c0a71-ee3f-4bfc-a61f-8b8855e95583"
      unitRef="usd">9547000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjUtMy0xLTEtOTUxMTc_08e9ae2b-ee6a-4900-accb-92fc15363096"
      unitRef="usd">10996000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjYtMS0xLTEtOTUxMTc_738fbcd6-ddd6-4adc-82bf-ce66739bea96"
      unitRef="usd">2345000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjYtMy0xLTEtOTUxMTc_f8574660-e062-4c2e-ab79-dc2e8e91d9a5"
      unitRef="usd">2053000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjctMS0xLTEtOTUxMTc_72957835-9e7d-44fc-bf31-1563e574f045"
      unitRef="usd">48000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjctMy0xLTEtOTUxMTc_8f3c0cbf-ec1a-4d4f-93ef-220ebc1cc33e"
      unitRef="usd">46000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjgtMS0xLTEtOTUxMTc_a8b7af63-85c0-4063-ad2b-f036b9a7738d"
      unitRef="usd">76600000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjgtMy0xLTEtOTUxMTc_6e4bc349-a672-4056-a5a6-096a91913311"
      unitRef="usd">0</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjktMS0xLTEtOTUxMTc_cfb30f90-4098-45bf-a1eb-2a6a5c73c8cc"
      unitRef="usd">135241000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMjktMy0xLTEtOTUxMTc_35d0aa44-ebf6-4e1c-8d4d-ff9643b62ee0"
      unitRef="usd">41665000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzAtMS0xLTEtOTUxMTc_63c6604d-d4af-425e-a307-249e1de9b15a"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzAtMy0xLTEtOTUxMTc_63b319e7-009a-4345-b8c3-9799605b8888"
      unitRef="usd">320717000</us-gaap:ConvertibleDebtNoncurrent>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzEtMS0xLTEtOTUxMTc_ed77601b-5d6c-494e-af48-904d8ac1ff57"
      unitRef="usd">6855000</lgnd:LiabilityForContingentValueRights>
    <lgnd:LiabilityForContingentValueRights
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzEtMy0xLTEtOTUxMTc_a0776847-9108-4ef4-841a-5e10bb86ace6"
      unitRef="usd">8483000</lgnd:LiabilityForContingentValueRights>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzItMS0xLTEtOTUxMTc_895a0013-b8a3-409b-8e1f-341451a812de"
      unitRef="usd">29832000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzItMy0xLTEtOTUxMTc_a88c2ef4-f2a0-46b6-ad90-4e202ececb6c"
      unitRef="usd">59095000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzMtMS0xLTEtOTUxMTc_1b3fe217-d86b-4453-ae39-65ee7e6ac41d"
      unitRef="usd">34893000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzMtMy0xLTEtOTUxMTc_cfca7000-9d33-408c-8810-67df56f1d122"
      unitRef="usd">15494000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzQtMS0xLTEtOTUxMTc_49e7e539-c4ba-4af0-89a1-4f0228ea15a8"
      unitRef="usd">5537000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzQtMy0xLTEtOTUxMTc_8a99bc9c-afae-4e86-ad86-9e387d07eed0"
      unitRef="usd">9270000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzUtMS0xLTEtOTUxMTc_d3f5bbfa-d56a-4fec-8293-301ba50baa79"
      unitRef="usd">21949000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzUtMy0xLTEtOTUxMTc_e200c1cb-aa98-4915-ac86-22ffd98fe01a"
      unitRef="usd">21707000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzYtMS0xLTEtOTUxMTc_9f6712ad-705c-4c63-8354-1777b2331436"
      unitRef="usd">234307000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzYtMy0xLTEtOTUxMTc_c4603ebf-d7f0-4cff-9a1c-b521fe157d49"
      unitRef="usd">476431000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzctMS0xLTEtOTUxMTc_268bd8e0-2a20-407d-87f6-f82874696be8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzctMy0xLTEtOTUxMTc_39a5d67f-013d-4ab4-910c-880f51830dfd"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF8yNA_b8a61b6f-a41d-4ebe-9039-cb1525b6bf28"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF8yNA_e66c0e8a-c41f-481a-8689-09683e5a6833"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF8zOA_96522c8d-c320-4674-8149-31623606ecc5"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF8zOA_e3dc2c77-8b42-44d7-ab9f-fda103715371"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF82MA_3037dab9-5cbb-4e60-a581-711a15f86378"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF82MA_3dfd3d05-57c5-4956-9ae3-59f61dd7ac28"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF82MA_54eafc1a-881e-4dec-9038-e7a87034efd0"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjo2MDViNWViOTQzYWU0MDc4YmU4ZTYwMjFiM2E2YTM4OF82MA_87ac3136-8fbc-4694-9d38-50c104cea535"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMS0xLTEtOTUxMTc_bcaaa901-7ca5-4e21-8bef-3023bb587560"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfMzktMy0xLTEtOTUxMTc_a2585635-7092-4b3d-a463-8e459053ce28"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl8yMQ_105a95aa-78d1-4824-821f-aa3d97a996d3"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl8yMQ_5267e081-45ad-453b-91f8-20ce41653906"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl8zNQ_21572250-0192-4910-9565-befb26958809"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl8zNQ_3f64e7ec-7111-46b8-a3e9-dbde02b9ab7f"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl81Nw_4d2f3315-d0dd-43dc-86da-a5e611b3fc13"
      unitRef="shares">16894000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl81Nw_6689141a-8638-4b67-956b-38df4a92a38c"
      unitRef="shares">16894000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl82NA_9818436b-6eed-4a75-8026-4e5c49891c64"
      unitRef="shares">16767000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMC0xLTEtOTUxMTcvdGV4dHJlZ2lvbjplNWY5YWExMGViOTQ0MDhkOWM0MWFhMDZjNzViMmU3Zl82NA_ecf78d31-4432-4ebe-b5f6-81e081d89511"
      unitRef="shares">16767000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMS0xLTEtOTUxMTc_d75ffd0c-393b-41d8-984b-f424632e6ecc"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDAtMy0xLTEtOTUxMTc_fd756018-2433-4db0-80e2-989032dc206e"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDEtMS0xLTEtOTUxMTc_47da1ba2-6724-4a55-969e-d11c73e248e6"
      unitRef="usd">348994000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDEtMy0xLTEtOTUxMTc_c4d20c2c-f633-4353-b66d-559c7f2d6740"
      unitRef="usd">372969000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDItMS0xLTEtOTUxMTc_8925eea2-16c8-4cde-ba63-7d59b4b01c47"
      unitRef="usd">-1060000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDItMy0xLTEtOTUxMTc_da8c8a70-8ab9-4fa4-87b9-cf31d52dfef0"
      unitRef="usd">-917000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDMtMS0xLTEtOTUxMTc_8a9fadd1-a365-4a51-842a-79179af75684"
      unitRef="usd">468347000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDMtMy0xLTEtOTUxMTc_bf1c4aa3-52aa-464e-bced-8ee10af10f59"
      unitRef="usd">449090000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDQtMS0xLTEtOTUxMTc_cc101a83-5f99-4892-9252-c74aab030834"
      unitRef="usd">816298000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDQtMy0xLTEtOTUxMTc_6809c18b-01d1-4523-8090-52685a7ece03"
      unitRef="usd">821159000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDUtMS0xLTEtOTUxMTc_7b291747-1126-4d2b-aebb-1a9c10436168"
      unitRef="usd">1050605000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xNi9mcmFnOmVmZTgwODQwNmI0MTQyNzk4NWU5ZGQwYTYyNTA0MzY1L3RhYmxlOmYxMDExNzM2Y2ZkNDQ4Y2U4MDAzMWYwNGQzMGRmYzMxL3RhYmxlcmFuZ2U6ZjEwMTE3MzZjZmQ0NDhjZTgwMDMxZjA0ZDMwZGZjMzFfNDUtMy0xLTEtOTUxMTc_9c032323-84fe-49d4-90df-7fe12caaa7a0"
      unitRef="usd">1297590000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e4c019116374680b437a7a7e84a8c80_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNC0xLTEtMS05NTExNw_3c8acf59-ec12-4980-8d37-d6df5ae58df6"
      unitRef="usd">19837000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe9d446b7d574e0a8a446713e4e31f27_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNC0zLTEtMS05NTExNw_7f823afe-80b5-4151-8eb6-b95487b4066d"
      unitRef="usd">15648000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6dd34ce0bee40ea82cba5bfc9584a46_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNC01LTEtMS05NTExNw_13be5c9b-1679-4905-ae26-a1114a106b84"
      unitRef="usd">51491000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61be445c11db419296ccc53f473da154_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNC03LTEtMS05NTExNw_9596a620-fe99-4940-bda1-e9e84d19ca03"
      unitRef="usd">31376000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27111ff24358446e8f6742f1a9a22280_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNS0xLTEtMS05NTExNw_0f8d3473-2815-48bd-b91b-9cb544470191"
      unitRef="usd">35949000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i805b7ce49b9b477ab1a86dfcd8f4b896_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNS0zLTEtMS05NTExNw_d61a7bdf-b9fa-4671-8343-c21a2034095d"
      unitRef="usd">35093000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbc5e665d17d410bbc8f43e5ef950091_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNS01LTEtMS05NTExNw_e171fce8-35b6-4ee6-a1c4-34cb63d8ba51"
      unitRef="usd">77616000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68593efff0be4bcea82e054922dea281_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNS03LTEtMS05NTExNw_bf3daed2-8c9b-4e50-9ea8-f9df2bc57892"
      unitRef="usd">128875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c883799387843e28ad63ef5c7a3a928_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNi0xLTEtMS05NTExNw_ace469a4-ce8e-4d80-9067-5e5b06e9b1c4"
      unitRef="usd">10302000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idca791879e154b79899726f73ac30955_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNi0zLTEtMS05NTExNw_a59703e8-e095-4b93-b4ba-81f3c1a7b563"
      unitRef="usd">14094000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb48e049cd074424a4b9c75318b0968f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNi01LTEtMS05NTExNw_d6406155-be63-4eba-bdfa-46b9a16bd5b2"
      unitRef="usd">40093000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d5bd9d373e34f7ab0ab2dc3b00f0266_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNi03LTEtMS05NTExNw_0ee85042-342c-4d99-8b04-e4436dd40174"
      unitRef="usd">44409000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNy0xLTEtMS05NTExNw_0701be9b-cd1d-479e-a1f1-dcd302639a2f"
      unitRef="usd">66088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNy0zLTEtMS05NTExNw_859a5e9c-8ff3-41e6-8525-f35ddc943daf"
      unitRef="usd">64835000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNy01LTEtMS05NTExNw_ce219e80-c139-40b5-8d2c-a86aade50705"
      unitRef="usd">169200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfNy03LTEtMS05NTExNw_8b548231-6229-4831-b699-f2b619bd8573"
      unitRef="usd">204660000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostDirectMaterial
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfOS0xLTEtMS05NTExNw_be57a5c2-9598-443e-926f-43f8eaa183d3"
      unitRef="usd">14153000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfOS0zLTEtMS05NTExNw_93abfdd8-5e79-4ccf-bef8-e3d63711136e"
      unitRef="usd">11446000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfOS01LTEtMS05NTExNw_8d202bf3-1d90-4a3d-bbfb-45bad40a5d23"
      unitRef="usd">31213000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfOS03LTEtMS05NTExNw_f2beb418-ee31-439c-b003-1ef1dcf9cdf0"
      unitRef="usd">50192000</us-gaap:CostDirectMaterial>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTAtMS0xLTEtOTUxMTc_77798849-a5a3-4979-8751-1fafd60d16f1"
      unitRef="usd">11818000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTAtMy0xLTEtOTUxMTc_988b77d0-acde-4712-b466-ba72dc86114a"
      unitRef="usd">11827000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTAtNS0xLTEtOTUxMTc_8c84b33c-2f51-4496-a29a-b3163796b8bc"
      unitRef="usd">35455000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTAtNy0xLTEtOTUxMTc_d9032b46-9294-4c49-8b1e-a022739d83ed"
      unitRef="usd">35391000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTEtMS0xLTEtOTUxMTc_453312bd-ebcb-472f-891a-856f27799544"
      unitRef="usd">22036000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTEtMy0xLTEtOTUxMTc_0177c231-6f31-4693-81f3-8b3c9ded17a3"
      unitRef="usd">16938000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTEtNS0xLTEtOTUxMTc_33430e9b-3352-4034-971c-8a67c03ffcc6"
      unitRef="usd">61461000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTEtNy0xLTEtOTUxMTc_c32cb811-e611-4710-985b-615d92f52006"
      unitRef="usd">50769000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTItMS0xLTEtOTUxMTc_1a99327c-6447-40ce-8ada-f48358cbd4c8"
      unitRef="usd">17445000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTItMy0xLTEtOTUxMTc_f4caab3c-8fc4-46e8-861e-df40f679d204"
      unitRef="usd">12718000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTItNS0xLTEtOTUxMTc_14ce7d09-2e70-4c5b-b357-6dff56364ec9"
      unitRef="usd">50210000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTItNy0xLTEtOTUxMTc_f87f4058-3041-4cd5-a1d4-8d690e5c9e37"
      unitRef="usd">39747000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTMtMS0xLTEtOTUxMTc_8561307f-1cd0-40e2-ace0-1b837c032e47"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTMtMy0xLTEtOTUxMTc_cde4217a-e27e-45bf-9853-0a141c3057b4"
      unitRef="usd">3800000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTMtNS0xLTEtOTUxMTc_51add167-2db2-498a-af0f-4deb393aed81"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTMtNy0xLTEtOTUxMTc_ce6c12a6-0979-4ae9-867e-7d5a2e79d4e8"
      unitRef="usd">37600000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTQtMS0xLTEtOTUxMTc_df4e7505-4fc5-4441-bf03-8d4170443549"
      unitRef="usd">65452000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTQtMy0xLTEtOTUxMTc_5a600a5d-2119-4237-802a-8d1e91b98a59"
      unitRef="usd">49129000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTQtNS0xLTEtOTUxMTc_26f2e11e-8e2b-437c-81e0-ad1331bfb3a6"
      unitRef="usd">178339000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTQtNy0xLTEtOTUxMTc_1464e509-fe8c-4223-a579-e6cc9b313804"
      unitRef="usd">138499000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTUtMS0xLTEtOTUxMTc_7c765aab-fa2f-4497-aa45-c2ec37d7b3d5"
      unitRef="usd">636000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTUtMy0xLTEtOTUxMTc_a752ad55-b555-4c52-b399-3edb28895763"
      unitRef="usd">15706000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTUtNS0xLTEtOTUxMTc_4b1b71c6-f4d7-4124-9d8a-33addcef4dff"
      unitRef="usd">-9139000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTUtNy0xLTEtOTUxMTc_7580fcd7-6d76-44fc-b922-5d524ece3bf0"
      unitRef="usd">66161000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnInvestments
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTctMS0xLTEtOTUxMTc_70c2d157-a080-47e5-bb3e-6435708ff26e"
      unitRef="usd">-923000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTctMy0xLTEtOTUxMTc_8c4bd9b3-45d7-4eb8-8bca-32397517555a"
      unitRef="usd">1937000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTctNS0xLTEtOTUxMTc_01bc900b-be62-40c7-a913-911bfbf2914e"
      unitRef="usd">-15709000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTctNy0xLTEtOTUxMTc_3f652411-caaa-48de-9d0c-9f6c6ff8dc79"
      unitRef="usd">8135000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTgtMS0xLTEtOTUxMTc_bb093c79-4cd8-44a3-8177-d360949f9b60"
      unitRef="usd">591000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTgtMy0xLTEtOTUxMTc_07e8e286-d893-43bc-995a-9175e8350468"
      unitRef="usd">169000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTgtNS0xLTEtOTUxMTc_cf673b1a-19f1-4a4f-b1cd-db67cc27c4e3"
      unitRef="usd">1023000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTgtNy0xLTEtOTUxMTc_7d447525-43a5-47b2-9fdb-e8aefd5120b0"
      unitRef="usd">698000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTktMS0xLTEtOTUxMTc_06e10b76-1194-49cc-88dc-f4a7a3b3b3fc"
      unitRef="usd">332000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTktMy0xLTEtOTUxMTc_67b2f207-dbf7-45b1-90b3-abfde75d5f5a"
      unitRef="usd">4439000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTktNS0xLTEtOTUxMTc_0d1be658-df4c-487c-b603-f7b5a0094f0f"
      unitRef="usd">1559000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMTktNy0xLTEtOTUxMTc_eeef6370-2129-4140-b1c6-df24bae00f24"
      unitRef="usd">15154000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjAtMS0xLTEtOTUxMTc_8b1f7a3b-def0-47f0-8c9d-4c8fb2f091a9"
      unitRef="usd">885000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjAtMy0xLTEtOTUxMTc_92a97c0d-4b85-46ca-8ee4-02ec3ee9bf8d"
      unitRef="usd">1886000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjAtNS0xLTEtOTUxMTc_abe8219c-c8d4-4df3-a082-dc1dc543c139"
      unitRef="usd">5465000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjAtNy0xLTEtOTUxMTc_160b4717-6b46-4a94-86e9-789beff6cb1b"
      unitRef="usd">-5516000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjEtMS0xLTEtOTUxMTc_6e921248-df09-4aab-a02a-24c1d9735d56"
      unitRef="usd">221000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjEtMy0xLTEtOTUxMTc_e05359c4-9003-4c87-ab74-ba265e9789a8"
      unitRef="usd">-447000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjEtNS0xLTEtOTUxMTc_7d8ff2d9-8ad1-4932-8d73-ed92ac6e1346"
      unitRef="usd">-10780000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjEtNy0xLTEtOTUxMTc_8715fc2f-9431-49c6-8540-4b319615942e"
      unitRef="usd">-11837000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjItMS0xLTEtOTUxMTc_9fa21f92-f1ed-40fd-bee4-01b657b88100"
      unitRef="usd">857000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjItMy0xLTEtOTUxMTc_505e3fa0-99fc-4fcf-be46-e827a2b909c2"
      unitRef="usd">15259000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjItNS0xLTEtOTUxMTc_a1627406-325a-4ee0-96e8-5f4e702f11b0"
      unitRef="usd">-19919000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjItNy0xLTEtOTUxMTc_f7aa0a01-7f8e-482b-99f3-9647b4261ead"
      unitRef="usd">54324000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjMtMS0xLTEtOTUxMTc_1447dd27-d7c3-439e-83e4-37faa73a916c"
      unitRef="usd">453000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjMtMy0xLTEtOTUxMTc_660ed5bd-af2b-45ef-86de-57e3649d103f"
      unitRef="usd">1536000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjMtNS0xLTEtOTUxMTc_ce8da757-aa20-4acc-87b4-c09a5a82b251"
      unitRef="usd">-4043000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjMtNy0xLTEtOTUxMTc_0874b4d5-6dae-4935-892a-d8a751bac7a3"
      unitRef="usd">-8230000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjQtMS0xLTEtOTUxMTc_76a5863e-029a-4b43-8a3f-fa07f60cdd51"
      unitRef="usd">404000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjQtMy0xLTEtOTUxMTc_509900ae-bf98-4ce2-80a0-91a5798e91a5"
      unitRef="usd">13723000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjQtNS0xLTEtOTUxMTc_ea5934ed-7a64-410d-afd4-acb9a1c00982"
      unitRef="usd">-15876000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjQtNy0xLTEtOTUxMTc_7a16483c-f896-43b1-a562-ddb1acac33d1"
      unitRef="usd">62554000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjYtMS0xLTEtOTUxMTc_dc0a1be3-3114-48e0-9c68-18094de405be"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjYtMy0xLTEtOTUxMTc_c2cae370-3f07-4c2e-8a9c-b67f7c60c019"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjYtNS0xLTEtOTUxMTc_af2d46b0-2244-4353-84f6-7fcca6c24183"
      unitRef="usdPerShare">-0.94</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjYtNy0xLTEtOTUxMTc_ac642d56-4ae2-48b3-b77c-b56ac1e00acd"
      unitRef="usdPerShare">3.77</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjctMS0xLTEtOTUxMTc_f47e43f3-6dc7-4bfe-80cd-a45616d1a51e"
      unitRef="shares">16888000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjctMy0xLTEtOTUxMTc_de389e71-be17-4b4c-8adb-fd5893955d38"
      unitRef="shares">16688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjctNS0xLTEtOTUxMTc_c1ab1b83-41fa-46d9-936b-0c6057b76518"
      unitRef="shares">16860000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjctNy0xLTEtOTUxMTc_f617aa76-fadf-43b7-8128-fc7a01f5b1b8"
      unitRef="shares">16595000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjktMS0xLTEtOTUxMTc_7c86f4b5-9ab6-4cdb-8e48-37fd465b45f9"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjktMy0xLTEtOTUxMTc_e102eb9a-0929-4341-885f-e5abadfb7a8b"
      unitRef="usdPerShare">0.80</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjktNS0xLTEtOTUxMTc_f67af115-b94c-4914-86c8-c9cc8c4c9b97"
      unitRef="usdPerShare">-0.94</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMjktNy0xLTEtOTUxMTc_bf5137f0-dea4-4f62-a49f-c3ae1cfaa884"
      unitRef="usdPerShare">3.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMzAtMS0xLTEtOTUxMTc_4c2710fb-dcef-44c0-b60c-c7fd6bdebac1"
      unitRef="shares">17132000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMzAtMy0xLTEtOTUxMTc_9fd16885-be19-47da-8cec-1ff20d08faed"
      unitRef="shares">17142000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMzAtNS0xLTEtOTUxMTc_929ffb8f-2dbe-44f5-bfbf-008b15c1fae8"
      unitRef="shares">16860000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8xOS9mcmFnOjRhMDU3NTQ4YjU0MzQyODlhZGRjMmZiNWVkYmI2NmE2L3RhYmxlOjMzMjM2ZmY5ZmMwZTQ2OTE4YzIyMjNlZDRjZDQ1N2U4L3RhYmxlcmFuZ2U6MzMyMzZmZjlmYzBlNDY5MThjMjIyM2VkNGNkNDU3ZThfMzAtNy0xLTEtOTUxMTc_86720d99-3b70-48a9-97cc-54a1b20231a6"
      unitRef="shares">17187000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfMy0xLTEtMS05NTExNw_7a0ff391-025a-4444-9491-b8aa3d08a315"
      unitRef="usd">404000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfMy0zLTEtMS05NTExNw_44197315-9ead-4bfc-979f-2880ce9d4ca9"
      unitRef="usd">13723000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfMy01LTEtMS05NTExNw_ecbb408b-60dd-4361-a9c7-6450a9d4f5b8"
      unitRef="usd">-15876000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfMy03LTEtMS05NTExNw_693c9e2b-faab-4f48-a2a2-61cb593dbf0d"
      unitRef="usd">62554000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNC0xLTEtMS05NTExNw_2398dea8-5a14-4cbb-8318-46bc292afe2a"
      unitRef="usd">6000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNC0zLTEtMS05NTExNw_c84174e5-aff6-4f63-b91e-4109b1e203aa"
      unitRef="usd">-14000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNC01LTEtMS05NTExNw_0d1c1f6a-5eb3-4554-a282-077739e24c65"
      unitRef="usd">-143000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNC03LTEtMS05NTExNw_1bb3ef8d-bf70-4dfd-aa8c-293de44df7b2"
      unitRef="usd">-74000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNS0xLTEtMS05NTExNw_dc6242a6-63a3-44c1-ab02-b93ffcbade2d"
      unitRef="usd">410000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNS0zLTEtMS05NTExNw_a2a88a62-824f-4b57-89c7-27fe9a30d0c6"
      unitRef="usd">13709000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNS01LTEtMS05NTExNw_bb6a4f90-d21c-4e72-92a1-87199cf4e0d7"
      unitRef="usd">-16019000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yMi9mcmFnOjE1MzA3OTY4MGM3NzQxNDFiMGY5MDM0ZGVhZWI5MGY0L3RhYmxlOjIyNmMxOTMxMDlkYTQxNTBiMDA2YTg4MDU1MzgzYmE2L3RhYmxlcmFuZ2U6MjI2YzE5MzEwOWRhNDE1MGIwMDZhODgwNTUzODNiYTZfNS03LTEtMS05NTExNw_dfe54f1a-0675-4d4d-835c-f14ff5f1a71e"
      unitRef="usd">62480000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i198ab94a85514554b7b186297e1b40e0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi0xLTEtMS05NTExNw_6ce6cddb-43a3-47d4-8d71-60a2aa82edf3"
      unitRef="shares">16767000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i198ab94a85514554b7b186297e1b40e0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi0yLTEtMS05NTExNw_22a02c62-2617-41c4-8344-2e6465b85c85"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie753396ec7e54b7284e025b438c69c9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi0zLTEtMS05NTExNw_c71ac05e-fa78-4844-afa2-fee6e8057299"
      unitRef="usd">372969000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i90959b048f9d4c9c901d541f37dd4d04_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi00LTEtMS05NTExNw_9a3d229d-65c6-4358-84a2-8d10d4b21b45"
      unitRef="usd">-917000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i009cac1d5b03430ea00be4a216999d58_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi01LTEtMS05NTExNw_f123724e-d107-4741-a709-240193d9b113"
      unitRef="usd">449090000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMi02LTEtMS05NTExNw_50fe5ebb-56aa-4d6e-bdd2-413ac16e4873"
      unitRef="usd">821159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i16919bc133394068b70b5dfa72c1fd0e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMy0zLTEtMS05NTExNw_0ee37107-014c-4620-bba3-2f34515aa281"
      unitRef="usd">-51130000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3d2ed7a3614b47c58739fe3a78c8cf50_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMy01LTEtMS05NTExNw_e6152ce6-d668-46e9-b0a8-b3eae0a0953c"
      unitRef="usd">35133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i239ddea2c7ce41f184f6267304338e4d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMy02LTEtMS05NTExNw_a5fb763c-5d17-495e-a1e4-dcab225d0f16"
      unitRef="usd">-15997000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i7464adf27f3344eaa673a32517540e7c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNC0xLTEtMS05NTExNw_abaf2a8f-fbab-47bf-b2af-26a703e3fb24"
      unitRef="shares">94000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i27cf2b1876194c95b8039376914f66a9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNC0zLTEtMS05NTExNw_4552de30-75c3-4666-8511-a0e3a68fc97e"
      unitRef="usd">-5515000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8d3fdee71cb945188b3a6480ad8b04b3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNC02LTEtMS05NTExNw_c8badddb-7815-4629-81fb-072908733b2d"
      unitRef="usd">-5515000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i27cf2b1876194c95b8039376914f66a9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNS0zLTEtMS05NTExNw_e2353782-f108-404e-b184-98307c8153b0"
      unitRef="usd">9044000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8d3fdee71cb945188b3a6480ad8b04b3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNS02LTEtMS05NTExNw_ba691c1e-405c-4745-9daf-52b533cb47e0"
      unitRef="usd">9044000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i90c76c0d56474350ace13a08c8b6be7d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNi00LTEtMS05NTExNw_4630a34f-6bab-4a9a-87f8-a946dd12c4ac"
      unitRef="usd">-114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i8d3fdee71cb945188b3a6480ad8b04b3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfNi02LTEtMS05NTExNw_cfc220f6-8f82-4657-860a-9ded04013998"
      unitRef="usd">-114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i622a51922d024361bd6340d3356b0611_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOC01LTEtMS05NTExNw_ab599318-b856-4b5d-84e6-7905665ad987"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8d3fdee71cb945188b3a6480ad8b04b3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOC02LTEtMS05NTExNw_6e587c94-c06b-4660-a351-06b31ed4a59b"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ifc60f1d7e4e64d4da82bc5998ca4409e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS0xLTEtMS05NTExNw_35defca6-4f9b-4e44-bbe1-7ff81393cda5"
      unitRef="shares">16861000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifc60f1d7e4e64d4da82bc5998ca4409e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS0yLTEtMS05NTExNw_6ef5449b-7a81-495f-b25e-48c09883a9e4"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic3d7b66aebc7403188ff43b263cbde5a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS0zLTEtMS05NTExNw_95edabfe-7f5f-4f4d-afc1-395cebf8d0d5"
      unitRef="usd">325368000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55d2a92d4b1a4569aa0e26eff50b27e1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS00LTEtMS05NTExNw_840e2eb0-ebf5-4eca-83c1-df0f23bd8fcc"
      unitRef="usd">-1031000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9bd3552261654e0aa2a6e538a4ffd6e0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS01LTEtMS05NTExNw_f926905a-6db3-4984-b264-fb62e9bdb0b1"
      unitRef="usd">468838000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe1aea5f82664c3d8279c4521c119e7f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfOS02LTEtMS05NTExNw_f895b835-d38c-4b0a-a3fa-4a1007bffe11"
      unitRef="usd">793192000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i185279a9c1154a6e970cdd3102fb2523_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTAtMS0xLTEtOTUxMTc_dfbec667-daf6-4a19-94a7-61e17172db17"
      unitRef="shares">21000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i81a5d969d3cd49018e396c6da4322e1d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTAtMy0xLTEtOTUxMTc_de31b6b7-9f1d-4c51-ae61-5eba60ac5041"
      unitRef="usd">604000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i19361f68c02f4b6fa38af8257cd7aa3b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTAtNi0xLTEtOTUxMTc_4cc04987-6982-4bb3-b9a9-113ff44eb6f2"
      unitRef="usd">604000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i81a5d969d3cd49018e396c6da4322e1d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTEtMy0xLTEtOTUxMTc_cc7e7138-2abe-410d-bb80-83fbdbaa9de2"
      unitRef="usd">9499000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i19361f68c02f4b6fa38af8257cd7aa3b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTEtNi0xLTEtOTUxMTc_a1fff2bb-0f3a-4c71-9e77-ffca90860687"
      unitRef="usd">9499000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib18e9df5868e4c7d9ffa15a018c90a12_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTItNC0xLTEtOTUxMTc_1c6d6f00-94df-436e-99b6-f771d2b22ea7"
      unitRef="usd">-35000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i19361f68c02f4b6fa38af8257cd7aa3b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTItNi0xLTEtOTUxMTc_2383ddab-ee71-4d94-ad4b-1abe6905935f"
      unitRef="usd">-35000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i3c3698d638594c138f050c501a4bb5bb_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTQtNS0xLTEtOTUxMTc_ca988738-7ec7-46c7-875a-2dfa0de4d3ad"
      unitRef="usd">-895000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i19361f68c02f4b6fa38af8257cd7aa3b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTQtNi0xLTEtOTUxMTc_aee8c8d3-72fa-4fb5-bbb8-22b795ca1f78"
      unitRef="usd">-895000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i589ed826afd94e66ac256c87c067d171_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtMS0xLTEtOTUxMTc_4ad5c3d6-5106-4950-961d-deb229a8db89"
      unitRef="shares">16882000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i589ed826afd94e66ac256c87c067d171_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtMi0xLTEtOTUxMTc_8461d97b-40fe-4110-a800-fb5d64ce8fe3"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i09ea69ed13a2487cb2c216e37f4468a5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtMy0xLTEtOTUxMTc_889f4acd-2b57-41ec-b20c-bb8b9610600f"
      unitRef="usd">335471000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icc472676953e452a9218d48cdabcd4c9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtNC0xLTEtOTUxMTc_33d69ffe-0fba-4ffb-a684-37e640192800"
      unitRef="usd">-1066000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibcc63139d2274ceab9cf48bff4553b66_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtNS0xLTEtOTUxMTc_1fbdb5f2-8c7a-4093-8143-3edc23d0c2a2"
      unitRef="usd">467943000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5baea90deb8e4265a72ea7026d08379c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTUtNi0xLTEtOTUxMTc_96587441-5b16-40a1-b91a-adf6de883073"
      unitRef="usd">802365000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i1b75eb328f4e4243b3e4fdb1e688d35c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTYtMS0xLTEtOTUxMTc_dcbbb5e0-0f3a-40f4-90fd-e18a3294702a"
      unitRef="shares">12000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i757ee12a916e4b45a2fd76ec35d70c95_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTYtMy0xLTEtOTUxMTc_5ad74697-7007-4f0d-9567-45f3d6093bda"
      unitRef="usd">724000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTYtNi0xLTEtOTUxMTc_fcdd0eaa-2463-4609-ac53-c1f0abc34cc5"
      unitRef="usd">724000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i757ee12a916e4b45a2fd76ec35d70c95_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTctMy0xLTEtOTUxMTc_8f3e57d4-7fe2-450a-9bbd-5cbac01eaf23"
      unitRef="usd">12597000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTctNi0xLTEtOTUxMTc_89b4612e-97db-4057-802a-6a544810b554"
      unitRef="usd">12597000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if291edfa693f417bbbb3aaa623e73077_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTgtNC0xLTEtOTUxMTc_4f2c84c9-378c-4269-bf5e-b9dee9b9f4b5"
      unitRef="usd">6000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMTgtNi0xLTEtOTUxMTc_5542331e-8c6e-4819-8461-d34d80cfb3bb"
      unitRef="usd">6000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i757ee12a916e4b45a2fd76ec35d70c95_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjAtMy0xLTEtOTUxMTc_eaab7739-0938-4067-804d-d6bc975f2b72"
      unitRef="usd">202000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjAtNi0xLTEtOTUxMTc_ba48c49d-43d8-42e5-a893-458a2e65f498"
      unitRef="usd">202000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <us-gaap:NetIncomeLoss
      contextRef="i7a6c4eeaf5ad4e0e94b7a1e461895686_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjItNS0xLTEtOTUxMTc_4cc3591c-b2f2-4512-898b-40e91dd708a9"
      unitRef="usd">404000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjItNi0xLTEtOTUxMTc_8600fa67-9c7e-43b5-ac76-5c993f41e77a"
      unitRef="usd">404000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iaf5089a880dd4f0c91f39d957943a6d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtMS0xLTEtOTUxMTc_35df7eaf-fe6d-4ddf-8cd9-ea17bd37bf8a"
      unitRef="shares">16894000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iaf5089a880dd4f0c91f39d957943a6d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtMi0xLTEtOTUxMTc_7e9415c7-b74d-4916-8e92-619917875b30"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i302273f452f341388964a61d9618c5ea_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtMy0xLTEtOTUxMTc_087bc19c-ba40-4eaa-b1a3-f9428a66c604"
      unitRef="usd">348994000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifa9e8c41a8d6418a8b594ee335f4c15e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtNC0xLTEtOTUxMTc_7b2bce05-d633-4707-9a54-6dd4de2d8ff5"
      unitRef="usd">-1060000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4a1087670b3d4e64b4a3354392f53abe_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtNS0xLTEtOTUxMTc_c996b0e1-1c6d-4ca0-bcf9-016da9fbcd30"
      unitRef="usd">468347000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjAzODk4MGNkMDY5YTQ1ZWNiYTg5MWM5YTE4NDZlMjdmL3RhYmxlcmFuZ2U6MDM4OTgwY2QwNjlhNDVlY2JhODkxYzlhMTg0NmUyN2ZfMjMtNi0xLTEtOTUxMTc_e2bf66c0-8531-4884-9891-01e4110bc1f9"
      unitRef="usd">816298000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i49019251c3644c1b9be5cc7120c8645b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi0xLTEtMS05NTExNw_72c0fc2a-8caa-4b8a-814d-1be5d81a7456"
      unitRef="shares">16080000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i49019251c3644c1b9be5cc7120c8645b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi0yLTEtMS05NTExNw_0f6b0006-efe3-468d-a5a7-54d78398f865"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2a0567a5633346ecad7f4de1f16113d6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi0zLTEtMS05NTExNw_3c283ae7-b3b2-455f-b8ff-13450a06c0f9"
      unitRef="usd">318358000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib5f7904b282b4637855d57757935605b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi00LTEtMS05NTExNw_e18ee83f-581d-4952-a525-a8ce04bdf5d9"
      unitRef="usd">-801000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0608bba36d7e4f2cb5bd38b7d5fa45af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi01LTEtMS05NTExNw_20bf4fcb-6544-45b5-92e5-adbe0d26d38c"
      unitRef="usd">391952000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5823b83aff4246d783748aff6ba9b978_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMi02LTEtMS05NTExNw_2759bf00-a4e7-4eb5-815b-a83d7569e89a"
      unitRef="usd">709525000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib4787c5b04654433aa93a05790c5bb00_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMy0xLTEtMS05NTExNw_b36cdb8a-72dd-48d1-9213-1a25b001c6fc"
      unitRef="shares">572000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib4787c5b04654433aa93a05790c5bb00_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMy0yLTEtMS05NTExNw_f36cce80-402e-48f2-bef7-2dcb5b13564f"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4de83da8ed6348dca0fb66d4c2b5ba46_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMy0zLTEtMS05NTExNw_cc15aedb-da77-4f61-945a-d77a1ab83ecb"
      unitRef="usd">20580000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMy02LTEtMS05NTExNw_703a16bf-a03e-4bf9-9353-1eba04da5b83"
      unitRef="usd">20581000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4de83da8ed6348dca0fb66d4c2b5ba46_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNC0zLTEtMS05NTExNw_13f04558-efc2-4bee-88bb-44fdf3c485f8"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNC02LTEtMS05NTExNw_29cfb5fc-d0c8-4e4a-aa87-b1ef1385459d"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i621f76587b9b4167af8ab0cce3f06136_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNS00LTEtMS05NTExNw_defb2056-2dd9-4d2b-bc2a-5b050dcfdf7b"
      unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNS02LTEtMS05NTExNw_15b8f467-b647-403d-aec1-4aa7e655c67e"
      unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i4de83da8ed6348dca0fb66d4c2b5ba46_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNi0zLTEtMS05NTExNw_3c1d1d99-b2f3-40b1-ae2d-a646a614337a"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNi02LTEtMS05NTExNw_3e6ee194-a886-42bc-9e10-a83203c6ec43"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax
      contextRef="i4de83da8ed6348dca0fb66d4c2b5ba46_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNy0zLTEtMS05NTExNw_1baba140-aa6f-4dfa-8a64-70a9f0ce29c8"
      unitRef="usd">-11118000</lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax
      contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfNy02LTEtMS05NTExNw_09abf193-6259-4617-8b25-290b62b7ed28"
      unitRef="usd">-11118000</lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i45854ed7c1894c938845c943e8170bfa_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfOS01LTEtMS05NTExNw_539ca091-0f68-4d3c-8545-9a787aa19a66"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9b5f1adf90e6400bbf153c2212770860_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfOS02LTEtMS05NTExNw_f7781759-08dd-4bb4-b9a0-38c697d3e4db"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ide4e95b565954f94bdabad5e12ec376c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtMS0xLTEtOTUxMTc_6e423f02-dde9-4159-afcf-dbce38a88e47"
      unitRef="shares">16652000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ide4e95b565954f94bdabad5e12ec376c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtMi0xLTEtOTUxMTc_1beb6e43-b6ec-47db-b396-315152f6dc7b"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2163920057fd4ca4898a01c500e82a08_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtMy0xLTEtOTUxMTc_297ec210-6578-49bc-b93d-51bcf253bfe9"
      unitRef="usd">336621000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i72687d1596d4483c86609fb362747b63_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtNC0xLTEtOTUxMTc_93a2a713-744f-47f9-8eb4-50b48f0e241f"
      unitRef="usd">-856000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idaa6a14b6ffd4636950c8681f0e560a1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtNS0xLTEtOTUxMTc_1e0c4f22-84f7-4218-b9f3-8a81cb637c42"
      unitRef="usd">410058000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7e93447e0b6144f2a48981aa605997ad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTAtNi0xLTEtOTUxMTc_72a57320-9af7-4ccf-9728-b37e0c97dada"
      unitRef="usd">745840000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ie1dce0e52afa44c69b20605abe6e40de_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTEtMS0xLTEtOTUxMTc_a575c002-89c3-4f62-a158-f16de5ec2477"
      unitRef="shares">24000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0ed614688b574fd0983b2980c43392fe_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTEtMy0xLTEtOTUxMTc_63ca3657-993b-4171-ae63-bb621fee2ff8"
      unitRef="usd">1103000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTEtNi0xLTEtOTUxMTc_b695bd21-3ee7-4dd9-9733-68a99d2e5932"
      unitRef="usd">1103000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0ed614688b574fd0983b2980c43392fe_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTItMy0xLTEtOTUxMTc_4a153a0d-0570-4463-8a96-4b85c979c994"
      unitRef="usd">10216000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTItNi0xLTEtOTUxMTc_ad67bd18-8e86-47bc-96a9-d64fb0d2e8d3"
      unitRef="usd">10216000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i15b4a7ad28414e03b02122a320252e75_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTMtNC0xLTEtOTUxMTc_5e8bb456-d388-4ab1-b317-b3f2d965db7b"
      unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTMtNi0xLTEtOTUxMTc_8b61dfb9-327b-4a26-8c3a-e2d5c87978e4"
      unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax
      contextRef="i0ed614688b574fd0983b2980c43392fe_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTUtMy0xLTEtOTUxMTc_5674be9e-2dfd-480d-ba24-f725f28e4fc6"
      unitRef="usd">-1362000</lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax
      contextRef="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTUtNi0xLTEtOTUxMTc_bb25f4a0-b5b9-4e64-a8b9-fbe456baf181"
      unitRef="usd">-1362000</lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i15167ff194f5408e9eff810879dae577_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTYtNS0xLTEtOTUxMTc_1000701d-0f98-4ced-98f5-12d47c31644c"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2a3d8617d0fd4137b768f8c6388b2684_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTYtNi0xLTEtOTUxMTc_68dbe594-3d6d-4858-9f18-7b17b599de54"
      unitRef="usd">30725000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i88faad5b2d5040e48a57bdd7eae38a44_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctMS0xLTEtOTUxMTc_86ed6a02-556c-49b7-befe-24412bcb95d3"
      unitRef="shares">16676000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i88faad5b2d5040e48a57bdd7eae38a44_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctMi0xLTEtOTUxMTc_8bf33544-f944-4e06-a0f1-52f5b5e6bd1d"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe07e2903f194de88402b53dfd03c119_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctMy0xLTEtOTUxMTc_9d9b3e8e-5b12-41e8-b7c4-47b9c5713ec4"
      unitRef="usd">346578000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifb0fba93854d45b3a71f274d86a0b25c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctNC0xLTEtOTUxMTc_08cff5e6-47bb-4f9d-a40e-1eb60721127b"
      unitRef="usd">-861000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib19b40a6687a4043b9c5f217b53cee1f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctNS0xLTEtOTUxMTc_10e6a4da-6fb3-4fa9-a88c-586b72d904f4"
      unitRef="usd">440783000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i06b5f93e548a4212a89cf839a5f62b6d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTctNi0xLTEtOTUxMTc_46c6746a-42b4-4cb3-b916-731bd54d4e54"
      unitRef="usd">786517000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i6d0cddc5d84e4d48b281640914f3c31a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTgtMS0xLTEtOTUxMTc_28740e24-de43-408f-8980-e4712c064b0b"
      unitRef="shares">31000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0f39828b4f0d4d30b1bbb778bcb4cb81_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTgtMy0xLTEtOTUxMTc_73d8e2ca-2d77-4207-bd91-81ff8c63655b"
      unitRef="usd">1898000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTgtNi0xLTEtOTUxMTc_b48216ea-831b-46d9-a55f-eeaba598873a"
      unitRef="usd">1898000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0f39828b4f0d4d30b1bbb778bcb4cb81_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTktMy0xLTEtOTUxMTc_7b701933-8191-4a01-bab3-e78cda166325"
      unitRef="usd">9754000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMTktNi0xLTEtOTUxMTc_e9b55802-4b53-45a3-9c65-79cc82080c66"
      unitRef="usd">9754000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i6902f9b70949440389390267fac2a002_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjAtNC0xLTEtOTUxMTc_e23b121f-6c31-41b2-b012-3169f7c103ed"
      unitRef="usd">-14000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjAtNi0xLTEtOTUxMTc_8a21c280-66c6-4827-834a-806e639a0f6d"
      unitRef="usd">-14000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax
      contextRef="i0f39828b4f0d4d30b1bbb778bcb4cb81_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjEtMy0xLTEtOTUxMTc_5265a182-d0a0-4d40-8e0f-fa66773e2d40"
      unitRef="usd">92000</lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjEtNi0xLTEtOTUxMTc_f139a03f-6737-4095-b94f-652f1eba8091"
      unitRef="usd">92000</lgnd:AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i0f39828b4f0d4d30b1bbb778bcb4cb81_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjItMy0xLTEtOTUxMTc_9798b50c-37bc-4d48-be9a-093a74b3465f"
      unitRef="usd">96000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjItNi0xLTEtOTUxMTc_c702538d-0114-49f9-80b4-d5b78770776f"
      unitRef="usd">96000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <us-gaap:NetIncomeLoss
      contextRef="id04346533cc6453daf6686d7ecd0494a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjMtNS0xLTEtOTUxMTc_eff2f06e-1e24-40c4-9884-16e5ec3cad8d"
      unitRef="usd">13723000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjMtNi0xLTEtOTUxMTc_fb52faf7-5539-4e63-b4d9-93ddd4853bb5"
      unitRef="usd">13723000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib9bd6db87aa44bcdb4346428bc52f796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtMS0xLTEtOTUxMTc_98564ee6-ac61-412d-ac43-9bf0c7ee658e"
      unitRef="shares">16707000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib9bd6db87aa44bcdb4346428bc52f796_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtMi0xLTEtOTUxMTc_6b1ca4a4-f299-4e84-a952-5a52b57f936b"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3b8e47316474452ea41d7654cf4c47aa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtMy0xLTEtOTUxMTc_4e19bac3-2001-4a5e-8ab7-e19055a6164b"
      unitRef="usd">358418000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iac1e1e884548420e9f7f74cb53177b5c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtNC0xLTEtOTUxMTc_0c5b2875-7656-4f01-9b83-6b383b815995"
      unitRef="usd">-875000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9c99db1599d84940b69a2da1fe5207cc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtNS0xLTEtOTUxMTc_701ab161-3260-4538-99d2-99ff19647978"
      unitRef="usd">454506000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5fd7205f82a3406b9f0c0dae4653b877_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yNS9mcmFnOmYwOWIxMzMzMzgwMzRiZGE4Y2I1YWI5MWNkZWI5ZmVkL3RhYmxlOjA1Njk0ZjE5NjFmZTQ0YWU5OTgwMDExMDQ1ZDk0ZTNhL3RhYmxlcmFuZ2U6MDU2OTRmMTk2MWZlNDRhZTk5ODAwMTEwNDVkOTRlM2FfMjQtNi0xLTEtOTUxMTc_933c7e7e-2644-471d-8e78-3c02bb1c3554"
      unitRef="usd">812066000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNC0xLTEtMS05NTExNw_ba889529-f8a1-4bbd-baa1-91af4425a832"
      unitRef="usd">-15876000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNC0zLTEtMS05NTExNw_0433e4c7-7ae9-421a-826f-935d9b966568"
      unitRef="usd">62554000</us-gaap:ProfitLoss>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNi0xLTEtMS05NTExNw_efac4e39-3679-430f-a854-c077e4d1362a"
      unitRef="usd">1378000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNi0zLTEtMS05NTExNw_8205f72b-3e02-496c-a8ec-cfc8dc6c7f81"
      unitRef="usd">39377000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNy0xLTEtMS05NTExNw_38b9df82-76ef-4507-bf01-6f3632dfb9f7"
      unitRef="usd">40399000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNy0zLTEtMS05NTExNw_2171f2d9-3ee9-42c2-a2be-07f5f8df43c7"
      unitRef="usd">37902000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfOC0xLTEtMS05NTExNw_ca9e226f-5323-45d6-a5f1-c144f7de0165"
      unitRef="usd">-75000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfOC0zLTEtMS05NTExNw_9cb018db-e5ba-4ff7-ac39-7470ad9c2ac5"
      unitRef="usd">-145000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfOS0xLTEtMS05NTExNw_fe5433f9-20ee-4f74-9977-fbe7016b8af6"
      unitRef="usd">639000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfOS0zLTEtMS05NTExNw_eb6b1765-9708-4224-8b0b-5ab27a6a5f43"
      unitRef="usd">12863000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTAtMS0xLTEtOTUxMTc_27a52be3-9b48-4138-b568-9f71b17685f6"
      unitRef="usd">-163000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTAtMy0xLTEtOTUxMTc_de28a715-c299-4858-87ca-7d214d016810"
      unitRef="usd">96000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTEtMS0xLTEtOTUxMTc_b7a98913-4e66-4dbe-896b-4b3405b8741a"
      unitRef="usd">4192000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTEtMy0xLTEtOTUxMTc_377528cc-6731-4b2d-92c9-4373867ef501"
      unitRef="usd">-7303000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTItMS0xLTEtOTUxMTc_1303a635-1441-4863-ba94-2b608c42787b"
      unitRef="usd">31140000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTItMy0xLTEtOTUxMTc_3175e579-03b2-4dce-9f34-ecc8d0ead626"
      unitRef="usd">28375000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTMtMS0xLTEtOTUxMTc_44a05653-5981-4ee6-a4c8-9f25df582a47"
      unitRef="usd">25570000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTMtMy0xLTEtOTUxMTc_84510c7b-4d5c-49dd-82ba-b298aa4e9a29"
      unitRef="usd">8229000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTQtMS0xLTEtOTUxMTc_1f96f105-2bad-4eb7-92b3-6befbfc06b78"
      unitRef="usd">-15709000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTQtMy0xLTEtOTUxMTc_2de161a1-5e2a-4c72-a03e-2699e2ea50ae"
      unitRef="usd">8135000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTUtMS0xLTEtOTUxMTc_1045a034-f4f9-4adc-b06f-7976a428a8bc"
      unitRef="usd">4535000</lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization>
    <lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTUtMy0xLTEtOTUxMTc_58967d12-8955-4f91-815e-758c6eb3fe08"
      unitRef="usd">3349000</lgnd:FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTYtMS0xLTEtOTUxMTc_f9b5b794-7ee0-43b0-aabe-86057e029cf3"
      unitRef="usd">-45000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTYtMy0xLTEtOTUxMTc_46452c25-4e5b-4b63-9040-17fb5f5c1c6a"
      unitRef="usd">658000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTgtMS0xLTEtOTUxMTc_32225bbc-13f6-4719-afde-a61435c2bfcd"
      unitRef="usd">-20550000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTgtMy0xLTEtOTUxMTc_f74c9189-7cd0-4366-b6d3-a050f2938428"
      unitRef="usd">8838000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTktMS0xLTEtOTUxMTc_9336aa35-611a-4932-b4dc-9a9e68e898da"
      unitRef="usd">-10702000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMTktMy0xLTEtOTUxMTc_4677dee2-ce0e-4212-a63d-2bc0fadd1967"
      unitRef="usd">3103000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjAtMS0xLTEtOTUxMTc_3005c6bc-ab59-48bd-8791-4ec23ee8f420"
      unitRef="usd">-405000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjAtMy0xLTEtOTUxMTc_9ad18921-495e-4ead-a0bc-00f79ad7bd81"
      unitRef="usd">-3635000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjEtMS0xLTEtOTUxMTc_5e0f3d47-dd16-4b08-9c32-d278d01781e2"
      unitRef="usd">15111000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjEtMy0xLTEtOTUxMTc_d66a3087-e2ca-4556-9d30-1b3308bf9f5b"
      unitRef="usd">-4167000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjItMS0xLTEtOTUxMTc_22a35a71-ad8c-47d4-9705-4613e3f72336"
      unitRef="usd">-5182000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjItMy0xLTEtOTUxMTc_8f8a41cd-9939-4b17-bedf-3303ef6b6992"
      unitRef="usd">-20696000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjMtMS0xLTEtOTUxMTc_040a8136-61ff-451f-8013-abac0871cad7"
      unitRef="usd">1671000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjMtMy0xLTEtOTUxMTc_34de83f5-e93c-47c0-a3f4-66d12857d2ca"
      unitRef="usd">5909000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjQtMS0xLTEtOTUxMTc_5e07a67b-c059-477f-b7dd-d91411d524ee"
      unitRef="usd">84378000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjQtMy0xLTEtOTUxMTc_f9221194-f649-4d70-a8ae-9f542ebdb6ed"
      unitRef="usd">51156000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjctMS0xLTEtOTUxMTc_e9ba8db7-35ba-41af-811f-f155112a37fa"
      unitRef="usd">39052000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjctMy0xLTEtOTUxMTc_07952533-bf05-4f5e-bac7-317e08c1ca43"
      unitRef="usd">116898000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjgtMS0xLTEtOTUxMTc_f6a3796a-210a-4ba7-af9c-7c6adb9d07ea"
      unitRef="usd">202552000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjgtMy0xLTEtOTUxMTc_ff6b5494-6c96-4c55-b828-9eac31a9926e"
      unitRef="usd">152465000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjktMS0xLTEtOTUxMTc_336b75a3-6022-49ba-a74d-2ee556102305"
      unitRef="usd">24830000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMjktMy0xLTEtOTUxMTc_244c5bca-1724-460d-8df8-0f184ea89e52"
      unitRef="usd">37100000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzAtMS0xLTEtOTUxMTc_be613473-444d-42fb-99d8-0e427b24373b"
      unitRef="usd">750000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzAtMy0xLTEtOTUxMTc_86c164cd-e73f-4254-867b-1c70e8813beb"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzEtMS0xLTEtOTUxMTc_d6341e30-8e5d-4670-ab7f-8338f2b231f1"
      unitRef="usd">15792000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzEtMy0xLTEtOTUxMTc_3b3d7555-2bef-4b41-bc42-7b7bf39420ff"
      unitRef="usd">6566000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <lgnd:PaymentsToContingentValueRightHoldersInvestingActivity
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzMtMS0xLTEtMTEyMTA5_e3a9fe90-827a-40f3-8f16-8f1029210e76"
      unitRef="usd">960000</lgnd:PaymentsToContingentValueRightHoldersInvestingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersInvestingActivity
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzMtMy0xLTEtMTEyMTE3_eb32b0d1-ac82-4320-8592-cc7a29e2d5c6"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHoldersInvestingActivity>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzItMS0xLTEtOTUxMTc_484d30ee-86db-4b61-8c07-750535cc784f"
      unitRef="usd">-80000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzItMy0xLTEtOTUxMTc_60382c7b-1b07-4798-9e6a-de23ecba3a7d"
      unitRef="usd">-135000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzMtMS0xLTEtOTUxMTc_46f1ce83-5740-4f22-b3f5-0b2959478540"
      unitRef="usd">170908000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzMtMy0xLTEtOTUxMTc_cbe50edc-c210-4804-bd0e-31441038eeb7"
      unitRef="usd">66236000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzYtMS0xLTEtOTUxMTc_b4109773-503a-45a9-83c1-70bfc8866004"
      unitRef="usd">260949000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzYtMy0xLTEtOTUxMTc_6188172d-d362-4f2a-b625-d2cda5c2d062"
      unitRef="usd">155760000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzctMS0xLTEtOTUxMTc_7dcb06fc-29fe-42c3-a690-66670d2cefa1"
      unitRef="usd">42000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzctMy0xLTEtOTUxMTc_ac65b35c-cdda-4698-87fa-665d0d9317b9"
      unitRef="usd">9188000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzgtMS0xLTEtOTUxMTc_054d5e04-0c9b-47e3-b1b9-4aa70adf53da"
      unitRef="usd">202000</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzgtMy0xLTEtOTUxMTc_c7e75192-ef4d-4974-9d39-f9d5906f9ee0"
      unitRef="usd">18938000</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzktMS0xLTEtOTUxMTc_40eaca57-9df6-43a3-bf7d-e70e38b47604"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfMzktMy0xLTEtOTUxMTc_bde80e90-2e80-40a5-9a5d-3139f91765b3"
      unitRef="usd">18446000</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDAtMS0xLTEtOTUxMTc_188ccc35-d0b0-400e-8828-271fa5567002"
      unitRef="usd">1831000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDAtMy0xLTEtOTUxMTc_e5f8a2ae-1948-4307-b2ef-7069da6f13ca"
      unitRef="usd">29484000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDEtMS0xLTEtOTUxMTc_c270c5fb-34e1-4c21-98cd-b99a3d3fbb10"
      unitRef="usd">6018000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDEtMy0xLTEtOTUxMTc_6043512c-7537-445e-9ac9-528beb0d4e4c"
      unitRef="usd">5903000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDItMS0xLTEtOTUxMTc_d916a087-169f-4140-94d6-76c99cf4eade"
      unitRef="usd">1545000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDItMy0xLTEtOTUxMTc_63e809c6-3ef7-4627-a60d-3c0f827b1fee"
      unitRef="usd">1050000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDMtMS0xLTEtOTUxMTc_3c010f4e-a479-464e-870c-64fd1150cbbf"
      unitRef="usd">-4171000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDMtMy0xLTEtOTUxMTc_7d45ec0e-e893-4b80-9d77-52265a8bf7b8"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDQtMS0xLTEtOTUxMTc_9535f182-43d0-469c-a3aa-543b7a16f1c2"
      unitRef="usd">-270692000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDQtMy0xLTEtOTUxMTc_38903d8d-b60e-4c27-be95-d6d5af934b9b"
      unitRef="usd">-141925000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDUtMS0xLTEtOTUxMTc_38904aad-af10-4695-a631-e3dd34f58b3e"
      unitRef="usd">-15406000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDUtMy0xLTEtOTUxMTc_26f087e8-4f38-4813-8673-d18cb9055b35"
      unitRef="usd">-24533000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDYtMS0xLTEtOTUxMTc_1eacfd39-4ce1-47f5-9c82-5ea51213d8ea"
      unitRef="usd">19522000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5823b83aff4246d783748aff6ba9b978_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDYtMy0xLTEtOTUxMTc_cf365b73-4a8a-4e05-990c-77758f35ef38"
      unitRef="usd">47963000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDctMS0xLTEtOTUxMTc_b3ab5e2c-574f-486c-8e10-a9d6a7656266"
      unitRef="usd">4116000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5fd7205f82a3406b9f0c0dae4653b877_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOmNlNTc4ODdmOGZmYzQ1MGViMDY2MDJlOWIzNTgzMDYwL3RhYmxlcmFuZ2U6Y2U1Nzg4N2Y4ZmZjNDUwZWIwNjYwMmU5YjM1ODMwNjBfNDctMy0xLTEtOTUxMTc_f176d511-eac8-482a-b98e-0e054344a52a"
      unitRef="usd">23430000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMS0xLTEtMS05NTExNw_a108dd8b-7e35-483f-85d9-9405eb6c207b"
      unitRef="usd">1139000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMS0zLTEtMS05NTExNw_1f128879-6db9-41ee-8497-06f8b221001e"
      unitRef="usd">1740000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMi0xLTEtMS05NTExNw_d71c2fc5-1b24-40c2-b5f3-4975cad67de4"
      unitRef="usd">6630000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMi0zLTEtMS05NTExNw_2629fc90-87f8-4532-aff2-045c0f975265"
      unitRef="usd">3720000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfOS0xLTEtMS05NTExNw_fc81a893-e544-4779-91e1-4e2db4a8ae23"
      unitRef="usd">3626000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfOS0zLTEtMS05NTExNw_c259ea94-bcef-4044-b81e-90d06d485aaf"
      unitRef="usd">557000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <lgnd:AccruedInventoryPurchases
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMTAtMS0xLTEtOTUxMTc_bf1dc8c1-175f-47cc-af7c-b410a96e1b0c"
      unitRef="usd">7676000</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedInventoryPurchases
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMTAtMy0xLTEtOTUxMTc_f3213a95-ede2-405e-8d3d-ffb895b0625b"
      unitRef="usd">4968000</lgnd:AccruedInventoryPurchases>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMTItMS0xLTEtOTUxMTc_dad7f8dd-948f-4e2f-a10f-049dd469eda7"
      unitRef="usd">-143000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8yOC9mcmFnOjFhZWM4NGE3NmEwOTQ3ZTE5MTA0YzUwZmMxZWZhYTFiL3RhYmxlOjMwYjYzOWY0NDc3ODQ4Zjg5NTQ1NGQ4N2ViNWYzYWExL3RhYmxlcmFuZ2U6MzBiNjM5ZjQ0Nzc4NDhmODk1NDU0ZDg3ZWI1ZjNhYTFfMTItMy0xLTEtOTUxMTc_f4c268f5-612d-4bd1-9154-e2ad8f0d17ce"
      unitRef="usd">-74000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMTA_1c547059-5749-4696-b057-9c9c24e3e3a7">Basis of Presentation and Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have described our significant accounting policies in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1, Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Notes to Consolidated Financial Statements in our 2021 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#x201c;long-term deferred revenue&#x201d; has been added to the condensed consolidated balance sheet, separated from &#x201c;other long-term liabilities&#x201d; in our prior period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Updates, Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (&#x201c;ASU 2020-06&#x201d;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Consequently, a convertible debt instrument, such as the Company&#x2019;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended September&#160;30, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 was $341.1&#160;million which included an unamortized discount of $2.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;amp;D services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For R&amp;amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended September&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $4.1 million, and $7.7 million, respectively. During the nine months ended September&#160;30, 2022 and 2021, the amount recognized as revenue that was previously deferred was $8.8 million, and $22.8 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation&#160;of&#160;Revenue &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Teriparatide injection &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rylaze &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - Core&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at September&#160;30, 2022 and December 31, 2021 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three and nine months ended September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of 8 positions which were in an unrealized loss position as of September&#160;30, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three and nine months ended September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three and nine months ended September&#160;30, 2022, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $(0.1)&#160;million and $(0.3)&#160;million of allowance for credit losses, respectively, as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three and nine months ended September&#160;30, 2022 and 2021. As of September&#160;30, 2022 inventory consists of Captisol prepayments of $7.4&#160;million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Other Identifiable Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;282,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(78,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;698,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to 2022, we only had one reporting unit and reportable segment. In connection with the announcement in March 2022 of our intention to separate the OmniAb business pursuant to a distribution to Ligand&#x2019;s stockholders of Ligand&#x2019;s shares in OmniAb followed by a merger with APAC, management concluded that we had two reporting units and reportable segments - the OmniAb business and the Ligand core business. See Note 2, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information. We performed a fair value analysis utilizing a combination of income approach and market approach to determine the fair value of each segment in order to appropriately allocate the goodwill between the segments as of the announcement date. The following table presents our allocation of goodwill balance by segment (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Ligand core business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;OmniAb business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;75,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Commercial License Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Receivables, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;as further discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of the Notes to Consolidated Financial Statements in our 2021 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three and nine months ended September&#160;30, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2022, 0.6&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. Under the new standard, we are required to reflect the dilutive effect of the 2023 Notes by application of the if-converted method.&lt;/span&gt;&lt;/div&gt;For the nine months ended September&#160;30, 2022, due to the net loss for the period, all of the 0.3&#160;million weighted average equity awards and 1.1&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMjE_aba5baaa-0eac-4a93-8db6-642eb9aae1e5">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNTg_f6d877a2-b572-426d-8af1-01b12956e645">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNDI_55ad6668-9cad-427f-969f-0593b1e44102">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period condensed consolidated financial statements have been reclassified to conform with the current period presentation. Specifically, &#x201c;long-term deferred revenue&#x201d; has been added to the condensed consolidated balance sheet, separated from &#x201c;other long-term liabilities&#x201d; in our prior period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMzE_43da52c2-ba32-45ae-a338-2da638b0895a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Updates, Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (&#x201c;ASU 2020-06&#x201d;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Consequently, a convertible debt instrument, such as the Company&#x2019;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended September&#160;30, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 was $341.1&#160;million which included an unamortized discount of $2.2&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConvertibleNotesPayable
      contextRef="if3f7ea577fbe4425b5634e5fec8b8b74_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDQwMA_72b0d118-c2f5-4719-81f2-0832fec31895"
      unitRef="usd">20400000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="if3f7ea577fbe4425b5634e5fec8b8b74_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDQ0MA_97bc4519-9a67-481b-a2fe-b21f3ece728b"
      unitRef="usd">-4400000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:StockholdersEquity
      contextRef="ibc3e336e701549d0a038218263d74105_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDQ4Mg_6d186329-9234-4ea7-8bf1-b81afb9f33f2"
      unitRef="usd">-51100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i32fea61e3e6a4354bd7504b5be38cea3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDUyMA_a9374528-1274-4e4a-9a02-f31546cf39b1"
      unitRef="usd">35100000</us-gaap:StockholdersEquity>
    <us-gaap:ConvertibleNotesPayable
      contextRef="ic5fe64e3bfa140528971aaeae19072a7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDU4MQ_e173f019-07dd-4584-bc99-9e15490d6a62"
      unitRef="usd">341100000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ic5fe64e3bfa140528971aaeae19072a7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfNDYyNg_abb0f285-da9e-4945-a16d-94e3f8b7453d"
      unitRef="usd">2200000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNDQ_0de827d9-8a79-48e9-957d-ecc74398c79b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;amp;D services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For R&amp;amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. &lt;/span&gt;&lt;/div&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTEzNzc_9a460c91-2440-40f6-8a5c-a79f6419552f"
      unitRef="usd">4100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTEzODU_6c604096-fc4a-465f-b4b0-ddf311c93a1c"
      unitRef="usd">7700000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTE0OTY_7d396ae9-1edb-4c8c-9664-e79b2557847a"
      unitRef="usd">8800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTE1MDQ_4f6eaf23-aad0-46e8-ae6f-b8a4b527de3f"
      unitRef="usd">22800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNTk_188746a0-6afa-4291-81e9-2f8f719de4aa">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Teriparatide injection &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rylaze &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - Core&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;204,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35e1f2ef2453421db235d4f5debc1ea8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNC0xLTEtMS05NTExNw_57038b05-3c64-4a5d-9bb7-caeb6935f0c7"
      unitRef="usd">9123000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibefdd74dcbb544c7bcd50c4bdc0ea3b1_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNC0zLTEtMS05NTExNw_35a7be80-6c16-4c32-a1fe-9ce11035fe9b"
      unitRef="usd">8821000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic183fe3cfc0444ec988c0505dc4aac87_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNC01LTEtMS05NTExNw_cb610a8e-fab3-435c-bc98-8323ed0d7cad"
      unitRef="usd">20872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0662d167252447899eb4741ca4b7d49_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNC03LTEtMS05NTExNw_bf26ad93-b2cf-401b-89f8-abea884b2fa9"
      unitRef="usd">18548000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7cd2d0377724f898a6c11769e623b6b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNS0xLTEtMS05NTExNw_37dc01cc-d119-47c1-9003-ab9c8f8d4f4c"
      unitRef="usd">3123000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id67bfd452ca34efbabd006d69f7f34b4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNS0zLTEtMS05NTExNw_710c16ed-8e93-4b13-b718-467f06133c98"
      unitRef="usd">2665000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47ac025acf224b88b1f6e6ddd566bd90_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNS01LTEtMS05NTExNw_49486e65-d5ea-4858-9112-283a39b45cd6"
      unitRef="usd">8218000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb81ed13c9ff4a1e8c098b5fdd85fce8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNS03LTEtMS05NTExNw_b5fdc396-1740-46ad-a8d2-f39b128238e4"
      unitRef="usd">7191000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e3e7744f301495cb31d4020806e39e6_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNi0xLTEtMS05NTExNw_ad26434c-9adf-46ef-9d2c-231a13e9cb4a"
      unitRef="usd">4071000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib36bf83f8a274b0a9bf13b0e4652e822_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNi0zLTEtMS05NTExNw_d4bdb4a5-83be-4dbf-a7fc-b6058b8b2578"
      unitRef="usd">2567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i827c7e6cdeac4886b9ec06b6f65e8455_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNi01LTEtMS05NTExNw_8c2e5ad7-ce22-4765-b2e4-43331ec8088a"
      unitRef="usd">12484000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2247afa58cf4d3995002065e43ff1c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNi03LTEtMS05NTExNw_ae46e0b0-dc01-489b-beec-86a14ea7eb6e"
      unitRef="usd">2831000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1971a4278a1432a897cda6cc91f0897_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNy0xLTEtMS05NTExNw_1b747ca9-490f-405e-92a2-0b349291694f"
      unitRef="usd">2099000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7253785dc35146fc8241d38b8d7cc8bd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNy0zLTEtMS05NTExNw_be940287-ecfc-45a0-9989-112c7bb37d6c"
      unitRef="usd">600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia48707413feb4dbab9c2496e3c59a6a0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNy01LTEtMS05NTExNw_b4115de1-8625-4507-a037-d9ba7d97d92b"
      unitRef="usd">6065000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a7b8932fa4845759b4d1dd6a1d7a232_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfNy03LTEtMS05NTExNw_338c7e96-7b39-49d7-bd54-8a8b6fab72dd"
      unitRef="usd">600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id95bfc92bd274c84aa1a9a7994070620_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOC0xLTEtMS05NTExNw_c28972ea-9641-4bef-9083-bd664f4ec7bd"
      unitRef="usd">1421000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i055d53a99e864487af223e1ee40ef3de_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOC0zLTEtMS05NTExNw_87a13272-90bb-4a6e-b32d-1cb2175b3455"
      unitRef="usd">995000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i289f60c3b5684e97b642fc712cb0729d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOC01LTEtMS05NTExNw_48e96180-9bd9-476f-a748-7f42b65cab45"
      unitRef="usd">3852000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1aca03e88f7c4ef7afd5a15c43b2a58b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOC03LTEtMS05NTExNw_fa9e90c5-7a15-41ba-8029-307d387795b6"
      unitRef="usd">2206000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e4c019116374680b437a7a7e84a8c80_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOS0xLTEtMS05NTExNw_867fd795-2dd9-4897-b95f-dcc052893748"
      unitRef="usd">19837000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe9d446b7d574e0a8a446713e4e31f27_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOS0zLTEtMS05NTExNw_8d3e68bb-c6f0-41a9-bd47-e289d2e7668d"
      unitRef="usd">15648000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6dd34ce0bee40ea82cba5bfc9584a46_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOS01LTEtMS05NTExNw_a4fc2505-6dfd-48fc-924f-84f927206aac"
      unitRef="usd">51491000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61be445c11db419296ccc53f473da154_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfOS03LTEtMS05NTExNw_135f99df-5a1d-4fae-94c5-239459308b68"
      unitRef="usd">31376000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia87b96b5149b41818034e32448024dfb_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTItMS0xLTEtOTUxMTc_df44eac8-6fc1-4373-954f-d6825b0310da"
      unitRef="usd">3582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2eac10c65b1641ffa06188a690f2aca9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTItMy0xLTEtOTUxMTc_4451be74-558f-40c9-bf4f-0a89bc0bf57f"
      unitRef="usd">5374000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba465a7198d54ee7b6ad82d779858fd9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTItNS0xLTEtOTUxMTc_f0602c01-454f-479f-8720-9be33d887744"
      unitRef="usd">13133000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a5fa29dc2e848a7b2ac184d57a87bc3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTItNy0xLTEtOTUxMTc_14b4ed35-b1d4-4c5a-b77f-825da5ad4196"
      unitRef="usd">16310000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i904cf14c4b3e4fbeb3f577b716e29d42_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTMtMS0xLTEtOTUxMTc_1da8ccfa-1890-4b90-959d-0f887d85ba9e"
      unitRef="usd">32367000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib22143b247d14e49b1f87a41cebc0533_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTMtMy0xLTEtOTUxMTc_3612a063-a261-4671-bb21-ea4121572dc4"
      unitRef="usd">29719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0411fb172a764e2e92a29821f037280d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTMtNS0xLTEtOTUxMTc_f52735f6-d080-41eb-b6d7-ea519110f050"
      unitRef="usd">64483000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78881cd8932b4b9093df9eaafe0b57dc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTMtNy0xLTEtOTUxMTc_c33e1752-5fe8-429a-93a6-4436186df1db"
      unitRef="usd">112565000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27111ff24358446e8f6742f1a9a22280_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTQtMS0xLTEtOTUxMTc_a64c5692-b06a-4db8-af51-d0db910159b6"
      unitRef="usd">35949000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i805b7ce49b9b477ab1a86dfcd8f4b896_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTQtMy0xLTEtOTUxMTc_dae16cdf-a8bc-4135-94d2-8c5e010e5f77"
      unitRef="usd">35093000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbc5e665d17d410bbc8f43e5ef950091_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTQtNS0xLTEtOTUxMTc_42f278c7-5a88-4e69-920d-9499c0d1fd25"
      unitRef="usd">77616000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68593efff0be4bcea82e054922dea281_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTQtNy0xLTEtOTUxMTc_7365b6af-6468-4427-9f86-5ef34fa4b576"
      unitRef="usd">128875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6c61f74a4ae46dfa6cd20104936b527_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTctMS0xLTEtOTUxMTc_8c98c8da-cdc2-40ee-971f-af419560b1b7"
      unitRef="usd">4975000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i588e8adf3218428d9d65e76ec58ffcb2_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTctMy0xLTEtOTUxMTc_df85113b-938e-4c53-9613-2f1ac7cec8c1"
      unitRef="usd">4828000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia44ee73068f14175b5fd0992341adbfb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTctNS0xLTEtOTUxMTc_b2777036-129e-4f6a-99a7-dae42b8f7769"
      unitRef="usd">15574000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57d398f1cb1742cc900354e71b1ecc8b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTctNy0xLTEtOTUxMTc_e57d506a-c39a-44b8-a023-6b896a2e3721"
      unitRef="usd">17650000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieedc3bed7980424b96288a7a097ef23f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTgtMS0xLTEtOTUxMTc_3a156ecc-0be1-45fb-9c04-f0b1659e9995"
      unitRef="usd">460000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b25204e1c1e45449277f115819b751e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTgtMy0xLTEtOTUxMTc_d67d09f5-3990-47d3-9a04-0b6f9b95ed90"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9683e5a36df8493692166626aea2d25e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTgtNS0xLTEtOTUxMTc_5971e621-a4c5-471d-adf0-5b1b114994a7"
      unitRef="usd">5154000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b3ad9c76fcb49c091bef77b6c7f4ab3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTgtNy0xLTEtOTUxMTc_dfedbeab-aa09-427a-b63d-351a148ab225"
      unitRef="usd">2293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9ac29ea1484471db0a5f3a8814367c8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTktMS0xLTEtOTUxMTc_4b6c67b3-8d62-4185-89df-cbc4c14e5fda"
      unitRef="usd">3658000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0a1285ff321448588acc1bf40c5d032_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTktMy0xLTEtOTUxMTc_885f71e0-516a-44ec-99f4-834bbad341e3"
      unitRef="usd">7419000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7911ef49fdd142e7b67a65d73023df8c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTktNS0xLTEtOTUxMTc_aea35ea4-cc02-4aee-84d7-039bc05ad45f"
      unitRef="usd">14022000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a70bf5a0b90462f88245ce9197a2e96_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMTktNy0xLTEtOTUxMTc_2772a214-1a99-40ec-ba2e-f68d20bfc082"
      unitRef="usd">19436000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i123c75669efe43bd9dc15885da57a867_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjAtMS0xLTEtOTUxMTc_1073c771-f9f3-416b-9f98-5f69a4e93b50"
      unitRef="usd">1209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c920df29ac544cd8c6902919042761f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjAtMy0xLTEtOTUxMTc_893e6be3-017d-48ac-ab5c-89492094a722"
      unitRef="usd">1647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7c767ef41d54b72a2eec06f317f26a3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjAtNS0xLTEtOTUxMTc_84f267c3-e9c2-4cfb-ad18-0678e80e5f98"
      unitRef="usd">5343000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98e6619944924d099ebf2550f8a566da_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjAtNy0xLTEtOTUxMTc_a0feb3a7-dc0c-471d-a1d2-14a9235df642"
      unitRef="usd">5030000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c883799387843e28ad63ef5c7a3a928_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjEtMS0xLTEtOTUxMTc_8a9326d3-0c6e-483e-b143-da2356f650d5"
      unitRef="usd">10302000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idca791879e154b79899726f73ac30955_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjEtMy0xLTEtOTUxMTc_38574fce-a3b4-4bbf-8b99-d4f4a587e2e6"
      unitRef="usd">14094000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb48e049cd074424a4b9c75318b0968f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjEtNS0xLTEtOTUxMTc_66a28e58-401c-46ba-8364-d22cfdd70038"
      unitRef="usd">40093000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d5bd9d373e34f7ab0ab2dc3b00f0266_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjEtNy0xLTEtOTUxMTc_39c25d4c-0c33-494a-96a3-e6f959f44d92"
      unitRef="usd">44409000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjItMS0xLTEtOTUxMTc_e3ee8a0b-45c4-4dab-b11d-ed4f5b135ddb"
      unitRef="usd">66088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjItMy0xLTEtOTUxMTc_66912aec-1989-45ad-84d3-175ff1debcd4"
      unitRef="usd">64835000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjItNS0xLTEtOTUxMTc_8b453162-5194-424f-9b25-61b23b45f190"
      unitRef="usd">169200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjZlYWZhOWIwNDM4ZjQ2ZmU5YTFjYzY0MmFhNGE4ZDA4L3RhYmxlcmFuZ2U6NmVhZmE5YjA0MzhmNDZmZTlhMWNjNjQyYWE0YThkMDhfMjItNy0xLTEtOTUxMTc_fc70c55f-326a-49c1-b12f-e1af4c4aee0c"
      unitRef="usd">204660000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <lgnd:ScheduleOfShortTermInvestmentsTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMjQ_331cb454-434e-41ed-ba4d-2a3b0a63cb49">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at September&#160;30, 2022 and December 31, 2021 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,062)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleOfShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibc2a7c797d8541648d78aca099e523a0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMi0xLTEtMS05NTExNw_9f16ad40-8abb-4ef0-bf76-f7d43c3b2a8b"
      unitRef="usd">2506000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibc2a7c797d8541648d78aca099e523a0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMi00LTEtMS05NTExNw_9db1fd82-b110-489c-9d0b-71f02aa1b262"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibc2a7c797d8541648d78aca099e523a0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMi03LTEtMS05NTExNw_a2191132-5ce9-4e81-a6a2-ce772936b65a"
      unitRef="usd">53000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc2a7c797d8541648d78aca099e523a0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMi0xMC0xLTEtOTUxMTc_c04220c7-5769-4b2f-a31e-fa8d720ec8b2"
      unitRef="usd">2453000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id269671958804d059d42ec1bf2798d24_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMy0xLTEtMS05NTExNw_1eb95133-e76a-4901-abf3-fd3687f9a108"
      unitRef="usd">4887000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id269671958804d059d42ec1bf2798d24_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMy00LTEtMS05NTExNw_58dbd9f8-4c99-4df4-a63f-d1f1ccda7964"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id269671958804d059d42ec1bf2798d24_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMy03LTEtMS05NTExNw_8486e85d-d237-46ca-a32e-cc397b29b416"
      unitRef="usd">107000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id269671958804d059d42ec1bf2798d24_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMy0xMC0xLTEtOTUxMTc_ca67ae68-af3d-4611-b155-f866b05959b7"
      unitRef="usd">4780000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i350e5ed791be46a4b5d11307ffa4cb26_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNi0xLTEtMS05NTExNw_6cd1aa18-c9d2-45cc-8b30-8e987cb0f855"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i350e5ed791be46a4b5d11307ffa4cb26_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNi00LTEtMS05NTExNw_1b7df2ef-e8a6-4d08-ad9f-23a0532f6167"
      unitRef="usd">312000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i350e5ed791be46a4b5d11307ffa4cb26_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNi03LTEtMS05NTExNw_08f975e3-6f6e-4f46-8c71-90f7f01c8d6d"
      unitRef="usd">3615000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i350e5ed791be46a4b5d11307ffa4cb26_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNi0xMC0xLTEtOTUxMTc_05db9da9-c983-4da4-b927-8730ab25f23b"
      unitRef="usd">2504000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i662334cf40d54566bec6fe57077ce69e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNy0xLTEtMS05NTExNw_a90c446a-67af-4cbd-a65d-d33a9952c4eb"
      unitRef="usd">88115000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i662334cf40d54566bec6fe57077ce69e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNy00LTEtMS05NTExNw_5a0055f0-37b6-4498-8f34-56a22ffb762c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i662334cf40d54566bec6fe57077ce69e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNy03LTEtMS05NTExNw_6d6b5b56-4348-4549-b91c-91c2bb1aaead"
      unitRef="usd">1203000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i662334cf40d54566bec6fe57077ce69e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfNy0xMC0xLTEtOTUxMTc_244496de-7bf2-4cb7-8c5a-d643e3730b35"
      unitRef="usd">86912000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i06f8d4ffb4a142d89bec0b51469e199e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOC0xLTEtMS05NTExNw_2159d594-5f7e-4447-a462-9c4b3159fef5"
      unitRef="usd">2229000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i06f8d4ffb4a142d89bec0b51469e199e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOC00LTEtMS05NTExNw_b3697db4-7c21-4fb9-b06e-591205969f17"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i06f8d4ffb4a142d89bec0b51469e199e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOC03LTEtMS05NTExNw_5f6c5677-fc9b-43dd-899a-4bd7d4c626fc"
      unitRef="usd">84000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i06f8d4ffb4a142d89bec0b51469e199e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOC0xMC0xLTEtOTUxMTc_0b501138-3bf0-4f35-8866-181b3a06598a"
      unitRef="usd">2145000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie20dcecc9b97461eb7567478745a495f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOS0xLTEtMS05NTExNw_079c2c62-60af-49ac-95e5-6eec016f1648"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie20dcecc9b97461eb7567478745a495f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOS00LTEtMS05NTExNw_2665fc1a-ffd6-4552-bb01-fcec665cc4a7"
      unitRef="usd">232000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie20dcecc9b97461eb7567478745a495f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOS03LTEtMS05NTExNw_20808dd2-fd05-4e95-a7df-b78b36828506"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie20dcecc9b97461eb7567478745a495f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfOS0xMC0xLTEtOTUxMTc_b3759c01-5c01-49fc-8a4d-8696df225d5e"
      unitRef="usd">232000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTAtMS0xLTEtOTUxMTc_bb54d691-a265-45cf-9f96-3f829cc6a0f8"
      unitRef="usd">103544000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTAtNC0xLTEtOTUxMTc_301f2df2-10e1-4de8-826f-1cf4975ae514"
      unitRef="usd">544000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTAtNy0xLTEtOTUxMTc_0a3be26b-2d97-4c86-9648-681ab7f894a0"
      unitRef="usd">5062000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTAtMTAtMS0xLTk1MTE3_dcb90c70-d0e5-4317-819c-51b2465f4090"
      unitRef="usd">99026000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iabc8605b5b5b4402bfa40c6f86cc4521_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTEtMTAtMS0xLTk1MTE3_b6111116-e8c2-4fd1-8992-0bb553692c93"
      unitRef="usd">18265000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTItMTAtMS0xLTk1MTE3_8242ff67-f535-4dbc-937c-44fa1a7d6485"
      unitRef="usd">117291000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic07a20125b6b4a8ebfc0faae2187f7dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTUtMS0xLTEtOTUxMTc_0bf04d66-f51f-4f4b-8f88-3ddd88c4ae8d"
      unitRef="usd">63389000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic07a20125b6b4a8ebfc0faae2187f7dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTUtNC0xLTEtOTUxMTc_795e4c52-7e1c-4640-bdd6-5bdfc83d93f2"
      unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic07a20125b6b4a8ebfc0faae2187f7dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTUtNy0xLTEtOTUxMTc_06bf4995-ca43-4a78-8b0f-e65a506f13f5"
      unitRef="usd">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic07a20125b6b4a8ebfc0faae2187f7dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTUtMTAtMS0xLTk1MTE3_561a10b9-2a3b-462c-8df6-097676a9fa01"
      unitRef="usd">63381000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i317970eca87540b8b1481240b27a7411_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTYtMS0xLTEtOTUxMTc_5f499a25-deec-455d-a371-62547f320bb6"
      unitRef="usd">29308000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i317970eca87540b8b1481240b27a7411_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTYtNC0xLTEtOTUxMTc_d7165828-84b9-4529-a18f-a483047ec40e"
      unitRef="usd">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i317970eca87540b8b1481240b27a7411_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTYtNy0xLTEtOTUxMTc_0e681206-3cfa-4080-9e49-fe8eb454fc5a"
      unitRef="usd">38000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i317970eca87540b8b1481240b27a7411_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTYtMTAtMS0xLTk1MTE3_65cc0c60-b588-4a30-a087-f2c0800a117c"
      unitRef="usd">29287000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ida31cd3b48ce4d1e9d75b4ab666e503d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTgtMS0xLTEtOTUxMTc_09bf0da3-6ec7-46cf-ab52-a9d699a79665"
      unitRef="usd">36008000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ida31cd3b48ce4d1e9d75b4ab666e503d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTgtNC0xLTEtOTUxMTc_991821a8-736d-48bb-afe6-edf2a0964e04"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ida31cd3b48ce4d1e9d75b4ab666e503d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTgtNy0xLTEtOTUxMTc_c44cde08-ad23-4a53-9d97-69b44ee38c75"
      unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ida31cd3b48ce4d1e9d75b4ab666e503d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTgtMTAtMS0xLTk1MTE3_74f5614e-2e25-4e64-bffa-d11a1bff5449"
      unitRef="usd">35998000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifba74fb91aff4709a648d885a295772a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTktMS0xLTEtOTUxMTc_d61e17fb-1e13-475a-bd48-e683481453d3"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifba74fb91aff4709a648d885a295772a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTktNC0xLTEtOTUxMTc_6f80efb6-883a-44af-b16f-50368e88c5e5"
      unitRef="usd">402000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifba74fb91aff4709a648d885a295772a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTktNy0xLTEtOTUxMTc_3cad0a9b-f079-4813-bff3-13b89db76ff3"
      unitRef="usd">2027000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifba74fb91aff4709a648d885a295772a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMTktMTAtMS0xLTk1MTE3_0ea881c0-00a6-4fed-a491-5395fb25f37b"
      unitRef="usd">4182000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibeb3f202176743cfbfef35c2aa9a206a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjAtMS0xLTEtOTUxMTc_e8773faa-8f03-4e14-9c0c-d4ecec7327ec"
      unitRef="usd">152136000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibeb3f202176743cfbfef35c2aa9a206a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjAtNC0xLTEtOTUxMTc_e63aa59c-c344-44f2-a790-5d455db946ec"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibeb3f202176743cfbfef35c2aa9a206a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjAtNy0xLTEtOTUxMTc_ba2f2489-86b9-4718-bf07-8185b6546077"
      unitRef="usd">249000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibeb3f202176743cfbfef35c2aa9a206a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjAtMTAtMS0xLTk1MTE3_ccc8c5e3-2e97-4999-b055-f40dbd32b248"
      unitRef="usd">151887000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifd672b4aeff947f2be4d57e9a811d2b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjEtMS0xLTEtOTUxMTc_fb4090be-19f0-4330-a2e3-d53e8512fee3"
      unitRef="usd">5577000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifd672b4aeff947f2be4d57e9a811d2b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjEtNC0xLTEtOTUxMTc_2a3739c1-a30a-48b0-94a6-bbf5b0203434"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifd672b4aeff947f2be4d57e9a811d2b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjEtNy0xLTEtOTUxMTc_223a40c7-da23-4680-b251-6f867007d753"
      unitRef="usd">23000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd672b4aeff947f2be4d57e9a811d2b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjEtMTAtMS0xLTk1MTE3_2998420e-17e8-4aa7-bc74-5a31508222b4"
      unitRef="usd">5554000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i20e1b9d42dae41b3b8d258ee144a3142_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjItMS0xLTEtOTUxMTc_e8247742-069d-4f56-836d-b815e3dac175"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i20e1b9d42dae41b3b8d258ee144a3142_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjItNC0xLTEtOTUxMTc_4ad83d87-5618-43a9-a18e-2bfb6e41161e"
      unitRef="usd">408000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i20e1b9d42dae41b3b8d258ee144a3142_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjItNy0xLTEtOTUxMTc_669e77b3-0d77-464c-b416-94613d728213"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i20e1b9d42dae41b3b8d258ee144a3142_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjItMTAtMS0xLTk1MTE3_bcdce107-4d42-43c3-963f-e916b9acdee0"
      unitRef="usd">408000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjMtMS0xLTEtOTUxMTc_c49782d2-5290-4dd7-bd2e-1db18f2e284e"
      unitRef="usd">292225000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjMtNC0xLTEtOTUxMTc_1a4a919d-7284-40b2-a0d9-2bc25d52018e"
      unitRef="usd">842000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjMtNy0xLTEtOTUxMTc_8644531b-8600-4205-a6a9-fe04ad0e7e13"
      unitRef="usd">2370000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjMtMTAtMS0xLTk1MTE3_584be315-af05-460f-9616-323f97849a41"
      unitRef="usd">290697000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ice501f8f87084c9b8479455e8bbbc32d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjQtMTAtMS0xLTk1MTE3_73c29727-7cca-4312-8141-52a3ddb3fa56"
      unitRef="usd">30889000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjU3OTlhYmQ4ZjBlZDRkMmViMjU0N2IwNTUzZGMyYjY3L3RhYmxlcmFuZ2U6NTc5OWFiZDhmMGVkNGQyZWIyNTQ3YjA1NTNkYzJiNjdfMjUtMTAtMS0xLTk1MTE3_d4d6260c-0630-4a6b-af1f-24da938298a7"
      unitRef="usd">321586000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNjA_b731cebe-46d7-49ed-9c26-7102e70b6ca9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfMi0xLTEtMS05NTExNw_56d04892-ab70-4737-8b91-e6803a02abe4"
      unitRef="usd">8659000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfMi0zLTEtMS05NTExNw_e5432ffa-b764-4ecb-8fa2-b2bd1a5c3d36"
      unitRef="usd">8458000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfMy0xLTEtMS05NTExNw_536d57ee-844c-4491-b0d1-ceb39ea115c7"
      unitRef="usd">982000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfMy0zLTEtMS05NTExNw_ecb836d9-8f78-43d2-8b38-8668340981bd"
      unitRef="usd">939000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfNC0xLTEtMS05NTExNw_e4dfafd4-e873-4cc6-9ec9-4f39065e1ce8"
      unitRef="usd">9641000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmI2OGMyMzY3NDU3NDQwZGY4OTJjOWUxY2VhZWM1MjdjL3RhYmxlcmFuZ2U6YjY4YzIzNjc0NTc0NDBkZjg5MmM5ZTFjZWFlYzUyN2NfNC0zLTEtMS05NTExNw_b9775c27-78db-4d69-8252-5901540bcdf3"
      unitRef="usd">9397000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTI4MzU_4d2bf840-65db-4c01-8edd-39a04175174c"
      unitRef="position">8</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTM0NTU_59272c1a-5218-4756-a85a-6cd1de1bfd7a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNjY_9dd1e5d5-7fae-43df-9b4e-9480e3c7b64f">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfODc5NjA5MzA0Mzc4Nw_3a14767e-1042-4eb7-9a2f-09e746516a12"
      unitRef="usd">-100000</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfODc5NjA5MzA0MzgwMw_d0d052e1-a4d1-42e3-8506-c5bbac6d6045"
      unitRef="usd">-300000</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMjg_38294fc0-220e-441e-94b6-176d8fd3f100">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. &lt;/span&gt;&lt;/div&gt;We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three and nine months ended September&#160;30, 2022 and 2021. As of September&#160;30, 2022 inventory consists of Captisol prepayments of $7.4&#160;million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryNet
      contextRef="i1f2f5a4645194ff8ac4a43834225e441_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTUxMzc_33bb5634-0c2d-43a8-95f1-593b26df5243"
      unitRef="usd">7400000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i51243c6c92784f7f9b969f7ff8364956_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTUyMTU_691a5d87-00e3-4d7b-ba82-9b600d71751c"
      unitRef="usd">24600000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMzI_30a65b4e-22b0-4810-adc4-7a9dedf5241b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;282,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(78,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(57,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;698,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMy0xLTEtMS05NTExNw_fb3fb198-21f3-4196-b9ce-7c1ca13c868e"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMy0zLTEtMS05NTExNw_ff3280bb-f939-4976-a35d-fc3778e0f009"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie89e441071a94390acf735662b9d84ca_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNS0xLTEtMS05NTExNw_46cffbcd-b072-4256-abf1-ffa3d34c06c3"
      unitRef="usd">282057000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i879eebb5a7c3459ebc5f9e1980194ee7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNS0zLTEtMS05NTExNw_a15797c8-a905-4e90-81b9-c407bef9f2fa"
      unitRef="usd">280617000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie89e441071a94390acf735662b9d84ca_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNi0xLTEtMS05NTExNw_f0e92425-6287-4956-afae-410845207a10"
      unitRef="usd">90611000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i879eebb5a7c3459ebc5f9e1980194ee7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNi0zLTEtMS05NTExNw_4506155d-bfcf-4a5f-b20a-b00256f7d966"
      unitRef="usd">78991000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i949f68cec8414dfb8cf22d6f87aad59c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNy0xLTEtMS05NTExNw_47f7ed42-7f65-4c30-a83d-24213763a710"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1d4422300f314cb5b2c8b76da9076612_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfNy0zLTEtMS05NTExNw_b9ef4945-f41a-43d7-97af-386205887517"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i949f68cec8414dfb8cf22d6f87aad59c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfOC0xLTEtMS05NTExNw_45a545c7-0f69-440a-bc70-0a6554cb625d"
      unitRef="usd">1544000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1d4422300f314cb5b2c8b76da9076612_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfOC0zLTEtMS05NTExNw_d20d2d05-a630-4111-aaf0-bc90017aa6b1"
      unitRef="usd">1444000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i65e7975e74c64f75b300ebf474efc3d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfOS0xLTEtMS05NTExNw_5afaedb6-1b85-4b26-89ed-2502998370a2"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibdfc802ffcea4059bb816a071f7ed3b8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfOS0zLTEtMS05NTExNw_9daf8c7d-1a28-44ae-abc2-98a60da2765b"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i65e7975e74c64f75b300ebf474efc3d0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTAtMS0xLTEtOTUxMTc_c714a3f9-d459-481b-91d3-354d2492a600"
      unitRef="usd">20272000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibdfc802ffcea4059bb816a071f7ed3b8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTAtMy0xLTEtOTUxMTc_e9ec322e-cf91-4618-98a6-6e06e632410f"
      unitRef="usd">18267000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib5860738973c46b7b442c1e31a1fa1b4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTEtMS0xLTEtOTUxMTc_22ab745b-2898-45e3-aded-cbd835523bf2"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8078205bd5974127a86e504b140fa260_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTEtMy0xLTEtOTUxMTc_7bde9173-1d4d-4649-9315-63de6b1ac0ef"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib5860738973c46b7b442c1e31a1fa1b4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTItMS0xLTEtOTUxMTc_93b65414-db30-4ecd-81c4-43b108479394"
      unitRef="usd">57947000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8078205bd5974127a86e504b140fa260_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTItMy0xLTEtOTUxMTc_fa980bbe-a958-431b-89c5-bed87ad84537"
      unitRef="usd">36217000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTMtMS0xLTEtOTUxMTc_e5ba7fc7-d786-434e-a373-485ab4c9c24e"
      unitRef="usd">698231000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmM5MjI5YjU2MThlYzQ4MTZiYTFlODhhYzY2ZWZmMDI2L3RhYmxlcmFuZ2U6YzkyMjliNTYxOGVjNDgxNmJhMWU4OGFjNjZlZmYwMjZfMTMtMy0xLTEtOTUxMTc_d3965b63-0501-44ff-9f20-9e5b12318fc9"
      unitRef="usd">732246000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:NumberOfReportingUnits
      contextRef="ice5667b832bb46b58768234cec087173_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTUzOTQ_2e3b0cc6-85df-4892-a946-c56e3de858d0"
      unitRef="reporting_unit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMzY_9e9637d2-7397-4594-9f9f-ec5b99a7c074">The following table presents our allocation of goodwill balance by segment (in thousands): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.298%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Ligand core business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;105,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:12pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;OmniAb business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;75,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i365d6d6bcee9448fa1c6ab3aa3d86e82_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjFiN2Q3NGM0MDc0NzQ4MDJiNDljYzA4ODZhNWVjZThjL3RhYmxlcmFuZ2U6MWI3ZDc0YzQwNzQ3NDgwMmI0OWNjMDg4NmE1ZWNlOGNfMi0xLTEtMS05NTExNw_b29a031a-5118-4537-8d74-897e85648d5a"
      unitRef="usd">105673000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if1caa4c3cd5f4732bfdc25dc6f6a9796_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjFiN2Q3NGM0MDc0NzQ4MDJiNDljYzA4ODZhNWVjZThjL3RhYmxlcmFuZ2U6MWI3ZDc0YzQwNzQ3NDgwMmI0OWNjMDg4NmE1ZWNlOGNfMy0xLTEtMS05NTExNw_da131ab1-2597-4930-80f4-3fedb81ffa8b"
      unitRef="usd">75533000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjFiN2Q3NGM0MDc0NzQ4MDJiNDljYzA4ODZhNWVjZThjL3RhYmxlcmFuZ2U6MWI3ZDc0YzQwNzQ3NDgwMmI0OWNjMDg4NmE1ZWNlOGNfNC0xLTEtMS05NTExNw_99a90d57-7af9-4263-a248-581d22b2649f"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRightsPolicyTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMjk_bbbc4a0f-3dc8-4f2e-bacf-e5637aaf5f8f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Commercial License Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. in January 2019. Commercial license rights acquired are accounted for as financial assets in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Receivables, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;as further discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of the Notes to Consolidated Financial Statements in our 2021 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three and nine months ended September&#160;30, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;</lgnd:CommercialLicenseRightsPolicyTextBlock>
    <lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNTA_0bb8aa29-0bae-4882-83c6-b051598d85cb">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.6 million and credit loss adjustments of $6.5 million as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7 million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7b95b921442e4621abaf805c9c6698fa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi0yLTEtMS05NTExNw_0455efa8-0077-4966-b781-2dc89c929f6f"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i7b95b921442e4621abaf805c9c6698fa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi00LTEtMS05NTExNw_eb90dd3f-a5f4-4d8f-9ff2-7a34c7cfa48f"
      unitRef="usd">9455000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7b95b921442e4621abaf805c9c6698fa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi02LTEtMS05NTExNw_d2f7ea47-84fc-4c5c-bce1-0fa34b826306"
      unitRef="usd">8241000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8c69d20029b545489f7ca2234d28aaa8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi04LTEtMS05NTExNw_fba83ee6-a778-4915-8199-83c6c10d86b0"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i8c69d20029b545489f7ca2234d28aaa8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi0xMC0xLTEtOTUxMTc_1170cb68-9604-4f14-92f0-6e04ab1d52a3"
      unitRef="usd">9461000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8c69d20029b545489f7ca2234d28aaa8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMi0xMi0xLTEtOTUxMTc_e214f348-26ae-4905-857e-e1d27f2f22e8"
      unitRef="usd">8235000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i73f41ef6652948d1841b05a5469daf7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy0yLTEtMS05NTExNw_fc0f3d50-336a-4064-8edc-df1641574673"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i73f41ef6652948d1841b05a5469daf7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy00LTEtMS05NTExNw_0a9e80be-5fb0-4218-a96e-5d635bb6eb20"
      unitRef="usd">8650000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i73f41ef6652948d1841b05a5469daf7f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy02LTEtMS05NTExNw_1efa762c-aade-48f8-bb16-e5090a4451cc"
      unitRef="usd">1952000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1cf12e3a53a14d8eb42d4b89b7cf304d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy04LTEtMS05NTExNw_5e07d225-7a8b-4d98-a078-c66d094da565"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i1cf12e3a53a14d8eb42d4b89b7cf304d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy0xMC0xLTEtOTUxMTc_8d256374-33ea-4497-a9d3-c128c3707742"
      unitRef="usd">8727000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1cf12e3a53a14d8eb42d4b89b7cf304d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfMy0xMi0xLTEtOTUxMTc_cfcb9a8d-1eb0-498b-9059-2f6aa2d95e14"
      unitRef="usd">1875000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie85097cc30914531bce5696bfe9a1638_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC0yLTEtMS05NTExNw_8491a837-586f-40a4-94d3-fca373cb7fc3"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="ie85097cc30914531bce5696bfe9a1638_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC00LTEtMS05NTExNw_d9c24d9b-c078-491f-8c9e-5da1ec33aff3"
      unitRef="usd">18105000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie85097cc30914531bce5696bfe9a1638_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC02LTEtMS05NTExNw_e8d9882a-17b2-4fad-89e9-2372356a4074"
      unitRef="usd">10193000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3ebb3d8dffba494eaf509dc473ba5887_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC04LTEtMS05NTExNw_5c208899-6603-4e54-9806-33ba9d8ffae9"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i3ebb3d8dffba494eaf509dc473ba5887_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC0xMC0xLTEtOTUxMTc_c14f3f8c-3394-44df-ba01-b9208d2adb3f"
      unitRef="usd">18188000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3ebb3d8dffba494eaf509dc473ba5887_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjkxNzYyMGZjNDQwYzRhMGZhMWMzZjNmNWNlOTAxOWU5L3RhYmxlcmFuZ2U6OTE3NjIwZmM0NDBjNGEwZmExYzNmM2Y1Y2U5MDE5ZTlfNC0xMi0xLTEtOTUxMTc_2ea86c25-86f1-48a1-9017-6c25d80cb8d0"
      unitRef="usd">10110000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie85097cc30914531bce5696bfe9a1638_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTA5OTUxMTY0OTI0NA_bf466789-2968-4a62-af0a-8855c9d88c00"
      unitRef="usd">11600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="ie85097cc30914531bce5696bfe9a1638_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTYzNzA_1f252207-8cd4-4e3a-8b0b-5742b73ad6cc"
      unitRef="usd">-6500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3ebb3d8dffba494eaf509dc473ba5887_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTY0NDY_52a4fcee-07a0-411f-9b1f-e885ab2dcf34"
      unitRef="usd">11700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="i3ebb3d8dffba494eaf509dc473ba5887_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTY0ODA_fe18cb70-eb0a-411b-9c44-b43ca1578554"
      unitRef="usd">-6500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMTk_7516a228-bbd9-4606-9ed7-7d915457472c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMi0xLTEtMS05NTExNw_ccc3ca67-8b5a-48df-b77c-7a11df7985c9"
      unitRef="usd">6229000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMi0zLTEtMS05NTExNw_a9fe48a0-7d5a-4838-92a0-47dc28615dac"
      unitRef="usd">6532000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMy0xLTEtMS05NTExNw_f9e71b1d-ef44-4a24-a2d9-f180a31efdfd"
      unitRef="usd">2848000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMy0zLTEtMS05NTExNw_d900de1b-a7bf-466a-affb-d8b7562907f2"
      unitRef="usd">2046000</us-gaap:AccruedProfessionalFeesCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNC0xLTEtMS05NTExNw_c19a568a-9819-4e8e-b6d1-85473d5a62eb"
      unitRef="usd">4042000</lgnd:LicenseeAccrualCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNC0zLTEtMS05NTExNw_34ae7bca-9ff3-4911-a70a-bd3041213f51"
      unitRef="usd">630000</lgnd:LicenseeAccrualCurrent>
    <lgnd:ReturnsAccrual
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNi0xLTEtMS05NTExNw_abd18448-ea9c-4465-b3e0-ebdd74227092"
      unitRef="usd">0</lgnd:ReturnsAccrual>
    <lgnd:ReturnsAccrual
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNi0zLTEtMS05NTExNw_576d25f2-f180-4fb9-9643-62d883ba4507"
      unitRef="usd">2420000</lgnd:ReturnsAccrual>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNy0xLTEtMS05NTExNw_90a1fdc8-68ce-4033-a037-86cd0793a7c7"
      unitRef="usd">0</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfNy0zLTEtMS05NTExNw_3b65b655-b19a-444e-86c5-c58166384e37"
      unitRef="usd">1000000</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfOC0xLTEtMS05NTExNw_1aa326b5-e89f-4ab3-8b60-2516b7e95c6e"
      unitRef="usd">1756000</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfOC0zLTEtMS05NTExNw_1cb2810c-d91a-4c02-b3cd-9de3751ca856"
      unitRef="usd">1759000</lgnd:AccruedSubcontractorExpensesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMTEtMS0xLTEtOTUxMTc_6ab36aa8-8906-4dee-8edd-a75cb9671f10"
      unitRef="usd">4463000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMTEtMy0xLTEtOTUxMTc_05232490-31da-428c-ba6b-ba6dc890d83a"
      unitRef="usd">3192000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMTItMS0xLTEtOTUxMTc_329df2c8-ccfb-4ebf-9f22-7868b3ce3c31"
      unitRef="usd">19338000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmNlOTZmMTgxM2M4MDQ0ZmM5ZjlmZTA5YzNhY2FjYjZhL3RhYmxlcmFuZ2U6Y2U5NmYxODEzYzgwNDRmYzlmOWZlMDljM2FjYWNiNmFfMTItMy0xLTEtOTUxMTc_0f3ef5e4-d954-42c6-8044-d5e5f77a8c1d"
      unitRef="usd">17579000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMTU_1aa483fd-e9aa-4c30-842b-be07b727e0d3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMzg_28dadd29-6323-4144-8f33-6bccf6e1ddac">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i321200c90e1841ba98e56d96bd03dca8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy0xLTEtMS05NTExNw_2a1cf51b-2cb4-42f8-aab1-fc6e16f1a025"
      unitRef="usd">6104000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i19b98503fe3c47908678fecb01ff99d3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy0zLTEtMS05NTExNw_51954843-bb6f-4632-b3f1-cf6589f4e3fd"
      unitRef="usd">4480000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i1920d37ac7d74b39bb53487c74e6eddb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy01LTEtMS05NTExNw_82fa6b7d-10fa-4139-ae1b-55dcdc88f643"
      unitRef="usd">14519000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i1920d37ac7d74b39bb53487c74e6eddb_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy01LTEtMS05NTExNw_b043c680-f53d-41b9-a9fe-095fdc59ec45"
      unitRef="usd">14519000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i3b02440b88c044d992035080107197f1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy03LTEtMS05NTExNw_d2e6a29e-9ec8-4da1-9cb2-6567c012b25d"
      unitRef="usd">12975000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i3b02440b88c044d992035080107197f1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfMy03LTEtMS05NTExNw_fefe5650-f2a8-450c-9978-f3b6b13ab268"
      unitRef="usd">12975000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i62640c7e221d4ddf9f77e8cd49490c14_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC0xLTEtMS05NTExNw_7fc44f67-d004-45bf-b8f2-a029987a792c"
      unitRef="usd">6493000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="iad2aaa41970748678e953d111259e623_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC0zLTEtMS05NTExNw_284aaf16-e7bd-43c7-9144-615986f22cf4"
      unitRef="usd">5274000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if3e5382a24354732b90a0c8d7480439c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC01LTEtMS05NTExNw_0acf3b6c-50db-4318-bbe9-67c46ffa6343"
      unitRef="usd">16621000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if3e5382a24354732b90a0c8d7480439c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC01LTEtMS05NTExNw_2b0ddccb-c39b-40d1-8e11-076df1adddba"
      unitRef="usd">16621000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ic86919d9459445b0acb504ef008126cb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC03LTEtMS05NTExNw_a1c8e842-49bd-4999-ba5c-fecc8210b053"
      unitRef="usd">15400000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ic86919d9459445b0acb504ef008126cb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNC03LTEtMS05NTExNw_e33a9416-a7ae-4e9d-b3b1-f2905745d5e8"
      unitRef="usd">15400000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNS0xLTEtMS05NTExNw_c5d75063-1771-467d-973a-20d626ea8375"
      unitRef="usd">12597000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNS0zLTEtMS05NTExNw_97e81475-532f-4ef5-be46-029f8cab169b"
      unitRef="usd">9754000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNS01LTEtMS05NTExNw_4e72da9c-4cc9-476f-b946-445e783f3cfc"
      unitRef="usd">31140000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOjRhMzc1MmNhODE0ODQ2NTM5MDRhZTBiZTNmNmU1NmMzL3RhYmxlcmFuZ2U6NGEzNzUyY2E4MTQ4NDY1MzkwNGFlMGJlM2Y2ZTU2YzNfNS03LTEtMS05NTExNw_e49058c2-fcf1-49d5-adf8-04c7d08d2497"
      unitRef="usd">28375000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNTM_36023a55-0c3c-4579-987f-424fdf82b21c">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy0xLTEtMS05NTExNw_33f0922d-42d9-4554-ae94-23a7734b6e45"
      unitRef="number">0.028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy0zLTEtMS05NTExNw_5a2a8c94-ce15-4eb2-8385-66c34b88a00f"
      unitRef="number">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy01LTEtMS05NTExNw_6f1ae708-641b-4cf6-ab19-aa3e4a628c2d"
      unitRef="number">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy01LTEtMS05NTExNw_960266da-d30f-48ca-b5a4-dc9586797b01"
      unitRef="number">0.029</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy03LTEtMS05NTExNw_263422a4-fc65-42b9-b7ae-35fb8af2959e"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfMy03LTEtMS05NTExNw_6a479f1d-ecc1-484f-adec-4e24e8051c17"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC0xLTEtMS05NTExNw_79585a30-4685-470e-ad75-3b1d9fcc058b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC0zLTEtMS05NTExNw_ddefe8f5-1206-438f-96db-14ff9586a21d"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC01LTEtMS05NTExNw_659a5478-eeac-4ee7-813a-e6cce4f07481"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC01LTEtMS05NTExNw_c29c7b44-5dc4-41f1-9a6d-cfd103b33ff3"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC03LTEtMS05NTExNw_34db0b39-7ec9-4e02-b49a-62fcdcaae7cf"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNC03LTEtMS05NTExNw_90ac3f3a-ce8c-483d-958f-4157f5083dee"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS0xLTEtMS05NTExNw_379f2653-cd68-4ded-a677-eb92162e040a"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS0zLTEtMS05NTExNw_ca0ad918-9380-4c08-befc-dd5b5f550626"
      unitRef="number">0.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS01LTEtMS05NTExNw_6a4cd086-79f6-4bec-bbab-61f1ce067400"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS01LTEtMS05NTExNw_da24d1fb-e177-46a5-9185-71acacc5cc04"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS03LTEtMS05NTExNw_1864e436-83f7-4233-befb-2e156a181f67"
      unitRef="number">0.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNS03LTEtMS05NTExNw_436ab003-02cc-4c1d-88b6-6714c7753bd5"
      unitRef="number">0.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNi0xLTEtMS05NTExNw_0c09ef6f-20cb-48ec-ac28-43404c3f84aa">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNi0zLTEtMS05NTExNw_17ffd122-9dfd-4cb0-8336-21780891e26a">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNi01LTEtMS05NTExNw_532fc20a-0220-4745-b307-e9d0301312ad">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmE3YTg5MDdkZTM5NjQzOWI4M2NhMzg5NWY0ZWRhNTEzL3RhYmxlcmFuZ2U6YTdhODkwN2RlMzk2NDM5YjgzY2EzODk1ZjRlZGE1MTNfNi03LTEtMS05NTExNw_4b118792-8d51-4546-93b2-c37ce4e3aa7a">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNzM_874a4263-2822-4238-84e8-cf0935b515b3">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i3f173828d5bf43d3b40f98cfda636157_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTg4MzM_e1b003fa-3510-45e2-88f5-796b9ff5cef5"
      unitRef="number">0</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i09fce991826e4593a4adb710b13eee0f_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMTg4Mzk_50052ea1-0c3e-4eb2-b6c1-7209450b77a4"
      unitRef="number">2</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyNDc_e9e35d6b-4c0a-4a4c-b8cd-e1716639825f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net (Loss) Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net (loss) income per share is calculated by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjEyMjY_7011037e-b5c0-4f2f-946e-f16fa1c9bed1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy0xLTEtMS05NTExNw_69130f1f-9ba1-4fa4-b992-3ad29970fb64"
      unitRef="shares">16888000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy0xLTEtMS05NTExNw_8aa0626f-27ac-4f04-9dff-ab2a12957755"
      unitRef="shares">16888000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy0zLTEtMS05NTExNw_3f451168-a822-4418-99c5-a1af7acb819b"
      unitRef="shares">16688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy01LTEtMS05NTExNw_2dee7072-3996-4919-ac42-2635f361975b"
      unitRef="shares">16860000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy01LTEtMS05NTExNw_a609f245-0783-44ca-9d27-6131c26b4191"
      unitRef="shares">16860000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy03LTEtMS05NTExNw_cca02332-651d-4090-a575-a68130287142"
      unitRef="shares">16595000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfMy03LTEtMS05NTExNw_fcc027d7-e581-4b70-a9cd-ae92217c82a1"
      unitRef="shares">16595000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id162adfcca81460486101e12b3597e00_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNS0xLTEtMS05NTExNw_7bffe9f9-b85e-41fa-b2f3-4ac17e08b4aa"
      unitRef="shares">65000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1bd82be627144b3482c05a70e537330b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNS0zLTEtMS05NTExNw_ffc87e0d-5689-4619-817e-1d408106a2cd"
      unitRef="shares">75000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i15c042b2ebf24feb89d24e634e666d27_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNS01LTEtMS05NTExNw_8f3e1c7a-9b86-4840-8db9-5f3a26cdd01e"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id1f728b109204a9a83575e9f16df629b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNS03LTEtMS05NTExNw_29bde807-fb8b-410a-87cb-325cc8786765"
      unitRef="shares">85000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i31dbf3fbde084ff3a4e51995b5baa515_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi0xLTEtMS05NTExNw_ed9e040f-82d4-4285-a6cf-bcc97ff91457"
      unitRef="shares">179000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7842cd71eeab430eb6922c6dc245b80a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi0zLTEtMS05NTExNw_366ad9a6-e047-49fe-8ea0-8cacbefafd0a"
      unitRef="shares">379000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi01LTEtMS05NTExNw_61ec666b-7a7c-4f46-b82b-f48140e56ee1"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i55c5ee22089f41b58b21043995b5b0e3_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi01LTEtMS05NTExNw_9a95d591-2e51-4b10-a402-31c71d67e730"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6ba11ede5ca045f4b14d3ba0dd1568fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi03LTEtMS05NTExNw_79b9d2e4-75f5-4fc4-9e5c-ee8460cd4032"
      unitRef="shares">507000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfNi03LTEtMS05NTExNw_c55d8988-0c1c-4059-8c50-a6011b54f07c"
      unitRef="shares">507000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOC0xLTEtMS05NTExNw_5a881a41-dfef-42b8-9f63-7b645ddb2b38"
      unitRef="shares">17132000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOC0zLTEtMS05NTExNw_d74053cd-d449-404c-91b8-e8b5992591cb"
      unitRef="shares">17142000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOC01LTEtMS05NTExNw_2cf4d4a3-abb3-4824-ad5c-c70107e7b540"
      unitRef="shares">16860000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOC03LTEtMS05NTExNw_7652985a-ee8a-48e4-a8cf-1e6a6f4ec219"
      unitRef="shares">17187000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS0xLTEtMS05NTExNw_6ded9d38-8d0a-4945-a7d9-8bf9763539a9"
      unitRef="shares">6706000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS0zLTEtMS05NTExNw_b1eba642-0ba2-4df0-bcfd-4403b57daa98"
      unitRef="shares">5574000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS01LTEtMS05NTExNw_40c45a7f-3ff7-4a66-8222-1972a4ba7667"
      unitRef="shares">6503000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS01LTEtMS05NTExNw_ed765a42-f32c-45d2-ac82-9fb19ed31466"
      unitRef="shares">6503000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS03LTEtMS05NTExNw_00e1b81f-13d8-405c-ae1a-f5a0a2b990df"
      unitRef="shares">4984000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RhYmxlOmFjYmVlYmUwZDU0ZTQ4ZWRiN2YyNjExYzA5M2NkOTNkL3RhYmxlcmFuZ2U6YWNiZWViZTBkNTRlNDhlZGI3ZjI2MTFjMDkzY2Q5M2RfOS03LTEtMS05NTExNw_83d1c867-40ef-4546-91e6-1c836a3656f9"
      unitRef="shares">4984000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i538684284d804c57bd3f118d72db7cbe_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjA3NzY_04be84f7-5240-4c4a-abe6-769b42b4ed19"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i766939c97c5b40dcb5b38a79e41a958f_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjA5Mzk_0f6b4c5e-0f0c-40be-807e-f158cd5f3157"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8da6cb831ae14f8089f18a5b3789e9dc_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNC9mcmFnOjYxZTE1MjVlNTRkYjQ0YzliNGQzZjRmYmRhNTAxZGEzL3RleHRyZWdpb246NjFlMTUyNWU1NGRiNDRjOWI0ZDNmNGZiZGE1MDFkYTNfMjA5Nzc_ceea5671-f036-44fa-bd8f-4c4f97823139"
      unitRef="shares">1100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RleHRyZWdpb246MDllNWNhODMzNGNhNDQ2NmE0OWFmNTQwY2MzNjY3ZjdfMzU0Nw_040a4734-12bf-4836-bf2c-73fcd6f58aca">Segment Information&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 280, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, establishes annual and interim reporting standards for an enterprise&#x2019;s operating segments and related disclosures about its products, services, geographic areas and major customers. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses, and for which discrete financial information is regularly evaluated by the chief operating decision maker in deciding how to allocate resources and assess performance. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our operating segments are identified in the same manner as they are reported internally and used by our chief operating decision maker for the purpose of evaluating performance and allocating resources. Historically, we have disclosed one reportable segment. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC would combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction (collectively, the &#x201c;Transactions&#x201d;). Immediately prior to the Merger and pursuant to the Separation Agreement, we, among other things, would transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#x201c;Reorganization&#x201d;) and, in connection therewith, would distribute (the &#x201c;Distribution&#x201d;) to Ligand stockholders 100% of the common stock of OmniAb. Immediately following the Distribution, Merger Sub would merge with and into OmniAb (the &#x201c;Merger&#x201d;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC. The entire transaction was completed on November 1, 2022. See Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Event&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the execution of the Merger Agreement, we made organizational changes to better align our organizational structure with our strategy and operations, and management has reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operated the following two reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. After the closing date of the Transactions, the historical financial results of OmniAb will be reflected in our consolidated financial statements as discontinued operations under GAAP for all periods presented through the date of the Distribution.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income (loss) represents income (loss) before income taxes, interest income, interest expense, other income (expense), net, unallocated share-based compensation, and unallocated corporate overhead. Our management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#x2019;s internal financial information as used for corporate management purposes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - Core &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Total Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;185,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;169,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shared-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i8f27bc960546423584fb5e22d31ba050_D20220101-20220322"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RleHRyZWdpb246MDllNWNhODMzNGNhNDQ2NmE0OWFmNTQwY2MzNjY3ZjdfOTQ3_95f1a39a-402a-48e4-9725-d8ea8298b17c"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i3c65682d715d4cebb23f79ad72073530_D20220323-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RleHRyZWdpb246MDllNWNhODMzNGNhNDQ2NmE0OWFmNTQwY2MzNjY3ZjdfMjIwMg_4b57d0eb-79c8-4e62-be01-ec9ad823e1a9"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RleHRyZWdpb246MDllNWNhODMzNGNhNDQ2NmE0OWFmNTQwY2MzNjY3ZjdfMzU0OA_769289ac-7105-4546-81ae-8b5aee644a66">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#x2019;s internal financial information as used for corporate management purposes (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - Core &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Total Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;185,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;169,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;91,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shared-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icba71108b7bb484f90495bc743d1cd62_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMy0xLTEtMS05NTExNw_1c747444-bc57-45ef-8b5e-71fccecf24f4"
      unitRef="usd">582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04151a540d6044408f287f42f0f848e3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMy0zLTEtMS05NTExNw_81a5e220-7390-4fd9-939d-e9e995dbc640"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i65de87043a1e4dcab7411f098886c292_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMy01LTEtMS05NTExNw_c4ee5cbe-12da-4482-b867-24ba5c78dc0a"
      unitRef="usd">984000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ad307c061f3441f89ff5551bae95b94_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMy03LTEtMS05NTExNw_de47d659-3a9e-4782-a916-62be8fad9823"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ac758bbffaf4b33b4bb7b96b8713d1a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNC0xLTEtMS05NTExNw_7be73c12-f4c8-4195-b2d1-9d84ae7063e8"
      unitRef="usd">6285000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfef621791484893826f75aa4da8f7d4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNC0zLTEtMS05NTExNw_dcfab4d9-29f3-4165-9d8f-b2f6c31773db"
      unitRef="usd">5140000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if060aacdc039409386f29263ea0888fe_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNC01LTEtMS05NTExNw_0476a386-6bb6-447a-a51e-2605eea474d8"
      unitRef="usd">22353000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia34a4d36cd974f88abc36f50a6cc10c1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNC03LTEtMS05NTExNw_df81bed1-69a2-47c7-9313-4f87b55dba11"
      unitRef="usd">19520000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i515e60d0096f49b39df04bcd1c448073_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNS0xLTEtMS05NTExNw_eefb44ee-bb93-4653-97b0-7cdb26d69a62"
      unitRef="usd">6867000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7806df4e0ca341bd947ac07ff78832bc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNS0zLTEtMS05NTExNw_962b85d6-3df9-420f-8d1d-fb8ca8d2e8b7"
      unitRef="usd">5140000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5584e6c9205484792148da209de79e0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNS01LTEtMS05NTExNw_65dad223-e093-4057-ba01-d3af54be0554"
      unitRef="usd">23337000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibac68a1cdeb3437cb24a409ec62e7ae0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNS03LTEtMS05NTExNw_a468fea1-1837-4e03-a221-a4122b2fa866"
      unitRef="usd">19520000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib56bece7e0da4f168b25d26c3a937bb8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNy0xLTEtMS05NTExNw_4f65b896-dbc5-49e9-afc6-f3ba89757232"
      unitRef="usd">19255000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30ae2842116c43ec9c4d10f553fb44c8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNy0zLTEtMS05NTExNw_28597dc6-ddc5-4d18-bd7d-8a31f561e1dd"
      unitRef="usd">15648000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cd956644674461e94c0667f968d8a8d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNy01LTEtMS05NTExNw_9fea9701-bfaf-43fd-ac8f-5bc5d9d6bfcb"
      unitRef="usd">50507000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a249f2388aa45ae9e1b4da3725d791b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfNy03LTEtMS05NTExNw_d2628055-108d-4d91-bd40-622a8ba06d2b"
      unitRef="usd">31376000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia87b96b5149b41818034e32448024dfb_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOC0xLTEtMS05NTExNw_df44eac8-6fc1-4373-954f-d6825b0310da"
      unitRef="usd">3582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2eac10c65b1641ffa06188a690f2aca9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOC0zLTEtMS05NTExNw_4451be74-558f-40c9-bf4f-0a89bc0bf57f"
      unitRef="usd">5374000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba465a7198d54ee7b6ad82d779858fd9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOC01LTEtMS05NTExNw_f0602c01-454f-479f-8720-9be33d887744"
      unitRef="usd">13133000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a5fa29dc2e848a7b2ac184d57a87bc3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOC03LTEtMS05NTExNw_14b4ed35-b1d4-4c5a-b77f-825da5ad4196"
      unitRef="usd">16310000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i904cf14c4b3e4fbeb3f577b716e29d42_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOS0xLTEtMS05NTExNw_1da8ccfa-1890-4b90-959d-0f887d85ba9e"
      unitRef="usd">32367000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib22143b247d14e49b1f87a41cebc0533_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOS0zLTEtMS05NTExNw_3612a063-a261-4671-bb21-ea4121572dc4"
      unitRef="usd">29719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0411fb172a764e2e92a29821f037280d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOS01LTEtMS05NTExNw_f52735f6-d080-41eb-b6d7-ea519110f050"
      unitRef="usd">64483000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78881cd8932b4b9093df9eaafe0b57dc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfOS03LTEtMS05NTExNw_c33e1752-5fe8-429a-93a6-4436186df1db"
      unitRef="usd">112565000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iabe4ebeb2dcf415199c31a3fe43b9779_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTAtMS0xLTEtOTUxMTc_a1e2c79c-8351-4f21-8989-28f065e8fcff"
      unitRef="usd">4017000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib76e0a2f4e02403e90689f0872ff43ca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTAtMy0xLTEtOTUxMTc_5f03d432-e1a6-49ed-8b3e-397b26f2df0f"
      unitRef="usd">8954000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71032e6cf99a4220b3ab9bdf9e1ce780_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTAtNS0xLTEtOTUxMTc_347b1c61-acb5-4613-b87b-d2eadbd590b1"
      unitRef="usd">17740000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb79cf209f1748b7aa2267af51ea59d2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTAtNy0xLTEtOTUxMTc_daea646f-fa79-4383-8ae7-1f7d6e128bfe"
      unitRef="usd">24889000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfd0f8876888448aad7af0288accc346_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTEtMS0xLTEtOTUxMTc_24dd6098-2f29-4209-9ed8-9286b6e91e04"
      unitRef="usd">59221000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3796b96c0d94c1da6299853875dac7c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTEtMy0xLTEtOTUxMTc_d6ece317-cd20-44d1-8ea3-d41baebf806a"
      unitRef="usd">59695000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if22d059e053745febd4c8b88a8df2cd8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTEtNS0xLTEtOTUxMTc_0d0b8b78-b681-4af8-b186-c63f3359703c"
      unitRef="usd">145863000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if30ec34df7ed4597981dae2bffa04dc6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTEtNy0xLTEtOTUxMTc_0559dead-f118-4553-8b6a-4808ce60b5de"
      unitRef="usd">185140000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2883789af81b412eaa37f1ebac40224b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTItMS0xLTEtOTUxMTc_193a3378-416d-4513-baf6-e407286ae82e"
      unitRef="usd">66088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0f10944b87f4bb2b93e8fac9eac402f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTItMy0xLTEtOTUxMTc_3ab15972-1623-4813-a9cd-37bb93319a10"
      unitRef="usd">64835000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf8fec3725d042efad094010d20f1c66_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTItNS0xLTEtOTUxMTc_d8f4a261-9525-48cd-81bc-5cb8bb56bc39"
      unitRef="usd">169200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93b00d99d3c34bc685177724979b4ff9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTItNy0xLTEtOTUxMTc_391fb849-8db6-4639-b8ae-1b5ca40f0a1a"
      unitRef="usd">204660000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i515e60d0096f49b39df04bcd1c448073_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTUtMS0xLTEtOTUxMTc_92d8a03f-c101-4cf2-8e61-99386e5f431c"
      unitRef="usd">-11721000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7806df4e0ca341bd947ac07ff78832bc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTUtMy0xLTEtOTUxMTc_3aec3439-c951-4d2b-9ac2-d85890f6b43d"
      unitRef="usd">-9177000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic5584e6c9205484792148da209de79e0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTUtNS0xLTEtOTUxMTc_1384bc70-61bb-49aa-af0a-181efa16c7e8"
      unitRef="usd">-26905000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibac68a1cdeb3437cb24a409ec62e7ae0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTUtNy0xLTEtOTUxMTc_f10422f2-4811-486a-b3a3-777aec13cd5d"
      unitRef="usd">-21587000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibfd0f8876888448aad7af0288accc346_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTYtMS0xLTEtOTUxMTc_6f739743-5c37-43fc-a944-3a9c5b335147"
      unitRef="usd">22022000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia3796b96c0d94c1da6299853875dac7c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTYtMy0xLTEtOTUxMTc_6a2f1692-f911-4662-8f3a-d0f0820dab94"
      unitRef="usd">32620000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if22d059e053745febd4c8b88a8df2cd8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTYtNS0xLTEtOTUxMTc_a9bdcfdd-16c8-48bf-9bfc-23ee68d6d1c3"
      unitRef="usd">49050000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if30ec34df7ed4597981dae2bffa04dc6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTYtNy0xLTEtOTUxMTc_5ab15b14-c63d-4a88-8ad8-f61c6fbd6188"
      unitRef="usd">112601000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2883789af81b412eaa37f1ebac40224b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTctMS0xLTEtOTUxMTc_7e0d44ae-f241-4ad3-8637-27a8d5fc4132"
      unitRef="usd">10301000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if0f10944b87f4bb2b93e8fac9eac402f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTctMy0xLTEtOTUxMTc_01ae8c43-75c8-4ae1-89b2-6bf33d82dd7a"
      unitRef="usd">23443000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iaf8fec3725d042efad094010d20f1c66_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTctNS0xLTEtOTUxMTc_58ef95a3-6505-4260-bdc2-0573e8b23eab"
      unitRef="usd">22145000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i93b00d99d3c34bc685177724979b4ff9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMTctNy0xLTEtOTUxMTc_e47154c6-5dcc-4dca-9ed1-b717f938430e"
      unitRef="usd">91014000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6bd2cbdef5c44f8fac9ee6db6ad8fc64_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjAtMS0xLTEtOTUxMTc_e5f5a2c8-9ca1-4ecf-8a81-f0314a440a79"
      unitRef="usd">6462000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib57783a54b7b44d0bfe7bfb7bd595b4f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjAtMy0xLTEtOTUxMTc_dbea4c2f-193c-4b32-b7a3-8aa3217a174a"
      unitRef="usd">5811000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4699144a009d4236a7a7d3ba4f5a71b6_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjAtNS0xLTEtOTUxMTc_4f07066c-c83c-4041-a497-cccb92a0d54d"
      unitRef="usd">17255000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i921e73649a7a4b69a8ed14e11dab4870_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjAtNy0xLTEtOTUxMTc_66ebdc18-1acb-4790-aa53-8d864c0a3336"
      unitRef="usd">16429000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i6bd2cbdef5c44f8fac9ee6db6ad8fc64_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjEtMS0xLTEtOTUxMTc_dce7881c-4286-4bd9-a8d1-9a47e012772b"
      unitRef="usd">3203000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="ib57783a54b7b44d0bfe7bfb7bd595b4f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjEtMy0xLTEtOTUxMTc_3e4b4ff6-2ed7-4ce9-a2f3-f210b220c84a"
      unitRef="usd">1926000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i4699144a009d4236a7a7d3ba4f5a71b6_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjEtNS0xLTEtOTUxMTc_c2656f9d-4bf0-462e-8d18-7d7201176be7"
      unitRef="usd">14029000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i921e73649a7a4b69a8ed14e11dab4870_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjEtNy0xLTEtOTUxMTc_1f0f845a-7685-41f5-90e6-6054381fddc0"
      unitRef="usd">8424000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i6bd2cbdef5c44f8fac9ee6db6ad8fc64_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjItMS0xLTEtOTUxMTc_d44e7e7d-2886-45f1-833b-0d24563f051e"
      unitRef="usd">9665000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ib57783a54b7b44d0bfe7bfb7bd595b4f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjItMy0xLTEtOTUxMTc_8942eece-0f56-435d-a418-cacb5555e672"
      unitRef="usd">7737000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i4699144a009d4236a7a7d3ba4f5a71b6_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjItNS0xLTEtOTUxMTc_d0fd4cb2-13b5-4464-b637-f48e17450418"
      unitRef="usd">31284000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i921e73649a7a4b69a8ed14e11dab4870_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjItNy0xLTEtOTUxMTc_4aa6c500-8178-4311-8fac-67342ac1c6dc"
      unitRef="usd">24853000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjMtMS0xLTEtOTUxMTc_5eab8c32-e5a3-4848-952a-eb0436e295b9"
      unitRef="usd">636000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjMtMy0xLTEtOTUxMTc_cdfad77b-e255-4ac8-9b58-e9063d3bdcee"
      unitRef="usd">15706000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjMtNS0xLTEtOTUxMTc_f1c0596b-e1dc-4656-a219-0dab72c59f56"
      unitRef="usd">-9139000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF8zNy9mcmFnOjA5ZTVjYTgzMzRjYTQ0NjZhNDlhZjU0MGNjMzY2N2Y3L3RhYmxlOjkwMTBlMzYyYTZjNTRlMDliMzVkNGI3ZmMzMmRlOWFmL3RhYmxlcmFuZ2U6OTAxMGUzNjJhNmM1NGUwOWIzNWQ0YjdmYzMyZGU5YWZfMjMtNy0xLTEtOTUxMTc_79127484-4795-4ee2-abfa-628377b7c431"
      unitRef="usd">66161000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfNTM2NQ_d7ca12ca-10c7-4329-92be-43b3b7cb69a5">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;94,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;94,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;117,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black-Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three and nine months ended September&#160;30, 2022, we adjusted the balance of the Metabasis CVR liability $0.1&#160;million and $(0.9)&#160;million to mark to market, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the nine months ended September&#160;30, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders, respectively. During the three and nine months ended September&#160;30, 2022, we adjusted the balance of the Icagen CVR liability $(0.2)&#160;million and $(0.5)&#160;million to mark to market, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. We concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three and nine months ended September&#160;30, 2022, we paid $1.0&#160;million contingent liabilities to former xCella shareholders. During the three and nine months ended September&#160;30, 2022, we recorded $0.5 million and $1.4 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of September&#160;30, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingent payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the organizational changes to the Company&#x2019;s reportable segments, we re-allocated goodwill between the two identified reporting units (OmniAb business and Ligand core business). We performed a goodwill impairment analysis immediately before and after the allocation of goodwill and concluded no impairment. At September 30, 2022, there were no indicators of impairment at either of the reporting units.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;At September 30, 2022, there were no indicators of impairment of our indefinite-lived intangible assets, or long-lived assets.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfNTM2NA_5d867837-1676-4279-9a4d-923dcaf6f2aa">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;94,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;99,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;94,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;117,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black-Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three and nine months ended September&#160;30, 2022, we adjusted the balance of the Metabasis CVR liability $0.1&#160;million and $(0.9)&#160;million to mark to market, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the nine months ended September&#160;30, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders, respectively. During the three and nine months ended September&#160;30, 2022, we adjusted the balance of the Icagen CVR liability $(0.2)&#160;million and $(0.5)&#160;million to mark to market, respectively.  &lt;/span&gt;&lt;/div&gt;4.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. We concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three and nine months ended September&#160;30, 2022, we paid $1.0&#160;million contingent liabilities to former xCella shareholders. During the three and nine months ended September&#160;30, 2022, we recorded $0.5 million and $1.4 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement, respectively.</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i9545ef6cc9054eaba5733eede4f83b2e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy0yLTEtMS05NTExNw_9eebf53d-6ba4-4d86-8c60-c2d1c84c75b2"
      unitRef="usd">4649000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id45baf2e1b7e452fa0ab3dee1b630a5e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy00LTEtMS05NTExNw_4357e579-fa2f-441b-a316-79c368a7a891"
      unitRef="usd">94145000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibb9c3ea5d1f94844bc6846f65c475bf2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy02LTEtMS05NTExNw_97f36247-fd3a-46af-b1de-9dbca1ffaf2e"
      unitRef="usd">232000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia44e8d68d457441f87d096b99b424cf9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy04LTEtMS05NTExNw_de926130-1d99-475c-b4d7-0feb8dc8a2b6"
      unitRef="usd">99026000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="idf43f3e6122f485d9604b85bdf24ca9a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy0xMC0xLTEtOTUxMTc_5992ae1e-d1a6-4a82-aeb1-1fb945cbaace"
      unitRef="usd">9735000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i409fb78206fa48e885e9a25ffed9be5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy0xMi0xLTEtOTUxMTc_5757fc68-362f-4dcc-a287-67ec1572d312"
      unitRef="usd">280553000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i02baf2e63f634118acc0b5cecd635f91_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy0xNC0xLTEtOTUxMTc_9c25dbe2-fdea-4a83-8ce1-ed686485770a"
      unitRef="usd">409000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="iea813cc62405437f966419cf2bf8c12d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMy0xNi0xLTEtOTUxMTc_ab7bdb47-d1da-40c5-8d50-fc97d270a452"
      unitRef="usd">290697000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iabc8605b5b5b4402bfa40c6f86cc4521_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC0yLTEtMS05NTExNw_b6111116-e8c2-4fd1-8992-0bb553692c93"
      unitRef="usd">18265000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i4f66174ae3354eb19f957fd4f8e8990f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC00LTEtMS05NTExNw_af540691-da98-469a-b750-90b4ae4c926d"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2e5a64e988a14bc3acc1c82b5a5bc74d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC02LTEtMS05NTExNw_09215555-3c9f-4be6-ad3a-b1f5144de110"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i1c4985c47c384c0b9b0ab0008644e5a3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC04LTEtMS05NTExNw_0fe24584-4a86-4d1a-ae2b-afeba924ee2b"
      unitRef="usd">18265000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="if45e52f2a26442e8b69b942641647814_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC0xMC0xLTEtOTUxMTc_a5dbf3e3-8f1e-4195-9188-e54da942c9ba"
      unitRef="usd">30889000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i006d5206c32b4ffa8c5bf11c4c32263d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC0xMi0xLTEtOTUxMTc_540ac133-03c3-4aef-87c4-c75fd47b9a98"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3eb2b3352eca4a009a173f9f0a39cc12_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC0xNC0xLTEtOTUxMTc_df5c64df-45a4-4bfe-994e-a71cd46fc4f4"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i29ad1d75d22a4e3f98195a322aa7aadc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNC0xNi0xLTEtOTUxMTc_275a20dd-c1e4-46de-88ab-0062d8cf1398"
      unitRef="usd">30889000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i82abec3a44c5436095d8c4e9189adff4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi0yLTEtMS05NTExNw_f5616ca9-e4e0-47dd-a282-8280312d2d87"
      unitRef="usd">22914000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i68afa5ce123e446ea968ab4615153660_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi00LTEtMS05NTExNw_7401dba7-ffd4-4463-893e-f73d96fceb53"
      unitRef="usd">94145000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2c76ceca320043319a729e346c30af96_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi02LTEtMS05NTExNw_243ec129-885e-4fd9-b578-b9aaea54413c"
      unitRef="usd">232000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i32d528942e7f4eec9ed16811189f131e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi04LTEtMS05NTExNw_dcf0ff64-9f2d-493f-881e-da56fe94b1a9"
      unitRef="usd">117291000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia70b1f37b5444463a665afeeb29fee23_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi0xMC0xLTEtOTUxMTc_230889fb-5550-4610-9185-4c9ca57da23e"
      unitRef="usd">40624000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6d63d2ebe7124c6c92192fbb621ceb55_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi0xMi0xLTEtOTUxMTc_aa78e02d-4750-4b6d-ac6b-c4af83606615"
      unitRef="usd">280553000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iaa6c7430ceed408ea0129815282f022b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi0xNC0xLTEtOTUxMTc_94486e06-57b4-478e-bfc0-ddb518082212"
      unitRef="usd">409000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9c4aa673a44a49ba91b41ff1867085ff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfNi0xNi0xLTEtOTUxMTc_b5b5ee83-5e11-45d5-850b-5020e40f05be"
      unitRef="usd">321586000</us-gaap:AssetsFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i8aa4c6644f944c0691c442c1da40ed28_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS0yLTEtMS05NTExNw_3ba030a7-bbb0-40c3-99a2-5f7af327b4ed"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="id0e423a6748f4ef5bf5198b8c0ddff62_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS00LTEtMS05NTExNw_1e52ebfa-0f83-44f5-8cd8-c2d0d39e39aa"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i0c75467deb3e4ddab92d1873ad3c9a15_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS02LTEtMS05NTExNw_358e2114-85fc-46d7-a0b4-18a88809e99a"
      unitRef="usd">308000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i2a46d7016abc41c5a9d9d807b0e437fc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS04LTEtMS05NTExNw_22058ac8-28e0-469e-916d-c4c9aa06fae5"
      unitRef="usd">308000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ia76e9fffc6114de8a391f206f62e3b3b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS0xMC0xLTEtOTUxMTc_9bee1fbf-c44a-420c-85e1-e1eb54fc0773"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ib4d765504d314a2aa80653e6e6cf32d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS0xMi0xLTEtOTUxMTc_7aa40b6d-8dce-48a3-8c6d-c47e22ed65bd"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ic4fa076f03644041966c14890e83f8e8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS0xNC0xLTEtOTUxMTc_cd547883-1251-4786-a089-8925a5ab1f5e"
      unitRef="usd">349000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i374aa010c5c546cd97bd8012be328ef2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfOS0xNi0xLTEtOTUxMTc_3ea8c159-6bb4-4ae8-a751-faa3b86a98fc"
      unitRef="usd">349000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i417f205a3d994398aa39d14f0aeb46d2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtMi0xLTEtOTUxMTc_a868e70c-a3a0-43c3-9034-d5f23bcb5375"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="id95d5b3a71314067be9a4acc1f0dec9d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtNC0xLTEtOTUxMTc_7f030216-5881-40ef-9e27-875207e6effd"
      unitRef="usd">2507000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i558cfad5a49e4d288fcb31a70e3d0423_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtNi0xLTEtOTUxMTc_4caa87af-bd30-4e61-9fed-20c02d887324"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i7b8eba0c2f244c68897f2c465f695cb4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtOC0xLTEtOTUxMTc_e5336867-bc30-47be-bddb-8e14636bb27d"
      unitRef="usd">2507000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i6cb0b263e3124cc9a0aca9d63fe8c3a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtMTAtMS0xLTk1MTE3_d54dfbb7-12c0-4278-8990-4b1d7fdea88a"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i177d784a77a54241a81da1f857fb9dce_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtMTItMS0xLTk1MTE3_5e4805ba-c1c3-4752-a68e-11fe30a57cf3"
      unitRef="usd">3358000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i1658e372295b494fa6a5129e877086f8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtMTQtMS0xLTk1MTE3_1931b4c0-09c9-412d-bb31-b5e1408480e5"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ib5196ee4cc484b1a8f52931d60ad16ca_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTAtMTYtMS0xLTk1MTE3_9ef55dd9-bfd4-4dd7-95c1-383a23e8638a"
      unitRef="usd">3358000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ic3ac0c4007a846e08014e8ab0f432750_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtMi0xLTEtOTUxMTc_c033be29-0e4f-4310-af82-82d215335163"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i0b43473351914f1a86d1acd39584c6c2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtNC0xLTEtOTUxMTc_eb90db9e-7050-4391-82a0-ce0f22504e8c"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i67aecd998ffc4380be51824531348e09_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtNi0xLTEtOTUxMTc_c7daf9f8-1ea0-4a57-9d14-6d3e0a5ecdec"
      unitRef="usd">5333000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="iebb7edd5169d406595ad57436f4ba57d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtOC0xLTEtOTUxMTc_11a4ea84-5bcb-4a38-9e14-a185440711c8"
      unitRef="usd">5333000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i5a6c5227f1ae46e7a867099dc194d21d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtMTAtMS0xLTk1MTE3_b2b1532c-7621-4c0a-9214-87824a070796"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i1e226666ee01416ea4437da7b90c7394_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtMTItMS0xLTk1MTE3_57d073e2-81d6-44f4-a2b5-208444562e5d"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i8807f0f1743448e897e2affdf0d534b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtMTQtMS0xLTk1MTE3_1b27ecee-a014-4d8e-a95c-689c09af2ab2"
      unitRef="usd">7364000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i82de593bdc9e4da984cd72ffbd180620_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTEtMTYtMS0xLTk1MTE3_27c12948-8cfd-4153-8ea1-2ad7bae23372"
      unitRef="usd">7364000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i7e4dff2f452e42e5b71d10fe5e7de15c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItMi0xLTEtOTUxMTc_7b1afd73-7dc0-4576-a2e8-c0a433d45af3"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i735aa43de0d8473b978acefb4731c01e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItNC0xLTEtOTUxMTc_c4ef9b35-0101-4d3a-88c7-1681b8110fe3"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i88db7dab6b7a424a8ab88ea1d64e42ee_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItNi0xLTEtOTUxMTc_32e5501f-6940-4afc-9990-a8cff03ec9a9"
      unitRef="usd">480000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i9ee4885695b241d9affa4f86640bf9aa_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItOC0xLTEtOTUxMTc_59cbe33a-022b-46e2-81ab-7e0b6ab29a4b"
      unitRef="usd">480000</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i4e74edc9a24a4d4aba01db56acc201d4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItMTAtMS0xLTk1MTE3_110b5fab-f9dc-4d12-b8f6-7b97b72c3ff2"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i7a71ba97a53b4cc0889174ac02780ee4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItMTItMS0xLTk1MTE3_634e4f8d-85f7-4178-b982-c930b1919f0b"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="ic942e4443ee741a5b559256a2d777257_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItMTQtMS0xLTk1MTE3_1e16ce53-8f05-4c41-96f2-6b385f332c5a"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure
      contextRef="i32d71f9ce3064ebfae407232f08153f1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTItMTYtMS0xLTk1MTE3_ecaeadbe-2284-4436-ba6a-894cfdaf184c"
      unitRef="usd">0</lgnd:BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="i82abec3a44c5436095d8c4e9189adff4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtMi0xLTEtOTUxMTc_8243e588-12db-45ed-8eaa-ca5f7b0f8e86"
      unitRef="usd">73000</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="i68afa5ce123e446ea968ab4615153660_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtNC0xLTEtOTUxMTc_836d4cdf-0535-4822-b10d-ba8996991c0a"
      unitRef="usd">0</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="i2c76ceca320043319a729e346c30af96_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtNi0xLTEtOTUxMTc_a00ce694-3ad3-4213-bb93-93a5ee6b9c5e"
      unitRef="usd">0</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="i32d528942e7f4eec9ed16811189f131e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtOC0xLTEtOTUxMTc_d04d6020-468f-456a-a2fb-923512d5a6bb"
      unitRef="usd">73000</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="ia70b1f37b5444463a665afeeb29fee23_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtMTAtMS0xLTk1MTE3_f79ee217-d1f1-43d3-8f2c-4840c7865379"
      unitRef="usd">86000</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="i6d63d2ebe7124c6c92192fbb621ceb55_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtMTItMS0xLTk1MTE3_bbf3eb30-3f8e-46ff-8c16-84426dc900a9"
      unitRef="usd">0</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="iaa6c7430ceed408ea0129815282f022b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtMTQtMS0xLTk1MTE3_6aeae50d-a504-42bc-93f8-9cda73200394"
      unitRef="usd">0</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <lgnd:AmountsOwedToFormerLicensorFairValueDisclosure
      contextRef="i9c4aa673a44a49ba91b41ff1867085ff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTMtMTYtMS0xLTk1MTE3_9c387531-7ed0-4ead-afb0-59177dea8d79"
      unitRef="usd">86000</lgnd:AmountsOwedToFormerLicensorFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i82abec3a44c5436095d8c4e9189adff4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtMi0xLTEtOTUxMTc_c491da85-98be-4935-a197-420575f8fcdb"
      unitRef="usd">73000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i68afa5ce123e446ea968ab4615153660_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtNC0xLTEtOTUxMTc_c860e9f3-6174-42c3-b9e0-fe86a4e425a4"
      unitRef="usd">2507000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2c76ceca320043319a729e346c30af96_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtNi0xLTEtOTUxMTc_12038643-7294-4ad5-a625-a3b7c1e14212"
      unitRef="usd">6121000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i32d528942e7f4eec9ed16811189f131e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtOC0xLTEtOTUxMTc_cee42954-cec8-432a-a739-f92e38fe7a30"
      unitRef="usd">8701000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia70b1f37b5444463a665afeeb29fee23_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtMTAtMS0xLTk1MTE3_3c0ef7c2-4568-437b-be91-286a47d6c7f7"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6d63d2ebe7124c6c92192fbb621ceb55_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtMTItMS0xLTk1MTE3_dd380fb2-204e-42ea-b764-c0865e29503f"
      unitRef="usd">3358000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iaa6c7430ceed408ea0129815282f022b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtMTQtMS0xLTk1MTE3_6c01245c-d855-42bb-b0b6-44b1365cc2b7"
      unitRef="usd">7713000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9c4aa673a44a49ba91b41ff1867085ff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmY4NWE4YWFhYTYxZDRhNzFhYTlhNjg1NTYzMzMzNDk2L3RhYmxlcmFuZ2U6Zjg1YThhYWFhNjFkNGE3MWFhOWE2ODU1NjMzMzM0OTZfMTQtMTYtMS0xLTk1MTE3_06d8fbbd-ff2a-4652-b9a3-0e960134dbf7"
      unitRef="usd">11157000</us-gaap:LiabilitiesFairValueDisclosure>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare
      contextRef="iea631c13053d4cb9a6c3ec25bbe89909_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMTQ0Mg_2f793654-da58-4049-8a14-74110c5c9f53"
      unitRef="contingent_value_right">4</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries
      contextRef="iea631c13053d4cb9a6c3ec25bbe89909_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMTQ2MA_79323b5f-2e98-4348-af4b-554044fdf642"
      unitRef="contingent_value_right">1</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries>
    <lgnd:NumberOfContingentValueRightsSeries
      contextRef="ia610e91d108b4828b2e383faf35f060c_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMTQ4MA_c1fb8e38-6860-474a-91d4-57867cd77b79"
      unitRef="contingent_value_right">4</lgnd:NumberOfContingentValueRightsSeries>
    <lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders
      contextRef="iea631c13053d4cb9a6c3ec25bbe89909_D20100101-20100131"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMTYxNQ_5c03a8c0-530c-465d-8293-43321609ea78">P6M</lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders>
    <us-gaap:Investments
      contextRef="i58dbd9eaa0a046348cb63f5bc71bc4e8_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMjQxNw_a9e3f832-da34-496f-88f0-4bea4014bd65"
      unitRef="usd">375000000</us-gaap:Investments>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i8ae80f0d98ee484383b7285db27e3bf8_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMjUzMg_988b06ff-cbcc-4e8b-82df-22dea864fe5f"
      unitRef="usd">10000000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i7dfa24a16ddb4468b3057a86ea1992f8_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMjY2Mg_f608d893-02b4-480c-bf95-e3d9fcee6bdc"
      unitRef="usd">100000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i286c91cbf234442b92d18be9042ac0d1_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMjY2OQ_515de574-45ae-42fa-b771-b9975e3a9411"
      unitRef="usd">-900000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i2a563f07df03433d9f3b406175fa5e0d_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzI2MQ_c3b3edbb-ab37-4e6b-8686-9da36cb6ca73"
      unitRef="usd">1500000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i52253af912264b92a50089624acefcd3_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzQyOA_a71edece-7cbc-4a28-bd42-80efc7b3b382"
      unitRef="usd">-200000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i2a563f07df03433d9f3b406175fa5e0d_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzQzNQ_1b9269c1-ddcd-4eb5-81e1-655f87fdb559"
      unitRef="usd">-500000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="i1b2e23fc4a3943ad849d871cbc73bb3d_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzI5ODUzNDg4ODk4MQ_2c0cb1c4-12e1-4e66-879b-162b5e7e16d0"
      unitRef="usd">1000000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="iae8e9c1682aa4055a75677062d0d3067_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzI5ODUzNDg4ODk4MQ_2ebae6af-5439-452e-9766-003f86fd64cb"
      unitRef="usd">1000000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="i28ca9f03e482413a80f84d8327155d06_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzc4Ng_04193cb2-d547-42f6-899f-9caad1567f7c"
      unitRef="usd">500000</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="ia13f08ef2fec488aa3e23297a819a673_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfMzc5Mw_b68b5cfb-6ed8-4ca4-8795-cb9bbff3a6db"
      unitRef="usd">1400000</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfNTM2MA_fc0a7967-7dc9-4573-bb74-ff9c80d74cc8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of September&#160;30, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingent payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="idf669638100c407a84acc68049e05107_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmUyZDA0MWNlMjlmZjRkYzliZjQ5MTg0ZjY2MGJjNjkxL3RhYmxlcmFuZ2U6ZTJkMDQxY2UyOWZmNGRjOWJmNDkxODRmNjYwYmM2OTFfMC0xLTEtMS05NTExNw_fb544fb9-9cf8-4df6-ad55-ac0c2bdb8e0c"
      unitRef="usd">7713000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="ib34d5ea9024943dab91936ef12ad4821_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmUyZDA0MWNlMjlmZjRkYzliZjQ5MTg0ZjY2MGJjNjkxL3RhYmxlcmFuZ2U6ZTJkMDQxY2UyOWZmNGRjOWJmNDkxODRmNjYwYmM2OTFfMS0xLTEtMS05NTExNw_ac003073-5bca-4ae1-b07f-1d3ae747e6f6"
      unitRef="usd">2505000</lgnd:PaymentsToContingentValueRightHolders>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ib34d5ea9024943dab91936ef12ad4821_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmUyZDA0MWNlMjlmZjRkYzliZjQ5MTg0ZjY2MGJjNjkxL3RhYmxlcmFuZ2U6ZTJkMDQxY2UyOWZmNGRjOWJmNDkxODRmNjYwYmM2OTFfMi0xLTEtMS05NTExNw_9280db99-b81a-45df-912d-a143511b6d32"
      unitRef="usd">-527000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition
      contextRef="ib34d5ea9024943dab91936ef12ad4821_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmUyZDA0MWNlMjlmZjRkYzliZjQ5MTg0ZjY2MGJjNjkxL3RhYmxlcmFuZ2U6ZTJkMDQxY2UyOWZmNGRjOWJmNDkxODRmNjYwYmM2OTFfMy0xLTEtMS05NTExNw_f1fe5faa-3d85-4086-841b-7cd02c0c2460"
      unitRef="usd">1440000</lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i853e09d80a6a46aabdbe6bf00b059c13_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RhYmxlOmUyZDA0MWNlMjlmZjRkYzliZjQ5MTg0ZjY2MGJjNjkxL3RhYmxlcmFuZ2U6ZTJkMDQxY2UyOWZmNGRjOWJmNDkxODRmNjYwYmM2OTFfNC0xLTEtMS05NTExNw_b6a09d4b-03d0-4cc1-87c5-58f2c678019f"
      unitRef="usd">6121000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:NumberOfReportingUnits
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80MC9mcmFnOjZmMGVjNTZlMGFjNjQwZWY5MzRmMjdhNjU0MzVjOTMzL3RleHRyZWdpb246NmYwZWM1NmUwYWM2NDBlZjkzNGYyN2E2NTQzNWM5MzNfNDk0Mg_c161b0a9-5245-46b9-a339-6d1d0b2f58e8"
      unitRef="reporting_unit">2</us-gaap:NumberOfReportingUnits>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzY3NA_5af0ff13-01af-4cd5-b695-44f93af177df">Convertible Senior Notes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share. The maximum conversion rate of the 2023 Notes is 5.2317 per $1,000 principal amount of the 2023 Notes which represents a maximum conversion price of approximately $191.14. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes (the&#x201c;Indenture&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In advance of the Distribution of the shares of common stock of OmniAb to Ligand&#x2019;s shareholders on November 1, 2022, a notice of convertibility was delivered to the holders of the 2023 Notes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No holders exercised their right to convert their 2023 Notes during the applicable period for conversion.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The conversion rate for the 2023 Notes will be adjusted in accordance with the requirements of the Indenture based on calculations determined with reference to a valuation period of the first 10 consecutive trading days after, and including, the ex-dvidend date of the spin-off (as determined in the Indenture).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48 (not accounting for the anticipated adjustment in the conversion rate). In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes, and the effective interest rate as of September&#160;30, 2022 is 0.5%.  During the three months ended September&#160;30, 2022 we recognized a total of $0.3&#160;million in interest expense which includes $0.2&#160;million in contractual interest expense and $0.1&#160;million in amortized issuance costs. During the nine months ended September&#160;30, 2022 we recognized a total of $1.5&#160;million in interest expense which includes $0.9&#160;million in contractual interest expense and $0.6&#160;million in amortized issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million. After the repurchases, approximately $343.3&#160;million in principal amount of the 2023 Notes were outstanding as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September&#160;30, 2022, we repurchased $38.6&#160;million in principal amount of the 2023 Notes for $37.7&#160;million in cash, including accrued interest of $0.1&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $0.9&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended September 30, 2022, and a $0.1&#160;million reduction in debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2022, we repurchased $266.4&#160;million in principal amount of the 2023 Notes for $261.4&#160;million in cash, including accrued interest of $0.5&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $4.2&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the nine months ended September 30, 2022, and a $1.3&#160;million reduction in debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Bond Hedge and Warrant Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, in connection with the repurchases of approximately $20.3&#160;million in principal of the 2023 Notes for approximately $19.1&#160;million in cash, including accrued interest of $0.1&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp;amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, in connection with the repurchases of $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. We received $18.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 598,021 as of December 31, 2021. These unwind transactions resulted in a $0.5&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, in connection with the repurchases of $227.8&#160;million in principal of the 2023 Notes for $223.7&#160;million in cash, including accrued interest of $0.4&#160;million made during the six months ended June 30, 2022, we entered into Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We received $0.2&#160;million as part of these Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 370,219 as of September 30, 2022. This transaction resulted in a $0.2&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of September 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMzU_a3951594-6dcc-47bb-a309-a5784d3d8a91"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfOTY_11752935-000a-4d87-829e-b4d16eccc695"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTI5_1998e37b-cdab-4db4-a4bd-0a4a017c1022"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i4e2b8f073bbb4eeea44fc317eeee6bed_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjg1_9e60b18e-5e65-4b2f-9c4a-8dc2077efd7e"
      unitRef="usd">733100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjA2_9bb5bed6-8bdc-495c-a07b-83f37004fa09"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i238c5b93b270426ea69664bad2955dba_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzc2_2d757748-ed49-431d-811c-ad8ad8683377"
      unitRef="usdPerShare">191.14</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i18ad0006f29c4e3782c1405fa1ec6c0f_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTEwMA_25b2830b-ed6d-4836-a5a6-0f2935bc5458"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i18ad0006f29c4e3782c1405fa1ec6c0f_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTE1Ng_f34a7469-378c-45a5-a428-756e1c545dfd"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i18ad0006f29c4e3782c1405fa1ec6c0f_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTM1MQ_e29c532b-dbee-4c29-8b09-c3c78c12a721"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ifd2de700e7ee4f82b95550662f3e922e_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTQxNg_866f1afd-fe3e-474d-8eb7-e91830fa70b2"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ifd2de700e7ee4f82b95550662f3e922e_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTQ2NQ_1a40b225-44fc-46e3-87cf-c9897eb3c838"
      unitRef="d">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger
      contextRef="ifd2de700e7ee4f82b95550662f3e922e_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTU3NA_8b28902a-585b-42a8-b104-2b99bd02e99e"
      unitRef="number">0.98</lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ie91d13b37a564e829094c6726d7a24e2_D20221101-20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzNDUxMg_7c66f336-722c-4367-88e2-0a75afc43a2c"
      unitRef="d">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMTk5OA_26e166b8-44a7-46bc-bcbc-b18854d676f9"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjA2NQ_28936958-8a91-46aa-82bf-8c9bab628f56"
      unitRef="usd">16900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentTerm
      contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzY3Ng_dff4f03d-8ae7-45b6-88cc-c6c7b2c92f55">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjMyOA_a5572945-23c6-4fe0-ba0b-6d00f192f5d1"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="ief8861b3c3714c46851e7e25c053e239_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjM3NQ_1058c8f8-6f66-49be-8e99-f13d1ff616ef"
      unitRef="usd">300000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ief8861b3c3714c46851e7e25c053e239_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjQxMw_8f18efa3-cf33-4eb4-90cc-60ee921af4dd"
      unitRef="usd">200000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ief8861b3c3714c46851e7e25c053e239_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjQ1Mg_f74e649d-5ade-4370-9957-9506754d5d87"
      unitRef="usd">100000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjUyNg_e1bcd97d-019f-4369-a704-fe8cb748fa4a"
      unitRef="usd">1500000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjU2NA_c4f2cae0-cb52-4629-87e3-9197869c72aa"
      unitRef="usd">900000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjYwMw_55dddf5e-c99e-483e-8a56-ac780c1fbe95"
      unitRef="usd">600000</us-gaap:AmortizationOfFinancingCosts>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjkyNw_43efa4e4-0587-4307-8c38-2ed187c583db"
      unitRef="usd">152000000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMjk2NQ_22cb6dc0-9fae-4712-944b-c405af08e84b"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMzAwNw_87f66afe-f669-4249-9f05-4474c4e17002"
      unitRef="usd">300000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfMzA0OA_af44eb3c-fbc7-48e0-92d4-831a51272170"
      unitRef="usd">343300000</us-gaap:DebtInstrumentCarryingAmount>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzIxNA_3a61cf44-e1a9-4339-ab83-8d8533552886"
      unitRef="usd">38600000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzM0Ng_79a6e46e-767a-46f3-8174-589b466afe3d"
      unitRef="usd">37700000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzIyOQ_5706d271-0f18-4b42-a19f-18abfc3f671e"
      unitRef="usd">100000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzI0NA_0bb9a910-5f22-49e6-98de-11fe35e0aa88"
      unitRef="usd">900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="if836e1e1ecfb4e1fb0630817a4b56f29_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzI1OA_6db261e5-63d9-43fd-9409-fcf635bb831f"
      unitRef="usd">-100000</lgnd:IncreaseDecreaseInDebtDiscount>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzI3Mg_1e3711d6-d0ae-45cf-833d-ece8934c1b1d"
      unitRef="usd">266400000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzMzMA_254bd483-ebe8-4438-a552-8143de869088"
      unitRef="usd">261400000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzI4OA_1359cc05-7eac-410d-a53c-fa1b656c6f03"
      unitRef="usd">500000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzMxNg_96868d4d-0379-4433-ac91-56ca97e5e7cd"
      unitRef="usd">4200000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="ib59bf2ec3e0d4b229bef0036e6e4318e_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzMwMg_8299bef0-7f8e-466b-a831-3b7886fa9f31"
      unitRef="usd">-1300000</lgnd:IncreaseDecreaseInDebtDiscount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNDA1Nw_634fa449-e967-45d7-8584-c801d049310b"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNDMzMQ_9335aac1-9f67-4885-9062-3e1c27ec3a35"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <lgnd:PaymentsForConvertibleBondHedges
      contextRef="i4e2b8f073bbb4eeea44fc317eeee6bed_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNDQxNA_bcf37870-505b-44c5-bfbb-8fdc80892dd0"
      unitRef="usd">140300000</lgnd:PaymentsForConvertibleBondHedges>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTMxNA_b8024107-cebf-47b9-8753-f27f68fa791b"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTM4MA_729460a5-45e2-4558-8af4-548e7823958b"
      unitRef="usdPerShare">315.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i4e2b8f073bbb4eeea44fc317eeee6bed_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQzOA_9bf6adfa-cc36-49ff-8d89-fa3aabab69ea"
      unitRef="usd">90000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="ie7d9a25c6c2143cfb4d8e1a7ebe0d185_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjA4MQ_5f71141e-cb4c-4987-ac7e-ffe86f02fad2"
      unitRef="usd">20300000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ie7d9a25c6c2143cfb4d8e1a7ebe0d185_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjEzMw_95a764e1-f178-4343-8661-960c5cfbe1c1"
      unitRef="usd">19100000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="ie7d9a25c6c2143cfb4d8e1a7ebe0d185_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjE3NQ_9c8c97d3-7d8b-4b13-b8f1-b85b85ac8ada"
      unitRef="usd">100000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjcxMg_3a9fc04b-cb1c-4cf3-8428-5ad8c8402efb"
      unitRef="usd">152000000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjc1MA_0fd5b126-045e-4fae-bfaf-93bc0c5984da"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="id55f80c84c954aac902f9ee2c887a327_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNjc5Mg_f2851f1d-c7e3-428e-a14a-83343516649f"
      unitRef="usd">300000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <lgnd:PaymentsToUnwindWarrants
      contextRef="ice5667b832bb46b58768234cec087173_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzA5Ng_e731c165-f6a6-423d-8f60-dfdda1ab0b78"
      unitRef="usd">18400000</lgnd:PaymentsToUnwindWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ic581556cc99e423a81de86ed53ca8b39_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzIwNQ_634fa449-e967-45d7-8584-c801d049310b"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzIxMQ_b41a9d5e-5d5a-4286-81b3-3a5e58dc323a"
      unitRef="shares">2559254</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <lgnd:ProceedsFromUnwindingConvertibleBondHedges
      contextRef="ice5667b832bb46b58768234cec087173_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzIyNw_83591f7f-2c70-42b9-9c34-53bedd226da0"
      unitRef="usd">18900000</lgnd:ProceedsFromUnwindingConvertibleBondHedges>
    <lgnd:NumberOfOptionsUnderConvertibleBondHedges
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzM0OA_451b90a8-782d-4c1f-9d16-466add327a3c"
      unitRef="option">598021</lgnd:NumberOfOptionsUnderConvertibleBondHedges>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="ice5667b832bb46b58768234cec087173_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzM5Mg_ad98c196-5efd-4955-8041-e18bd88ec7ec"
      unitRef="usd">500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <lgnd:DebtInstrumentRepurchasedAmountDuringPeriod
      contextRef="ib75f8705715d4191a83e17e50b6d144f_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQ5NzU1ODIzNDIx_7ab0dc17-a54f-4899-ada8-e5cf95ff6500"
      unitRef="usd">227800000</lgnd:DebtInstrumentRepurchasedAmountDuringPeriod>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ib75f8705715d4191a83e17e50b6d144f_D20220801-20220831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQ5NzU1ODIzNDYy_19d1da11-aad2-4cae-9235-de48ccf2edd1"
      unitRef="usd">223700000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="i22017c391fb94339803ce6d3d455c551_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQ5NzU1ODIzNDkz_17b46246-0369-4748-b313-7756a9dc242d"
      unitRef="usd">400000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <lgnd:ProceedsFromUnwindingConvertibleBondHedges
      contextRef="ibe725b5fc54141e2b22eb8fcd4b19e03_D20220801-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQ5NzU1ODI0MTk0_a3b5a7c5-d035-413c-8670-b0d595eb2590"
      unitRef="usd">200000</lgnd:ProceedsFromUnwindingConvertibleBondHedges>
    <lgnd:NumberOfOptionsUnderConvertibleBondHedges
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfODc5NjA5MzAzMzM2MQ_13738fb5-a81b-49a5-80cf-48eb6d66b592"
      unitRef="option">370219</lgnd:NumberOfOptionsUnderConvertibleBondHedges>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNTQ5NzU1ODI0ODE2_7daed2f9-c20b-4f8e-af26-fdd04b011266"
      unitRef="usd">200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RleHRyZWdpb246M2U3NGIxYmYzZWE0NDg3ZmE1YzlmNTA3ZDZjOWZiNWFfNzY3Mw_744ea397-2fee-4c3a-86f1-c86a7c4e6f96">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMS0xLTEtMS05NTExNw_5795715a-4c01-477c-ab81-c3a8e9489971"
      unitRef="usd">76854000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMS0zLTEtMS05NTExNw_40f4075a-6002-4d4e-b810-88382711bd64"
      unitRef="usd">343301000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMi0xLTEtMS05NTExNw_4449e5a1-60c3-47ba-9e13-f15167ff3faf"
      unitRef="usd">254000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMi0zLTEtMS05NTExNw_e73edf63-86b0-4f5e-acbc-9b9cef02db0e"
      unitRef="usd">22584000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermNotesPayable
      contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMy0xLTEtMS05NTExNw_7a6f4d59-6785-444c-b507-6e81608f8cfe"
      unitRef="usd">76600000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfMy0zLTEtMS05NTExNw_ee6bdf09-8a90-4e6c-aaa5-40e06a9a6a13"
      unitRef="usd">320717000</us-gaap:LongTermNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfNi0xLTEtMS05NTExNw_afcc4ac2-8c5e-4a20-9c6e-4afe479a66d0"
      unitRef="usd">74395000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i187ac97ada164f7f8fe99815499cf29b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80My9mcmFnOjNlNzRiMWJmM2VhNDQ4N2ZhNWM5ZjUwN2Q2YzlmYjVhL3RhYmxlOjNjNjE5MmI1MmU3NTQwNjM4MWNjOWMzYmFkNTE3YWU4L3RhYmxlcmFuZ2U6M2M2MTkyYjUyZTc1NDA2MzgxY2M5YzNiYWQ1MTdhZThfNi0zLTEtMS05NTExNw_96d6b658-20bf-4a42-9d3b-271d1cf96a14"
      unitRef="usd">341801000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfMTM1OA_a24a0029-fd66-4f35-b5c5-cf125ceb6ed9">Income Tax&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three and nine months ended September&#160;30, 2022 and 2021 was 52.9% and 10.1%, and 20.3% and (15.1)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three and nine months ended September&#160;30, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation, non-deductible ISO related stock compensation expense and recognition of non-refundable foreign taxes paid during the period. The variance from the U.S. federal tax rate of 21% for the three and nine months ended September 30, 2021 was significantly impacted by tax benefits related to (1) a $3.8 million and $37.6 million Pfenex CVR adjustment recorded during the respective period, due to the lower probability of achieving the specific development and regulatory milestone by December 31, 2021 as defined by the Pfenex CVR, and (2) net excess tax windfalls from share-based compensation resulting from increased stock option exercise&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;activity.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDM4_85dcd560-7d83-40b1-86f7-7861c6914f3e"
      unitRef="number">0.529</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="icad679edea5848ca92af3def315765fa_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDQ1_345fbc39-54de-4fb7-946c-e2a1720e695b"
      unitRef="number">0.101</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDUz_92e4959c-33ca-4d19-a427-c60d12ffa77e"
      unitRef="number">0.203</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib1477bb864504da399c7b87ea5a1e6cc_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDYw_ce3d3861-8078-48d5-927c-2d3e6a2d81ae"
      unitRef="number">-0.151</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <lgnd:EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount
      contextRef="ic9c3c0791990421eab75d178e60313f8_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDk0NzgwMjMyODAxOA_e9b925ab-5d29-4409-85b2-68966d676112"
      unitRef="usd">3800000</lgnd:EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount>
    <lgnd:EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount
      contextRef="i87ba2111bb0e419c9909cb001f40f3f1_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80OS9mcmFnOmY1ZDQ2OTM0MWU5MjQ3Y2E4NGViMWM1ODkwZGM2MDUzL3RleHRyZWdpb246ZjVkNDY5MzQxZTkyNDdjYTg0ZWIxYzU4OTBkYzYwNTNfNDk0NzgwMjMyODAyNw_7631b4ee-fce0-49f1-b146-41aefbe88598"
      unitRef="usd">37600000</lgnd:EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTU2MA_f29ea9a7-7d21-4df4-b3c0-6213071d6633">Stockholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, of the Notes to Consolidated Financial Statements in our 2021 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;852,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;260,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(136,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,980,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, outstanding options to purchase 1.7 million shares were exercisable with a weighted average exercise price per share of $102.23.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of September&#160;30, 2022, 38,007 shares were available for future purchases under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. We did not have any share repurchases during the three and nine months ended September&#160;30, 2022. Authorization to repurchase $248.8 million of our common stock remained available as of September&#160;30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;At-the Market Equity Offering Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2022, we filed a registration statement on Form S-3 (the &#x201c;Shelf Registration Statement&#x201d;), which became automatically effective upon filing, covering the offering of common stock, preferred stock, debt securities, warrants and units. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2022, we also entered into an At-The-Market Equity Offering Sales Agreement (the &#x201c;Sales Agreement&#x201d;) with Stifel, Nicolaus &amp;amp; Company, Incorporated (the &#x201c;Agent&#x201d;), under which we may, from time to time, sell shares of our &lt;/span&gt;&lt;/div&gt;common stock having an aggregate offering price of up to $100.0&#160;million in &#x201c;at the market&#x201d; offerings through the Agent (the &#x201c;ATM Offering&#x201d;). The Shelf Registration Statement included a prospectus covering the offering, issuance and sale of up to $100.0&#160;million of our common stock from time to time through the ATM Offering. The shares to be sold under the Sales Agreement may be issued and sold pursuant to the Shelf Registration Statement. To date, we have not issued any shares of common stock in the ATM Offering.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTU1OQ_25d1d33f-3930-4a12-9977-43c66ad24a10">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;852,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;260,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(136,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,980,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTU2MQ_1ff793b4-2dd5-43ee-9871-72598061485e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;852,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;260,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(136,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,059)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,980,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;386,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2834ca94385d4db2aacdb319acd70cba_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMi0xLTEtMS05NTExNw_aa0ff004-0aaf-4215-8938-5dbf1ae169cf"
      unitRef="shares">2199598</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2834ca94385d4db2aacdb319acd70cba_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMi0zLTEtMS05NTExNw_8d570b3c-4401-40ed-ba48-94d1aafc3cbc"
      unitRef="usdPerShare">106.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i27be544b5f9b4843871454a4846e31e7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMi01LTEtMS05NTExNw_aa1e9d3f-bfda-4ed0-a8d8-520d3086f9e5"
      unitRef="shares">264143</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i27be544b5f9b4843871454a4846e31e7_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMi03LTEtMS05NTExNw_022005ce-3a3a-4561-b2dd-3021da66d582"
      unitRef="usdPerShare">138.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMy0xLTEtMS05NTExNw_dfe48691-5021-41ae-8111-55da18ced33d"
      unitRef="shares">852475</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMy0zLTEtMS05NTExNw_a63ea86d-e9bb-4b8a-8c8c-cfac268f8735"
      unitRef="usdPerShare">91.39</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMy01LTEtMS05NTExNw_947fec5e-4ebf-4820-8ed7-cb9e222cfa99"
      unitRef="shares">260577</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfMy03LTEtMS05NTExNw_19ab04e1-c6d6-479f-bc04-0ebda6ef8bc2"
      unitRef="usdPerShare">89.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNC0xLTEtMS05NTExNw_6ee146b8-d463-4b8e-b537-0be14f310072"
      unitRef="shares">34941</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNC0zLTEtMS05NTExNw_9eeb4103-3615-464a-ab15-69897fb653bc"
      unitRef="usdPerShare">38.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNC01LTEtMS05NTExNw_9afece25-c98e-4b1d-8130-17bea88d475a"
      unitRef="shares">136448</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNC03LTEtMS05NTExNw_9b35aa93-27fb-43d7-8eac-b3bef9b6ca5b"
      unitRef="usdPerShare">120.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNS0xLTEtMS05NTExNw_4f51c1c4-03fa-4c55-be9d-6e6cec800a26"
      unitRef="shares">36529</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i02a30d45593a408b87c1d919818c80e8_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNS0zLTEtMS05NTExNw_960e55da-bc60-4119-a6e1-4d61ca7dd14b"
      unitRef="usdPerShare">76.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNS01LTEtMS05NTExNw_d4e66d5d-1435-45fa-a6d6-6e13ca906e16"
      unitRef="shares">2059</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i21444600f9864988b0ee5f279198c4fc_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNS03LTEtMS05NTExNw_bed72e22-96b0-4a2d-b2fc-1266dfeabe99"
      unitRef="usdPerShare">121.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i6abb45e394d9463b85d36c87fa45855a_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNi0xLTEtMS05NTExNw_a7f36f55-41b5-4c6c-9413-690cd9068463"
      unitRef="shares">2980603</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i6abb45e394d9463b85d36c87fa45855a_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNi0zLTEtMS05NTExNw_a2c166ba-06d8-47f1-89b7-fa6ab53521e2"
      unitRef="usdPerShare">102.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="icd55699f74a443efb3dad3f864d69f0d_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNi01LTEtMS05NTExNw_7fa73ffe-10bc-47ee-bc68-3709464be47c"
      unitRef="shares">386213</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="icd55699f74a443efb3dad3f864d69f0d_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RhYmxlOmY5ZDNkN2Q3NDA0ZTQ4OTQ5YTkyNjY3MTkyZGU1ZmQxL3RhYmxlcmFuZ2U6ZjlkM2Q3ZDc0MDRlNDg5NDlhOTI2NjcxOTJkZTVmZDFfNi03LTEtMS05NTExNw_f3a8e2ab-7444-4a6c-9728-914cd49e01a3"
      unitRef="usdPerShare">111.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfNDUw_b6865217-5a77-4c26-8f8c-f504737225fa"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfNTI5_e3b64433-e32f-4ff0-b533-bb01a3b65d7d"
      unitRef="usdPerShare">102.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="ifa972f2a8689410b8773aec2b27958d0_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfNjc4_eb476b35-20cc-4d22-9c1c-311a68fcd0a9"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod
      contextRef="ifa972f2a8689410b8773aec2b27958d0_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfODA1_cb1038df-67e9-4ba8-bc36-48afaeb0a3f1"
      unitRef="shares">38007</us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i6d8fd471caf841f7ac94f8e517939089_I20190911"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTAyNg_ca880901-1f3e-40d1-a395-a0b7cc2ddcd1"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i3b41dd4334ec4f4f8a4cfe7c0d306776_D20190911-20190911"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTA4MQ_952add28-6b2c-4e2e-b49e-b35155a64aa4">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTQyNw_44381f58-6061-441f-bc99-4824c00e4e82"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTQyNw_c0d125b0-7b34-4195-bd59-7ba4ab1708cc"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMTUwNA_cda77398-fd66-4402-aae4-051c41b40bdd"
      unitRef="usd">248800000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <lgnd:SaleOfStockAuthorizedOfferingAmount
      contextRef="i9961ee71da6d43899ffda6ea8268a9b4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMzI5ODUzNDg4ODQ1OA_7377aa6b-437b-4976-8149-dd6a3ad30953"
      unitRef="usd">100000000</lgnd:SaleOfStockAuthorizedOfferingAmount>
    <lgnd:SaleOfStockAuthorizedOfferingAmount
      contextRef="i9961ee71da6d43899ffda6ea8268a9b4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81Mi9mcmFnOmFmMjBhMjFhYzJiYzQ1M2JhMjljMWI3MjNlZTY5ZTY3L3RleHRyZWdpb246YWYyMGEyMWFjMmJjNDUzYmEyOWMxYjcyM2VlNjllNjdfMzI5ODUzNDg4OTY5Mw_7377aa6b-437b-4976-8149-dd6a3ad30953"
      unitRef="usd">100000000</lgnd:SaleOfStockAuthorizedOfferingAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81NS9mcmFnOjRlM2Q2NDFhMTUxNTQ5OGJhODAzMDIyNTA2ZWNjM2JjL3RleHRyZWdpb246NGUzZDY0MWExNTE1NDk4YmE4MDMwMjI1MDZlY2MzYmNfMzM2Mg_15255f0f-bae1-4bc4-9b1c-14fce7450e74">Commitment and Contingencies: Legal Proceedings&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#x201c;JPML&#x201d;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#x201c;MDL&#x201d;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CyDex, a wholly owned subsidiary of Ligand, and Baxter Healthcare Corp. (&#x201c;Baxter&#x201d;) are parties to a license agreement relating to Ligand&#x2019;s Captisol&#xae; technology and, more specifically, relating to Captisol&#xae;-enabled Nexterone&#xae; (amiodarone HCl premixed injection).  CyDex contended that Baxter has not paid all of the royalties due to CyDex under the terms of the license agreement and Baxter contends that it has overpaid royalties for several years.  On April 6, 2021, Baxter initiated an arbitration with AAA pursuant to the arbitration provision of the license agreement.  On April 21, 2021, CyDex filed an answering statement and counterdemand. On December 2, 2021, Baxter filed an Amended Notice of Arbitration Demand seeking a declaration limiting the &#x201c;royalty term&#x201d; of the license agreement to &#x201c;the later of i) the expiration of the licensed [p]atent; or ii) when there are no longer any CyDex patents listed in the Orange Book for [Nexterone&#xae;].&#x201d; Baxter later clarified its position, and asserted that royalties should have ceased being due upon the May 4, 2022 expiry of CyDex&#x2019;s U.S. Patent No. 6,869,939.  The parties conducted a three-day arbitration hearing May 24-26, 2022.  In a September 9, 2022 Final Award, the Tribunal ruled in CyDex&#x2019;s favor by (1) denying Baxter&#x2019;s request for a partial refund of previously paid royalties, (2) granting CyDex&#x2019;s request for underpaid royalties, and (3) concluding that &#x201c;[g]oing forward Baxter shall pay CyDex&#x201d; a royalty consistent with CyDex&#x2019;s construction of the license agreement until, at least, the March 13, 2029 expiry of CyDex&#x2019;s U.S. Patent No. 7,635,773.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 22, 2022, Pfenex Inc. (&#x201c;Pfenex&#x201d;), a wholly owned subsidiary of Ligand, received a notice of alleged breach from Beijing Kangchen Biological Technology Co., Ltd. (&#x201c;Kangchen&#x201d;) with respect to a Development and License Agreement between Pfenex and Kangchen (&#x201c;License Agreement&#x201d;) pertaining to the development and commercialization of teriparatide in certain Southeast Asian countries. The allegations in the notice focused on the activities of Pfenex and other parties. On June 16, 2022, we rejected all claims raised by Kangchen in the notice. On June 24, 2022, Kangchen served Pfenex a notice of termination of the License Agreement and demanded initiation of the dispute resolution process in accordance with the License Agreement. On June 29, 2022, we again rejected all claims raised by Kangchen in the notice of termination and agreed to engage in the applicable dispute resolution process, including good faith negotiations between the parties. On October 20, 2022, we agreed to make a single lump sum payment to Kangchen in connection with a termination agreement that, among other things, terminates the License Agreement and releases all claims between the parties arising from the License Agreement.  We anticipate that the termination agreement between Pfenex and Kangchen will go into effect the fourth quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i0f4e7138c0694ae2ae0c918afaf6d867_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81NS9mcmFnOjRlM2Q2NDFhMTUxNTQ5OGJhODAzMDIyNTA2ZWNjM2JjL3RleHRyZWdpb246NGUzZDY0MWExNTE1NDk4YmE4MDMwMjI1MDZlY2MzYmNfNjcw_2a342ce8-9379-4b33-8117-6f308c17771f"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i0f4e7138c0694ae2ae0c918afaf6d867_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81NS9mcmFnOjRlM2Q2NDFhMTUxNTQ5OGJhODAzMDIyNTA2ZWNjM2JjL3RleHRyZWdpb246NGUzZDY0MWExNTE1NDk4YmE4MDMwMjI1MDZlY2MzYmNfMTI1Nw_db2cc8a2-8839-433b-80e4-0497f666ef87"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMjI1MA_363a1326-a452-4ec7-8ed9-f46d39572b3e">LeasesWe lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are primarily related to our right to use the equipment under the agreement with Hovione, our third-party manufacturer, to exclusively manufacture Captisol.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2022, we entered into several lease agreements and amendments, which resulted in an increase in lease assets of $8.3&#160;million and $18.4&#160;million, and liabilities of $8.5&#160;million and $21.7&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of September&#160;30, 2022 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining three months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less estimated tenant improvement allowance:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMjI1MA_9bdf1b41-2ea6-4fb2-99f7-014119ca641e">LeasesWe lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are primarily related to our right to use the equipment under the agreement with Hovione, our third-party manufacturer, to exclusively manufacture Captisol.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended September&#160;30, 2022, we entered into several lease agreements and amendments, which resulted in an increase in lease assets of $8.3&#160;million and $18.4&#160;million, and liabilities of $8.5&#160;million and $21.7&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of September&#160;30, 2022 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining three months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less estimated tenant improvement allowance:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="ifa102a08d9284fa6b57fb76fdcab4852_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMTU4_be9a752d-940c-4443-80ee-c349728f2682">P10Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ifa102a08d9284fa6b57fb76fdcab4852_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMjIz_fdd3e280-ba8c-4ea8-995c-31729ff0d5d5">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <lgnd:AssetsAndLiabilitiesLeasesTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMjI1MQ_2225a3e9-3c09-4260-9dae-df30b324de6e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lgnd:AssetsAndLiabilitiesLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMS0xLTEtMS05NTExNw_349cb7ff-5f3b-41c6-b3eb-1710e174223b"
      unitRef="usd">32108000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMS0zLTEtMS05NTExNw_796b479d-b9d1-42f4-8224-bb917e0c5575"
      unitRef="usd">16542000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMi0xLTEtMS05NTExNw_3f1ed65c-2e4b-46b6-9e07-20e33ca92386"
      unitRef="usd">14444000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMi0zLTEtMS05NTExNw_178d051b-75fd-4c7f-89f0-d469d8c12728"
      unitRef="usd">16207000</us-gaap:FinanceLeaseRightOfUseAsset>
    <lgnd:LeaseRightOfUseAsset
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMy0xLTEtMS05NTExNw_9c02c24c-a5a7-4c03-ad0e-7fab0a18e952"
      unitRef="usd">46552000</lgnd:LeaseRightOfUseAsset>
    <lgnd:LeaseRightOfUseAsset
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMy0zLTEtMS05NTExNw_78193ae3-34bb-47d2-85bf-9bcec21208e8"
      unitRef="usd">32749000</lgnd:LeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfNi0xLTEtMS05NTExNw_738fbcd6-ddd6-4adc-82bf-ce66739bea96"
      unitRef="usd">2345000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfNi0zLTEtMS05NTExNw_2b83ec5f-4140-4be7-b922-05bcd94f9aac"
      unitRef="usd">2053000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfNy0xLTEtMS05NTExNw_72957835-9e7d-44fc-bf31-1563e574f045"
      unitRef="usd">48000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfNy0zLTEtMS05NTExNw_23e8bb1c-4ddf-442b-9939-9f516a2c27ed"
      unitRef="usd">46000</us-gaap:FinanceLeaseLiabilityCurrent>
    <lgnd:LeaseLiabilityCurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfOC0xLTEtMS05NTExNw_8ec45c52-d685-49c6-8a46-b8c3a7a1f5ee"
      unitRef="usd">2393000</lgnd:LeaseLiabilityCurrent>
    <lgnd:LeaseLiabilityCurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfOC0zLTEtMS05NTExNw_75cce8d1-2e08-407c-b3a0-f975c1287485"
      unitRef="usd">2099000</lgnd:LeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfOS0xLTEtMS05NTExNw_1b3fe217-d86b-4453-ae39-65ee7e6ac41d"
      unitRef="usd">34893000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfOS0zLTEtMS05NTExNw_ead5c1b2-3474-4426-9839-79ca5f61a584"
      unitRef="usd">15494000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMTAtMS0xLTEtOTUxMTc_8d516033-ce0f-4bf8-86c4-3624a6a296d9"
      unitRef="usd">14000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMTAtMy0xLTEtOTUxMTc_6e31da82-6aee-4213-a348-6acc78a9a725"
      unitRef="usd">58000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <lgnd:LeaseLiability
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMTEtMS0xLTEtOTUxMTc_cd07f8c8-850b-41b3-a18e-c421b535d7d0"
      unitRef="usd">37300000</lgnd:LeaseLiability>
    <lgnd:LeaseLiability
      contextRef="id713d77cfce844c9acd459debe60471f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOmViMjllMWZhYjUwNDRjYTQ5YjM0MTIyOTc2M2E3NGM3L3RhYmxlcmFuZ2U6ZWIyOWUxZmFiNTA0NGNhNDliMzQxMjI5NzYzYTc0YzdfMTEtMy0xLTEtOTUxMTc_819a1c96-7767-459e-8f5e-4e55e2c5a8e9"
      unitRef="usd">17651000</lgnd:LeaseLiability>
    <lgnd:OperatingLeasesRightOfUseAssetsIncreaseDecrease
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfODc5NjA5MzAyNTQxMA_1f91d496-0437-4444-911b-973466bf71bd"
      unitRef="usd">8300000</lgnd:OperatingLeasesRightOfUseAssetsIncreaseDecrease>
    <lgnd:OperatingLeasesRightOfUseAssetsIncreaseDecrease
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfODc5NjA5MzAyNTQyNA_471ad5e6-0f0e-4814-ab42-fabf53c1b225"
      unitRef="usd">18400000</lgnd:OperatingLeasesRightOfUseAssetsIncreaseDecrease>
    <lgnd:OperatingLeaseLiabilityIncreaseDecrease
      contextRef="i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfODc5NjA5MzAyNTQzOQ_c350ad2f-6a2a-4015-a297-a8273c68d15f"
      unitRef="usd">8500000</lgnd:OperatingLeaseLiabilityIncreaseDecrease>
    <lgnd:OperatingLeaseLiabilityIncreaseDecrease
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfODc5NjA5MzAyNTQ1Mw_d551fbf7-d875-4f9d-bf5f-126f729774bf"
      unitRef="usd">21700000</lgnd:OperatingLeaseLiabilityIncreaseDecrease>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RleHRyZWdpb246NWNkY2RjYzA1YTNiNGJmNDhlMjk3MDQ1MGNjZWI1YTFfMjI0OQ_a52bdf5e-a0c0-46b0-85ac-6f1c539d0a84">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of September&#160;30, 2022 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.132%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining three months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less estimated tenant improvement allowance:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfMS0xLTEtMS05NTExNw_152290cb-e36f-44a3-b720-75f7a4928cd0"
      unitRef="usd">1306000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfMi0xLTEtMS05NTExNw_4944caa5-51e2-48fb-bfa6-fc0fcbad6db4"
      unitRef="usd">4842000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfMy0xLTEtMS05NTExNw_ee05a48e-37ee-4f2f-a561-baec14ff765f"
      unitRef="usd">4735000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfNC0xLTEtMS05NTExNw_6fa45c5a-07a5-48a7-a4b5-217a3a82c187"
      unitRef="usd">4939000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfNS0xLTEtMS05NTExNw_757492bd-6274-429c-9cee-e7b9e52b3442"
      unitRef="usd">5242000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfNi0xLTEtMS05NTExNw_e1336766-76af-4a8c-a322-3254be660c78"
      unitRef="usd">5381000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfNy0xLTEtMS05NTExNw_1235af05-7e66-4414-8ba8-023cce7830f9"
      unitRef="usd">22317000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfOC0xLTEtMS05NTExNw_584be296-4b37-4b3f-83a5-e849e032abee"
      unitRef="usd">48762000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <lgnd:LesseeOperatingLeaseLiabilityTenantImprovementAllowance
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfOS0xLTEtMS05NTExNw_5bece715-a090-4c0a-bef1-9641546c5641"
      unitRef="usd">1030000</lgnd:LesseeOperatingLeaseLiabilityTenantImprovementAllowance>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfMTAtMS0xLTEtOTUxMTc_36fd737f-0700-458f-a03b-2de147d85aef"
      unitRef="usd">10494000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i7ed21a608d174035a9614928545bff44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF81OC9mcmFnOjVjZGNkY2MwNWEzYjRiZjQ4ZTI5NzA0NTBjY2ViNWExL3RhYmxlOjFmMzZiYTIwMjU1NDQ5NjBiMWY0ZDE5ODNhNjhhMTcwL3RhYmxlcmFuZ2U6MWYzNmJhMjAyNTU0NDk2MGIxZjRkMTk4M2E2OGExNzBfMTEtMS0xLTEtOTUxMTc_0abc0a09-4110-446e-a68f-59f23725b362"
      unitRef="usd">37238000</us-gaap:OperatingLeaseLiability>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80NzYvZnJhZzpiMzlkNDA5YzA0YWY0NGI3OTRjZjFkOWQ0ZDEzOWNkOS90ZXh0cmVnaW9uOmIzOWQ0MDljMDRhZjQ0Yjc5NGNmMWQ5ZDRkMTM5Y2Q5Xzg3OTYwOTMwMjI3OTM_14bbb390-b07b-437e-8275-9389e44ae541">Subsequent EventOn November, 1, 2022, Ligand completed the Transactions. Pursuant to the Distribution, Ligand distributed on a pro rata basis to its shareholders as of the close of business on October 26, 2022 shares of the common stock of OmniAb representing 100% of Ligand&#x2019;s interest in OmniAb. The Distribution was immediately followed by the Merger, pursuant to which OmniAb merged with Merger Sub, with OmniAb continuing as the surviving entity and becoming a wholly owned subsidiary of APAC. Prior to the Distribution and Merger, OmniAb changed its name to OmniAb Operations, Inc. and APAC changed its name to OmniAb, Inc. Following the Merger, OmniAb, Inc. is an independent, publicly traded company whose common stock trades on NASDAQ under the symbol &#x201c;OABI.&#x201d;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="iae84b3f2dac8479f98e3fbba153cb912_I20221026"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI5NTljZjM2MTBhMDRkODM4NWQxYzRjMjI3YjU5ZGY0L3NlYzoyOTU5Y2YzNjEwYTA0ZDgzODVkMWM0YzIyN2I1OWRmNF80NzYvZnJhZzpiMzlkNDA5YzA0YWY0NGI3OTRjZjFkOWQ0ZDEzOWNkOS90ZXh0cmVnaW9uOmIzOWQ0MDljMDRhZjQ0Yjc5NGNmMWQ5ZDRkMTM5Y2Q5Xzg3OTYwOTMwMjQxMTU_bfec13f5-f053-4216-acf2-f912b2df8bd2"
      unitRef="number">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>61
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M9FC#M\DQD_?BY5?>$JH'N!996?^/7EJL,T/K8RG%OC56(]BG>?,W^=8&XL1
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M;"]W;W)K<VAE971S+W-H965T-RYX;6RM6FMOV[@2_2N$[^*B!9I:?.CAWB1
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MU8*EQ0SB(6T:V:(6Q!8V$?#)9&"!+<7C2<!P Y*M 8G7@+,!7C!G6:PAT50
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M0K$,FMFJ$0P"/$!DH ^02^]JHF5J2Y*>&C"N+8T:V\8PB[$-6=4 OY:@V6C
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M+CB82&_M7IGI_RA*^D:#"W]UC5:'@TL:E#-[3$=[W34+26Q(((+D%(= 61O
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M(70\YW%4A%>=-4+ Q(5$0)SEISRK'<XI[\CJ%0<WT8' SL;M!KML51A%TXP
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MY*B([#5]S3,@=T4KL6+"'.XE<-=<U[$"RL! &VB/'9VV=C'PG,6#%'^X"&]
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M0B&ZK)!55<L"/[E0E2.CR@XIZ*I<FMP*< :-(";9&&7IQQ^F:3*YM )UQ,A
M'419S\Q0(1WE(E<V*[2M#<M:H'P(!8J-T7F=.1L)MD%EA*<5Z961F[7*A$0=
M"FQ*^4](#@E#QO;%O'HI42C+&0NL<L'G1*;+C:YX1R^/U19N+1W>5ZA,%A:+
M16UQSMI01Y136%X:78HM%%E#6:BP$R0-UZI'JFIJL,IJ(^@)1=2R\KS&&(53
M;+0A1P(ZR2I3 %AUG -U#:WJ0IH"K!]E47NH%CMH1R);*UIVC,PI4[Y6EO(+
M&=:95W+>6B,$G1:R*'0&%N!J=6TR"MA):]DP,/*BJXSZXD]B< '10NG-6F(Y
MH]JI#!HR:++:P0S #74T"WI$>=^P*/9_]K56AE\<9>M*%WK%:'E$UU1LQ$F&
M3,)XZ$<R7JV&J2@I5QECWQ<?@.6I.(*F*L>C6BIBS#T^5I8$+*J*^;%XVGG*
M$+;4Q'$%4'9>GC<&V *9[V'+'F01F]IL-((%T=.XAXD[0 9\ ^R\M0>^+WY5
MB%7# !2[2&Q)K.4CM6G@86U510Y2:RPPJ,1[:1 \Z2#41W_81VZP27O5WI-9
M0=/YRA#QP8B5M;5$K(,BA-_\X_P.7;,N<O;! ABC^[BU^%!6:KX(P1J<29YG
M6!>W32I$C+1$487' ,)[;9 YXK-!$@K4ULK*T'G/T*1\%X8_82ISXJJ0QI>?
M#U36+R67YWUQ7[++$:=P#)*1L3ZRB=7J&L-;Z!C2-"7M8/*68$2I.2Q!Q#Z#
M$Z!WL-GKN"3S+=NRHO;9LT QJK03A2H5QTTCD@",VX4H0J6T' 7@<%^A.&AQ
MJ[Q(N?%1#G[W5=:/Q)W9H5@6O&TS10B1=N<^0ZFI(O'NW5TD/LL:,':HK-_P
MIC_Q#"./]Y@%Z]58<=;!^!-A9$-Z_<NCTZ+,G+S_,HT$"7YB?8D#H 4(P>B,
M@OETQ/'G=KG+#\+?J17KA[#.OJQUD2,J1!+'?V%@?,'2)7P1]GDM*'OL[R5"
M16]][<")KJ2H=?]#O6CT*WDAA&S3ETXB$,ZUFD;=&&?SD9@U"PPU N,I&LTC
M+[2%KJDGG>CSS6,+&Z&QWG([L?7"HM9BKO5A@,3JB\]KGY<^>SKIL,5I9EV0
M"]7S-Y2\<@'624CH/J*9L K89Q&;:Q%JW*1^>>2_46BR><YQ5AVW#(!YY%)O
MJ@_6)\H\C*TS7M:'+5?+',6L$RY<G=>RXAX(;!?D'"-0J%7ER^0S4C@+S1HM
M/,AE"AZR'*U"A6WJ*9(]:IIVA9CWG7DMN=<U_#C'UJ>J7U<+3.]<5$)O _6^
M0:,&_9>]LB]N::6JBG<:9R^5017[6DO#LH#9OM(&)HV*G7#=ZE,*OQ5GR7D;
M;(<9 L:?I>=MQF3:'/0/<?/\1&>"Z?1=JG@^:Y*E;9Z[QL5M[1$99*@<.H?Q
MC-V"8NDJSD_@LY&A6:.:JH7.=VP&&:<5CV(H28VY?MCQ9XU&52;'L>[C&C0\
MBU6JE(4]N/ZY"1L,>ARH@F<>\F [C>M+,/@4%%VK3TTB>[K_QRA"A7IE$IDO
M7=,XN%W[D.+!JDFN;E\+#6^][_:=60\ X_)H#[40X!4PB]K@#L.,'TC 21?>
MBWF' WJ)HV8(:L8G7\^HFVRBQK7,B+_-YQ]#Z8 ,;"J=\X"-VT$5PMGH>A6J
M1=>6;@T.$]AWAB-,] P@SZ_-@-5-],.E 7&$WF5;=^#U$4/<T?1\D(%NC,&>
MP_5EDGFC()OI#M"T6ME79K#VTO-"SAF<:L]95L#'/MM8T)(#M5ET\HG\Q! F
M@6:YL]#,_U$SAK2\FF6TI(I0@.NJ'=#13Q"7]!-_;_"S&=/)T 7]J-JA1,8
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MTCB^Z.#Z3H\'TBA@=8[<%5KSE?3MXJIT/L&$DI7:MW*7 !@X@Z91$B-'^<1
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MV_SQ'?,\&$VY6DOAY0-'\<YTLO"<V<4<V-1R ?1H%;GV48&60A6O*N#_4K9
M,@- HA0YEQ;I">V%TUG@QG.]>9@<,<[>S.,SW 1U[5]7>'PS?Q>?CI*;$IH;
M=O7UEO'B&UXR7Q^7'NW [(7]R-XA Y/]FP=C@^M8K3*>B5I85T%T=27H86?
MJ;L(GC A%&/= ;7C.6 12H><(+ /E ^)2(9$./HB3CD$#J./^$/;':9'3((X
MM,%=87QN>B&+$J0RH4BFXIK>NAFA>,H/!(@AP:'UY\!NS$]FY))J!Q:1SH6C
M4;BRMO%S3\IT[ZUO2*_]1&/@KY,V//NC=!R:+L*L\'@\3%P?N5X+]&1-)51G
M\;N3B.DPQ82%5:V?'#)E,8?XSPJ#'VEW /NE4G:W< [&47+U#U!+ P04
M" !H@&A5B\/Z +X&   '#P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6R-5]MRXS82_164,CL[J:(EDKI8&E^JY(DGFX=D7-8F>=C:!XALB:@A"0X
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M5)>6YHIGS"Z8*T6_"-I-YV>#J@V.1B@8WQHA* ;+"LUJ[3P.BIG7>Q0(D$@
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M965T,3<N>&ULO5S9<MO(DOV5"EWW#2F"I$A*U.(M0I9[F^AN>ZSV]</$/(!
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MUP\7@G?/QY6P;K(#63N3VSFT[$,85=,< +HPFT!M36'&K2[((3&)QXLK[L3
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MR9%DD/Z7ME[Q'SB9UFU;+_GC0F=P=&J Y[,:@G:_T 3A3]Z\_#]02P,$%
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M5QP--T8O[:?O:VV,7MCA7(I2-C0![Z<:JNAOB,'XQQ"G_P502P,$%     @
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MLN!&7*O\3YG9]45OUF.96/(ZMU_4YE<1['$ 4Y4;]Y=M_-K)H,?2VEA5A,U
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MX604_CY0.^'/2AX]E3R:#=R__>?[UZM"U51>:H-JL8H*JT#VYS)%0T2130\
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MW](= @'#C'P -;AY&\_<%DF)D@K <BZNC8=>:96Z9'1WY%K'GT!:(=JE<#D
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M(J@60S4*U1A4XRA-K<8V"&"_E 0HJR*9-Q]7WS7)$.OMDRB.1)J1N\,SJ!9
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M\[SZ]DLSP%->?-K<G>O_ U!+ P04    " !H@&A5=O,(AI4'   I00  &0
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M0)D/^+57(GZO]+%=RMK5/G_>2T<:*(V#T@04S:R =G $GT@,"*C! Z5Q4)J
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MD>Z26\W!;'=AF]]F^;+*%WF65@)<9QG;5"*OEN".%7F64PXNP/MJ2[F0EU>
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M<W5K<A;CQ,M=EO4&O?#CAW:_]?F,NT[MKG../7SAE-J\*8FP0Z:;[%4$_9+
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M:&5E=#(X+GAM;+U8[X_B-A#]5ZST5-U)MYLXA 2V@+3+JM>56A4==^UG;QC
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M";O:UG,@W4C%BQJL/2@HJ][DM8[#$2 87@ $-2"X%M"O ?USP. "(*P!X1G
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M(TU/MSHSLQ]&^X'8E<0:&[) DAYI?_P6V#&F*%?,Y%U_27PYYSG@<UR'>EW
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M :4E4%J*HO7KI)/ Z,@U6F]I 5!Q#$J+H30!I2506HJB]0NJ$^ZH7;A[O05
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M; +DWV^+HM[_T&S@L2B_;';O\O]02P,$%     @ :(!H56*V^Z4. P  S <
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M3? 5J.8CH&D86=;'XEH:/&3KVSU^-X&R =B_E0BH;=B3MOL22_\"4$L#!!0
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M@2D#>3^F5.PGRD'UQ\'[!5!+ P04    " !H@&A5R+B0D6@$  "6$P  &0
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M/ZY9E@ 7OZ+;[]M4_D 7J+R,_MF4D9MG5(6O2- =",G36$)2WW"E8ZHM/MR
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M# ,RAP5;"7NK-E]A&]# ^9LI89HGV;1K\S0@LY6QJMH:HX**R_;-GK8;L6-
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MT&X!SB^4LB\=5S.[7Y[B+U!+ P04    " !H@&A5(% +8_\!  "F!   &0
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MF:)BT[2I_?>\RJ]V''7?RK+]5MDU[/58O[_?N\FK8S 9'X/)HZC)WC&83([
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
M:(!H5=_V^C[@ P  +B    \   !X;"]W;W)K8F]O:RYX;6S%F5MSVC@4@/^*
MQB_;?>B"+8=<IG0F#:1EAD"FSN0U(\PA:&)+5)))VU]?V5Z2XRTYLR^J7S"Z
M(#[+EK_CHP_/VCRMM'YBW\M"V7&T=6YW,1C8? NEL/_H'2C?LM&F%,X7S>/
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MPH]N?7TNBOS6L/K0)MK3DSHCMJF*XLK7+=5<B_5AN_NP5?_Q%U!+ P04
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M.^KMS]0[Y=,NIEO/=8WO?R;5^?QLO+W^LKQNHH3#"\X!_FN^_P)02P,$%
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M;"ORZ?D2)WHT\WF946ZR51V7I-XZTKDOB$)=I;NB_?/)(>XP[:[\ZORNS+G
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M<' N>&UL4$L! A0#%     @ :(!H58L2*VGM    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ :(!H59E<G",0
M!@  G"<  !,              ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " !H@&A5*<A#L/ %  #N'@  &               @($,"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ :(!H58!0MCF&
M!P  /R(  !@              ("!,@X  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( &B :%5YT\ME_@(  "4*   8              "
M@>X5  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !H@&A5
MM;]::[H'  !J*P  &               @($B&0  >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ :(!H5?L!FW!# P  _@D  !@
M     ("!$B$  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M &B :%7Z.:,P<1$  +_:   8              " @8LD  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " !H@&A5VMJ&6F0)  ".*@  &
M            @($R-@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ :(!H55YG1TO*(@  S&<  !@              ("!S#\  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( &B :%78H*"KY@D  "@8
M   8              " @<QB  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " !H@&A5=>J8ZKX+  ">'P  &0              @('H;
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( &B :%7[FL U
M<0T  #HL   9              " @=UX  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ :(!H56;:0JAT!   5@H  !D
M ("!A88  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !H
M@&A5B\/Z +X&   '#P  &0              @($PBP  >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( &B :%5-DOS2R@D  "(8   9
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M970Q."YX;6Q02P$"% ,4    " !H@&A56+X3_GL$  #*"0  &0
M    @(&QRP  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M &B :%5H.PN+B0D   ,9   9              " @6/0  !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ :(!H5;05$PTN P  K@8  !D
M             ("!(]H  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " !H@&A5M+4]N4H#  !F"0  &0              @(&(W0  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( &B :%5DN0C9A@,
M /0(   9              " @0GA  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ :(!H55?,BRNU#@  [L0  !D              ("!
MQN0  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !H@&A5
M=O,(AI4'   I00  &0              @(&R\P  >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( &B :%7%Q]_6OP8  " K   9
M      " @7[[  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ :(!H51>B[5&X @  ;P<  !D              ("!= (! 'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " !H@&A5(D*R-BD$   0%
M&0              @(%C!0$ >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( &B :%574.4MY@(  ,L*   9              " @<,) 0!X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ :(!H5<2:^?[;
M P  M0\  !D              ("!X P! 'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " !H@&A511ZO(S0#  "W"0  &0
M@('R$ $ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( &B
M:%6)=S?6H0,  )80   9              " @5T4 0!X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ :(!H50 K2 AE P  E0L  !D
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M=#,W+GAM;%!+ 0(4 Q0    ( &B :%5&+MAC6@(  -8%   9
M  " @1X] 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
M:(!H57WD7:Q3#P  RL@  !D              ("!KS\! 'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6Q02P$"% ,4    " !H@&A5MUXB(1@#  "5"0  &0
M            @($Y3P$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4
M Q0    ( &B :%4(:3-1"0,  $0,   9              " @8A2 0!X;"]W
M;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ :(!H5<BXD)%H!
MEA,  !D              ("!R%4! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6Q02P$"% ,4    " !H@&A5L&M/#Y<$  #9%@  &0              @(%G
M6@$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( &B :%4,
M.FFA1@(   P%   9              " @35? 0!X;"]W;W)K<VAE971S+W-H
M965T-#0N>&UL4$L! A0#%     @ :(!H5;+<D6GI @  3 H  !D
M     ("!LF$! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
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M  #6%   #0              @ '*;0$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( &B :%67BKL<P    !,"   +              "  3]Q 0!?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( &B :%7?]OH^X ,  "X@   /              "
M 2AR 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !H@&A5DBR@EK@!  #G
M'   &@              @ $U=@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " !H@&A5C$_JC[H!  #N'   $P              @ $E
L> $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     .  X #\/   0>@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>327</ContextCount>
  <ElementCount>326</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>75</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotes</Role>
      <ShortName>Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Commitment and Contingencies: Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SegmentInformation</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/FairValueMeasurements</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesTables</Role>
      <ShortName>Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/ConvertibleSeniorNotes</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/StockholdersEquity</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/Leases</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SegmentInformationTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Convertible Senior Notes - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails</Role>
      <ShortName>Convertible Senior Notes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails</Role>
      <ShortName>Convertible Senior Notes - Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxDetails</Role>
      <ShortName>Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/IncomeTax</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails</Role>
      <ShortName>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails</Role>
      <ShortName>Leases - Operating and Finance Lease Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturity of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="lgnd-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Subsequent Event (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SubsequentEventDetails</Role>
      <ShortName>Subsequent Event (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SubsequentEvent</ParentRole>
      <Position>48</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:DebtInstrumentConvertibleConversionRatio1 -  lgnd-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="lgnd-20220930.htm">lgnd-20220930.htm</File>
    <File>exhibit101-aremployeematte.htm</File>
    <File>lgnd-20220930.xsd</File>
    <File>lgnd-20220930_cal.xml</File>
    <File>lgnd-20220930_def.xml</File>
    <File>lgnd-20220930_lab.xml</File>
    <File>lgnd-20220930_pre.xml</File>
    <File>lgnd_93022exhibit311.htm</File>
    <File>lgnd_93022exhibit312.htm</File>
    <File>lgnd_93022exhibit321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>lgnd-20220930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="887">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>67
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lgnd-20220930.htm": {
   "axisCustom": 0,
   "axisStandard": 27,
   "contextCount": 327,
   "dts": {
    "calculationLink": {
     "local": [
      "lgnd-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lgnd-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lgnd-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 531,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 8
   },
   "keyCustom": 51,
   "keyStandard": 275,
   "memberCustom": 33,
   "memberStandard": 39,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "role": "http://www.ligand.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Fair Value Measurements",
     "role": "http://www.ligand.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Convertible Senior Notes",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotes",
     "shortName": "Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Income Tax",
     "role": "http://www.ligand.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Stockholders' Equity",
     "role": "http://www.ligand.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Commitment and Contingencies: Legal Proceedings",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings",
     "shortName": "Commitment and Contingencies: Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Leases",
     "role": "http://www.ligand.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Subsequent Event",
     "role": "http://www.ligand.com/role/SubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Segment Information (Tables)",
     "role": "http://www.ligand.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Convertible Senior Notes (Tables)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesTables",
     "shortName": "Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.ligand.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Leases (Tables)",
     "role": "http://www.ligand.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxLiabilitiesNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i35e1f2ef2453421db235d4f5debc1ea8_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i365d6d6bcee9448fa1c6ab3aa3d86e82_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "lgnd:CommercialLicenseRightsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ie85097cc30914531bce5696bfe9a1638_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "lgnd:CommercialLicenseRightsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ie85097cc30914531bce5696bfe9a1638_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i3c65682d715d4cebb23f79ad72073530_D20220323-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Segment Information (Details)",
     "role": "http://www.ligand.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i3c65682d715d4cebb23f79ad72073530_D20220323-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ia610e91d108b4828b2e383faf35f060c_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ia610e91d108b4828b2e383faf35f060c_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "idf669638100c407a84acc68049e05107_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "idf669638100c407a84acc68049e05107_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Convertible Senior Notes - Narrative (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
     "shortName": "Convertible Senior Notes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostDirectMaterial",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Convertible Senior Notes - Notes Payable (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails",
     "shortName": "Convertible Senior Notes - Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ic00ea85c0a3a4626ab2f9a3bb3172a5c_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Income Tax (Details)",
     "role": "http://www.ligand.com/role/IncomeTaxDetails",
     "shortName": "Income Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i2834ca94385d4db2aacdb319acd70cba_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails",
     "shortName": "Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i2834ca94385d4db2aacdb319acd70cba_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i6d8fd471caf841f7ac94f8e517939089_I20190911",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i0f4e7138c0694ae2ae0c918afaf6d867_D20191031-20191031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "civil_complaint",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails",
     "shortName": "Commitment and Contingencies: Legal Proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i0f4e7138c0694ae2ae0c918afaf6d867_D20191031-20191031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "civil_complaint",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:OperatingLeasesRightOfUseAssetsIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.ligand.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:OperatingLeasesRightOfUseAssetsIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)",
     "role": "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails",
     "shortName": "Leases - Operating and Finance Lease Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:LeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)",
     "role": "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturity of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i7ed21a608d174035a9614928545bff44_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "iae84b3f2dac8479f98e3fbba153cb912_I20221026",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Subsequent Event (Details)",
     "role": "http://www.ligand.com/role/SubsequentEventDetails",
     "shortName": "Subsequent Event (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "iae84b3f2dac8479f98e3fbba153cb912_I20221026",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestOwnershipPercentageByParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i1f77816f92f64e30961bcaaf45363c3a_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "i49019251c3644c1b9be5cc7120c8645b_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib4787c5b04654433aa93a05790c5bb00_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Segment Information",
     "role": "http://www.ligand.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220930.htm",
      "contextRef": "ib99a96de680646a09947a01ff4b82ad8_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 75,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lgnd_AccruedAssetAcquisitionsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Asset Acquisitions, Current",
        "label": "Accrued Asset Acquisitions, Current",
        "terseLabel": "Acquisition related liabilities"
       }
      }
     },
     "localname": "AccruedAssetAcquisitionsCurrent",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedInventoryPurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Inventory Purchases",
        "label": "Accrued Inventory Purchases",
        "terseLabel": "Accrued inventory purchases"
       }
      }
     },
     "localname": "AccruedInventoryPurchases",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSubcontractorExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Subcontractor Expenses, Current",
        "label": "Accrued Subcontractor Expenses, Current",
        "terseLabel": "Subcontractor"
       }
      }
     },
     "localname": "AccruedSubcontractorExpensesCurrent",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Reacquisition Of Equity Due To Debt Extinguishment, Net Of Tax",
        "label": "Adjustments to Additional Paid in Capital, Reacquisition Of Equity Due To Debt Extinguishment, Net Of Tax",
        "terseLabel": "Reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalReacquisitionOfEquityDueToDebtExtinguishmentNetOfTax",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "label": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "terseLabel": "Warrant and bond hedge unwind transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Commercial License And Other Economic Rights",
        "label": "Amortization Of Commercial License And Other Economic Rights",
        "verboseLabel": "Amortization of commercial license rights"
       }
      }
     },
     "localname": "AmortizationOfCommercialLicenseAndOtherEconomicRights",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmountsOwedToFormerLicensorFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts Owed To Former Licensor, Fair Value Disclosure",
        "label": "Amounts Owed To Former Licensor, Fair Value Disclosure",
        "terseLabel": "Amounts owed to former licensor"
       }
      }
     },
     "localname": "AmountsOwedToFormerLicensorFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AssetsAndLiabilitiesLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities Leases",
        "label": "Assets and Liabilities Leases [Table Text Block]",
        "terseLabel": "Schedule of Operating and Finance Lease Assets and Liabilities"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLeasesTableTextBlock",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_AtTheMarketEquityOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-The Market Equity Offering",
        "label": "At-The Market Equity Offering [Member]",
        "terseLabel": "At-the Market Equity Offering"
       }
      }
     },
     "localname": "AtTheMarketEquityOfferingMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_AziyoAndCorMatrixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aziyo and CorMatrix",
        "label": "Aziyo and CorMatrix [Member]",
        "terseLabel": "Aziyo and CorMatrix"
       }
      }
     },
     "localname": "AziyoAndCorMatrixMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_BasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation.",
        "label": "Basis of Presentation [Line Items]",
        "terseLabel": "Basis of Presentation [Line Items]"
       }
      }
     },
     "localname": "BasisOfPresentationLineItems",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation.",
        "label": "Basis of Presentation [Table]",
        "terseLabel": "Basis of Presentation [Table]"
       }
      }
     },
     "localname": "BasisOfPresentationTable",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "label": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "terseLabel": "Earnout rights recognized"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "label": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure",
        "verboseLabel": "Contingent liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "label": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "terseLabel": "Frequency of cash payments to CVR holders"
       }
      }
     },
     "localname": "BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "label": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "terseLabel": "Number of CVRs issued from each CVR series"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "label": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "terseLabel": "Number of CVRs issued per acquiree share"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "label": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Allowance for credit losses adjustment related to COVID-19"
       }
      }
     },
     "localname": "COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights",
        "label": "Commercial License and Other Economic Rights [Abstract]",
        "verboseLabel": "Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAbstract",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_CommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial License Rights",
        "terseLabel": "Commercial license rights, net"
       }
      }
     },
     "localname": "CommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseRightsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License Rights",
        "label": "Commercial License Rights [Policy Text Block]",
        "terseLabel": "Commercial License Rights"
       }
      }
     },
     "localname": "CommercialLicenseRightsPolicyTextBlock",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ContingentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Liabilities",
        "label": "Contingent Liabilities [Member]",
        "terseLabel": "Contingent Liabilities"
       }
      }
     },
     "localname": "ContingentLiabilitiesMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue",
        "label": "Contract Revenue [Member]",
        "terseLabel": "Contract revenue"
       }
      }
     },
     "localname": "ContractRevenueMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue, Service",
        "label": "Contract Revenue, Service [Member]",
        "terseLabel": "Service Revenue"
       }
      }
     },
     "localname": "ContractRevenueServiceMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ConvertibleSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes due 2023",
        "label": "Convertible Senior Notes due 2023 [Member]",
        "terseLabel": "2023 Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2023Member",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CurrentPortionOfLiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CurrentPortionOfLiabilityForContingentValueRights",
        "verboseLabel": "Current contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionOfLiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CyDexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CyDex",
        "label": "CyDex [Member]",
        "terseLabel": "CyDex"
       }
      }
     },
     "localname": "CyDexMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
        "terseLabel": "Maximum threshold of debt trading price trigger (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_DebtInstrumentRepurchasedAmountDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Repurchased Amount During Period",
        "label": "Debt Instrument, Repurchased Amount During Period",
        "terseLabel": "Repurchased amount of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedAmountDuringPeriod",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Equity Securities, FV-NI",
        "label": "Debt Securities, Available-For-Sale And Equity Securities, FV-NI",
        "totalLabel": "Total short-term investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]",
        "terseLabel": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties"
       }
      }
     },
     "localname": "DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnout Rights for Partner Research and Development",
        "label": "Earnout Rights for Partner Research and Development [Member]",
        "terseLabel": "Earnout Rights for Partner Research and Development"
       }
      }
     },
     "localname": "EarnoutRightsForPartnerResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, CVR Adjustment, Amount",
        "label": "Effective Income Tax Rate Reconciliation, CVR Adjustment, Amount",
        "terseLabel": "Pfenex CVR adjustment amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationCVRAdjustmentAmount",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_EmployeeStockPurchasePlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Abstract]",
        "label": "Employee Stock Purchase Plan [Abstract]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanAbstract",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EmployeeStockPurchasePlanMember",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EvomelaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evomela",
        "label": "Evomela [Member]",
        "terseLabel": "Evomela"
       }
      }
     },
     "localname": "EvomelaMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "terseLabel": "Contingent liabilities from xCella asset acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease And Operating Lease, Right-of-Use Asset, Amortization",
        "label": "Finance Lease And Operating Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Lease amortization expense"
       }
      }
     },
     "localname": "FinanceLeaseAndOperatingLeaseRightOfUseAssetAmortization",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "negatedTerseLabel": "Adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "label": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "negatedLabel": "Credit loss adjustments of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_GainLossOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Short-term Investments",
        "label": "Gain (Loss) on Short-term Investments",
        "negatedLabel": "Loss (gain) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnShortTermInvestments",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_IcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Icagen",
        "label": "Icagen [Member]",
        "terseLabel": "Icagen"
       }
      }
     },
     "localname": "IcagenMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_IncreaseDecreaseInDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Debt Discount",
        "label": "Increase (Decrease) in Debt Discount",
        "negatedLabel": "Decrease in debt discount"
       }
      }
     },
     "localname": "IncreaseDecreaseInDebtDiscount",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_KyprolisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kyprolis",
        "label": "Kyprolis [Member]",
        "terseLabel": "Kyprolis"
       }
      }
     },
     "localname": "KyprolisMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Current",
        "label": "Lease, Liability, Current",
        "totalLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilityCurrent",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Right-Of-Use Asset",
        "label": "Lease, Right-Of-Use Asset",
        "totalLabel": "Total lease assets"
       }
      }
     },
     "localname": "LeaseRightOfUseAsset",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LesseeOperatingLeaseLiabilityTenantImprovementAllowance": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Tenant Improvement Allowance",
        "label": "Lessee, Operating Lease, Liability, Tenant Improvement Allowance",
        "negatedTerseLabel": "Less estimated tenant improvement allowance:"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityTenantImprovementAllowance",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LiabilityForContingentValueRights",
        "verboseLabel": "Long-term contingent liabilities"
       }
      }
     },
     "localname": "LiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LicenseFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees",
        "label": "License Fees [Member]",
        "terseLabel": "License Fees"
       }
      }
     },
     "localname": "LicenseFeesMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees, Milestones, and Product, Other, Product, Other",
        "label": "License Fees, Milestones, and Product, Other, Product, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LicenseFeesMilestonesAndProductOtherProductOtherMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseeAccrualCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensee Accrual, Current",
        "label": "Licensee Accrual, Current",
        "terseLabel": "Amounts owed to former licensees"
       }
      }
     },
     "localname": "LicenseeAccrualCurrent",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LigandCoreBusinessSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ligand Core Business Segment",
        "label": "Ligand Core Business Segment [Member]",
        "terseLabel": "Ligand core business"
       }
      }
     },
     "localname": "LigandCoreBusinessSegmentMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolCOVIDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol, COVID",
        "label": "Material Sales, Captisol, COVID [Member]",
        "terseLabel": "Captisol - COVID"
       }
      }
     },
     "localname": "MaterialSalesCaptisolCOVIDMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolCoreMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol, Core",
        "label": "Material Sales, Captisol, Core [Member]",
        "terseLabel": "Captisol - Core"
       }
      }
     },
     "localname": "MaterialSalesCaptisolCoreMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol",
        "label": "Material Sales, Captisol [Member]",
        "terseLabel": "Captisol"
       }
      }
     },
     "localname": "MaterialSalesCaptisolMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Metabasis",
        "label": "Metabasis [Member]",
        "terseLabel": "Metabasis"
       }
      }
     },
     "localname": "MetabasisMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone",
        "label": "Milestone [Member]",
        "terseLabel": "Milestone"
       }
      }
     },
     "localname": "MilestoneMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
        "negatedLabel": "Change in estimated fair value of contingent liabilities"
       }
      }
     },
     "localname": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_NotesRepurchasedDuringCurrentPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Repurchased During Current Period, One",
        "label": "Notes Repurchased During Current Period, One [Member]",
        "terseLabel": "Notes repurchased during current period"
       }
      }
     },
     "localname": "NotesRepurchasedDuringCurrentPeriodOneMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NotesRepurchasedDuringCurrentPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Repurchased During Current Period, Two",
        "label": "Notes Repurchased During Current Period, Two [Member]",
        "terseLabel": "Notes repurchased in August 2022"
       }
      }
     },
     "localname": "NotesRepurchasedDuringCurrentPeriodTwoMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NumberOfContingentValueRightsSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Contingent Value Rights Series",
        "label": "Number of Contingent Value Rights Series",
        "terseLabel": "Number of CVR Series"
       }
      }
     },
     "localname": "NumberOfContingentValueRightsSeries",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfOptionsUnderConvertibleBondHedges": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Options under Convertible Bond Hedges",
        "label": "Number of Options under Convertible Bond Hedges",
        "terseLabel": "Number of options under convertible bond hedges"
       }
      }
     },
     "localname": "NumberOfOptionsUnderConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_OmniAbMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OmniAb",
        "label": "OmniAb [Member]",
        "terseLabel": "OmniAb"
       }
      }
     },
     "localname": "OmniAbMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_OmniAbTechnologiesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OmniAb Technologies Segment",
        "label": "OmniAb Technologies Segment [Member]",
        "terseLabel": "OmniAb business"
       }
      }
     },
     "localname": "OmniAbTechnologiesSegmentMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_OperatingLeaseLiabilityIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Increase (Decrease)",
        "label": "Operating Lease, Liability, Increase (Decrease)",
        "terseLabel": "Increase in operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityIncreaseDecrease",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_OperatingLeasesRightOfUseAssetsIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases, Right Of Use Assets, Increase (Decrease)",
        "label": "Operating Leases, Right Of Use Assets, Increase (Decrease)",
        "terseLabel": "Increase in operating lease assets"
       }
      }
     },
     "localname": "OperatingLeasesRightOfUseAssetsIncreaseDecrease",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsForConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Convertible Bond Hedges",
        "label": "Payments for Convertible Bond Hedges",
        "terseLabel": "Payments for convertible bond hedges"
       }
      }
     },
     "localname": "PaymentsForConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders",
        "label": "Payments to Contingent Value Right Holders",
        "negatedTerseLabel": "Payments to CVR holders and other contingent payments"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHolders",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersFinancingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders, Financing Activity",
        "label": "Payments to Contingent Value Right Holders, Financing Activity",
        "negatedLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersFinancingActivity",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersInvestingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Contingent Value Right Holders, Investing Activity",
        "label": "Payments To Contingent Value Right Holders, Investing Activity",
        "negatedTerseLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersInvestingActivity",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToUnwindWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Unwind Warrants",
        "label": "Payments to Unwind Warrants",
        "terseLabel": "Payments to unwind warrants"
       }
      }
     },
     "localname": "PaymentsToUnwindWarrants",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PfenexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfenex",
        "label": "Pfenex [Member]",
        "terseLabel": "Pfenex"
       }
      }
     },
     "localname": "PfenexMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_Phase3ClinicalTrialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase 3 Clinical Trial",
        "label": "Phase 3 Clinical Trial [Member]",
        "terseLabel": "Phase 3 Clinical Trial"
       }
      }
     },
     "localname": "Phase3ClinicalTrialMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ProceedsFromUnwindingConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Unwinding Convertible Bond Hedges",
        "label": "Proceeds from Unwinding Convertible Bond Hedges",
        "terseLabel": "Proceeds from unwinding convertible bond hedges"
       }
      }
     },
     "localname": "ProceedsFromUnwindingConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RepaymentsOfNotesPayableInterestPortion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments Of Notes Payable, Interest Portion",
        "label": "Repayments Of Notes Payable, Interest Portion",
        "terseLabel": "Accrued interest portion of repurchased amount of debt instrument"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayableInterestPortion",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ReturnsAccrual": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Returns Accrual",
        "label": "Returns Accrual",
        "terseLabel": "Return reserve"
       }
      }
     },
     "localname": "ReturnsAccrual",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RoyaltyOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Other",
        "label": "Royalty, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RoyaltyOtherMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_RylazeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rylaze",
        "label": "Rylaze [Member]",
        "terseLabel": "Rylaze"
       }
      }
     },
     "localname": "RylazeMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_SaleOfStockAuthorizedOfferingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Authorized Offering Amount",
        "label": "Sale Of Stock, Authorized Offering Amount",
        "terseLabel": "Sale of stock, authorized offering amount"
       }
      }
     },
     "localname": "SaleOfStockAuthorizedOfferingAmount",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]",
        "verboseLabel": "Schedule of Accounting for Share-Based Compensation"
       }
      }
     },
     "localname": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Commercial License Rights",
        "label": "Schedule of Commercial License Rights [Table Text Block]",
        "terseLabel": "Schedule of Commercial License Rights"
       }
      }
     },
     "localname": "ScheduleOfCommercialLicenseRightsTableTextBlock",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Short-Term investments",
        "label": "Schedule of Short-Term investments [Table Text Block]",
        "terseLabel": "Schedule of Short-Term Investments"
       }
      }
     },
     "localname": "ScheduleOfShortTermInvestmentsTableTextBlock",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_SelexisAndDianomiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis and Dianomi",
        "label": "Selexis and Dianomi [Member]",
        "terseLabel": "Selexis and Dianomi"
       }
      }
     },
     "localname": "SelexisAndDianomiMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "label": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "terseLabel": "Payout range (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_TeriparatideInjectionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Teriparatide Injection",
        "label": "Teriparatide Injection [Member]",
        "terseLabel": "Teriparatide injection"
       }
      }
     },
     "localname": "TeriparatideInjectionMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US District Court for the Northern District of Ohio",
        "label": "US District Court for the Northern District of Ohio [Member]",
        "terseLabel": "US District Court for the Northern District of Ohio"
       }
      }
     },
     "localname": "USDistrictCourtForTheNorthernDistrictOfOhioMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_XCellaBiosciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "xCella Biosciences, Inc.",
        "label": "xCella Biosciences, Inc. [Member]",
        "terseLabel": "xCella"
       }
      }
     },
     "localname": "XCellaBiosciencesIncMember",
     "nsuri": "http://www.ligand.com/20220930",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r120",
      "r169",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r191",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r298",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r120",
      "r169",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r191",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r298",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r48",
      "r50",
      "r118",
      "r119",
      "r308",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r2",
      "r125",
      "r132",
      "r227",
      "r450",
      "r451",
      "r452",
      "r471",
      "r472",
      "r506",
      "r511",
      "r512",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Adjusted Balance"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r125",
      "r132",
      "r138",
      "r227",
      "r450",
      "r451",
      "r452",
      "r471",
      "r472",
      "r506",
      "r509",
      "r511",
      "r512",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r125",
      "r132",
      "r138",
      "r227",
      "r450",
      "r451",
      "r452",
      "r471",
      "r472",
      "r506",
      "r509",
      "r511",
      "r512",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r125",
      "r132",
      "r138",
      "r227",
      "r450",
      "r451",
      "r452",
      "r471",
      "r472",
      "r506",
      "r509",
      "r511",
      "r512",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r278",
      "r280",
      "r281",
      "r282",
      "r307",
      "r349",
      "r406",
      "r408",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r608",
      "r658",
      "r660",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r278",
      "r280",
      "r281",
      "r282",
      "r307",
      "r349",
      "r406",
      "r408",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r608",
      "r658",
      "r660",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r194",
      "r280",
      "r281",
      "r385",
      "r388",
      "r611",
      "r657",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r194",
      "r280",
      "r281",
      "r385",
      "r388",
      "r611",
      "r657",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r269",
      "r278",
      "r280",
      "r281",
      "r282",
      "r307",
      "r349",
      "r396",
      "r406",
      "r408",
      "r442",
      "r443",
      "r444",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r608",
      "r658",
      "r660",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r269",
      "r278",
      "r280",
      "r281",
      "r282",
      "r307",
      "r349",
      "r396",
      "r406",
      "r408",
      "r442",
      "r443",
      "r444",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r608",
      "r658",
      "r660",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r49",
      "r50",
      "r118",
      "r119",
      "r308",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r126",
      "r127",
      "r128",
      "r129",
      "r204",
      "r205",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r450",
      "r451",
      "r452",
      "r471",
      "r472",
      "r488",
      "r489",
      "r490",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r544",
      "r545",
      "r553",
      "r554",
      "r555",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r199",
      "r200"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premium on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "verboseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r54",
      "r55",
      "r56",
      "r645",
      "r668",
      "r672"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r53",
      "r56",
      "r62",
      "r63",
      "r64",
      "r122",
      "r123",
      "r124",
      "r496",
      "r571",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r450",
      "r451",
      "r452",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r126",
      "r127",
      "r128",
      "r129",
      "r138",
      "r204",
      "r205",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r450",
      "r451",
      "r452",
      "r469",
      "r470",
      "r471",
      "r472",
      "r488",
      "r489",
      "r490",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r544",
      "r545",
      "r553",
      "r554",
      "r555",
      "r556",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r613",
      "r614",
      "r615",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r410",
      "r454",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r303",
      "r363",
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "verboseLabel": "Adjustments to additional paid-in-capital from warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r446"
     ],
     "calculation": {
      "http://www.ligand.com/role/SegmentInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Shared-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r71",
      "r100",
      "r327",
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortized issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r100",
      "r327",
      "r338",
      "r339",
      "r549"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance fees"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r18",
      "r114",
      "r177",
      "r183",
      "r189",
      "r223",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r492",
      "r497",
      "r527",
      "r572",
      "r574",
      "r619",
      "r643"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r11",
      "r36",
      "r114",
      "r223",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r492",
      "r497",
      "r527",
      "r572",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r515"
     ],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r208",
      "r235"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r213",
      "r214",
      "r636"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r206",
      "r209",
      "r235",
      "r625"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r413",
      "r414",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r437",
      "r438",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "verboseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r405",
      "r407",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r405",
      "r407",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r104",
      "r105",
      "r106"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued fixed asset purchases"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r8",
      "r14",
      "r102"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r94",
      "r102",
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r94",
      "r536"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant exercise price (in USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Warrants issued in public offering (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r46",
      "r627",
      "r649"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r283",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitment and Contingencies: Legal Proceedings"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r122",
      "r123",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r25",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Common stock outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.001 par value; 60,000 shares authorized; 16,894 and 16,767 shares issued and outstanding at September\u00a030, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r58",
      "r60",
      "r61",
      "r68",
      "r630",
      "r653"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r201",
      "r232",
      "r373",
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Gross contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r373",
      "r374",
      "r386"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r373",
      "r374",
      "r386"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Long-term deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was previously deferred"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contractual relationships"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Convertible Debt, Current",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Fair value of the 2023 Notes outstanding (Level 2)"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r22",
      "r621",
      "r644",
      "r674"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable",
        "terseLabel": "Increase of carrying amount of Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r19",
      "r620",
      "r640",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r397",
      "r404",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r191",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostDirectMaterial": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of material used for good produced and service rendered.",
        "label": "Cost, Direct Material",
        "terseLabel": "Cost of Captisol"
       }
      }
     },
     "localname": "CostDirectMaterial",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r110",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r321",
      "r328",
      "r329",
      "r331",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r21",
      "r22",
      "r113",
      "r120",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r311",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r336",
      "r337",
      "r338",
      "r339",
      "r551",
      "r620",
      "r621",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r22",
      "r332",
      "r621",
      "r640"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Outstanding principal amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r306",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price (in USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r43",
      "r306",
      "r364",
      "r367",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate (shares per $1,000)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Stock price trigger to classify convertible debt as current (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r304",
      "r336",
      "r337",
      "r548",
      "r551",
      "r552"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount of the 2023 Notes outstanding",
        "verboseLabel": "Aggregate principal amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r42",
      "r334",
      "r548",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r42",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r44",
      "r113",
      "r120",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r311",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r336",
      "r337",
      "r338",
      "r339",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r44",
      "r113",
      "r120",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r311",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r330",
      "r336",
      "r337",
      "r338",
      "r339",
      "r364",
      "r368",
      "r369",
      "r370",
      "r547",
      "r548",
      "r551",
      "r552",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r317",
      "r547",
      "r548",
      "r549",
      "r550",
      "r552"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedTerseLabel": "Unamortized discount (including unamortized debt issuance cost)",
        "terseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r210",
      "r235",
      "r239",
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "terseLabel": "Credit losses related to available-for-sale debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r218",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of positions in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r458",
      "r459"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r458",
      "r459"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedLabel": "Decrease of deferred tax liabilities",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
        "label": "Demand Deposits [Member]",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "DemandDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r100",
      "r172"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive potential common shares:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r385",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "verboseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r69",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r139",
      "r141",
      "r146",
      "r147",
      "r148",
      "r151",
      "r152",
      "r512",
      "r513",
      "r631",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net income (loss) per share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r69",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r141",
      "r146",
      "r147",
      "r148",
      "r151",
      "r152",
      "r512",
      "r513",
      "r631",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (loss) per share (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r149",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "verboseLabel": "Net (Loss) Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.",
        "label": "Share-Based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period",
        "verboseLabel": "Shares available for future purchases (in shares)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r62",
      "r63",
      "r64",
      "r122",
      "r123",
      "r124",
      "r127",
      "r135",
      "r137",
      "r154",
      "r227",
      "r363",
      "r371",
      "r450",
      "r451",
      "r452",
      "r471",
      "r472",
      "r511",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r571",
      "r663",
      "r664",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r10",
      "r20",
      "r526"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r219",
      "r641",
      "r676",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Corporate equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r515",
      "r516",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r515",
      "r516",
      "r517",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "verboseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r319",
      "r336",
      "r337",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r516",
      "r581",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r515",
      "r516",
      "r518",
      "r519",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r319",
      "r397",
      "r398",
      "r403",
      "r404",
      "r516",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r319",
      "r336",
      "r337",
      "r397",
      "r398",
      "r403",
      "r404",
      "r516",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r319",
      "r336",
      "r337",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r516",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r520",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Level 3 Financial Instruments"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments to contingent liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value of level 3 financial instruments as of September\u00a030, 2022",
        "periodStartLabel": "Fair value of level 3 financial instruments as of December\u00a031, 2021"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r319",
      "r336",
      "r337",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r581",
      "r582",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r522",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "verboseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r559",
      "r563"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments under financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Financing lease right-of-use assets",
        "verboseLabel": "Finance lease assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r216",
      "r217",
      "r220",
      "r221",
      "r222",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r237",
      "r238",
      "r241",
      "r242",
      "r330",
      "r361",
      "r501",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r16",
      "r264"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization",
        "terseLabel": "Accumulated amortization on finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r260",
      "r261",
      "r264",
      "r265",
      "r612",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r264",
      "r616"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "netLabel": "Gross",
        "verboseLabel": "Definite lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r260",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r264",
      "r612"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r76",
      "r100",
      "r207"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "verboseLabel": "Gain (loss) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r100",
      "r340",
      "r341"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss (gain) on debt extinguishment",
        "terseLabel": "Gain on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "verboseLabel": "SBC - General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r15",
      "r246",
      "r247",
      "r254",
      "r258",
      "r574",
      "r618"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r215",
      "r635"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r66",
      "r177",
      "r182",
      "r185",
      "r188",
      "r191",
      "r617",
      "r628",
      "r633",
      "r655"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Total segment operating income",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r267",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r463",
      "r464",
      "r466",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r115",
      "r462",
      "r465",
      "r467",
      "r473",
      "r475",
      "r477",
      "r478",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r116",
      "r136",
      "r137",
      "r175",
      "r460",
      "r474",
      "r476",
      "r656"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r96",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r26",
      "r626",
      "r651"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax receivable and payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r148",
      "r412"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive potential common shares (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r259",
      "r262"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Total goodwill and other identifiable intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Including Goodwill) [Abstract]",
        "verboseLabel": "Summary of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r65",
      "r171",
      "r546",
      "r549",
      "r632"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r78",
      "r325",
      "r335",
      "r338",
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r80",
      "r326",
      "r338",
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r91",
      "r95",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r9",
      "r34",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r13",
      "r33",
      "r108",
      "r153",
      "r243",
      "r244",
      "r245",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r75",
      "r170"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r650"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r515"
     ],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investments, fair value"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 7.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remaining three months ending December 31, 2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r564"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lease renewal term of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r39",
      "r114",
      "r184",
      "r223",
      "r288",
      "r289",
      "r290",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r493",
      "r497",
      "r498",
      "r527",
      "r572",
      "r573"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r114",
      "r223",
      "r527",
      "r574",
      "r622",
      "r647"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r41",
      "r114",
      "r223",
      "r288",
      "r289",
      "r290",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r493",
      "r497",
      "r498",
      "r527",
      "r572",
      "r573",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "netLabel": "Current liabilities:",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.",
        "label": "Liabilities, Fair Value Adjustment",
        "terseLabel": "Mark-to-market adjustment of CVR liability"
       }
      }
     },
     "localname": "LiabilitiesFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r515"
     ],
     "calculation": {
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Noncurrent liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Commercial license rights"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "totalLabel": "Total long-term portion of notes payable"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r44",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable, Current and Noncurrent [Abstract]",
        "terseLabel": "Notes Payable, Current and Noncurrent [Abstract]"
       }
      }
     },
     "localname": "LongtermNotesPayableCurrentAndNoncurrentTotalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r277",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of civil complaints filed against entity"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual fund"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r94",
      "r97",
      "r101"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r7",
      "r57",
      "r59",
      "r64",
      "r67",
      "r101",
      "r114",
      "r126",
      "r130",
      "r131",
      "r132",
      "r133",
      "r136",
      "r137",
      "r145",
      "r177",
      "r182",
      "r185",
      "r188",
      "r191",
      "r223",
      "r288",
      "r289",
      "r290",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r513",
      "r527",
      "r629",
      "r652"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Standards Updates, Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash activity:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.ligand.com/role/SegmentInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "verboseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r177",
      "r182",
      "r185",
      "r188",
      "r191"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Income (loss) from operations",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Operating lease right-of-use assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r35",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r51",
      "r52",
      "r54"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of deferred tax",
        "verboseLabel": "Unrealized net gain (loss) on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.ligand.com/role/SegmentInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Cost and Expense, Operating",
        "terseLabel": "Other corporate expenses"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other operating income"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentedTechnologyMember": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.",
        "label": "Patented Technology [Member]",
        "verboseLabel": "Complete technology"
       }
      }
     },
     "localname": "PatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "terseLabel": "Payment for contingent consideration liabilities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r90",
      "r98"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for Hedge, Financing Activities",
        "negatedTerseLabel": "Payments to convertible bond holders for warrant purchases"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r81",
      "r84"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Cash paid for equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-Term Investments",
        "negatedTerseLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r413",
      "r414",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r437",
      "r438",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r413",
      "r414",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r437",
      "r438",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r24",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at September\u00a030, 2022 and December\u00a031, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeFinancingActivities": {
     "auth_ref": [
      "r87",
      "r98"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Proceeds from Hedge, Financing Activities",
        "terseLabel": "Proceeds from convertible bond hedge settlement"
       }
      }
     },
     "localname": "ProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "auth_ref": [
      "r81",
      "r84"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r87",
      "r90"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Payments for OmniAb transaction costs"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-Term Investments",
        "verboseLabel": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r85",
      "r449"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from stock option exercises and ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r7",
      "r57",
      "r59",
      "r64",
      "r93",
      "r114",
      "r126",
      "r136",
      "r137",
      "r177",
      "r182",
      "r185",
      "r188",
      "r191",
      "r223",
      "r288",
      "r289",
      "r290",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r491",
      "r494",
      "r495",
      "r499",
      "r500",
      "r513",
      "r527",
      "r633"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net (loss) income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r266",
      "r574",
      "r637",
      "r648"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r181",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r181",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Revenue from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repurchase of 2023 Notes"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r457",
      "r610",
      "r682"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "SBC - Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards",
        "verboseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r371",
      "r574",
      "r646",
      "r667",
      "r672"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r122",
      "r123",
      "r124",
      "r127",
      "r135",
      "r137",
      "r227",
      "r450",
      "r451",
      "r452",
      "r471",
      "r472",
      "r511",
      "r663",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r168",
      "r169",
      "r181",
      "r186",
      "r187",
      "r194",
      "r195",
      "r197",
      "r384",
      "r385",
      "r611"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalties",
        "verboseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Schedule of Carrying Values and Coupon Rates on Financing Arrangements"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r260",
      "r263",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule Of Goodwill Balance by Segment On Relative Fair Value Basis"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "verboseLabel": "Schedule of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r409",
      "r411",
      "r413",
      "r414",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r437",
      "r438",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r417",
      "r433",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Stock Option Plan Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of Fair-Value Options Awarded to Employees and Directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r111",
      "r155",
      "r156",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r356",
      "r361",
      "r363",
      "r364",
      "r365",
      "r366",
      "r368",
      "r369",
      "r370",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r164",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r197",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r258",
      "r271",
      "r272",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r164",
      "r166",
      "r167",
      "r177",
      "r180",
      "r185",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r196",
      "r197",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "terseLabel": "Performance period for awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Share purchase price as percent of market price (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (in shares)",
        "periodStartLabel": "Nonvested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (in USD per share)",
        "periodStartLabel": "Nonvested at beginning of period (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "RSUs vested (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Outstanding options that are exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Outstanding options that are exercisable, weighted average exercise price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (in USD per share)",
        "periodStartLabel": "Balance at beginning of period (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r413",
      "r414",
      "r415",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r437",
      "r438",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r416",
      "r439",
      "r440",
      "r441",
      "r442",
      "r445",
      "r453",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r35",
      "r623",
      "r624",
      "r642"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r675",
      "r676",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r6",
      "r164",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r197",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r258",
      "r268",
      "r271",
      "r272",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleOfGoodwillBalancebySegmentOnRelativeFairValueBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r47",
      "r62",
      "r63",
      "r64",
      "r122",
      "r123",
      "r124",
      "r127",
      "r135",
      "r137",
      "r154",
      "r227",
      "r363",
      "r371",
      "r450",
      "r451",
      "r452",
      "r471",
      "r472",
      "r511",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r571",
      "r663",
      "r664",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r154",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r363",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r25",
      "r363",
      "r371",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r24",
      "r25",
      "r371",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Period in force of stock repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r24",
      "r25",
      "r363",
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock repurchased during period"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r30",
      "r31",
      "r114",
      "r203",
      "r223",
      "r527",
      "r574"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedLabel": "Decrease (increase) of stockholders' equity",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r348",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r371",
      "r372",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r543",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r543",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r543",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r543",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r575",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r385",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r385",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r216",
      "r217",
      "r220",
      "r221",
      "r222",
      "r330",
      "r361",
      "r501",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r126",
      "r127",
      "r128",
      "r129",
      "r138",
      "r204",
      "r205",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r450",
      "r451",
      "r452",
      "r469",
      "r470",
      "r471",
      "r472",
      "r488",
      "r489",
      "r490",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r544",
      "r545",
      "r553",
      "r554",
      "r555",
      "r556",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r613",
      "r614",
      "r615",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r117",
      "r397",
      "r404",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US government securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "verboseLabel": "Unrealized loss on AFS investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r140",
      "r148"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in diluted per share calculations (in shares)",
        "totalLabel": "Shares used to compute diluted income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r139",
      "r148"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in basic per share calculations (in shares)",
        "verboseLabel": "Weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r683": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r684": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r685": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r686": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r687": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r688": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r689": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r690": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r691": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r692": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r693": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r694": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r695": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>68
<FILENAME>0000886163-22-000135-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-22-000135-xbrl.zip
M4$L#!!0    ( &B :%47@*@X^&H   W> P >    97AH:6)I=#$P,2UA<F5M
M<&QO>65E;6%T=&4N:'1M[;UI<QO'EB;\_?T5-?:TAX@HTN*BS;I](R 2DM$M
MD6R2LL:?WDB@$D19A2JX%E+PKY^S9&9E;5@H4BA Z)GP%5%;+N></.MS_O6_
MSBY.;_Z\[#GC=!(XEY_>?NB?.C_M__KKY^/37W\]NSES?K_Y^,$Y.7AVZ-S$
M(DS\U(]"$?SZ:^_\)^>G<9I.?_OUU_O[^X/[XX,HOOWUYNI7?-7)KT$4)?+
M2[V?_OTO_ 7^*X7W[__O7_]K?]\YBX;91(:I,XRE2*7G9(D?WCJ?/9E\<?;W
MU5VGT706^[?CU#EZ=G3D?([B+_Z=X.NIGP;RW_H]__J5__[7K_21?PTB;_;O
M?WG^G>-[__F3/Q@\&[T^.AX*^>SP9'#RZO7SY\<G)R^?#\2+T4MO=/3_'\(@
M?X7;^9DDG07R/W^:^.'^6.+W?WMY-$W?W/M>.O[M\-FS__BI<%\JOZ;[(O!O
MP]]HM'!U%,'<U.5A%$3Q;S\_H_][@U?V1V+B![/?_L^-/Y&)<R[OG:MH(L+_
MXR:PPON)C/T1WYCX_\C?#O'C].>]&@V\)_!#J4?'0^I]'?L#/W4.GQT<_NM7
MO%_/J3(S:\1#6#T9/_J0#Q<-^?CU?[RA87AR&,4"J>JW+/1DC'?]]._NQ][Y
M6>_,Z9Z?.5>]ZYON#?S1^WCYX>+/7L_YV+VYZ5U=.]WW5[T>W'E3G.\2,P42
MB?^]S%-_94GJCV8\5A\&&*:_';^8/OXFEU?LI&;%?OKWS=A/G!47Q]E+\:E?
M?GYU=/3LC9[T]Q_]W/V^C:5D3E[7\'[Z-ZW0X9N.ZW@DE$3B1".GF]T"#3B'
MKUP20ZX#:TFD!'?X81HY@YDC0KA[$H$(^^#?XA^78Q%/Q%!FJ3\40>+T0YCU
M%"<N/=<1SID,Q+V(I:-_AO7 ?9+MWJ;3:#(5X:P=FW0Q"?WNP,6U/6A<4]H9
MYWX<!<',B>Y#V+0D&R2^YXMXAMN+:ZZFY>RU>O&OIWYX&K5C[;MW?I(*YS(;
M!/[0Z0[_SGQ6#6 MX^F!T^_CCIR*&7S3Z2<!; -PS5<YF2)C#?5ZWX_]X=BY
M]X/ F?BWR!T.,!3NF1?!N)%YX"?@P_K=[;1\QRYAO&T1:;BH%_&]A*7^*.-;
M&3O7V6 Q[Q0XY[K .3R[EF]!/M<V;,-!N\4[[&C:!N'N1''[%\J721N6:B+A
M)?8IYCI\4+B:06$Q<RX ]24$3=?W,D%\'0/'!X$<IOZ=#.!9P>\:BD0Z$S%S
M!O( Q/C43T$=_@=$ .@]DP3,-5)^'%(LC>[F.H,L=<((/@GOB.]]>(<G1WY8
M?S-^YUI.A9(VY@H."J^I05M/)&,8M#,6=Y)NP*FCV9C(U!E%<3K&KUSC7.!U
MAP>'!_,5_*HVO[15\)VLIOJ=_^STG1OGW.DYU_#_>O#OWW_Y^?FK-S^,$?3Y
M]]Y5KWOM%JE>P+X#,:3C.,IN@132Q/'\&*B!SC&D>OK#G&' OZXSS&+D$>"$
M811ZV3 ML))S)5-!Y/L6'10R2>A=1+C$8^9WV(#72VW @J7<IBUQWD8B]IQI
M+._\*$M@C3V)XH,6-!V+%/8(C2DQG<;1-/9!U0/+2R9^+ :!5+M&+QR *HBV
M%MA<29J4M7:Z$7Y.TFCX!=05D-()JI$)RQ99N)DLMO3>NLK**%%#%$H4)(X4
MH)7"5_;\SGQR<!W68%DP#:32DW!$BI[0W&/*8VFKZ1!E+1B.=?.P*=39(U&*
MRQ5JFJN[KT._[OEJP"7J_.9ASOFRJS<):"B4>)S /DVF 5G0:H:6E,=7G('M
M$/MP5A3%?L&.QL?4*5LTQS^*&&9R=,S6^ ;8S'5'7 L4AXX194QAY-T5?'9J
MMRJ+-6<GUUP0"T$0W?N*,L^,=:IINH;,IUF<9 +&C!*G5I^Q##%FS0G^ /8P
MJ#(L_N!1B_?4/\E>'K!<2[+X#M0Y&-<"KT>=[;;JJ;4MFPD2"\14J#1%6FY<
MRS1G@621',O%EM[]ZO9:,LP^!0O.0SH'AS+&@\7IP?>BF81WB33%4\Q6K1=(
MQXV3BY>Q'\4M$XDC97H ZTXCL%Z 4X M(^1S6'61@*4!"_[!%P,_\&E?<4]
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M&O\>2'&0YR2\4=.2T8CK#NXP*YKU9PY>@HJ5^M+3*=#JU?C9PY=OL$HCA:,
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MA5&E"4H!V4[\;** [5/2"3"C&F:)/$,MT[3A7@S*6OZXA.J]DMP/%CWDJ.-
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M;RE?:G&DL'6U2JM$"M']L7(X<,GP'Y&Z?GGC6]<K<!ICA,U1M19%M"B*I67
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MCZ7)>=N2R56FGKJBC"K9M'"2ND?<$H49\UEEV=*%E<HU=/(MZC9<?A&B'OC
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MQ!SR+Q4'A!DTPPBS4NZ$'Q!5X(X8K2W_3LU&EO.32.W(%X;9780A[H3B:<Q
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MV6@Z?:.80Q(3X8>8S54\E4.9$",2W]4OU!["D>!7"V_0FZLV2Q$+2$1:B(Q
M2?*_)$<M.)F,['<_[)#<3#BGGW:;CW:=5FN?KLLO$$P"QVG+FI6Z\&U\T[V7
MK3:\5;X/6T5=4,4##);";JL+:S6[MSJI1C1#$-[,J<I$@8NF$$CA#'/9[< T
M^31KZUB0LZE>M*%(@6X !I]&B32I3Z54?I.T;H+=J#.8S'6=(9U[0W6,SJW(
M9!(I21Y=+8J6@HO0U44Z<)LUM_R\XAF]A[V<YEDJ*?:2A"=$LN!Q/4=^OCS.
MNA7("P<:%U,E0"S]V=6'79AU>=1%"TS7OD2Q6](2RIKF7 NO8Z;=6,J]W?S:
MW&/@/$IQ"XPJC6L+_"1O(_BK2ORX=EF(N26Y%?#8>Z7/;"H\:2P6K_76%SG7
M9STB L/)QYR,6IFP9TIPJ"24\ROU $V:6,U4OW6FG0Y]57DIW%5JAUQ:&^O
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M!YQSQ=#@!J34DR.$'U9]9Q +F>LZN.6(E6 :%R*'=O-7H?N3\"4QB91C32T
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M9:NE@Z$H#<[C= L%Z.N5$-V4COV4WEH$^R(H&F1I1 >S"?/>)Z^L3DHJ>CY
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ML4+JEJICH.(_8]QY=NO8$FN[!L[:2E$FEK7"B98'JBP9%',K[:/>$L*+F"F
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M<$L-<35]1/=R9JWXKPR6V6,?JR*T^R@+/*T$Y:>YK9GK6>![[#>4&_Y5/MX
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MDY1JTGJ3:1#-I*RV"YF?^MHT^]533K<F+?;70>3-X'_&Z23X]_\#4$L#!!0
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M!R#.5),R-GF7A'59NJO,I_E@SK%V8+]YD8[K8W "H65TI$8%C$A424E+VA4
MZ]&L##0+JAW,"*:4P"GK;#":.+_!H*3/X%/&F.IPM]6!:?&U@QE!%E.R6NJ0
ME7*0"&-(!7Q=^\<8':U=&<CF73N8$3XF(F$0F2)K2F4-.D7HA+)9U&F$:7[X
M+*H%9'2&HE:^ +< Z,B^I>0HR7J?M4D-F#"Y3/%Y\;-6G'%$DJ,#1W"(8%"5
M["PE;;(3*9C5 W1AM8/Y@UM4D)0+JS5=0+K(?S0B6J7):7&Q-.>*@;L,.? "
MK!AM B(L!C.0H #1H22PT@=CO5T]H.>? \\?5893^(#>BYRAL#>6A;5A,"Z
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M,AKVNBNY6E*DDED8Y12C 4@NIFQ$XL"2!,>3V(2.B^5 ;R&ES22]+J1320(
M* 7ODS#"Y 2(R;N;.X"MT9O)3E\SZVZP5F5IG3(*P/D0* (G*0DAN@SAYG2]
M-7HSF98W(_3(I:RRT,XY!:7._+))2F<#6:6CC<V/>T_?#OO4PU4,>]FZ6#(8
ME5 #E8@QLU[.ME:V-41H?MB;#W@+B7K@, EE,!6E('H?9;%D<\[&VIB#:'[4
MFYOE+2#H12_K+@@IE (HB05+\-&P"O6F)/+-#WISL[SYQSQ#FIP#*%I(""9%
M+3,();RPI#GP-3_F[7%CG."(L_1,FX-CSM+Y5ZL8 :.VL7#VX%$YB )#+%)'
M43N@%'G5A$%-2PCE0N*A5RXYLBD3)N#FC8&2L-$6:\B#,<V/APNRROE'1V)%
MX["@\:E UB$8P>Z5<01=BDRN^=%Q058Y_UB992UC@W(>)>@ZR)T31LX1ZX+D
M@M\T/U;NG/?P_6KN#*!,76$T)VTDV)*\ EF7KO39I>1C;GYPG MV"XF&"-X)
M!U(7BI!CW0Y*06!]FDQ BRN0'<[+[N8?_@*ZZ(-6A4$$XTQ@!&7.%F5VJ+1J
M?OB;E]TM(-X%$TL**N:Z#9L'1(F,9PC ?M(JL0+Q;GB.O<GY=&3H*D8]49?4
MUA@">0OL1;$HI4D2@:"B/ZQHT^2H-S\$%Q+[E _%BJ2CL1XHN&A!E;K-0(K"
MJ9!7(/;-U0;G'P$E)A2:O"\N 16VP6Q0F@0Z*LX*XPI$P+G:X/SC(-9U=FWD
MQ*&NMNNE%QI(*W:H0D$N*] OV.&6&76QMXL]&C_!DTEW/.P]&8Y6,A54A$F*
M9$V4%F0I**ST'FT01;&MAN8'Q47!N9C)@ AU!UH9?#9 Q!$2LU?9N>"-+SDT
M/T(NT#KG'RX%FH(L;)(B#YZS1[9)Z2$;5]UPTLT/EPNTSOG'SB @%0D)ICLD
M1XJZ&.>BDY889%"K&CNW?]O<6,7@&9625;F"RQ*(!9$L=4T>F2@F8;1>U> Y
M!SP7L\P)2%FBK(/R+9"BH-CY>B6+T$YYL0+YY2+M<_[ATWGO9<JUY!HA!L8K
MET"(A40T+J=5#9_SL<\%C$FUR<KB *'.)*Y[F*=<S1&"YHQ4K4"?XQ-^W!&F
MR0Z]I<$I71ZPBK'3>$\><]&*!:WR.61KR%E*G*>4%%=@@,Y"L%Q0GV3--;6P
MGM6M=*:.=Q0A* T2<_Q0$VIPW%R47<X_9G)<U(%Q3*R#0*44A- &R,DHJ0X.
M:'[,7)1=+B!>4DXZ4G;!"U"L@*SR'AV*X*@H79H?+U_PV\&8GA&MY/1%%Y51
M D@F26  @G*N2&F\#-$9N0)=EO,#<"&1,5BOR=0]@HNO*C4H::U5%@E55H::
M'QGG:H'S#X<Z:LPA.<N:%$(2048JSD6;7 &,*U"!G:L%SC\&IH!)<=(OP0,X
MF6.MJ6OT7H*V+JW _/U.EW/_R7"PDFDB"93*FU+S1 #/62.F)&,!D4P6>@72
MQ'G!MY#XYX*45""4G"6HVA_IT)K,N:+2'!)3\^/?'*UO 054K!OK&A0Q"+"J
M>*_ ) HR.%04/ME:>0W?4L4^J71RQMI A4#'''+BW,&;C+4#V:Y O?1C\7*%
MY/CQ(%_]I(["^OCU*H;(D((2N2@6.G6-F^Q37=&=;91S?F=E:7Z(7#*4%U-C
M=9R$.(ZE,AN(3K'_K=,@BY:N<#ZIFQ])EPSEQ<P0\62M#*&6>J#6T"D698PH
M'MF/YT^VN%^CW,2X').JYAQ<]@:D!9^=KP.C&6ZC-(KIBH!+:<)7*S,^ZPYP
MD+K8VQR,)Z/3^NOK2S=N4!^Y@>AD..Y.[G;5ZAO6]SV[<BL;K).!-9)@ZS-U
M3!;5;%.YX+."%<#ER7!T,APQ;S<H3G8IG8ZZD^Y=5'[N!"!M!)G:GR$C@46(
M)DNIA2L%(45E5P"@BP5:&X>,M4KKNK&%8'E2%RJB9 L9)YQ+Q G("B#3.9V<
M8N_9Z2 W!!-6ASY#*1%0@LH^,"BBSMQ@/%ACK (FKW;W1H3CTU'S+(8X:4N4
M4HC!@944.5-WX+P#@Q!,60%T7N-HA'^YB/6R ((Q>2M,K/] W:V6@XI@+^9M
M2F"47 % YK6%TNQ 2<(A9[7*1,MNS',ZE$1!)"6]*R[GY5T\>QFE\@R7Q9:<
MO@A*Z)T!$7V4X*7B5\JA RE7 )=%2.79 911RY1U!)\(LJ20';LUC-9:,D*O
M@N%4;T:C>L1+/+F+2L&= %,B&TB)06(IX$3 FO][;U %XYS"%0!FKCG,#/?6
MJ1.RZAD="S&=2BQ4M$D*,7 ,LJN S)QRF!E:2[9.L=^B4@*XHCCOS\910"]E
M5E&M "9SSV%FAXX2)&.MDM6MW634T6=E/)$$X/ #JX#./'*8&>XUP[%=%E^\
M$QXXM?3@ AA#/L:8M%J5J#^?;6"_ Y330?<"D:FHYP?\T-S]J:G316?(U;=7
M9[GZ\NI]/<UG<99%%8-@P<@ I7A,@*"]!J4, 2QQKOHM$]H:DJL:3H!TLBDH
MYZ&X$F*8KKA?O+80C%U>XULZ4&;G$<F':A#"20R@@\!4G#;6JEBWCDVXO);R
MD4?L3NA%]RWES0$WPV$W]NCQ>$R3\<_G'3P>CI[T<'QCZ[27#!FW0MZC=#08
M]H:'YPTQ(N\"48P&7=)@ L5D2BU7>\&>CFB)=TMK$EZSLZ\ H5B?*'F0=?TG
M7[>MR+8NA(#9A+2B]K4WPDQ;V&],=X/,P.) "U%8F*=HHDH^.ILQ"&>M;(94
M7UJ<9F=/=19T</P7),LBPD2&C&(!!U22SLT8&_+U.#TY'4^&?1KM4-U"<C@8
M'W5/FF):,9?DA2HE$8(P(48O+;+B*(XRY\0K:EKSAVR&I3[CK7#:!Z<3V.@B
M.\<D24N4!65LQDB?;X#L<NKS*?9VNH='C1F8Y87S2IC(@L*!5'7P.M6=H26(
M@LJ*5;6PN<(UFX+'B$Z&H[IE\^_UH\^7/:X?\]7%#VU-MMG&1!0 /!MLLA@U
MHL[,"Z^6WWAWK[;C_OETW!W0>+Q[<8KQM8&RASC(=2F\&P<UQ&:+3(B0=,J&
MU8M6L>2D3$ZV6 PN-&"LWFU0VNX/NH_CAZRM2PU#R<5@8JAS*Q6!51(C%B],
M"LG:P*:U_"A]DV>]&(7.'NCQX8@NMI[_"\#^\GZF6Z#7[>II=(*CR7E-.CXB
MRN/WW?/AXZE!=W RZIXUA"!U-E%60J@0#1CPH;B$G$A"5AX15U7<KCI!9B>E
MG2X@J5AK5 "?I0<9A4$#S!LLKAGC&)M D%WJ$;]CBFQT<3#L=QOB060J4I%&
MHU%"]A1!98@^1)>*%M",/LDU0>[.@Y W(KB4M @2C)8L[(T--A8*R$CZM0=9
M,HO6%"/G6KF4B!" L#" .;'*CVB\7]4^FGD#-L/1NDJRA$M!T#0\8_!L89E-
M+ N=$S9A$9PK$#8':=BG#ZG9BV&:%A^O([5#8\)1.JJND-Y2;WA2CWUZ=E*G
MGJ[B&@ RQ,!>5!?2;(9!>.M\H12%+"6$W(25R!L#\$*F_\NZQH-VF%QV$'6(
MT6CP+CD@2SDW88G5Q@"\H(7FA((ZD\(G 9 #XZV-\**.7 FNR ;,_&\,P N9
M]&^5!9$<*24SY%Q"<8Y\RBR@@D@25BT&/Z<!C;#'^#[.?99;XTG=%?LMK7 4
MQJP0$=A>A8,:@BD8G24K81/(JI6+PHN%>"%QN&@RVBM4H,VT5R,(%,ES4/8"
M=&C"@G8-@G@AD3AY&V3( 4P ,%%@BD8 %<9 *IN:L )Z@R">5RS^T$$].*TW
M_DG'].4Y^.57]T?7WC.P0I3@+03OHR R=<T8&7R"TB2?\/@=CO+>^0E](M8F
MHVZ:4+ZC>1>+MWI=I&/'[K.)!72=.%OQ3"6CU58:UP 0:WEX!P>'E^#5MQVV
MY_YI_WL+SVMZB% 2A2"]LL2!02-@CDZ**#41B=)0>N#9FAZSH$>65F$N*:&7
M' I8_#,32*JH37 D1(.2N\=\AMSMG58)\,>$U*=GJ7>:*3\;#?M/AOV3T\E4
M26R7IS@:= >'XY<TVCW"$?U\_OD3+)@2"RC)QNQ5Y+3/L3R(&KQ*PJ 3G#\X
MK45L4#*X@I183!'7) $JJKJH)Q2*/F0%9#7_9VU63= 8*TR)!06.XI2/;/Y*
M  ;TVCA#H4B;BU6A2<GF"E)B(85B+7,LNL1,PD,I+#7)R!#JLF2(1IJUEKBQ
MVDS_I#<\)YH28ONDGFH5]83SH%)VD@@C:$'1!J62S4F!B5[@6D\LFA8+T13&
M)$/$;L"' C(:'QE[T!?^0E 3UH5?<5HL1%?8B%)2)I-0@"EUJE36$47.TEA?
M:*TK%DV+A6@+H[VMVRU#]@*2<3'K(J7/3N7H4J0F:8M\?#J>3$?A/1N.MNC=
MXY3JV%C&_N5H.."7B3Z:K?/A9Q^.VIW@(.,HCU^=9&Y.?EXA[$HJ!VN##BFX
M9"*(7"?_:X\N$$@,QC>A=CE77S#U ?4\?/7IB5[V<"6#A,]H4_1:(DDHODH(
MZ9'9X7R@D!O5<=50;[  T(MR,04K#%A0VG".&0T+R*PEZP,C;H*NE;IKT.^V
MW71;J>_L,[Y$^/.SF2^__.IN8YTL2S'%*9W)D"A&I8L+R+%8.&WT%1!:Z4L@
M[GXX_3< P3>G;PW$'X/9OV=\1D0GI?#1Q0C,WB" DYWD0&>9LE4-TC!W.</X
M+V_BRXN^?2BV#<^Q-_FKE:AN=:$GP\%XV.OF:3S=Y(>^X8BWF0 X]<.7+;"*
M0DR -!(-:S K $"P*_:N@"JB>/#4I/&!:^8NBKD+J3)9D\D[ 1HE04X8ZQK_
M103/S$HJJ 8IQ35S%^AS%[&%<=;")6%ET0"R<(Y3C#&L=:FN? $-*H2MF;M
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M'[6%=I!MZ^)*]6T'S[K]TWY#BDH>R8LB<O"U# ILT-$I;W)4CG0L2TS.9:+
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M6_[KTZ>_<<"=5UOD[:LMUP[]#B8G]M7H31*H$:RR&%4)6#M>I5/8A*545H_
MRU+;B2;$HBAI$AFB4B%2$4);L@1:>FI0M75-DJ6H[5*IT$:=M).0P'HC62DJ
M=C^F]O*%!O4DKQGU&4;-O[<X&U.\2!Y2,("8@N#X1:22]PZUNAAL(J]\U%)W
MY*T9=9-1\O8^ZD8?X_>,1V/BI. PH[107/&%0O#20 BI< Q<_A[A-9&N*Z+9
M]3\7S^I'\C^I1"!9HK!:>.D0HJGEP77\:D+>]_2LCLHY[8Z/ZM6W2[V;C^YA
M>LD=.CD=I3K-)&^<UIFW3TY'(S[ZML7/1@93<CD@JS&;E 1=.9X]2704.0.0
MWMP(ILL\@W7UZ#W78#J+V;3#:1WP\[-G+[[[ZO)R=*SVG#!.F@PR2/2:I",C
MHLT2H%SZ7W_E?_V:H"OI?^^\K%R=JK^]__4SZMY60KJD PN+ %H'+W0BFW4&
M8Y(QGPQOLVMYT1S_^W4%%SN;B![)*1--208D2%)1*8J^I Q1!A+ZIL.<@V"]
M6TN<U92'F% [*8I7'A1X-(F<CRIX:V1T;MV/N<R!9IXC3A;?&9E"TDFX($.=
M?RP)625EZ3Q9H:6^G%(NKY)2N<Q)Z9_/27A9:$!G=R^3;YMXR=F->781E90R
M1D&L:U-=+BA%(60!4>H:5S<2KS6$L\MT9C9)3D-"EFV>4Y,<%6+*4<O _W,B
MQ0;LJ_[X'8[RIQ'B:?^D-SPGVIT,TYOM:=[6D&J=<I$, ,N?$*?+L#@)!A#J
MSN):4@/F]GP!DAWBB-I-$\I34!H"AU"H14UE@D80/GJ79.:HY:5/7I!O4'?R
M(DUE\;VX%F,$0SI #F!U9(^G;?*N(!AO3 ,6=U\25S?#:3C9&!M"<5"W?:02
M=<;,VL]"MJ&(!NS?NP2N;G9P% Q.%87>^@!2L*MS&BEQ^NV"\5DTR-6][.%@
M"_O7IBM_;"8O+\MT];B5=';9EPQ.)BP>9*E]PU \&>F"#L)?3'!CN2Z785W&
MCZ8_A-H"<B8+\$:0.8/60 D*/SQ"*N32Q6H>;KK\PT4+M)>H*:[EY3<:X\_R
M\AN'?@=S0K"2R,F,EEO/LW<N_)+0*^N1%>GR^^0Z_K6;NS@ZW\4>;9>IP7_D
M"!Y/]HZH@Z,W-'G*V=[D?+L4NL4RQ<OBID4!QD?[)&P )(4D4I >"Q8V^XN5
M:F200E\PN[Y8-JAJ;>L%9]F'TY4EGK C_@B?5[L;W8OP^61X.IH\&XX8KZWA
M:')$H\'55]ME^ZA[UZ/TV:3$1UG$GQO@M4._=2G?[MMN[_<TY%"%W<&7UO"]
M?M!7=T<6E)S4")^#\E#01N-*=+;DA)QP&K6\%M[X)5:1/$1=5,;DP842/.D2
M(TJC4PSRLND9'KN,3;_];D"C\5'WY"-CW>X/NH_CZLQMN 8[F[2R7PO[@^[9
MPQ&-V74E&E^\/2+,T_O)W;>/?N*_+BL]P814M)5U->CL:PU.)DA*N6A"+O![
M]=M__&8\.>\QWOWNH'U$==&=AUK>-R>3']]U\^3HH13B_[LW/?+13^,3'#SZ
M*8X>\.\O7G\XS9>__.1*]7G:V.L>#AXF;C,:_3C]I#NH/'JH[4EU4/4,5S](
MP]YP]/ _Q?3/CX5;I%VPW^V=/_RONKSNN+5%[UH[PSX._NN',0[&[3&W8;DX
M<-Q]3P\EG_/B[;N+)W1\GEYW0%=/+%5]R%=;FWM/-UJ[>X_WGNY^\H1?O/T%
MW>WNTR>O=C;W-I_NMAYO;;2>_N^3_WZ\]?QIZ\EVI[.YN[NYO?7%1^CCZ)#A
MCL/)9-A_J/ER=_]0XE8/]1K9$0P.)\/!#ZV-^T_NMUI*& BW?!([CR>Y'3J_
MW]&?I<(4;M44S[9W.JV?V%\-AH.MTSZ?)+4NW=H.E=HO'P(&F\EZ8<&B" $<
M"ED*1*\P?[86VAI@C5*9N@\WAFG:H5K=^KW+@?#ZM_.X,7S[0NV\W=>=TWS\
M].W!\W"\?;QIMO9ZQP?''=79^_FHL['S9GNC UNO?SW;?[]SW#G>U/O'K\S!
M\WWQ0F_U]M\/S[?W7IE]M?]^Z_CIN_V]Q^)@X_#]]L9O;SJO.V+__>;YEMJ4
MVZ]W^EO/_-D+=7"^_SK9SNO]\ZV]_7<'KY]U.Z^?O6&[?'_P_%GOX/7!T39_
M=G#\YOS@^)?>_G%ZFY__!OF_?^D=J-[;>#P\.SC>E%O'/_?V7V^>[;_^5>SO
M;;W9?_U;[Z#_U.R__J6_O?=+O]/_K;LE_=G6^\W?2S#<(F#:)6G5!FEE.Y),
M[0 Q $C->I[#/L><7Z=!XP\0/G7BG^=26(15P4*L:E*[^Z^>*0Y''%[;_&@]
M/!G3PZL7/^;NF#7R.8?NZ1U.?_3C]3:K\7/:I9^P=]ENTR:\^/J/T'I?7(37
M"8?Q2;ZZ\N77]Z=?/9CD3[]3]T/07_Q6W)=?_.[/SAK@OA?N5J=],+WCB[OF
MAJG-]Z][^M[5#TXP9_;C#]7)64M^CC^?M,[PY/:4>LVGKJ<??\DQJ;]BTT6K
MW[U/^O64<SL:]<YWZ(13S7NM,ASU<<(7.)L\+-TSRNW)Z+29;NM9-SY_9?>/
M?^EN;1P<'?1_A>W7O[[?VOBMO]7?%)WC-^\.-K;>=-X_ZVZ]WCDZ>+UY^9O?
M^%IF<+!WTNWP<5O]9WV^-W.PT1%;K_F.CW_E>__Y34?]^K[S>E/6Z^_W_+L7
M>X\GG5UQ]F+OC>SL/=6_0\K.88QM5KJE#0Q6.Z V[:A25G7]K83EWJ/_\Y_!
M@?WQBZ[ODN=?1^$>E4_->TK@N>K$FRS_)/Q.6?Z!@JT+#K9>GH[&IYQRM";#
MUBZE6BII2=T:CEK2M/Z1_]D:EM;DB.IWIZ/I;E>MIV?IJ";(K<=I4K^6''!N
MJ/P/3N'!U!\NB4+YRR:Z4"C\[/6)__VAJ2ZRL!9Q3I+GH5TN1O(^O2CO7/<2
MF3]I]_F:1_5G[8SG[7/"49L&C?0:WRQV^-[V?T<%*;BDVB4;UX:J>-!'VP:=
M/"-AK2YL]+MT,IGFZO_G/Z45/VKQ0ZLV_DTGT&HME9J^'5>'H\6(E1#N>Z._
M3:LX86>O5<Q]$6"M56:8/]6=BZ9CU+XL5@KVQDU6*UM[^;C3[YSO]Y^^W]_;
MZ6W5Z[Q^>L;G.-HZKO^]>M?9ZRB^WQMJ92BW%/_N_2]=]E%'6\]?"3[&[.^Q
M.GG]5'7XOZV]QV>=]_O0D9]1*\4Z[YR%MO66U8J/G*45$]I>6:.T3EH;>:E6
MX.^L5OX@X6WDRM]:K7S45!?RH?5L-.RW+C+:VEJ7K^ZWZI\&AKJZT5]W7$OY
MK6==#G5L#AS3']ZE'GLZK>'7JUU<K)&N[MLE5F?O$'Y/1J@<E&LK;[ -DE([
M&I9<W@<?@\[925_[@61;:VZ_;ZPJ_1G1OM#'\'4GZO8/6^-1^M>]VJ'T >S?
M#^7]XY/#>RWL3;[TU>5E+KGH[<G9MP@F9<3)V;T'\VN(N=3I;MDY<><FND.'
MM<N>XT(=C_7W,M/WVWN'G FA 58+;>V";+-H3&VLA1#&(\8 J)6D>X]>;#ZO
MG4,O__OQ3N?QDZ>O]C:?/'ZQV]K<>K*]\W)[Y_'>TXU;V^\<^XBF9WS8G?#5
MTBW*PO]X>H8<ZBM':KP??>!&"\>M\0FEVCN=6]U!JSL9MU@<U"S_G]_I7^:<
M?IG[8-VWI%\ZW ?_Y1SK6_,OX^]K&>XX_UH2Z?J7?9=WG:)=^+S-01J.6!-/
M1S?M3G!"3X:G@TG=$3E?+QKQ(Z0ZKFA")Z/AVWJ>AE:++K,V=7"\KW:..GN]
MWM;S9_VMY[_T.J\WS[<W]@7[Q./.\U_>\#WVMXYOUIB'^H _/7C^]&S[]2NQ
M_WI?[/=?G>T?;\+6\:_G!Z\[[_;[.\=;S_=5YW,UYDCDO 5JIP#0AIAU.T29
MV=.RKPU!&?+EWJ,-ZN$['-&?>])&)V]+8@%[>+9Y.=HH3:V@P2I]WM1^>IW:
MQ&*>0/JVS8KU@]?4#LFXMG7&9Y1.AJ+N/7)U^J<5#N 6Y%X=/W][_3'E_3^F
MSKB6)(9U-&GK^'34'>?N1:UB6)JEJ*9/U/TXU$P?;'2(@^[[Z?M_KJ)C^UK(
M-^_OW-^]W[J<_C%J(,;7/6EK:WC_<\!>&O6-I%A/!^G].>BB0G[O5ORX=NA"
MR_7-BH>/<Q[5Z>47_WO!-R#7L?"O8N'[3V2>#LJ1KA&04^=VG;G>1DJQ+55B
M)*+32NE[CW20LK4[G*Z\-&S]AKT>G;=^'I[VZ"V.\@^MW=,N!P$IQ7>4[]>&
M\%V&\*1.NQGM#=^MLYV_- /QB1DX8YQ1R;>#\IK-(+HVNJ+;5)24*2<37;SW
M:)?IL]&EP^&:YHNB^51N;H]><F[/0JV9U<^Y<EU^PG6CF>BZL(\OP%RWS/6H
M36D+[[V3*#$CW'OTY/%LNV(_3]A^-^<>K3AG7P['+$P/NB<7Q:HU8_^2L3<2
M=LB14!2L YZ $_8DVTQ@;OE S%9O!99T[U%04LD_)6VCW.W79F679*N] "<C
M]HW=$^RUZ(S2Z:3[MG8.<+I#XW_>A14O53NPG;6JH?WS4^B7:L3#[68%_>,.
MG525C(]'A(UU2]_5VV]^]R(465QIYU*H#9J57W1&MS594_L8HZTK&'CC;SJ5
M?][E.(P70S:LET?#P=]U',:;=[\G<!Z!/3R&E-N 6-K1%M%VL6[TZEP.B26*
M,?R)$5]..I?1S+_0C?M'I_Y_C5M[U*.3RH#+<3\_M#8'J7=:G7*K&NR%?_LP
MKFD1?NG+@ZJ^<4#'$CA<:?C!3/"B]=_#T60X:.U.1D23J_(&"+/T=_^4+>#\
M;;?7HQ]:3QZW ECAFV@.SX8C?I+6UG18PZAU^?92XOS0ZI;6D^DXQ]S:K6E@
MZP6.)Y>C)K\\N*$QS/RD4:;8?C3,\V*8!XWX^4\^-T94_2-^&!WZ.$T>MA8S
M</X[9OEI?U^IV\W'^YK32GT_&#_STP+<-U.,YC\B_Z+!YT_)BR'+W4EO.NZ(
M,!VU4@_'XX=WD6!\]B'O[K&N^8.%M.L(I\%^?-Z/P][\FG1>S[=U.5QM2ANZ
M&K/.GNO=49<_^<.]/?R:_/W2GW$V^I";H#4>]KJY51_FQV5MG9M!_&)6S]WE
M%I<AY%RJ.#7=1N86%\6H3O]7N;VQ<[2_]\9L[SU66QN_\>M#M?7^,6R]S]W.
M^Z?O.AL'W8/7^S>+4><'&Z]@Z_FSHVW^;6=C7VR]YM<;_.0;AYKO[WUG[_&[
MK3[G+SV^QYOE4^&4U*(NVFY4:@.XW([&IG9$)WQ=#;5HN!C /U60P_3FA]8)
MCEIOL7=*K?^W1D19)UFVQD=_-G#JRZ;^333_W)B##R1?*B%[US9PZ5MWIZYU
M;0"W,( ;U=ADA,.H7#MIJ]M@$K:]1]&V5,=322@IYGN/7CS?^HOQU6N*W[6;
MOYH-=C%/X.8@V1IW&S\^=GY6L'EC?*PUT2>);1FE:C/I.0((C6VB3$YGZ44J
M+.0X =O"<<9_MY[WAA%[K8ME,F\[I/"6%>L_6_WIJR;2+&09J<4L>//74XIF
M_=SA5L^].<AU7!JUXGDK'5%ZT^(;>\/*F*8#+&M*_]$LCW_(?[:.<-PJW1[E
M%O9Z_&6M@M0:P;]/N[5",!FV(ET>P.?\]HFDK3S=@6UZZ,F($DUS%*E:TR4:
MQJU_\/G8R;3&IZSAQT?#.M7D:CF)R1%.;M[[.[Q^E_46+WY\^0S__*&%@]SZ
MA[IXQLBNBK^/Q_P$]?CIH?RC>A>7YZF3N<?3FYC>9*T*!='*>#Z>3@6]\Q[?
MR]WI+BI1565,<'(Z;J1__:X2_MGO&@&M!6A[C)G]H[3MF+-MIRA4<D$GE.+>
MHWT:?[HTQ>7"-16PK6'K:\O<?[7JP.VL\,-T]%5R%M6(V'[ZW<F$+8YZ;$>C
MX:#*I=YYBU@ZG;<VJ\/'-.TRWL )7DP_ON%+_CC'Q]7'G=/>M$A>W<4.'9[V
M+@;7[K;W6O^HJY&X'Y56]R\/F!QUI]/13NITM+MV+!?W^\%?T/B?\_$&'S5F
M;<M+Y_"W\P:'ZG<L&'(HN>T)?)UR$=L^6&AK8<!X*B0MKKW!?+T!&R"V>GSG
MU,*4V!N,L)IT-9!1#;R?_;3%V+0_^\6X7X<%CRYC=S7@NJ V#LY_J#J#3\?!
MN;;28>MP-'PW.;KZFDUQEZB5J70'TR4=ID-8&';/9O7CE^YO^K7\\>JP+Q]P
M=<27;^_JR"^B>]7&>KHV\,GP8N6)AR.J'NXM?;):\!]9[)0.XH^?8.14]G3R
MY9]\C8C_^.^CT1^%X$-JQQ'AFS86/L%#[+UC^5-GXR]DR>,E,8VJ(^]]@8'W
MZO3H:?22*K;5E1K^6 (S2?_Q9&I1P\$?(XOFVYOFX;Z%\$W+4 7^I9IYKY>Z
M[]T=G-7==W=PLTQS=\LNNJ]K Z,6-Q5\OH8TGT&S57".GK G/QR.SANIE2XJ
M4P<;O6Y'/>O7*M+VWJ;:VCC@>^L==?9^Z6V][IB##;Y^'16[D6ZN#OIF^_7F
M^_W7^V>=C<>F<[POMJ8KC#X]Z_1?R?WWO3?\K-U]M?5FZW/K;65%*A065YFR
MJ*-E;=M+G]LV8D@.O8M1WWOT8AI8'W\4-Z<-?_?K;WUMU]KC41=[W]?=^&$E
MU&^;I7$W$SR7)#!^A@%W,\-U4;C#CU_3AWS'#S5+3[S%2OS+Z*T:;HNQUP7
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M,ZT*GE=]EO5]MVD[.&D]/^U]+L;VX[=ENODU!<4K/LN,Y,L>0VC3L#=-%+M
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MX<'+W>W<C];O6R\!/CNMP__L[!P=-GUF?GO;M1<A)^+^H]7XME:)P[T+>$0
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MM#/<.\0P%O!YG_\RCD@; T&)>HZX\1196+F(I:2"$$RPD#8V>9L0^>]__KA
MKKAA%DCD;7-*:-2YV1>&6EF&"HJPH)1//FK.O;$^<&%"=%%BKDBJ&(H0RDAA
MJ&8QU-=QAN(16Z4,8I1JQ .72 M#D%*"*Q>M%,%M;!+3%MGQ; Q%K86I/VD=
M'I[T^D,$3OE9J]/]% ?#L]M,PV\#0J<;D%M)>+F)JBY3JAKX(QCWW>_#7GBI
M+E[:?S9A.0F*=;+!(J><1-PZ@S1S&F'.'%4*\^ P\!)1;6K(K,1T.SG,U7:Z
MK_M<(%R7K5$@/&<(CYL6DA"LE5*(8.D0%XPA3:1$GCI')7Q%12XX24E;Z)G=
MGQHAO*:1IRO=ID&K'WT$4]R=QG:K&^_.$_X9-=W7Q5MN:JK+NK@>^C??1GX_
M#J\"O86B:J.HPPDK(TA'HF$*!1O RF":(TM\0-@+DP1,I!)Q8U.*-I&Z0=Y/
MW:<Q!<EU&1D%R0M"\KBQX;TE+HF$G- ><2TC<C19Y 4.W%JO?;(;FUJTP0YI
M$)+7-(Z13?#NL->_6Q._^#UU&1??QAJ8J%!0;134F3 F(M'<8(X1AR4+QD1T
M8$P$C 37SLD .XL@&YN4MAEMDKM3(A9--28*<N>$W''C(;($\P%V@\MGM5Q2
MBXP%^$:AN(G&@/W@ ;FJ8<A=TT!%EA0]BZVA_1)O!BM*G&(!ID0>^:,\\-\=
MG$(^TY#/9(Z(-S0JR1TR#N<8!*'(\B2031%6)\$\Z;BQJ;1HD-M2 A#-M1EN
MA6@Q'FK#[[CQH"+\Q[!!*OD$Q@.3R#).$-4\<.T3=TQL;,HV,27P\.BVP\'P
M)/9;_H<<ZA*#F+OA4 W[5C7:)1A:,R4=3"9/$.IARB)%R< +5XX@&XE#V,!6
MHJC&0::-38+;BC?)GRF1B*9:%06_<\7ON$G!85(2%@8%%3GBQ'%DM3.(^>C!
M'S "0)S3QJ5J4NK3FH8C)E^/>KGL90U&QJ]NPJTZ?=667U&8:R[,-9E0P3$Q
M5BB-6#)@>6@OD8[9-U(RIU,D$4C*9R"XS5E=^>3W@\<2A3K6%N^U96$4O,\)
M[^.62J#>!:#E'/+P^> 3(Y,C("E:'$WR!N>T"RYY6XF9;96%X'TM B/;,44
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MP:-P3"@D0TI",K#%O*G<"J#G NK5!77=D8("ZD6">GRGU@KV9*$1PYP J(-
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MWO?.H#67T.56MS>$SQOV8(.Q%Z&3@WVPLX1<[J?ZJAHEF[^=.EW;]1U["KV
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MK8/G\-;>JS<[_X&?V_UCI^K?WD[KMY<'AX?_:'P'?WM[37U+T-9.MS4\Z5W
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M-,E5Q(I@I G,!VXPT9$9Z66PG%$:2:B+Y7ZJ+%A(;CJ2NQPCN<B(DTXADTA
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M;&$6#,5U5=*N$3XU3K$%$KX"L5-"Q4BH-41&[KBP- 4EHV<B*.R-6!?*U3*
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MA->7]D*$XU;90#4G/&+F@.518(7 ]@2-2ER" -96HFTB=:]6LF9$U,YQ(5$
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M"]^:+FI\^A7K8 1'DXN_<N.R_B'8%\'JLY)8_)D'6]"5&F%\8I)@BWG03(M
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ME AMI J$(FV$0*#M!&DB(E)">QD=2Q&#F<&ZC+<I0^T1N$1*%/7C<GBTHQE
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MFI&K3=U:&RI3_91W@!SO!J,(H_@&9+4_'(\[ !Y;+]X6XCJ>E%KEU5EY?UT
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MP3@ PCT(=A3&G7>'60O&76#9^9@)+.*M,#R$Y=]RV"H'#R\'G:VC/=@ZL[V
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M&2V&FX < -;@.[  \K5QUK?\V4P=\@>*K&=Z-'7?315ZZG0OU!GD.U.ZXB:
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MGT]$:Y7%BJ1-L/U28&:: .+1I),B)D1N;[?FWP_K Y^&]Y5N?=F=TU09&N<
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MB[8!(4S0R2JBO2CL.VKBHP1BG/$J.Z]YC&W;KA]3",*K4FBW!AQ<91>PTN>
MFTWD&H(!YYA#5+)(0355G%:[P";!TZOEY!R!&ZMY<L0J8 1\"3B@1B!&*049
M$JH4"$^L"P_QG'L5\YF84RFC%,[:9!2@;N$RYR*QE("F4A^DV@7:)\F+=@&<
M-2:XYBB_WA-P*A$O>"0L>,ZT] *DW-JQ]L8*0Y7CULHQ@GE6- @OE8%DM5?
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MGC))QBF"*BTJ0]%F4ASZ4O"LF$(52+ ;5\^JHM]6T5_%ZGG?LK]@]:RL8&W
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M/&O+P&PQGE5;F2!(3G1B@8 "2GR,BD@?<S B6I'YU@Y;SG%=@:P"60N!;)4
MU/M&LIJT[D9(MAACJGP&:R4)#@0!IPTQGF:2E'22JLQ$D\IVV5;\.++U5Q#;
M'!!K 8;5D- [42T7O5Y2,<>HMX0[X9&.\4!,S(I0JY56SF9'V4RWO+'3JT:^
MM,M"^&PX.AZ.D"=T_' 0:R&"*\O1,FTU3<$9+8%ZXQD8QO$WKIT&QJI5K?W0
M]V[)JB8+>7-<XH"F4')R1>*$9D1Q"3H+3KU72-]L5U#3^ORC-?OP@X&!:H>Z
M%?%?M$-%S90T''4V0/8#DEOBF,G$@1$4= I 49*8KJ+_4$5_%<O-?<M^M=S<
M2/87+3=)X>Q1143(C@ UE-@$EN2$^BQ(R$&ZK1VQO.W7>@.;+_8MD/IJZ[@3
MPK]HZRB)=FE0E'AI# $G*''4:))Y0 B@CC$=&L;/3?NW_;5&0UT?3.J5FWGE
MHP^'>S8\.DJCT'/]SK$[3J-:>N**32\ZP4(4'DQ($%FR44L/SBNEDJ2BQI!M
MP.9WL!Q#9GVF.+5$I: )J(":KI><.!N5M4Y;I2127M6E-[=V;;+7LL+ W<)
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MSYVQKF"*=?W%^ZPZ]A-S]A.-_=:8_9;RP@BOP8%B,9J:%%?5(U=%L%2,=KX
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M"GD?SCO/I"O<:'0EE;*S"WTN;AQI:$LA:XOS: WR(&NR%PE<H>?&^<*=E:6
M2J%%&C8.Y^\_Q[DF9S*#D@Q%-4@\9N:B0J:\C=(4F0LGG+N^UVUKP_;BW JN
M))I4O ] ^CJJ$'VL7HA(:%W+V[)Q.-]?T.<*;!3)"!92U R,4"PZ&UF6&'+,
MVO-8TUO:OFWIJK<8Z#&235<(P$58<-&&(*6QH6B!0?LL6ZAAXX"^H-!SP&#
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MBIQG[[-*"F(R3@MKK01O?812? MV;AP++IJ"7I3HP#.7HV%@E&?1!60BZA2
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M$=2E=<QY7_/6B6Q+QN#<Z@Y7-+"O+=B%M=DZ"-8&#1)$<"('49RV)?J<\,[
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M#^E+FR>BC.2=R\2LD8)!XH%Y6?/ 63+D K?<>M-,^>T'NT I#?V#R 4(@P%
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M+9;M+84"& Z\5!E#&(^>2 4ZPB3G2'!@M'B*G>KTH\?5)O'J[[MMM7'9J9"
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M"PZ&##,X.CUKI@ NW?,@"1_+[,.=\?'KNV^W7EV^8J/A"!X@ P+,/3B,%BX
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M)W%>R*B2LY1+*T5TWH(QKE-F8!Q(PZ\-+9MOW7AUDLFJ'),-;GT-;KU:PBW
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MZ!QY3&!RIRHEF0WW8& JJC7/(EG.TYVK[H<0#O7-)?_E)\!LHW5F+D>2P6C
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MY2H]N$P?6UW!+.-8I@U]!Y..ONUZ9S=ZK7D%MVXN ;^5S+WZC;JAPHKI;OJ
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M<;4L!0/@D;!:&W&X=7%X>WX4DH@"M  Q%-NCF:B(Y54@/(JD'8^&N82]0%:
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M8F?YA'#=0LH2RR.5H/9!$&7S(L=E4RJ'E/P^>LM6>"973E%;_;B>?8-&VJW
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M":;L*7RF&$LY3DWLZLVD0(1WP-$?36)M3A$?]#SS;^0>%F[F5!1$HIR*\N9
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M^<&P%P3P'YL%?L\U05?Q^7 XLL8>AS-]]J.I6[;3(D_8C@1ZQY8.DBW=3R)
MQY;ND2TMFE"FYUK<=\*>;=B#GNWQ4<\;FV9OX "S&MOAF#$?V=+ L5K$E@Y*
MB;]>^6M<1;Y.]=LH:+@"#@<7-+R/V/\R3^K8SN9L9]DE/3+'SLBUG-Z8CX*>
M;8=^SPLMHV<X0XL[(SL<V,ZS'^U=95BVR.G<D>D]QO8[,KT;F2YI!Q9W/>S'
M9@<!J BVZ?7&8VO<&X>.,62F;P*OQ<A1B\CTKGZAN^3BW"%@M,^4O+NH<*?Z
MWQ=Q?WB])(-=[MN.[YB]8.@Z/7OL#WLNLX<]S_4M-F)&Z'!.'HGQKE3_=D2%
M.X)_;-'=$?R#$/Q2N-0!.0M,NF?R@=NS!R-0NBTVZ(5C>&*8[LAV';+UQW>.
MECX(P3\!+\ O27PNZI-L$03J3(R'"9N<)K'?L:T=LZWE&YF&9X7<-$:]P,46
M\+9C]1@'(V0(^LF(#YEO&V"$6+;NWEU1Z?P%K27F>PXV=,1\+\2\J(-P%H"N
MX9D]RQ[9Z%$8]L;80'(T]ID3#@WFN/:S'PU'M\=WOMC3(J_"7JD:NPTY/(5[
M2O<:<JASIH[Y;)XO>G:<J_H.L+=O)V?^WV[@  >QK)[/!V'/]D*WYPY]NV<-
M39L-F3D>!F.\5MBB4.<3OU)X8PGO5H4=.E*]/:E>-4EUR"TC8*[9&S+.>[9I
M@-9OV2[\T_='+ANSD>D\^]&Y<X2P?5D)>W=M\#;YJ,UT>EFK<#&!N[N <T?(
M=/K56H=S9^7MCGN_75*T_& P"ET?U"MG@%6T/.#>ALM[/C!RS[&<8!0,GOUH
MC71K,-CMS9P[$<Q^7$CLN&7'+1\X/-=QRYURRP5=US7&S/#'P]YH-!SUX*QX
MSPT=T'JYXW#3=YC+T2P=Z4/'. !N>8.>K(I:8W/<ZQGL0[VYGPO^)Y4#_['6
M,K?>CK*=;0C>%"FUFL?NU9.4B_X5,;97D*T?.#5)+ZLT"^2WZHV_J8HR-5+/
M$RW#9L-5?9.J3QOU@8$_ ]DY0S3R$WV.Z6/1@<)/97N89B.$)-1^V((A&^%H
MY!K#<&R&0YM; ]!>/9^QT':LH>5;3'86&#4Z"]0XL]/@S MM>Q<NG&?OY:+?
M</&_F['NX7ZR[EMW)?CPQG=.OQP[)]^/KT[/@$T?_VV$8R.P@0L/;&N$32'M
MWM@PO-YX9-G#H1>.#"_ [LSK@HQ #E-JM0ZHM0UVW*KO1(<=#X@=5Z?'?X/B
MQ *' W:$ Y#,KF'WF&>;P :]T+$PI(7^*,/MKW,>2_30ESIXM8B9E/I>AR:W
M0)/O'W[]V[>< 0O,L#=D)NO9 \/I,7,\ZC'7'%G^T T,)T0FLNZ29QN92(<5
M=\$*X^3R[\!QC! D2"]P1T[/#K'R;NB$/<,<AB- CY'M 5:81G]=%;R2>8"&
M@FV5J"'DX_<]NJ[W<(DU)RP'K2Z_>NI=D ; 'IAC>@&:=FS@#["NZ:#G.LSO
M#4/#=ZQQ,&"NW>8N2.HL46A=UQ&I7H*$D8A;H[(O-DE:[MVG-OWX79+&X[XY
M'-^F29)K](?#>VF29%CFIL/NQMAM94;+ZCHX);*^8?DUR2M[VIRG(K]FS\_=
M'O<A)%%_XMCU4O@5T*=0N1+PM\4F1TL-G^Z<==DV>&SM73](+_FN<K:NU7T^
MRD:G @5!/'T(WT6H%__)6?H$G.I?WLU.OO\5_7GV_O+DRV_&Z9M?037^*3KY
MXT^8\ZWSX<WIY/3+9')RYE\N.M7AG>^GLW]/3KZ@&OW;X/3-5_/DY_??_OKR
MZ>O)V5?[Q'QK?OCY[;?3[S^MZN-C.*8Y'OA>CUM#O+K*K)XW,@=8B7K$\)Q]
MC$ :NC5HT^W5>^3;^Y>1"O1G=2FG;6!?;PI^"C.?7?+I!3\A\=DQKYTQK^5B
M8?;8MGW&G)YC<+-GNZ'7\T(V[(7^(/0]%@P#SW[VHZV[=V_/<^^IJD]4Z03J
ML[N+>2UA7JAMG5TF'<_:&<]:+NG#^<!AMLM[U@@3=D,S[#%G:/0\QGW##L/1
M$#W?MCZR[ES@L%.X[HUG.9W"U2:>A?Z*CFOMBFN=+A=!&88,BZ"PWF $ZI;M
MLE&/V9[3,XT1LYAK^H8[0JXUMG95$Z'E7&LO-:UAIVFUB&N]2XK.M[4[IK7L
MVQHY(SA#+^@-3;Q$;8[]WAAPN<='WI@[IF?9MOGL1T<W=]:]M>5,:R]5K5&G
M:K6):447G::U.Z:U[-/BAF4-1\-A;S1D8<]FKM]CEFGV+-.Q/3X<#OR1BTS+
M<N^<X]YI6O=TZ7/"4\["G*>=OM42UG6,I]'QKYWSKV7_EF'":88#IS<"9M6S
M;</NN1YS>P/3 L0>N=8@'(-<-W7+N',OVWW6N@1%6RWG9+7KZW-)37=1QYYH
M(="'YG8=@]L5@UM1#]AQ00\SQ\#;/+S_XEEAS[68T^.N/>8#RV0>U@.V77TT
MW%74\3%N93]1W0U)3.-9#I2"%]QR'K,XUZ+9/$TNZ$Z<QJ;3Y!)S>%\^+>WN
MZ.$+45S#[<[H8-Y7YW*LCJ5C?CMC?LLN-<?CH,3A;9W!>( ]LEG/XZ'1&P]M
MP[&'O@/_B^EB VNY7L6+)Z'7M9ZY 2\KQ-U=O "<Y4_+O?:07&PCM>VW&)#1
M!]C"F;S]YL.KQS/\5\?&=I:$L:+"H34,@Y$U"GN#T0#XF..&P-$LKV<&W+!'
M@>LP'@(?&ZRLK[HY(^L\;/=#Q1^!<:$N=L&F!<=K4UV%M:YFT#Y9\FN$0<?T
M=\?TEZNM#9@'"NM@W+,- YB^/>0]-@3.[XQ#TQJ9CF<-3:JV9EJ[ZJC7OFIK
M+2[<TZ9E7%\5"/^-?"&*"T;8L>*7FRH'J25(5F3CW=IYDD7X]<N43QG>7I=7
M:B6?JGTE,6I0?<(\P!_0[-=^LNIF\,,6(::[T;5\;P';VG\G:77'])SWO)2S
MKSV*I+UDTTMVE3W[9V-+LRCNU>&WN/4-2C>M>KC!*[@(8L+FV!G[H34T@+/8
M@6NY3F#XMF^:(\\9!Z']MST:/GO @E%+MV )Z..^=L^U#3X77L;_4P!BO;U
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MHZ^=+2"P=LG0VS?C0<1R/KT"VP)]Y(#%WA6AV0E/SY%BYC4J$ 7^),+-\(5
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MI<GB9'D@H80:2R.I@>K;A7'ZVA^3:"KSN>B\<8/H,5%9O"(G$HX@$RE&E2J
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M ZOL@42]<Q>[ >VF^;.<SL8.D/,DHW;T+U,^9=B!539^%-A;_TKRTT'U"?.
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M2LBFBRGU21>\*>6S@&?1191NP3!!;CJK>6 ,<-1F -Q)IG$XPT#[S.<YGWG
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M.]9T:D!IJCFZU".=1:M*+L19TO$J]+]/=4D>OXT=W.=)%B$,7Q*[@^FJQNV
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M@(2AP8"*L@FV(0&0<CP!J?60YIZ \@^+R\0H2N<!0T/!3K9B:>Y-(U,6OY9
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MV[N8Y%MX7PC F,X=<,S7I*S46%Z%Q<NYQY1,#D/C35G804'WS_!&*R9S%M,
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MYO.^.DG\@30;*E4N-_XU1D"H>96>7KVF+EIKT:P$09(V/U#SUZOX%YDNM&:
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MI[RT;90SGY0EL7;2$& H0-J S8CKJ,W(J1")8E4W2+1Z+N^BAZK#)&C:EYB
M(5)4ZNRD3/9K1M;EX,1_Y#UYP5]6L(O#29A ,30#_H7H )M3_$ZJM2H9H$R?
M62]"B#]=8,V.@%/;-L%%!/?[4H :$$1$526F8I GRD2H!/6WGY40TFO\Z%+%
MCM09-I@RJ(9*R,@<'G%^V#^0?/!E S%BDT+LP)P4EJJ*L905J,B=4M->:NRN
MUH&L]L:+5Y6\N>4*\'<@"(_>;@3=XB8?)[58\7Z*(JMT!.$2)@X?T()@1<AB
M6(R2=4$@E+EO6VVT]IU?7@@"+MR4+T*:11<T_0W"4?6BK?76D]@24>MXH7(
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M09$)GP41YBMC8$'H#\I9O=_\91E8GU<!"_YQFER(KL^&+.*P,P"B+U+4NRF
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MW#MKM>6_O<B?P;]A.@J/_@]02P,$%     @ :(!H5;SR)S&O$0  D[P  !$
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MT46O!^:UL3]KS[ (@UVO(P3,<4#L5: M6/0O]/OM&1H;9.-;+*/;?4?B/2/
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M&04&H7F?^:V(^N1ONR%*0XVT:1Y?I5FX !9&:R FE>P,K1%C]?A,&/#6& H
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M6P;<$G$(8%)Q-VK=[[E]<JA=4:A#3;3KXE@XB&UPDN'6B)P@I>KS1=3@BM'
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MAQWNK!HM]$#GM6RVK$^\2/#6'1@6F?3%$=-4O2)82@,1$X,<,!86%#-:[-;
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M(+@WF@O%RP,)Y K01QF*W8=M][)X3=1Y'%][">KBD@LB$0Y0<PQ%!O"F#J+
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M&7FZMOKWG#-(RC*5M#>)5FG, 2VIZ_"./TZN+4&ZGX)[*>JP)ODET*M3QCK
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M(D3%A09DNM2^<1+(XP-%CKU1/$K,T8I.V8IW3D_9]/1GXF@U$'WO9%BW_>J
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MUR17DK4P D"UCFWTL(P_^?X Z-%#QLGB^%O.X%X6,R^Q+98QNV(!SM;SX//
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MY#K P?GK_-=#?MW^ZR[Z-P<+A(7C/WS0Z@ >EGWLS,V,#!+ /AX&1AX&6B,
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M?BC\\UJ)3T3S92W"U.*V=49 S]</-TQ.'7EB['QX3T*6+*<*J>@V$!#GMS0
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M/7C>^UF8BM3VKIZ,7CT0H/;TS[XDC-0@/LDDK-4/O_E<.*KP)CW'MBTL\&1
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MH;ND%A3!U"<2QZ-CIUX6CG_Z\E-UVM?,XS[OC^.?/6B3UARS\I^X[EA;MBG
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M9M[K^6<L2T-5P.DDMV:TO$>P5Z6QV.%I9K1ZW'Z_9MF_\;F#BD'[=.8!#C6
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MB4\:M>%B&F]:0!T9^_8 R[$+6K9[MPOJ*K36^T.&X\U_7#IBD\*["\*T[X(
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M7L,Z0(>,FE%O^IM\4>S$*^3A:R=%J\KCI=QR+KSEX,P?T5>,!(B?L,OF.@'
MO< P(@>A^DOABNOMJ<Z::QP4T0LU3PZ8^[>?8:E+.B<>\XQF_1BFR<*O[&."
MJ<PGYAC.KE/W[]\HB#RH3G>7065![@XLPT("GSTN3>8:FP16[GB]!-M36..4
M>:'L%_ZA,XD,&:^'@P^?]_OZ5OCIIG0CEB@M'^AAQH8P&L>RSY?$!@[=[QQK
M1E^YUE3G1T/VZ1D,V(KB6N<. S#A(?% 7FL2V125]8*C?$ZCQK:?E_+UMLHN
MZ/.)71!9I82 V 6E YK]B0I@U<3.%T&U#.%'B?E4)ET<K+&KN+06?[1*\TZY
MHNZAV^^4UUE7=F(0WHE->YTR$%',L=[2=0QQT$J/0NL$VB5F-0<JM>LF>'[]
M-_54>XV2CQHO0+'L@AP<3Y92A!=A L1TR=0WW5G[A\"[H*Q^$">OPH>LV??U
MM(5(1P2"@D5*4+OP[:Z3TERC6IF7&,N3LE%I@V]V01ZQI^R@FYW%&/ZL=' .
MLAM=#H[&NL Y3Z9-CEQN<[G=-.B44-=L>P,";H\1GU49";/M/@>"2/^FL21\
M)[(;A;RFP)&N]Z$'G;H7?3)'9\W2H1Z<MQUN>%^]?$#2&V3"\A\S[>_-M#V/
M<C >-M'R%(^:F"V9B+K[]=J"XDK&X-?L"V4A\L>7/]Q17U93R<<Y$!X1^0J0
MG\9XRSK +H[(_E?Z5Q0"G^J^-Y#YF$3EN0(IUU8. OX=(@(043O*(P%"/-$B
M11*WDAK?DL(>G&0;=>]H[DW9#K!@HE&B^J*5>R+=F3IR0'H@8QR#2'1Z>-%O
M+U"LM#JA8?'X>(*V0W!3;)L E_> 8,C>F6KVZR5!4?7.<F.AGGU5D&8!2RSG
M@N&-<YO/$4(7Z5=F<P\Y"*G>RM\4JYRL94N/H"&MX+0(^41?DL;"@GP0V3C3
M^<N;51<9Z:</> 17 _"'M^9NGQM/WCA!O5NX*E;Z\DC8Z/$;U^?G+[YAO<L@
MFL:UA *VRBTF$LM\.%I%=%(ZS(2W>*;Y@3MA_O%!?[&)'LBM&]D %<R3P%=H
M 7#QGNS9?6CP+#9CD<5?_JLC8?&K%V4H=6YA./)J/Q9GCHWVNL,98]KI^EQA
M3#B6S2W[4^S.E9GKR!93%3S'9$>(*MO\IQSOC"9^U8";&:JNE"$UZ* 7J]D.
M39P+'MXR!NBU:!CK(<<UJNA2IZ@'OU=B-O3S""NU;"IY[9$TV3!7QS=WS-I9
M/N[;^LBE[HN[(),;.MD?P MS*U+ =C3B*AZF5G;7\CL9>6=<J;_:L]:U4DI\
M7B+IP-Z^H6JVT(;Y/!:-+H4#I-=)FONE0XO%RFCQ_4I6S6DQ[G"#K^%'&E(7
M.NVFQ.(_N9\QTOXMNXK&"AV*W$=,;,*"E2],#1182#,1[YJYSKU+/!'?(?DH
M@ADU:H.]9QO,VT;_!&H.O"(D< A@'IAAB1:T2S5)\^FXU8GK<E+:)_DG0B"#
MXQW[S\LD3(LH*!PQKET'/IU!5NE"<@)?.>OA!O'VU:_X4NIZPE65R<61AXD_
M C GV)NF$Q0D=<3B=%X-0!__;P0QT.ZT0Y_QV@5QFLWF9M=S!5F=GJ;^55#K
M9T/(K4Y%KQ0>7<M8HZ8[Y-)W^AB83\*=3Y"P .^T0JE":6^AKQ#[QTF.1?9O
M^Y8S+KU@3NJ$S,$[_7Z/8OU[TNW@S^&XJP;$$^*$1$),(SRD*F9'_I/K:Y>$
M#FIUB:5E$54X;1KJ^]1:UOP5V!(0*&[@%9<VXQ;]+M1AF5ZG5?5G2+GENN2'
M1NC9/.Y2'YP18OJ6^Y[OMM&ZP-7>DQ[O+DY^(TSZMK=7\CO-I5P0BU<2+#DM
M;!XF%O= CO[[)5IE-4SC>@Z3;A&W[D,A"Q4^M<6Y'PZ7EY9'UL156+_T!\7I
M@T!Q:G2=^_6X=HQP7E0&]<P1[X.?44+$$M-R/.?4QY1A[6^U'8X0[:TJ&4^A
M@>L._@P"T3-K9%:#>EF#YVY"WEG'BK?L*@(U.WKHJ5=?^Y.KTK&7;F/' _@%
MOLH$39KD"VJMYB^P54-RV2.IYTN.[H*"4(99]Z#-"69M2L8U,F\#!C@(Q?%K
M 1J=T!=G3.>- -FD*0MXB>4XT[WPDJL%]4W._M,NB(X-']XP"Q,FVK]B],RW
MT$]-J4NYHX)SK*(=3Y985<(01>::2BMLP1$(%K&,U?SV^^'(5^?=MTWLY\BL
MF"GZPLK[_:K"7XMV00GNBSPV,93-6^ EX#_R=,&M]XJRV6OES!OX3T\(9(D+
M'.[E95M;U\R QOA\Z(6-1Z&$;K%=LN".0FB+/?)X1,.[LOYTB:)D>!_<SFGZ
MEEA!/8#!=]>[5ULCY/MO,L@BZ[K@*?XX$2]QC!OJ@K4.8*70N& A91P.&,>J
M\C!/V$Q(FL.14O16N[]30/P?35/K81($.<R_"UIVP"NJG._*QN+ZTA>3/\=C
M9ZHBW6>/>IL_9C=^VS&BS&%]!%"A%\8.(@_-[X*X$2R9Q/C&K2YGQ;,EMRO.
M5K!M>*@\4LZG?7SUVRM6-9'P(<R'-:(HSTJL>"/ZT=R$9^5=5%&-D4R\S@.!
M" DR*I]OOH0F$M6A]@RJQ$\QS''<*QH OX?A3" #.@!T&82& 6M@-N>K<9OP
MYN6]<:TM?S"RY#S8)/; 334%!8]ZR;?DD/LRE2;TYOH,HG3\U*BE]7XJ8S"P
M9]7HYHJJT"9,2!_C3E#(V[X-I?N@$5;9_K.+8%EAW=29CH^R32&OZLA=Z2\E
M]9@CHPNB'^9+,'.)%F?U_GV+1W.<P7AH&-81_LC3FA>7]?QD9IYU2K@,5\WU
MJ"\?*.QR'9)^_FTBPFL$-4J(L@O)UCM5/6U8"*96_N1HVFLK362[T]>\C76[
MEE/AOE'-ZB/P(OB;UN6H\;5!CCI;3=R[6'D>7A>*_OC^ZAX[:--*-.>],A[&
M2F6[.*/K=W9!;TR790!V-= XCLQW<YM>1$KT;&P?Q.0_:;SHR3'=G&+"I0(V
M$76? R'%33?TIJ2W.>7@.^O/=T%J<N3E+]]+Y\#+K62V,>JETXW0S6W4KP9/
M#]<WP-;\X>'O'2S^/05L/P0F :#[<SIP_XKI#X60;_U_ZZ>V@OJAO+$?F/L/
M:<-9>TBI_4=PAS[;NQ@90Q2_E,+64P8)KP47@S6K;-TGA539/D46/*B*0LT]
MYTBD7949V=(9W :LRZ["3Z5>Y5\NG'&2E,W5TKK\85&3002G+I2_3DMEA %2
MF%I)])7:BJ[E65BW(B)6W_9LG%-_4#JJ(ZN6:I^VJ9\;&?G:\\IU!,<?&P/^
M.'1M;%3S_5C*"DY?^_KU7/2Q]/-K$AS^>1EQ.O/T( VX*:I>%36>I#BV8IDS
M3(QIBO!((\."OSG0VG\N4A?)K-4Z$!OR&*=X4M^3I+6\UX3R7MRDKC0/ EXF
MT_0VN:/Q2*W#:J&G^KC7-RWQJ&G$>Y26I*3(EP*1LK+ O8S[OF,V8?NTV(\U
MY.6,@T"@@R NJ0#TN-L^X/RS*(O;ICGR>V3%OW**97 M=(VW<S]&M7L1I[^G
MQ,7Z/V-Q9C';ISJ ?]H_$[IGO?XCAOJO#W5HB!V_W4/P/U0:$X+%75[S]T*5
M]*_83KZ3M?2*N-1[>[IWHY)QXDCYR\$ZHS%;[DA2BTN3RU8$H802HWR(=,.;
M[0R*0UU2/D'C5;>'TBVI/K0H3=RK2-FS^Z>5SX+/<X7.RK>BB:);S6L/+5ZL
MI2\4>\]I7GJVNI%EJ*H$+K>=W4_0FZ+DE=9M6X1OA%*BJ"=;9@P:.AX-&D4K
MRWMKS<U\034*(:P )F>*A^Z"#N2/4>4O0<ZEOX-2>9<FURCL6$"Y$_6L=T'X
M*MA$=.W)75"7!#%F%_2P=VT7))#ZGX_^6S_J5[%LCT<N3AR&!Z/9:+7KU5$'
M1](C=XHC02IMJ2Q8HGB%_Q%B/,D9<:Y[2F_)K: Y]R+#AVW/RLI;)#8V:+3$
MEGXM0-X##5'URIMN@^DJ%UJH\A7A_<T^946E;XK,Z:*R+&689\_+UKH\-?37
M[[WF(%F/[,VY];=P^VLC@1# 9#BE[#N!BJ"*X1.#[OMB.(FV\-K$*Z<6%F^^
MZYY^&M$F<'X_06UYV)S6QKT:C&FQ& WPFRA47Y$3D'BGN@A[Q_)1BC/BLX()
M*%J=G-?)]6OZYF6:&R"Z^$[3-U3@T!7)-TL/R9N7AVK@7F?:9UW22LIWOJR2
M&:DS4O%6^.;I+5OFT9%YVDV>GP!\,_4S8$TN8QU0@=8".&NTTHCE/'<@K=+)
M1O=#1Z;CW92\M#\/M+6XQ_=57_ST3[[JW;\R3#*QH+Y'E1 R)V6F/[VV0A?-
MEW>\3U[H6;DIU 4Z.9KF_MCL,O@3%F<*)Q[[!7WPUFTDM_=)4GN_]$3+.Q03
M8@AQL,;RT(I$;CMTXKQ,NSU*.F_N$>*"W^0GGZVK/:O9M3T>?*.SLY,WI<2^
M*7$[V'Z-T\GS^.W"OU+EXQ-ZNJW61XNZ2GT5-H6,KKZ4*G1-L_IB("IX(F!5
M#^1,%B5J34*BT:SWUYB];?6?&_7)*9S58+^3 PL;J3IQ;+IXG 9> BWJ7X9,
M8 8ZZO-NF'FX\3JS'>O9#-776;SA+WQ%!,5=)S4@"<,98 =L=2E12-Z\ST76
MQ&[S*+A9#^<^UDUNO*#=+Z%4DLW;71 #/-7Y7YO+_S:,I5F)+GIXSWBID,+L
M0>>$TY$ZKE[[.CB#1LQ846RFCJF0A%I55/TA)"O9/N3!1J$LG'9Q]8!NE, !
MM^H7M\MAU<,=OPP8%"+]J+T #.ON@L)@;R9'G.%VPA*XPJJD@Y@LS=;E>:4.
MB#0W6(S\_O06R71%3_28O8B_^GC0:/)UE *GZ0*8S 5LO:^M0]HBG)TJX#1F
M']?OT5>9;IG*^LS_R*IKC]^7=U9@.OL0QL=CSS=UOFMFM%[/ZS.NFJ/?OCBY
MOBX4,T]+.'L"K_C8^$GT0U8&.5(7Z1#"*X+PA/("(3%%;T<RR;[)OLU#^Z$J
M\MDLKQ#X68$:=<%H%$LGL=&ZEZAGOD;FFT+3&QP7U:L*-2N]<N_;QZSC:AN@
M9K;6_.0KM!O"_Z2"M-/2PXW4 UH3:T/6NE@.;XT599FIL--B@^?+%:M1W?:&
M3QZCMQU3YUY^:)I&FI%O$CDFQP;76]@=K4]UKMW74Y>]?*DR>D*]A?B*3X>#
MDBGFN010O7MH3B0KT78*'IS9A3!/6Q@B)$FKZGU5)YR5J118$_61?:Q5>*:.
MZI.#^8(>.DUE,'9 ;O&'-NR"V)[S*+B_<OFEC>?UP"HGM^$ V&2I/9R(GH(O
MF^.U"(@X$[Q6D$>$TK&P3V0VO[SW 9W;7:OJ*6]O0"HL\@-F>KZ7A_]S2&"(
MACAP"U9P$_;&^T+#3O\C,9:RT2^#R;P&I+M^38+1YOZSM9\H+U'CP521_MD*
M+#$)4Y\Z.'UZP<=(ZM-4]&*W8#/?EJ'(CN$=54X<^J$<7-@[<%BGZ\SP"OSJ
M.[_'%N9UW7H2/B=RQ/KG(<MN@/%@\+8FH1M.?"<_.,X;!SMH_BE)C/ V29\3
M5<PG-K?VF@'F3@91GB+H23*.-]OK4X1+OHQ>/>#NK?7\@:<B]=O-]J(.I7NE
MPOZF:3V5-"\G8 ><D'2XE:S8] 6"CTFB#6_X:%\?5SCO54]C:WK'+@UMOEK9
M75#L!>,]YH_=H(5__H323/0L'K-HI\L3/OXX(Y=Z1)0.:4Q,))FCZA61AZ@?
MJ6=Z3%1HC?MKCKTI&73AYEYQ9PN"2;\LXN (\+\ DCWX19/EJMHV-9SAA+9(
MH.*OV9_O1,<-EB/P'(3'O=<K<.C@,J4EIVL2B^SG.P?J5*P]:?8KG*,KKJ\[
M0[.3!KP!KUU0/#.NE8*$_QH!V:1_T+'\%'<0-AA#\,9U!)I,2!_M*AQ>D6=@
M,)^+TTPPN;9>X5MT;;V4<</YTW<7W<_J:C'ENZ#Q=!3N$E3(VP$@/H]J',;?
M":\U6_/C6::K7CPVTYJU=OKR868ZLD'52Z_IJ1V8-G"_+%*Z;X-IC<49XI0S
M:+6P94B9OVWC^,K:_4,1W5W(C(E_[J]97_Y,K""QE,!W\00D)5#U.+)KYU.-
MHG1PF8#461/AFX6YYPGEIS!\KLO[R?M4S1KE560^@9 9/\LY?XL>;!^/"EV>
MPEUH3#G0G>6;[[JOO^WT&SIY]I(S<6VE?B-?E,IEW5_8;;X>*OG+NY;_I@ 0
MT"9.;@$$5&E,'8:=>)3@61IJ7?8M[DYU;<<)Q3;.9ZO<OYS7U%1KT;(@VQ!)
MI/WD*Y27<OG/Y+",SEX^]YG/.P_=AWC8R$9'S1[;EE48FK ,:N4RI&W-20U\
M%<@@FI.>LR_\Q&SPQ,B%9L4X\X4$^>2H:?1=)C,+)X'YO -G:'I^EI@,L%AQ
M<3+[7$M51W,A;0M5^<MM99F)-8B51J[E(%P\T3>G0P <=DE\-OK4.+<L2%O@
M_.,FS&*4[O4_<XQ?K5,>Z@@4IUU(.]54D2*.8S(GVC9_B9<D!'LZ#65XB 5#
M*Q_O@AZH7_%YK>.^[8MW&!\+5Z4G-OB!FZN.$$+SU/LD'M;%^KAI\9FS$NS%
MH!;4A_GQQ$:<= ,,6B,Y)!]YGP5FW?WYHE0#\MM^4?J,QS93MU#LK'X+6>#U
M.0UD*+(+@/[S[4O<Z,M$JTG.VM $?LW2!H704B_&LQ6I!_.[$^7P6LUK@YA6
M+(TTL^HI7$I%&FB8VS?BKNLKU3#96?E=D']QWJ6#A_\UY@4R\Z<1VP"$VWH&
M)TX]T(;W)00D'#B#.3#JY&,W !NR>'_V;)H!GF5JSY]\K2M_=6PP@\H $(F0
M-\.+2)7:Q):= F]4<=YS/]FS2Q^":J^A2NL-[I]Y3KN^"R)<HX0B1:A].V\-
MF!>D#L8*+%?VN5VX8..V*#^>:$/I80;D0;!_$;WL"AS/$9SX<J@K=QJS:!-2
M^GB81_Y R+S.HM34]/EW;P[<BV-BJ]L:@6J6X B)]-%H)U=;>^? <ZXKDV;I
MP5H:QI=!M)V,)5?^41+]:S.@)E1;B#>:BI6$;>0I[@36K!$P1!I7TF4$",\3
M>/ND1H0+:VY%U>!;2P.!@E@%H7X?D-ITKN@[!DA=E40/\MRO*;,HAY<FLQ!V
MHI9IR)?!#U$7AT9>2QX52KJI9AK[F3=$J$[9-/$?27L_SP/<EL>)$@X17Y(T
M7$SZ1H5Q*7GE]XI&<D?K"'VL&,_3YT#C]\J\9)99D(,(.J*>*TY\'!N"@+J<
MOM8\L:(J<5J&]W153,HESZ\SSX5*PI-H^O\RN?;_<' 9F7;>0JB[3H\-6L#/
MWR-5/S(QGL,P,^3?OPP6>D!2(L-Z3O*[Q.PC*CZ "Z3H<0\F%9V2O>B0"9BW
MS/VX.>I#"-U>K7(_@'RO^\)![SM5H8["7$]T,N=]-)^+@/:7E41S^#,(Y@B%
M0<,*??[8'$@ -EXX5EJ-\*'DNI5&2 1)AY*9L#JEC$CSDS10I\1%.P'9<Q*,
M*9L[^20CA#7<'UM2$8FPJC3QX[B48.DZPC\1\OXJB<\</ 4/D/>Z,F:EJ_Q%
MN>32S+27@L.-NSHJ;7*&:EK?NS?L7</J0#@5TUC+[Q:1(E(&-NPU7B&K"$9\
M*JN]V'8OJ.N52%[*J8"8P_HPV"[( 1)4 2T%M[HQ>9\=J#J+S=%RDPR+ZFQ0
M=7K%M_3FB&<K28ZT,(%F&2#*-_H@8[,LM1RRG3R[ABSJ>1L:.9VY.'WI05?;
M GS^?_I,T AQ_W*B3K:HGLZ.#?YH+X.@8S!%>C"4D-V[,:)( PXMZ^%OB0L_
M];A9XI2C5FJTA@?MZ\Z'FYCA9#(!D/)M;V$%LA!NO2G<7\_E@4>6]A2?1RS[
M+V#L?O%64DLR[?KYWS)U,1A@C\)4I=P@U,%/-C4/^TL%JL]7GKNI&7W'?9%.
M:UVU[!N]WR% BA\_S=A+V2+22<B&\H<7@05""1Y=]60U6/!1\(K&GY)8P0ED
M TH8DIUL^\ .#_%7EO=R5T6T/W.M;;N[O7HSU.[A+J@NOP&Q9X"H$M4GM1Z<
MR1_C\?;H&(D>W18/1J8[#G90"!++X<>_0CYCV?;\N*YVDD-:34N/U$C%HXXW
M+FTL+BE.87'),ZO8\8#1X[HAK&1U'#D64M5A(RNSX]\*?8E,,=08@"9XHG#J
M*.B[.A[A,SB$H9=CWZPF-" *]?*V(Q:GYN?L!1V"L6]4&[>UE7>]>BMB&[1^
M\<5<Q2XH#WOI6/HRY"%98*\, B><O#BT%4DVSN=2D'#@Y+XXVGKW@_N&W"J,
M&3O^;&\1W-IQ0]X\^KTGC=!*9EX]!U2KCQR5(1[#^*9'%$DL6.B]#LUN=K)W
M=7-P @T+GM(4C9:9Y[Q.LY'_)U\9LP$;XC1N+%)HV 1'#<L[$^0B4,V;+:ER
M<$:A $Z\B0V%;8AX RR-SA-+UO LO0R6SB"SXN"A=F/9Q L-!.F7PX4;.8<5
M-K>OWK-2S#$&@4#C-$,)_QJV/)&%21T@!@ZW8=^4UCZ<V_)B+<COL.9E,YE/
M/:BX3O BHG*NG>D7IL?=_U8KKYPL57+Z^G6[)QT78ZA\F(D."H/P@;V0+" V
M;%:%G#0Q:0B53F6I8WZG+W1MS/'2%-[*>!BY#WP"K&8P9_E?#,/P[JPUCM V
MRR;V;*A #>\]MEC\H!#V'O2M;A.$- [^.9I,+0-G$0URZM]GB:+U5CU@ZH^?
M[_O0B#]@=3(66!YRN*WH36GQ0]LM3UR!;JL^)PVPO+\MFTA_5QQD5!HW.LO[
M6B3IHH[@(R%!X=2@>BXI3IH) /.QX\_'Z%4EV\6&8OSO1RCE*IQ>\-V8Z]AZ
M]#"O>!?DS8^'\*'J#R#YG3^NI1/1+?RG:^_$Z]!_U5D(F,FW79RM'4M_64<>
M[H>-^R>ZOV_5(Z)=3[QX:OGR0(;$/)/D"OI>P,9K3Q*507S*<?Q3172-Q)DD
MTIOAKYIO=_S'/F -<P!9;'\.(8ID1TT_?(X1))KPR=\I5G<7$>T_8II2<Z,*
M#4'5TPA\9,E'& C0S"KI,<7!QIR(NZ!:/61T%W .!+R9J Q^N(A&6:V3Q7Z3
M'>SO96J5(GK* XK[F1@E(H$/NLQ+/QQ[P],(#2CD3.'&:85N5.<<M*TFG4I9
M0:W4/,_<!;7F=\UGWOFA9J$.#VF(8?(NFW8U;;38G_6%LNZ5W2B#]+I7J?]@
M;LERXS*8Z\<M+(1#$.(XS$,[K2\(N0F*U-2,1;=^R+Z:N:@\F??@18G4_WHO
M]/^IH7H&P+<)A)H;,[*-F_^,_B\I1_M% C4^RU]@5_[HAS^LL=T__109O=<_
M7NX+QX3GLP+/^%PK[;?CZ WC"SO8.?@+X]\O9H<Z )]C(=.EB%$*Y/2<[9A3
M_K_VKCT:RG6-#\HMEQ)RB7%+M1$B(69TVD/"2812+H6*<2O%V,9\+I7<LBG=
M7,8UUS$8C%LS)B'7BC0Q8M!NRG5(YLN,F3/V.6N??=99=<[Y^_3'[Z]W?6M]
M:WW/][S/\WO?Y_?;^?)"AGS77N-:FZUPUER/SI?'9!-^-+@']%:AG5IU\^GQ
M]M?WC1\-;]9BT'JA#U;P@]\Q+/D#)%G^2Z]X6&,)K+A)W4VUJ.O-^')<71ZV
MK9HSN]#,Z><O@VAKNPEE#IR9[22Y=BUSH"(TGIP]*^N[;I$(+.*+#S1"L<8G
M_C$J$[V17)()&0RNN!#]HI4X[7&A5O:*UQP[DQNH\Z&'K<\5#:-_H)*1.)N3
MOK"_WIAD)QZ9CM7*Z)!)ZW _PH,(&#^ XNJ^P^7^P#<X[D=PIA?VJS)7D0>A
MYO+[TGP:E8'#/.2'472KWJZ)&*[RK#=4YSCY28U/KI'%95-^+Q/F]3#S3R''
MKS I(A8A4G>6ICO--U65:=<7%+\V@T?C/D!*630C: 'VV+H#OBUD)&PZASI'
M6V*UJQK7N]V]1(RM.N=)H#4:]BO,WTO-EE@QM:Q@95$\]P_!U$$;!^I59"-^
M!><YLF\^6-/LM$^H.#986FU96KC RO_5?QB2]NOO"W<==#!.E#7<&Q'A79XD
M;*O%A*C,,M-6)\$U<AUY_O 47H[V?+%X[.SZ?7O)].2C5K<UXUD1F\=M*AYM
MZ'N)L:]2F"_:J%Y;T ?"E9^1U.,O$(P=!K)\IQ\D0I<'_4R[+O7ZHGN0RPWE
M>P3_*9C/@X!J+YXV#,+D4=1.9^LCR$<I[GY-?HQ>XE_F>J(52RBLY%&RP3RN
MZ$G3;06?R N9<1H:]RZ>#X4(9=C.>ST!:A8IF]=SX!>PHJB?"XK''WKCT6XY
M5*<[N@S+K@=S(M6J=XM$BK^G0OD#WV )AGF0S4C0:4*6?!XJTVH82<Q5N*<2
M+I!"_TN'7TC@8:TN)KZCAYM\;5U\J$-);N$A(.AQ:L; %AFV):6RICG3#_9,
M!J[$$5LOPHA[<@?(.UOMZ+WSB]H)O[Q"Z*0HWY)2503HEVL/3KML-4W:L\$.
M;&3)I_PT>!&@')M8/=NB*K64/.8!2JT%,0?RNK5O:&YO&K;273(T\]T9?\_1
MUB\D[5*>],>2I]R]0^B@2;;#&1LR8=BX!7S60 VOK:P>2"C4V:N61/:Z#M3R
M(/,M2R*K1X=3<N6'B9_"8.P<#5"Q<I]TF7U<*G=0SB<VPT9N;2_[$$#QQRAQ
M'&^.O^@T]$!M/Q4JEQL:?/6KPM)R7_P5*1ZDU46(W84[8A6=CO #;3K7])])
M*EG:'!Y>Z4<>O^NW+S X8TI[;;^,CM._SVS+J;P;<Y4?=+"H:9<XYO$^/:Y<
MX'4&2I!T>3T/3J^ BL(VM5ML0Q9VC/:=/N&3']0DD* 06:OA*'W6\-SZT& ,
M+ .?#*?G09FNECOH?L6LZUS5L5$DR5@]KY%D;^=7D'N84420>KZ_',-2RP=G
M5_G%3EP5VGJ]>+[J:I;8#HJG?+9LE*3)!:-WZES%*@/%!$<7P;TBFQW0Y),%
MF_L!+]*29U-$V4Q$Q(ZU5$Z_97_?LN*N7&NS"Q<L,FP'')S_N-Z."Q$$H2Y@
MYK2>4?N:2G;S37SEV5VXXE:?#_>L385>2KW/A6S*%K"".@ 4#< O$6;!'33A
M:I*)>I-D0?. [83'3E.+N^>6));:I0W8-FE3<NQMGJ?9RMP^]XBY3*:R+3/G
MX>VHU\*S)UM=NFC!8]*&/,@[!='"V@)&]IV9:Y+_D]S##_P=.I-84)<QA]3O
M@$(H2T;MJX\]0I[^JE!_R<?^R7#,KM8!,STQ+>RJXFV,E<Y"0&"-[E*M>45A
M7&7E?@75O*3M0E^["T@;>EY8@&*\@!$*8)%@3$36"WKRB#WQS8F]>GG/NW+A
MC+$[%*Y@>*[)G2672W_N,86)\9S(*K3%,((;6SDSJK+,W&?,;M(KAC*UU+CU
MBX 4F5[)@^SDJB)V[NXHPY]!#.IY]NAD8&IC:K$=LQ]F]@@MAHCPM\PHM-_Y
MT@/\T@5$.FLN*F\IFXN02%O\^G8:CIWT3,@#*&B.46C9>AEST8.P6YG;6X8(
M(]Z^W*3Y G[\*=FPM-A79.8+EK,C:M*.%G]Y,NW6";MW/G6$=)NI8+>OKN4
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MW"K\:QTTKWY7"[9:%D_BMB+:C'E+GNMP%K)$8(YS2,*00Z1]50CE*<QB08-
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MA\OW=<,0I.QO!_IQ<'6R?Z*7<4_E^U4].%$_\_@ENY1]]_2/!:'%O%@^KW/
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MR>)$X!RJ!N<F#K'R3*4=3+NB@D[6\XEY[+&S.%AQB.%(9RP]6#HZ93'$I/?
MY5P;XYV]&&JS=PQC^L[ M,E;'_=90*3 ,9$P"!(&49)*F".4PQ3KX@LX2+(
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MTTHO(#=R6WOC#9G/=5Z<[KFZ>[">24P2&<01)")+=(DU"G.!)0RIR*(H#I%
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MT*/?6_!!"V#X,A:L)(;SP",7R? EY+ALAO<3KHQC;[Q'$!.(<0YRFE" <BP
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M2WP^F@?5':IK3X<1MXQ^%>L?/]2\[JOXR)Z-(/-HS?[PK1/48W+=-B[#3MG
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MJ%]L;G._9D@CF<1* 9+F&B"(<\ 39G8HW#8C(QE42>JCTBZ,-S4E5N&+5C7
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M>&"MZXT]D%KIS5FGOO%_ZGB*J+?$>QJJ_U/"U ;?Z2C^5NE"%.N9%E(F&6-
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M$YV&'-5<]"'AT&KTNM<_[>1#L2Z^5TO6&U:J>_. M\L'5BQF&&&,(!9 BY@
MI(VY2!(D 8R%2A"2&,=.40M=@TQMA[G%:0_65?1[#=,C'>4LG=U*)!1) RL-
M;WZ\TE0N$7!%ULK91X^6Q'))N-V<EHO7CEP,M*E']NX/M1)%:3WO!\7(FM^H
MSZM"J!D6.M,IB0'1 @.4"0TH41G(18HY3C-CF$@O)]4XN*>FC#[MN-67M22V
MV.(Z,J)&:BO33?2K+;'(FA*+S6]5]&@%>[D2H)XOCJ/S;7JOP] 'G->7[]P4
MZ'RW^^(<U>9L&8@J"B90E+/?G+UTR4U/U'^.@IK]IB)8N<R>P_=PI^XG=\\4
MCCG5D( \2R5 6$! !&& 9X(*GBJ<*F,(+]=L[N PW7^VUY*S&6$X17-OQ^A;
MP.$4=P[>S?Z,#&WL'I1BZ,^"AU>R/QLCN1^=6?%S,IZ6N].;>'#+>&[#TUCW
M_(-G+NEGM]\7#\8&_*3OC8XLM>V6^=?E4GY:?56KGT;55>>6'.9ISB4#&14)
M0$0*P(QR H(QI#,,!9)>!\,.8T[-7JXAV_B4%K3]NX5MV(X:X+V.C%TFP,UV
M#4SKP!HP"*/>MJ('1X'L/)<11[71/"@XM*]\;NUE&QT7T-SHN7NU8(OUW</C
M:OFSLN4V0>*S6,.$(L8 @C %*$\RP!(M $E1#&.,<9PPW\/GGE@F>AQMI8E4
MN2X>JF3"=84_*K8"1*R5P+'>WE43YF2Y#<?_"]?KW:F_50L2[4BRS7T881Z\
M;,?!YV,T(W.@>?$U2J\B](+UVN_98YJY5TE_8 ]?]ZS^]9C?%Z5@\_]4;/7>
M_$LY(X@+'"L&*$Z068W,DD12*$">T%B8%S-CJ5-R2L<84S.,-P6':YR1!1I5
M2/T+,A_2V;U,!")IX%6@!S^]*C*?8>"JBLR'SQR](O,9H4Y59#YW:;]=L<UL
M8^6/ST9I%%+)U\_?2ILF<B*]=E-B.,FU2J"&@&74-L3-".#"[)E5ED"2485A
MDOD%R_B#F%[H3)5"KHW&+2,[Q3N57-D&O6>%YQYSX[9_'I;O@?6, 5_GZ[?P
M[9G-*RM!5"Q^.YG@/TC]Z/XD!MIO]P PZO:[/T&'N_$KGG1E^LB'8J'NS%_+
M&4LAEYJD9L.-S=:;)0F@C"<@P23)H-9<$J\BU<=#3,W@V6E.:S%&%<B^:2);
M(AV/IZ^B9^B39#]F^J>#' D?.@=D.\#+)'X<"7@VV^/XRI[QP,7"[HFJO=/G
M5;$0Q2.;MX'(,X$2*!*A >>06B\;!81S8^7@)%>,PS1+,P\'F].@$_6D;2+D
MGQ:&W4A7(FPKTR_YO(FN\BQZUCT!;MKA>CY'"@^N<;9^EPW4-JXD8$:J$R6A
M0H,[QQHW)MA%[*-@8*>;IM8K_*/-FK6]3#\^50'U2',2IX* .,<Y0"G3@&HM
M (YA$@L;>(SA[+'J>FJTZ&KM:)>,A=_G,SV48L#=10LR8NN(J^_%8M$<WM48
MJBC *OJOG$P'\,,70Z8<QX0HP&)BEJXDIX!A'0.:*1['N4[SC#4OQKN%_-._
M%JT,([T4RB8V_IE>!T>#>XH3/+0=/UI#]PT'YJ\5"Q,("NT[<2\=%NJ-^\\1
M&-IW.L;KI'X.0$_/\W*Q\9'>+<3R0;W[P\)5,XQHAI6M*!W'&""D"*!YG@ 9
M$YARG>=:8)=0T8LC>7E<1@L<K;/F50VQ1V'%\\0Z>H=#T#6T$W@'8U2#C%XU
M, -6CKY(12A7[MEQQO787A+WR#%[\88>P5'_Z_G1@"[*)F\80T81ACDP*H$"
ME-,$,*09D%Q P@46*'7*H#SQ[*EY7%MT'@$Q!V1U?^%74C#P-]T"NYP^?9$&
MCW"?_G2,%,5S\:7PB\8Y+6]GD,W!+>/%SIS&NA<2<^:2*VM%O'[>_/5OA=%O
M*_'CN2K)5P4I,XE%3A(,)";2V"<9,_OKE #->$PY58FBRN<HR&W8J2FKG1)[
M&[!5U9^/M__H%1_NR+ZCAS@XIT.[BJ^@LW\Y"2=V0A>4Z![T94I*.!%QMJB$
MV]V]#ZS.E6_]ZVI9EK,\U5HQPD&*$@8010)PR#- )8)<9N;O!'L6K[DPY/2B
M;VPS$HLYFE<EBXMMR>*ZM[KW$54WY9SI.,$L T1"!5"6I8!";-;.)*$9P82E
MW!:!<W2Y!Z%[<T XM(>\@A283^=3OV"OY? '?QT%M&^B;A+['/XY,1/N_*][
MN+&/ )V$/W$*Z'9?CSUL5=+YBWHT[],/ZV=[^V3+#+5]W*JC@_M?RV:WDJ!8
M9XH8C0V54>"<"D")@$!HPHE >1P+[KS#]1EY:B9E70A[M05O%'ET^_3]J5S;
M2MFIQX;0:P(<=LU#T3JXG\PRNH,[JH&WW46B&OI-9,#WV7=[T>RQ*Q^*[I'V
M[#ZT!]K7]V&L<]?O]<#Q? )]Y-SS&/1Z0#_3W3;RV52V%(5JFH@H&D-""0$2
MIQB@1!+ ; URCB7$>8QY3KU"24\/,S7E;E%&>S#[=6LY0ZJ;"7D]50,K[!XL
M>5N+W20$LA'/##*J9=@MZ*$]>.'JGDWD?K)B;I_S?KGZRNI^!U]MV<DZ7'W;
M3K,R.;\M5HK-BW\I:<&\5GJY4O?L#[/?I"@E3 ,,$P&0%F:_270.8B9I!I,D
MU2ENPU+==$807'X;TRVZ@3>GT=,&;C0W/[N6W@D[9VX*:;QY&"D+T."/M@+<
M1!L!@0$+K(CFWW;:_=8SMA6LZ7['*]DB(US !G@AN0[5*2\(IG%;ZH6D\:CW
M7M"']^Q)O)=@7=4B_Z2_E;5O8*85S&7&)$!"&%V<6^LMB1,@,JT4-#MVA%)W
MWU_G6--R_&TSZ^H,@)4%"Y8:/)7]W*S=/*LT(\0L<$!"97B6,@%,( @XRD@"
MTU3'V*O_X?5,CUFU](#K\/2Z+4_!2!MXV3DJ<?&E?3D-V-KK&K"ALPLIH9HX
M=XXU;N-F%[&/FC4[W=0W2W,I_NMH)U]OX:NSN)E(8YFKF ,A8PB0T@H0SCC@
M+,LS'N=)K(1?TN:%$:>F1RK >QY563NBZO!UWV3.2WR[*96@+ ZL6&H"3WCR
M6@]>!3ADZJ<C-\$R02^--W)BJ*/XQWFBKC?V;@;?6IY56+2-K5ZI'VI1%C]5
M'?K8QBLJ9>P6BH B/ 6(IQA0GMK.\!G4<9HSQ)%G9WBWD:>F>W9W>6TGL!WH
MU=;<NV6\XR0X;KZ'H'9@A73[Z<U==+M>KPK^M+8;)=O!ZC.K3A7"]YWQ9BA<
M WG'<<?N)N]'QXG6\IX/Z%^SJZI=6=B#+J,7EZOUC"O!$QNWR&,< Z1A"CB$
M&D :YYKD4C.<^Q;M.AQD:DIH4Y5J"S2JD?I7[3HBM%O+A*)I:(^=/T.]ZG:=
MH^"JPEU'#QV]<M<YL4Z5[CI[K?]'_L%P/O_\8[E0399GFL$8,\@!H4J:K4Z>
M XZPL4)$BE7*B<JUTU;GU,.G]E%7^*(*X*5TRLO$7?Z(KZ%C\.-"9R:\/MIS
M(O?Z6(\>-MI'>DZ,W8_S[#7]-@J?S=J^J$JTB!^+Y7SY_;DQ26,E$\Y8 F*L
M*4 9MT5FL@3PE!+"XMPLSL@O3/?<4#[OYTC%\8R9,U=K8ZMNH/I9_F=9=3/T
M0S U\)?<0HRV& >PYR\1$<A\/SO,J-;Z)6$/C?.+U_=T4XH?2C[-U2=].C6[
M<ETT*=9-);OG*O3@7OVQ?FT$^J^9B*$0E!MED><8(!9S8\,GF>U+(8T9GV.S
M^/OICNM!34_+M#+9\ARUWZX6(/IL+FO+07HJG@"3Y^@4'75"AO::GBJ8L:U
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M=O2J01DPK^L"#^%R.$Z.,G;V1I>H)_(V.B_O&Q:AU6IEU4[S]!T;V)[OBIQ
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MM'.;#,%#=V%XR1=BX'4@0)YSS<Z.45I&%3_1VA#4U=GAJ.)%=4EDJ=I)GIY
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MTV&,_K+_;\^A?[*Y56-?5+E>%;9>N/W%[4+N_\/.E3,5BQ1B;)81CC1 S#9
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M6CP&'[V$BS\QIPJ\]'A*STYD6UOS35U"]Y:7ZQ43ZUF:ITA1+ !#V)A]/-:
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M7 =LBG ]IM$;)@2C\50SA7 /]U/E4A6SVP>UD-8]\7[.OL\T29(L51E(.14
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M%>OB9V6XS!*&-,E%"BA''" ;[LDX9" 6*148*Z6EV<@MUVSNIJ?<A_;251L
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MCM1<BA%U?4S/2*F?K)A;=?I^N?K*YLJ6-M@ZDYJP VN=E^M*]<YRF:<")C'
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M0HB".('$XPPR'L6<IM+S8ZMJ4XX@G8)W2]V 0RS-B-410B,3K-9RE_%8*KH
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M@$H>P%2(6+G7$8<TQ CZ/(@2E@@A46!"R9=%S(U;#^O)E&I:E8[N +.; -U
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M+?- PEC&A".>>BD:5K!K+(WGYJ[5@TY6Y4;TY\U:[OZA!8'ZD,\5N0*_:\M
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M4$.G@+HZL=Q$=%8K"6AT?3-&^R,8$4'XQ 068DBTKEG_#DEC9[I&@-:A"ND
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MP3CJ[B(8N9#!_:QO>/UMOH@K7&X>O;R<?SY=7S\VKC07D#XC'49@0VT"'8,
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M^'WQX=-R<?KQTXOI%[Q%!-)9YYDP(&RA.-@D"Y$Y#MGF&AGS+'9;'CS:-G@
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M@22.WK)K&*CL#\FC]=8!+-_203)?8_Z Z=-\,5M\_';1B$=$CTI <3K7@O(
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M*X<6A(\\SJ^'>.#\ .BS[^$C?J['R)M9F2^^;M[&'=ZYL/O#&O0>#*2T4??
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MJS%=K7"R1:CZ/%C'=8AG)45W,0,:E$SH('R4C;'S($%]0>@0C?_\+K:1^#O
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M/Q3_M=;@M61D"90(F RR#AM6/GGP*AHH0EA'>8&0H?7DNG/Q]D0+HL_)#(\
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MU]\:P=Z];K>[P8*?I)G6]0-6#W3(-?24]81X:N;"9Q(&5 \'(Y$P&6)1@4Y
ML8S 'HYX7G;=+U<9]VHEL8Q S@E7,^ZF2];=-2Y/N:3+Q6[652.OAU>S-[9"
M@0:Z4EIJ_ <3+&<";+(33\]HG5 ;E$8+M=HMCT.*[P+K)9\B)VTR78&30",!
M*RU['OD.B4!WET85S79($RR7HB4)M$4BE']$AGI[D",OG.YNP0%(#!H4D@N&
M'HL+C4"HS!BU5Q3)%6YHT,-IFV 46F[(0Z+/#TE3P:^8QBI0Q26EC'G&#(O
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M.3,P+GAS9%!+ 0(4 Q0    ( &B :%6 2YZ#:"4  "!O 0 5
M  "  :ZY @!L9VYD+3(P,C(P.3,P7V-A;"YX;6Q02P$"% ,4    " !H@&A5
M5VJ/M7!=  !#_P, %0              @ %)WP( ;&=N9"TR,#(R,#DS,%]D
M968N>&UL4$L! A0#%     @ :(!H53^.W(.#D@  *LH  !0
M ( ![#P# &QG;F0M,C R,C Y,S!?9S$N:G!G4$L! A0#%     @ :(!H51E
MG.; ]@  W2P* !4              ( !H<\# &QG;F0M,C R,C Y,S!?;&%B
M+GAM;%!+ 0(4 Q0    ( &B :%6*"FAJ[9   $AY!@ 5              "
M 93&! !L9VYD+3(P,C(P.3,P7W!R92YX;6Q02P$"% ,4    " !H@&A5>7Q:
M=[X(  "V.@  &               @ &T5P4 ;&=N9%\Y,S R,F5X:&EB:70S
M,3$N:'1M4$L! A0#%     @ :(!H56+#1!*7"   ASL  !@
M ( !J& % &QG;F1?.3,P,C)E>&AI8FET,S$R+FAT;5!+ 0(4 Q0    ( &B
M:%53UM1PHP8  )<K   8              "  75I!0!L9VYD7SDS,#(R97AH
A:6)I=#,R,2YH=&U02P4&      L "P#J @  3G %

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
